Clustering O 0 7.202860388133558e-07
of O 0 1.1740873162580101e-07
missense O 0 1.1146825045216247e-06
mutations O 0 7.144028146832682e-10
in O 0 1.276785066561814e-10
the O 0 1.0024559315979786e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 3.1249232534946714e-08
in O 0 1.2662597359547334e-10
a O 0 2.155915203305714e-11
sporadic B-Disease 0 1.321433416023865e-07
T I-Disease 0 2.1760743038612418e-06
- I-Disease 0 1.1553980812095688e-06
cell I-Disease 0 2.1806592940265546e-06
leukaemia I-Disease 1 0.6749507784843445
. O 0 2.4049202806963876e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0009827614994719625
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.7944716892981383e-12
is O 0 3.1577113834965406e-14
a O 0 7.698956218642888e-14
recessive B-Disease 0 1.1889035589351948e-10
multi I-Disease 0 0.00020565219165291637
- I-Disease 1 0.9917171597480774
system I-Disease 0 5.461452929012012e-06
disorder I-Disease 0 1.0170733730774373e-06
caused O 0 1.394004009447336e-11
by O 0 1.9940342779745102e-13
mutations O 0 9.371487960652125e-13
in O 0 4.4771567638164644e-13
the O 0 2.5261945313381773e-11
ATM O 0 1.0950994777658707e-07
gene O 0 3.1006298223390516e-11
at O 0 1.6591048535019581e-09
11q22 O 0 5.4960996749287006e-06
- O 0 4.622030246537179e-06
q23 O 0 4.478699338505976e-05
( O 0 2.3849439090284363e-10
ref O 0 1.8124794110008224e-08
. O 0 3.745684665212856e-11
3 O 0 1.4605476550411112e-10
) O 0 2.551262673344823e-11
. O 0 2.6209088233031252e-09

The O 0 9.65614859183006e-08
risk O 0 1.4929786118500488e-07
of O 0 9.214787155542581e-08
cancer B-Disease 0 0.008821559138596058
, O 0 6.160722487713599e-10
especially O 0 3.14213615126846e-08
lymphoid B-Disease 1 0.9704712629318237
neoplasias I-Disease 1 0.9999970197677612
, O 0 9.561461622453749e-10
is O 0 3.0575122295095625e-11
substantially O 0 7.236437227220449e-09
elevated O 0 7.326484419145629e-10
in O 0 1.573609020866229e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.641795155497675e-07
and O 0 3.8819170100623523e-11
has O 0 1.7852260197469966e-13
long O 0 5.663090439297913e-13
been O 0 5.743511135442025e-13
associated O 0 1.79054188143013e-10
with O 0 3.540795989742662e-10
chromosomal O 1 1.0
instability O 1 1.0
. O 0 9.201926332025323e-06

By O 0 2.800439324879278e-10
analysing O 0 5.989033269315769e-08
tumour B-Disease 1 1.0
DNA O 0 2.5109088142016844e-07
from O 0 4.370021011723679e-11
patients O 0 4.5654023096697305e-12
with O 0 2.6046612105644004e-14
sporadic B-Disease 0 5.290353932707603e-09
T I-Disease 0 4.433159617178717e-08
- I-Disease 0 8.003137708101349e-08
cell I-Disease 0 2.8130313012297847e-07
prolymphocytic I-Disease 0 0.050193749368190765
leukaemia I-Disease 1 0.9999996423721313
( O 0 3.2537503247276334e-10
T B-Disease 0 1.3986235671836766e-06
- I-Disease 0 1.7673205547907855e-06
PLL I-Disease 0 0.00016331950610037893
) O 0 1.45665198653111e-11
, O 0 1.892738786882231e-12
a O 0 9.430305494828595e-12
rare O 0 1.0681519557742547e-10
clonal B-Disease 0 1.8245012611828315e-08
malignancy I-Disease 0 1.8869108941999002e-07
with O 0 6.330507298923926e-12
similarities O 0 4.1833501940313766e-11
to O 0 2.3292201500879628e-11
a O 0 1.217441147893794e-10
mature B-Disease 0 5.080752885078255e-07
T I-Disease 0 2.0601922301466402e-07
- I-Disease 0 1.1143600175955726e-07
cell I-Disease 0 2.4049134594861243e-07
leukaemia I-Disease 0 0.02921385131776333
seen O 0 9.831464531373513e-10
in O 0 1.5238012240903487e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999548196792603
T I-Disease 1 0.9999995231628418
, O 0 3.641732748693727e-11
we O 0 4.547464401566392e-12
demonstrate O 0 7.92163279417224e-11
a O 0 1.7055236346472102e-12
high O 0 7.831146321690685e-12
frequency O 0 2.608041838048081e-10
of O 0 4.939998965447501e-10
ATM O 0 1.3725663166042068e-06
mutations O 0 3.40834227507969e-09
in O 0 2.21756408791407e-08
T B-Disease 0 4.351600000518374e-05
- I-Disease 0 0.00013953437155578285
PLL I-Disease 0 0.0022043094504624605
. O 0 9.93620119515981e-07

In O 0 3.2339531053082737e-09
marked O 0 3.012030846960556e-09
contrast O 0 3.04696462505305e-10
to O 0 3.4954400485176507e-11
the O 0 1.4258082214890777e-10
ATM O 0 7.873334197938675e-07
mutation O 0 5.694832799774119e-11
pattern O 0 4.016129095951726e-10
in O 0 5.002082636984539e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 9.243679433001972e-11
the O 0 1.770386094668286e-11
most O 0 4.4770114807253514e-13
frequent O 0 9.002850548389674e-13
nucleotide O 0 7.595250817171717e-11
changes O 0 5.410155396595728e-12
in O 0 1.0094302997643023e-11
this O 0 1.4311539453526478e-10
leukaemia B-Disease 0 1.5468936908291653e-05
were O 0 3.678697169107181e-08
missense O 0 4.1899752432073e-06
mutations O 0 1.3658139152994409e-07
. O 0 1.5365137073786173e-07

These O 0 4.108235529542981e-09
clustered O 0 7.932360546192285e-09
in O 0 1.3588656241902974e-11
the O 0 2.6257947205454713e-11
region O 0 1.416472911186517e-10
corresponding O 0 7.345695718363743e-10
to O 0 2.4282284516452535e-10
the O 0 1.1006519029521655e-09
kinase O 0 6.692760234905393e-10
domain O 0 1.3288353750695592e-09
, O 0 3.085160599214376e-12
which O 0 2.288597371509493e-13
is O 0 5.06723894615202e-13
highly O 0 1.7501083915405502e-10
conserved O 0 3.5390404495849737e-10
in O 0 6.311404177061775e-10
ATM O 0 0.0023208593484014273
- O 0 9.056503813553718e-08
related O 0 1.0563274344121965e-07
proteins O 0 2.5494981126250593e-10
in O 0 2.3216012445814727e-10
mouse O 0 1.307412955675602e-09
, O 0 2.1128373356438246e-11
yeast O 0 3.0864306665989716e-09
and O 0 3.1980920689456127e-10
Drosophila O 0 4.276652276757886e-08
. O 0 2.4762130124145187e-08

The O 0 4.948884857469693e-09
resulting O 0 8.569847054218371e-09
amino O 0 1.0313653042715032e-08
- O 0 2.1518788972940683e-09
acid O 0 5.673334024791643e-11
substitutions O 0 1.7368334548351072e-10
are O 0 8.217320053571786e-13
predicted O 0 5.691152063502791e-11
to O 0 6.7499560628403454e-12
interfere O 0 4.639338246903435e-09
with O 0 5.951662079839437e-11
ATP O 0 5.9892668105021585e-06
binding O 0 2.2226105400591223e-09
or O 0 4.344575255110783e-10
substrate O 0 9.280965329594437e-09
recognition O 0 5.042357997808722e-08
. O 0 1.714546300490838e-07

Two O 0 3.0132432105034468e-09
of O 0 2.36305219836197e-09
seventeen O 0 1.0488686363885336e-08
mutated O 0 1.4791402824787525e-10
T B-Disease 0 3.158002526149062e-09
- I-Disease 0 4.79310280354639e-09
PLL I-Disease 0 3.30472857967834e-07
samples O 0 4.567244360487166e-10
had O 0 8.140044194249185e-12
a O 0 1.1825179507471417e-12
previously O 0 4.173085835224022e-11
reported O 0 3.5207609050402766e-10
A B-Disease 1 1.0
- I-Disease 1 0.9993884563446045
T I-Disease 1 0.9999996423721313
allele O 0 7.367204943875549e-07
. O 0 1.2660973425226985e-07

In O 0 3.0073024959165195e-08
contrast O 0 6.464850432763569e-09
, O 0 6.457006457294412e-11
no O 0 4.577367304636759e-11
mutations O 0 1.3016769606633005e-10
were O 0 2.0983884074787795e-10
detected O 0 3.9476102942082036e-10
in O 0 8.563771219938232e-12
the O 0 2.6884547366101685e-10
p53 O 0 4.3031583851771416e-10
gene O 0 2.705640052280689e-11
, O 0 3.30711131223127e-12
suggesting O 0 9.154756813734011e-11
that O 0 5.21723235360344e-13
this O 0 3.639607712435655e-11
tumour B-Disease 1 1.0
suppressor O 0 1.563457203701546e-07
is O 0 3.716831530053977e-12
not O 0 7.801433977994154e-12
frequently O 0 1.503545760117575e-10
altered O 0 1.1925037624038737e-09
in O 0 4.642759787731876e-11
this O 0 4.965864386363705e-10
leukaemia B-Disease 0 0.0006285713170655072
. O 0 3.441602132170374e-07

Occasional O 0 7.958958576637087e-07
missense O 0 1.696665094641503e-06
mutations O 0 9.494204311621957e-10
in O 0 3.3211478012162843e-10
ATM O 0 1.4037057553650811e-05
were O 0 6.234725624665316e-09
also O 0 2.124494590666215e-12
found O 0 1.3981491745612695e-12
in O 0 4.01680685241379e-12
tumour B-Disease 1 0.9999998807907104
DNA O 0 8.807247553477282e-08
from O 0 6.254908396785552e-11
patients O 0 1.8879516006098385e-11
with O 0 2.784408445997977e-13
B B-Disease 0 3.583567442788649e-09
- I-Disease 0 2.1100363678527856e-09
cell I-Disease 0 9.718323212837277e-08
non I-Disease 1 0.6032224297523499
- I-Disease 1 0.9999567270278931
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 0.00013052400026936084
( O 0 8.649015531547732e-12
B B-Disease 0 6.554384412993386e-08
- I-Disease 0 6.395665774761028e-09
NHL I-Disease 0 3.685545095777343e-07
) O 0 3.456268474547053e-13
and O 0 6.943077297989764e-13
a O 0 8.519034436216266e-12
B B-Disease 0 7.24218107706065e-09
- I-Disease 0 4.5278505389489965e-09
NHL I-Disease 0 2.4209799676100374e-07
cell O 0 1.5091447380655154e-07
line O 0 2.4007466237208064e-08
. O 0 7.244156829955273e-09

The O 0 7.213575514697368e-09
evidence O 0 7.916037603195036e-09
of O 0 1.9668977557785183e-09
a O 0 3.580366211841657e-11
significant O 0 5.678725892299674e-11
proportion O 0 2.911929308790917e-10
of O 0 2.4662133446540224e-10
loss O 0 2.633923301686991e-09
- O 0 3.699776707222213e-09
of O 0 2.1728896015815735e-08
- O 0 6.219297521425915e-09
function O 0 1.5626441807192748e-10
mutations O 0 3.0407145985150708e-12
and O 0 2.7927950208526953e-14
a O 0 4.2009666280590566e-14
complete O 0 1.0633079833288761e-10
absence O 0 1.9211074953062734e-09
of O 0 1.1263893984203577e-10
the O 0 1.9703088119382706e-11
normal O 0 1.9871043699382085e-10
copy O 0 2.371078333673893e-10
of O 0 1.8101767307321381e-10
ATM O 0 6.581957734397292e-08
in O 0 1.4272060096243155e-11
the O 0 2.503654228380725e-11
majority O 0 5.691756961578864e-12
of O 0 4.534408126755096e-10
mutated O 0 2.232732398965709e-08
tumours B-Disease 1 0.9999997615814209
establishes O 0 6.981279443429855e-10
somatic O 0 1.5069780090470886e-08
inactivation O 0 1.9468222589580364e-08
of O 0 5.227522859030387e-09
this O 0 9.46108261179468e-11
gene O 0 1.5494333246990344e-11
in O 0 1.0537295862256268e-11
the O 0 5.436535596703429e-11
pathogenesis O 0 2.098954965390476e-08
of O 0 2.3533950344045707e-09
sporadic B-Disease 0 3.3748367513908306e-06
T I-Disease 0 7.932028893264942e-06
- I-Disease 0 6.547995326400269e-06
PLL I-Disease 0 3.9959257264854386e-05
and O 0 8.207851065478167e-11
suggests O 0 5.401146890848807e-11
that O 0 3.504247673286054e-13
ATM O 0 3.2909902358824183e-08
acts O 0 4.45636721968512e-10
as O 0 1.1801538635225484e-09
a O 0 3.6831480088039825e-08
tumour B-Disease 1 1.0
suppressor O 0 2.878812847484369e-05
. O 0 1.4120281832674664e-07

As O 0 1.3659716691094559e-09
constitutional O 0 3.2730351762211285e-09
DNA O 0 1.4372726298006455e-07
was O 0 1.1607187433426702e-09
not O 0 2.8238273264841185e-12
available O 0 4.4414132094328096e-11
, O 0 3.21551297957981e-13
a O 0 1.4060310207786308e-11
putative O 0 2.7048702833099014e-08
hereditary O 1 0.6327784061431885
predisposition O 0 5.692294962500455e-06
to O 0 0.0010803660843521357
T B-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.9999996423721313
will O 0 2.285346634156582e-10
require O 0 1.068239594004261e-10
further O 0 3.651623448064356e-11
investigation O 0 5.086147614186132e-10
. O 0 1.9637405590522405e-10
. O 0 3.890392896721551e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 3.755272928174236e-06
kinase O 0 6.191377188713432e-09
is O 0 2.4815887192386477e-12
involved O 0 3.2098358693222195e-11
in O 0 5.1894265794272254e-12
the O 0 2.390375744565354e-11
modulation O 0 1.4583270147028315e-09
of O 0 4.460312952314638e-10
the O 0 6.342744662823918e-10
Ca2 O 0 1.3790852015915789e-08
+ O 0 9.660031885516673e-09
homeostasis O 0 4.207731407745996e-08
in O 0 1.6865631113915924e-09
skeletal O 0 3.135086444672197e-05
muscle O 0 3.469752698492812e-07
cells O 0 1.3042575801591738e-06
. O 0 5.256480903881311e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.7768571675987914e-05
DM B-Disease 1 1.0
) O 0 6.447324341074534e-10
, O 0 7.300865641213239e-12
the O 0 1.8607424628891422e-11
most O 0 2.0308107626099137e-11
prevalent O 0 9.244368266081437e-05
muscular B-Disease 1 0.9969987869262695
disorder I-Disease 0 0.008462943136692047
in O 0 1.1289236212519427e-09
adults O 0 2.838461554688365e-08
, O 0 1.957243395134256e-12
is O 0 8.409076386606262e-13
caused O 0 1.6842414962692231e-10
by O 0 1.1823747536610085e-10
( O 0 1.81105394569947e-10
CTG O 0 2.7218149512009404e-07
) O 0 3.5376530264225048e-12
n O 0 2.0936580594210774e-11
- O 0 7.020586889616709e-11
repeat O 0 1.4823168734134917e-11
expansion O 0 1.3865737551188584e-11
in O 0 1.0311031000374837e-13
a O 0 4.8200531836250365e-14
gene O 0 2.772245323925948e-14
encoding O 0 2.365290949213339e-11
a O 0 1.8785129007881096e-10
protein O 0 9.70945879252838e-10
kinase O 0 1.228151691456958e-09
( O 0 6.732039370405118e-10
DM B-Disease 1 1.0
protein O 0 1.5270265052436116e-08
kinase O 0 2.090012052313739e-10
; O 0 1.1087629078754269e-11
DMPK O 0 0.019145319238305092
) O 0 2.5494467648101704e-12
and O 0 8.99313663902529e-13
involves O 0 4.418270610484498e-11
changes O 0 4.336277864558369e-11
in O 0 1.4300133299727236e-10
cytoarchitecture O 0 5.736507660003554e-07
and O 0 4.968197409027653e-09
ion O 0 7.085747711244039e-06
homeostasis O 0 8.010831516003236e-05
. O 0 1.8050108110401197e-06

To O 0 2.5851832674561592e-08
obtain O 0 2.87191568304479e-07
clues O 0 3.654186571111495e-07
to O 0 1.1564355723026054e-10
the O 0 1.6225853993745432e-10
normal O 0 1.115499426163069e-08
biological O 0 1.371333491206883e-09
role O 0 4.979360812562561e-10
of O 0 7.468685225830995e-08
DMPK O 1 0.9999998807907104
in O 0 2.5993635688337235e-08
cellular O 0 8.860389755227516e-08
ion O 0 4.694807032024073e-08
homeostasis O 0 2.4264187459266395e-07
, O 0 9.909343484659772e-11
we O 0 5.6092384209671664e-11
have O 0 1.3430798357152995e-12
compared O 0 2.6895714821950634e-11
the O 0 2.2036971206174094e-11
resting O 0 9.063568562339697e-09
[ O 0 4.769507566670939e-10
Ca2 O 0 4.1032524600304043e-10
+ O 0 1.5607437564568727e-10
] O 0 5.478331122077407e-10
i O 0 1.80568004992665e-10
, O 0 2.290488220098308e-13
the O 0 6.251049482729198e-13
amplitude O 0 1.306486863139611e-11
and O 0 1.3965874897520214e-12
shape O 0 5.404540148745696e-10
of O 0 6.7329928299386665e-09
depolarization O 0 6.673428742942633e-08
- O 0 7.41398480386124e-08
induced O 0 1.3997103032181712e-08
Ca2 O 0 1.9018611130405816e-09
+ O 0 5.87865867096582e-10
transients O 0 3.4539167081959476e-09
, O 0 2.4563744050951075e-13
and O 0 8.236459610047944e-14
the O 0 2.793596950989574e-12
content O 0 1.480689876265373e-10
of O 0 1.7228143911474092e-10
ATP O 0 6.321735668279871e-08
- O 0 5.24007104374391e-09
driven O 0 5.2262563166038944e-09
ion O 0 3.2229185986665243e-09
pumps O 0 1.499456780962305e-09
in O 0 2.583420977142481e-10
cultured O 0 3.3031451494025532e-06
skeletal O 0 8.386445551877841e-05
muscle O 0 9.547999724190959e-09
cells O 0 1.4568349193666563e-08
of O 0 1.0281854478932928e-08
wild O 0 4.681273702011879e-10
- O 0 5.531839430972241e-10
type O 0 8.467346962470756e-11
and O 0 1.0215635282140312e-10
DMPK O 0 0.03009687177836895
[ O 0 2.6222053861602035e-08
- O 0 2.551762889879683e-08
/ O 0 2.6736177716202292e-08
- O 0 1.6454253071174207e-08
] O 0 5.805432135019828e-09
knockout O 0 6.33213744549721e-07
mice O 0 4.6022016420010914e-08
. O 0 5.494984023357574e-09

In O 0 5.5926879127810025e-08
vitro O 0 1.3668667975252902e-07
- O 0 1.0040709952363613e-07
differentiated O 0 1.0181529574992965e-07
DMPK O 0 0.0011777819599956274
[ O 0 1.736613164382561e-08
- O 0 2.063475434965767e-08
/ O 0 2.3379563174330542e-08
- O 0 3.002213233571638e-08
] O 0 3.1539935108071404e-09
myotubes O 0 3.790363933831031e-08
exhibit O 0 4.0576877795295285e-12
a O 0 2.3270920780638082e-12
higher O 0 7.848858785131085e-10
resting O 0 1.917012504293325e-08
[ O 0 1.4839789397314007e-09
Ca2 O 0 1.1408288758119056e-09
+ O 0 7.223333597927706e-10
] O 0 1.9820711738560703e-09
i O 0 5.290128890500512e-10
than O 0 5.977506250393061e-12
do O 0 1.324855589818208e-11
wild O 0 7.65466093288758e-11
- O 0 1.7270322671958382e-10
type O 0 2.514524144459074e-10
myotubes O 0 9.236833875547745e-07
because O 0 3.936758211087188e-11
of O 0 4.849997625733238e-10
an O 0 1.4695411771140088e-12
altered O 0 5.960295451634678e-11
open O 0 2.5204864237404756e-11
probability O 0 1.3202727799921377e-10
of O 0 1.9432626341409076e-10
voltage O 0 1.5358675442556091e-09
- O 0 1.9568506814948705e-09
dependent O 0 1.9230321779417636e-09
l O 0 7.667577683889704e-11
- O 0 3.860697594948448e-10
type O 0 3.113477878291526e-11
Ca2 O 0 3.437169715514443e-10
+ O 0 4.6441792078688593e-10
and O 0 1.402549743012571e-10
Na O 0 3.432089457078291e-08
+ O 0 2.970417245506951e-09
channels O 0 1.309455122111558e-08
. O 0 6.860775947359343e-09

The O 0 5.948947645606495e-08
mutant O 0 6.617531767005858e-08
myotubes O 0 6.204572287060728e-07
exhibit O 0 9.12978581624202e-11
smaller O 0 6.135340065854811e-12
and O 0 2.3211296166364415e-12
slower O 0 2.328982562360693e-09
Ca2 O 0 1.116412073898232e-09
+ O 0 1.9274964957460838e-10
responses O 0 5.052957618295606e-12
upon O 0 2.3233985915749322e-11
triggering O 0 2.0967430916507546e-11
by O 0 4.367368879737432e-12
acetylcholine O 0 2.823610900648532e-09
or O 0 3.1586272486450184e-10
high O 0 9.73956648664398e-09
external O 0 5.347993123905326e-07
K O 0 9.483422900302685e-07
+ O 0 2.1654099668921845e-07
. O 0 5.4843795282977226e-08

In O 0 9.667257216960934e-09
addition O 0 1.4022160099713687e-09
, O 0 2.7209847222597894e-11
we O 0 1.6159998686426924e-11
observed O 0 1.3392484170260399e-11
that O 0 1.3875061039350656e-13
these O 0 6.795721212322914e-13
Ca2 O 0 3.0469529677112916e-10
+ O 0 5.586733298201807e-10
transients O 0 1.178280251146191e-09
partially O 0 1.0584173815164633e-10
result O 0 2.621626180032699e-11
from O 0 5.182624121524704e-11
an O 0 1.7840696368148778e-12
influx O 0 6.129331070470201e-11
of O 0 2.528018072656124e-10
extracellular O 0 5.352906451427941e-10
Ca2 O 0 1.995498349893765e-10
+ O 0 6.638495309019277e-11
through O 0 4.072802511911888e-11
the O 0 2.356020066540676e-11
l O 0 7.23629142718174e-11
- O 0 2.844279256564164e-10
type O 0 1.148517808635674e-10
Ca2 O 0 5.150660786767958e-09
+ O 0 6.1636522552532824e-09
channel O 0 1.2121665449171815e-08
. O 0 6.185592926755135e-09

Neither O 0 7.516415507780039e-07
the O 0 2.0930210897773804e-09
content O 0 2.667534637623703e-09
nor O 0 6.691969201000347e-10
the O 0 2.3540525431742232e-11
activity O 0 3.499257272832068e-10
of O 0 9.875537054782058e-10
Na O 0 2.3888752309630945e-08
+ O 0 1.2664631565684203e-09
/ O 0 1.6829385662830987e-09
K O 0 1.6277473813275378e-09
+ O 0 2.892378281327268e-10
ATPase O 0 2.002751520180368e-09
and O 0 6.949788661225753e-11
sarcoplasmic O 0 1.714207940040069e-07
reticulum O 0 4.947754632667056e-07
Ca2 O 0 5.4887333789110926e-08
+ O 0 3.0389465166535956e-08
- O 0 1.346558242687479e-08
ATPase O 0 3.4980511820492666e-09
are O 0 1.6432641922539681e-12
affected O 0 2.4497796152767037e-11
by O 0 8.857740235734823e-11
DMPK O 0 0.478648841381073
absence O 0 3.3086589610320516e-06
. O 0 3.04104901260871e-07

In O 0 1.0143224926650873e-08
conclusion O 0 6.67677753085627e-08
, O 0 1.7245174732671842e-10
our O 0 1.0839703579179627e-09
data O 0 8.557167197054127e-10
suggest O 0 6.717260081501308e-11
that O 0 2.2144994171746646e-12
DMPK O 0 4.564787741401233e-05
is O 0 7.031546352120888e-12
involved O 0 2.8886018577090056e-10
in O 0 4.1753229346186416e-11
modulating O 0 1.4198874298543274e-09
the O 0 1.850962091931585e-11
initial O 0 1.1460559584675067e-10
events O 0 8.283859709301566e-12
of O 0 1.08534341236588e-10
excitation O 0 3.6021614846504235e-07
- O 0 2.0294476144044893e-07
contraction O 0 2.339141769169828e-09
coupling O 0 7.208121599600048e-11
in O 0 2.0588422633416315e-10
skeletal O 0 2.3132113255996956e-06
muscle O 0 1.0321977939042881e-08
. O 0 5.737052166665535e-09
. O 0 6.206465741342981e-08

Constitutional O 0 1.0534684406593442e-05
RB1 O 0 0.0036497856490314007
- O 0 1.1314526773276157e-06
gene O 0 6.351618675459747e-10
mutations O 0 1.126423676556243e-10
in O 0 2.0818470211625417e-11
patients O 0 8.905211013043868e-10
with O 0 1.1288966289546565e-11
isolated O 0 1.0671857175736932e-08
unilateral B-Disease 0 1.707207246681719e-07
retinoblastoma I-Disease 1 0.9997913241386414
. O 0 1.9589710063883103e-05

In O 0 6.777289396353581e-09
most O 0 1.175758657101511e-10
patients O 0 2.2359308848862725e-10
with O 0 1.8106616466589953e-12
isolated O 0 5.156595705990696e-10
unilateral B-Disease 0 1.911181213287705e-09
retinoblastoma I-Disease 0 0.15246650576591492
, O 0 1.336544347418922e-10
tumor B-Disease 0 1.2086988299131463e-08
development O 0 7.207647811924289e-09
is O 0 6.001917712827876e-13
initiated O 0 3.5740754106283745e-11
by O 0 2.205201299343429e-12
somatic O 0 8.393545303242433e-10
inactivation O 0 2.4140709431463847e-09
of O 0 1.993356590901385e-10
both O 0 9.715789284214793e-11
alleles O 0 2.901327962601119e-11
of O 0 5.966975802351726e-10
the O 0 3.716355001515126e-09
RB1 O 0 1.1487551091704518e-05
gene O 0 1.5367174199809597e-09
. O 0 1.930485993284492e-08

However O 0 4.207651116416855e-08
, O 0 5.330783731105626e-11
some O 0 1.6017755698205516e-12
of O 0 3.9961228770479806e-11
these O 0 4.365846920095784e-11
patients O 0 3.4144828631177404e-10
can O 0 1.173565272738486e-10
transmit O 0 2.4534102749385056e-07
retinoblastoma B-Disease 0 1.1495331818878185e-05
predisposition O 0 6.752930659104095e-08
to O 0 1.038059593838625e-08
their O 0 9.93490587575252e-08
offspring O 0 3.1523948109679623e-06
. O 0 3.269119304150081e-07

To O 0 2.8499935744719096e-09
determine O 0 3.7646548101122335e-09
the O 0 2.5549792836976337e-10
frequency O 0 5.576303419019268e-09
and O 0 6.527797399846769e-12
nature O 0 7.17145162698607e-11
of O 0 1.4863490993555217e-10
constitutional O 0 7.388993861212612e-09
RB1 O 0 0.0001160323663498275
- O 0 8.196360923307111e-09
gene O 0 2.0353671872919143e-11
mutations O 0 1.282671885372011e-11
in O 0 1.8846189799720525e-12
patients O 0 9.960336028180805e-11
with O 0 5.764718563616711e-12
isolated O 0 9.351147634006907e-10
unilateral B-Disease 0 1.6837155003557314e-09
retinoblastoma I-Disease 0 0.13609857857227325
, O 0 2.700819429213297e-11
we O 0 7.331425397327784e-12
analyzed O 0 9.022783908907428e-11
DNA O 0 2.5356394761644196e-09
from O 0 4.564803743334345e-11
peripheral O 0 1.9581694488124413e-08
blood O 0 1.3792843533977361e-09
and O 0 6.077159331319137e-10
from O 0 2.95092519309037e-08
tumor B-Disease 0 1.2117456208216026e-05
tissue O 0 1.1853105206682812e-05
. O 0 4.3905802726840193e-07

The O 0 2.9722646566199273e-09
analysis O 0 3.4784970459611486e-09
of O 0 5.7034185374504887e-08
tumors B-Disease 1 1.0
from O 0 6.188661139105989e-09
54 O 0 3.15985992926926e-08
( O 0 3.5493320522245186e-12
71 O 0 1.628586687729694e-08
% O 0 3.1849375914383415e-10
) O 0 4.089604360452831e-13
of O 0 3.213057944706499e-11
76 O 0 4.268256414974303e-09
informative O 0 1.0436137509728383e-09
patients O 0 3.438387768950335e-11
showed O 0 1.6111104117477737e-10
loss O 0 1.7929134565886073e-10
of O 0 1.1922922649176826e-09
constitutional O 0 1.7900950410876248e-07
heterozygosity O 1 0.9999688863754272
( O 0 7.681064016651362e-05
LOH O 1 0.9999853372573853
) O 0 7.485292385922548e-10
at O 0 4.3752987011203004e-08
intragenic O 0 3.13495206683001e-06
loci O 0 1.0848192033563464e-07
. O 0 7.437240157059932e-08

Three O 0 9.500984887722552e-09
of O 0 8.308429499948033e-09
13 O 0 4.008694176604877e-08
uninformative O 0 5.1121111027896404e-05
patients O 0 2.0387428634194293e-08
had O 0 2.710048629950279e-09
constitutional O 0 1.5867232150412747e-07
deletions O 0 5.978761237201979e-07
. O 0 2.431967232041643e-07

For O 0 4.453157398387475e-09
39 O 0 2.8466592638665134e-08
randomly O 0 3.791200686720231e-09
selected O 0 3.45629729281427e-08
tumors B-Disease 1 1.0
, O 0 1.0050588139520755e-09
SSCP O 1 0.9842360019683838
, O 0 1.2028290585774926e-09
hetero O 0 8.266384838861995e-07
- O 0 1.1282633494147376e-08
duplex O 0 8.440217413863138e-09
analysis O 0 3.6753269871958594e-10
, O 0 4.2433035709298073e-13
sequencing O 0 3.079413946061038e-10
, O 0 1.1440695396255918e-12
and O 0 4.961750194737435e-12
Southern O 0 1.5343040171700295e-09
blot O 0 2.1082069423528083e-08
analysis O 0 7.257208722855069e-10
were O 0 2.0709807480034925e-10
used O 0 7.972806442824165e-11
to O 0 4.862854563469909e-10
identify O 0 1.5745195014460478e-07
mutations O 0 1.5894978844244179e-07
. O 0 1.7657306727869582e-07

Mutations O 0 1.4246208479562483e-07
were O 0 4.909623374516059e-09
detected O 0 3.213447286043447e-09
in O 0 4.671566952718642e-11
21 O 0 5.217141163527117e-10
( O 0 2.9346080687026044e-12
91 O 0 4.560761546201775e-09
% O 0 4.623083027510688e-10
) O 0 2.006086269323859e-12
of O 0 2.5967891725819925e-10
23 O 0 1.7223961776835495e-06
tumors B-Disease 1 1.0
with O 0 0.010140121914446354
LOH O 1 1.0
. O 0 1.3177944310882594e-05

In O 0 4.883493787133375e-08
6 O 0 8.142882812478547e-09
( O 0 5.313614999391536e-12
38 O 0 1.990705600363185e-09
% O 0 1.1295907959008034e-10
) O 0 8.317736690383049e-13
of O 0 2.515948838155424e-10
16 O 0 1.8442433713516948e-07
tumors B-Disease 1 1.0
without O 1 0.9938116073608398
LOH O 1 0.9999910593032837
, O 0 4.790355959127801e-11
one O 0 2.591266264062586e-11
mutation O 0 4.3084699002937654e-11
was O 0 7.392218503987635e-10
detected O 0 6.8089818228145305e-09
, O 0 3.879265398493148e-12
and O 0 1.2200649344984438e-11
in O 0 2.4473617576958873e-10
9 O 0 2.3631514523003716e-09
( O 0 3.6327466642477324e-12
56 O 0 3.0696047925715675e-09
% O 0 2.0504713205138358e-10
) O 0 1.183899115894671e-12
of O 0 1.846689190454498e-10
the O 0 1.804848537290127e-08
tumors B-Disease 1 1.0
without O 1 0.9593682885169983
LOH O 1 0.999996542930603
, O 0 1.1678154276939523e-10
both O 0 3.4556610351010875e-10
mutations O 0 8.940951867764113e-10
were O 0 1.466393451110548e-09
found O 0 2.094778350780757e-09
. O 0 2.3967983153738714e-08

Thus O 0 3.110591961785758e-08
, O 0 4.83562252739933e-11
a O 0 1.1293402844836375e-11
total O 0 1.1814234313067828e-10
of O 0 1.046910821922431e-10
45 O 0 1.22086696308088e-09
mutations O 0 5.2936287298077644e-11
were O 0 8.922752814388701e-11
identified O 0 9.725583671738036e-10
in O 0 1.1265918198333225e-09
tumors B-Disease 1 1.0
of O 0 3.91997360793539e-07
36 O 0 1.8572316548670642e-05
patients O 0 4.6463947001029737e-07
. O 0 4.6922914975766616e-07

Thirty O 0 8.573848390369676e-06
- O 0 2.418127387215918e-08
nine O 0 1.366941226876861e-09
of O 0 1.0918402293391694e-10
the O 0 5.7460373265039166e-11
mutations O 0 4.175179646459526e-11
- O 0 2.600673842945156e-11
including O 0 2.0526841944951135e-12
34 O 0 1.477912192626718e-08
small O 0 6.694978599286472e-11
mutations O 0 1.8018723180190932e-09
, O 0 3.8987757466912853e-11
2 O 0 2.425790013305118e-09
large O 0 9.707527837132801e-11
structural O 0 1.6190649603231577e-06
alterations O 0 8.970852860556988e-08
, O 0 7.427321258024477e-11
and O 0 1.9017876162763514e-10
hypermethylation O 0 2.5927345632226206e-05
in O 0 1.4178663576558392e-08
3 O 0 5.332266823643295e-07
tumors O 1 1.0
- O 0 4.233231543082638e-09
were O 0 2.4217389205105633e-10
not O 0 6.349771403124649e-12
detected O 0 2.005663551907233e-10
in O 0 1.6620353097268614e-12
the O 0 2.539988532002102e-11
corresponding O 0 1.0641774572661689e-08
peripheral O 0 1.9388704686207348e-07
blood O 0 2.9115879485175356e-08
DNA O 0 3.895752342941705e-06
. O 0 2.8030987664351414e-07

In O 0 6.85151988477628e-08
6 O 0 2.0739552297754926e-08
( O 0 1.4675980916645237e-11
17 O 0 1.453788339711437e-10
% O 0 2.144894158118138e-11
) O 0 5.0645695726407244e-14
of O 0 2.87600390551368e-12
the O 0 1.8416582495128786e-11
36 O 0 4.4235792806546215e-09
patients O 0 3.6252195689812083e-10
, O 0 4.388721157322362e-12
a O 0 2.6442651887559343e-11
mutation O 0 1.5922158036474343e-10
was O 0 1.2967438234312567e-09
detected O 0 7.904641941003376e-10
in O 0 1.1012953569922157e-11
constitutional O 0 1.4377153911837581e-09
DNA O 0 7.749326300654502e-07
, O 0 3.3706998997518056e-11
and O 0 5.5750716543290224e-12
1 O 0 1.3381946939450273e-10
of O 0 4.052121485575988e-11
these O 0 2.236359318216752e-12
mutations O 0 3.466014367875525e-12
is O 0 4.182593805806753e-14
known O 0 6.831472778960623e-13
to O 0 1.0654391431608179e-11
be O 0 4.967377204012635e-11
associated O 0 8.50004155950046e-09
with O 0 1.9205019519130673e-10
reduced O 0 3.6468233588493604e-07
expressivity O 0 2.224528907390777e-05
. O 0 2.0091390240395413e-07

The O 0 6.390641793529994e-09
presence O 0 1.2539516647258608e-10
of O 0 4.934085362506835e-10
a O 0 3.8249566708392635e-11
constitutional O 0 8.636562021102634e-10
mutation O 0 7.287512954201603e-11
was O 0 2.0842190820435924e-11
not O 0 1.2632856729016123e-13
associated O 0 9.047836264930442e-12
with O 0 1.2217520560780376e-13
an O 0 5.789946565812679e-14
early O 0 6.573157573797062e-10
age O 0 4.984845869415722e-09
at O 0 6.0036331461788e-10
treatment O 0 4.781755080784933e-08
. O 0 6.321651113694315e-08

In O 0 6.673974262128013e-09
1 O 0 1.2913785596424532e-08
patient O 0 6.422096276992306e-08
, O 0 2.715918982765242e-11
somatic O 0 3.720981212040897e-08
mosaicism O 0 5.310860160534503e-07
was O 0 1.0542769435240018e-10
demonstrated O 0 2.7960345844180168e-11
by O 0 1.4301885684856602e-13
molecular O 0 1.4167795625921742e-12
analysis O 0 2.0817030824821225e-12
of O 0 2.873185630386521e-12
DNA O 0 7.021127013118189e-10
and O 0 1.7439829094745285e-11
RNA O 0 2.2591805759475392e-08
from O 0 1.3653472130670252e-08
peripheral O 0 4.129041826672619e-06
blood O 0 1.053057985700434e-06
. O 0 1.0430082966195187e-06

In O 0 1.699033447266629e-08
2 O 0 8.718260779971843e-09
patients O 0 7.828406256571441e-10
without O 0 1.0077879503134213e-10
a O 0 8.982808247237628e-11
detectable O 0 2.648771690871854e-08
mutation O 0 9.151770313797769e-11
in O 0 1.0457772148253497e-10
peripheral O 0 1.8142283408906223e-07
blood O 0 3.496831979532544e-08
, O 0 5.499982691503646e-10
mosaicism O 0 3.217398261767812e-05
was O 0 1.1210792294491512e-08
suggested O 0 6.954207765197395e-10
because O 0 5.170920983066374e-12
1 O 0 1.9694522054858332e-11
of O 0 1.530564217033792e-11
the O 0 2.5631686009774945e-11
patients O 0 1.5592499513772395e-10
showed O 0 9.167101744367301e-09
multifocal O 1 0.9999997615814209
tumors B-Disease 1 1.0
and O 0 3.4561420392265063e-10
the O 0 9.041911108731426e-10
other O 0 7.352518593961577e-11
later O 0 6.387778306304881e-09
developed O 0 2.813129817980098e-08
bilateral B-Disease 0 0.4424225091934204
retinoblastoma I-Disease 1 0.9387535452842712
. O 0 2.0124691673117923e-06

In O 0 1.4088437083614735e-08
conclusion O 0 5.445001605153266e-08
, O 0 1.2443808483642016e-10
our O 0 7.372111254788649e-10
results O 0 1.6308479566795597e-10
emphasize O 0 2.65810679023204e-10
that O 0 7.180834702899541e-13
the O 0 2.293441478395941e-11
manifestation O 0 1.2185203956960322e-08
and O 0 7.695224318871041e-11
transmissibility O 0 1.6535682334506419e-07
of O 0 2.466459037009372e-09
retinoblastoma B-Disease 0 1.3662672415648558e-07
depend O 0 8.648863847326993e-09
on O 0 1.0529229710343202e-09
the O 0 1.0601711869506758e-10
nature O 0 2.551181210730391e-10
of O 0 1.7580878419742874e-10
the O 0 4.5704579010319435e-11
first O 0 1.4578759033323507e-10
mutation O 0 2.3636674215121722e-11
, O 0 7.288951343539796e-13
its O 0 5.947479921747378e-13
time O 0 3.2222102763768135e-10
in O 0 9.077278512181763e-11
development O 0 2.6202805258890294e-08
, O 0 6.5061944547195605e-12
and O 0 1.8185843456142159e-12
the O 0 1.0527612635813366e-11
number O 0 1.3622236151589195e-11
and O 0 1.5927093628340105e-12
types O 0 7.892435316403379e-11
of O 0 1.8784769573176874e-10
cells O 0 1.4392458058676283e-10
that O 0 1.8680848968416486e-12
are O 0 1.1602278382830122e-12
affected O 0 7.477483215945213e-11
. O 0 3.332232545449898e-10
. O 0 1.4369815559689414e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999984502792358
the I-Disease 0 8.614477701485157e-05
fifth I-Disease 0 3.849991844617762e-05
component I-Disease 0 3.221451194690417e-08
of I-Disease 0 2.363908624403166e-09
complement I-Disease 0 3.814767612908554e-09
in O 0 3.730914688304665e-09
man O 0 4.203119488010998e-07
. O 0 5.671568032994401e-07

I O 0 0.14810991287231445
. O 0 4.2949568523908965e-06

Clinical O 0 2.9242519303807057e-05
, O 0 9.664344879922737e-09
immunochemical O 0 0.00021710387954954058
, O 0 5.006206005297997e-10
and O 0 2.9315341820712604e-10
family O 0 1.0511130854595763e-09
studies O 0 2.4795685504841458e-08
. O 0 3.858330899220164e-08

The O 0 5.646933143310662e-09
first O 0 5.24464804918523e-10
recognized O 0 2.3421942163537324e-10
human O 0 6.734967583632567e-10
kindred O 0 2.605450163173373e-06
with O 0 6.196855251161537e-10
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999996423721313
the I-Disease 0 6.921343810972758e-06
fifth I-Disease 0 7.0040582613728475e-06
component I-Disease 0 7.5189397819031e-08
of I-Disease 0 2.1236385805423197e-07
complement I-Disease 0 1.290038881052169e-06
( O 0 2.928312525796173e-08
C5 O 1 0.9996932744979858
) O 0 4.244241069706334e-10
is O 0 1.0969187363985e-10
described O 0 1.1409294842223972e-08
. O 0 1.6843016226175678e-07

The O 0 2.501138851584983e-07
proband O 0 3.761581319849938e-05
, O 0 4.5078888538663264e-11
a O 0 2.1540531511266003e-11
20 O 0 2.458515613312784e-10
- O 0 2.792117578809261e-11
year O 0 6.669004931625366e-11
- O 0 2.535629706201803e-09
old O 0 6.673848673699467e-08
black O 0 5.771149114153218e-10
female O 0 2.042674118740706e-08
with O 0 5.002488379091119e-08
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999997615814209
age O 1 0.9999128580093384
11 O 0 1.0282171558628761e-07
, O 0 5.361047022978127e-11
lacked O 0 5.630438693060569e-08
serum O 0 9.380380561196944e-08
hemolytic O 0 1.1804599608922217e-07
complement O 0 2.121639930408037e-08
activity O 0 3.929615033371192e-08
, O 0 3.855492661242188e-11
even O 0 3.873049103653159e-11
during O 0 2.354851069696906e-08
remission O 0 3.6690589695353992e-06
. O 0 1.6517487821943178e-08

C5 O 0 0.0014602390583604574
was O 0 1.3444686146613094e-06
undetectable O 0 7.374670190074539e-07
in O 0 1.1940144706290567e-10
her O 0 6.92396209811541e-11
serum O 0 7.051672579194701e-10
by O 0 8.189801267710628e-12
both O 0 2.933547571526418e-10
immunodiffusion O 0 8.719110269339581e-07
and O 0 1.5802508190887465e-09
hemolytic O 0 1.343505005024781e-06
assays O 0 8.454503017674142e-07
. O 0 1.3744918305746978e-06

Other O 0 6.880914171780717e-10
complement O 0 2.765849771435569e-10
components O 0 5.2891833135504385e-09
were O 0 8.886270191910128e-11
normal O 0 1.1231032770453453e-09
during O 0 2.9217055441677076e-09
remission O 0 8.978493610811711e-07
of O 0 5.550337522919335e-09
lupus O 0 1.339710387071591e-08
, O 0 1.1630051782729467e-10
but O 0 2.0620225527068214e-09
C1 O 0 0.0007008977700024843
, O 0 4.8993733514635096e-08
C4 O 0 0.08437471836805344
, O 0 6.297038446234637e-09
C2 O 0 1.8454662495059893e-05
, O 0 2.889313899245849e-09
and O 0 2.4095363926335267e-08
C3 O 0 0.04513894394040108
levels O 0 2.0749559553223662e-05
fell O 0 3.938052032026462e-06
during O 0 2.5260790152970003e-06
exacerbations O 0 0.005351569503545761
. O 0 3.708193503371149e-07

A O 0 1.5514353890466737e-06
younger O 0 5.510330538527342e-07
half O 0 1.3676616283930798e-08
- O 0 1.4573323880995304e-08
sister O 0 1.5290696708802898e-08
, O 0 1.4221082644816363e-11
who O 0 3.0481138446614153e-11
had O 0 1.396946447407288e-09
no O 0 9.473853923580577e-10
underlying O 1 0.9907900094985962
disease O 0 0.26194310188293457
, O 0 5.017024296005701e-11
was O 0 8.726249944857045e-08
also O 0 7.777398863817453e-11
found O 0 1.5120273921809257e-09
to O 0 4.725045599229816e-08
lack O 1 0.9999998807907104
immunochemically O 1 1.0
detectable O 1 0.999988317489624
C5 O 1 0.999795138835907
. O 0 4.4681187318929005e-06

By O 0 5.240483602619861e-08
hemolytic O 0 5.321026492310921e-06
assay O 0 6.188864176692732e-08
, O 0 1.2936978155408951e-09
she O 0 3.1568084257749263e-10
exhibited O 0 6.930241380764812e-10
1 O 0 4.4468576043676933e-10
- O 0 2.4785401508964355e-10
2 O 0 1.5724950855333653e-11
% O 0 1.1085958540046903e-11
of O 0 1.4827062104136313e-12
the O 0 9.202580537881477e-12
normal O 0 8.358306935463133e-09
serum O 0 3.6824929772194537e-09
C5 O 0 8.821604069453315e-08
level O 0 9.742687545610806e-09
and O 0 2.2377728142730646e-11
normal O 0 2.1395274441005085e-09
concentrations O 0 5.269987224387762e-10
of O 0 7.584668310078868e-11
other O 0 3.043710422589996e-11
complement O 0 2.0233084097043275e-09
components O 0 1.5629025540420116e-07
. O 0 1.56467152123696e-07

C5 O 0 0.00011705789802363142
levels O 0 5.208625353247953e-08
of O 0 3.986352137275162e-09
other O 0 6.500392585317982e-11
family O 0 3.4800464593365277e-11
members O 0 8.240380600099684e-12
were O 0 1.546835576293759e-10
either O 0 3.789406011200924e-10
normal O 0 5.4304088337175926e-08
or O 0 2.1119389223556162e-11
approximately O 0 3.164028414270881e-11
half O 0 1.6102440214549318e-10
- O 0 2.147949457187437e-10
normal O 0 9.554752544715939e-10
, O 0 2.67579578286381e-12
consistent O 0 5.6056370656421e-10
with O 0 1.628441305412398e-11
autosomal O 0 4.314298607255296e-08
codominant O 0 5.978316721666488e-07
inheritance O 0 1.5711872691781537e-08
of O 0 2.680519806119719e-09
the O 0 7.524704415118322e-09
gene O 0 4.089365290838032e-08
determining O 0 0.00027151554240845144
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 4.104605977772735e-06

Normal O 0 4.710468783741817e-05
hemolytic O 0 9.106482139031868e-06
titers O 0 1.1955467016377952e-06
were O 0 5.132391400763936e-09
restored O 0 6.545387343237508e-09
to O 0 3.857927866057764e-11
both O 0 1.3067591453364003e-10
homozygous O 0 2.4373773044317204e-07
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 5.516882310985238e-07
C5D B-Disease 1 1.0
) O 0 1.1356764140213471e-10
sera O 0 6.141516739610609e-10
by O 0 1.5397390664990268e-13
addition O 0 1.1422385606807417e-11
of O 0 5.610278908108057e-10
highly O 0 1.3411171551069856e-07
purified O 0 2.632052371609461e-07
human O 0 2.1005273254104395e-07
C5 O 0 0.0649590790271759
. O 0 4.2024544200103264e-07

In O 0 6.569954535962097e-08
specific O 0 5.3445869951929126e-08
C5 O 0 2.0243367544026114e-05
titrations O 0 6.288741474236303e-07
, O 0 5.2162028169044916e-11
however O 0 1.68090055763237e-10
, O 0 2.083800580005013e-12
it O 0 2.287183571876572e-13
was O 0 1.7602083679513214e-10
noted O 0 1.0387374120568449e-11
that O 0 1.390969452249799e-13
when O 0 1.0708558605826424e-12
limited O 0 8.739958409775817e-12
amounts O 0 2.32314601583683e-11
of O 0 1.0261982374970557e-09
C5 O 0 3.3129424537037266e-07
were O 0 2.227525053299928e-09
assayed O 0 1.9017496910578302e-08
in O 0 6.121208574738635e-12
the O 0 1.2056255299652818e-11
presence O 0 9.18634092406112e-12
of O 0 5.017007365104575e-10
low O 0 6.488432902074237e-09
dilutions O 0 2.895893089771562e-07
of O 0 9.307981940764876e-09
either O 0 3.965655537285784e-07
C5D B-Disease 1 1.0
serum O 0 2.1392352778093482e-07
, O 0 3.2580521613923e-11
curving O 0 2.7839083815983656e-10
rather O 0 1.4120886751567419e-11
than O 0 3.851703569805742e-13
linear O 0 1.371939784000631e-10
dose O 0 3.965830330798781e-09
- O 0 1.8984061544990993e-10
response O 0 2.8374219206844797e-12
plots O 0 3.457737707268649e-10
were O 0 5.7457743424249585e-11
consistently O 0 2.8969814394597115e-11
obtained O 0 9.05516148175245e-11
, O 0 5.937066810401959e-12
suggesting O 0 7.241529043078287e-10
some O 0 4.0887505187159334e-11
inhibitory O 0 2.7864238916208706e-08
effect O 0 1.0854686927075363e-08
. O 0 1.5535940178779128e-07

Further O 0 5.824674964571841e-09
studies O 0 6.443292566160608e-10
suggested O 0 3.263494335881134e-11
that O 0 4.5402169437241957e-13
low O 0 2.7218788334337773e-10
dilutions O 0 1.5418758891883044e-07
of O 0 1.4816383497873176e-07
C5D B-Disease 1 1.0
serum O 0 1.510031495399744e-07
contain O 0 1.2925502335114913e-10
a O 0 2.3140316052217003e-11
factor O 0 2.5365657491116522e-11
( O 0 9.300581138571573e-13
or O 0 1.3054381360622092e-11
factors O 0 1.6142540082419998e-10
) O 0 2.6486855243812446e-12
interfering O 0 6.442459898892139e-09
at O 0 3.5103493445376444e-09
some O 0 4.818421703300935e-12
step O 0 2.186165276585328e-10
in O 0 2.415316557868863e-11
the O 0 3.6707312189854235e-10
hemolytic O 0 7.987277683696448e-08
assay O 0 2.0226805119705205e-08
of O 0 4.48356968263397e-06
C5 O 0 0.012464712373912334
, O 0 1.0042152526201775e-10
rather O 0 1.4789568181239332e-10
than O 0 1.2067964683115662e-11
a O 0 2.728136605512077e-10
true O 0 7.18529022947223e-08
C5 O 0 3.0038285331102088e-05
inhibitor O 0 5.888761922534513e-09
or O 0 3.90878662770433e-09
inactivator O 0 6.7791997935273685e-06
. O 0 3.093351494953822e-07

Of O 0 4.159643083312403e-07
clinical O 0 1.9367355434951605e-06
interest O 0 6.948126074490801e-09
are O 0 5.647905320510516e-12
( O 0 1.5545505421127315e-12
a O 0 6.462856291800101e-12
) O 0 5.896583134962219e-13
the O 0 1.2930131791655253e-11
documentation O 0 1.6999450735966093e-07
of O 0 2.5902819444922898e-08
membranous O 0 0.0006791441119275987
glomerulonephritis B-Disease 1 1.0
, O 0 3.3221834172536546e-08
vasculitis B-Disease 1 1.0
, O 0 6.280773234834669e-09
and O 0 1.235120379305954e-07
arthritis B-Disease 1 1.0
in O 0 1.0236221896775533e-06
an O 0 1.2253034697984333e-10
individual O 0 1.0144366235920188e-08
lacking O 1 0.9999996423721313
C5 O 1 0.9999992847442627
( O 0 3.361018754977074e-11
and O 0 4.717102142920426e-12
its O 0 2.9323813342807536e-12
biologic O 0 2.7712796502044057e-09
functions O 0 8.908060400436568e-11
) O 0 7.112392814458135e-13
, O 0 8.847295725894488e-13
and O 0 1.6551261229624803e-12
( O 0 1.0048790142005992e-12
b O 0 1.7751774009089338e-11
) O 0 2.859232761578262e-13
a O 0 6.893019141585022e-12
remarkable O 0 1.7216130743236135e-09
propensity O 0 1.7515695560632594e-08
to O 0 7.603302876191265e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 2.5321100771691363e-10
the O 0 3.1782013132364284e-10
proband O 0 1.2039480168368755e-07
, O 0 1.3656985698579094e-12
even O 0 5.965566582388782e-13
during O 0 1.0577211329021452e-10
periods O 0 1.3194258130511116e-08
of O 0 2.435580348514321e-10
low O 0 1.743475808169137e-09
- O 0 1.1399886590268693e-10
dose O 0 6.116858408677928e-11
or O 0 8.620190065228295e-13
alternate O 0 2.5039863515985417e-09
- O 0 4.156550659217828e-09
day O 0 5.486375354024631e-09
corticosteroid O 0 1.4387237570190337e-05
therapy O 0 1.118432919611223e-05
. O 0 2.170482993335554e-08

Other O 0 3.3896905282659873e-09
observations O 0 2.2809496513787053e-09
indicate O 0 1.845844033177002e-10
that O 0 6.446318630802528e-13
the O 0 9.175261245220057e-11
C5D B-Disease 1 1.0
state O 0 3.1650562726248666e-10
is O 0 4.209439058173309e-13
compatible O 0 1.064351495827509e-09
with O 0 1.2653192296013804e-12
normal O 0 3.5623051175548426e-09
coagulation O 0 4.6075282478241775e-10
function O 0 1.3282644428791457e-10
and O 0 3.5589177004718975e-12
the O 0 5.223351612348992e-11
capacity O 0 1.977445318601667e-09
to O 0 8.799846268336964e-11
mount O 0 7.711809502097822e-08
a O 0 9.916292675882232e-09
neutrophilic O 0 0.004214731510728598
leukocytosis O 0 4.391784386825748e-05
during O 0 2.733061228354927e-05
pyogenic B-Disease 0 0.004085457418113947
infection I-Disease 0 9.291289643442724e-06
. O 0 5.562493576860561e-09
. O 0 3.8265749680022054e-08

Susceptibility O 0 2.6212255761492997e-05
to O 0 5.7275869949080516e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 2.0212291929055937e-05
twins O 0 4.569201053072902e-07
: O 0 4.911879822148968e-13
the O 0 3.1267592681683e-12
role O 0 2.0118656740564234e-11
of O 0 4.5852688312919554e-10
genes O 0 1.0485115553571234e-10
, O 0 2.47809429226864e-11
HLA O 0 5.6312330798391486e-08
, O 0 2.4391494032882655e-11
and O 0 4.738259437586656e-11
the O 0 9.495784603075208e-09
environment O 0 2.598992750790785e-06
. O 0 1.8986530392339773e-07

OBJECTIVE O 0 2.8058639145456254e-05
To O 0 9.884959517592051e-10
determine O 0 1.960003270795596e-09
the O 0 7.674864910267587e-11
relative O 0 1.0561638674744245e-08
effects O 0 6.4179550562926124e-09
of O 0 3.839965567742354e-10
genetic O 0 7.340751895235087e-10
and O 0 2.048991401895628e-12
environmental O 0 3.5354424249289806e-11
factors O 0 7.981170412063587e-12
in O 0 1.536600707785496e-12
susceptibility O 0 7.270772317546914e-10
to O 0 2.3959984218890895e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 1.8510801965021528e-05
AS B-Disease 1 1.0
) O 0 1.1469027949573274e-09
. O 0 7.432883641911303e-09

METHODS O 0 1.2262887139513623e-05
Twins O 0 4.261868866706209e-07
with O 0 3.757950201022098e-11
AS B-Disease 1 0.9999821186065674
were O 0 5.397295110842748e-11
identified O 0 1.8982062449657278e-11
from O 0 1.3119649680884415e-12
the O 0 9.215244886617846e-12
Royal O 0 1.907256574895655e-08
National O 0 4.005835663178914e-08
Hospital O 0 0.0005227997899055481
for O 0 6.12154735790682e-08
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999992847442627
database O 0 1.086889938051172e-06
. O 0 3.3008637956299935e-07

Clinical O 0 7.295561204045953e-07
and O 0 8.790150551885034e-11
radiographic O 0 4.245791629386986e-08
examinations O 0 3.7112573636477464e-07
were O 0 2.1442081443723282e-10
performed O 0 1.5167578304442486e-10
to O 0 2.0808505959979406e-11
establish O 0 1.613928546362331e-09
diagnoses O 0 9.437286507818499e-08
, O 0 2.977709051554811e-11
and O 0 2.083174882594463e-10
disease O 0 0.0006548091769218445
severity O 0 0.004502849653363228
was O 0 1.9101280557265454e-09
assessed O 0 2.2065414773120295e-10
using O 0 6.213086902601139e-12
a O 0 3.333118937104418e-12
combination O 0 3.6777515061148236e-11
of O 0 2.0816098844633757e-10
validated O 0 8.380304450383846e-09
scoring O 0 5.190602614391082e-09
systems O 0 2.25976933165839e-07
. O 0 6.442806466111506e-08

HLA O 0 4.713546786661027e-06
typing O 0 3.649429345387034e-07
for O 0 3.0078628476815084e-09
HLA O 0 6.44473630018183e-07
- O 0 7.629454756852283e-08
B27 O 0 2.168873862729015e-07
, O 0 1.6146195491728577e-11
HLA O 0 5.460911722821038e-09
- O 0 1.406694982719614e-09
B60 O 0 1.0979078091111205e-08
, O 0 2.832343192447906e-13
and O 0 1.3466273452236721e-12
HLA O 0 7.602172225062986e-09
- O 0 1.188814024999374e-08
DR1 O 0 0.3634031414985657
was O 0 1.0450853377141911e-10
performed O 0 1.5565986000165566e-11
by O 0 2.0840855354409965e-13
polymerase O 0 4.233725783148179e-12
chain O 0 6.244173472551295e-13
reaction O 0 1.9399155133832668e-13
with O 0 1.4144296899085834e-13
sequence O 0 5.229890825964034e-11
- O 0 3.33453230305647e-11
specific O 0 3.2104343055533446e-12
primers O 0 7.590023054504513e-11
, O 0 1.1087665074266395e-12
and O 0 7.1973746407216765e-12
zygosity O 0 1.0677847939177809e-07
was O 0 8.74423589092288e-10
assessed O 0 3.4435365670049123e-09
using O 0 3.268342263496038e-10
microsatellite O 0 2.9622523811667634e-07
markers O 0 2.2355790108008478e-08
. O 0 1.0937071692751488e-07

Genetic O 0 2.869386150905484e-07
and O 0 1.0576929609928953e-10
environmental O 0 8.239552096167557e-11
variance O 0 5.973711542789362e-12
components O 0 1.1319070680748666e-10
were O 0 6.604443120866721e-12
assessed O 0 3.701156395252703e-11
with O 0 1.1683372097472805e-13
the O 0 4.118805557035143e-12
program O 0 5.8030902999606226e-11
Mx O 0 1.7890568193568157e-10
, O 0 2.2981713171496727e-14
using O 0 4.009189085319581e-13
data O 0 5.829382115907222e-11
from O 0 1.4860357952853342e-12
this O 0 6.413194086028751e-13
and O 0 8.772270019760664e-13
previous O 0 3.9321598754860076e-10
studies O 0 1.0952964230037665e-10
of O 0 4.05978792250572e-11
twins O 0 1.7389260031919207e-09
with O 0 3.907157930527205e-11
AS B-Disease 1 1.0
. O 0 2.727047672124172e-07

RESULTS O 0 1.0708620266086655e-06
Six O 0 1.4046264595890534e-07
of O 0 7.501374632568059e-09
8 O 0 8.45421954664971e-09
monozygotic O 0 3.1216026741276437e-07
( O 0 3.4890004774190686e-10
MZ O 0 3.933862899430096e-06
) O 0 1.589772237464704e-11
twin O 0 2.125673193020816e-09
pairs O 0 4.3581033226658406e-10
were O 0 5.861956253738754e-09
disease O 0 6.872553370840251e-08
concordant O 0 1.7552390829678188e-07
, O 0 1.2295285449492876e-11
compared O 0 4.836704370347888e-10
with O 0 4.021130216996793e-12
4 O 0 3.6340394582445867e-10
of O 0 3.837461459710312e-10
15 O 0 3.1487745744129825e-10
B27 O 0 1.9274065010677077e-08
- O 0 3.2274935501952484e-10
positive O 0 7.6774671689539e-12
dizygotic O 0 3.951591764916884e-08
( O 0 2.5757736221709848e-11
DZ O 0 3.424982253363851e-07
) O 0 7.561192991167864e-12
twin O 0 8.598084466626688e-10
pairs O 0 1.021660950284442e-10
( O 0 1.2387458680346297e-12
27 O 0 5.330877961284841e-10
% O 0 8.159697223453222e-11
) O 0 1.7722322632855725e-13
and O 0 9.300935672681976e-13
4 O 0 5.642405986883148e-11
of O 0 2.720902947395132e-10
32 O 0 4.441841117142076e-09
DZ O 0 4.804665536539687e-07
twin O 0 2.6427195987110963e-09
pairs O 0 1.3777823326677208e-10
overall O 0 7.919619804397371e-08
( O 0 1.5171679884629086e-11
12 O 0 9.556612168282186e-10
. O 0 1.4348265631181079e-11
5 O 0 4.398469088950918e-11
% O 0 5.392047572327918e-11
) O 0 3.762279984081962e-12
. O 0 1.6675724134884717e-09

Nonsignificant O 0 8.232866821344942e-05
increases O 0 1.415982109342906e-09
in O 0 1.439406926984077e-11
similarity O 0 5.5409600518974145e-11
with O 0 7.925524386082072e-13
regard O 0 3.053975683453558e-10
to O 0 7.167636623117701e-11
age O 0 1.6309428474414744e-08
at O 0 1.8081417474391515e-09
disease O 0 2.0504030473489365e-08
onset O 0 1.6748208508943208e-07
and O 0 1.0519463772284965e-11
all O 0 1.7985845451873317e-11
of O 0 2.3684745831253906e-10
the O 0 9.603682293857219e-10
disease O 0 1.0148895057682239e-08
severity O 0 1.6719960971300907e-09
scores O 0 9.216145901991268e-11
assessed O 0 2.171615526291859e-10
were O 0 1.9495030589844475e-10
noted O 0 5.5724591607742013e-11
in O 0 6.871953006637455e-11
disease O 0 2.846127244993113e-08
- O 0 4.5445580632019755e-09
concordant O 0 2.1340433420391491e-07
MZ O 0 1.864283694885671e-05
twins O 0 1.326055976136331e-08
compared O 0 3.6074376819072995e-10
with O 0 3.872502665758226e-11
concordant O 0 3.9108431337808724e-06
DZ O 0 0.0005918493261560798
twins O 0 3.955701686209068e-06
. O 0 4.108441942207719e-07

HLA O 0 0.0004796402354259044
- O 0 2.54587775998516e-05
B27 O 0 8.054596037254669e-06
and O 0 3.0414601392969587e-10
B60 O 0 6.547774660248251e-07
were O 0 3.044291208009753e-11
associated O 0 6.844965566576988e-11
with O 0 5.637440926402337e-13
the O 0 8.399787115864754e-11
disease O 0 1.7814208774780127e-08
in O 0 3.6985452894766624e-11
probands O 0 3.3371704830642557e-06
, O 0 2.763242325926063e-12
and O 0 1.5240468392505035e-12
the O 0 1.4353611355044649e-10
rate O 0 7.974016114076221e-09
of O 0 3.1553937240857977e-10
disease O 0 5.737478936396201e-09
concordance O 0 1.2735510424022323e-09
was O 0 5.306783901204426e-10
significantly O 0 7.015116265662868e-10
increased O 0 7.572746874018321e-10
among O 0 1.8958913605704453e-10
DZ O 0 9.234068443220167e-07
twin O 0 4.109740103785953e-09
pairs O 0 1.1885294137758962e-10
in O 0 3.9846147215083505e-11
which O 0 1.02210438463618e-12
the O 0 1.624874124139808e-10
co O 0 2.8109827798772358e-09
- O 0 2.175924329606005e-09
twin O 0 1.656038084441036e-09
was O 0 1.093230159177061e-10
positive O 0 2.6644387651070245e-12
for O 0 1.1771014935338386e-12
both O 0 1.1641326097544535e-10
B27 O 0 9.532341209705919e-07
and O 0 7.145939395769574e-09
DR1 O 1 0.9745733737945557
. O 0 4.060104572545242e-07

Additive O 0 1.5417619181334885e-08
genetic O 0 8.229378289925648e-10
effects O 0 8.476525037437455e-11
were O 0 1.6065527380648703e-11
estimated O 0 2.4972669331740915e-12
to O 0 1.0204290754392553e-12
contribute O 0 6.713699735039214e-11
97 O 0 1.2816419037164906e-08
% O 0 1.0824331431180667e-09
of O 0 5.956954374219947e-11
the O 0 2.7531428525850998e-11
population O 0 2.46854012925235e-12
variance O 0 1.0258141558416867e-10
. O 0 3.1613653916906514e-09

CONCLUSION O 0 1.548010914120823e-05
Susceptibility O 0 2.57081609333909e-07
to O 0 1.6301466843060552e-08
AS B-Disease 1 1.0
is O 0 1.201475585688172e-10
largely O 0 5.690470872288245e-10
genetically O 0 4.6204511570946405e-12
determined O 0 5.549752879474568e-10
, O 0 1.330505323970943e-11
and O 0 1.0692501571651913e-11
the O 0 1.681923628149562e-10
environmental O 0 4.58805077263591e-10
trigger O 0 5.709373945839147e-11
for O 0 4.175512366422218e-12
the O 0 2.638925467035591e-10
disease O 0 7.764722198544405e-08
is O 0 8.571828143122406e-12
probably O 0 5.043163220364022e-09
ubiquitous O 0 8.764782677417315e-08
. O 0 5.385138734936845e-08

HLA O 0 0.00010665430454537272
- O 0 6.41362839814974e-06
B27 O 0 3.6406590879778378e-06
accounts O 0 2.1532901850473962e-10
for O 0 1.7457225985964553e-12
a O 0 4.0909797251187374e-12
minority O 0 9.784107551924492e-12
of O 0 2.1831555660489776e-11
the O 0 2.4756093008893032e-11
overall O 0 6.606519331597838e-09
genetic O 0 1.6022425608497315e-09
susceptibility O 0 8.74550321050549e-10
to O 0 2.567545731579912e-09
AS B-Disease 1 1.0
. O 0 1.332823285338236e-05

Cell O 0 2.9270739787534694e-07
cycle O 0 1.8144274349651823e-07
- O 0 4.823001376053071e-08
dependent O 0 2.028158441191863e-08
colocalization O 0 1.771877123246668e-06
of O 0 3.735658893333493e-08
BARD1 O 1 0.9999972581863403
and O 0 2.412915423022355e-09
BRCA1 O 0 3.313057161946631e-09
proteins O 0 5.451714166909705e-12
in O 0 1.4104494482081176e-11
discrete O 0 5.70635316776702e-09
nuclear O 0 4.359509091500513e-07
domains O 0 1.8912564314632618e-07
. O 0 1.0677929651592422e-07

Germ O 0 0.03012012131512165
- O 0 5.850035449839197e-06
line O 0 2.2888475115223628e-08
mutations O 0 2.6591256974128896e-10
of O 0 1.0127793048653189e-09
the O 0 1.166013685605094e-08
BRCA1 O 0 2.3329494780455207e-08
gene O 0 4.88169851764475e-11
predispose O 0 1.0431043806491402e-09
women O 0 5.147949666377272e-13
to O 0 1.0892930437864101e-12
early O 0 1.5476463488539594e-07
- O 0 3.094274870818481e-05
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999994039535522
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 4.716102175450487e-09
compromising O 0 2.263043086259131e-07
the O 0 1.1464412752459907e-09
genes O 0 5.323064766749042e-10
presumptive O 0 7.473772711819038e-08
function O 0 1.420336959156998e-09
as O 0 1.7999890467024215e-10
a O 0 2.7924715872984507e-09
tumor B-Disease 0 1.6654172441121773e-06
suppressor O 0 1.2907613609058899e-06
. O 0 2.388388509189099e-07

Although O 0 4.5082998667567153e-08
the O 0 4.392052055379736e-09
biochemical O 0 3.7693698828888955e-08
properties O 0 6.7672791814743505e-09
of O 0 1.581614661461117e-08
BRCA1 O 0 8.818337171589974e-09
polypeptides O 0 4.558411148547492e-10
are O 0 6.908309102722499e-13
not O 0 1.6061321109900328e-12
understood O 0 1.3536614884568365e-10
, O 0 5.457860183764873e-13
their O 0 3.4426381016749996e-12
expression O 0 4.6054344365886735e-11
pattern O 0 5.479585118983721e-10
and O 0 1.3968278790577049e-11
subcellular O 0 1.3899099826630845e-07
localization O 0 2.2154158614284825e-06
suggest O 0 2.165296608680478e-09
a O 0 9.463085176575348e-11
role O 0 3.8849704009358277e-10
in O 0 5.357329024846536e-10
cell O 0 1.909418642753735e-06
- O 0 1.3103399965075369e-07
cycle O 0 3.137749899906339e-07
regulation O 0 3.020172556489342e-08
. O 0 1.2822531481049282e-08

When O 0 5.7743701376011813e-08
resting O 0 8.646953574498184e-06
cells O 0 2.453154657189316e-08
are O 0 2.668244097892014e-11
induced O 0 2.078080152401185e-09
to O 0 1.2440745655872831e-10
proliferate O 0 2.9786380029150905e-09
, O 0 3.252859787084006e-12
the O 0 8.431536718811472e-11
steady O 0 1.0350549217719163e-07
- O 0 3.192539566043706e-10
state O 0 2.6031007210880475e-11
levels O 0 8.558636022115707e-10
of O 0 9.59699403280112e-11
BRCA1 O 0 1.3197031141498616e-11
increase O 0 1.0518616143026516e-12
in O 0 9.653344746826664e-13
late O 0 9.610920947977775e-10
G1 O 0 9.391476041287206e-09
and O 0 8.15390463482224e-12
reach O 0 4.4350495498335363e-10
a O 0 8.795210219847416e-12
maximum O 0 3.6894934329900764e-10
during O 0 7.28447657749598e-09
S O 0 2.624262265271682e-07
phase O 0 1.9201249870093307e-06
. O 0 3.282897296230658e-07

Moreover O 0 1.0782659956021234e-06
, O 0 1.0616139217711762e-10
in O 0 1.0011933643250259e-10
S O 0 2.4477751381368762e-08
phase O 0 7.025204808996932e-07
cells O 0 1.772730406912615e-08
, O 0 1.0554095791759366e-10
BRCA1 O 0 6.423389597998153e-10
polypeptides O 0 1.300155955119564e-10
are O 0 8.982786736666526e-12
hyperphosphorylated O 0 2.615581706777448e-08
and O 0 2.6789392926218625e-10
accumulate O 0 3.2876572575446517e-09
into O 0 9.353341434703566e-10
discrete O 0 2.3081707922756323e-07
subnuclear O 0 8.904876267479267e-06
foci O 0 1.9348560726939468e-06
termed O 0 4.161099411703617e-07
" O 0 4.2075390638274257e-07
BRCA1 O 0 8.88184217728849e-07
nuclear O 0 3.2678710795153165e-06
dots O 0 4.065306711709127e-06
. O 0 4.4756399120160495e-07

" O 0 1.0427665984025225e-06
BRCA1 O 0 1.0054352514998754e-06
associates O 0 7.462362816568202e-08
in O 0 3.1414440493371387e-10
vivo O 0 1.0385546644897659e-08
with O 0 1.3736568306443875e-11
a O 0 5.932194180324757e-10
structurally O 0 1.0734412114743463e-07
related O 0 3.86518905770572e-07
protein O 0 6.118488471429373e-08
termed O 0 1.159615550250237e-07
BARD1 O 0 0.42627835273742676
. O 0 1.9967231423834164e-07

Here O 0 1.7050042799837684e-07
we O 0 8.862898748240866e-10
show O 0 9.400033529338714e-11
that O 0 3.2450748360147996e-13
the O 0 1.5465309588513776e-11
steady O 0 8.072771606748574e-08
- O 0 2.924185060759754e-10
state O 0 3.3424540912818657e-11
levels O 0 3.4184466368714084e-09
of O 0 7.220055109335988e-10
BARD1 O 0 5.681453330907971e-05
, O 0 9.05356779129507e-12
unlike O 0 6.766949500747188e-11
those O 0 5.04746678481327e-12
of O 0 4.02271438382229e-10
BRCA1 O 0 4.073226200773661e-09
, O 0 1.0843413840444516e-11
remain O 0 1.2059532261687878e-09
relatively O 0 1.719761139051812e-10
constant O 0 4.252165564100352e-10
during O 0 1.3887647476451548e-08
cell O 0 6.734382651529813e-08
cycle O 0 9.649501464537025e-08
progression O 0 1.247350525090951e-07
. O 0 3.8108204591935646e-08

However O 0 5.249196632917119e-08
, O 0 7.521069878002606e-10
immunostaining O 0 1.511736059001123e-06
revealed O 0 3.456198527373999e-08
that O 0 1.4584904117764808e-10
BARD1 O 1 0.9928584098815918
resides O 0 2.1931462867996743e-08
within O 0 4.278175591565514e-09
BRCA1 O 0 1.568446705846327e-09
nuclear O 0 2.1260838423131645e-08
dots O 0 5.412041925723088e-09
during O 0 2.5652560964317672e-08
S O 0 1.608063548985683e-08
phase O 0 1.0707681212807074e-06
of O 0 6.483410253110833e-09
the O 0 2.2524059006823194e-10
cell O 0 5.625752086402258e-10
cycle O 0 3.5541458665022674e-10
, O 0 1.7557259628358385e-13
but O 0 9.629194550010364e-14
not O 0 2.0622503813134963e-13
during O 0 6.826924026093195e-10
the O 0 7.41437300444403e-10
G1 O 0 2.933445273356483e-07
phase O 0 6.214680752236745e-07
. O 0 2.433233987630956e-07

Nevertheless O 0 7.715760148130357e-06
, O 0 8.027380538067064e-09
BARD1 O 0 0.0025428386870771646
polypeptides O 0 3.188544894783263e-08
are O 0 1.7320323994485243e-11
found O 0 4.8111853043208974e-12
exclusively O 0 5.0844189969367903e-11
in O 0 4.098203547353574e-12
the O 0 2.5303996745162927e-11
nuclear O 0 3.5856595470562524e-09
fractions O 0 6.447451017521644e-09
of O 0 1.003865213178301e-09
both O 0 3.4410793658956607e-10
G1 O 0 3.046116887617245e-07
- O 0 1.7177042010985133e-08
and O 0 1.6288832782596074e-10
S O 0 3.779932171710243e-07
- O 0 1.7113469752416677e-08
phase O 0 1.0692842806747649e-06
cells O 0 1.049447320156105e-07
. O 0 7.642238841754079e-09

Therefore O 0 2.5162153249880248e-08
, O 0 7.244661121008633e-11
progression O 0 4.800486230749357e-09
to O 0 7.128303503023403e-11
S O 0 4.140204179492457e-09
phase O 0 6.479420022742488e-08
is O 0 2.271394877739752e-12
accompanied O 0 2.3065196974592084e-10
by O 0 1.6545012972504769e-12
the O 0 3.389615671478552e-11
aggregation O 0 2.7998877522028565e-11
of O 0 1.4783448076816086e-10
nuclear O 0 1.9362022385394084e-07
BARD1 O 0 0.0027927823830395937
polypeptides O 0 7.085141362495051e-08
into O 0 2.042218305575716e-08
BRCA1 O 0 6.987040279682333e-08
nuclear O 0 5.161196554581693e-07
dots O 0 1.2549072607725975e-06
. O 0 2.1816110518102505e-07

This O 0 5.56588664046842e-10
cell O 0 5.289324533919171e-09
cycle O 0 1.3419814592907642e-08
- O 0 2.3794155534773154e-09
dependent O 0 2.8349000924521306e-09
colocalization O 0 7.126288181780183e-08
of O 0 7.681433267237026e-09
BARD1 O 1 0.9921181797981262
and O 0 1.3952468347344649e-10
BRCA1 O 0 4.038281931073584e-10
indicates O 0 1.8114260091905976e-11
a O 0 1.742110253798168e-12
role O 0 1.7695791013072615e-11
for O 0 6.847316463831632e-11
BARD1 O 1 0.9904266595840454
in O 0 3.0107916160204695e-08
BRCA1 O 0 7.518638085457496e-07
- O 0 3.2892526746763906e-07
mediated O 0 5.7036472753679845e-06
tumor B-Disease 0 9.62458761932794e-06
suppression O 0 1.2283381693123374e-05
. O 0 2.5527785396661784e-07

Ethnic O 0 1.3771564510989265e-07
differences O 0 4.496672190157369e-08
in O 0 1.8952803215732672e-10
the O 0 1.0894235513703165e-09
HFE O 0 9.613083420845214e-06
codon O 0 1.4513038593122474e-07
282 O 0 2.108348269302951e-07
( O 0 1.3983520119609238e-08
Cys O 0 0.010864983312785625
/ O 0 1.0429872418171726e-05
Tyr O 0 4.1026573853741866e-06
) O 0 9.353288143998384e-10
polymorphism O 0 3.2488955525877827e-07
. O 0 1.1728361215546101e-07

Recent O 0 3.657244951327243e-09
studies O 0 5.488727805591509e-10
have O 0 4.996163530633646e-13
shown O 0 1.318815473494439e-10
that O 0 5.856711227103517e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 7.160841164477461e-07
HH B-Disease 1 1.0
) O 0 5.6737128883987964e-11
is O 0 9.683662292175876e-13
likely O 0 2.2134702057363675e-11
to O 0 1.060480089160043e-11
be O 0 5.8129161206732505e-11
caused O 0 8.208074220306116e-10
by O 0 3.915872140436427e-11
homozygosity O 0 2.668516003723198e-07
for O 0 2.490257479392799e-11
a O 0 1.990712178434606e-10
Cys282Tyr O 0 6.129071152827237e-07
mutation O 0 8.486992358891499e-11
in O 0 8.31109573523614e-12
the O 0 7.030467319424361e-10
HFE O 0 5.076133311376907e-05
gene O 0 3.1759548324572506e-09
located O 0 4.3806716587546646e-10
4 O 0 1.2059354403959333e-08
. O 0 6.247989858820802e-08

5 O 0 2.0870808725703682e-07
Mb O 0 7.867301064834464e-06
telomeric O 0 1.2219693417137023e-06
to O 0 1.0153502927323643e-08
HLA O 0 2.5435592760914005e-06
- O 0 6.066615014788113e-07
A O 0 5.228313284533215e-07
. O 0 9.74259890540452e-08

Population O 0 8.6492879525224e-10
studies O 0 6.601250657212177e-10
of O 0 5.840555816760684e-11
this O 0 4.5216473794351675e-12
polymorphism O 0 1.3223425687769463e-09
are O 0 9.569000323020327e-13
facilitated O 0 2.791676889657424e-10
by O 0 4.396613281776318e-12
the O 0 2.38608455910283e-11
fact O 0 2.132383505881741e-11
that O 0 2.1558349181348413e-13
the O 0 4.597667385697335e-11
Cys282Tyr O 0 3.080885335293715e-06
mutation O 0 1.6290332416346587e-09
creates O 0 1.0175866399508848e-10
a O 0 5.960231197477128e-10
Rsal O 0 5.590636192209786e-06
restriction O 0 8.750279612002032e-09
site O 0 2.1660868654294063e-08
. O 0 3.682059457332798e-08

We O 0 1.343472000314705e-08
have O 0 1.6863042212600377e-11
studied O 0 2.3092179557426817e-10
the O 0 3.0694904951111823e-11
codon O 0 3.925395564152723e-09
282 O 0 3.9779386895588686e-08
( O 0 3.5111729079773113e-09
Cys O 0 0.11816003173589706
/ O 0 3.994447524746647e-06
Tyr O 0 4.4984651026425126e-07
) O 0 1.1280249304079781e-11
polymorphism O 0 5.798490021469149e-10
in O 0 3.1744966898228366e-12
different O 0 2.0286234497790545e-11
ethnic O 0 2.53963627905307e-10
groups O 0 5.442781642051031e-11
. O 0 6.1496781000869305e-09

In O 0 7.73050568003697e-10
agreement O 0 4.078450022149127e-09
with O 0 1.549383017718231e-11
previous O 0 2.1775820258085332e-08
observations O 0 2.23732254944764e-09
the O 0 6.124376700222811e-11
Tyr O 0 6.7465553144074875e-09
allele O 0 1.9132882778105653e-10
appeared O 0 1.6430622140628515e-10
to O 0 5.919216505834157e-11
be O 0 3.8068792562739873e-10
rare O 0 6.973071897675709e-09
or O 0 1.083731060447235e-08
absent O 0 0.0014788939151912928
in O 0 4.1495802349800215e-09
Asiatic O 0 3.789626816796954e-06
( O 0 1.5269688291574823e-11
Indian O 0 1.2284585571009643e-09
, O 0 1.2729207445050239e-11
Chinese O 0 1.4232142131476166e-09
) O 0 4.268252418171414e-11
populations O 0 9.43549266496646e-11
. O 0 3.2150104800621193e-09

The O 0 1.6422421200701365e-09
highest O 0 2.6790989426928036e-09
allele O 0 8.991636601951569e-11
frequency O 0 1.7792604056765526e-09
( O 0 5.983183783489499e-13
7 O 0 9.216180596460788e-11
. O 0 2.6805771144444712e-12
5 O 0 1.0986016783787189e-11
% O 0 1.3506511881145045e-11
) O 0 1.5905226896824332e-13
was O 0 4.2240166225893105e-11
found O 0 2.4941836790359773e-11
in O 0 1.1917687670059962e-10
Swedes O 0 1.5813182017154759e-06
. O 0 5.111228915666288e-07

Saamis O 1 0.9967177510261536
( O 0 2.925440167889093e-10
2 O 0 6.811342601054093e-10
% O 0 1.8936074930309132e-10
) O 0 2.0493891685676585e-13
and O 0 1.1108987861552233e-11
Mordvinians O 0 0.11302416771650314
( O 0 3.790407224202319e-12
1 O 0 1.9936979150925183e-11
. O 0 7.437292968981435e-13
8 O 0 6.8414254296433885e-12
% O 0 2.2291665041640485e-12
) O 0 3.902921144908686e-14
had O 0 7.230393584203854e-13
significantly O 0 4.7784172452214335e-12
lower O 0 6.008980119043272e-11
frequencies O 0 2.363795825743864e-09
of O 0 9.199290773587165e-10
the O 0 5.936838576303671e-09
Tyr O 0 2.3726720428385306e-06
allele O 0 8.254475858393562e-08
. O 0 1.2882976818673342e-07

Comparisons O 0 3.046233931769393e-09
with O 0 9.439230647112495e-12
allele O 0 8.059374695390531e-11
frequencies O 0 4.744945547585644e-10
based O 0 2.577448237478519e-12
on O 0 1.2206707866724287e-10
prevalence O 0 1.0921051840639961e-09
estimates O 0 3.227085612622638e-11
of O 0 2.2759853723908208e-10
HH B-Disease 0 0.1285228282213211
showed O 0 3.104149470800621e-08
some O 0 5.7139713099951805e-11
disagreements O 0 1.3812918098210503e-07
with O 0 1.4633717848600014e-11
the O 0 1.2811034455495474e-09
RFLP O 0 4.6217738258746976e-07
data O 0 2.9156224101711814e-08
, O 0 1.0874113415271225e-10
particularly O 0 2.496821915887182e-10
in O 0 1.667346594125263e-09
Finns O 0 7.612412900925847e-06
. O 0 4.515744080890727e-07

The O 0 4.344405368783555e-08
newly O 0 1.6093973442821152e-07
described O 0 1.3323612435556242e-08
HFE O 0 0.00019976797921117395
marker O 0 2.099411311462518e-08
provides O 0 3.9057198447656205e-11
a O 0 1.736450826878011e-12
new O 0 7.725054862288416e-13
approach O 0 4.20559073677218e-11
to O 0 7.520086983681118e-12
the O 0 1.2780856234462235e-11
screening O 0 2.6661242658043705e-10
of O 0 1.0050223986368678e-09
HH B-Disease 1 0.9998934268951416
as O 0 1.7080939440639042e-10
well O 0 5.377278830542842e-11
as O 0 2.255567911266243e-12
studies O 0 3.978266327475666e-11
of O 0 1.930402018790467e-11
the O 0 5.7682733589636825e-11
relationship O 0 1.4511213342061069e-09
between O 0 1.8948367319637782e-09
the O 0 4.34838254292913e-09
HFE O 0 1.5861385691096075e-05
Tyr O 0 1.8720662353644002e-07
allele O 0 2.1149801909814414e-09
and O 0 3.180061422525249e-11
different O 0 6.002307539887397e-09
disorders O 1 0.9937278032302856
including O 0 7.74906894207561e-08
cancer B-Disease 1 0.9999998807907104

Autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 0 0.32541656494140625
associated O 0 2.2013939116050096e-08
with O 0 6.5001285604049386e-12
a O 0 4.248806861895105e-11
missense O 0 1.879918887226495e-09
mutation O 0 3.0239317994062986e-11
encoding O 0 6.5494085710327e-09
Gly23 O 0 0.00018954584083985537
- O 0 7.776194979669526e-05
- O 0 3.892309905495495e-06
> O 0 3.2569084851274965e-07
Val O 0 1.8739196860906304e-08
in O 0 8.817996333121414e-10
neurophysin O 0 7.021399596851552e-06
II O 1 0.5658453702926636
. O 0 1.6062770100688795e-06

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 2.0963062397072463e-08
ADNDI B-Disease 1 1.0
) O 0 2.5321184385362905e-11
is O 0 4.369502155932015e-12
an O 0 8.107709642546368e-11
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 4.3008078876027866e-08
by O 0 8.289316455467599e-11
progressive O 0 0.11316943168640137
degeneration O 1 0.9999995231628418
of O 0 2.023645890858461e-07
the O 0 5.5602975557178524e-09
magnocellular O 0 1.0133353498531505e-06
neurons O 0 1.886061262723615e-08
of O 0 1.7276756691941841e-09
the O 0 3.914270241267559e-09
hypothalamus O 0 1.1667612653809556e-08
leading O 0 5.558855598053469e-09
to O 0 6.484408565654576e-10
decreased O 0 3.642891499566758e-08
ability O 0 4.096746275550345e-10
to O 0 5.477095860184633e-11
produce O 0 6.34601204918539e-10
the O 0 2.7344519981653548e-09
hormone O 0 6.116993134241966e-09
arginine O 0 6.798187968115599e-08
vasopressin O 0 1.6703450000932207e-07
( O 0 5.56405033158569e-10
AVP O 0 2.715996060942416e-06
) O 0 1.1123204579632784e-09
. O 0 4.119552343695432e-08

Affected O 0 1.9817569807401014e-07
individuals O 0 1.7085012571360636e-10
are O 0 1.496167079118038e-11
not O 0 5.5966811046692655e-11
symptomatic O 0 1.9788839011880555e-08
at O 0 1.582786957055049e-10
birth O 0 3.148733940250281e-09
, O 0 5.608336711704354e-12
but O 0 6.110068614256781e-12
usually O 0 3.4597830156357645e-10
develop O 0 3.9927618900037487e-07
diabetes B-Disease 1 0.9997320771217346
insipidus I-Disease 1 0.5797719359397888
at O 0 1.018049488266115e-06
1 O 0 1.7114636818860163e-07
- O 0 1.8738988671884727e-07
6 O 0 2.3010688465774365e-08
yr O 0 1.1143891924803029e-06
of O 0 2.115093433729953e-09
age O 0 2.4097200679307207e-08
. O 0 1.4264706749145262e-08

The O 0 7.491395059844308e-09
genetic O 0 3.0326681166314984e-09
locus O 0 4.677488951720932e-10
of O 0 5.971507177626734e-10
the O 0 1.1217589079848267e-09
disease O 0 1.732214229832607e-07
is O 0 3.2749035688145467e-12
the O 0 2.7134414715135335e-09
AVP O 1 0.8531174063682556
- O 0 0.02318914420902729
neurophysin O 1 0.8502070903778076
II O 1 1.0
( O 0 3.377668278403689e-08
NPII O 1 0.9999992847442627
) O 0 1.1755478535047104e-10
gene O 0 4.864317629249548e-11
, O 0 2.774904004493317e-12
and O 0 1.891707450407676e-11
mutations O 0 4.5010092875052976e-10
that O 0 1.0742624671766787e-11
cause O 0 1.3919204455703493e-08
ADNDI B-Disease 1 0.9999964237213135
have O 0 3.7074305431206156e-11
been O 0 2.2728346982248127e-11
found O 0 1.0924827665778625e-12
in O 0 3.050600137083359e-13
both O 0 8.696022417778448e-13
the O 0 3.474281409440727e-12
signal O 0 4.783063389801612e-10
peptide O 0 3.259705699809601e-11
of O 0 1.7786759565208143e-10
the O 0 1.9347941027092475e-09
prepro O 0 2.7731173759093508e-05
- O 0 3.456038029980846e-05
AVP O 0 0.0035665598697960377
- O 0 0.01009129174053669
NPII O 1 0.9999537467956543
precursor O 0 5.2039087705679776e-08
and O 0 2.1036258845974487e-10
within O 0 4.843328227366328e-08
NPII O 1 0.9997650980949402
itself O 0 7.311188543468461e-09
. O 0 1.8044492122726297e-08

An O 0 1.6186020301844906e-09
affected O 0 1.603784305359568e-08
girl O 0 1.2837659824072034e-07
who O 0 1.4510539991796634e-10
presented O 0 2.4968136447256484e-09
at O 0 8.959097907990099e-10
9 O 0 1.6748009923350793e-10
months O 0 1.0925172572173736e-10
of O 0 2.7535522473254304e-11
age O 0 1.2259726567265261e-09
and O 0 1.570369875802946e-11
her O 0 1.3872648862989223e-10
similarly O 0 3.428925754445089e-10
affected O 0 7.216406361365557e-10
younger O 0 3.7166172361935423e-09
brother O 0 5.89857496180457e-09
and O 0 5.873578706738769e-11
father O 0 5.8501750999084834e-08
were O 0 2.3704611606945036e-08
all O 0 1.8183710093211403e-10
found O 0 2.4714341684273222e-11
to O 0 1.6772038619050633e-11
have O 0 2.335148350726679e-12
a O 0 2.3917790491212454e-12
novel O 0 1.949196229769634e-12
missense O 0 1.0376414172341697e-09
mutation O 0 5.1689191121750966e-12
( O 0 1.4760302355365518e-12
G1758 O 0 4.6900768779778446e-07
- O 0 1.641031843746532e-07
- O 0 3.657511982169126e-08
> O 0 8.697163544901798e-10
T O 0 4.2264584193540955e-11
) O 0 1.2113400390991857e-14
encoding O 0 3.774096053038578e-12
the O 0 4.793050071422167e-12
amino O 0 1.2377427208165592e-11
acid O 0 3.764705994863116e-12
substitution O 0 3.5544778231866303e-10
Gly23 O 0 6.507827947643818e-06
- O 0 6.505184501293115e-06
- O 0 2.587169319667737e-06
> O 0 3.803595802764903e-07
Val O 0 1.494651087341481e-07
within O 0 1.8672875512493192e-07
NPII O 1 0.9995108842849731
. O 0 7.379742896773678e-07

The O 0 1.422813245000043e-08
mutation O 0 1.1317651260611683e-09
was O 0 3.025548700463787e-10
confirmed O 0 1.0874092598589513e-10
by O 0 4.631913342462157e-12
restriction O 0 1.2901463231074217e-10
endonuclease O 0 2.8219093728409916e-09
analysis O 0 9.218264374055707e-09
. O 0 3.5926166930266845e-08

A O 0 7.991847041921574e-07
T1 O 0 6.529156962642446e-06
- O 0 4.259359531744167e-09
weighted O 0 3.0940604245355274e-11
magnetic O 0 2.0012155821369504e-10
resonance O 0 1.1415123291058649e-09
imaging O 0 8.636948933826716e-08
of O 0 6.638996019603383e-09
the O 0 2.2088933349095896e-08
fathers O 0 1.4748252397112083e-06
pituitary O 0 2.4288899567181943e-06
gland O 0 6.045949163535624e-08
demonstrates O 0 4.5302437357008785e-09
an O 0 1.2804994564685757e-10
attenuated O 0 1.004078399091668e-06
posterior O 0 1.311009418714093e-05
pituitary O 0 0.00674990750849247
bright O 0 1.4342605027195532e-05
spot O 0 6.352255149977282e-05
. O 0 1.6846563539729686e-06

This O 0 7.405699165019541e-09
mutation O 0 6.229436078086792e-09
may O 0 1.468435928408951e-10
be O 0 8.014643115838993e-11
valuable O 0 2.500769369362388e-09
for O 0 2.0933185740368287e-11
developing O 0 1.194138010696122e-09
models O 0 1.0560927687919275e-09
of O 0 1.851550246456668e-09
dominantly B-Disease 0 0.001753740245476365
inherited I-Disease 1 0.9999986886978149
neurodegeneration I-Disease 1 1.0
, O 0 2.6242039097290615e-10
as O 0 1.9854584556305843e-12
the O 0 2.090173520374883e-12
early O 0 5.211154285866826e-10
age O 0 8.694576170142909e-10
of O 0 1.037619226651465e-10
onset O 0 2.4937698981375434e-05
of O 0 3.044481289293799e-08
symptoms O 0 5.797860012535239e-06
suggests O 0 1.1126934096328256e-10
that O 0 5.660789762287899e-13
this O 0 8.712246202247087e-12
mutation O 0 6.002381924830047e-11
may O 0 3.6902661482152155e-11
be O 0 3.227604294941955e-10
particularly O 0 2.4704938095254647e-09
deleterious O 0 1.6726094287378146e-08
to O 0 1.1506495756208324e-09
the O 0 8.987293398377005e-08
magnocellular O 0 0.00010905132512561977
neuron O 0 4.848901653531357e-07
. O 0 8.507925031153718e-09
. O 0 6.555259801643842e-08

Frequent O 0 1.7468060775627237e-07
inactivation O 0 3.0050919122004416e-06
of O 0 4.708093183580786e-05
PTEN O 1 0.9990693926811218
/ O 1 0.9881975054740906
MMAC1 O 1 0.9999998807907104
in O 0 1.2620847478217456e-08
primary O 1 0.9405372738838196
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.037661594542442e-06

Sporadic B-Disease 1 0.9999982118606567
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.253079972229898e-06
the O 0 4.6795554453638033e-07
most O 0 1.2604578492059204e-09
common O 0 6.383770845275194e-09
male B-Disease 0 1.4859345753848174e-07
cancer I-Disease 0 3.5604429626800993e-07
in O 0 4.061100788987915e-09
the O 0 2.1262364668928058e-07
Western O 0 1.1917552910745144e-05
world O 0 1.0807538197710187e-09
, O 0 6.469935264624693e-12
yet O 0 2.5700807801398717e-11
many O 0 5.848441847998431e-13
of O 0 8.802225441584266e-12
the O 0 1.3300182136188887e-11
major O 0 7.456376488468308e-11
genetic O 0 1.2717031594444705e-10
events O 0 1.0475415673782962e-11
involved O 0 2.2518004128002644e-10
in O 0 5.2248656789988246e-11
the O 0 1.7666056117970896e-10
progression O 0 2.990021243931551e-07
of O 0 1.3482305272205508e-09
this O 0 1.8293359882459725e-10
often O 0 5.178498518887409e-09
fatal O 0 0.0008528588223271072
cancer B-Disease 0 0.003366363001987338
remain O 0 1.8280492213307298e-06
to O 0 4.381609741699322e-09
be O 0 2.1753985279815424e-08
elucidated O 0 8.118682308122516e-05
. O 0 6.859698373773426e-07

Numerous O 0 8.464679268627151e-08
cytogenetic O 0 1.0020342415373307e-05
and O 0 2.475078364483352e-09
allelotype O 0 4.33207878813846e-06
studies O 0 2.700873524830172e-09
have O 0 1.0956087382815727e-12
reported O 0 1.351024760815056e-11
frequent O 0 9.322341509854226e-12
loss O 0 5.557909132924976e-10
of O 0 1.3957966338296046e-08
heterozygosity O 0 0.00020190465147607028
on O 0 1.767402011410013e-07
chromosomal O 0 9.78720527200494e-06
arm O 0 5.1262286433484405e-06
10q O 0 0.00011841566447401419
in O 0 2.787784758595535e-08
sporadic B-Disease 1 0.9999991655349731
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.3344564397120848e-05

Deletion O 0 1.1153322247992037e-06
mapping O 0 1.6863877760897594e-07
studies O 0 7.820694314375487e-09
have O 0 4.7468709518661e-11
unambiguously O 0 7.868299900515296e-10
identified O 0 4.039491519058913e-10
a O 0 2.7203930080821337e-11
region O 0 2.8364521842405566e-09
of O 0 3.780960433630298e-09
chromosome O 0 1.8717157601599865e-08
10q23 O 0 1.5861845668041497e-06
to O 0 6.15259301839366e-11
be O 0 3.037447030007634e-11
the O 0 1.6214438125494723e-10
minimal O 0 8.758415503962169e-08
area O 0 9.270769152358582e-10
of O 0 2.6373618844388602e-09
loss O 0 9.166510750446832e-08
. O 0 2.9913931598457566e-07

A O 0 2.320932026123046e-06
new O 0 1.440587471535082e-08
tumor B-Disease 0 2.679765316315752e-07
suppressor O 0 5.7811138987062805e-08
gene O 0 5.166065908390749e-10
, O 0 2.970562962278933e-10
PTEN O 0 7.621119584655389e-05
/ O 0 0.003928551450371742
MMAC1 O 1 1.0
, O 0 4.183631774345997e-10
was O 0 8.416409791323076e-09
isolated O 0 2.114169728173465e-09
recently O 0 2.914861754743647e-11
at O 0 1.8640426008298405e-11
this O 0 1.379927097068523e-12
region O 0 3.0281527285680454e-10
of O 0 2.7356189535865383e-10
chromosome O 0 8.478247437437858e-09
10q23 O 0 1.013716996567382e-06
and O 0 1.2784567848811434e-10
found O 0 8.533383027975461e-11
to O 0 1.3770355515585475e-11
be O 0 2.412741447604949e-12
inactivated O 0 1.6596507154686968e-11
by O 0 3.910195734910249e-13
mutation O 0 9.385088192703783e-12
in O 0 3.0268634820806994e-11
three O 0 1.0174557196762635e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.00014186663611326367
lines O 0 1.0496631119849553e-08
. O 0 1.3689326117116707e-08

We O 0 4.598621572426964e-08
screened O 0 9.238439702130563e-08
80 O 0 1.2172176866442896e-07
prostate B-Disease 0 0.0007645090227015316
tumors I-Disease 1 1.0
by O 0 7.800500523291731e-11
microsatellite O 0 1.0327452670821913e-08
analysis O 0 5.530331192993287e-10
and O 0 9.653220063576828e-12
found O 0 5.115234277819347e-11
chromosome O 0 4.812594212033616e-10
10q23 O 0 1.853442057608845e-07
to O 0 5.15553322255613e-10
be O 0 1.2030630935910835e-09
deleted O 0 1.421364803633196e-08
in O 0 7.397474993675601e-11
23 O 0 8.888618729940845e-09
cases O 0 5.854678963856941e-10
. O 0 2.3617060307401516e-08

We O 0 6.1697682518513375e-09
then O 0 2.895456617524328e-11
proceeded O 0 3.7959307919166463e-10
with O 0 5.536620356519188e-14
sequence O 0 3.6184115599635636e-12
analysis O 0 1.124523391071719e-11
of O 0 1.4651004368038123e-11
the O 0 4.913065440592668e-11
entire O 0 2.3739276855394564e-07
PTEN O 0 1.8538623407948762e-05
/ O 0 8.053106625993678e-07
MMAC1 O 1 0.585045337677002
coding O 0 3.355494754941901e-06
region O 0 2.2251893661007216e-09
and O 0 3.314872681903225e-12
tested O 0 4.111147186569575e-11
for O 0 6.533527625168789e-12
homozygous O 0 1.7636968274725717e-10
deletion O 0 8.195540079913854e-11
with O 0 3.4512375596262856e-12
new O 0 9.793317545803149e-11
intragenic O 0 5.1467441153363325e-06
markers O 0 8.569285836479423e-10
in O 0 1.7018135164970083e-11
these O 0 5.337984394782058e-12
23 O 0 1.1158345775141854e-10
cases O 0 1.7428348261100401e-12
with O 0 4.995317961359325e-12
10q23 O 0 1.2054740636813221e-06
loss O 0 2.650060260123155e-08
of O 0 2.0760833763233677e-07
heterozygosity O 0 0.0013868316309526563
. O 0 3.881122665916337e-06

The O 0 9.523186683679796e-10
identification O 0 1.4854154350985027e-08
of O 0 4.5360368794433725e-09
the O 0 5.055228458061833e-10
second O 0 3.621220212579601e-09
mutational O 0 4.9093074494521716e-08
event O 0 2.582696556618913e-10
in O 0 6.630244964167531e-11
10 O 0 1.5496585958896247e-10
( O 0 2.0283980658314382e-12
43 O 0 8.95927332322799e-09
% O 0 4.926404617577873e-09
) O 0 1.0449123788447423e-09
tumors B-Disease 1 0.9999998807907104
establishes O 0 4.831564126561716e-08
PTEN O 0 6.312990444712341e-05
/ O 0 0.001620726310648024
MMAC1 O 1 0.9999998807907104
as O 0 3.785114999210748e-10
a O 0 4.9495029602608653e-11
main O 0 1.2392198378563535e-10
inactivation O 0 7.77498510018404e-10
target O 0 2.767739093467725e-10
of O 0 1.0968439490000037e-09
10q O 0 5.896907168789767e-06
loss O 0 1.2223869028105128e-08
in O 0 2.0259267596856034e-09
sporadic B-Disease 1 0.99036705493927
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.2154598983424876e-08
. O 0 2.1103394587385083e-08

Risk O 0 4.269522833055817e-06
reversals O 0 4.110299300918996e-07
in O 0 3.857973940313286e-10
predictive O 0 2.4370047313482246e-08
testing O 0 2.795136122557551e-09
for O 0 1.5113705842395575e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.1621474388666684e-07

The O 0 9.66551949588279e-10
first O 0 5.865294361306894e-11
predictive O 0 4.800447261921192e-10
testing O 0 3.844925419715928e-11
for O 0 6.759006132561751e-10
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 5.527211175727909e-13
HD B-Disease 0 2.3452281538993702e-07
) O 0 1.7851784503766788e-13
was O 0 2.0846393188056478e-12
based O 0 4.1343379999884966e-14
on O 0 4.5429649625505775e-12
analysis O 0 6.466410046312987e-11
of O 0 4.2610612954741e-11
linked O 0 1.2277183714104467e-09
polymorphic O 0 5.959685522860525e-10
DNA O 0 2.991695069454181e-08
markers O 0 1.5017372068104606e-10
to O 0 4.065669675923367e-11
estimate O 0 2.091926493141827e-10
the O 0 2.8246798997044742e-11
likelihood O 0 1.1209952965884895e-09
of O 0 6.250808759489246e-10
inheriting O 0 8.786223304468876e-08
the O 0 2.478952376705479e-09
mutation O 0 8.17668266428484e-10
for O 0 1.5261260033483381e-09
HD B-Disease 0 0.0004159659438300878
. O 0 8.79143499332713e-07

Limits O 0 8.398898465600269e-09
to O 0 4.087144511721874e-11
accuracy O 0 2.1516244341768243e-09
included O 0 1.7069954824644462e-11
recombination O 0 3.328863920626368e-11
between O 0 7.617433073203728e-11
the O 0 3.253308039630198e-11
DNA O 0 1.5607245273940862e-08
markers O 0 1.2832744589186262e-10
and O 0 5.523167426885189e-12
the O 0 7.696971532356045e-11
mutation O 0 6.044257455650737e-11
, O 0 6.73295707381838e-12
pedigree O 0 2.2027832891069465e-09
structure O 0 2.4535324882890563e-09
, O 0 5.963112816032012e-12
and O 0 1.9829604538251777e-12
whether O 0 4.775565359826928e-12
DNA O 0 2.454084713221505e-09
samples O 0 6.741133345977701e-11
were O 0 1.6138930469811186e-11
available O 0 5.2457555660412325e-11
from O 0 1.519264575255974e-11
family O 0 4.6085368160531104e-11
members O 0 2.5473156917144024e-10
. O 0 5.5198508874809704e-08

With O 0 5.7362586902698354e-11
direct O 0 6.537644731130499e-11
tests O 0 2.6765933219818905e-11
for O 0 3.080773700384065e-12
the O 0 4.3505518632080964e-11
HD B-Disease 0 9.07149853901501e-07
mutation O 0 1.6929978252644418e-11
, O 0 2.2179433040604019e-13
we O 0 1.0885515579206473e-12
have O 0 1.1452457363524127e-13
assessed O 0 2.5015016100193854e-11
the O 0 1.6493371338827112e-12
accuracy O 0 9.860027239128044e-10
of O 0 9.695735533887806e-12
results O 0 4.3629310234050145e-12
obtained O 0 1.1883979911253562e-10
by O 0 9.025481750857267e-12
linkage O 0 3.1278495349340574e-09
approaches O 0 4.5107123591847653e-10
when O 0 1.4904192463527366e-11
requested O 0 2.0827298219394663e-10
to O 0 1.0237676678626073e-10
do O 0 6.695297788406052e-11
so O 0 5.449343667279782e-12
by O 0 4.66314270183843e-12
the O 0 4.798796776617209e-11
test O 0 1.7348106284842402e-10
individuals O 0 2.251293595989523e-10
. O 0 2.8190756395929384e-08

For O 0 1.8033337045864073e-09
six O 0 3.7271857822318566e-10
such O 0 7.086339978354395e-13
individuals O 0 1.5499379123901091e-12
, O 0 7.004543429653398e-13
there O 0 2.3367612098784685e-12
was O 0 7.832928056172861e-11
significant O 0 1.5192479219106048e-10
disparity O 0 6.371654759362855e-09
between O 0 1.4869078190926643e-10
the O 0 1.5951309717543438e-10
tests O 0 1.95505989175615e-09
. O 0 4.2745156747514557e-08

Three O 0 9.0874907598959e-09
went O 0 4.0262115419409383e-08
from O 0 3.378470281312218e-10
a O 0 6.953315700997109e-11
decreased O 0 1.998871645980671e-08
risk O 0 1.4578174778456798e-10
to O 0 9.294755937139243e-11
an O 0 9.821914982721669e-12
increased O 0 8.12184541842953e-10
risk O 0 3.825111616340138e-10
, O 0 1.7739241065656275e-12
while O 0 7.499017899703642e-12
in O 0 4.2224197228935e-12
another O 0 1.4698223541054212e-11
three O 0 1.215519351838168e-11
the O 0 2.182398983752165e-10
risk O 0 1.9675392426421467e-09
was O 0 5.000711400526825e-09
decreased O 0 4.363664345419238e-07
. O 0 4.085100613338e-08

Knowledge O 0 5.31946134287864e-05
of O 0 8.171669918510815e-08
the O 0 1.9901778003372783e-09
potential O 0 3.6254135804547616e-10
reasons O 0 9.460504601932485e-11
for O 0 8.633979490559052e-13
these O 0 9.849299110673004e-13
changes O 0 1.9635289488090235e-12
in O 0 8.112451682640298e-13
results O 0 2.7342822450648896e-11
and O 0 6.408990959466676e-12
impact O 0 1.7433020305102076e-10
of O 0 2.4687628677466655e-11
these O 0 4.66552707925616e-12
risk O 0 2.9836043358155706e-11
reversals O 0 4.283488841405614e-10
on O 0 7.48790196514193e-11
both O 0 5.177436951386838e-11
patients O 0 4.031478761934437e-10
and O 0 2.8659609407899467e-12
the O 0 1.2502428259342224e-10
counseling O 0 6.06396310942614e-09
team O 0 6.24028745344063e-11
can O 0 9.80355466945193e-12
assist O 0 4.356642602232341e-09
in O 0 3.0598690248240246e-11
the O 0 6.91799534324744e-11
development O 0 2.3759552103541637e-09
of O 0 6.142814035214883e-11
strategies O 0 4.5444084606494073e-10
for O 0 2.9400874096419116e-12
the O 0 3.210435736700212e-11
prevention O 0 3.937881132287657e-09
and O 0 2.9515495950094284e-12
, O 0 1.7140702377425876e-13
where O 0 3.0007569237593124e-13
necessary O 0 3.818922678089365e-10
, O 0 2.0375337701772356e-12
management O 0 2.3551551819878114e-09
of O 0 3.6737499153893793e-10
a O 0 2.204950944051376e-10
risk O 0 8.316226041138464e-10
reversal O 0 5.781063960874633e-10
in O 0 1.5562363897547726e-11
any O 0 2.181399158529551e-11
predictive O 0 1.142736572035119e-09
testing O 0 7.532278273325588e-11
program O 0 1.6321091145243827e-09
. O 0 1.7008215669189752e-10
. O 0 5.772736955123037e-09

A O 0 1.5997203206552513e-07
novel O 0 2.42713543707751e-10
common O 0 3.5130601205857204e-10
missense O 0 2.871504278800785e-08
mutation O 0 2.891495654022691e-10
G301C O 0 2.0699479463814896e-08
in O 0 2.1167257183152266e-11
the O 0 2.190940762147875e-10
N O 0 3.352067423634253e-08
- O 0 2.7103290278773784e-08
acetylgalactosamine O 0 3.10647078549664e-06
- O 0 6.93245496563577e-08
6 O 0 2.277038468889714e-08
- O 0 1.4318106700272892e-08
sulfate O 0 2.07501460458559e-09
sulfatase O 0 2.8925521533551546e-08
gene O 0 8.29739887908687e-11
in O 0 4.2231484975729927e-10
mucopolysaccharidosis B-Disease 0 1.671869722486008e-05
IVA I-Disease 1 0.9999942779541016
. O 0 1.0871452104765922e-05

Mucopolysaccharidosis B-Disease 0 0.4096389412879944
IVA I-Disease 1 1.0
( O 0 2.057978463199106e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 3.060993014614155e-09
is O 0 4.8601074553733525e-11
an O 0 2.2696648727116298e-10
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
caused O 0 2.5978229700740485e-07
by O 0 2.0490246999127493e-10
a O 0 8.424343889146257e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 5.780512735142906e-10
N O 0 9.595392924666157e-09
- O 0 5.5797180209538055e-09
acetylgalactosamine O 0 8.944444402914087e-07
- O 0 2.1092125379595927e-08
6 O 0 1.6709703842821e-08
- O 0 5.395337510094578e-08
sulfate O 0 4.061952996181617e-09
sulfatase O 0 1.9319341504342447e-07
( O 0 1.1272791727856557e-10
GALNS O 0 0.0001739609579090029
) O 0 3.850974816810293e-10
. O 0 2.1361033830658016e-08

In O 0 4.5679091620343115e-09
previous O 0 1.3363798956333994e-08
studies O 0 1.0064169497780995e-09
, O 0 5.011503365071057e-12
we O 0 6.158953989171545e-12
have O 0 6.383221859071475e-13
found O 0 1.4740607822902319e-12
two O 0 7.824498427649873e-13
common O 0 1.3564677159294547e-11
mutations O 0 4.4919592351311266e-11
in O 0 1.084941858575661e-10
Caucasians O 0 2.284350841819105e-08
and O 0 1.8618510899681695e-10
Japanese O 0 8.773778290560585e-07
, O 0 3.5906605466706765e-10
respectively O 0 4.5094265033185366e-07
. O 0 1.769920174865547e-07

To O 0 1.6867224417183024e-07
characterize O 0 3.882521923515014e-06
the O 0 2.38628850013356e-08
mutational O 0 3.0956853152019903e-06
spectrum O 0 2.0039639281321797e-08
in O 0 9.653496751971247e-12
various O 0 2.0066575137644982e-11
ethnic O 0 8.265713113964068e-11
groups O 0 1.3113920756605002e-12
, O 0 3.839878989862072e-13
mutations O 0 1.3818760588937828e-12
in O 0 2.320186794427248e-12
the O 0 2.6763344318503357e-10
GALNS O 0 0.0002196499117417261
gene O 0 7.074921898331255e-11
in O 0 6.604093660822485e-11
Colombian O 0 2.1377098164521158e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 7.001988251431612e-07
were O 0 1.2120779935287374e-09
investigated O 0 1.972582097664599e-09
, O 0 4.3865701002121504e-12
and O 0 3.3513955499664405e-12
genetic O 0 3.915067159354635e-10
backgrounds O 0 1.78151182694819e-09
were O 0 2.6501234540177165e-10
extensively O 0 5.617560305815061e-10
analyzed O 0 3.31006166920389e-10
to O 0 1.8281770194916724e-11
identify O 0 3.9227812664854866e-10
racial O 0 1.8991476793961404e-11
origin O 0 1.858015304112559e-11
, O 0 1.38679703571426e-13
based O 0 7.239276859178842e-14
on O 0 1.1584748785264942e-11
mitochondrial O 0 1.169088020835929e-10
DNA O 0 8.043657295786488e-09
( O 0 2.1750757445149205e-11
mtDNA O 0 3.5773664031069075e-09
) O 0 5.093621011087457e-11
lineages O 0 3.010997007280025e-09
. O 0 4.295815259069968e-08

Three O 0 2.415361777252656e-08
novel O 0 1.7311952982268508e-09
missense O 0 2.9182717753428733e-07
mutations O 0 1.0075194012415523e-09
never O 0 3.105545376413943e-09
identified O 0 4.390343644189443e-09
previously O 0 5.416616932762963e-09
in O 0 5.2250256205033097e-11
other O 0 2.1017639018072742e-11
populations O 0 7.353916954555562e-12
and O 0 1.4633039788561342e-12
found O 0 2.0452285698357997e-11
in O 0 1.0568696091894925e-11
16 O 0 4.2042058723268383e-10
out O 0 9.171617458558767e-12
of O 0 9.608532719473928e-11
19 O 0 4.297435740596711e-09
Colombian O 0 1.1301238373562228e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 2.0003024303605343e-07
alleles O 0 2.942587007392916e-10
account O 0 1.844133734607567e-10
for O 0 1.6281656578520654e-10
84 O 0 3.3436327839808655e-07
. O 0 3.160776600452664e-07

2 O 0 5.927947910322473e-08
% O 0 1.317283349067111e-08
of O 0 2.328746084856448e-10
the O 0 6.27985649592766e-11
alleles O 0 1.1296289424700401e-11
in O 0 8.592551149766425e-12
this O 0 1.8994266229310774e-11
study O 0 6.611204916850966e-10
. O 0 1.0030676733663313e-08

The O 0 4.189173523627687e-07
G301C O 0 4.3223095417488366e-05
and O 0 4.409805853811122e-09
S162F O 0 4.642382918973453e-06
mutations O 0 9.894164376689218e-10
account O 0 6.270317598477959e-11
for O 0 1.6195274288310912e-10
68 O 0 2.788625579341897e-06
. O 0 6.863663770673156e-07

4 O 0 1.4070597842419375e-07
% O 0 1.4963577044113663e-08
and O 0 1.0288768448329932e-10
10 O 0 5.090362353854516e-09
. O 0 1.5922203999707563e-08

5 O 0 5.044715223334606e-08
% O 0 5.636796363006624e-09
of O 0 2.55187232456322e-10
mutations O 0 2.943034357882901e-11
, O 0 1.68316380798339e-12
respectively O 0 6.760270121475287e-10
, O 0 1.699918200995243e-12
whereas O 0 6.808286573400935e-11
the O 0 1.2996724529923398e-10
remaining O 0 6.482133017016167e-07
F69V O 1 0.9988590478897095
is O 0 1.4411293339233744e-11
limited O 0 3.341357399100353e-11
to O 0 2.7180124470560507e-11
a O 0 1.488136280869412e-10
single O 0 6.499395244219386e-09
allele O 0 7.832669979279672e-08
. O 0 1.591245109011652e-07

The O 0 4.8342929659384026e-08
skewed O 0 6.883599468210377e-08
prevalence O 0 1.0801938010729373e-08
of O 0 5.795040558531639e-10
G301C O 0 1.5860742053064314e-07
in O 0 7.759052081390827e-12
only O 0 9.037091387720242e-12
Colombian O 0 3.299103923382063e-08
patients O 0 3.5288216793105676e-10
and O 0 3.154842923361323e-12
haplotype O 0 4.587637214559237e-11
analysis O 0 1.211022948588436e-11
by O 0 5.172614723700231e-13
restriction O 0 3.2412844110096817e-12
fragment O 0 5.160046001595475e-11
length O 0 2.8623911574321426e-10
polymorphisms O 0 1.678431393870028e-09
in O 0 9.556880981032023e-11
the O 0 6.29433660748191e-09
GALNS O 1 0.9284282326698303
gene O 0 1.1217716755496099e-09
suggest O 0 7.634557430691302e-10
that O 0 4.717444750806932e-12
G301C O 0 1.3360963180275576e-07
originated O 0 6.672964958376326e-10
from O 0 8.324950451221724e-11
a O 0 9.117395033397813e-11
common O 0 2.2521149389831407e-09
ancestor O 0 4.5976921114743163e-07
. O 0 5.764608204117394e-07

Investigation O 0 4.97180280945031e-07
of O 0 4.917291818173908e-08
the O 0 4.175693568697625e-09
genetic O 0 1.8165035031714183e-09
background O 0 3.3282943068257964e-10
by O 0 1.5285882368903936e-12
means O 0 3.205126719585394e-10
of O 0 1.4999974595752974e-09
mtDNA O 0 1.8733301132556335e-08
lineages O 0 1.4176512741492786e-10
indicate O 0 5.641857120375349e-11
that O 0 5.906353964940658e-13
all O 0 1.2737975604859564e-11
our O 0 1.2269084637139827e-09
patients O 0 1.4551920779481975e-10
are O 0 1.3643161036677731e-12
probably O 0 1.9303957043970144e-10
of O 0 4.206379411453298e-10
native O 0 1.0075001943832262e-09
American O 0 2.5746331289155933e-08
descent O 0 0.00012280333612579852

Low O 0 1.666222715357435e-07
frequency O 0 1.9564746267519695e-08
of O 0 6.221231085845602e-09
BRCA1 O 0 1.5687737331404605e-08
germline O 0 7.717607530821624e-08
mutations O 0 3.045046159666498e-11
in O 0 1.231507083809813e-11
45 O 0 4.970216238575631e-09
German O 1 0.9999994039535522
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.3547818866754824e-07
. O 0 3.680978011288971e-08

In O 0 2.612095428844441e-09
this O 0 2.837937523869627e-11
study O 0 1.084858591848814e-11
we O 0 6.971727882498779e-13
investigated O 0 2.2065066787591014e-11
45 O 0 5.513963174941239e-10
German O 1 0.9679982662200928
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.159743743377021e-10
for O 0 4.631094119300627e-11
germline O 0 8.895966630007024e-08
mutations O 0 4.829796979022305e-11
in O 0 2.6385567342135374e-11
the O 0 3.001226600574114e-09
BRCA1 O 0 4.43437748742781e-08
gene O 0 2.1120536430885295e-09
. O 0 3.818482241513266e-08

We O 0 2.8512237904010362e-08
identified O 0 2.1878861389268422e-08
four O 0 6.004159947003984e-10
germline O 0 8.840956979838666e-07
mutations O 0 1.3058454317871337e-09
in O 0 6.724387713319402e-11
three O 0 1.5439682865547866e-09
breast B-Disease 0 7.961562573655101e-07
cancer I-Disease 0 7.760352787045122e-07
families O 0 2.8844174271291934e-10
and O 0 2.0574712072951584e-11
in O 0 1.2371869084759624e-09
one O 0 3.8032655993447406e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.9597650862124283e-06
. O 0 1.8379815724944848e-10
among O 0 6.166873652360683e-13
these O 0 1.0888002738990155e-13
were O 0 4.238460710875858e-12
one O 0 4.675522122243869e-12
frameshift O 0 5.94492854943951e-09
mutation O 0 9.516408494558704e-11
, O 0 2.4773145340661884e-11
one O 0 2.394314746467785e-10
nonsense O 0 5.412983341557265e-07
mutation O 0 1.2298487783724e-09
, O 0 1.6710476752335168e-11
one O 0 1.7319003869920024e-11
novel O 0 4.10276534967835e-11
splice O 0 5.1828887848159866e-08
site O 0 6.325033830023585e-10
mutation O 0 9.440244419511856e-11
, O 0 3.7078742853857705e-12
and O 0 3.6594186014760055e-11
one O 0 1.514136926950016e-09
missense O 0 4.666596396418754e-06
mutation O 0 8.938265949609558e-08
. O 0 3.452818759797083e-07

The O 0 5.787358858810876e-08
missense O 0 7.704222184656828e-07
mutation O 0 2.3021915485088584e-09
was O 0 5.282146275931154e-09
also O 0 5.841246236704123e-11
found O 0 1.349938355543756e-10
in O 0 5.059559438080896e-10
2 O 0 1.9259793759829336e-07
. O 0 2.5050104568435927e-07

8 O 0 1.1677680333832541e-07
% O 0 2.351857197879781e-08
of O 0 4.473467707377665e-10
the O 0 1.60276750205135e-10
general O 0 6.865550350454441e-10
population O 0 6.161726944647894e-12
, O 0 4.996258398323739e-13
suggesting O 0 3.730697348269807e-11
that O 0 3.9529390503077744e-13
it O 0 2.917834702152733e-13
is O 0 3.3206057261508937e-12
not O 0 3.9170391930021253e-10
disease O 0 1.3485341696650721e-06
associated O 0 8.975317200565769e-07
. O 0 1.9240899291617097e-06

The O 0 5.437173822286923e-09
average O 0 1.3824792421957e-09
age O 0 1.2996012044297345e-09
of O 0 2.941818177948363e-10
disease O 0 1.2457456932679634e-07
onset O 0 2.1333067934392602e-07
in O 0 3.338503432037676e-11
those O 0 5.01957989063051e-11
families O 0 6.981742267653246e-11
harbouring O 0 1.7939318297521822e-07
causative O 0 1.552692907580422e-08
mutations O 0 2.539346732888248e-09
was O 0 6.983973399599108e-09
between O 0 2.0731999228473796e-08
32 O 0 6.421361717912077e-07
. O 0 2.198977284706416e-07

3 O 0 1.8583729399779259e-07
and O 0 4.937024122853018e-09
37 O 0 5.687850261892891e-07
. O 0 1.8154763381517114e-07

4 O 0 5.055001750520205e-08
years O 0 2.8341269331377816e-09
, O 0 7.200766025117211e-12
whereas O 0 1.191718806969888e-10
the O 0 3.1077525969314124e-11
family O 0 4.3304096419838345e-11
harbouring O 0 2.3981517216498105e-08
the O 0 1.383330533455407e-10
missense O 0 3.316257846108783e-08
mutation O 0 8.453646116457492e-11
had O 0 1.0130177946487962e-11
an O 0 9.635644197683937e-14
average O 0 2.024306243464391e-11
age O 0 3.3513353203673546e-10
of O 0 4.965277078383679e-10
onset O 0 2.3315451471717097e-06
of O 0 1.8356243458583776e-07
51 O 0 2.1110997749929084e-06
. O 0 8.930356329983624e-07

2 O 0 6.158566634439921e-07
years O 0 1.8942546375910752e-07
. O 0 2.633227325077314e-07

These O 0 4.329661962287901e-09
findings O 0 2.437338109118059e-09
show O 0 5.89409576701172e-10
that O 0 8.964797654220646e-12
BRCA1 O 0 2.5099253786464715e-09
is O 0 3.81808864038935e-12
implicated O 0 9.38986488563387e-09
in O 0 1.9351696634029025e-10
a O 0 9.980627435624001e-11
small O 0 1.4545615580063842e-11
fraction O 0 1.3732128767429685e-09
of O 0 6.808269858993299e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.359733933398616e-10
suggesting O 0 2.004813502709535e-11
the O 0 7.077910848564406e-13
involvement O 0 7.727449929939567e-11
of O 0 9.426857905392438e-11
another O 0 7.855265743428319e-11
susceptibility O 0 1.0554664919837364e-09
gene O 0 1.9252478777875837e-10
( O 0 1.1926215570667864e-10
s O 0 1.0544292194936133e-07
) O 0 1.0328875532650272e-07

Paternal O 0 1.7223357644979842e-05
transmission O 1 0.9999825954437256
of O 0 0.2244674265384674
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9994105100631714

We O 0 4.6513555673755036e-08
report O 0 1.1840589619893649e-09
a O 0 2.4378749019504653e-11
rare O 0 1.1311900201260716e-11
case O 0 1.4229929734543845e-11
of O 0 7.942090873847008e-10
paternally O 1 0.9995366334915161
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.650977512530517e-05
DM B-Disease 1 1.0
) O 0 2.6097897176668994e-09
. O 0 1.346211409014586e-08

The O 0 2.5750512122613145e-07
proband O 0 0.000233764891163446
is O 0 1.3652390329355057e-10
a O 0 2.833491601073046e-11
23 O 0 2.506383711686766e-10
year O 0 4.645478793308122e-11
old O 0 5.532330860091861e-08
, O 0 2.490990191894582e-10
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 5.720860372093739e-07
who O 0 4.403459819002364e-09
suffers O 1 0.9992629885673523
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999998807907104

He O 0 6.556757359277299e-09
presented O 0 1.1979757630342647e-08
with O 0 2.675166976828791e-09
respiratory O 1 0.9999957084655762
and O 0 2.7485651532543898e-09
feeding O 0 8.801503526001397e-08
difficulties O 0 0.0002923411666415632
at O 0 4.137269371540242e-08
birth O 0 1.2863116580774658e-06
. O 0 3.8061287455093407e-07

His O 0 2.474523341788881e-07
two O 0 1.6619592813071904e-08
sibs O 0 0.000736268877517432
suffer O 0 5.007777303944749e-07
from O 0 2.997292725126499e-08
childhood O 1 0.9968920350074768
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 5.251507445791503e-06

Their O 0 2.5812942894276603e-09
late O 0 4.688882881964673e-08
father O 0 1.785216952043811e-08
had O 0 6.160343068994933e-11
the O 0 1.1047494299573635e-12
adult O 0 1.2230098878074358e-11
type O 0 1.9346040394663255e-11
of O 0 3.655613145525649e-09
DM B-Disease 1 1.0
, O 0 2.588901037992031e-10
with O 0 3.1109372022886106e-11
onset O 0 0.0018731902819126844
around O 0 1.0146297135804616e-09
30 O 0 1.6136022518153936e-09
years O 0 1.3754618555239517e-09
. O 0 1.1668858768132395e-08

Only O 0 1.1513653364048082e-09
six O 0 1.394938192733619e-10
other O 0 4.658233434401415e-13
cases O 0 9.692347835779658e-13
of O 0 1.2162869669762877e-11
paternal O 0 7.123679068854472e-08
transmission O 1 0.9999955892562866
of O 0 0.000124338548630476
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 1.0481346457424934e-08
been O 0 2.427278933403443e-10
reported O 0 4.1034875497558687e-10
recently O 0 6.887190817650435e-10
. O 0 6.592508761116278e-09

We O 0 5.000616365435917e-09
review O 0 1.689924034042889e-10
the O 0 2.082089188559788e-11
sex O 0 9.133509053238509e-12
related O 0 6.807987507073676e-11
effects O 0 1.0523723559252574e-10
on O 0 8.888169367171628e-11
transmission O 0 0.015969661995768547
of O 0 2.251554178656079e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 6.544004281749949e-05

Decreased O 0 8.954609711508965e-07
fertility O 0 7.0874088820005454e-09
of O 0 7.596322876279871e-11
males O 0 1.515432744569889e-11
with O 0 9.262160943811562e-14
adult O 0 2.943277288558477e-10
onset O 0 3.7051766412332654e-05
DM B-Disease 1 1.0
and O 0 2.061624204685586e-10
contraction O 0 3.1605695838266e-09
of O 0 1.0446288972731921e-10
the O 0 2.4325010755665843e-11
repeat O 0 2.073514276945687e-10
upon O 0 2.1826945806324716e-10
male O 0 2.356493056243636e-10
transmission O 0 2.0591024441074524e-09
contribute O 0 7.667387558196737e-11
to O 0 3.5893784472440515e-11
the O 0 2.458018510953508e-10
almost O 0 7.878181440545973e-10
absent O 0 3.726349007138197e-09
occurrence O 0 1.0922677207148013e-09
of O 0 3.7519914258821174e-11
paternal O 0 1.9959419006454482e-08
transmission O 0 0.013936038129031658
of O 0 2.275450924571487e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00012465407780837268

Also O 0 2.356930428604187e-09
the O 0 1.3536519682944004e-09
fathers O 0 2.4344309679236176e-08
of O 0 7.708728655408947e-10
the O 0 8.223023928444206e-10
reported O 0 1.0242374059998838e-08
congenitally O 0 2.9980474209878594e-05
affected O 0 9.422080893273233e-10
children O 0 3.653351232646429e-11
showed O 0 4.378123974468906e-10
, O 0 1.2260550647652524e-12
on O 0 1.0673047862175267e-10
average O 0 7.853755978892707e-10
, O 0 1.8500444232127933e-11
shorter O 0 5.0073950319529104e-08
CTG O 0 5.4859983720234595e-06
repeat O 0 2.691392353426636e-08
lengths O 0 4.112636418085458e-07
and O 0 8.691387887171942e-11
hence O 0 1.0317425802597313e-09
less O 0 1.5067408432045681e-10
severe O 0 2.194773029984276e-09
clinical O 0 1.4679922166749293e-08
symptoms O 0 5.5462314740850616e-09
than O 0 3.04380002105753e-13
the O 0 5.007920293731427e-12
mothers O 0 6.428484827791792e-11
of O 0 1.536991367512286e-11
children O 0 1.5272900999452332e-10
with O 0 6.4703646884822774e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.004125986248254776

We O 0 2.943873811389608e-09
conclude O 0 4.126519925762295e-08
that O 0 4.757809597688567e-12
paternal O 0 4.276063059194257e-09
transmission O 0 0.0007585211424157023
of O 0 1.2887527418570244e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 3.6088589894234246e-08
rare O 0 6.858221213157378e-10
and O 0 2.730705852410642e-12
preferentially O 0 8.893999252357343e-12
occurs O 0 6.3797079598304496e-12
with O 0 2.1183632647504835e-13
onset O 0 6.720421765749052e-07
of O 0 3.960798551361222e-07
DM B-Disease 1 1.0
past O 0 3.414571025928126e-08
30 O 0 4.2377695796957937e-10
years O 0 9.958640682927733e-12
in O 0 3.428325331955584e-13
the O 0 4.324910221620293e-12
father O 0 1.0242409143046416e-09
. O 0 6.003701424894814e-10
. O 0 9.358895880495766e-09

The O 0 8.2572782389434e-08
RB1 O 0 1.356714801659109e-05
gene O 0 1.750031647373973e-10
mutation O 0 3.891420866097839e-11
in O 0 1.74513094947093e-11
a O 0 9.502393316651592e-10
child O 0 1.8085162082570605e-05
with O 0 2.4290172859764425e-06
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 1 0.9629411697387695

The O 0 7.371654220378332e-08
RB1 O 0 2.6875539333559573e-05
gene O 0 8.725575817436493e-10
mutation O 0 9.133129669214313e-11
was O 0 2.9968721948492316e-10
investigated O 0 1.967704443828211e-09
in O 0 5.716543904910054e-11
a O 0 2.76676820343269e-10
child O 0 1.8816818680988945e-07
with O 0 2.9107090071534003e-09
ectopic B-Disease 0 0.0011739011388272047
intracranial I-Disease 0 0.0008147892658598721
retinoblastoma I-Disease 0 6.971957304813259e-07
using O 0 2.3790375225374305e-10
DNA O 0 2.9336627349607625e-08
obtained O 0 1.8437337212517946e-09
from O 0 1.1420168977149814e-10
both O 0 4.51125213574155e-11
the O 0 8.001359574905109e-10
pineal B-Disease 0 7.029627340671141e-06
and I-Disease 0 1.1782022468764808e-08
retinal I-Disease 0 0.0027681433130055666
tumours I-Disease 1 1.0
of O 0 1.4251212633098476e-05
the O 0 4.747571153984609e-07
patient O 0 1.4857115274935495e-05
. O 0 1.5063551472849213e-07

A O 0 3.127134959868272e-06
nonsense O 0 1.0561542694631498e-05
mutation O 0 8.651602101394928e-09
in O 0 2.12554351897154e-09
exon O 0 9.92770399221854e-09
17 O 0 8.044343524638009e-10
( O 0 7.521995179504692e-12
codon O 0 2.888057792915788e-09
556 O 0 1.6475064645860016e-09
) O 0 4.515864678727999e-12
of O 0 2.2966292756443352e-10
the O 0 1.4092677025345779e-09
RB1 O 0 1.5422790966113098e-05
gene O 0 1.7228801718616182e-10
was O 0 5.974024608335071e-10
found O 0 3.4176803748176e-11
to O 0 1.9317759197834405e-11
be O 0 1.5696639821261016e-10
present O 0 8.989141875304085e-09
homozygously O 0 7.0627561399305705e-06
in O 0 3.890687771956891e-10
both O 0 1.5246944817803865e-09
the O 0 1.6554452031414257e-08
retinal B-Disease 0 9.452371045881591e-07
and I-Disease 0 6.655643147723822e-09
the I-Disease 0 3.211732291674707e-06
pineal I-Disease 1 0.9999966621398926
tumours I-Disease 1 1.0
. O 0 2.4474156816722825e-05

The O 0 8.468320489285475e-10
same O 0 8.860089051321296e-11
mutation O 0 1.7903224042159493e-11
was O 0 9.310582860244665e-11
present O 0 1.11826339854737e-10
heterozygously O 0 5.976674799512693e-08
in O 0 7.56784392097476e-12
the O 0 9.615842844201694e-12
DNA O 0 6.866772039870739e-09
from O 0 3.6979880962961786e-11
the O 0 2.0758559801659082e-11
constitutional O 0 4.4899828299804767e-10
cells O 0 3.139970505827705e-10
of O 0 1.6064002905658015e-10
the O 0 1.67750882629214e-10
patient O 0 1.9981893473186574e-08
, O 0 1.2661117813894673e-11
proving O 0 1.4521436497716422e-08
it O 0 3.1085377327766395e-13
to O 0 8.883520655200705e-12
be O 0 1.0885527201853762e-10
of O 0 5.979055028859648e-09
germline O 0 3.973142611357616e-06
origin O 0 7.931229362156955e-08
. O 0 2.6992225343747123e-07

The O 0 3.345888899275451e-09
initial O 0 5.2447703957625436e-09
mutation O 0 1.8776316612623134e-10
was O 0 2.0208737461224757e-10
shown O 0 2.2860353887654838e-10
to O 0 8.21020057495403e-11
have O 0 7.201480731189314e-12
occurred O 0 2.776962437778252e-09
in O 0 3.6748885184900715e-12
the O 0 1.043231195874128e-10
paternally O 0 1.4948706450468308e-07
derived O 0 1.195590471070318e-08
RB1 O 0 7.62102763474104e-06
allele O 0 8.785787741771856e-08
. O 0 1.20833732353276e-07

The O 0 2.9295806669438207e-08
mutation O 0 8.414062779849019e-10
is O 0 2.3190232286557366e-12
in O 0 5.044493035094577e-12
an O 0 2.3115335600482068e-12
area O 0 7.034755417079097e-11
of O 0 7.204067203891995e-11
the O 0 1.0324665428163016e-10
gene O 0 3.804625451492294e-12
that O 0 4.2736325004018305e-13
encodes O 0 1.6431482910417294e-12
the O 0 3.6876696141163734e-11
protein O 0 1.1049169912347168e-10
- O 0 1.231559437764318e-10
binding O 0 1.0146504469954465e-10
region O 0 1.5303241340802742e-08
known O 0 1.0682624784763561e-09
as O 0 2.7908941824250633e-10
the O 0 6.962267651289267e-09
pocket O 0 4.915200770483352e-05
region O 0 4.82648431443522e-07
and O 0 1.978577301997575e-09
has O 0 4.549583279556124e-11
been O 0 1.8930837453190463e-10
detected O 0 1.7816715880414336e-09
in O 0 4.975681758973005e-12
other O 0 3.177573872428785e-12
cases O 0 3.585395869087904e-11
of O 0 5.151329141028782e-09
retinoblastoma B-Disease 0 7.53219819671358e-06
. O 0 2.274928689871558e-08
. O 0 1.7699709076168801e-07

Low O 0 4.488565821247903e-07
levels O 0 1.0209781464709522e-08
of O 0 2.4605234516528185e-10
beta O 0 2.0614721041312123e-09
hexosaminidase O 0 1.060890681969795e-07
A O 0 1.2193985821085107e-09
in O 0 1.9001548598462925e-11
healthy O 0 2.3421853345695354e-10
individuals O 0 6.422619597615253e-13
with O 0 2.77556038048854e-12
apparent O 0 4.2699881305452436e-05
deficiency O 1 0.9982280135154724
of O 0 9.331464525530464e-07
this O 0 5.236863831470373e-09
enzyme O 0 5.493086874253095e-09
. O 0 4.80285109460965e-08

Appreciable O 0 6.118482929196034e-07
beta O 0 1.4173040518983271e-08
hexosaminidase O 0 2.390494501014473e-06
A O 0 3.3785551067921915e-07
( O 0 8.618850771968667e-11
hex O 0 1.3503498053069052e-07
A O 0 2.9273687474073995e-08
) O 0 4.7692119350961626e-12
activity O 0 1.524705500743906e-10
has O 0 2.58217085951154e-13
been O 0 1.2884537187174416e-11
detected O 0 9.249350618745211e-09
in O 0 2.7669382340889115e-09
cultured O 1 0.9999948740005493
skin O 1 0.9999998807907104
fibroblasts O 1 0.9999996423721313
and O 0 1.3337613324893027e-07
melanoma B-Disease 1 0.9999985694885254
tissue O 1 0.7367759346961975
from O 0 9.360663355550969e-09
healthy O 0 2.6517679163617913e-09
individuals O 0 7.26283291320462e-13
previously O 0 8.452625752108922e-12
reported O 0 5.5886779579128465e-12
as O 0 3.16289854550289e-12
having O 0 1.7521768480577293e-09
deficiency B-Disease 0 5.615968916572456e-07
of I-Disease 0 1.94123487062825e-07
hex I-Disease 0 3.354460034188378e-07
A I-Disease 0 1.533544136123055e-08
activity O 0 3.3343323657675228e-09
indistinguishable O 0 7.710408311822903e-09
from O 0 2.8701405401648783e-12
that O 0 6.018846716599607e-14
of O 0 1.6065120154312718e-12
patients O 0 1.3915254365448604e-11
with O 0 4.2479986195331776e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 8.234206205770533e-08
TSD B-Disease 1 1.0
) O 0 6.397459451079612e-09
. O 0 4.518957652521749e-08

Identification O 0 1.2639257818136684e-07
and O 0 6.583308342911209e-10
quantitation O 0 0.00014614532119594514
of O 0 2.79318760476599e-06
hex O 0 2.547875737946015e-06
A O 0 4.288021955289878e-07
, O 0 2.100141067995498e-11
amounting O 0 5.645522271890968e-09
to O 0 8.022738584578804e-10
3 O 0 6.389863926870021e-08
. O 0 8.06536846198469e-08

5 O 0 4.33265512356229e-07
% O 0 2.2238417329845106e-07
- O 0 8.923735350663264e-08
6 O 0 4.059902636299739e-08
. O 0 3.8403943136700036e-08

9 O 0 1.934599502817491e-08
% O 0 5.156320370680589e-10
of O 0 3.7130850477629096e-11
total O 0 1.2005318961172406e-10
beta O 0 3.4497932288601874e-10
hexosaminidase O 0 1.6767140564866168e-08
activity O 0 4.3452880182925924e-10
, O 0 1.8509399742072663e-12
has O 0 3.303205555220054e-14
been O 0 2.4572366168727766e-13
obtained O 0 8.187692711325578e-12
by O 0 4.309486795195383e-12
cellulose O 0 2.454955572162021e-09
acetate O 0 7.943939395183008e-10
gel O 0 3.2579128284027092e-09
electrophoresis O 0 1.5266325981144746e-09
, O 0 2.488800832090021e-10
DEAE O 0 0.00016877532470971346
- O 0 7.028180704082843e-08
cellulose O 0 1.0725366195174502e-07
ion O 0 1.2931045034747513e-07
- O 0 5.694439764170056e-08
exchange O 0 2.1540882411130724e-09
chromatography O 0 1.3577071023007647e-08
, O 0 2.424575644421889e-11
radial O 0 5.1479576157476e-10
immunodiffusion O 0 2.70027300075526e-07
, O 0 6.899362331447279e-11
and O 0 3.888766531012777e-10
radioimmunoassay O 0 0.00011284546053502709
. O 0 9.44670318858698e-07

Previous O 0 1.2712730494968127e-05
family O 0 1.5888461657453945e-09
studies O 0 3.6677638703963567e-10
suggested O 0 3.169392179258601e-11
that O 0 2.0972607602410404e-13
these O 0 6.40984390131577e-13
individuals O 0 1.05117563958812e-12
may O 0 6.739420219809e-12
be O 0 4.2419058716991476e-12
compound O 0 4.452306023861041e-10
heterozygotes O 0 2.3243849067711153e-09
for O 0 2.294548405445962e-11
the O 0 1.992136455797322e-10
common O 0 2.870083060102502e-10
mutant O 0 2.288772282810214e-09
TSD B-Disease 0 7.018319593043998e-06
gene O 0 3.518854374551239e-10
and O 0 5.797724106360036e-11
a O 0 2.8402025176177403e-10
rare O 0 7.438013538418886e-10
( O 0 1.631214260888747e-11
allelic O 0 4.6448369594997985e-09
) O 0 1.9546812085602383e-11
mutant O 0 2.8438031929312046e-09
gene O 0 1.1864643711945178e-09
. O 0 2.3577138463792835e-08

Thus O 0 5.0282018548841734e-08
, O 0 1.4747372767409672e-10
the O 0 1.2277598382404165e-10
postulated O 0 5.587404983131705e-10
rate O 0 2.4978972015810008e-11
mutant O 0 2.4329312436205397e-12
gene O 0 7.31870727216366e-13
appears O 0 2.414274292636409e-12
to O 0 2.892270624388349e-12
code O 0 3.4403933694970856e-12
for O 0 7.50258015436156e-12
the O 0 6.988576384259204e-11
expression O 0 1.6703474714496735e-10
of O 0 2.5087656951860993e-10
low O 0 4.442118617387081e-10
amounts O 0 1.598523050039269e-11
of O 0 3.5672667597630436e-10
hex O 0 9.50356096041105e-08
A O 0 2.831730228081142e-07
. O 0 3.084749380377616e-07

Heterozygotes O 0 1.5212003745546099e-05
for O 0 2.8340836344398213e-09
the O 0 4.419868471217114e-09
rare O 0 1.825488871176617e-09
mutant O 0 2.409512145362669e-09
may O 0 4.23594145870787e-11
be O 0 2.0816327828132586e-11
indistinguishable O 0 7.086584652427064e-09
from O 0 5.2105056380646886e-11
heterozygotes O 0 1.182994058268605e-08
for O 0 8.144427493528283e-11
the O 0 1.7069126112545518e-09
common O 0 1.5084763660411227e-08
TSD B-Disease 0 9.18544246815145e-05
mutant O 0 1.774131561660397e-07
. O 0 7.400591073292162e-08

However O 0 1.441049146677642e-08
, O 0 2.264397176710009e-11
direct O 0 1.418035411315799e-10
visualization O 0 8.358310310541128e-08
and O 0 1.2662017268016967e-10
quantitation O 0 0.0001402798661729321
of O 0 1.94746164083881e-07
hex O 0 7.078927666270829e-08
A O 0 1.8133049506374732e-09
by O 0 1.2709550209141773e-12
the O 0 4.7640389896908e-12
methods O 0 2.6987210244300286e-09
described O 0 6.05776054318774e-11
may O 0 3.319162002538012e-12
prevent O 0 2.6502989039500768e-11
false O 0 2.6884242054769913e-10
- O 0 2.937680099179829e-10
positive O 0 1.4379087330540496e-11
prenatal O 0 1.6720640871881187e-08
diagnosis O 0 3.2751852785395386e-08
of O 0 2.7321165330107533e-09
TSD B-Disease 0 1.487598547100788e-05
in O 0 5.315090034763159e-10
fetuses O 0 1.9209361212801923e-08
having O 0 1.0269163297493833e-10
the O 0 8.52178536070447e-11
incomplete O 0 7.254572409465254e-08
hex B-Disease 0 9.450919833398075e-07
A I-Disease 0 3.3619041914789705e-06
deficiency I-Disease 0 0.00011575685493880883
of O 0 2.9165347470438974e-08
the O 0 2.032529700102259e-09
type O 0 1.474550348490311e-08
described O 0 7.148744929352802e-10
in O 0 3.100748130480113e-11
the O 0 5.271595937550444e-10
four O 0 3.402548465203381e-09
healthy O 0 5.372529798819414e-08
individuals O 0 4.823192067959781e-09

The O 0 1.3552083544254856e-07
tumor B-Disease 0 4.452709845281788e-07
suppressor O 0 1.10247867723956e-07
gene O 0 1.218013134796081e-09
Smad4 O 0 2.3474314730265178e-05
/ O 0 3.545243544067489e-06
Dpc4 O 0 3.933748303097673e-05
is O 0 5.640420313972327e-13
required O 0 5.119206794579334e-11
for O 0 6.6941578148738135e-12
gastrulation O 0 3.6464197705754486e-07
and O 0 4.2708558044279865e-12
later O 0 1.0024889945947635e-10
for O 0 6.0417872961571195e-12
anterior O 0 5.251366896885656e-09
development O 0 9.994447935923745e-09
of O 0 2.9875140139523637e-09
the O 0 7.398118118118191e-09
mouse O 0 1.3362600803645819e-08
embryo O 0 1.1584847925405484e-07
. O 0 5.2126406302477335e-08

Mutations O 0 2.3135584115152596e-08
in O 0 5.510987222123731e-10
the O 0 9.051579041852165e-09
SMAD4 O 1 0.9999997615814209
/ O 0 0.001112236874178052
DPC4 O 1 0.999850869178772
tumor B-Disease 0 4.2625472929103125e-08
suppressor O 0 9.16884512758287e-10
gene O 0 4.495282184685534e-12
, O 0 8.871714669324293e-13
a O 0 2.1283202630839604e-11
key O 0 1.4078231025393961e-08
signal O 0 1.8164025732403388e-06
transducer O 0 1.4092594824433036e-07
in O 0 1.0940984784824082e-09
most O 0 1.7578607458546003e-09
TGFbeta O 1 0.7141891121864319
- O 0 2.4477407123413286e-07
related O 0 1.2230181312133936e-07
pathways O 0 8.23780066383506e-09
, O 0 4.225712661731773e-13
are O 0 1.7976077102007347e-14
involved O 0 2.8991468514066865e-12
in O 0 1.5521070539925574e-11
50 O 0 3.840920026476624e-09
% O 0 1.6059454210903823e-08
of O 0 4.056349922620939e-08
pancreatic B-Disease 1 0.9998617172241211
cancers I-Disease 1 0.9998469352722168
. O 0 1.9658953533507884e-05

Homozygous O 0 4.385743977763923e-06
Smad4 O 0 1.6856925867614336e-05
mutant O 0 5.1790056687650576e-08
mice O 0 5.795021351673313e-09
die O 0 4.945735909700488e-08
before O 0 6.4461720405972756e-09
day O 0 2.680306465663307e-08
7 O 0 9.687841640015904e-08
. O 0 1.9995960442997784e-08

5 O 0 3.5395981967667467e-07
of O 0 1.8569150483926933e-07
embryogenesis O 0 0.000494432810228318
. O 0 3.900283900293289e-06

Mutant O 0 1.1568993585342469e-07
embryos O 0 2.9281506996881035e-08
have O 0 5.158009089289983e-11
reduced O 0 2.379223484894055e-10
size O 0 2.482977018436472e-11
, O 0 1.6115789258641655e-12
fail O 0 5.0493134118312355e-09
to O 0 1.8967458714769236e-09
gastrulate O 0 2.152565684809815e-05
or O 0 1.5040941825361642e-09
express O 0 6.031189436761508e-10
a O 0 1.5268997177741994e-10
mesodermal O 0 6.900023095113283e-07
marker O 0 9.945633649977026e-09
, O 0 6.19919324207352e-11
and O 0 2.1249221826558085e-10
show O 0 1.809837186783625e-07
abnormal O 0 3.5235570976510644e-06
visceral O 0 7.398600132546562e-07
endoderm O 0 2.03899217012804e-05
development O 0 1.1451020327513106e-06
. O 0 1.9982164189968898e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 1.6113463630063052e-07
the O 0 3.641765999873314e-08
Smad4 O 0 0.015168669633567333
- O 0 1.0813342044002638e-07
deficient O 0 2.1716952680606028e-09
embryos O 0 7.445206950951189e-11
results O 0 4.9630587833915385e-11
from O 0 1.9719706770282563e-11
reduced O 0 1.5114672013982755e-10
cell O 0 7.910584964854195e-10
proliferation O 0 3.940901827093057e-09
rather O 0 8.649547744710162e-11
than O 0 9.122523049465148e-12
increased O 0 8.958140895742872e-10
apoptosis O 0 7.664839785093136e-08
. O 0 3.676571580513155e-08

Aggregation O 0 5.995948271220186e-08
of O 0 2.2545789235550728e-08
mutant O 0 3.5175762747030603e-08
Smad4 O 0 0.001106860232539475
ES O 0 4.095355052413652e-06
cells O 0 4.3240730440707864e-10
with O 0 1.6726187492335787e-12
wild O 0 7.480079056154665e-11
- O 0 3.8434827542843664e-10
type O 0 2.7391017232147874e-10
tetraploid O 0 1.1466686800076786e-07
morulae O 0 3.147987627016846e-06
rescues O 0 2.2217305684080202e-07
the O 0 5.871187980233117e-09
gastrulation B-Disease 0 0.00013612923794426024
defect I-Disease 0 4.59215953014791e-05
. O 0 2.688447864329646e-07

These O 0 1.7800064200379495e-10
results O 0 1.999117399398287e-10
indicate O 0 1.7857465506310177e-10
that O 0 9.544593847915506e-13
Smad4 O 0 8.264305506600067e-08
is O 0 2.1276158460904748e-13
initially O 0 2.5158310764522573e-12
required O 0 4.982331561209641e-11
for O 0 4.6146914414735285e-12
the O 0 7.367651627676608e-11
differentiation O 0 8.84974493686741e-09
of O 0 4.021696309308709e-09
the O 0 8.945134410964783e-09
visceral O 0 2.9721810790306336e-08
endoderm O 0 4.255756209659012e-07
and O 0 2.4271156265354143e-11
that O 0 1.1111822182871545e-12
the O 0 2.800720939888368e-11
gastrulation B-Disease 0 1.0482144716661423e-06
defect I-Disease 0 1.4255424218845292e-07
in O 0 6.578095707032716e-11
the O 0 7.97959531784187e-10
epiblast O 0 3.818548066192307e-06
is O 0 1.268783082070124e-11
secondary O 0 1.5508577533296375e-08
and O 0 5.257706076067237e-11
non O 0 1.9403628357395064e-06
- O 0 9.356004966321052e-07
cell O 0 1.2064197107974906e-05
autonomous O 0 3.48572175425943e-05
. O 0 6.966167802602286e-07

Rescued O 0 4.541657472145744e-05
embryos O 0 4.163520657129993e-07
show O 0 1.6498091781613766e-08
severe O 0 6.450061107443616e-08
anterior O 0 3.3511262245156104e-06
truncations O 0 0.00017171933723147959
, O 0 1.7831018606084825e-10
indicating O 0 5.258664170781913e-09
a O 0 4.784083199038669e-11
second O 0 2.2793795739772804e-09
important O 0 1.4445515894578875e-09
role O 0 1.172328456533478e-09
for O 0 1.4779480972393344e-09
Smad4 O 0 0.22222577035427094
in O 0 6.518066530958322e-09
anterior O 0 2.69045108325372e-06
patterning O 0 3.7128171243239194e-05
during O 0 0.0005122881848365068
embryogenesis O 1 0.9974606037139893
. O 0 2.9094342153257458e-06

Prevalence O 0 9.008709639601875e-06
of O 0 8.731943523798691e-08
p16 O 0 1.1085520554843242e-06
and O 0 1.2877531041510792e-08
CDK4 O 1 0.9999959468841553
germline O 0 0.00043098104652017355
mutations O 0 1.0661847404946911e-08
in O 0 7.242703103926829e-10
48 O 0 1.6041965409385739e-06
melanoma B-Disease 1 0.9999569654464722
- O 0 7.661780546186492e-05
prone O 0 9.69690631791309e-07
families O 0 2.8157158826758177e-09
in O 0 5.299847671835778e-09
France O 0 1.7290300320382812e-06
. O 0 1.1971544608968543e-06

The O 0 8.8306762791035e-07
French O 0 0.00019728488405235112
Familial B-Disease 1 0.999988317489624
Melanoma I-Disease 1 1.0
Study O 0 1.2066967656210181e-06
Group O 0 6.267203200849281e-09
. O 0 8.137079987591278e-08

Germline O 0 0.0006964629283174872
mutations O 0 2.4607418325217623e-08
in O 0 5.560761295875238e-10
the O 0 2.9402489332142068e-09
p16 O 0 2.792628492898075e-07
and O 0 4.2336009697940824e-10
CDK4 O 1 0.9977217316627502
genes O 0 2.8126384554738593e-10
have O 0 6.239923400035152e-13
been O 0 2.2050414879432045e-12
reported O 0 7.22035061948012e-12
in O 0 2.720163504166262e-12
a O 0 1.4498720800337761e-11
subset O 0 2.2038084690478854e-09
of O 0 7.952644764941397e-09
melanoma B-Disease 0 9.924639016389847e-06
pedigrees O 0 1.4594692743230553e-07
, O 0 2.400431763083244e-11
but O 0 1.6538962907541865e-11
their O 0 9.816451124189385e-11
prevalence O 0 3.3939876686872594e-08
is O 0 1.0319615171075491e-12
not O 0 8.375913677916014e-12
well O 0 6.637334015735519e-10
known O 0 5.842600625527439e-09
. O 0 4.076065351910074e-07

We O 0 5.4143676209150726e-08
searched O 0 5.338259967402337e-08
for O 0 1.2030670903939722e-10
such O 0 2.0444650139506138e-10
germline O 0 1.698437813502096e-06
mutations O 0 1.0654117588160261e-09
in O 0 6.342209396548171e-11
48 O 0 1.3973554757740203e-07
French O 0 2.8407200716173975e-06
melanoma B-Disease 1 0.9999980926513672
- O 0 8.202796379919164e-06
prone O 0 3.325645181462278e-08
families O 0 1.832859038153334e-11
selected O 0 3.6951608439750316e-11
according O 0 3.327765840666075e-11
to O 0 5.798616795060774e-12
two O 0 3.6416820080320544e-12
major O 0 2.0181802409813265e-11
criteria O 0 3.071061460691027e-10
families O 0 1.8382821306839325e-11
with O 0 7.234807913349128e-13
at O 0 1.8018268821418104e-10
least O 0 9.735707032221264e-12
three O 0 2.2169771227154023e-11
affected O 0 8.831764763961303e-10
members O 0 2.4014085164836274e-10
( O 0 3.885338925591064e-11
n O 0 6.482837600074731e-10
= O 0 3.788567515261576e-10
20 O 0 4.553266652607135e-10
) O 0 4.675921108643344e-13
or O 0 2.303910100892592e-12
families O 0 1.4635245055780177e-12
with O 0 2.044048659716538e-13
two O 0 3.662796628500775e-12
affected O 0 6.882722863865709e-11
members O 0 8.525243878898525e-12
, O 0 1.1286744108773838e-12
one O 0 2.153107336519411e-12
of O 0 2.9090523392949486e-11
them O 0 3.7327740724790726e-12
affected O 0 2.6820103429803233e-11
before O 0 2.6111364806458148e-11
the O 0 1.25828037225717e-11
age O 0 1.7756734971285937e-09
of O 0 9.868043049365838e-10
50 O 0 2.328902404258315e-09
( O 0 6.2651975621386136e-12
n O 0 4.245161513982687e-11
= O 0 3.5401660769540655e-11
28 O 0 3.4091857115114976e-10
) O 0 1.3360510614512933e-12
, O 0 6.759254072251364e-13
and O 0 9.071592760832858e-13
one O 0 1.7355632989796144e-12
additional O 0 2.508630456143912e-11
minor O 0 2.283752964515884e-09
criterion O 0 7.205780434560438e-07
. O 0 3.7397089158730523e-07

Sixteen O 0 1.3816109003528254e-06
different O 0 7.831218340470514e-09
p16 O 0 7.423287797792e-07
germline O 0 8.232523782680801e-07
mutations O 0 1.1148288958651165e-09
were O 0 8.49234016442324e-10
found O 0 2.739523538575206e-11
in O 0 6.444735804050916e-12
21 O 0 3.54245771605477e-10
families O 0 3.6896253413631896e-11
, O 0 2.191230920670084e-12
while O 0 3.6883870957460374e-11
one O 0 2.199624926646493e-10
germline O 0 2.859922005882254e-06
mutation O 0 2.556682199283955e-09
, O 0 1.9688296826192442e-10
Arg24His O 0 0.0003367242752574384
, O 0 4.498280359310769e-10
was O 0 8.152921893156417e-09
detected O 0 8.160327524819877e-09
in O 0 1.1574904229538774e-10
the O 0 7.616322683645649e-09
CDK4 O 1 0.9337048530578613
gene O 0 5.672563574421474e-08
. O 0 1.1254203258204143e-07

The O 0 4.930286845450382e-09
frequency O 0 3.950911597883078e-09
of O 0 7.442952365543931e-10
p16 O 0 7.390967393661185e-09
gene O 0 7.113970437039319e-12
mutation O 0 3.3283798894084837e-12
in O 0 5.018744534540653e-12
our O 0 8.661785733110605e-10
sample O 0 4.9601819179789786e-11
( O 0 5.649787278641516e-13
44 O 0 3.391544822761716e-10
% O 0 1.152854617325616e-10
) O 0 2.478389672308512e-13
is O 0 2.8351051974823127e-13
among O 0 1.2745162997901405e-12
the O 0 1.1877243112634606e-11
highest O 0 2.0320956028996306e-09
rates O 0 1.1067351202154185e-10
yet O 0 1.72146689264574e-11
reported O 0 5.32641326878025e-11
and O 0 1.1095731972110556e-11
the O 0 5.544769088317025e-10
CDK4 O 0 0.15632683038711548
mutation O 0 3.613477017605504e-10
is O 0 2.025900280866466e-12
the O 0 2.048773650731306e-11
second O 0 8.892260816573128e-10
mutation O 0 2.0135941525278866e-10
detected O 0 2.5167648520785235e-10
in O 0 3.7107894881871495e-12
this O 0 3.9875342611184195e-11
gene O 0 5.801587543707853e-10
worldwide O 0 1.1442371494752024e-09
. O 0 3.991527464108913e-08

In O 0 1.6560326443482154e-08
summary O 0 4.5964554828969995e-08
, O 0 9.132572476033829e-11
our O 0 1.3646305196957087e-09
results O 0 5.475844777613759e-10
show O 0 4.5227299683148203e-10
frequent O 0 2.2611256617066644e-11
involvement O 0 8.730037248660949e-10
of O 0 1.0621045154479702e-09
the O 0 2.243433216975177e-09
p16 O 0 2.172973125880162e-07
gene O 0 2.850127911457889e-10
in O 0 2.729635684151077e-10
familial B-Disease 0 5.653046173392795e-07
melanoma I-Disease 0 0.04828913137316704
and O 0 5.741088715538467e-10
confirm O 0 9.057263383738245e-08
the O 0 3.132500481228817e-09
role O 0 4.073350101663209e-09
of O 0 2.3537509719062655e-08
the O 0 2.993282066654501e-08
CDK4 O 1 0.9999945163726807
gene O 0 2.1456236787287253e-10
as O 0 1.6463864993543353e-11
a O 0 2.9508545607015435e-10
melanoma B-Disease 0 3.1415955163538456e-05
- O 0 3.524722842485062e-07
predisposing O 0 6.958446618909875e-08
gene O 0 6.267128482839723e-10
. O 0 1.1401697364021857e-09
. O 0 4.8649187789351345e-08

Progression O 0 9.043960744747892e-06
of O 0 1.0691884426705656e-06
somatic O 0 8.677304322191048e-06
CTG O 0 3.38214922521729e-05
repeat O 0 1.7091418058612362e-08
length O 0 1.336157517961567e-09
heterogeneity O 0 1.666437321468095e-09
in O 0 5.130122455315744e-12
the O 0 1.1798150130470919e-11
blood O 0 3.595986008964047e-10
cells O 0 1.7919511208219774e-08
of O 0 1.3027245415742073e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.5632109352736734e-05
. O 0 1.6317869722115574e-07

The O 0 3.7078709547166966e-10
genetic O 0 8.021755482090498e-11
basis O 0 1.1617331541202702e-09
of O 0 2.2253560771900993e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.289040245770593e-07
DM B-Disease 1 1.0
) O 0 2.2273188501897856e-11
is O 0 2.0253507801003962e-13
the O 0 1.0730496352584495e-12
expansion O 0 1.4002962678283382e-10
of O 0 1.905120367018398e-10
an O 0 8.223004221985519e-11
unstable O 0 2.905962446675403e-06
CTG O 0 5.861316367372638e-06
repeat O 0 2.6282174214742327e-09
in O 0 3.351499633374999e-11
the O 0 6.704294064352467e-11
34 O 0 1.7478443137264321e-09
UTR O 0 9.735612138683791e-07
of O 0 5.006320358269534e-10
the O 0 4.697922051377645e-09
DM B-Disease 1 1.0
protein O 0 6.317827594415348e-09
kinase O 0 3.752401167567143e-10
gene O 0 3.789953073596308e-11
on O 0 7.680681646249354e-10
chromosome O 0 3.46827455643961e-09
19 O 0 8.6032436286132e-08
. O 0 2.5343021547996614e-07

One O 0 4.0172190018950005e-09
of O 0 2.049682423788113e-09
the O 0 4.751909976619118e-10
principal O 0 5.769721145298945e-09
features O 0 1.663380717886742e-11
of O 0 1.9140365681291627e-10
the O 0 2.69140110198407e-09
DM B-Disease 1 1.0
mutation O 0 6.375128203117697e-10
is O 0 1.6473689816789983e-12
an O 0 2.2850306716226676e-12
extraordinarily O 0 8.512729188225876e-09
high O 0 6.609745639707398e-09
level O 0 8.50891638037865e-07
of O 0 1.224933221521951e-08
somatic O 0 2.3628511769402394e-07
mosaicism O 0 1.0079639878313174e-06
, O 0 3.114082125846296e-12
due O 0 2.995142356354563e-09
to O 0 5.477638828632614e-11
an O 0 1.4999579269620034e-12
extremely O 0 1.5299958522341228e-10
high O 0 1.7409859665029614e-10
degree O 0 2.551475830614436e-08
of O 0 7.943064872506511e-09
somatic O 0 3.1354543352790643e-06
instability O 0 3.3740633398338105e-07
both O 0 1.383407138844106e-10
within O 0 7.0743322311273e-10
and O 0 7.238552205551807e-12
between O 0 3.3421304612701874e-10
different O 0 1.6147937431654213e-09
tissues O 0 3.7975929956246546e-08
. O 0 2.4219170668970946e-08

This O 0 5.471038022619723e-08
instability O 0 3.7202405565039953e-06
appears O 0 5.442607475814043e-10
to O 0 1.786290559913084e-11
be O 0 1.8897600498335443e-11
biased O 0 8.800420947530085e-10
towards O 0 9.541987200378799e-10
further O 0 2.6863570395940783e-11
expansion O 0 1.8434655191246208e-10
and O 0 6.457431160969418e-13
continuous O 0 3.953987803839709e-09
throughout O 0 1.3783500729669385e-10
the O 0 3.0994238425785525e-11
life O 0 1.762956725048781e-10
of O 0 1.221339279711131e-10
an O 0 1.327959226957165e-12
individual O 0 3.058736944283602e-11
, O 0 7.326085918468728e-12
features O 0 1.5584047940997436e-11
that O 0 1.437792078321301e-13
could O 0 1.2701261483533122e-12
be O 0 1.3292718705273932e-12
associated O 0 2.9246424726458997e-10
with O 0 8.327710049327308e-12
the O 0 4.725836166841191e-09
progressive O 0 0.0035086809657514095
nature O 0 6.470834090777089e-09
of O 0 1.9952175467352617e-09
the O 0 1.3162988032888734e-08
disease O 0 1.933924522745656e-06
. O 0 1.7815160902046046e-08

Although O 0 4.348506887907888e-09
increasing O 0 4.859331270701261e-10
measured O 0 1.6138967939838267e-10
allele O 0 1.6347970199781514e-10
size O 0 1.806399127501912e-11
between O 0 2.376601970777159e-10
patients O 0 5.449775630772535e-10
clearly O 0 1.2210876754181754e-10
correlates O 0 1.5805342590269333e-09
with O 0 9.113596379298206e-13
an O 0 1.9905268839465196e-13
increased O 0 2.0233526659696466e-11
severity O 0 4.155987998188948e-09
of O 0 1.0608042916304683e-10
symptoms O 0 1.9261154893257526e-09
and O 0 5.508373162980973e-13
an O 0 8.006258416654033e-14
earlier O 0 3.025680053725388e-11
age O 0 5.270469616291962e-10
of O 0 7.220244541139564e-11
onset O 0 1.0818846263305204e-08
, O 0 5.039912714596695e-13
this O 0 5.540912238581608e-13
correlation O 0 1.8532963792089463e-12
is O 0 2.2442364942332552e-14
not O 0 3.8872399223122134e-13
precise O 0 4.101601835948543e-10
and O 0 6.6056647998746776e-12
measured O 0 1.4796114333748278e-10
allele O 0 1.4076122212269837e-10
length O 0 1.256736381627377e-10
cannot O 0 8.63061219713579e-11
be O 0 6.129187869047259e-12
used O 0 2.2689105802498055e-11
as O 0 1.6726443364048493e-12
an O 0 2.737703184811646e-13
accurate O 0 3.5043219437369544e-09
predictor O 0 1.1295600188532262e-07
of O 0 8.622686453740869e-10
age O 0 1.0974852671097324e-07
of O 0 1.3584894098528366e-08
onset O 0 0.0004629807372111827
. O 0 3.0932099548408587e-07

In O 0 1.7299145449456432e-09
order O 0 7.806707363888776e-11
to O 0 1.107243949305392e-10
further O 0 2.8396932028051936e-10
characterize O 0 2.11202255684384e-08
the O 0 1.1526222198909863e-09
dynamics O 0 4.2426265167705424e-07
of O 0 8.029617674765177e-06
DM B-Disease 1 1.0
CTG O 0 0.002724618185311556
repeat O 0 3.124440866031364e-07
somatic O 0 1.6875411574801547e-06
instability O 0 3.977153824052948e-07
, O 0 1.0103105851921867e-11
we O 0 4.236140951907608e-12
have O 0 1.586819868212852e-13
studied O 0 1.5184853374705654e-11
repeat O 0 1.634004390127508e-11
length O 0 7.204282743283885e-12
changes O 0 6.961987952282256e-13
over O 0 5.944440903057902e-13
time O 0 1.8363546794297747e-11
in O 0 3.754052971260968e-11
111 O 0 1.6108466525110998e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.8338548457563775e-08
with O 0 5.652442489761933e-12
varying O 0 1.9742447954218534e-10
clinical O 0 2.345002636516824e-09
severity O 0 5.159532534548816e-08
and O 0 4.671381614862469e-10
CTG O 0 7.958412311381835e-07
repeat O 0 3.2253293369421954e-09
size O 0 5.853738327399327e-11
over O 0 1.2572175939196129e-11
time O 0 4.404732134588585e-11
intervals O 0 4.5462402731288876e-09
of O 0 4.35046276781037e-10
1 O 0 2.4943194176785255e-09
- O 0 3.792256730861254e-09
7 O 0 2.0664085997879056e-09
years O 0 3.726391639702342e-09
. O 0 7.320020589673959e-09

We O 0 8.743539225974928e-09
have O 0 1.4069430516461257e-11
found O 0 3.902173723036029e-12
a O 0 5.246441302231286e-13
direct O 0 1.5065993591578675e-11
progression O 0 9.210830320682817e-09
of O 0 1.1373634256628407e-09
the O 0 1.0336571598656974e-09
size O 0 4.2291617430301187e-10
heterogeneity O 0 2.4698343370488374e-09
over O 0 1.2106581362414381e-11
time O 0 3.613275650904413e-11
related O 0 2.4679450150166815e-10
to O 0 4.308519166440483e-11
initial O 0 6.776242678085964e-09
CTG O 0 1.8078463881465723e-06
repeat O 0 3.015014016227724e-09
size O 0 2.5238540424243894e-11
and O 0 1.1661137550370015e-12
the O 0 1.3321710921887497e-11
time O 0 1.1797660071088956e-10
interval O 0 5.493296928449354e-09
and O 0 7.65576577826943e-12
always O 0 8.338553458830944e-11
biased O 0 1.004393790360325e-09
towards O 0 1.1078360451222125e-09
further O 0 6.909427474610652e-10
expansion O 0 5.648304579608521e-08
. O 0 5.220630328039988e-08

Attempts O 0 8.542040177417221e-07
to O 0 1.6928380919267738e-09
mathematically O 0 9.719379789885352e-08
model O 0 1.1072424088709454e-09
the O 0 2.2322492465587374e-10
dynamics O 0 8.724565070394874e-09
have O 0 2.25341030557491e-11
proved O 0 9.3574321624601e-09
only O 0 1.0777761495772697e-11
partially O 0 3.6074307430133956e-10
successful O 0 4.228871419709179e-10
suggesting O 0 1.5570210398774265e-10
that O 0 2.8838449640453123e-14
individual O 0 1.3795263759455723e-13
specific O 0 4.040627641505035e-12
genetic O 0 6.285695852703554e-10
and O 0 3.5024472905265114e-11
/ O 0 9.248918649973348e-05
or O 0 7.442058080897596e-10
environmental O 0 1.533484894622461e-09
factors O 0 2.530931852984253e-10
also O 0 7.245220591013679e-13
play O 0 4.1154957219902144e-10
a O 0 1.7550992603698745e-10
role O 0 1.398780868910876e-09
in O 0 3.731989384192502e-09
somatic O 0 1.7331573189949268e-06
mosaicism O 0 6.013442089169985e-06
. O 0 9.477491680343064e-09
. O 0 6.700660293290639e-08

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 2.1065270416897874e-08
Palestinian O 0 0.0001848827232606709
Arabs O 0 8.155760951922275e-06
. O 0 2.613296032905055e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 0.00029343049391172826
AGU B-Disease 1 1.0
) O 0 5.040978190429257e-10
is O 0 9.53846463619401e-12
a O 0 8.875192941681931e-11
rare O 0 4.844205747644992e-08
disorder B-Disease 1 0.9999988079071045
of I-Disease 0 0.11619032174348831
glycoprotein I-Disease 0 4.098214958503377e-06
metabolism I-Disease 1 0.999600350856781
caused O 0 6.6797301023768796e-09
by O 0 7.0700754278840705e-12
the O 0 9.253244837026386e-10
deficiency B-Disease 0 9.233239325112663e-06
of I-Disease 0 9.075798779178967e-09
the I-Disease 0 6.872838298477291e-09
lysosomal I-Disease 0 2.1495259261428146e-07
enzyme I-Disease 0 4.6473869197427575e-10
aspartylglucosaminidase I-Disease 0 3.836053679151519e-07
( O 0 3.3490923923018556e-10
AGA O 0 0.00016473526193294674
) O 0 3.934202297273259e-09
. O 0 9.545853885128963e-08

AGU B-Disease 1 1.0
is O 0 1.455085385515531e-08
inherited O 0 0.00012175463052699342
as O 0 7.978362415173024e-10
an O 0 5.564069344154987e-11
autosomal O 0 0.0028315221425145864
recessive O 0 0.000920371909160167
trait O 0 1.6771989521657815e-06
and O 0 5.3957102674750956e-11
occurs O 0 1.6088755883103545e-09
with O 0 2.448545489627807e-12
a O 0 6.125007445678676e-11
high O 0 1.997959575561481e-09
frequency O 0 1.1969160773617205e-08
in O 0 7.414822228435369e-11
Finland O 0 2.5446766471759474e-08
because O 0 1.3479308814956514e-11
of O 0 5.053714668967757e-10
a O 0 1.025292406531264e-09
founder O 0 5.467877173259694e-08
effect O 0 1.429311335954253e-08
. O 0 3.635013712255386e-08

While O 0 6.290198939495895e-08
very O 0 1.9142603058242003e-09
few O 0 7.301484972188632e-10
patients O 0 1.13346310115503e-09
with O 0 2.733230308749057e-10
AGU B-Disease 1 1.0
have O 0 1.6608952060903626e-11
been O 0 6.798550871572884e-12
reported O 0 1.6742475461573036e-11
from O 0 1.6998152885250306e-11
non O 0 6.443025224456278e-09
- O 0 1.1086900286727541e-09
Finnish O 0 2.51812679152863e-07
origin O 0 2.078032634855731e-09
, O 0 1.9619800575854107e-11
we O 0 1.5113922613441133e-10
diagnosed O 0 0.007549516391009092
the O 0 2.857690528657031e-09
disorder O 0 9.546502951707225e-06
in O 0 6.036595529002042e-11
8 O 0 3.791692737564745e-09
patients O 0 1.9139344276108972e-10
originating O 0 4.03564293094405e-09
from O 0 2.648309349595479e-10
3 O 0 1.0998397748096522e-09
unrelated O 0 3.5709244450288224e-09
families O 0 6.00013485077544e-12
, O 0 2.445678208562452e-13
all O 0 4.590214926908365e-13
Palestinian O 0 6.454177423620422e-07
Arabs O 0 3.825115513222954e-08
from O 0 9.71393590565306e-11
the O 0 1.4813424098480965e-10
region O 0 3.5616123383874765e-09
of O 0 2.235859497545789e-09
Jerusalem O 0 6.105658030719496e-06
. O 0 6.662313012384402e-07

The O 0 8.962059538930589e-09
clinical O 0 6.635194154114288e-07
diagnosis O 1 0.999985933303833
of O 1 0.9999920129776001
AGU B-Disease 1 1.0
is O 0 3.9671697038556886e-09
often O 0 2.0678428414022676e-10
difficult O 0 2.3050911579503008e-07
, O 0 1.303912706973609e-11
in O 0 4.6694440848649155e-12
particular O 0 1.6353793319545673e-11
early O 0 1.323324005930715e-09
in O 0 9.446904196408479e-12
the O 0 1.1696829269047804e-11
course O 0 1.2329755882944937e-08
of O 0 4.976910550347213e-10
the O 0 3.715368013246234e-10
disease O 0 1.865553400648423e-08
, O 0 4.615718614611741e-13
and O 0 6.3544081021355e-13
most O 0 1.56865080820634e-12
of O 0 3.8277447184098534e-11
the O 0 6.663066626222403e-11
patients O 0 1.2241331559526003e-10
are O 0 4.59818001816853e-13
diagnosed O 0 1.152956285999096e-09
after O 0 1.0042841558366433e-10
the O 0 6.216432923977777e-11
age O 0 2.231523410500813e-08
of O 0 1.2744646449291963e-09
5 O 0 2.4509694274144067e-09
years O 0 3.1767304342622538e-09
. O 0 1.3855791181072163e-08

However O 0 8.334988166325275e-08
, O 0 4.282825136203705e-11
since O 0 4.080430091035758e-11
these O 0 6.010111245485783e-12
patients O 0 5.852532347638828e-11
excrete O 0 5.686803805637908e-10
early O 0 9.798847844244563e-11
large O 0 4.649312618926205e-13
amounts O 0 3.2355600837474796e-11
of O 0 1.0696449281866194e-09
aspartylglucosamine O 0 6.290930514296633e-07
in O 0 5.92583870862029e-10
urine O 0 9.398141820327055e-09
, O 0 4.766610717243935e-12
biochemical O 0 3.3749086858492205e-10
screening O 0 2.1596985311234107e-10
is O 0 2.4521814700334543e-12
easy O 0 9.464119488100664e-10
by O 0 1.1771049412967471e-10
urine O 0 9.907727971381064e-09
chromatography O 0 2.4252406305436125e-08
. O 0 2.9820657054813182e-09
. O 0 3.944649051845772e-08

Detection O 0 1.141360257861379e-06
of O 0 5.478062448105447e-09
heterozygous O 0 1.0268223077369854e-10
carriers O 0 2.014725409074658e-12
of O 0 5.6549254862092724e-11
the O 0 2.8053710465769655e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 5.422491256013018e-08
ATM O 1 0.8938292264938354
) O 0 4.306438452367223e-12
gene O 0 7.427383903226004e-13
by O 0 1.7411136551612194e-12
G2 O 0 9.13259867729721e-09
phase O 0 2.964096879054523e-08
chromosomal O 0 5.6593147945704914e-08
radiosensitivity O 0 1.9718061139428755e-06
of O 0 1.1471806260487938e-07
peripheral O 0 0.00031463889172300696
blood O 0 5.757884537160862e-06
lymphocytes O 0 3.6667327663053584e-07
. O 0 1.4791595503993449e-06

In O 0 1.43497061344533e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9612736105918884
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.6591443496860592e-11
patients O 0 1.2431063123319319e-11
, O 0 2.994643310996574e-14
mutations O 0 4.1154874511539416e-14
in O 0 6.939711121294739e-14
a O 0 2.529711737395829e-13
single O 0 4.118711014605703e-12
gene O 0 1.2278242658703142e-12
, O 0 1.3362701787103526e-12
ATM O 0 1.3794094400054746e-07
, O 0 1.2662148890160707e-12
result O 0 3.8323833689846154e-11
in O 0 3.327239178618768e-11
an O 0 4.7513144529887086e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 2.9580409233176397e-09
embraces O 0 6.590783474536011e-10
a O 0 5.927144192119371e-12
variety O 0 1.3611560663318034e-11
of O 0 1.9185542043942405e-10
clinical O 0 1.8599141116126816e-09
features O 0 4.404043449368622e-11
and O 0 1.9718691957049117e-11
manifests O 0 6.538944941070213e-10
extreme O 0 9.186389426929509e-09
radiosensitivity O 0 2.7752646474255016e-06
and O 0 8.948829177679585e-11
a O 0 3.593922104361269e-10
strong O 0 3.0435201581191507e-10
pre O 0 9.041796147357672e-06
- O 0 2.9435354917950463e-06
disposition O 0 5.207575213717064e-06
to O 0 2.4886332994356053e-07
malignancy B-Disease 1 0.8680095076560974
. O 0 4.4305309643277724e-07

Heterozygotes O 0 5.463414822770574e-07
for O 0 2.5914059786913413e-10
the O 0 2.2853259284971728e-09
ATM O 0 9.854611562332138e-06
gene O 0 4.3489007534036617e-11
have O 0 1.5177345057820757e-12
no O 0 3.964537031997395e-13
clinical O 0 1.490061199427295e-11
expression O 0 6.284155053964957e-12
of O 0 3.3025462364832947e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 4.0105946341739696e-10
may O 0 4.0907163073589103e-11
be O 0 2.2595392570878836e-11
cancer B-Disease 0 4.557544119876411e-09
prone O 0 7.915806898850519e-10
with O 0 3.868964610492798e-12
a O 0 1.4024534311651848e-10
moderate O 0 1.8785999422732402e-09
increase O 0 1.2354554879134838e-10
in O 0 7.457116174558465e-11
in O 0 1.088272916227595e-09
vitro O 0 1.4233675926789147e-07
radiosensitivity O 0 7.14640418664203e-06
. O 0 2.9609589091705857e-07

We O 0 5.822420323653432e-09
performed O 0 9.056604355350828e-09
a O 0 1.0764871216650818e-09
blind O 0 1.9697375819305307e-07
chromosomal O 0 8.293407915971329e-08
analysis O 0 2.2409314404114866e-09
on O 0 3.943924742344507e-09
G2 O 0 2.2288313061835652e-07
- O 0 3.123437952723407e-09
phase O 0 6.485441161885319e-08
lymphocytes O 0 4.5210482579882694e-10
from O 0 7.350751951573642e-11
7 O 0 2.564950196681792e-10
unrelated O 0 2.315615788006653e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.9335243450768758e-06
, O 0 5.709436395884282e-12
13 O 0 1.0120333737706488e-10
obligate O 0 8.336972001643517e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 0.9999998807907104
heterozygotes O 0 9.027415899254265e-07
( O 0 1.3799382643508995e-11
parents O 0 1.501003314696714e-11
of O 0 1.5483078361078206e-11
the O 0 2.1570255998026866e-11
patients O 0 5.142056919149596e-11
) O 0 7.925398618630064e-14
, O 0 2.0820355801833695e-13
and O 0 4.031841592359864e-13
14 O 0 4.043860038493996e-11
normal O 0 1.29543109572694e-09
controls O 0 9.196163275326796e-11
following O 0 1.7351372075258276e-11
X O 0 6.094295734726529e-09
- O 0 5.907523359383049e-10
irradiation O 0 9.732834677089741e-11
with O 0 4.640012766371493e-12
1 O 0 4.322720514871037e-10
Gy O 0 6.931209828309193e-09
in O 0 2.5175290996846955e-13
order O 0 4.375170473309986e-13
to O 0 1.4940247389932937e-12
evaluate O 0 3.7166138222577416e-11
this O 0 8.024149378803302e-13
cytogenetic O 0 5.385639489929872e-09
method O 0 8.412682217517897e-10
as O 0 1.3821508174083341e-11
a O 0 2.457079852080657e-11
tool O 0 1.3694078759840522e-08
for O 0 5.7819211224385825e-11
detection O 0 7.735217195659061e-07
of O 0 7.364206311422095e-08
ATM O 0 0.00026517087826505303
carriers O 0 2.972073431806166e-08
. O 0 2.5316884944004414e-07

Both O 0 1.709692014628672e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 1.1369624189683236e-05
and O 0 1.346960043502321e-10
heterozygotes O 0 8.726012801218985e-09
showed O 0 1.7710793942526948e-10
significantly O 0 2.3048517955315262e-11
increased O 0 4.374054937694716e-12
levels O 0 8.434400400325615e-11
of O 0 5.462010704837539e-11
radiation O 0 4.481193172978237e-06
- O 0 1.6024947058213002e-07
induced O 0 6.969005994506006e-08
chromatid O 0 2.6384864213468973e-06
damage O 0 4.632134675830457e-08
relative O 0 2.1237370972926328e-08
to O 0 4.5378752838720615e-11
that O 0 3.2981282635513587e-12
of O 0 2.21834856040104e-10
normal O 0 2.7953728931606747e-07
controls O 0 7.996241180308061e-08
. O 0 4.2037047620624435e-08

These O 0 1.004219485345459e-09
results O 0 7.937547841230241e-10
show O 0 3.496882228226639e-10
that O 0 3.064468167071621e-13
the O 0 2.110030206114999e-11
G2 O 0 4.830559774404719e-08
- O 0 9.093641395452323e-10
phase O 0 3.9290004139047596e-08
chromosomal O 0 4.466310343786972e-08
radiosensitivity O 0 2.360508233323344e-08
assay O 0 6.408872044172398e-11
can O 0 2.4952102016528865e-12
be O 0 1.1515260316466436e-12
used O 0 5.156056246020946e-13
for O 0 4.025555930264879e-13
the O 0 5.551917432733422e-12
detection O 0 2.4131098896873482e-08
of O 0 3.055214037317455e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 7.88651013863273e-05
. O 0 4.596490441599599e-07

In O 0 5.207807962648303e-09
combination O 0 2.088686112955429e-09
with O 0 2.2109175601414677e-11
molecular O 0 2.0034203185304023e-09
genetic O 0 6.22699780628011e-10
analyses O 0 7.178585503808677e-10
, O 0 3.5792362454954707e-13
this O 0 8.903969683955737e-14
test O 0 2.2068549244969038e-12
may O 0 4.43451861602967e-13
be O 0 1.2306283379490135e-12
of O 0 1.6337020278256453e-11
value O 0 5.230759228536108e-11
in O 0 3.480442930386962e-12
studies O 0 1.6415523107493613e-10
of O 0 1.6582499262618455e-10
familial B-Disease 0 2.710658586480008e-09
and I-Disease 0 2.494085216131481e-10
sporadic I-Disease 0 3.7239212247186515e-07
cancers I-Disease 0 7.166005957515154e-07
aimed O 0 2.4343751903188604e-08
at O 0 1.0365119873512185e-09
determination O 0 3.0296231301463195e-08
of O 0 3.88752230406908e-09
the O 0 1.7661541673597014e-10
potential O 0 5.896881594136261e-11
involvement O 0 8.021223685261702e-10
of O 0 1.1481071204855198e-08
ATM O 0 0.00952020101249218
mutations O 0 7.129766110836044e-09
in O 0 7.475989272087702e-10
tumor B-Disease 0 1.3998431995787541e-06
risk O 0 2.366330908998293e-09
or O 0 9.13902009624934e-11
development O 0 9.958203150972622e-08
. O 0 3.880366250541556e-09
. O 0 2.9716540339563835e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 9.513908549863004e-10
identification O 0 2.5173224571517494e-07
and O 0 1.2680040177570628e-11
detection O 0 2.8285766617841546e-08
of O 0 1.6301833216658679e-09
founder O 0 4.0910659748760736e-08
- O 0 2.9704567694466277e-09
effect O 0 4.789131938243152e-11
mutations O 0 9.769561895578427e-12
in O 0 1.9160692997510775e-12
the O 0 1.2146185446315627e-10
ATM O 0 1.5859212680879864e-06
gene O 0 2.7803781846302833e-11
in O 0 2.7731117749341117e-11
ethnic O 0 5.574354311477236e-10
populations O 0 1.518459941118877e-10
. O 0 2.686165068155333e-09

To O 0 1.6464447583075525e-09
facilitate O 0 7.141416347167251e-09
the O 0 1.2534256965679447e-10
evaluation O 0 2.4211734839241217e-08
of O 0 8.284930075319608e-09
ATM O 0 0.0002098382537951693
heterozygotes O 0 8.74110881454726e-08
for O 0 3.273695203809268e-10
susceptibility O 0 1.0471355338381727e-08
to O 0 6.459017209969886e-10
other O 0 1.2136233129567131e-09
diseases O 1 0.5315373539924622
, O 0 3.45768344511832e-11
such O 0 6.34487115624971e-11
as O 0 3.0597686162536775e-08
breast B-Disease 0 0.056374505162239075
cancer I-Disease 0 0.41983240842819214
, O 0 1.0000431593937265e-09
we O 0 2.9277122393089883e-10
have O 0 3.315492195024583e-12
attempted O 0 8.252138417041976e-10
to O 0 7.527423823150414e-11
define O 0 3.87789489408874e-09
the O 0 4.5505058055006486e-10
most O 0 8.402153972575377e-12
common O 0 5.9746912278724196e-12
mutations O 0 4.85626859905719e-12
and O 0 2.6141637682677854e-13
their O 0 3.395185174670523e-12
frequencies O 0 3.527430791905317e-09
in O 0 1.4051074748167025e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.016082660498796e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.934396822751317e-11
homozygotes O 0 5.1635986153542035e-08
from O 0 1.0829214261431908e-11
10 O 0 2.046399161237389e-11
ethnic O 0 2.2456784695701337e-11
populations O 0 2.2047945066883123e-11
. O 0 1.3334537918296974e-09

Both O 0 3.4217864097740858e-09
genomic O 0 2.6349196602382108e-08
mutations O 0 7.269160273715158e-11
and O 0 1.9724586547420486e-12
their O 0 5.130026958788392e-11
effects O 0 6.646543870836297e-10
on O 0 3.0548552576448174e-10
cDNA O 0 4.1886259793955105e-08
were O 0 1.2119346637362582e-09
characterized O 0 2.9252575917126933e-09
. O 0 6.579783828897234e-09

Protein O 0 3.52287372606952e-08
- O 0 3.6298224426190018e-09
truncation O 0 8.095202730373785e-09
testing O 0 5.271063030498624e-10
of O 0 1.463163062931372e-10
the O 0 4.5325208863911115e-11
entire O 0 2.3383521785547146e-09
ATM O 0 1.8722049688335574e-08
cDNA O 0 3.871051923454161e-09
detected O 0 6.224669668597471e-10
92 O 0 2.019314271350936e-09
( O 0 6.1389456885996285e-12
66 O 0 7.376081967436221e-09
% O 0 2.652484898391094e-10
) O 0 1.6934071332685985e-12
truncating O 0 3.3906992769061617e-09
mutations O 0 4.455157770477669e-11
in O 0 2.316822775294547e-11
140 O 0 1.327553511565327e-09
mutant O 0 3.0458098265739864e-09
alleles O 0 7.86754938975065e-10
screened O 0 2.087400829964281e-08
. O 0 2.8229615622876736e-07

The O 0 2.392783926552511e-07
haplotyping O 0 0.0008936456288211048
of O 0 2.3837367635337614e-08
patients O 0 4.545589682436457e-09
with O 0 6.245570900731412e-12
identical O 0 8.412506247168494e-10
mutations O 0 1.4322407149158778e-10
indicates O 0 1.5710298340021467e-10
that O 0 6.10671018960729e-13
almost O 0 2.0290840188619264e-11
all O 0 2.183504245467649e-12
of O 0 1.736564191057166e-11
these O 0 7.314762510979289e-12
represent O 0 3.461193831544307e-11
common O 0 1.6252429957397396e-10
ancestry O 0 1.2582216379897204e-09
and O 0 3.102286136313914e-11
that O 0 8.612174341726675e-12
very O 0 2.1116740300808345e-10
few O 0 7.948425806425519e-10
spontaneously O 0 6.365510785144579e-08
recurring O 0 5.023825906391721e-07
ATM O 0 0.00012380743282847106
mutations O 0 1.9792638283888664e-07
exist O 0 3.2608366495878727e-07
. O 0 7.675166671106126e-07

Assays O 0 7.599391693702273e-08
requiring O 0 4.6631143391095975e-09
minimal O 0 8.939234241722716e-09
amounts O 0 4.1088504126873815e-11
of O 0 7.653784550587517e-11
genomic O 0 4.567723699278048e-10
DNA O 0 6.389057283229249e-09
were O 0 1.897997176092403e-10
designed O 0 2.7221058740423132e-11
to O 0 1.4045381177552052e-11
allow O 0 7.955762437727998e-11
rapid O 0 9.614661289347737e-10
screening O 0 1.912259517400372e-10
for O 0 1.2739433639941122e-11
common O 0 1.9076293322761728e-10
ethnic O 0 3.837712370113877e-09
mutations O 0 1.3984347901896399e-08
. O 0 1.6553567405708236e-08

These O 0 5.740215414107297e-09
rapid O 0 1.4345825860573314e-08
assays O 0 5.87135540186523e-09
detected O 0 1.745139255326933e-09
mutations O 0 6.802143483891632e-12
in O 0 1.8800308532185284e-12
76 O 0 6.076464331705722e-10
% O 0 1.3280442023866357e-10
of O 0 6.209322639394443e-11
Costa O 0 2.554561673306921e-09
Rican O 0 2.3893633738225617e-07
patients O 0 9.511754939239836e-09
( O 0 2.4792643524111646e-13
3 O 0 2.185475108176793e-12
) O 0 1.7244877604355967e-14
, O 0 3.980671993203053e-15
50 O 0 3.672294131111531e-13
% O 0 1.270351553984972e-12
of O 0 5.2394534023891826e-12
Norwegian O 0 1.0156320968235377e-05
patients O 0 3.882256578435772e-07
( O 0 7.1877304455569835e-12
1 O 0 6.45059283765903e-11
) O 0 3.7665717441716373e-13
, O 0 1.233739401872852e-13
25 O 0 2.3954542776455368e-12
% O 0 2.500670460633958e-12
of O 0 5.259468641855003e-12
Polish O 0 3.243132960051298e-05
patients O 0 1.525378024780366e-06
( O 0 9.123549138401188e-12
4 O 0 1.3923491526401932e-10
) O 0 6.363990280935927e-13
, O 0 4.2682640733447685e-13
and O 0 2.2760168316010576e-13
14 O 0 5.7290717309088635e-12
% O 0 1.0928418760214331e-11
of O 0 7.43722618212761e-12
Italian O 0 2.589452030576922e-08
patients O 0 3.772455841044575e-07
( O 0 6.231351806079699e-12
1 O 0 9.155454866460744e-11
) O 0 2.230514601145317e-12
, O 0 1.3848338708405405e-12
as O 0 2.240389514532315e-12
well O 0 9.284350198368596e-12
as O 0 3.846368536175593e-12
in O 0 1.3255254532884564e-11
patients O 0 2.2621965412028544e-10
of O 0 1.6730297147660167e-09
Amish O 0 5.946360488451319e-07
/ O 0 9.639715159437401e-08
Mennonite O 0 4.044896968480316e-07
and O 0 2.84485435209092e-10
Irish O 0 7.064198825901258e-08
English O 0 1.2600119703165547e-07
backgrounds O 0 2.7411175551605993e-07
. O 0 1.239413052189775e-07

Additional O 0 5.1857171001756797e-08
mutations O 0 1.9280563812174023e-09
were O 0 4.142950982277682e-10
observed O 0 8.508565380038746e-11
in O 0 1.6092299368053453e-11
Japanese O 0 2.1300170516269645e-08
, O 0 5.1251371202543083e-11
Utah O 0 6.772508331920335e-09
Mormon O 0 8.045897281760972e-09
, O 0 4.810221665429992e-12
and O 0 1.73156333022062e-11
African O 0 7.905822663190065e-09
American O 0 7.336108609479197e-09
patients O 0 2.845318469724134e-08
. O 0 6.157790721772471e-08

These O 0 4.810244980113509e-10
assays O 0 1.292801837804447e-10
should O 0 3.5280912306229206e-12
facilitate O 0 3.028169937024927e-10
screening O 0 5.849207229680076e-11
for O 0 1.7393894657935505e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 6.099903657741379e-07
in O 0 1.56298390896481e-10
the O 0 4.8767847399266984e-11
populations O 0 2.1234168937067643e-12
studied O 0 8.05129296566065e-11
. O 0 7.112183064705846e-11
. O 0 5.931360291810961e-09

The O 0 1.1308242875429642e-07
von B-Disease 0 0.3046444058418274
Hippel I-Disease 1 0.9983079433441162
- I-Disease 0 0.18998022377490997
Lindau I-Disease 0 0.0008348754490725696
tumor I-Disease 0 5.197941277401696e-07
suppressor O 0 9.902589859223099e-09
gene O 0 3.479938559536322e-12
is O 0 6.529335177998113e-14
required O 0 1.8921189268161775e-11
for O 0 4.689097200805126e-12
cell O 0 1.0524330296135531e-09
cycle O 0 2.1643264958015607e-09
exit O 0 1.7005629127098132e-09
upon O 0 3.930045733291365e-10
serum O 0 1.600013987967941e-08
withdrawal O 0 1.138396470423686e-07
. O 0 1.3697638223675312e-07

The O 0 3.146412552723632e-08
inactivation O 0 2.5879270992845704e-07
of O 0 1.2430583673506135e-08
the O 0 1.5384337359591882e-08
von B-Disease 1 0.9999915361404419
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Lindau I-Disease 1 0.999996542930603
( I-Disease 0 4.051354807188545e-08
VHL I-Disease 1 0.9838647842407227
) I-Disease 0 1.8397783296819625e-09
tumor I-Disease 0 2.178377144446131e-06
suppressor O 0 9.985712949855952e-07
gene O 0 2.7107618372212983e-09
predisposes O 0 6.918612172057692e-08
affected O 0 2.584692460061433e-10
individuals O 0 2.7810555507795653e-12
to O 0 2.6419508941666336e-11
the O 0 9.112306464942321e-10
human O 0 0.00012928235810250044
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 0.9999940395355225
and O 0 8.860084541040258e-12
is O 0 1.6880722893738292e-13
associated O 0 1.4072068510451174e-10
with O 0 1.327061030509391e-11
sporadic B-Disease 1 0.9999973773956299
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 8.909565622161608e-06
RCC B-Disease 1 1.0
) O 0 5.068118813511546e-09
and O 0 9.169168890821311e-08
brain B-Disease 1 1.0
hemangioblastomas I-Disease 1 0.9788352251052856
. O 0 5.867921117896913e-07

VHL O 0 0.0011233268305659294
- O 0 1.6146355847013183e-05
negative O 0 2.246830277385925e-08
786 O 0 3.9809361624065787e-05
- O 0 6.634955298068235e-06
0 O 0 1.7303172228366748e-09
RCC B-Disease 0 5.185394002182875e-06
cells O 0 1.07825481876489e-08
are O 0 5.504723413207735e-11
tumorigenic O 0 6.245261374715483e-07
in O 0 2.6292805710426137e-09
nude O 0 6.625651849390124e-07
mice O 0 2.1154886731267197e-09
which O 0 2.7705567874625192e-12
is O 0 1.7036184745897187e-12
suppressed O 0 9.187011568156933e-11
by O 0 5.6373686101174325e-12
the O 0 4.225630401144542e-10
reintroduction O 0 2.3731986686925666e-07
of O 0 4.088476046604228e-08
VHL B-Disease 0 9.650408173911273e-05
. O 0 8.753744964451471e-07

Remarkably O 0 9.301314275944605e-05
, O 0 7.418669845105086e-11
this O 0 5.89246056462156e-12
occurs O 0 6.338847502451728e-11
without O 0 7.840281895932222e-11
affecting O 0 1.2752761346934705e-10
the O 0 2.3185998260233376e-11
growth O 0 2.2500916407874882e-10
rate O 0 1.9284747410086567e-10
and O 0 1.854265005429845e-12
cell O 0 8.077445934340233e-10
cycle O 0 5.790690593698855e-09
profile O 0 2.9495153541780894e-10
of O 0 4.413480692022631e-10
these O 0 5.316050724624155e-11
cells O 0 1.1565067792318473e-09
in O 0 2.1875876110577508e-10
culture O 0 1.4342411702727986e-07
. O 0 5.3153090817659177e-08

The O 0 4.0988459204527317e-07
786 O 0 8.541252464056015e-05
- O 0 2.9293601073732134e-06
0 O 0 2.0207811812777976e-10
cell O 0 1.8736052709300566e-08
line O 0 1.871812216336366e-08
, O 0 1.2593559875484495e-11
like O 0 8.320914270110169e-12
many O 0 1.111746632254107e-11
cancer B-Disease 0 2.290025502560411e-09
cells O 0 3.428140826766679e-10
, O 0 1.2563996067485594e-12
fails O 0 1.641649316486138e-10
to O 0 1.229590179674389e-10
exit O 0 1.278547614447234e-07
the O 0 8.505032234040755e-10
cell O 0 5.978564754371973e-09
cycle O 0 2.531483467294038e-09
upon O 0 1.720900755231014e-09
serum O 0 2.4629722261693132e-08
withdrawal O 0 4.589771052110336e-08
. O 0 7.552372238706084e-08

Here O 0 1.3828355349687627e-06
, O 0 2.2259651066836028e-10
it O 0 7.653192858093905e-13
is O 0 1.967253942213032e-13
shown O 0 8.002297609277509e-12
that O 0 4.1660351926021966e-13
reintroduction O 0 1.9436527942673365e-09
of O 0 9.394942462881417e-11
the O 0 1.3727564918131208e-10
wild O 0 2.9951707780639936e-09
- O 0 1.187184839324118e-08
type O 0 3.6258160918123394e-09
VHL B-Disease 0 5.066120138508268e-06
gene O 0 2.325359488297707e-10
restores O 0 1.2491898626620923e-09
the O 0 6.606058755576072e-11
ability O 0 2.0858117455446745e-09
of O 0 1.7961976794822476e-08
VHL O 1 0.9862392544746399
- O 0 0.000289868883555755
negative O 0 6.543289909899386e-09
RCC B-Disease 0 1.6316002074745484e-05
cancer I-Disease 0 8.22687162838065e-09
cells O 0 8.440676629861699e-11
to O 0 1.4405110784765363e-11
exit O 0 2.1863746368921966e-09
the O 0 3.9735114504280133e-11
cell O 0 5.965428706566911e-10
cycle O 0 1.0644530812342623e-09
and O 0 1.1641630368042222e-11
enter O 0 6.491133319741493e-08
G0 O 0 0.003577439347282052
/ O 0 2.6728255306807114e-06
quiescence O 0 9.798179235076532e-06
in O 0 1.7052269596362635e-09
low O 0 9.414705459676043e-08
serum O 0 5.85396975338881e-08
. O 0 1.597428145316826e-08

Both O 0 3.419283700623055e-07
VHL O 0 0.00012064596376148984
- O 0 2.729936170453584e-07
positive O 0 3.0639818460187485e-10
and O 0 2.0466500716409541e-10
VHL O 0 0.0001478128251619637
- O 0 1.9261540273873834e-07
negative O 0 5.557623250496135e-10
RCC B-Disease 0 1.6551729231650825e-07
cells O 0 8.962823816460741e-10
exit O 0 4.315160673229457e-09
the O 0 1.7298138615950975e-11
cell O 0 1.8762461029275812e-10
cycle O 0 1.9957191454977874e-10
by O 0 7.724705423928224e-12
contact O 0 9.241538201365529e-09
inhibition O 0 1.1016462764246171e-07
. O 0 5.106800315957116e-08

The O 0 3.0948623930271424e-07
cyclin O 0 3.432887024246156e-05
- O 0 1.0210841537627857e-05
dependent O 0 1.2835324696425232e-06
kinase O 0 1.4235435052967205e-08
inhibitor O 0 7.861879480763889e-10
, O 0 7.62486115912786e-11
p27 O 0 1.5307875855796738e-07
, O 0 2.1736822411466683e-11
accumulates O 0 2.4662133446540224e-10
upon O 0 2.278278676826062e-10
serum O 0 9.875291695493615e-10
withdrawal O 0 3.0106410697783303e-09
, O 0 6.54527690727158e-12
only O 0 1.2415062467657778e-12
in O 0 8.636153315914885e-13
the O 0 1.37430943361605e-11
presence O 0 4.148499946343698e-11
of O 0 2.7024349424920047e-09
VHL B-Disease 0 0.0002854855265468359
, O 0 1.079033459805423e-10
as O 0 1.2371857878445969e-11
a O 0 3.911823989732888e-12
result O 0 4.07526547230308e-11
of O 0 1.6063421426348867e-10
the O 0 8.668722684124219e-11
stabilization O 0 6.580708600267826e-07
of O 0 5.095034616431349e-09
the O 0 2.5641407219723078e-08
protein O 0 4.733280789537275e-08
. O 0 1.4981482721054817e-08

We O 0 1.040198149837579e-08
propose O 0 2.4455057978656214e-09
that O 0 2.737913411612891e-12
the O 0 3.1666849698019917e-11
loss O 0 4.739744152715275e-10
of O 0 9.795358968389678e-10
wild O 0 6.440576405530862e-10
- O 0 1.1273743050210783e-09
type O 0 3.253719238482944e-10
VHL B-Disease 0 6.461062866947032e-07
gene O 0 7.965537084098084e-12
results O 0 1.0608644171461457e-11
in O 0 1.336328834047884e-12
a O 0 7.743848964847366e-13
specific O 0 2.3078518263108805e-11
cellular O 0 6.720521916747657e-09
defect O 0 3.729769382232462e-09
in O 0 7.499164483837362e-11
serum O 0 2.9138602641864964e-08
- O 0 9.669842881976365e-08
dependent O 0 4.2532730049060774e-07
growth O 0 5.386222579062405e-10
control O 0 6.499923932423712e-10
, O 0 1.0964762084397783e-12
which O 0 1.9784637795249027e-13
may O 0 1.7536694318920354e-11
initiate O 0 9.886434781947173e-09
tumor B-Disease 0 1.7871016666504147e-07
formation O 0 6.998042749728484e-07
. O 0 2.4717949145269813e-06

This O 0 2.346626670757246e-09
is O 0 3.472818907446218e-11
corrected O 0 1.9377681681476133e-08
by O 0 5.39079024475253e-12
the O 0 7.75015190912498e-11
reintroduction O 0 8.077604363165847e-09
of O 0 3.514789292946574e-10
wild O 0 1.849129183106868e-09
- O 0 1.2385405590009668e-08
type O 0 2.3623909939374244e-08
VHL B-Disease 0 0.12019271403551102
, O 0 6.5002376814504714e-09
implicating O 1 0.6096686720848083
VHL B-Disease 1 0.9993622899055481
as O 0 1.000716620680464e-09
the O 0 2.37214581311207e-10
first O 0 7.456352202339644e-10
tumor B-Disease 0 2.2645028074919082e-09
suppressor O 0 6.246149153454894e-10
involved O 0 1.1927352161489324e-10
in O 0 2.5545104226365467e-11
the O 0 3.456128994105967e-10
regulation O 0 3.580492791144252e-09
of O 0 4.2290815294165895e-10
cell O 0 7.290532622050705e-10
cycle O 0 5.192523300223684e-09
exit O 0 7.4253594384288135e-09
, O 0 6.624675851288342e-13
which O 0 4.796977634449577e-14
is O 0 1.0423027051913517e-13
consistent O 0 5.770532385263039e-10
with O 0 4.441902574925383e-12
its O 0 4.40802672141416e-11
gatekeeper O 0 3.2268427929693644e-09
function O 0 2.4726426461896267e-10
in O 0 5.644214262634506e-11
the O 0 1.5409027387391916e-09
kidney O 0 3.941535737794766e-07
. O 0 2.937586174311946e-09
. O 0 2.2911887498366923e-08

Piebaldism B-Disease 1 1.0
with O 0 0.21938078105449677
deafness B-Disease 1 1.0
: O 0 7.021327963485646e-10
molecular O 0 2.9314350946663126e-09
evidence O 0 2.112447577973242e-10
for O 0 1.2074986843746416e-11
an O 0 4.99857030766826e-11
expanded O 0 2.5574303208486526e-07
syndrome O 1 0.6175194978713989
. O 0 1.0989809595685074e-07

In O 0 9.752932683682047e-09
a O 0 1.087175460767753e-09
South O 0 1.5293613486733193e-08
African O 0 8.625010039509107e-09
girl O 0 1.0420553309131719e-07
of O 0 2.0506845999079815e-08
Xhosa O 1 0.9984480142593384
stock O 0 4.717395363229571e-10
with O 0 6.410372233034423e-12
severe O 0 3.9660750417169766e-07
piebaldism B-Disease 1 0.9979633092880249
and O 0 1.3871239445961692e-07
profound O 1 0.999776303768158
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 3.959158689781361e-08
identified O 0 1.7511501970712828e-10
a O 0 6.40441746944248e-13
novel O 0 3.809052411592878e-13
missense O 0 3.9921785321972436e-10
substitution O 0 3.34389654854661e-10
at O 0 4.404146214387339e-10
a O 0 4.181738635922194e-11
highly O 0 1.8048958994043574e-09
conserved O 0 4.927259933396044e-09
residue O 0 3.808088777645935e-08
in O 0 1.571266589062148e-10
the O 0 1.1051620729674028e-09
intracellular O 0 9.552152846481476e-09
kinase O 0 2.376321084351929e-10
domain O 0 8.26653689944834e-10
of O 0 1.1412183420489441e-09
the O 0 4.490363636477923e-08
KIT O 1 0.9999696016311646
proto O 0 0.36322036385536194
- O 0 5.5978209275053814e-05
oncogene O 0 5.637919002765557e-06
, O 0 9.539474765674072e-10
R796G O 0 5.451295237435261e-06
. O 0 5.951511994339853e-08

Though O 0 2.809044644891401e-06
auditory B-Disease 0 0.0020223716273903847
anomalies I-Disease 0 1.0179400305787567e-05
have O 0 3.1336225281286545e-10
been O 0 2.060150244842518e-10
observed O 0 2.402717434735191e-11
in O 0 1.880347440252894e-11
mice O 0 1.1157196000421976e-10
with O 0 6.356278350883038e-12
dominant O 0 3.065451664951979e-06
white O 0 5.307255079856077e-08
spotting O 1 0.9874316453933716
( O 0 1.3626310746417403e-08
W O 0 3.13957134494558e-05
) O 0 8.45188502518468e-12
due O 0 1.278542782756631e-07
to O 0 1.1262653032417802e-09
KIT O 0 0.43453940749168396
mutations O 0 1.3761139427970193e-07
, O 0 2.951779265458754e-09
deafness B-Disease 1 1.0
is O 0 1.1635132440845908e-10
not O 0 7.983016331314374e-11
typical O 0 2.573125890137362e-08
in O 0 1.4305270301662176e-09
human O 0 9.216967100655893e-08
piebaldism B-Disease 0 0.00021722770179621875
. O 0 4.886261422143434e-07

Thus O 0 1.5992329238656566e-08
, O 0 1.2335688026610114e-11
the O 0 2.075847826965571e-11
occurrence O 0 4.397578479142794e-08
of O 0 4.781107350027014e-07
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 9.904444198127749e-08
this O 0 4.365724171062624e-10
patient O 0 1.2926551384850882e-08
extends O 0 1.0066732170077586e-11
considerably O 0 6.116519790655417e-11
the O 0 8.067491119589931e-12
phenotypic O 0 2.0514101528590345e-10
range O 0 3.434554862735695e-10
of O 0 7.634498588870997e-10
piebaldism B-Disease 0 1.8685274483232206e-07
due O 0 3.9444230992558005e-08
to O 0 2.232322771078543e-09
KIT O 0 4.5827622670913115e-05
gene O 0 3.2618299172781917e-09
mutation O 0 2.909320007127292e-10
in O 0 4.309513856881608e-11
humans O 0 1.9130301787129156e-09
and O 0 1.486250011950574e-10
tightens O 0 1.7155586951034252e-09
the O 0 6.41219785602054e-11
clinical O 0 3.423059613538726e-09
similarity O 0 1.8189953709946138e-10
between O 0 1.2471995658458468e-09
piebaldism B-Disease 0 4.819805781153264e-07
and O 0 6.750084866058437e-12
the O 0 8.459093668589102e-12
various O 0 2.4030747877712422e-11
forms O 0 7.116909284121675e-10
of O 0 1.4316009355752612e-07
Waardenburg B-Disease 1 1.0
syndrome I-Disease 0 0.0016251348424702883
. O 0 3.490260302996262e-09
. O 0 5.338259967402337e-08

Cycloheximide O 0 3.363439464010298e-05
facilitates O 0 3.579932794650631e-09
the O 0 1.217629330696468e-10
identification O 0 2.2842247204835076e-08
of O 0 2.089870854149467e-08
aberrant O 0 2.3008318805750605e-08
transcripts O 0 8.398677664445131e-08
resulting O 0 1.507233116093687e-09
from O 0 4.957495525204081e-11
a O 0 8.131028836344534e-12
novel O 0 3.141011062357535e-11
splice O 0 2.263182885542392e-08
- O 0 8.230351955518245e-10
site O 0 7.029458265472854e-11
mutation O 0 1.2351439315771984e-11
in O 0 1.912466539299995e-11
COL17A1 O 1 0.9902142286300659
in O 0 2.71682176755661e-10
a O 0 1.0609524370153167e-09
patient O 0 1.0167455002374481e-06
with O 0 3.2961084972527033e-09
generalized O 0 0.0015854926314204931
atrophic B-Disease 1 0.9999949932098389
benign I-Disease 1 0.9999462366104126
epidermolysis I-Disease 1 0.9987670183181763
bullosa I-Disease 0 0.027896184474229813
. O 0 2.7770784072345123e-06

Patients O 0 1.0175750503549352e-05
with O 0 4.680990262073692e-09
generalized O 0 6.579094770131633e-05
atrophic B-Disease 1 0.9999991655349731
benign I-Disease 1 0.9999727010726929
epidermolysis I-Disease 1 0.9999669790267944
bullosa I-Disease 0 0.2030171900987625
often O 0 1.7526170792425688e-10
show O 0 1.8225236597668726e-10
decreased O 0 1.0092273683426356e-09
expression O 0 1.8691229120015862e-11
of O 0 8.684460789387671e-11
type O 0 1.1484263540140205e-09
XVII O 0 4.016875209345017e-06
collagen O 0 4.899410654957137e-08
, O 0 5.707871675308951e-11
a O 0 5.078810150216384e-10
transmembrane O 0 2.4114443775147265e-08
hemidesmosomal O 0 1.387391250773362e-07
protein O 0 2.1327629939893455e-10
encoded O 0 5.3146820278016094e-11
by O 0 2.4629367989525974e-10
COL17A1 O 0 0.01577126234769821
. O 0 2.983566673719906e-07

This O 0 1.3337946302982573e-09
report O 0 3.8935832336051135e-10
documents O 0 5.71029223905839e-10
a O 0 1.7241680305701834e-11
novel O 0 2.2393439533252568e-11
splice O 0 6.672525643125482e-08
- O 0 5.516245793479868e-10
site O 0 5.5488079409027335e-11
mutation O 0 9.646282037034659e-12
in O 0 5.102703329318281e-11
COL17A1 O 1 0.9999088048934937
in O 0 9.112358645424479e-10
a O 0 1.7162755661104256e-09
patient O 0 1.950682417373173e-06
with O 0 1.996572907003724e-09
generalized O 0 0.00024837948149070144
atrophic B-Disease 1 0.9999886751174927
benign I-Disease 1 0.9969981908798218
epidermolysis I-Disease 1 0.9958440661430359
bullosa I-Disease 0 0.001583193545229733
, O 0 7.78428502212769e-11
and O 0 7.107731070377099e-12
applies O 0 3.6343358877921617e-11
a O 0 3.007015209749442e-12
new O 0 1.3378563664886989e-12
methodology O 0 1.159313756105007e-09
to O 0 3.4304482865454844e-11
define O 0 2.3502864099356202e-09
and O 0 1.369725305400138e-10
characterize O 0 2.746313221280161e-08
the O 0 4.795450703198867e-10
resulting O 0 4.402048947582671e-09
mRNA O 0 2.4308627999403143e-08
splice O 0 1.0689361573668066e-07
variants O 0 9.203349193853683e-09
. O 0 5.831770621966825e-08

Mutational O 0 8.816590707283467e-06
analysis O 0 1.7403701590978926e-08
of O 0 2.8596874201980427e-08
COL17A1 O 1 0.9995352029800415
identified O 0 2.7576668060191878e-08
a O 0 6.911457517411179e-10
maternally O 0 2.0081351692624594e-07
inherited O 0 2.4388955921494926e-07
G O 0 4.6532012021316405e-08
- O 0 1.9419786667640437e-08
to O 0 6.491379433981592e-09
- O 0 1.595093635842204e-06
T O 0 1.5503688644002978e-07
transversion O 0 6.386017048498616e-06
at O 0 1.4559340399955545e-09
the O 0 1.3738514492711573e-10
- O 0 2.0276691437004501e-10
1 O 0 3.421965835692653e-11
position O 0 7.701174697949398e-10
of O 0 1.2339442800879397e-09
exon O 0 8.27891177834772e-09
32 O 0 2.0858008653590332e-08
. O 0 3.836697004544476e-08

This O 0 7.430994708457206e-10
acceptor O 0 4.2353821783081e-08
splice O 0 3.0569008231395856e-06
- O 0 3.235139089952099e-08
site O 0 1.3243947050156635e-09
mutation O 0 6.264053858950902e-11
led O 0 6.154107085043492e-11
to O 0 3.0559318964229476e-11
the O 0 1.9669155193469123e-10
formation O 0 1.9590331135077577e-07
of O 0 8.449642905361543e-07
aberrant O 0 2.905131850639009e-07
transcripts O 0 1.8086344653056585e-06
present O 0 9.233468212244134e-09
at O 0 2.3242042956894693e-08
extremely O 0 4.9761091247546574e-08
low O 0 3.041588456653699e-07
levels O 0 6.422856699828117e-07
. O 0 6.844375377568213e-08

Based O 0 2.069197035936554e-09
on O 0 1.2367716850647525e-09
our O 0 1.0347579459946132e-09
recent O 0 1.4795543262779987e-11
finding O 0 1.093935150797698e-10
that O 0 1.310356879426211e-12
cycloheximide O 0 6.114230899356699e-08
stabilized O 0 4.715646184649813e-07
mutant O 0 2.702013546240778e-08
COL17A1 O 0 3.9695671148365363e-05
transcripts O 0 8.859679212491756e-08
in O 0 2.190623099584954e-10
keratinocytes O 0 4.3751151679316536e-07
homozygous O 0 7.84824538690998e-10
for O 0 2.2564769497357418e-11
a O 0 4.1332584577169484e-10
frameshift O 0 2.687499716103048e-07
mutation O 0 5.427700511262401e-10
, O 0 6.7833061216659996e-12
the O 0 7.796156775707885e-11
effects O 0 2.327024350989859e-09
of O 0 6.390724061056119e-10
the O 0 1.3102214868609963e-09
splice O 0 2.698835643855091e-08
- O 0 1.703756719040328e-10
site O 0 1.796400528331077e-11
mutation O 0 9.576651537751557e-13
on O 0 1.0962113161649967e-11
splicing O 0 2.8971280929823706e-09
of O 0 4.5882631027893694e-09
COL17A1 O 0 0.0047770170494914055
transcripts O 0 2.1929622562311124e-08
were O 0 2.4921958594048554e-11
determined O 0 2.882401782533517e-12
using O 0 9.792200280885413e-14
reverse O 0 2.8652340916535124e-12
transcriptase O 0 5.513410474694558e-12
polymerase O 0 3.02192407382329e-12
chain O 0 1.3574764142626483e-12
reaction O 0 5.339468559135974e-13
of O 0 2.0371615852554648e-11
total O 0 2.1662002747113718e-10
RNA O 0 3.106599866242732e-09
from O 0 1.092909540645337e-09
keratinocytes O 0 9.246228387382871e-07
incubated O 0 3.4277459093345897e-08
for O 0 1.4731854625082974e-10
2 O 0 1.1250548936914129e-08
. O 0 2.9286365332836795e-08

5 O 0 2.5119428315178993e-08
h O 0 1.924378656426029e-09
in O 0 6.870563840077892e-11
the O 0 1.2187724440781977e-10
presence O 0 4.722848501170773e-11
or O 0 5.1055847050118786e-11
absence O 0 3.538740145359043e-08
of O 0 2.8777767724363912e-08
10 O 0 5.593293384009712e-09
microg O 0 1.7774270588688523e-07
cycloheximide O 0 1.317795295108226e-07
per O 0 5.0438011101050506e-08
ml O 0 5.782933385489741e-07
. O 0 5.482758425046086e-08

Using O 0 1.1292466961521086e-09
this O 0 4.8235554439557404e-11
approach O 0 1.626568102430781e-09
, O 0 1.0565047968424945e-11
an O 0 4.812047895569327e-12
abnormally O 0 9.431969649753569e-10
spliced O 0 4.5136663295863855e-09
transcript O 0 2.7056133333758225e-08
was O 0 3.9857267486453907e-10
identified O 0 2.0227364228020406e-10
that O 0 2.3629842115131805e-13
contains O 0 1.274816976157625e-13
an O 0 3.5162306145095426e-14
extra O 0 7.975707767837736e-12
264 O 0 4.535030961871911e-10
bases O 0 1.156590490047904e-09
upstream O 0 5.5000062282317685e-09
from O 0 2.2105823838103333e-09
exon O 0 1.0036723452344631e-08
32 O 0 8.035606846590326e-09
, O 0 1.7457667256248754e-11
resulting O 0 3.0147997986951225e-10
in O 0 3.490829153518504e-11
a O 0 5.484897536156552e-10
premature O 0 7.942234958591143e-08
termination O 0 7.573489568812874e-08
codon O 0 8.454335898022691e-08
27 O 0 1.0202077049825675e-07
bp O 0 3.755136788186064e-07
downstream O 0 1.9356042457729927e-07
from O 0 3.6254634849797185e-09
the O 0 3.3110058694774125e-08
cryptic O 0 1.3236195854915422e-06
splice O 0 3.074213964282535e-06
site O 0 1.1667039245821798e-07
. O 0 2.1286467699610512e-07

Three O 0 7.784352717976617e-09
other O 0 1.5223515503759444e-10
splice O 0 7.20118942254544e-09
variants O 0 1.4369581913253882e-10
, O 0 9.757229746387708e-13
including O 0 2.986368476728257e-13
one O 0 8.737720291231155e-13
derived O 0 1.9967992537228696e-11
from O 0 3.719450095140964e-11
the O 0 1.4287156180348148e-10
skipping O 0 2.8841343535646047e-08
of O 0 4.725793445459203e-08
exon O 0 2.868482695816965e-08
32 O 0 1.5272421549639148e-08
, O 0 3.9335534829376684e-11
were O 0 6.512905215139142e-10
also O 0 1.0156030877395139e-10
identified O 0 1.456507003894103e-08
. O 0 1.4382338520135818e-07

These O 0 1.1054298587609424e-09
results O 0 8.184422584101014e-10
indicate O 0 5.993655571856493e-10
the O 0 4.470548237156535e-11
usefulness O 0 1.5115839246959695e-08
of O 0 1.2376637492650389e-09
cycloheximide O 0 2.1184116860695212e-07
treatment O 0 2.2525445952936707e-09
in O 0 5.530304512946227e-12
evaluating O 0 6.884770531456752e-11
the O 0 2.998042786250821e-11
abnormal O 0 5.063575669872478e-10
processing O 0 7.253047051847261e-09
of O 0 1.7198922841465958e-10
mRNA O 0 7.449315053698058e-10
due O 0 5.775060873958182e-09
to O 0 1.6045056394631274e-09
splice O 0 5.368119673221372e-07
- O 0 6.304429422954172e-09
site O 0 2.8643246108295273e-10
mutations O 0 1.395017990013514e-10
, O 0 2.987777126400859e-12
because O 0 3.405492554620082e-11
( O 0 4.9247651096040457e-11
i O 0 9.302072001560191e-09
) O 0 8.1117439154621e-12
aberrant O 0 1.3552019506590796e-09
splicing O 0 1.1999882865154632e-08
often O 0 1.7314247258148896e-11
generates O 0 8.932794608174088e-12
a O 0 7.495214518482562e-12
premature O 0 1.1130845134488254e-09
termination O 0 1.3901075845978994e-09
codon O 0 8.393261197170432e-09
, O 0 8.103072379750387e-11
( O 0 1.035339262239754e-11
ii O 0 2.661833242711964e-08
) O 0 1.272765920434793e-10
transcripts O 0 5.809987513316628e-08
with O 0 2.308706177622799e-11
premature O 0 8.584209787443342e-09
termination O 0 1.6450917295074419e-09
codons O 0 4.641203810162864e-10
can O 0 1.3816658754606248e-11
occur O 0 1.1418737067003804e-09
at O 0 2.3498560874912755e-09
low O 0 1.2490285250521538e-08
or O 0 2.2603764693318595e-10
undetectable O 0 8.891433367352874e-09
levels O 0 1.0672198680339307e-09
due O 0 9.1584634320796e-10
to O 0 7.365726778507664e-11
nonsense O 0 1.9273661777674533e-08
- O 0 6.008306630000959e-10
mediated O 0 5.65380897654677e-09
mRNA O 0 5.2827711094494134e-09
decay O 0 5.4746706723562966e-08
, O 0 2.4840227531158776e-12
and O 0 2.5050812119120636e-12
( O 0 6.715831233142233e-13
iii O 0 1.6022915216851175e-09
) O 0 4.874169210605794e-12
the O 0 4.6042839679794056e-11
levels O 0 1.569413377033868e-09
of O 0 7.870562535039483e-11
these O 0 1.2426274419163885e-11
transcripts O 0 3.4325984277217003e-09
can O 0 4.0804985258768856e-12
be O 0 6.21587200114182e-12
increased O 0 6.707862737487247e-11
by O 0 1.2441957186748454e-10
cycloheximide O 0 3.905192897946108e-06
. O 0 1.9640839354906348e-07

A O 0 4.460504783310171e-07
deletion O 0 5.5731693038296726e-08
mutation O 0 4.807814146801093e-10
in O 0 2.161849865789378e-10
COL17A1 O 1 0.9951924085617065
in O 0 1.5222935412229077e-10
five O 0 9.707157300198332e-11
Austrian O 0 3.341974164072781e-08
families O 0 2.3226066903081488e-10
with O 0 2.740695725922393e-10
generalized O 0 8.707105735084042e-06
atrophic B-Disease 1 0.9997749924659729
benign I-Disease 1 0.9989525079727173
epidermolysis I-Disease 1 0.9834253191947937
bullosa I-Disease 0 8.050916221691296e-05
represents O 0 4.49544096392529e-10
propagation O 0 1.2361360290924495e-07
of O 0 6.015304254702869e-09
an O 0 2.3995311293489863e-10
ancestral O 0 8.220585101526012e-08
allele O 0 5.347686382606298e-08
. O 0 7.217032305106841e-08

Patients O 0 1.3872451745555736e-05
with O 0 1.7047010913984195e-08
generalized O 0 0.00020402604422997683
atrophic B-Disease 1 0.9999996423721313
benign I-Disease 1 0.9999961853027344
epidermolysis I-Disease 1 0.9999918937683105
bullosa I-Disease 1 0.9911972284317017
, O 0 2.407687105243639e-10
a O 0 3.2823216367106056e-11
usually O 0 2.8091792780848834e-11
nonlethal O 0 6.86961740825609e-08
form O 0 9.261583500119741e-09
of O 0 3.721459142980166e-05
junctional B-Disease 1 0.9999983310699463
epidermolysis I-Disease 1 0.9998078942298889
bullosa I-Disease 0 0.02613743022084236
, O 0 3.2170943686793407e-10
have O 0 1.2672932148127813e-11
generalized O 0 4.066385284051677e-10
blistering B-Disease 0 2.6201292246952335e-09
, O 0 2.146237493283465e-10
nail B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999887943267822
, O 0 1.8772581711345993e-07
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 6.342508527268365e-07
and O 0 0.0002533403458073735
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.9997190833091736

Skin B-Disease 1 1.0
fragility I-Disease 1 1.0
in O 0 1.8726371564525834e-08
most O 0 1.7338769309205304e-11
cases O 0 1.7512587517296008e-12
is O 0 3.373563499950785e-14
due O 0 1.671724425555965e-10
to O 0 1.5575402079193168e-11
mutations O 0 1.411149062185979e-11
in O 0 1.1893400760770723e-12
the O 0 2.0713746690104173e-11
gene O 0 1.6843915151554256e-11
encoding O 0 4.116424090483406e-09
type O 0 6.092160020898518e-08
XVII O 0 0.0011908330488950014
collagen O 0 1.5811907360330224e-05
( O 0 6.4549570133465295e-09
COL17A1 O 1 0.9999617338180542
) O 0 2.370889484737404e-09
. O 0 2.4111269425475257e-08

Recently O 0 7.84280587140529e-08
, O 0 2.7350385845004155e-11
we O 0 7.705340705765895e-12
reported O 0 1.0616659461282207e-11
five O 0 3.775002879735645e-12
Austrian O 0 4.438292844355374e-09
families O 0 9.55177811845509e-11
with O 0 9.608294715413024e-11
generalized O 0 5.595612492470536e-06
atrophic B-Disease 1 0.9999849796295166
benign I-Disease 1 0.9999836683273315
epidermolysis I-Disease 1 0.9999986886978149
bullosa I-Disease 1 0.99928879737854
who O 0 3.5286620292396265e-09
share O 0 2.1180930342978854e-09
the O 0 6.685131337391681e-10
same O 0 1.3063268688995322e-08
COL17A1 O 1 0.9976897239685059
mutation O 0 6.620334147555695e-08
. O 0 4.305592682385395e-08

Affected O 0 6.479012171212162e-08
individuals O 0 3.59469468080853e-11
in O 0 1.0478812262348924e-11
three O 0 1.1280270988123231e-11
families O 0 3.4479738942466698e-12
are O 0 1.362819904669743e-13
homozygous O 0 3.121563120836446e-12
for O 0 3.83606037560047e-12
4003delTC O 0 6.407451280665555e-08
, O 0 1.8493600748015204e-11
whereas O 0 1.126667092954392e-09
those O 0 2.459086580197667e-11
in O 0 1.0763689418935574e-11
two O 0 2.8583959851835594e-11
others O 0 1.1667646016011446e-10
are O 0 1.3543685270511752e-11
compound O 0 9.815543045021968e-09
heterozygotes O 0 3.1827002544559946e-07
. O 0 4.57802912023908e-07

To O 0 8.347043944922916e-09
determine O 0 1.4315867602476828e-08
if O 0 7.214971675661985e-11
the O 0 3.6385460616683574e-11
occurrence O 0 2.384958674994664e-09
of O 0 3.860550212841929e-10
4003delTC O 0 1.1929548016098579e-08
in O 0 5.56913109378554e-12
these O 0 1.5975833937004191e-12
unrelated O 0 1.382325642840243e-10
families O 0 1.3062918802209111e-12
signifies O 0 9.731251394973217e-12
propagation O 0 2.5414013116176193e-09
of O 0 2.838501933499771e-10
an O 0 3.806376394632771e-11
ancestral O 0 3.136190684926987e-08
allele O 0 2.41345983198471e-08
or O 0 3.3822440403952214e-09
a O 0 3.633121181678689e-08
mutational O 0 1.7636466509429738e-05
hot O 0 1.0544629276409978e-06
spot O 0 1.1455789206138434e-07
, O 0 5.932123542384815e-11
haplotypes O 0 9.090069252870592e-10
were O 0 7.666774159975631e-11
determined O 0 7.729901163600061e-10
for O 0 1.0035029751609414e-10
polymorphisms O 0 1.1987848935746115e-08
both O 0 1.5832376520918956e-09
within O 0 2.510012642176207e-08
and O 0 5.877988762392761e-09
flanking O 0 2.9154027288313955e-05
COL17A1 O 1 0.9999970197677612
. O 0 9.704959666123614e-06

Five O 0 2.6805474817592767e-07
intragenic O 0 1.958354687303654e-06
polymorphisms O 0 5.291342919377939e-09
were O 0 1.858023318535018e-10
chosen O 0 2.67272287635123e-10
based O 0 1.1140264058462357e-11
on O 0 1.592711629250232e-09
their O 0 5.317526863279909e-09
informativeness O 0 6.53170354780741e-05
. O 0 3.0857529509376036e-07

One O 0 2.0695807734227856e-08
of O 0 2.2630952667412885e-09
these O 0 4.244432930122777e-11
, O 0 1.4178662584296564e-12
not O 0 1.3968910663603173e-12
previously O 0 1.1130966981465207e-10
reported O 0 7.650340083653617e-11
, O 0 6.979138946448804e-13
was O 0 3.4410396754225303e-10
2988 O 0 5.878484330423817e-07
A O 0 1.887019038804283e-07
or O 0 7.278042613023672e-10
C O 0 1.727342691992817e-06
that O 0 1.6072514846809938e-11
introduces O 0 5.731566610212013e-11
a O 0 4.078980642835406e-12
new O 0 1.5240728601026432e-12
restriction O 0 6.156980741217621e-12
site O 0 2.8433231463731445e-11
for O 0 1.4942791795591326e-11
Eco0109 O 0 5.5348596106341574e-06
I O 0 4.043346780235879e-05
. O 0 2.7071470753980975e-07

All O 0 6.733738011632795e-09
the O 0 3.6402064695906233e-10
4003delTC O 0 9.508834608595862e-09
alleles O 0 2.1186847415366472e-11
showed O 0 6.092662485635003e-11
the O 0 3.208340711158275e-12
same O 0 5.9791030633526976e-12
haplotype O 0 1.0109203057995231e-10
for O 0 5.666929165509815e-12
these O 0 5.223122281905468e-11
five O 0 9.226210351265252e-10
polymorphic O 0 1.3018174094270307e-08
markers O 0 1.6957507398274174e-08
. O 0 1.647528620196681e-07

Fourteen O 0 3.506072800973925e-07
microsatellite O 0 4.67559395644912e-08
polymorphisms O 0 1.8060390960528139e-09
were O 0 1.346816269620632e-10
selected O 0 3.154513802949843e-11
based O 0 9.709480398509274e-13
on O 0 7.726550649289621e-11
their O 0 1.8431561832343846e-10
high O 0 3.331497078207235e-09
heterozygosity O 0 8.829800890453043e-07
and O 0 8.213708879711845e-11
their O 0 2.3198440390892472e-10
location O 0 1.5962151600490415e-09
within O 0 1.4011154014781368e-08
10q23 O 0 1.010766027320642e-05
- O 0 4.265565110017633e-07
q25 O 0 5.2268105719122104e-06
near O 0 5.109196763442014e-07
COL17A1 O 1 0.5290041565895081
. O 0 1.42234591749002e-06

Three O 0 2.476324922895401e-09
families O 0 1.640857311135946e-10
shared O 0 1.0161150809651076e-09
microsatellite O 0 2.1829174912113558e-08
polymorphisms O 0 8.499766224190353e-09
covering O 0 7.099412613342793e-08
at O 0 1.1125056431637859e-08
most O 0 3.437620327284563e-11
19 O 0 5.841918060411899e-10
cM O 0 4.416160770404076e-09
, O 0 1.0392665894531916e-11
whereas O 0 3.2327610033355825e-10
the O 0 3.266397985424163e-10
others O 0 2.9681274105186617e-10
shared O 0 9.536291756262472e-10
smaller O 0 1.3443184065931035e-11
regions O 0 4.074682605215152e-11
consistent O 0 4.506524320380123e-10
with O 0 3.316946977499624e-12
cross O 0 3.796960967861196e-09
- O 0 4.222685845434171e-08
over O 0 8.138496127019224e-11
events O 0 4.2102141217803535e-11
during O 0 1.0067970901417311e-09
passage O 0 8.555025438061747e-11
of O 0 5.286492597844639e-12
this O 0 9.293841737867403e-13
mutation O 0 7.99187972744253e-12
through O 0 1.5709211709236115e-11
several O 0 8.05756086852405e-11
generations O 0 2.3422680683893304e-08
. O 0 3.1211229156724585e-08

These O 0 2.119317388249442e-09
results O 0 7.932704493285314e-10
indicate O 0 8.258578265696315e-10
that O 0 9.405385541574884e-13
4003delTC O 0 2.5837669781481054e-09
occurs O 0 1.634047931686755e-11
on O 0 1.8034350054985104e-11
a O 0 6.43503262828804e-12
single O 0 2.4131258102855213e-10
ancestral O 0 1.3988990410496172e-08
allele O 0 2.9409332746865857e-09
. O 0 1.4255207014812754e-09
. O 0 5.5394579590029025e-08

The O 0 9.161599479057259e-08
haptoglobin O 0 1.4885805285302922e-05
- O 0 1.6535950919660536e-07
gene O 0 4.006450726734556e-10
deletion O 0 1.627250778568623e-09
responsible O 0 1.2461889298265305e-09
for O 0 1.1315757220131673e-08
anhaptoglobinemia B-Disease 1 0.9997276663780212
. O 0 1.8485289956515771e-06

We O 0 1.3044246571780604e-08
have O 0 1.486351319801571e-11
found O 0 2.0135460139514283e-12
an O 0 5.959047545776169e-14
allelic O 0 4.4045328495556646e-10
deletion O 0 1.2182431730067833e-09
of O 0 6.277061093129532e-09
the O 0 1.7496729398658317e-08
haptoglobin O 0 0.00017860323714558035
( O 0 1.7496511184322827e-10
Hp O 0 3.183754593294452e-09
) O 0 3.165874246785494e-12
gene O 0 6.275949811923587e-12
from O 0 2.557303847849912e-11
an O 0 2.5968758393668523e-12
individual O 0 1.0547918094516717e-10
with O 0 9.834878467174235e-10
anhaptoglobinemia B-Disease 0 0.0005742714274674654
. O 0 1.4956749510020018e-06

The O 0 4.2525751808852874e-08
Hp O 0 1.1395115073753459e-08
gene O 0 6.716500619563526e-12
cluster O 0 1.7715311856347782e-11
consists O 0 2.6200415101373942e-11
of O 0 6.433100163683036e-10
coding O 0 5.011058419768233e-06
regions O 0 9.08556696543883e-09
of O 0 1.4584863095024048e-08
the O 0 3.325389741348772e-09
alpha O 0 2.8096627802121077e-10
chain O 0 3.74282592766062e-12
and O 0 3.173611005068133e-13
beta O 0 1.9072864815283808e-11
chain O 0 3.0747097576333537e-12
of O 0 1.490262947767551e-11
the O 0 8.545321394937133e-11
haptoglobin O 0 8.773479720503019e-08
gene O 0 7.164493304179231e-11
( O 0 6.95625360699198e-13
Hp O 0 1.9816578933351536e-10
) O 0 7.114807874797346e-13
and O 0 3.114557223238279e-12
of O 0 6.172778954649516e-10
the O 0 6.903446703176996e-10
alpha O 0 1.6911365363636577e-10
chain O 0 9.827593600020279e-12
and O 0 6.723918839247889e-13
beta O 0 3.840322851389466e-11
chain O 0 4.975017359881706e-12
of O 0 2.1239243003234876e-11
the O 0 1.5478861248308107e-10
haptoglobin O 0 3.4738252452370944e-07
- O 0 4.8058272916762235e-09
related O 0 2.2555195489104563e-09
gene O 0 1.1040848096888212e-10
( O 0 7.263695721293484e-12
Hpr O 0 1.6290968574139697e-07
) O 0 7.81662668619676e-12
, O 0 3.7334003076539e-12
in O 0 6.5632659897174594e-12
tandem O 0 9.9199430891872e-09
from O 0 2.6192847890627036e-09
the O 0 7.643245147903599e-09
5 O 0 4.550076582177098e-08
side O 0 3.3881732974805345e-08
. O 0 1.4823069705016678e-07

Southern O 0 3.747548817045754e-06
blot O 0 2.4835244403220713e-06
and O 0 3.7697112098555863e-10
PCR O 0 1.6206355368808545e-08
analyses O 0 3.088586053578979e-09
have O 0 5.460047019546777e-13
indicated O 0 4.076398940622283e-12
that O 0 4.601886803752304e-15
the O 0 5.365345551199864e-14
individual O 0 2.8106607753014545e-13
with O 0 7.138092200653645e-13
anhaptoglobinemia B-Disease 0 6.888800641036141e-08
was O 0 8.235596093975062e-10
homozygous O 0 6.615692715872257e-11
for O 0 3.7336713581970216e-12
the O 0 1.2951340000455502e-10
gene O 0 3.074353618903736e-11
deletion O 0 1.4945476800587443e-10
and O 0 3.4666026559743157e-12
that O 0 6.45484533878804e-13
the O 0 4.07983855033045e-11
gene O 0 1.591501583297905e-11
deletion O 0 9.724873684113788e-11
was O 0 2.1003183914292123e-10
included O 0 6.678143454896812e-11
at O 0 3.74148101389693e-10
least O 0 1.5461446359332776e-11
from O 0 1.0974748887448982e-11
the O 0 1.0543935169415874e-10
promoter O 0 1.8040643112726684e-07
region O 0 1.478919529063205e-07
of O 0 1.4978374451857235e-07
Hp O 0 1.06051444959121e-07
to O 0 6.387303130850341e-09
Hpr O 0 5.106449521008471e-07
alpha O 0 2.988167768780414e-10
but O 0 9.626120213435119e-12
not O 0 7.323180256646467e-12
to O 0 4.4038439561688847e-10
Hpr O 0 8.171527952072211e-07
beta O 0 2.2933747345632582e-08
( O 0 3.985741736656223e-10
Hpdel O 0 1.2346848052402493e-05
) O 0 1.4560895822413045e-09
. O 0 4.3717200526316446e-08

In O 0 9.26635479459037e-09
addition O 0 1.1151159995392845e-09
, O 0 2.5585967372565577e-11
we O 0 1.893920610618327e-11
found O 0 3.7078035954041244e-12
seven O 0 6.745940177993459e-12
individuals O 0 2.1481469760550181e-13
with O 0 1.9501110795627774e-12
hypohaptoglobinemia B-Disease 0 2.525421223253943e-07
in O 0 1.0674798545107222e-10
three O 0 1.0251354626289455e-10
families O 0 3.8630307286346977e-11
, O 0 1.9839290800460763e-12
and O 0 1.936079768727339e-12
the O 0 1.231420798664118e-10
genotypes O 0 1.5430387634296494e-08
of O 0 1.3910385066040476e-09
six O 0 7.221748754560053e-10
of O 0 5.312637552101762e-10
the O 0 1.0914341652679127e-10
seven O 0 5.977555256331257e-11
individuals O 0 1.895990742878384e-12
were O 0 6.290142018361422e-11
found O 0 3.154640090818894e-11
to O 0 2.0823247293133562e-10
be O 0 4.5993402864041855e-08
Hp2 O 1 0.9999822378158569
/ O 1 0.999972939491272
Hpdel O 1 0.9997054934501648
. O 0 4.38861025031656e-06

The O 0 1.6968255067695281e-07
phenotypes O 0 9.238052456339574e-08
and O 0 3.010472982012402e-10
genotypes O 0 1.9581358756681766e-08
in O 0 4.227409741708321e-11
one O 0 9.260880257100368e-12
of O 0 1.3477766645786371e-11
these O 0 7.696155995481901e-13
three O 0 3.942028994896596e-13
families O 0 8.289149531701123e-13
showed O 0 3.2882620237817406e-11
the O 0 8.555918126762485e-12
father O 0 1.2176507580008433e-09
to O 0 3.641262291687042e-10
be O 0 8.132670537008835e-09
hypohaptoglobinemic B-Disease 1 0.9643552303314209
( O 0 2.719026337416608e-09
Hp2 O 0 0.005538896191865206
) O 0 9.148019147753317e-11
and O 0 5.357083665558093e-10
Hp2 O 0 0.3587004840373993
/ O 0 1.8856151655199938e-05
Hpdel O 0 0.00265485025011003
, O 0 2.601259312118298e-11
the O 0 2.0573151515712595e-10
mother O 0 2.3262998471995644e-10
to O 0 1.0904603608974384e-10
be O 0 1.8835331072608597e-09
Hp2 O 1 0.9995344877243042
- O 0 2.673473034064955e-07
1 O 0 2.140948085482819e-09
and O 0 4.4802220267037285e-10
Hp1 O 0 0.0016685716109350324
/ O 0 6.420835347853426e-07
Hp2 O 0 1.787992187018972e-05
, O 0 2.835706929688042e-12
one O 0 1.1060671692778024e-12
of O 0 5.207475076152157e-11
the O 0 5.253696089280169e-11
two O 0 7.405066143606476e-12
children O 0 6.217378174799837e-12
to O 0 9.01151462479044e-12
be O 0 5.133299341153474e-10
hypohaptoglobinemic B-Disease 0 0.00120064290240407
( O 0 1.9822601338148615e-09
Hp2 O 0 0.07962798327207565
) O 0 1.8926434031119044e-10
and O 0 1.3461569636774584e-09
Hp2 O 1 0.9988126754760742
/ O 0 0.0012156552402302623
Hpdel O 1 0.99979168176651
, O 0 5.081239248805325e-11
and O 0 1.2799274660968418e-11
the O 0 4.687679688863966e-10
other O 0 3.411200488745436e-11
child O 0 1.2722011222265905e-09
to O 0 1.0028083224922213e-10
be O 0 1.7965909870909513e-09
Hp1 O 1 0.9427011013031006
and O 0 1.9713606747018275e-08
Hp1 O 1 0.9999983310699463
/ O 1 0.9993636012077332
Hpdel O 1 0.9985798597335815
, O 0 9.484480562038655e-11
showing O 0 4.926338892374815e-09
an O 0 2.430159025401668e-11
anomalous O 0 1.2095721046989638e-07
inheritance O 0 7.567578904854599e-06
of O 0 0.0010352032259106636
Hp O 0 2.999877551701502e-06
phenotypes O 0 1.2420297679227588e-08
in O 0 7.000276747159973e-11
the O 0 3.473628884531621e-10
child O 0 1.3003556453838883e-08
with O 0 6.97098045954192e-10
Hp1 O 0 0.009395260363817215
. O 0 7.969205171320937e-07

The O 0 4.137909570545162e-07
Hp2 O 0 0.0027006997261196375
/ O 0 3.0521991902787704e-06
Hpdel O 0 3.746488437172957e-05
individuals O 0 1.8213074104433957e-10
had O 0 3.655276636926885e-10
an O 0 1.9199873895620057e-12
extremely O 0 1.0372397385438603e-09
low O 0 3.119545866070439e-08
level O 0 3.2716179703129455e-05
of O 0 9.636112707767097e-08
Hp O 0 7.910709420855255e-09
( O 0 4.306619297289593e-12
mean O 0 1.215040151825164e-10
+ O 0 2.0383521259770276e-10
/ O 0 1.853426412345982e-09
- O 0 2.6651747475625598e-09
SD O 0 3.9319242972624124e-08
= O 0 1.0175090631170391e-10
0 O 0 7.069306945384213e-12
. O 0 9.937124040293455e-12
049 O 0 3.0872018275118762e-09
+ O 0 3.6227729149906907e-10
/ O 0 4.835009281833891e-09
- O 0 1.951959704982187e-09
0 O 0 3.434413994515828e-12
. O 0 2.1015435919258252e-11
043 O 0 2.7814538228199126e-08
mg O 0 1.4763872346890139e-09
/ O 0 1.4586664098814595e-09
ml O 0 1.3145268207281902e-09
; O 0 9.032502935706066e-13
n O 0 1.6568042077169665e-11
= O 0 2.386529559042505e-12
6 O 0 8.960472988595036e-12
) O 0 1.720663237272154e-14
, O 0 1.7249021289533935e-14
compared O 0 1.3850954888247613e-12
with O 0 1.7420429248432567e-13
the O 0 1.0384388487993945e-10
level O 0 5.33565412297321e-07
( O 0 7.593345440273791e-13
1 O 0 7.603770044162239e-12
. O 0 1.0498732959385304e-12
64 O 0 3.84714066159475e-11
+ O 0 1.1160877777527389e-10
/ O 0 9.099627718001102e-10
- O 0 5.318325224656917e-10
1 O 0 1.1011106089420242e-11
. O 0 6.722755598737029e-12
07 O 0 5.051961071700362e-10
mg O 0 3.7942368691368245e-10
/ O 0 3.469675657896687e-10
ml O 0 1.6297782567953334e-10
) O 0 4.119743961120484e-14
obtained O 0 1.4530447157989901e-11
from O 0 2.319382706728046e-11
52 O 0 5.110753154013992e-09
healthy O 0 3.7016616438734218e-09
volunteers O 0 3.4111372060330325e-10
having O 0 8.663917361317885e-10
phenotype O 0 3.952871807655356e-09
Hp2 O 0 8.306086556331138e-07
, O 0 1.5077751547298845e-11
whereas O 0 4.362178396277727e-10
the O 0 5.161180927082398e-10
serum O 0 3.558651817670011e-09
Hp O 0 1.1363767704608563e-09
level O 0 2.7083034481734103e-08
of O 0 2.3916355007536083e-10
an O 0 5.525208654315328e-13
individual O 0 4.3482682732243205e-12
with O 0 2.8231071994011536e-11
Hp1 O 0 0.004920922685414553
/ O 0 2.4692699298611842e-05
Hpdel O 0 0.0004608425952028483
was O 0 1.969691965086895e-08
0 O 0 1.3481920024815963e-09
. O 0 4.656297125649189e-09

50 O 0 3.7806498198733607e-07
mg O 0 9.825006230812505e-08
/ O 0 3.024317152267031e-08
ml O 0 2.1155786456006354e-08
, O 0 5.430812050066791e-12
which O 0 1.1869758648197504e-13
was O 0 3.503382653424758e-11
approximately O 0 2.1716753829253976e-12
half O 0 1.963974555901915e-12
the O 0 8.187645873791727e-12
level O 0 5.992015417177754e-08
of O 0 5.274555459067187e-09
Hp O 0 3.167962558947579e-09
in O 0 1.2405512728186352e-10
control O 0 2.7721904771738082e-08
sera O 0 1.8602626994379534e-08
from O 0 8.99867055870196e-11
the O 0 7.358302300808361e-10
Hp1 O 0 3.2568535971222445e-05
phenotype O 0 1.5575752243535135e-08
( O 0 5.6698369957364214e-12
1 O 0 9.68514921040331e-11
. O 0 1.2145993412426836e-11
26 O 0 1.8066791118709347e-10
+ O 0 2.7638566435506107e-10
/ O 0 2.4284749766678715e-09
- O 0 6.2281380053264e-10
0 O 0 1.5763049502834359e-12
. O 0 4.217027334968426e-12
33 O 0 4.408163556401945e-10
mg O 0 1.2051163400528253e-09
/ O 0 1.4864859343433068e-09
ml O 0 1.621472511814659e-09
; O 0 2.5344507308816544e-12
n O 0 5.4588861209126094e-11
= O 0 2.130749222895023e-11
9 O 0 1.579677361140952e-10
) O 0 5.538460857469618e-13
, O 0 3.5276927321144236e-13
showing O 0 3.2011907014073415e-11
a O 0 4.046529777923524e-11
gene O 0 7.961671322220809e-10
- O 0 8.628070702343393e-09
dosage O 0 8.959344910408618e-08
effect O 0 6.0730376283402165e-09
. O 0 6.43230819719065e-08

The O 0 1.3273768750821091e-08
other O 0 1.774196622950086e-10
allele O 0 1.6644678968447124e-09
( O 0 3.017076172229238e-11
Hp2 O 0 1.8767670553643256e-05
) O 0 3.829100665014851e-12
of O 0 8.358442410427713e-11
individuals O 0 2.7539569583123757e-11
with O 0 1.7963672216403381e-10
Hp2 O 1 0.9999997615814209
/ O 1 0.999589741230011
Hpdel O 1 0.9997475743293762
was O 0 2.218414429933091e-08
found O 0 3.998264913596117e-11
to O 0 1.664656607003323e-11
have O 0 4.006584126969859e-12
, O 0 6.313573795713179e-13
in O 0 5.749422205686416e-12
all O 0 3.171605339469252e-11
exons O 0 3.807897996921383e-09
, O 0 6.684202887366486e-13
no O 0 9.759500065736892e-13
mutation O 0 1.2327072956147545e-12
, O 0 1.2903510183091826e-13
by O 0 4.014226017562406e-12
DNA O 0 4.752767068794128e-08
sequencing O 0 2.3117286218621302e-07
. O 0 1.953292922962646e-07

On O 0 1.1234724262010332e-08
the O 0 3.0867631367614834e-11
basis O 0 5.02155483861344e-10
of O 0 3.3650471298329876e-11
the O 0 9.163067006545678e-12
present O 0 7.832804717333719e-12
study O 0 3.114337347037699e-12
, O 0 4.94472084805464e-14
the O 0 7.513043464267566e-13
mechanism O 0 9.4925922677902e-10
of O 0 1.2069796273550537e-09
anhaptoglobinemia B-Disease 0 4.295972757972777e-06
and O 0 5.311783651817947e-11
the O 0 4.0049685789966816e-10
mechanism O 0 5.328372765234235e-08
of O 0 4.091610161793824e-09
anomalous O 0 7.315515659911398e-08
inheritance O 0 1.748509532717435e-07
of O 0 5.267953042675799e-07
Hp O 0 1.7244180128273e-07
phenotypes O 0 6.488556802963785e-09
were O 0 1.724373643874344e-09
well O 0 9.489315999644532e-10
explained O 0 2.8395554352300678e-08
. O 0 3.203803800033711e-08

However O 0 4.848910961641195e-08
, O 0 5.040311917836604e-11
the O 0 2.1686394346964732e-10
mechanism O 0 3.596140274453319e-08
of O 0 2.0776928622012747e-08
hypohaptoglobinemia B-Disease 0 0.03368153050541878
remains O 0 4.261952199158259e-06
unknown O 0 7.72326675360091e-05

ATM O 0 0.000650736503303051
mutations O 0 3.0176217080679635e-08
and O 0 3.2441946351546846e-10
phenotypes O 0 1.962390783205592e-08
in O 0 2.4061376890927022e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 7.703863229835406e-05
in O 0 5.468945851738738e-10
the O 0 3.112458069054469e-10
British O 0 5.874278841133673e-09
Isles O 0 2.1434662045294317e-08
: O 0 3.470576961667887e-13
expression O 0 2.8810385067218336e-12
of O 0 1.1228965673959479e-11
mutant O 0 1.6805735969516178e-10
ATM O 0 2.3728433973246865e-07
and O 0 1.9485208585523495e-11
the O 0 2.128812542911973e-10
risk O 0 1.3162403389443966e-09
of O 0 2.5351991617128533e-09
leukemia B-Disease 1 1.0
, O 0 1.5911707862414914e-07
lymphoma B-Disease 1 1.0
, O 0 6.113798008300364e-06
and O 0 0.0035407363902777433
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999815225601196

We O 0 7.647706468105753e-09
report O 0 9.702270931111201e-11
the O 0 2.0060680547273613e-11
spectrum O 0 1.5411703024881263e-09
of O 0 3.2255242921053195e-10
59 O 0 1.313998509999692e-08
ATM O 0 1.8146710090150009e-06
mutations O 0 3.391182334944176e-10
observed O 0 1.8594130402060927e-10
in O 0 5.218278253948938e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.42478373646736145
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.485715799860344e-11
patients O 0 1.6185261464407574e-11
in O 0 5.006857558761957e-13
the O 0 1.578237193711196e-11
British O 0 5.8456994800337725e-09
Isles O 0 6.041286724212114e-07
. O 0 9.720436366933427e-08

Of O 0 3.0284240892797243e-06
51 O 0 3.2486118470842484e-06
ATM O 0 0.000607689784374088
mutations O 0 6.7440466544610445e-09
identified O 0 2.4120963004747864e-09
in O 0 6.765297350108668e-11
families O 0 1.3785263208720977e-10
native O 0 5.730102156653594e-11
to O 0 9.675493739536023e-11
the O 0 9.254621513576922e-10
British O 0 1.280122745583867e-07
Isles O 0 2.9689572329516523e-06
, O 0 1.3834538549473141e-11
11 O 0 3.002055271039694e-10
were O 0 2.552325018001511e-10
founder O 0 2.523832254297531e-09
mutations O 0 3.160079420361228e-10
, O 0 1.1122514367856162e-11
and O 0 4.152038435289995e-11
2 O 0 2.4261970210659456e-09
of O 0 2.9512388088903663e-09
these O 0 1.1877793193448838e-10
11 O 0 6.735250135392334e-10
conferred O 0 1.0741904254985002e-08
a O 0 9.789152127792633e-11
milder O 0 2.1745542866380418e-10
clinical O 0 3.184615349205444e-10
phenotype O 0 5.407506734056433e-11
with O 0 9.975783220317336e-13
respect O 0 2.1889316748069376e-10
to O 0 1.9907244741546037e-09
both O 0 5.997252117140306e-08
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 1.4815933013778704e-07
cellular O 0 3.137985231660423e-06
features O 0 3.3732374671302523e-09
. O 0 2.243947960778314e-08

We O 0 4.547248266817405e-08
report O 0 7.23215598519289e-10
, O 0 4.800339271048004e-13
in O 0 4.612304461970584e-13
two O 0 3.802702944200043e-12
A B-Disease 1 1.0
- I-Disease 1 0.9999940395355225
T I-Disease 1 1.0
families O 0 4.2129152943992665e-10
, O 0 7.650273643744487e-13
an O 0 2.5289400564995623e-13
ATM O 0 1.41345907422874e-07
mutation O 0 2.380957930814276e-10
( O 0 9.454258556584882e-12
7271T O 0 2.1855019440408796e-05
- O 0 2.6306712243240327e-05
- O 0 6.62145112073631e-07
> O 0 1.2084313993909745e-08
G O 0 4.719341362147134e-09
) O 0 3.934952678367326e-13
that O 0 2.4787287565379568e-14
may O 0 5.756581599207153e-14
be O 0 7.901218877304564e-14
associated O 0 7.047174909596832e-12
with O 0 3.031459360879757e-13
an O 0 3.9816706789291834e-13
increased O 0 1.2577890118325996e-10
risk O 0 9.611489382166383e-10
of O 0 2.8129258922149347e-08
breast B-Disease 0 0.0034526896197348833
cancer I-Disease 0 9.920645425154362e-07
in O 0 9.752295637710517e-10
both O 0 1.8514725308449442e-09
homozygotes O 0 1.348692109104377e-07
and O 0 1.4081653898490032e-10
heterozygotes O 0 1.8856511019293976e-08
( O 0 3.0472419726423894e-11
relative O 0 2.1328952826138448e-08
risk O 0 1.3209611182674053e-09
12 O 0 3.9363473591791376e-10
. O 0 1.8002148383100547e-11
7 O 0 2.2305850222448242e-10
; O 0 4.481413937856837e-12
P O 0 6.847950206889664e-09
= O 0 5.517758125406225e-11
. O 0 2.3247152466931986e-11
0025 O 0 3.911861767846858e-08
) O 0 1.1848026899852204e-12
, O 0 2.900981863583618e-13
although O 0 3.4800248620292518e-12
there O 0 2.7530783642398804e-12
is O 0 7.387044128519607e-14
a O 0 4.132584031923958e-12
less O 0 3.45688699887603e-10
severe O 0 1.8579703464638442e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.6841009697898812e-09
in O 0 1.5612096034359202e-12
terms O 0 1.3791278015429231e-11
of O 0 4.7393781607563135e-12
the O 0 4.767302004549112e-12
degree O 0 1.738698074404965e-08
of O 0 3.073021659361075e-08
cerebellar B-Disease 1 0.994766116142273
degeneration I-Disease 1 0.9999854564666748
. O 0 2.068708681690623e-06

This O 0 9.903510234110513e-10
mutation O 0 8.684892388588494e-11
( O 0 2.186409039928172e-12
7271T O 0 2.0908998976665316e-07
- O 0 6.473762681480366e-08
- O 0 1.0278010442732466e-08
> O 0 4.717440327262068e-10
G O 0 3.758969802092338e-10
) O 0 3.945810488786318e-14
also O 0 7.434265029482908e-15
allows O 0 2.987306989233815e-14
expression O 0 3.0741275952768377e-13
of O 0 2.2962150843935936e-12
full O 0 2.775593470338844e-11
- O 0 2.289988164372314e-11
length O 0 1.1868893368127686e-10
ATM O 0 2.911797025717533e-07
protein O 0 3.069445253522929e-10
at O 0 1.8943117907621598e-10
a O 0 2.041985504297461e-11
level O 0 3.496843925532289e-09
comparable O 0 3.0437132814142842e-09
with O 0 8.733987925252373e-13
that O 0 4.1294224983889904e-13
in O 0 2.4979209672926217e-11
unaffected O 0 8.604553514146573e-09
individuals O 0 1.4931060554612685e-10
. O 0 3.115442837042792e-08

In O 0 6.608888103443178e-09
addition O 0 7.170101734566003e-10
, O 0 9.300798846367808e-12
we O 0 5.8936965550981935e-12
have O 0 1.0140182422034572e-13
studied O 0 4.391344232690386e-11
18 O 0 1.3211500782261965e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.158082553360146e-07
, O 0 2.2420739310274884e-12
in O 0 8.925313287923287e-13
15 O 0 2.2010674533001762e-11
families O 0 1.6240979915094211e-12
, O 0 4.79769381774714e-13
who O 0 4.8203793387435745e-12
developed O 0 2.757856165658268e-08
leukemia B-Disease 1 1.0
, O 0 1.4077886589802802e-07
lymphoma B-Disease 1 1.0
, O 0 2.358952770009637e-05
preleukemic O 1 1.0
T O 1 0.9999978542327881
- O 0 0.0003659393696580082
cell O 0 0.00010944469249807298
proliferation O 1 0.9999899864196777
, O 0 2.305104773725475e-09
or O 0 0.005707049276679754
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 3.400896275707055e-07
mostly O 0 8.009941043773949e-10
in O 0 2.570185175798656e-10
childhood O 0 1.4234602531359997e-05
. O 0 3.1686144552622864e-07

A O 0 2.475453811712214e-06
wide O 0 1.1184906334449352e-08
variety O 0 9.54420764642805e-10
of O 0 8.91238638445202e-09
ATM O 0 0.00010450987610965967
mutation O 0 8.060608291948768e-10
types O 0 3.2360183976898327e-10
, O 0 5.9253353092147965e-12
including O 0 2.7757312073828366e-11
missense O 0 1.2372812818739476e-07
mutations O 0 3.1989338955540347e-10
and O 0 1.0614013140619605e-10
in O 0 2.1172134267999354e-08
- O 0 1.4698126733492245e-06
frame O 0 1.7948574395632022e-06
deletions O 0 8.572658138916722e-09
, O 0 1.0756217964924542e-11
were O 0 3.746544186000733e-10
seen O 0 5.038450212602186e-10
in O 0 1.2978931297757956e-11
these O 0 2.165365803330488e-10
patients O 0 7.49654027742963e-09
. O 0 2.496295969933726e-08

We O 0 2.3153507555662145e-08
also O 0 1.7392459000786786e-11
show O 0 3.640934082005387e-11
that O 0 1.0337753873421174e-13
25 O 0 4.923025095221467e-12
% O 0 1.3068182820596963e-11
of O 0 6.949109256776387e-12
all O 0 8.277924179456164e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.349800963865391e-09
carried O 0 1.6684878478834264e-10
in O 0 1.2629672307973294e-10
- O 0 1.1198589611183252e-08
frame O 0 2.7233667765358405e-08
deletions O 0 1.298909757529998e-09
or O 0 4.847701406962557e-11
missense O 0 3.065352771614016e-08
mutations O 0 2.480417815586833e-10
, O 0 3.1422319173718405e-12
many O 0 2.25913298484981e-12
of O 0 1.8125527120882445e-11
which O 0 2.7258753522614587e-13
were O 0 3.503462797649348e-11
also O 0 1.15218463025632e-13
associated O 0 1.657211867733821e-11
with O 0 9.844641378140007e-13
expression O 0 1.769667884454762e-10
of O 0 2.8610007696272532e-09
mutant O 0 2.0328950967041237e-08
ATM O 0 4.103830724488944e-05
protein O 0 1.0960670238091552e-07
. O 0 5.654189649817454e-08

The O 0 4.7083119625312975e-08
DMPK O 0 0.13308118283748627
gene O 0 3.586069885486154e-09
of O 0 9.263597888775621e-09
severely O 0 0.4927191138267517
affected O 0 0.13982266187667847
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.8623059077071957e-06
is O 0 2.4050374539119623e-11
hypermethylated O 0 1.3773521345683548e-07
proximal O 0 2.3117968339647632e-07
to O 0 2.2307731217807714e-09
the O 0 1.5420678067812332e-08
largely O 0 1.2763389634073974e-07
expanded O 0 4.497487182675286e-08
CTG O 0 3.0355598937603645e-05
repeat O 0 4.5933265369058063e-07
. O 0 2.5905990241881227e-07

Using O 0 1.5625801097485237e-08
methylation O 0 6.263387035687629e-07
- O 0 1.3713546422877698e-06
sensitive O 0 7.152897296691663e-08
restriction O 0 9.566400449578794e-11
enzymes O 0 1.523530260283401e-11
, O 0 6.430023614251157e-13
we O 0 1.9197529850523143e-12
characterized O 0 3.4963982663976934e-12
the O 0 5.438949637892598e-12
methylation O 0 1.4209404486376087e-10
pattern O 0 1.52680146303652e-09
on O 0 3.778277413157838e-10
the O 0 1.8813635371817128e-10
5 O 0 6.081774528432504e-10
side O 0 2.0564637492892501e-10
of O 0 1.0675883510558037e-09
the O 0 6.135092434078615e-09
CTG O 0 6.914871391927591e-06
repeat O 0 6.150511211444609e-09
in O 0 8.7384287306147e-11
the O 0 4.99258911990097e-10
DMPK O 0 7.564599218312651e-05
gene O 0 6.914024908155625e-11
of O 0 1.101871718867109e-10
normal O 0 5.624574583862341e-09
individuals O 0 4.7565844492336584e-12
and O 0 2.373360839455496e-12
of O 0 1.0022920687857706e-10
patients O 0 4.33751257133963e-10
affected O 0 6.114855288785748e-10
with O 0 6.473583336052968e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 2.441244983941715e-10
showing O 0 1.9985388899357304e-09
expansions O 0 1.946580008294063e-09
of O 0 2.4763002759442543e-10
the O 0 4.705048572972714e-10
repetitive O 0 3.084231181560426e-08
sequence O 0 4.713143653134466e-09
. O 0 2.3754171962764303e-08

The O 0 2.5232321121393397e-08
gene O 0 6.325022172681827e-10
segment O 0 4.864879166177616e-09
analyzed O 0 1.0685152762590633e-09
corresponds O 0 5.034223038435925e-10
to O 0 6.557676623941688e-11
the O 0 7.901446164026993e-10
genomic O 0 4.628089911307143e-08
SacI O 0 2.233990471722791e-06
- O 0 1.7660886086900973e-08
HindIII O 0 6.286636278218793e-08
fragment O 0 3.8590042272801384e-10
carrying O 0 4.1830192643033115e-09
exons O 0 1.466327717025706e-07
11 O 0 2.7480686171088564e-08
- O 0 5.974041528133966e-08
15 O 0 1.9185343091976392e-08
. O 0 4.943057163586673e-08

There O 0 6.574539579418115e-09
is O 0 1.3736883158754765e-11
constitutive O 0 1.3866471526569057e-08
methylation O 0 8.001133977586505e-09
in O 0 3.983896768033901e-09
intron O 0 2.0474492146149714e-07
12 O 0 3.9249163918952945e-09
at O 0 3.9420350317342923e-10
restriction O 0 5.896631707219546e-12
sites O 0 2.1607358263731058e-11
of O 0 1.2215047029418002e-10
SacII O 0 1.5168019444899983e-06
and O 0 1.6849683870390209e-09
HhaI O 0 0.011859618127346039
, O 0 1.2655836101327367e-10
localized O 0 2.6123396779098584e-09
1 O 0 5.26874099904262e-10
, O 0 6.2585453312891115e-12
159 O 0 4.473870607313302e-09
- O 0 5.6055542430044625e-09
1 O 0 3.4129202242105805e-10
, O 0 2.9475227814046434e-11
232 O 0 5.885558151952353e-10
bp O 0 6.112339523411947e-09
upstream O 0 5.745889541941551e-09
of O 0 3.78148712343318e-09
the O 0 3.840496987095321e-08
CTG O 0 0.00012276410416234285
repeat O 0 2.948399924207479e-07
, O 0 1.8116032285409034e-10
whereas O 0 4.7506985012546465e-09
most O 0 4.098760914006405e-11
, O 0 1.7170980349395792e-12
if O 0 2.5642185857294164e-12
not O 0 5.164415336350592e-12
all O 0 4.6763804634197825e-11
, O 0 7.866641366094385e-12
of O 0 1.0995643978661818e-10
the O 0 8.040704213563288e-11
other O 0 8.882809418575555e-12
sites O 0 1.9797125050402542e-10
of O 0 9.778483578415376e-10
SacII O 0 6.661959560005926e-06
, O 0 5.323409490998188e-10
HhaI O 0 4.102144157513976e-05
, O 0 2.789425357363484e-10
and O 0 6.01596661375936e-10
HpaII O 0 0.024788210168480873
in O 0 3.327507158701337e-10
this O 0 7.592831918756815e-11
region O 0 7.238548871413286e-09
are O 0 3.720095759218722e-11
unmethylated O 0 7.162411748140585e-07
, O 0 8.3326028368913e-12
in O 0 6.755726186802313e-12
normal O 0 8.053743449920603e-09
individuals O 0 7.660864130565326e-12
and O 0 5.260682514607318e-12
most O 0 6.9268380094300586e-12
of O 0 2.7233018617955906e-10
the O 0 5.761868759890376e-09
patients O 0 2.0142147505453067e-08
. O 0 3.526490388594539e-08

In O 0 6.085676407252549e-09
a O 0 1.3387332908898486e-10
number O 0 8.106550153375025e-11
of O 0 8.404117957105939e-10
young O 0 1.1395637322664243e-08
and O 0 6.348542247458511e-10
severely O 0 6.085765562602319e-05
affected O 0 1.6835620897381887e-08
patients O 0 6.421184695071247e-10
, O 0 5.652978085635141e-13
however O 0 7.869417791017685e-12
, O 0 1.2512500801101223e-13
complete O 0 6.361330351367656e-10
methylation O 0 3.5381038099302486e-09
of O 0 7.753704345248025e-10
these O 0 9.622393160046983e-12
restriction O 0 7.425149904649597e-12
sites O 0 2.8022436801555806e-11
was O 0 8.088078817802824e-11
found O 0 1.1438038884092894e-11
in O 0 8.218578595453607e-12
the O 0 5.471689767944099e-10
mutated O 0 9.526098132539573e-09
allele O 0 5.365566480008965e-08
. O 0 1.6077451903129258e-07

In O 0 4.46901804451727e-09
most O 0 8.232262788121503e-11
of O 0 9.243749515830402e-11
these O 0 5.132226674892104e-12
patients O 0 1.8940541843259773e-11
, O 0 6.257035091872948e-14
the O 0 1.386633863287301e-12
onset O 0 3.1466259997614543e-07
of O 0 1.587725284579733e-09
the O 0 2.2393942700205116e-08
disease O 1 0.9776346683502197
was O 0 3.4208867873530835e-05
congenital O 1 1.0
. O 0 0.022545792162418365

Preliminary O 0 2.0621030216716463e-07
in O 0 1.8108346822032217e-08
vivo O 0 3.189232984368573e-07
footprinting O 0 6.336297246889444e-06
data O 0 5.689877013992373e-09
gave O 0 2.4579328156137947e-11
evidence O 0 5.094573027331073e-11
for O 0 8.105093853016943e-12
protein O 0 2.573192214860853e-10
- O 0 1.5406845244037015e-10
DNA O 0 1.3820239175288407e-08
contact O 0 1.307994779153887e-08
in O 0 1.3885408101099728e-10
normal O 0 1.0097095071159856e-07
genes O 0 1.2134028504195982e-10
at O 0 9.748775398055187e-11
an O 0 4.3497757479249444e-13
Sp1 O 0 2.590911651889627e-10
consensus O 0 1.8486698283304293e-10
binding O 0 1.0963533900176792e-11
site O 0 2.003438387410128e-10
upstream O 0 1.3539049881217124e-09
of O 0 3.177152985145426e-10
the O 0 3.737167908468564e-09
CTG O 0 1.9688091924763285e-05
repeat O 0 2.944723576092656e-08
and O 0 6.428313437112365e-11
for O 0 1.1084521321647056e-11
a O 0 7.2118170810209214e-12
significant O 0 9.791015220805832e-12
reduction O 0 2.609969129707679e-09
of O 0 1.4974782525101205e-10
this O 0 6.866983977976693e-12
interaction O 0 4.692358723801249e-10
in O 0 1.3993611824858476e-11
cells O 0 2.0350811313907258e-10
with O 0 9.355901470220473e-12
a O 0 8.320367728131828e-10
hypermethylated O 0 3.827995442406973e-06
DMPK O 0 0.000829228782095015
gene O 0 2.309514357534681e-09
. O 0 2.395499132390455e-09
. O 0 2.1869015043307627e-08

The O 0 1.8809815856002388e-06
hemochromatosis B-Disease 1 1.0
gene O 0 4.122251984206571e-10
product O 0 1.043328687333478e-10
complexes O 0 8.505186138707543e-12
with O 0 3.9618606789346145e-13
the O 0 9.611979268075999e-11
transferrin O 0 6.333415569770295e-09
receptor O 0 4.269976299625666e-12
and O 0 3.441989748775853e-11
lowers O 0 2.5500124581356864e-11
its O 0 9.995858307743077e-13
affinity O 0 6.3043238164584015e-12
for O 0 2.3526701420362173e-11
ligand O 0 2.1439965358638347e-09
binding O 0 8.97493901419466e-09
. O 0 2.476471081536147e-07

We O 0 1.7085843850850324e-08
recently O 0 5.565695682108185e-10
reported O 0 7.235656518389533e-11
the O 0 1.5473601566728945e-11
positional O 0 3.5834171185911146e-09
cloning O 0 8.106585402956057e-10
of O 0 1.4236017920055133e-10
a O 0 3.307484841563735e-11
candidate O 0 2.9810989232714746e-09
gene O 0 2.0819919122061492e-09
for O 0 1.0770158098694083e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 0.020194677636027336
HFE O 1 0.999840259552002
. O 0 3.99918718585468e-07

The O 0 3.2599530186416814e-08
gene O 0 2.1855649234847618e-10
product O 0 6.417854025997372e-10
, O 0 4.127881196580585e-12
a O 0 4.287189700469263e-11
member O 0 1.271075689146528e-09
of O 0 1.830678186820478e-08
the O 0 1.8122685574439856e-08
major O 0 9.907539677556088e-09
histocompatibility O 0 2.809204957543443e-08
complex O 0 2.559311873540082e-09
class O 0 1.0527136107274515e-10
I O 0 1.7928250599652529e-06
- O 0 2.7372660582614117e-08
like O 0 1.7445184186115625e-11
family O 0 7.697058962419234e-11
, O 0 4.576195325456389e-12
was O 0 6.534606189489978e-10
found O 0 1.9577334545162195e-11
to O 0 2.3697387802057435e-11
have O 0 9.212679230596876e-12
a O 0 7.769955512326732e-11
mutation O 0 1.6486374765367628e-10
, O 0 5.33182109574426e-11
Cys O 0 1.3081779798085336e-05
- O 0 1.2065225973856286e-07
282 O 0 4.5343190322455484e-06
- O 1 0.9946709275245667
- O 0 0.0005176421836949885
> O 0 7.250711746564775e-07
Tyr O 0 1.3402084277913673e-06
( O 0 8.688084973673682e-12
C282Y O 0 3.640939638671625e-08
) O 0 7.513441773040683e-14
, O 0 2.604785385594468e-14
in O 0 2.3482116858625224e-13
85 O 0 3.095862177726616e-10
% O 0 2.3648724645219943e-10
of O 0 3.236851620069814e-10
patient O 0 8.252130356822818e-08
chromosomes O 0 7.938918145100615e-08
. O 0 2.2571137492377602e-07

This O 0 8.947472984743854e-09
mutation O 0 1.3416991961889835e-09
eliminates O 0 3.0490285296558284e-10
the O 0 8.79813374932148e-11
ability O 0 2.38223085702316e-09
of O 0 3.351191324441061e-08
HFE O 0 0.0010353797115385532
to O 0 7.291441228574058e-09
associate O 0 2.9630850661988006e-08
with O 0 9.299241932048119e-11
beta2 O 0 0.027009153738617897
- O 0 0.0001899601484183222
microglobulin O 1 0.6495175957679749
( O 0 1.2399030413501322e-10
beta2m O 0 5.1479506510077044e-05
) O 0 3.478876475088155e-12
and O 0 3.067908557405352e-12
prevents O 0 6.290034465505911e-11
cell O 0 9.266981919608952e-07
- O 0 1.1833590463083965e-07
surface O 0 4.7289401550187904e-07
expression O 0 7.766009275655961e-07
. O 0 1.747515909755748e-07

A O 0 2.892075769977964e-07
second O 0 2.969410317632537e-08
mutation O 0 4.3679063144175245e-10
that O 0 1.7853699204803397e-12
has O 0 3.707921827651034e-13
no O 0 1.6626503776193124e-12
effect O 0 5.411135515359655e-12
on O 0 3.3521344033893286e-10
beta2m O 0 6.543180006701732e-07
association O 0 1.8677447088943921e-10
, O 0 9.262422079325816e-11
H63D O 1 0.8701079487800598
, O 0 3.1589932059095105e-11
was O 0 3.5332936576537577e-10
found O 0 7.909173316278384e-12
in O 0 1.631835833994233e-12
eight O 0 2.8500448528978595e-11
out O 0 2.98009945713662e-12
of O 0 3.3999757870217806e-11
nine O 0 4.917061757758745e-10
patients O 0 1.2421447204147285e-10
heterozygous O 0 4.45891552847133e-11
for O 0 2.128442040671974e-11
the O 0 1.062364418658035e-08
C282Y O 0 1.207193054142408e-05
mutant O 0 1.1138797617604723e-07
. O 0 1.1095752938672376e-07

In O 0 4.1136534179031514e-09
this O 0 1.004008404192902e-10
report O 0 1.3061561554561507e-10
, O 0 2.2866654316583412e-12
we O 0 5.778544743401115e-12
demonstrate O 0 4.5798148606834843e-10
in O 0 1.4178894169880607e-10
cultured O 0 5.839472905222465e-08
293 O 0 5.259315649652763e-09
cells O 0 1.0763520741363664e-08
overexpressing O 0 2.2189311721376725e-07
wild O 0 1.1876553074330332e-09
- O 0 2.20779283743866e-09
type O 0 3.9171213495059476e-10
or O 0 1.6347471987199214e-10
mutant O 0 2.516717945155733e-09
HFE O 0 5.667270102094335e-07
proteins O 0 4.2201489698634465e-12
that O 0 1.581332992068446e-13
both O 0 5.785820498920013e-13
the O 0 9.93810936322781e-12
wild O 0 7.348677222296374e-11
- O 0 1.0755690782460192e-10
type O 0 7.075501989861621e-11
and O 0 3.004083093394172e-10
H63D O 1 0.7502080202102661
HFE O 0 2.8993328669457696e-05
proteins O 0 5.672836506098733e-11
form O 0 1.7237109309342635e-11
stable O 0 9.942712431154632e-09
complexes O 0 3.6153087468182576e-11
with O 0 8.592038755819709e-13
the O 0 2.4839066914417174e-10
transferrin O 0 1.9761154490538502e-08
receptor O 0 4.0641188331358435e-11
( O 0 1.513950770304362e-11
TfR O 0 3.950579241518426e-07
) O 0 2.345189320518415e-10
. O 0 2.415320210502614e-08

The O 0 1.609398907476134e-07
C282Y O 0 2.417685027467087e-05
mutation O 0 1.8423488290508772e-09
nearly O 0 3.216002464334622e-10
completely O 0 1.2493757139964146e-09
prevents O 0 1.2171734974086856e-11
the O 0 1.855699101327435e-11
association O 0 6.0662442950831785e-12
of O 0 4.555644403381187e-11
the O 0 4.3525519993758977e-11
mutant O 0 9.899487896092296e-10
HFE O 0 3.6286417071096366e-06
protein O 0 6.439360711318898e-10
with O 0 1.0617267481860537e-11
the O 0 2.7691240411797935e-09
TfR O 0 2.8455564461182803e-05
. O 0 1.2681275052273122e-07

Studies O 0 4.751081306153537e-08
on O 0 2.907723839484788e-09
cell O 0 2.4265222720032398e-08
- O 0 4.87401852211633e-09
associated O 0 2.8080247016504245e-09
transferrin O 0 5.5840541079987815e-08
at O 0 2.6340640779665137e-09
37 O 0 9.216273300083344e-10
degrees O 0 3.941330373180563e-09
C O 0 9.001392520247009e-09
suggest O 0 7.540716662202129e-11
that O 0 2.5761936529346274e-13
the O 0 2.302979681956252e-11
overexpressed O 0 3.7285474263626384e-08
wild O 0 7.027343151833065e-10
- O 0 2.365288631622775e-09
type O 0 1.8294380454975112e-09
HFE O 0 4.6786904022155795e-06
protein O 0 2.475724070194474e-10
decreases O 0 3.899311082355972e-11
the O 0 8.532776048231216e-12
affinity O 0 7.195470608234444e-11
of O 0 3.786754243506607e-10
the O 0 2.1350188283975058e-09
TfR O 0 1.3336931488083792e-06
for O 0 1.2089748091526076e-09
transferrin O 0 4.0347987351196934e-07
. O 0 1.6492687393565575e-07

The O 0 3.35504023496469e-06
overexpressed O 0 0.0015455952379852533
H63D O 1 0.9999949932098389
protein O 0 1.9176269461240736e-08
does O 0 1.1481689730918898e-11
not O 0 3.2892705486425866e-12
have O 0 4.150656326886576e-13
this O 0 2.359291418913695e-13
effect O 0 1.6338602562906979e-12
, O 0 6.610183456374e-14
providing O 0 6.012427101326212e-12
the O 0 1.7034787209296853e-12
first O 0 1.415937332660544e-11
direct O 0 3.882353813433603e-11
evidence O 0 1.2425355189193965e-10
for O 0 8.013401574247236e-12
a O 0 7.571399063266426e-11
functional O 0 3.3633707374747246e-08
consequence O 0 3.6460037211583085e-09
of O 0 8.9958962501413e-10
the O 0 1.1292191182121769e-08
H63D O 0 0.010376262478530407
mutation O 0 4.419895560658915e-08
. O 0 6.162302668144548e-08

Addition O 0 1.44440832627879e-07
of O 0 4.035599374674348e-07
soluble O 0 3.2122483162311255e-07
wild O 0 8.917266036689853e-09
- O 0 4.3421024997769564e-08
type O 0 3.5475526516393074e-08
HFE O 1 0.9971433281898499
/ O 0 0.00037893434637226164
beta2m O 0 3.572064088075422e-05
heterodimers O 0 1.4293910055585002e-07
to O 0 1.5036065725837489e-09
cultured O 0 1.0836673425274057e-07
cells O 0 5.80776537972838e-10
also O 0 2.1670317450206422e-13
decreased O 0 1.3076111374243915e-11
the O 0 3.9304445657341314e-13
apparent O 0 3.0337645590128304e-11
affinity O 0 7.759347851743481e-12
of O 0 3.212410060182691e-10
the O 0 1.5418956389456895e-10
TfR O 0 2.4303387746726912e-08
for O 0 2.064085230860102e-12
its O 0 5.943828328830447e-13
ligand O 0 8.792257720491303e-12
under O 0 6.635245131114687e-10
steady O 0 4.877434207628539e-07
- O 0 4.811798515191867e-09
state O 0 9.809562884210976e-11
conditions O 0 6.307617095302476e-09
, O 0 2.3212935480049213e-12
both O 0 3.124195780551675e-12
in O 0 5.1216557037103705e-12
293 O 0 4.747960358209014e-10
cells O 0 2.6581928325164483e-10
and O 0 3.2936164212626906e-11
in O 0 1.1288675549891991e-09
HeLa O 0 1.5308576166717103e-06
cells O 0 8.724568800744237e-08
. O 0 9.644975307310233e-08

Furthermore O 0 2.948141286651662e-07
, O 0 1.5575735146100556e-10
at O 0 2.802817145042269e-10
4 O 0 9.53648687795905e-11
degrees O 0 4.539161047034668e-09
C O 0 2.754523187320501e-08
, O 0 1.2229563715882019e-11
the O 0 1.2734119314572467e-10
added O 0 1.8127033207804288e-09
soluble O 0 2.7088804532837685e-09
complex O 0 7.124012491033227e-10
of O 0 4.177047596698458e-09
HFE O 0 5.2963136113248765e-05
/ O 0 3.676599931168312e-07
beta2m O 0 3.0827615660200536e-07
inhibited O 0 1.7444737876459726e-09
binding O 0 1.4561277184022003e-10
of O 0 3.426907202452867e-09
transferrin O 0 6.279961439759063e-08
to O 0 7.1438135407220216e-09
HeLa O 0 1.906240299831552e-06
cell O 0 6.740987856801439e-08
TfR O 0 1.7353740133785323e-07
in O 0 5.3161829105530245e-11
a O 0 1.8634427334518477e-10
concentration O 0 2.721690464113635e-07
- O 0 6.41865511852302e-08
dependent O 0 2.8199469426226642e-08
manner O 0 6.597078083814267e-08
. O 0 1.0981261056031144e-07

Scatchard O 0 5.8364126743981615e-05
plots O 0 1.2402016125179216e-07
of O 0 4.182237667293975e-09
these O 0 4.771898848288103e-11
data O 0 3.608297827195628e-10
indicate O 0 6.817110070889143e-11
that O 0 2.705962624111047e-13
the O 0 6.642827260483486e-11
added O 0 3.802126391505567e-10
heterodimer O 0 7.579711858163307e-10
substantially O 0 1.2127046034038358e-09
reduced O 0 2.2479638983607941e-10
the O 0 6.19040235738666e-11
affinity O 0 1.0558188767717525e-09
of O 0 6.034150068501276e-09
TfR O 0 1.9410661025176523e-06
for O 0 2.0905115416525177e-09
transferrin O 0 6.449962484111893e-07
. O 0 2.5882059162540827e-07

These O 0 5.65799240792586e-10
results O 0 5.07477171396431e-10
establish O 0 6.524866758006453e-10
a O 0 1.6287611884213682e-11
molecular O 0 3.008871207743624e-10
link O 0 9.372181919431455e-10
between O 0 1.7224474069266194e-09
HFE O 0 0.009137747809290886
and O 0 1.223468548694484e-09
a O 0 1.6381782597107986e-09
key O 0 8.694683373278167e-08
protein O 0 4.4448053571066737e-10
involved O 0 1.2725311915318116e-09
in O 0 4.916311246994098e-10
iron O 0 4.422104993295761e-08
transport O 0 2.1606402000884373e-08
, O 0 1.7545761718529285e-11
the O 0 2.11752629319939e-10
TfR O 0 1.3147665640644846e-06
, O 0 6.489252277891433e-12
and O 0 3.155547004252135e-12
raise O 0 2.0852090887313324e-11
the O 0 9.713079299200622e-12
possibility O 0 1.809807304020694e-10
that O 0 7.962479417131241e-13
alterations O 0 3.0484179069922845e-10
in O 0 5.899421142568917e-12
this O 0 3.870381879572671e-12
regulatory O 0 1.457868159526754e-09
mechanism O 0 5.15009146440093e-09
may O 0 1.0513912657161839e-10
play O 0 5.270532899004365e-09
a O 0 6.585982870177531e-10
role O 0 1.6385564016729859e-09
in O 0 3.662967984485732e-10
the O 0 7.12036163363905e-09
pathogenesis O 1 0.9994500279426575
of O 1 0.9048335552215576
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.3946961189503781e-05
. O 0 7.27516251686211e-08

Genomic O 0 3.287160836862313e-07
organization O 0 2.8585951383774955e-09
of O 0 1.375740765752198e-08
the O 0 1.2387276626668609e-07
UBE3A O 1 0.9997795224189758
/ O 0 0.001866297097876668
E6 O 0 0.0002958338300231844
- O 0 2.6408577014080947e-06
AP O 0 0.0001392510166624561
gene O 0 3.0058369682173236e-10
and O 0 1.9360067368690004e-11
related O 0 1.3946124255426184e-08
pseudogenes O 0 2.8843936661360203e-07
. O 0 2.913609975507825e-08

The O 0 1.0709420905641309e-07
UBE3A O 0 2.866397517209407e-05
gene O 0 2.6691820975699443e-10
encodes O 0 1.6151401396879983e-11
the O 0 3.5549591048678053e-10
E6 O 0 1.1519126701386995e-06
- O 0 1.7411890667062835e-06
AP O 0 0.00038398796459659934
ubiquitin O 0 1.0090472812862572e-07
- O 0 6.233134541844265e-08
protein O 0 6.356960791098487e-11
ligase O 0 9.076650021866417e-12
and O 0 9.183607867224719e-12
has O 0 4.3291664198787105e-13
recently O 0 2.5237418491835806e-12
been O 0 1.1450758960820928e-12
shown O 0 4.79012532764167e-12
to O 0 2.969642110342563e-12
be O 0 1.4444840289173921e-11
mutated O 0 5.796347846143135e-09
in O 0 2.19940883283698e-08
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.3427802869614425e-08
who O 0 5.942678293902048e-11
lack O 0 3.030345965271408e-07
15q11 O 0 0.2049284279346466
- O 0 5.2091149882471655e-06
q13 O 0 1.94979347725166e-05
deletions O 0 7.51271578280921e-09
or O 0 2.5242499757105463e-10
chromosome O 0 1.0381842940887509e-08
15 O 0 3.9539514773423434e-08
paternal O 0 6.450303771998733e-06
uniparental B-Disease 1 0.5804230570793152
disomy I-Disease 0 0.00463572284206748
. O 0 5.030239663028624e-06

Previous O 0 7.504046379835927e-07
UBE3A O 0 1.9016853912035003e-05
cDNA O 0 1.1216722128892798e-07
analysis O 0 1.0616508783201084e-09
has O 0 1.6303168396455264e-13
shown O 0 2.9648427810058386e-12
a O 0 1.1826989908259034e-11
coding O 0 2.966077090604813e-07
region O 0 1.1213615813687738e-08
of O 0 2.885123251417099e-09
approximately O 0 9.48027101266291e-10
2 O 0 1.5738926606445602e-08
. O 0 3.815919313865379e-08

6 O 0 4.832789954889449e-07
kb O 0 6.01088504481595e-06
and O 0 5.341778686052123e-10
a O 0 5.856063411968648e-10
3 O 0 1.5650618578888498e-08
- O 0 1.0785508948174538e-06
untranslated O 1 0.9963196516036987
region O 0 8.74934897865387e-08
( O 0 7.609301383437739e-11
UTR O 0 1.7098343960242346e-05
) O 0 1.9842363863098456e-11
of O 0 1.6054790830111187e-09
< O 0 5.697373239854642e-08
50 O 0 6.800026763897904e-09
bp O 0 5.487348797572622e-09
, O 0 1.3635962151092862e-11
whereas O 0 3.277756399633347e-10
Northern O 0 7.308326166466372e-10
analysis O 0 5.151326032404313e-10
has O 0 8.696287505209621e-13
indicated O 0 3.1419818136146915e-11
mRNA O 0 5.541333503167323e-10
sizes O 0 2.5034885275942997e-10
of O 0 2.920095498737396e-09
5 O 0 2.028158441191863e-08
- O 0 9.180840976341642e-08
8 O 0 2.098886753287843e-08
kb O 0 2.6928230454359436e-06
. O 0 5.216270793084732e-08

We O 0 2.432945400698827e-08
have O 0 3.2034444541473306e-11
analyzed O 0 9.435348335973259e-11
additional O 0 6.431743592577588e-12
cDNA O 0 1.4869404374451278e-08
clones O 0 6.810212394015025e-10
and O 0 8.235650876542433e-12
provide O 0 5.0044180605057775e-11
evidence O 0 8.335897944133919e-11
for O 0 7.79477003776119e-12
an O 0 1.077030131746426e-11
additional O 0 4.1590234034494244e-10
0 O 0 3.1111242471126843e-09
. O 0 3.371656731587791e-08

5 O 0 4.9062180096370867e-08
kb O 0 1.5417788290505996e-06
of O 0 1.7609254499006965e-08
5 O 0 3.74173438899561e-08
- O 0 3.9254803141375305e-07
UTR O 0 1.4462678336712997e-05
and O 0 7.857112183096149e-10
> O 0 2.7558668680427445e-09
2 O 0 4.453690471972749e-10
kb O 0 5.128763191919461e-08
of O 0 2.313477853732593e-09
3 O 0 1.0261658900390103e-07
- O 0 2.8421645765774883e-06
UTR O 0 0.00016866449732333422
. O 0 2.626390767090925e-07

We O 0 1.5951872711639226e-08
have O 0 1.3717769108134714e-11
established O 0 1.4109634467740495e-11
the O 0 5.136065617944441e-12
genomic O 0 1.4014719940114162e-10
organization O 0 9.493778159452848e-12
of O 0 6.002957020356803e-10
UBE3A O 0 7.91736147220945e-06
and O 0 1.9956000393839268e-11
the O 0 3.5952157917407135e-11
sequence O 0 3.5706226864107293e-10
of O 0 1.2750877687039974e-08
intron O 0 9.572069075147738e-07
- O 0 2.4012151698116213e-06
exon O 0 1.848263195824984e-07
borders O 0 3.89680394619063e-08
. O 0 4.523537029399449e-07

We O 0 3.0145383078661325e-08
have O 0 6.121059908936743e-11
also O 0 5.727083304124525e-12
mapped O 0 2.8112832062276993e-09
two O 0 4.531898814552626e-11
highly O 0 1.3225367467839533e-09
homologous O 0 1.144922601170606e-09
processed O 0 2.2880257688484562e-09
pseudogenes O 0 6.219546211383431e-09
, O 0 2.105929146345442e-11
UBE3AP1 O 0 0.00012369899195618927
and O 0 6.82984169220191e-10
UBE3AP2 O 1 0.9999722242355347
, O 0 1.1287400181192453e-10
to O 0 2.241806740244101e-10
chromosomes O 0 1.3892356154343588e-09
2 O 0 1.6941582858809312e-10
and O 0 9.806527985489755e-12
21 O 0 4.6464740388607595e-10
, O 0 1.9704281609134178e-12
respectively O 0 3.314167829060466e-10
, O 0 2.1733329112066935e-12
and O 0 1.262224157659586e-12
determined O 0 3.4434430307150876e-10
their O 0 1.8195574214008303e-10
genomic O 0 1.5655871266062604e-08
organization O 0 1.9393313621662855e-09
. O 0 8.566565412593263e-08

These O 0 2.0191255334367497e-09
results O 0 6.974917310387241e-10
will O 0 1.1661298662812847e-11
form O 0 6.001085045559407e-12
the O 0 8.835395089168419e-12
basis O 0 1.492536649827514e-10
for O 0 6.464825419785769e-13
studies O 0 1.8657428033086454e-11
of O 0 1.1338253252946018e-11
mutation O 0 9.109986202904263e-12
and O 0 7.332446282093397e-12
imprinting O 0 4.0461856087858905e-07
of O 0 6.552697300321597e-07
UBE3A O 1 0.6332728266716003
. O 0 3.5621822007669834e-06

Mutation O 0 2.699057688460016e-07
spectrum O 0 1.701263698805633e-07
and O 0 1.9522947702910187e-09
genotype O 0 2.313553295607562e-06
- O 0 4.188059108400921e-07
phenotype O 0 1.834425056301825e-08
analyses O 0 7.1347447949676734e-09
in O 0 5.552568960176529e-10
Cowden B-Disease 0 0.05221949890255928
disease I-Disease 0 1.5741996151064086e-07
and O 0 7.707375848653442e-10
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 6.043865408145166e-11
two O 0 1.0400825756207155e-09
hamartoma B-Disease 1 0.5572101473808289
syndromes I-Disease 0 5.1201409405621234e-06
with O 0 8.969399090119623e-08
germline O 1 0.9998898506164551
PTEN O 1 0.9951071739196777
mutation O 0 7.876826657593483e-07
. O 0 2.3408797744650656e-07

The O 0 5.574451279244386e-06
tumour B-Disease 1 1.0
suppressor O 0 7.812317926436663e-05
gene O 0 5.72178890934083e-08
PTEN O 0 2.462916881995625e-06
, O 0 4.805868203394681e-11
which O 0 1.6337978062455627e-12
maps O 0 8.823817787551036e-10
to O 0 3.938677384240918e-09
10q23 O 0 4.1051695006899536e-05
. O 0 4.579583787744923e-07

3 O 0 3.4321794295522068e-09
and O 0 2.0609116843650632e-11
encodes O 0 1.7234502670479546e-12
a O 0 6.274127268071639e-13
403 O 0 5.15167465978128e-12
amino O 0 1.26179882514732e-11
acid O 0 8.725366783257638e-12
dual O 0 3.0990365829097755e-09
specificity O 0 3.920496283171815e-08
phosphatase O 0 9.255041391043051e-07
( O 0 2.3488522238324094e-09
protein O 0 4.9070418839392005e-08
tyrosine O 0 8.70414140763387e-08
phosphatase O 0 4.422931709768818e-08
; O 0 2.313771223227956e-11
PTPase O 0 4.7305511543527246e-06
) O 0 2.645524858208015e-12
, O 0 7.103837917216138e-13
was O 0 1.1945422949410922e-11
shown O 0 5.2237696807067024e-11
recently O 0 2.436243394521309e-11
to O 0 1.2407612264009327e-11
play O 0 1.3386631358969225e-08
a O 0 3.4008227345339037e-09
broad O 0 3.5413851851018308e-09
role O 0 3.625449718214213e-09
in O 0 3.295410611059424e-09
human O 0 4.1216986801373423e-07
malignancy B-Disease 1 0.9990063309669495
. O 0 4.9999607654172e-07

Somatic O 0 0.004204113502055407
PTEN O 0 0.0002239495370304212
deletions O 0 1.875304178611259e-07
and O 0 4.767888861501035e-10
mutations O 0 4.774495798720579e-10
were O 0 2.385385222680725e-10
observed O 0 3.933403255884649e-11
in O 0 2.8273479044105265e-11
sporadic B-Disease 0 1.0307329603165272e-06
breast I-Disease 0 2.0053919342899462e-06
, I-Disease 0 2.387033903872293e-09
brain I-Disease 1 0.9999995231628418
, I-Disease 0 1.0696965091483435e-08
prostate I-Disease 1 1.0
and I-Disease 1 0.9981306195259094
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999915361404419
lines O 0 3.413770244264924e-08
and O 0 9.144472505606682e-12
in O 0 9.83308660190696e-12
several O 0 7.814677377426804e-11
primary O 0 2.1607572762150085e-06
tumours B-Disease 1 1.0
such O 0 1.3966587886216075e-09
as O 0 1.866283412255143e-07
endometrial B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
, O 1 0.9999966621398926
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9931730628013611

In O 0 4.216904603282501e-09
addition O 0 1.587858511342688e-09
, O 0 1.9921973792857983e-10
PTEN O 0 1.2328060847721645e-06
was O 0 8.574583265641422e-10
identified O 0 2.612567662207965e-10
as O 0 3.9406403487540764e-12
the O 0 3.331404596629284e-11
susceptibility O 0 2.69173877631701e-10
gene O 0 3.657072474710921e-12
for O 0 1.806492282152572e-11
two O 0 5.79473402595454e-09
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 0.9999921321868896
Cowden B-Disease 1 0.9999996423721313
disease I-Disease 0 0.404109388589859
( O 0 4.7188690455168825e-11
CD B-Disease 1 0.818535327911377
; O 0 4.947693366119665e-10
MIM O 0 4.0193549466494005e-06
158350 O 0 9.27431500485909e-08
) O 0 3.730809498142529e-12
and O 0 4.844817255711398e-11
Bannayan B-Disease 1 0.9345495104789734
- I-Disease 0 0.0033175849821418524
Zonana I-Disease 1 0.9860094785690308
( I-Disease 0 6.805252472652512e-10
BZS I-Disease 0 2.0044390112161636e-05
) I-Disease 0 6.947240525911891e-12
or I-Disease 0 4.399232714225043e-11
Ruvalcaba I-Disease 0 3.2015074680202815e-07
- I-Disease 0 1.522864323533213e-08
Riley I-Disease 0 8.603261449025013e-06
- I-Disease 1 0.9999901056289673
Smith I-Disease 1 0.9999473094940186
syndrome I-Disease 1 1.0
( O 0 5.206427733384089e-09
MIM O 1 0.9997385144233704
153480 O 0 0.00010263371950713918
) O 0 5.482700959902331e-10
. O 0 4.9486796882547424e-08

Constitutive O 0 1.1498613048388506e-06
DNA O 0 1.693873201702445e-07
from O 0 1.737626265096992e-09
37 O 0 6.554832232552599e-09
CD B-Disease 0 1.9810633489214524e-07
families O 0 7.625050590931437e-11
and O 0 2.484240677752547e-12
seven O 0 2.1296249486102425e-10
BZS B-Disease 0 5.239601705397945e-06
families O 0 7.205894908546284e-11
was O 0 2.6108440409622347e-10
screened O 0 1.421675888124696e-09
for O 0 2.9538631540759752e-09
germline O 0 0.00016070417768787593
PTEN O 0 0.00012347885058261454
mutations O 0 2.863841928046895e-07
. O 0 2.2063801452532061e-07

PTEN O 0 9.166140080196783e-05
mutations O 0 1.3349991334621336e-08
were O 0 1.2928467185702175e-09
identified O 0 3.319323704786825e-10
in O 0 1.0331515157280258e-11
30 O 0 2.609743532389075e-10
of O 0 7.406755209160565e-10
37 O 0 1.2782241043396425e-08
( O 0 1.1728037811742364e-11
81 O 0 5.600830466079287e-09
% O 0 2.2302659719031226e-10
) O 0 6.930111866310096e-13
CD B-Disease 0 4.9428972914711267e-08
families O 0 2.1162250771200597e-11
, O 0 1.0604227999172489e-12
including O 0 5.003079114190845e-12
missense O 0 1.1436136482245729e-08
and O 0 7.868870000038442e-10
nonsense O 0 2.4858370579750044e-06
point O 0 4.2806920674820503e-08
mutations O 0 8.818568097979096e-10
, O 0 3.8204796964924626e-11
deletions O 0 3.427323980176311e-10
, O 0 1.1947997279049272e-11
insertions O 0 4.655986263202294e-09
, O 0 2.4823140071239536e-11
a O 0 4.255759911142576e-10
deletion O 0 5.952205128778587e-08
/ O 0 1.6262823692159145e-06
insertion O 0 2.61357769204551e-07
and O 0 1.637844881940964e-08
splice O 0 2.2126469048089348e-05
site O 0 1.1730946170018797e-07
mutations O 0 5.0879382484936286e-08
. O 0 7.574039528890353e-08

These O 0 4.317350477123227e-09
mutations O 0 4.4119824460508994e-10
were O 0 1.484422584852041e-10
scattered O 0 1.6202257591135805e-10
over O 0 4.0188681375841195e-12
the O 0 1.2177378029554209e-11
entire O 0 4.151218924164368e-09
length O 0 1.012821826407162e-09
of O 0 2.720717651172322e-09
PTEN O 0 2.2554978329480946e-07
, O 0 2.4269154394462866e-12
with O 0 2.044672482541532e-13
the O 0 2.8690690448418543e-11
exception O 0 3.00515341777885e-11
of O 0 1.4987955321288382e-10
the O 0 7.537250684697128e-11
first O 0 3.202566267734852e-10
, O 0 1.1371995359277243e-11
fourth O 0 7.697962267627645e-09
and O 0 2.761817163854374e-10
last O 0 3.917715574175418e-08
exons O 0 1.5960736163833644e-06
. O 0 5.77666128265264e-08

A O 0 4.5370041334535927e-05
hot O 0 1.2650848475459497e-06
spot O 0 8.999764844475067e-08
for O 0 4.719069024439193e-10
PTEN O 0 5.493545245371934e-07
mutation O 0 2.2638313099121454e-11
in O 0 1.0766543039053555e-11
CD B-Disease 0 6.210391347849509e-07
was O 0 2.016754763189965e-09
identified O 0 1.6058252505501969e-09
in O 0 2.693823775157256e-10
exon O 0 3.345646426566873e-09
5 O 0 7.008212066228481e-11
that O 0 7.076588121913974e-13
contains O 0 1.0212138209717003e-12
the O 0 1.0690141827307542e-10
PTPase O 0 5.3706730795965996e-06
core O 0 1.9611827895005263e-07
motif O 0 1.0078058387819055e-09
, O 0 5.557395255789688e-12
with O 0 1.642596757396586e-12
13 O 0 7.311937166853966e-10
of O 0 2.819284139476963e-09
30 O 0 1.6124823698504542e-09
( O 0 2.654526988846162e-12
43 O 0 1.898269541555919e-09
% O 0 4.4696361195528667e-11
) O 0 5.920632907552292e-13
CD B-Disease 0 4.636068240415625e-08
mutations O 0 7.572814597622823e-11
identified O 0 2.0123848420983137e-10
in O 0 7.4615834344538e-11
this O 0 1.1246595876812648e-09
exon O 0 6.423566674129688e-07
. O 0 2.4835807721501624e-07

Seven O 0 3.065394196255511e-07
of O 0 2.75254841142214e-08
30 O 0 5.2154423002548356e-09
( O 0 5.549122793213623e-12
23 O 0 4.5040668417151153e-10
% O 0 8.759989955642311e-11
) O 0 2.1881601348569535e-13
were O 0 2.7660171028620617e-11
within O 0 3.4309080576555573e-10
the O 0 3.912574153552839e-10
core O 0 5.6545669480101424e-08
motif O 0 5.809770997622365e-10
, O 0 2.887491461212033e-12
the O 0 6.197928281714837e-11
majority O 0 6.746986302985647e-11
( O 0 3.39464112202037e-12
five O 0 3.0077637602765606e-10
of O 0 1.945461708396934e-10
seven O 0 4.944900600101221e-10
) O 0 1.653031335945021e-12
of O 0 1.7258625084615176e-11
which O 0 5.604601526799924e-13
were O 0 7.611888896974506e-10
missense O 0 3.8755604947482425e-08
mutations O 0 3.655590552487098e-10
, O 0 9.784368627807627e-12
possibly O 0 6.584730538605754e-09
pointing O 0 9.369169617912121e-08
to O 0 2.11098649671726e-09
the O 0 2.1683645101688853e-08
functional O 0 1.8506402739149053e-06
significance O 0 7.140898983237776e-09
of O 0 7.931947876294032e-10
this O 0 1.3066295267982753e-10
region O 0 2.2597923532430286e-08
. O 0 7.377703070687858e-08

Germline O 0 0.0028858189471066
PTEN O 0 3.628508056863211e-05
mutations O 0 6.434624832962754e-09
were O 0 5.142157810666959e-10
identified O 0 1.9072218804261354e-10
in O 0 2.312027522557991e-12
four O 0 5.467260758701409e-12
of O 0 7.423058001609917e-11
seven O 0 2.0770013486881567e-10
( O 0 4.635130387148356e-12
57 O 0 7.620245767725464e-09
% O 0 2.5242223866683844e-09
) O 0 1.0678424117172014e-10
BZS B-Disease 0 1.0805176316353027e-05
families O 0 4.6023460043009834e-10
studied O 0 1.4107251899986295e-07
. O 0 1.4243165935567959e-07

Interestingly O 0 9.465767334404518e-07
, O 0 1.8546066071767342e-10
none O 0 1.542472927162919e-09
of O 0 1.0987509513338267e-10
these O 0 1.0171591867391694e-11
mutations O 0 1.7864746140738852e-11
was O 0 4.966685743235111e-11
observed O 0 4.3600300453361385e-11
in O 0 3.251440783280657e-11
the O 0 6.2918044108073445e-09
PTPase O 0 0.0011579908896237612
core O 0 7.304162863874808e-06
motif O 0 3.617529102939443e-07
. O 0 2.6031673883153417e-07

It O 0 1.0826272101027712e-09
is O 0 2.529675947882115e-11
also O 0 2.197014488738991e-12
worthy O 0 4.514062457161572e-09
of O 0 1.480967459777105e-09
note O 0 5.622512455616402e-10
that O 0 1.2352939851578704e-12
a O 0 7.829905994405362e-12
single O 0 5.774011824222214e-10
nonsense O 0 5.6140098791956916e-08
point O 0 1.8966987980206795e-09
mutation O 0 4.9433516308150516e-11
, O 0 1.4720639637810784e-11
R233X O 0 4.561799187285942e-07
, O 0 2.765331366672008e-11
was O 0 4.148169585604933e-10
observed O 0 1.0035201142288841e-10
in O 0 1.2677670545302444e-11
the O 0 2.215126831961456e-10
germline O 0 7.633646958993268e-08
DNA O 0 2.5842465944947435e-08
from O 0 1.1335533900425077e-10
two O 0 1.918798453459658e-11
unrelated O 0 1.641233815519172e-09
CD B-Disease 0 1.0441866606925032e-06
families O 0 6.409679037533422e-11
and O 0 3.476331375540376e-11
one O 0 1.3453071989744103e-09
BZS B-Disease 0 0.0005352032603695989
family O 0 2.8256055273345737e-08
. O 0 2.2224827489480958e-07

Genotype O 0 4.180933956376975e-06
- O 0 7.984824890172604e-08
phenotype O 0 6.369707539199965e-10
studies O 0 1.075394703842214e-10
were O 0 1.1493674935414422e-11
not O 0 5.642378925196923e-13
performed O 0 1.4818342386480055e-10
on O 0 1.1544345340785966e-10
this O 0 5.6639901102606416e-12
small O 0 6.0000546198146765e-12
group O 0 1.298834217261513e-11
of O 0 6.67300659173975e-09
BZS B-Disease 0 0.019418248906731606
families O 0 2.1034113117934794e-08
. O 0 1.7941029284429533e-07

However O 0 1.2013782857422939e-08
, O 0 1.1785605824599088e-10
genotype O 0 2.1126792759673663e-08
- O 0 4.831939293126197e-09
phenotype O 0 3.2820354767260085e-10
analysis O 0 2.3953242167529254e-10
inthe O 0 3.4546701499493793e-07
group O 0 6.326958488372947e-12
of O 0 4.141923748424148e-10
CD B-Disease 1 0.9239357113838196
families O 0 4.94873142464769e-10
revealed O 0 6.816541220366901e-10
two O 0 8.244385534504628e-13
possible O 0 6.011372823133687e-12
associations O 0 2.8303520551581363e-12
worthy O 0 6.729780066550006e-10
of O 0 9.805004586027621e-10
follow O 0 1.3428033796003547e-08
- O 0 5.991318374753973e-08
up O 0 3.862317687897132e-10
in O 0 1.2260725767987424e-10
independent O 0 3.521105185200213e-09
analyses O 0 8.681923446829387e-08
. O 0 3.673284254546161e-08

The O 0 1.0898689062344147e-08
first O 0 4.696873556753189e-09
was O 0 1.0993998600383748e-08
an O 0 1.0752525606005925e-11
association O 0 4.528925845459497e-11
noted O 0 3.300892892355023e-11
in O 0 1.1578358714500747e-12
the O 0 1.815341453548225e-11
group O 0 1.859329530617959e-12
of O 0 1.3215703531521683e-10
CD B-Disease 0 0.029636859893798828
families O 0 1.329923171589087e-09
with O 0 1.391187165467045e-09
breast B-Disease 1 0.7181215882301331
disease I-Disease 1 0.9983958601951599
. O 0 1.971616029550205e-06

A O 0 3.760028448596131e-07
correlation O 0 5.8970339722463905e-09
was O 0 1.5068681857854926e-09
observed O 0 1.1888015571948074e-10
between O 0 1.5050118096215925e-10
the O 0 3.8385798012408046e-11
presence O 0 3.241867191361436e-11
/ O 0 1.288470485860671e-08
absence O 0 2.559679401770154e-08
of O 0 3.3470186622253095e-09
a O 0 4.905099659779921e-10
PTEN O 0 1.3791922981454263e-07
mutation O 0 4.21054944382826e-12
and O 0 2.996398973127007e-13
the O 0 3.196783766520883e-12
type O 0 2.8704824628356107e-10
of O 0 8.336113133111667e-09
breast O 0 2.241873602315536e-07
involvement O 0 2.0011564174637897e-06
( O 0 5.2770010583458316e-09
unaffected O 0 4.353218537289649e-05
versus O 1 0.9433996677398682
benign O 0 0.005026866216212511
versus O 0 0.002213482279330492
malignant O 0 2.809644502121955e-05
) O 0 2.0324211202904507e-09
. O 0 5.129252400593032e-08

Specifically O 0 7.527833467690925e-09
and O 0 1.1582058923043093e-10
more O 0 3.0481589474717907e-12
directly O 0 1.6979756489732267e-10
, O 0 1.2415110172553367e-12
an O 0 7.138269467708847e-13
association O 0 6.285536674477399e-11
was O 0 2.807815979721795e-09
also O 0 2.067615826814584e-12
observed O 0 1.3163545774241836e-11
between O 0 2.310882388223412e-11
the O 0 8.472803188219746e-12
presence O 0 3.4473034236232047e-12
of O 0 1.3540076004847634e-10
a O 0 2.0765589248128435e-09
PTEN O 0 0.0015023532323539257
mutation O 0 3.568645752238808e-07
and O 0 2.177468587660769e-07
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.4683891751919873e-05

Secondly O 0 1.1644405276456382e-05
, O 0 1.5820905696628529e-09
there O 0 2.1759481716454587e-10
appeared O 0 3.09656522645696e-10
to O 0 7.610665569979247e-11
be O 0 3.4267028103940333e-10
an O 0 3.055653785555279e-10
interdependent O 0 3.507650035317056e-05
association O 0 2.4663744380148955e-09
between O 0 2.1115472037536165e-08
mutations O 0 5.629756105740569e-10
upstream O 0 4.5850415131276634e-10
and O 0 2.8970242003933944e-12
within O 0 7.648855437913937e-10
the O 0 4.352871840751504e-09
PTPase O 0 3.1292140192817897e-05
core O 0 7.286549816853949e-07
motif O 0 7.598953466469993e-09
, O 0 2.858237951874898e-11
the O 0 2.3753152222916185e-10
core O 0 4.984544688113601e-08
motif O 0 2.2236820718113393e-10
containing O 0 5.236416335263616e-12
the O 0 8.274920679229858e-12
majority O 0 2.2104746852380508e-11
of O 0 4.792030661171509e-10
missense O 0 6.3573089903457e-08
mutations O 0 3.219519095765122e-10
, O 0 5.4547200090127035e-12
and O 0 1.0222646514013167e-11
the O 0 8.310644949993673e-10
involvement O 0 1.0184332495555282e-05
of O 0 2.4638236482132925e-06
all O 0 1.4614485177588676e-09
major O 0 3.5445613111306784e-09
organ O 1 0.6137326955795288
systems O 1 0.9873110055923462
( O 0 9.910676723734468e-09
central O 1 0.9969097971916199
nervous O 0 0.030478360131382942
system O 0 3.875437869282905e-06
, O 0 2.106533836254698e-09
thyroid O 1 0.9972146153450012
, O 0 2.1370571090528756e-08
breast O 1 0.9999998807907104
, O 0 0.009346423670649529
skin O 1 1.0
and O 1 1.0
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 2.3951673711053445e-07
. O 0 0.00010796509741339833

However O 0 1.614648823533571e-07
, O 0 1.2519585368409025e-10
these O 0 1.0145008964845825e-11
observations O 0 3.954272187467467e-10
would O 0 1.1250275017138378e-11
need O 0 9.986206306322742e-11
to O 0 7.54495684679446e-12
be O 0 8.683413363352877e-12
confirmed O 0 1.6208778763626697e-10
by O 0 3.980754094412564e-12
studying O 0 3.289342687118335e-10
a O 0 6.060946883268414e-12
larger O 0 5.1371333402439046e-12
number O 0 8.504374288120786e-12
of O 0 1.5152831767117902e-10
CD B-Disease 0 4.314383204473415e-06
families O 0 1.5232411998411521e-09
. O 0 3.0922951310685676e-08

Molecular O 0 5.545263775275089e-05
defects O 1 0.8562092185020447
leading O 0 6.620170012183735e-08
to O 0 7.184092210010817e-10
human O 0 9.598289096857116e-08
complement B-Disease 1 0.9928203225135803
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 6.715495937115179e-10
an O 0 5.128283648431209e-12
African O 0 7.0257790696359734e-09
- O 0 3.382476299051973e-09
American O 0 3.15895282154699e-10
family O 0 5.171981176665952e-10
. O 0 8.70855387802294e-09

Complement B-Disease 0 3.432167068240233e-05
component I-Disease 1 0.9999864101409912
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 8.572244580840049e-10
C6D B-Disease 1 0.9999955892562866
) O 0 2.1001131389475347e-11
was O 0 2.5290705085723175e-09
diagnosed O 0 4.104521451608889e-07
in O 0 6.3300488982453995e-12
a O 0 5.979604832118124e-12
16 O 0 9.331419664748708e-11
- O 0 1.4113024984774292e-11
year O 0 6.287838999474715e-11
- O 0 5.631141108963789e-10
old O 0 2.528589426731287e-08
African O 0 3.3783191355496456e-08
- O 0 1.2957203088248548e-09
American O 0 7.820984831985456e-11
male O 0 9.507469256320178e-10
with O 0 1.818464545610965e-10
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 8.416556624979421e-07

The O 0 1.3183817593187541e-08
patients O 0 9.167975711932286e-09
father O 0 1.4568126260883218e-08
and O 0 6.694429732778673e-11
two O 0 2.0723557592194908e-10
brothers O 0 4.968623734669109e-09
also O 0 4.3640403790679017e-11
had O 0 2.364986206870867e-09
C6D B-Disease 1 0.9999984502792358
, O 0 2.1001171288115295e-11
but O 0 5.070808790225145e-12
gave O 0 1.4500517973858873e-11
no O 0 3.4141797462111656e-12
history O 0 8.712055521442608e-10
of O 0 1.2370437119102462e-08
meningitis B-Disease 1 1.0
or O 0 1.8695562875592486e-09
other O 0 2.522855258035861e-09
neisserial B-Disease 1 0.5994049906730652
infection I-Disease 1 0.9919903874397278
. O 0 2.3475961370422738e-06

By O 0 2.4700688716627894e-10
using O 0 2.9169769377723753e-10
exon O 0 1.3322334346810294e-09
- O 0 1.84050639312483e-11
specific O 0 1.2877356516186045e-12
polymerase O 0 3.1117426343985066e-12
chain O 0 2.5499040812865248e-12
reaction O 0 5.921717109724778e-13
( O 0 2.3217027394573445e-14
PCR O 0 2.4354209621213485e-11
) O 0 1.0299316195901131e-13
/ O 0 7.139471305817047e-12
single O 0 4.447870891044481e-12
- O 0 7.392605624878534e-12
strand O 0 2.0280654326049197e-12
conformation O 0 3.3767598092704354e-12
polymorphism O 0 3.11835106348024e-11
as O 0 3.30117931688495e-13
a O 0 4.5328622582871403e-13
screening O 0 9.610617857092052e-12
step O 0 3.741379081545482e-11
and O 0 1.2233664602179228e-12
nucleotide O 0 2.8126440065889824e-10
sequencing O 0 3.001318527040553e-09
of O 0 6.194586510410716e-10
target O 0 1.2959847639493205e-09
exons O 0 8.194047218523792e-09
, O 0 3.63172144267343e-12
we O 0 3.07557798673308e-12
determined O 0 1.4254493418963676e-10
that O 0 1.187064660977677e-12
the O 0 1.3463540005087538e-10
proband O 0 5.950637955720595e-07
was O 0 9.953332602563592e-10
a O 0 1.8481187066821114e-11
compound O 0 5.779157152829839e-10
heterozygote O 0 6.659325979541109e-09
for O 0 1.3253391439871365e-10
two O 0 8.213074664809028e-09
C6 O 0 0.09311223030090332
gene O 0 6.107190841930787e-08
mutations O 0 2.2477774308526932e-08
. O 0 8.271843654483746e-08

The O 0 3.013417071429103e-08
first O 0 2.6573325762058175e-09
, O 0 5.490274554431629e-11
1195delC O 0 6.89321666413889e-08
located O 0 1.2164130813729912e-10
in O 0 9.95526508451583e-11
exon O 0 6.389520468275123e-09
7 O 0 5.289768623129021e-09
, O 0 4.7178518036705697e-11
is O 0 1.5566185493365303e-12
a O 0 7.446736803584653e-12
novel O 0 8.913324071879725e-12
mutation O 0 1.507154123725485e-11
, O 0 2.71493851705662e-12
while O 0 5.183978246670051e-11
the O 0 2.684754918380605e-10
second O 0 9.556234026319999e-09
, O 0 7.335877044711836e-11
1936delG O 0 3.724673902638642e-08
in O 0 4.3206105360127367e-10
exon O 0 6.434195398696829e-09
12 O 0 1.1048268966362684e-09
, O 0 1.6313761105890556e-11
has O 0 6.230195396042526e-13
been O 0 1.9467599407518854e-11
described O 0 6.657743800708715e-11
before O 0 1.9515020710514364e-09
to O 0 1.7346493130787621e-09
cause O 0 6.397370384547685e-07
C6D B-Disease 1 0.9999998807907104
in O 0 1.38751432565698e-09
an O 0 3.3378542985129656e-11
unrelated O 0 1.097096031799083e-07
African O 0 1.914270342240343e-06
- O 0 5.912973932709065e-08
American O 0 1.1979111036453105e-09
individual O 0 1.6996938301261366e-09
. O 0 5.221078325234885e-08

Both O 0 1.3858222125406883e-08
mutations O 0 2.665805132195942e-09
result O 0 8.451570554512955e-10
in O 0 3.3245636799072997e-10
premature O 0 5.05096373615288e-08
termination O 0 2.889491845792236e-08
codons O 0 2.1381946879728275e-08
and O 0 5.30579491453409e-09
C6 O 0 2.7437079552328214e-05
null O 0 1.5909583339634992e-07
alleles O 0 6.870741309228379e-09
. O 0 1.242779177346165e-07

Allele O 0 1.0261267391342699e-07
- O 0 2.275539534579707e-09
specific O 0 6.008005898339164e-11
PCR O 0 1.0204792566526066e-09
indicated O 0 2.380975971938426e-10
that O 0 3.3487169742892064e-13
the O 0 1.4628555311535507e-11
probands O 0 8.893066194559651e-08
two O 0 3.6045128687378636e-11
brothers O 0 1.7723204015496208e-09
also O 0 1.2372140638372553e-11
inherited O 0 6.660163975880096e-09
the O 0 4.5486925337456796e-10
1195delC O 0 3.814769655718919e-08
mutation O 0 4.1031174985439733e-11
from O 0 1.7383736811149575e-11
their O 0 8.737129075786498e-11
heterozygous O 0 8.695006936676464e-10
mother O 0 2.030389745222294e-10
and O 0 2.6111814099838426e-11
the O 0 1.1528134002958268e-09
1936delG O 0 8.973112386456705e-08
mutation O 0 7.93937554588453e-11
from O 0 1.4887174826228033e-11
their O 0 5.5538691701162435e-11
homozygous O 0 3.5709019075014226e-10
father O 0 4.276127896218895e-09
. O 0 5.458829388516051e-09
. O 0 8.843977639116929e-08

PAX6 O 0 0.004375464282929897
mutations O 0 4.4181263092468726e-07
reviewed O 0 6.456006076405174e-07
. O 0 5.320806621966767e-07

Mutations O 0 1.76715417410378e-07
in O 0 3.4571197016219912e-09
PAX6 O 0 9.175400919048116e-05
are O 0 2.6822046320096327e-11
responsible O 0 7.410216884551346e-10
for O 0 2.221850620154342e-10
human O 0 7.534178507739853e-07
aniridia B-Disease 1 1.0
and O 0 1.3333519843783392e-09
have O 0 6.820514205502226e-12
also O 0 1.9004067796420804e-13
been O 0 3.415248119031933e-12
found O 0 1.0589454660370201e-12
in O 0 6.253697104434408e-13
patients O 0 3.081421923178951e-11
with O 0 1.4516319570001546e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.5516913309809865e-09
with O 0 1.0017640050818954e-07
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 3.3913786410266766e-06
with O 0 3.230336460546823e-07
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 8.057892131319022e-09
and O 0 1.8492490871935274e-09
with O 0 9.899099495669361e-08
isolated B-Disease 1 1.0
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9998947381973267

No O 0 6.169664601429758e-08
locus O 0 2.1499999558471927e-09
other O 0 2.5248794374710393e-11
than O 0 9.652539184612507e-12
chromosome O 0 3.352123245647931e-09
11p13 O 0 1.5311658216887736e-06
has O 0 1.471303114064515e-11
been O 0 3.1038738246280673e-10
implicated O 0 1.9818759255940677e-07
in O 0 2.0198466899046252e-08
aniridia B-Disease 1 1.0
, O 0 1.754052680880136e-09
and O 0 1.3025791556486865e-09
PAX6 O 1 0.9895082712173462
is O 0 1.6701913463368356e-10
clearly O 0 6.293769394538629e-10
the O 0 2.8713806332625325e-10
major O 0 2.23434604151862e-09
, O 0 2.11872498712129e-11
if O 0 9.50684236195043e-12
not O 0 5.633466783339092e-12
only O 0 1.6230426724828106e-11
, O 0 1.7083310460686008e-11
gene O 0 1.7019377573923578e-10
responsible O 0 3.978128049197949e-08
. O 0 1.2870749515059288e-06

Twenty O 0 1.0751824675026e-06
- O 0 6.079852177265366e-09
eight O 0 6.14015838173998e-10
percent O 0 1.3526858799739472e-10
of O 0 2.003743178324857e-11
identified O 0 1.6983782158419558e-09
PAX6 O 0 2.5296660624007927e-06
mutations O 0 9.005475254397766e-10
are O 0 2.070300354761745e-11
C O 0 1.6760093330958625e-06
- O 0 1.6346152733603958e-06
T O 0 4.917066576126672e-08
changes O 0 1.4847064688794376e-09
at O 0 5.405779379685782e-09
CpG O 0 8.067461010341503e-08
dinucleotides O 0 1.4872841802571202e-07
, O 0 3.963805412371402e-12
20 O 0 6.259932849861372e-11
% O 0 1.8372236024188915e-11
are O 0 4.4839145959575666e-14
splicing O 0 6.121191331587283e-10
errors O 0 5.18869498478125e-08
, O 0 2.4277869645206174e-11
and O 0 1.7082332076645557e-11
more O 0 1.94389448114618e-12
than O 0 2.71837934107122e-12
30 O 0 3.6618991172687743e-10
% O 0 4.111282703167518e-10
are O 0 1.2621278805066694e-12
deletion O 0 2.7376861888583903e-10
or O 0 1.71814160121464e-10
insertion O 0 1.812071559470496e-08
events O 0 5.0982453814185646e-08
. O 0 1.2655591490329243e-06

There O 0 2.7719577744278467e-08
is O 0 8.474310836392718e-11
a O 0 9.95785232049684e-10
noticeably O 0 2.580929674422805e-07
elevated O 0 6.540694652557022e-09
level O 0 1.5862429592061744e-08
of O 0 1.7058962575866587e-10
mutation O 0 1.0315290288609447e-11
in O 0 4.118208378478538e-12
the O 0 6.893311615963071e-11
paired O 0 1.6110120182322163e-10
domain O 0 1.2746706468114155e-10
compared O 0 3.064775169758782e-11
with O 0 2.3563320890838957e-13
the O 0 1.503797260327122e-11
rest O 0 2.281724142960684e-09
of O 0 2.331772552821576e-10
the O 0 6.016827036603445e-10
gene O 0 1.4674427228911213e-09
. O 0 2.1016308693333485e-08

Increased O 0 2.40625706027231e-08
mutation O 0 1.6647241918299471e-10
in O 0 4.387358878976677e-11
the O 0 6.227306448280956e-10
homeodomain O 0 2.5596094133106817e-07
is O 0 4.640959925389376e-12
accounted O 0 4.942505849037104e-10
for O 0 1.1695572895570328e-12
by O 0 1.1383497443284707e-11
the O 0 1.5014686161052282e-09
hypermutable O 0 7.025178092590068e-07
CpG O 0 1.6445397932329797e-07
dinucleotide O 0 5.780011065326107e-07
in O 0 2.927607489766615e-09
codon O 0 1.8976376736645761e-07
240 O 0 2.0660004906858376e-07
. O 0 2.3862438069954806e-07

Very O 0 4.3999026644314654e-08
nearly O 0 3.160961492554293e-09
all O 0 4.630846747732953e-11
mutations O 0 9.654717303408944e-11
appear O 0 3.7199560098954976e-10
to O 0 1.4859012631429636e-10
cause O 0 7.801743251434345e-09
loss O 0 2.3912365421097093e-08
of O 0 1.1426543267134548e-08
function O 0 4.384535845503024e-09
of O 0 8.846043897392519e-10
the O 0 4.449646553994491e-11
mutant O 0 2.5910489032110462e-11
allele O 0 1.3362733662647397e-11
, O 0 5.037741057645206e-13
and O 0 7.381865301317458e-13
more O 0 3.820300738081872e-13
than O 0 4.5156380804739493e-13
80 O 0 8.792783168232177e-11
% O 0 1.339167526870355e-10
of O 0 7.320585804215796e-11
exonic O 0 2.8165230148147202e-08
substitutions O 0 6.941578423180772e-10
result O 0 6.671883046038829e-10
in O 0 1.1176584102656761e-09
nonsense O 0 8.084911655714677e-07
codons O 0 3.146892879613006e-07
. O 0 2.191522270322821e-07

In O 0 3.2623526102781852e-09
a O 0 4.1886297208471035e-10
gene O 0 3.851612084826428e-11
with O 0 4.775009814633746e-12
such O 0 4.0495100328552525e-11
extraordinarily O 0 9.609938445009902e-08
high O 0 2.156785194884492e-09
sequence O 0 4.2649989095977503e-10
conservation O 0 1.0714901882424854e-10
throughout O 0 7.031281806790801e-11
evolution O 0 5.02263730606245e-10
, O 0 5.421900775570698e-12
there O 0 6.293691262593271e-12
are O 0 1.7356602266538346e-11
presumed O 0 3.100941739830887e-06
undiscovered O 0 8.475687354803085e-05
missense O 0 4.7521598389721476e-06
mutations O 0 1.1712764091953431e-08
, O 0 6.299578914070736e-11
these O 0 2.101797069720135e-10
are O 0 7.001358520719592e-11
hypothesized O 0 2.4505906193184046e-09
to O 0 3.22722265577724e-10
exist O 0 4.3122501125480994e-08
in O 0 1.3024449296850094e-09
as O 0 3.675511228706796e-09
- O 0 4.626969030141481e-08
yet O 0 5.3895541363147e-09
unidentified O 0 1.0069110203403397e-06
phenotypes O 0 4.1556017293942205e-08
. O 0 7.967717596812918e-10
. O 0 1.6211455289294463e-08

Genetic O 0 5.402596343628829e-07
heterogeneity O 0 9.408297074742222e-08
and O 0 4.539175979534349e-10
penetrance O 0 4.271322723070625e-06
analysis O 0 4.782573448380845e-09
of O 0 2.9320335048765855e-09
the O 0 1.4698189332307265e-08
BRCA1 O 0 2.00502299207983e-08
and O 0 5.725276364110243e-10
BRCA2 O 0 4.339693404631362e-08
genes O 0 1.099101587520579e-09
in O 0 9.365962450047505e-10
breast B-Disease 0 5.766037816101743e-07
cancer I-Disease 0 2.966507111068495e-07
families O 0 9.898623254400718e-09
. O 0 2.6989394541487854e-07

The O 0 0.00015275915211532265
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.00023227430938277394
Consortium O 0 4.556442334546773e-08
. O 0 1.7439422350662426e-08

The O 0 6.821356812736212e-09
contribution O 0 4.3041314512493045e-08
of O 0 4.285994137376292e-08
BRCA1 O 0 2.9503850029755085e-08
and O 0 5.558227211821531e-10
BRCA2 O 0 1.536443363647777e-07
to O 0 2.283336613118081e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 1.2268864338693675e-05
assessed O 0 2.6794106933181183e-09
by O 0 2.080941842452777e-11
linkage O 0 5.669099856220328e-09
and O 0 5.8429038517215925e-12
mutation O 0 8.784513914894543e-12
analysis O 0 2.28804961088791e-11
in O 0 7.633675809526341e-12
237 O 0 5.223712573609873e-10
families O 0 4.144300180808358e-11
, O 0 7.170856790306157e-13
each O 0 1.1390790654458582e-12
with O 0 1.1026063959432286e-12
at O 0 1.28343377592266e-10
least O 0 5.8969912286599424e-12
four O 0 1.9332419779610754e-12
cases O 0 5.156039657727707e-12
of O 0 7.23309467876021e-10
breast B-Disease 0 2.6425800214724404e-08
cancer I-Disease 0 2.2802535415422653e-09
, O 0 1.3783328861941002e-12
collected O 0 4.634389746960288e-11
by O 0 2.490067353699832e-11
the O 0 1.327617979995921e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 1.5025864740891848e-05
Consortium O 0 2.153082867550893e-08
. O 0 1.758720280520265e-08

Families O 0 6.169580402115571e-09
were O 0 2.1550447537599382e-10
included O 0 1.474258388978189e-11
without O 0 7.737685492337221e-11
regard O 0 3.4827440931195497e-10
to O 0 2.8327890380652754e-11
the O 0 7.645384325627447e-10
occurrence O 0 0.00017222239694092423
of O 0 0.01908828318119049
ovarian B-Disease 1 1.0
or I-Disease 0 1.1420265764172655e-06
other I-Disease 0 2.7391993739911413e-07
cancers I-Disease 1 0.9999983310699463
. O 0 3.4995107853319496e-05

Overall O 0 5.018041338189505e-05
, O 0 6.46612097199295e-09
disease O 0 9.088063961826265e-06
was O 0 1.8068394780357266e-08
linked O 0 7.08680403249673e-08
to O 0 1.6870264074597685e-09
BRCA1 O 0 1.598159649063291e-08
in O 0 6.59909418776472e-11
an O 0 8.012373316906851e-13
estimated O 0 7.550599902261812e-12
52 O 0 1.4498202638435487e-10
% O 0 1.8568895032711197e-10
of O 0 2.7770336377686e-11
families O 0 2.3896417830626682e-11
, O 0 2.9003249454873092e-12
to O 0 2.5681418103218334e-10
BRCA2 O 0 1.8103295529314778e-09
in O 0 1.1019304912984751e-10
32 O 0 5.935174129945153e-09
% O 0 4.839315614901807e-10
of O 0 6.037136762726547e-11
families O 0 2.0961192850887933e-11
, O 0 2.2250163950882085e-12
and O 0 2.809402883940937e-12
to O 0 3.779832002948069e-11
neither O 0 1.6733170404847897e-09
gene O 0 1.7669822202637242e-11
in O 0 2.0042552686949655e-11
16 O 0 2.687449984772883e-10
% O 0 4.715485640849337e-11
( O 0 9.304994383514675e-14
95 O 0 2.7870800112239635e-10
% O 0 1.0910636977223831e-10
confidence O 0 5.362709387668474e-09
interval O 0 1.6594855267726416e-08
[ O 0 8.9198515240696e-09
CI O 0 5.410547032624891e-07
] O 0 1.8160358772334462e-09
6 O 0 4.114491247708685e-10
% O 0 1.431784690808513e-10
- O 0 1.068928487391041e-10
28 O 0 1.66855473882066e-10
% O 0 1.8646871546845745e-10
) O 0 1.470623536142801e-12
, O 0 3.4351085344275223e-12
suggesting O 0 7.052694539488868e-10
other O 0 3.4367236834143e-10
predisposition O 0 1.3986073099658825e-07
genes O 0 1.0893600688177685e-07
. O 0 9.75231955635536e-07

The O 0 2.1694276597372664e-08
majority O 0 8.492518355218692e-10
( O 0 5.618712092814171e-12
81 O 0 2.905389928642421e-09
% O 0 1.285280770702002e-10
) O 0 2.080983497500244e-13
of O 0 2.5383079318985757e-11
the O 0 4.416878596202878e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.952848880497186e-09
were O 0 6.772604699278872e-11
due O 0 2.6922379881000325e-09
to O 0 1.4108052226458057e-10
BRCA1 O 0 7.596398510223423e-10
, O 0 1.3812384395961441e-12
with O 0 9.456526273848853e-13
most O 0 9.26462639244674e-12
others O 0 1.4774738377187902e-10
( O 0 3.753786344262711e-12
14 O 0 4.556359456397985e-10
% O 0 1.0472982203690862e-10
) O 0 1.0998967578737529e-12
due O 0 3.8299248217299464e-09
to O 0 2.5434196970763878e-08
BRCA2 O 0 1.3083812291370123e-06
. O 0 3.5309537338434893e-07

Conversely O 0 2.076643710324788e-07
, O 0 3.0882001816889826e-11
the O 0 1.7759087603264057e-11
majority O 0 5.136202661099043e-12
of O 0 1.57856835242276e-11
families O 0 5.0041581121929024e-12
with O 0 2.3571470296468444e-12
male B-Disease 0 4.469744752100269e-08
and I-Disease 0 1.060062970736908e-08
female I-Disease 1 0.9999938011169434
breast I-Disease 1 0.9999961853027344
cancer I-Disease 1 1.0
were O 1 0.9525834321975708
due O 1 0.9999995231628418
to O 0 6.101102485445153e-07
BRCA2 O 0 1.4350113985983626e-07
( O 0 6.404485275446348e-11
76 O 0 5.571170902385347e-08
% O 0 3.4866804998756606e-09
) O 0 5.3042310127482395e-11
. O 0 6.752193471015744e-09

The O 0 9.558862501535259e-08
largest O 0 1.71162028994587e-09
proportion O 0 6.634713889397403e-10
( O 0 2.4738852459627036e-12
67 O 0 5.491267174306813e-08
% O 0 1.2717061848022126e-09
) O 0 5.553704740014764e-13
of O 0 3.2761800217162573e-11
families O 0 1.7959519288401893e-11
due O 0 9.928556643501452e-09
to O 0 2.091699174977535e-10
other O 0 2.929682538233003e-11
genes O 0 1.815397693283316e-10
was O 0 6.919318451537038e-10
found O 0 2.0059993596777126e-11
in O 0 1.5982752231066821e-12
families O 0 6.6456874725506765e-12
with O 0 1.8362338017295643e-13
four O 0 6.212482351469761e-12
or O 0 1.3460751610572252e-12
five O 0 2.537130228130735e-12
cases O 0 1.1998484887934535e-12
of O 0 8.130510154025217e-10
female O 0 7.739489774394315e-06
breast B-Disease 0 5.738004620070569e-05
cancer I-Disease 0 0.0003902220050804317
only O 0 1.0326333921284458e-07
. O 0 2.8562124043673975e-06

These O 0 6.870069513276178e-10
estimates O 0 3.6144559567574674e-10
were O 0 1.1634333774157568e-10
not O 0 4.0629231749800265e-12
substantially O 0 9.099449665983528e-11
affected O 0 3.854821843674028e-12
either O 0 2.3699815981242933e-12
by O 0 5.110948014634686e-13
changing O 0 1.9568868747654733e-10
the O 0 4.463493463724433e-11
assumed O 0 2.321553838058321e-09
penetrance O 0 5.568058725202718e-08
model O 0 1.541284044836999e-10
for O 0 3.939018902721081e-11
BRCA1 O 0 2.3099329116149647e-09
or O 0 5.694319148152882e-12
by O 0 6.2528415605001e-12
including O 0 1.2734866113028875e-11
or O 0 2.8697164089486193e-10
excluding O 0 2.178379610029424e-08
BRCA1 O 0 4.71974921367746e-08
mutation O 0 1.994106657576822e-09
data O 0 6.792433282498678e-08
. O 0 8.261185513447344e-08

Among O 0 3.947763005385241e-09
those O 0 5.6026412675880266e-11
families O 0 3.406895945912147e-11
with O 0 6.422684432905168e-12
disease O 0 4.78402633063979e-08
due O 0 3.4701208733167732e-06
to O 0 4.270561237973425e-09
BRCA1 O 0 8.21914003523716e-09
that O 0 1.5051136335528237e-12
were O 0 5.432314320596987e-12
tested O 0 2.610637183861342e-12
by O 0 1.2685421560843652e-13
one O 0 4.327523311486309e-13
of O 0 4.339014390841722e-12
the O 0 3.455288355783126e-12
standard O 0 2.365250356684001e-11
screening O 0 4.2324178016472924e-12
methods O 0 2.330616810652941e-10
, O 0 1.3427878600702492e-12
mutations O 0 7.473258990808862e-12
were O 0 2.7673207475542583e-11
detected O 0 1.0854531856674399e-10
in O 0 1.758776934854267e-12
the O 0 2.4333408552013047e-11
coding O 0 2.5205768139358042e-08
sequence O 0 3.3428637635779523e-10
or O 0 7.170002092049543e-11
splice O 0 4.4153689593429135e-09
sites O 0 4.318589930107919e-11
in O 0 4.48054180562929e-12
an O 0 5.986448858331939e-13
estimated O 0 4.8290232923520193e-11
63 O 0 5.008749415225111e-09
% O 0 7.251936828822636e-10
( O 0 1.8611071884999664e-12
95 O 0 5.504330324868079e-09
% O 0 8.510290250285379e-10
CI O 0 8.085838487659203e-08
51 O 0 4.024835131843929e-09
% O 0 1.7618888570325453e-09
- O 0 1.6476573438950481e-09
77 O 0 1.304553354231075e-09
% O 0 1.1656484666389133e-09
) O 0 5.677079639720972e-11
. O 0 8.34409874528319e-09

The O 0 5.059851204691768e-09
estimated O 0 9.235454068168281e-10
sensitivity O 0 2.6043298628763978e-09
was O 0 1.1758931328653688e-10
identical O 0 1.4951657967277043e-11
for O 0 3.780058948146814e-13
direct O 0 1.2122663116398424e-11
sequencing O 0 1.2661878212583133e-09
and O 0 3.6755352234019156e-11
other O 0 6.458817508603332e-11
techniques O 0 2.4018725071073277e-06
. O 0 1.7306985000686836e-07

The O 0 5.508596956360634e-08
penetrance O 0 1.478787908126833e-05
of O 0 1.1762335105913735e-07
BRCA2 O 0 1.644731817407319e-08
was O 0 4.5208498056226176e-10
estimated O 0 4.94346187249195e-12
by O 0 1.0123644544196564e-12
maximizing O 0 3.477740762036774e-09
the O 0 7.454275530172083e-10
LOD O 0 1.3988121281727217e-05
score O 0 1.3377162488836802e-08
in O 0 1.3275408550228462e-09
BRCA2 O 0 4.946886633661052e-08
- O 0 7.053855277661114e-09
mutation O 0 7.359772513648721e-11
families O 0 2.823521798311912e-11
, O 0 3.152064330033677e-12
over O 0 1.0884711534875358e-11
all O 0 1.8514918764811483e-11
possible O 0 2.725672576531224e-09
penetrance O 0 3.4114184472855413e-06
functions O 0 8.8259135111457e-08
. O 0 1.4649593538251793e-07

The O 0 1.413273054140518e-09
estimated O 0 1.4147125138030958e-10
cumulative O 0 9.635571229793527e-10
risk O 0 7.505921995054621e-10
of O 0 6.4360370366500774e-09
breast B-Disease 0 1.734227623728657e-07
cancer I-Disease 0 4.016202126422286e-08
reached O 0 1.9786013183420437e-07
28 O 0 2.499291440472007e-09
% O 0 2.902722853748152e-11
( O 0 3.92837380734732e-14
95 O 0 4.078401782958707e-10
% O 0 1.0597445837534636e-10
CI O 0 6.121906981348957e-09
9 O 0 2.1334586874921513e-10
% O 0 3.6488732174655425e-11
- O 0 2.353792161180479e-11
44 O 0 2.0688003393720678e-11
% O 0 2.9892932747188627e-12
) O 0 5.30589993192861e-15
by O 0 1.3036602776028e-13
age O 0 5.643890910178584e-11
50 O 0 2.4761951170071406e-11
years O 0 2.2531051677154856e-11
and O 0 9.57493416151034e-13
84 O 0 3.4922428837624864e-10
% O 0 4.634071598674794e-11
( O 0 3.196147773526503e-13
95 O 0 6.690922260688126e-10
% O 0 1.1358800705574268e-10
CI O 0 7.927353884440436e-09
43 O 0 1.1168188596144546e-09
% O 0 1.0149717871721364e-10
- O 0 9.532922368160612e-11
95 O 0 4.4375117469463987e-10
% O 0 1.2428691756327659e-11
) O 0 1.7810826056195717e-14
by O 0 2.7690656300045913e-13
age O 0 4.0592562644548025e-10
70 O 0 1.2368094326475898e-09
years O 0 2.659167774865523e-09
. O 0 2.0852041870966787e-08

The O 0 4.93950381041941e-07
corresponding O 1 0.9999997615814209
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 6.522582793877518e-07
were O 0 3.2757832002516807e-09
0 O 0 9.331762029773927e-10
. O 0 5.1135615741770835e-09

4 O 0 1.65780242866731e-08
% O 0 1.2369769653020057e-09
( O 0 9.792168161396053e-13
95 O 0 1.1369665209315372e-09
% O 0 4.633040062707039e-10
CI O 0 3.1670278843876076e-08
0 O 0 1.327020524716227e-11
% O 0 6.855249007342579e-11
- O 0 2.7438639901844475e-11
1 O 0 3.785313208715113e-12
% O 0 2.5437347540846478e-12
) O 0 2.3814422368096484e-15
by O 0 3.1943059173233576e-14
age O 0 1.5785261986422938e-11
50 O 0 4.3389974772878315e-12
years O 0 4.900092050869054e-12
and O 0 4.2776367300753626e-13
27 O 0 2.9392311501341695e-11
% O 0 1.8613248095600277e-11
( O 0 1.1809035195022022e-13
95 O 0 4.2443137893144467e-10
% O 0 1.893798728946905e-10
CI O 0 1.0442713360703237e-08
0 O 0 4.8281552367246405e-12
% O 0 3.117358107762591e-11
- O 0 4.001599052116944e-11
47 O 0 6.154435988614537e-11
% O 0 1.6509148215160252e-11
) O 0 2.8746736301056217e-14
by O 0 3.029493973391584e-13
age O 0 4.794801222729461e-10
70 O 0 1.1462379934101818e-09
years O 0 1.0380907244922355e-09
. O 0 1.72503575868177e-08

The O 0 1.1357706775072529e-08
lifetime O 0 2.1153411466912075e-07
risk O 0 2.029846513096345e-07
of O 0 4.571423914967454e-07
breast B-Disease 1 0.959740400314331
cancer I-Disease 0 5.8865625760518014e-05
appears O 0 1.2368897017722702e-09
similar O 0 1.5848676537810746e-11
to O 0 1.5183845847310806e-10
the O 0 2.9514808375097346e-09
risk O 0 3.9306327082044845e-09
in O 0 3.0191385502753576e-10
BRCA1 O 0 8.205382484582913e-10
carriers O 0 9.83334941251357e-12
, O 0 1.6188835211608521e-12
but O 0 1.4051804424902725e-12
there O 0 5.981178659991704e-12
was O 0 6.90296916849853e-11
some O 0 1.1739669566329658e-12
suggestion O 0 1.2733317178437176e-10
of O 0 6.241147598728958e-10
a O 0 7.990683670300314e-10
lower O 0 5.048536522167524e-08
risk O 0 4.1986223386913935e-09
in O 0 7.593458639654216e-10
BRCA2 O 0 6.824909526415013e-09
carriers O 0 6.366959737214017e-11
< O 0 6.385926454299806e-09
50 O 0 5.751094600547901e-10
years O 0 2.4599228209964963e-10
of O 0 8.403348572549874e-10
age O 0 1.223354075818861e-07
. O 0 7.410308455746417e-08

Eye B-Disease 1 0.9833532571792603
movement I-Disease 0 9.307430445915088e-06
abnormalities I-Disease 1 0.8236351609230042
correlate O 0 4.0597288375465723e-07
with O 0 5.047893353316013e-11
genotype O 0 5.30863211167798e-08
in O 0 5.704544059348393e-10
autosomal O 0 0.10221961885690689
dominant O 0 0.3896690309047699
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 1.8646162061486393e-05

We O 0 2.4926515962420126e-08
compared O 0 2.9613673291351006e-08
horizontal O 0 1.9030056819246965e-07
eye O 0 4.162208369962173e-06
movements O 0 5.4070187616162e-07
( O 0 2.4059849668134348e-09
visually O 0 9.089348651514229e-08
guided O 0 2.4342506321772817e-07
saccades O 0 6.851102625660133e-06
, O 0 3.511023971558558e-10
antisaccades O 0 1.0956589449051535e-06
, O 0 1.806347432742328e-11
and O 0 1.9448524388177013e-11
smooth O 0 3.896729694474743e-08
pursuit O 0 1.2068194621406292e-07
) O 0 3.4820828945930637e-12
in O 0 1.3529226350339485e-11
control O 0 7.28024041052322e-09
subjects O 0 5.475421858136542e-07
( O 0 5.256610251247462e-12
n O 0 2.858237951874898e-11
= O 0 1.4480121095228338e-11
14 O 0 1.3435519190252432e-11
) O 0 1.9662224593711836e-13
and O 0 2.568519941008318e-13
patients O 0 2.0989787598985066e-12
with O 0 2.3573291146254498e-14
three O 0 1.3660424787870218e-12
forms O 0 1.16381730641546e-10
of O 0 1.4048965546464842e-08
autosomal O 0 0.009976361878216267
dominant O 0 0.022343983873724937
cerebellar B-Disease 1 0.9999974966049194
ataxias I-Disease 1 0.9988597631454468
type I-Disease 0 0.09356814622879028
I I-Disease 1 1.0
spinocerebellar B-Disease 1 0.9999253749847412
ataxias I-Disease 0 0.2538130283355713
1 I-Disease 0 1.3309083612966788e-08
and I-Disease 0 1.6667701940864532e-10
2 I-Disease 0 1.2654924885779906e-09
( O 0 5.6049286739634496e-11
SCA1 B-Disease 0 0.000167485122801736
, O 0 3.096020315118686e-11
n O 0 2.370001070395311e-11
= O 0 1.2307133610833798e-11
11 O 0 2.4920010499585032e-11
; O 0 2.183237748573652e-12
SCA2 B-Disease 0 3.36543598677963e-06
, O 0 1.3819031856321384e-11
n O 0 1.9419832061884357e-11
= O 0 6.5320700237680995e-12
10 O 0 1.6201909605606524e-11
) O 0 8.943000962165215e-13
and O 0 8.185760402845688e-11
SCA3 B-Disease 1 1.0
/ O 0 4.25085232791389e-07
Machado B-Disease 0 3.448041070441832e-07
- I-Disease 0 1.0635833547212314e-07
Joseph I-Disease 0 7.124370995370555e-07
disease I-Disease 1 0.9969384670257568
( O 0 3.400937309550045e-10
MJD B-Disease 1 1.0
) O 0 8.137398532781503e-10
( O 0 1.412781090032178e-11
n O 0 1.5471393610688722e-10
= O 0 9.374662157668467e-11
16 O 0 2.8739613466832736e-10
) O 0 1.2954916653318271e-11
. O 0 1.046216668854072e-09

In O 0 1.1452534920408652e-07
SCA1 B-Disease 0 0.00031199888326227665
, O 0 1.1399973326442492e-10
saccade O 0 9.458569394382721e-08
amplitude O 0 1.122851145396453e-08
was O 0 2.276425048464148e-09
significantly O 0 8.9075208320466e-10
increased O 0 1.74518510753785e-10
, O 0 1.2784848050020892e-12
resulting O 0 1.5724987978416038e-10
in O 0 3.5063726921968907e-10
hypermetria B-Disease 0 7.404398729704553e-06
. O 0 2.979620603582589e-07

The O 0 1.727634497683539e-07
smooth O 0 1.8355979136686074e-06
pursuit O 0 2.1558337266469607e-06
gain O 0 8.065450742833491e-07
was O 0 2.1787993631505742e-08
decreased O 0 6.03606906679488e-07
. O 0 2.6268606845292197e-08

In O 0 1.8295790482625307e-07
SCA2 B-Disease 0 0.0005384898977354169
, O 0 3.148294125399076e-10
saccade O 0 2.56295066947132e-07
velocity O 0 6.746686409542235e-08
was O 0 3.892050060017027e-08
markedly O 0 3.1892498100205557e-06
decreased O 0 1.1069715810663183e-06
. O 0 5.061359686919786e-08

The O 0 6.1067462198138855e-09
percentage O 0 2.2121312781564484e-08
of O 0 2.1126893290368542e-10
errors O 0 2.510501815322641e-07
in O 0 8.582698995951432e-10
antisaccades O 0 1.9409108062973246e-05
was O 0 1.3998003867143893e-09
greatly O 0 1.608782690398769e-10
increased O 0 4.999838737473894e-11
and O 0 2.1241704142166418e-12
was O 0 1.727308990284726e-10
significantly O 0 3.538243864564805e-10
correlated O 0 7.554872283321856e-10
with O 0 2.072357476595732e-12
age O 0 2.5080984400460693e-08
at O 0 3.540090531828355e-08
disease O 0 1.9095953120995546e-06
onset O 0 9.474390026298352e-06
. O 0 1.968257947737584e-07

In O 0 4.853146329253377e-09
addition O 0 5.48111167564258e-10
, O 0 6.0206210676649885e-12
a O 0 1.018389973045375e-11
correlation O 0 6.503405453051059e-11
between O 0 6.144551534248421e-10
smooth O 0 6.615045577973433e-08
pursuit O 0 1.8904539444974944e-07
gain O 0 3.6826001803547115e-08
and O 0 2.4039504761819153e-11
the O 0 4.4232204704508504e-11
number O 0 7.674762214637809e-11
of O 0 2.7838498173338166e-10
trinucleotide O 0 1.216940290760249e-07
repeats O 0 6.292800502905038e-09
was O 0 2.1588471010858257e-09
found O 0 8.451603861203694e-10
. O 0 2.023996437117148e-08

In O 0 9.077201639229315e-07
SCA3 B-Disease 1 1.0
, O 0 1.6242228184637497e-07
gaze B-Disease 0 0.028833290562033653
- I-Disease 0 1.8194563381257467e-05
evoked I-Disease 0 1.9503493930983495e-08
nystagmus I-Disease 0 2.484804717539646e-08
was O 0 1.2589538300744607e-09
often O 0 1.4044684686076447e-11
present O 0 4.7826690524610527e-11
as O 0 6.2096981202908186e-12
was O 0 2.591410697139196e-10
saccade O 0 2.1740073918863345e-07
hypometria O 0 2.3210338895296445e-06
and O 0 1.3380779817495636e-09
smooth O 0 1.6430440155090764e-06
pursuit O 0 4.650877144740662e-06
gain O 0 2.6147095013584476e-06
was O 0 7.060238260692131e-08
markedly O 0 1.3907310858485289e-06
decreased O 0 6.031149268892477e-07
. O 0 2.9610680130076616e-08

Three O 0 1.3478704818936649e-09
major O 0 2.3331517273739166e-10
criteria O 0 9.21912157725302e-10
, O 0 3.569012273219041e-12
saccade O 0 8.150466079825947e-09
amplitude O 0 7.935821444426949e-10
, O 0 7.231417721575983e-12
saccade O 0 1.3550320865363119e-08
velocity O 0 1.1689776258094753e-08
, O 0 9.311879045625915e-11
and O 0 4.48348511095098e-11
presence O 0 9.529763644877676e-10
of O 0 1.3523373354473733e-06
gaze B-Disease 1 0.9945698380470276
- I-Disease 0 0.0006948913214728236
evoked I-Disease 0 4.9373849009271e-08
nystagmus I-Disease 0 3.179809748843354e-09
, O 0 1.7007224621667927e-12
permitted O 0 3.3776828556320027e-11
the O 0 3.4652476200991433e-12
correct O 0 4.5561424077966706e-10
assignment O 0 1.1116099152275183e-09
of O 0 8.835147197183701e-11
90 O 0 5.613168818641157e-10
% O 0 9.270729323107574e-11
of O 0 2.1348457723835423e-11
the O 0 1.3047865565773975e-10
SCA1 B-Disease 0 4.7210818593157455e-05
, O 0 6.604228882517438e-12
90 O 0 5.185553098030482e-10
% O 0 9.753722135519283e-11
of O 0 2.890281070033751e-11
the O 0 1.888334349997578e-10
SCA2 B-Disease 0 0.00019147912098560482
, O 0 8.136769036326541e-12
and O 0 9.679636649509438e-13
93 O 0 4.89552898219614e-10
% O 0 5.937568492431211e-11
of O 0 8.17212183340521e-12
the O 0 9.945485407447663e-12
patients O 0 7.73210870330665e-11
with O 0 3.8067250740514424e-11
SCA3 B-Disease 1 1.0
to O 0 3.4573175433649794e-09
their O 0 3.984373664334129e-10
genetically O 0 4.422756258448679e-11
confirmed O 0 7.230501197774686e-10
patient O 0 4.277247711570453e-08
group O 0 1.558470193174788e-11
and O 0 4.60950375091862e-11
, O 0 1.4224148768560152e-11
therefore O 0 8.592739852986142e-10
, O 0 2.9320584155057006e-11
may O 0 5.545044423627132e-10
help O 0 2.178770230898408e-08
orient O 0 3.329255150674726e-06
diagnoses O 0 3.5893676795240026e-06
of O 0 1.351322680420708e-06
SCA1 B-Disease 1 0.9999995231628418
, O 0 3.6604064224121657e-09
SCA2 B-Disease 1 0.9999842643737793
, O 0 1.5706942690929537e-10
and O 0 1.608452260271065e-09
SCA3 B-Disease 1 1.0
at O 0 1.1947810740764453e-08
early O 0 1.3461697312422416e-09
clinical O 0 8.01961719254507e-10
stages O 0 1.6805591585011825e-08
of O 0 3.402353732084862e-09
the O 0 9.445009219177791e-09
diseases O 0 2.7978931029792875e-06
. O 0 5.096366439971689e-09
. O 0 3.857153529907009e-08

Genetic O 0 2.5979412399124158e-08
basis O 0 6.181583245279398e-09
and O 0 1.0688056342744723e-11
molecular O 0 5.472211572765673e-10
mechanism O 0 7.419940573072381e-08
for O 0 1.1640732111573016e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9998676776885986

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.9999991655349731
causes O 0 9.82779874902917e-06
more O 0 9.292060870746965e-11
than O 0 1.807525158194212e-12
300 O 0 2.075163131609603e-11
, O 0 5.590882032509292e-13
000 O 0 1.0152471086044557e-09
sudden O 0 6.275139435851784e-11
deaths O 0 1.580719583005319e-11
each O 0 1.6835779732132794e-12
year O 0 2.757152318955125e-11
in O 0 2.679985226794468e-11
the O 0 1.0993007615311967e-09
USA O 0 6.278955311245227e-08
alone O 0 4.997672320428137e-08
. O 0 3.685481075876851e-08

In O 0 2.4470935500175983e-08
approximately O 0 8.127238326771646e-10
5 O 0 7.665403312095975e-10
- O 0 8.147399976898839e-10
12 O 0 3.2108785075202206e-10
% O 0 1.7387791206857628e-10
of O 0 4.8395228796627165e-12
these O 0 6.050179346232809e-13
cases O 0 1.7389763674185987e-12
, O 0 4.3922442180717447e-13
there O 0 7.363879471478096e-13
are O 0 3.49145191924638e-13
no O 0 1.5327990612878928e-11
demonstrable O 0 1.002907339398007e-07
cardiac O 0 0.0027408909518271685
or O 0 7.403072377343278e-09
non O 1 1.0
- O 1 1.0
cardiac O 1 1.0
causes O 0 3.274388973295572e-07
to O 0 8.370071996610662e-11
account O 0 1.5966459057659144e-11
for O 0 1.7906423956451367e-12
the O 0 1.014683337352551e-10
episode O 0 1.500046087343776e-09
, O 0 2.3054824650932393e-13
which O 0 1.1739366735110356e-14
is O 0 2.159479836432148e-14
therefore O 0 4.084874365845037e-12
classified O 0 1.1584185832802518e-09
as O 0 8.86973605673802e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 0.1675930768251419
IVF B-Disease 1 1.0
) O 0 9.843759585237422e-09
. O 0 3.0061325873020905e-08

A O 0 8.749999835799827e-08
distinct O 0 1.862374143790646e-09
group O 0 5.6228206118946744e-11
of O 0 3.1637316766364165e-08
IVF B-Disease 1 1.0
patients O 0 5.166839756043373e-08
has O 0 1.550096720903324e-13
been O 0 4.1755257563190484e-13
found O 0 1.3202531787010613e-13
to O 0 4.3985149723868577e-13
present O 0 2.46295900341309e-11
with O 0 4.627312855803867e-12
a O 0 8.004396589988971e-10
characteristic O 0 8.899989012434162e-08
electrocardiographic O 0 3.333521817694418e-05
pattern O 0 3.2381387882196577e-06
. O 0 3.8102399457784486e-07

Because O 0 2.5030660211200484e-08
of O 0 4.430894051665746e-08
the O 0 3.4755525124552378e-09
small O 0 2.2757063594669447e-11
size O 0 1.2689718199843103e-11
of O 0 5.508368067230762e-11
most O 0 6.110441579804116e-12
pedigrees O 0 3.886351240822705e-09
and O 0 2.1573753200554435e-11
the O 0 1.7516112171822584e-10
high O 0 8.881531066151638e-10
incidence O 0 5.355410781504588e-09
of O 0 7.561762882524192e-10
sudden B-Disease 0 5.1910578058311785e-09
death I-Disease 0 1.6437087246856663e-09
, O 0 5.40060834594569e-12
however O 0 4.158291419531501e-11
, O 0 8.328689842830583e-13
molecular O 0 7.401116525196372e-11
genetic O 0 9.179375315415683e-11
studies O 0 5.00026076100113e-10
of O 0 7.85942422254493e-09
IVF B-Disease 1 1.0
have O 0 2.8029439880228324e-11
not O 0 1.41146599616504e-12
yet O 0 1.0128400722286823e-11
been O 0 2.1072752917628e-11
done O 0 2.758149264536769e-09
. O 0 1.6571132022136226e-08

Because O 0 1.0379110335634323e-06
IVF B-Disease 1 1.0
causes O 0 0.001082147005945444
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 0 4.65846324004815e-06
, O 0 1.3616079617972954e-11
we O 0 8.570487201875476e-12
investigated O 0 3.912350166057621e-10
whether O 0 9.65151361609351e-11
malfunction O 0 4.430604349181522e-06
of O 0 8.66044735925442e-10
ion O 0 1.9961765929110697e-07
channels O 0 4.040151111439627e-07
could O 0 3.252236258077801e-10
cause O 0 5.915900547215358e-10
the O 0 1.401354310370806e-10
disorder O 0 1.5792143148729565e-09
by O 0 1.0263337488908286e-12
studying O 0 1.9176249477226293e-10
mutations O 0 1.694752151115697e-11
in O 0 6.907417346435629e-12
the O 0 6.729857227050218e-10
cardiac O 0 7.806910434737802e-05
sodium O 0 1.8440546867282137e-08
channel O 0 1.8741593166282655e-08
gene O 0 2.3406949711812786e-09
SCN5A O 0 4.7372999688377604e-05
. O 0 1.801813738211422e-07

We O 0 4.727334967924435e-08
have O 0 8.189852268580822e-11
now O 0 3.8854724992987144e-11
identified O 0 1.88620327690181e-10
a O 0 6.419294956705457e-11
missense O 0 4.503529993371558e-08
mutation O 0 1.9806151163592745e-10
, O 0 5.725445291482334e-12
a O 0 8.514376703683268e-11
splice O 0 2.501138851584983e-07
- O 0 1.4604126796768924e-08
donor O 0 1.0004003847541298e-08
mutation O 0 1.1170787628245193e-09
, O 0 9.465661761354216e-12
and O 0 1.1297237451080022e-11
a O 0 1.2232159729563818e-10
frameshift O 0 2.506319596307094e-08
mutation O 0 3.3136608040829074e-11
in O 0 5.011225809314901e-12
the O 0 6.094475618612094e-11
coding O 0 2.223312549176626e-06
region O 0 5.212150711031427e-09
of O 0 3.808900306268015e-09
SCN5A O 0 0.45421186089515686
in O 0 2.2213506034596264e-10
three O 0 9.557779012681067e-10
IVF B-Disease 1 1.0
families O 0 1.1723420012543784e-09
. O 0 1.0977990072547072e-08

We O 0 2.0986504978282028e-08
show O 0 4.57941295994857e-10
that O 0 1.221659600737779e-12
sodium O 0 1.1049817311148402e-11
channels O 0 2.3669066706588637e-11
with O 0 5.724107711262139e-14
the O 0 1.3702444560947935e-11
missense O 0 1.247757008826511e-08
mutation O 0 1.474158017877869e-10
recover O 0 6.172584221530997e-08
from O 0 7.171989113707866e-10
inactivation O 0 1.4837708306458808e-07
more O 0 9.233137691910809e-12
rapidly O 0 2.376665531045319e-10
than O 0 7.860908105006281e-13
normal O 0 4.673618714257088e-10
and O 0 9.065485992096334e-13
that O 0 2.9067975240368304e-13
the O 0 8.056716405135944e-11
frameshift O 0 1.2830291495902202e-07
mutation O 0 6.338173874631536e-10
causes O 0 5.348821038864138e-11
the O 0 1.2990256093026176e-10
sodium O 0 2.235278490081427e-10
channel O 0 2.7413962766509314e-10
to O 0 1.9428797112808205e-11
be O 0 1.2795692283518179e-10
non O 0 5.059429781795188e-07
- O 0 3.234350174352585e-07
functional O 0 6.943927814972994e-07
. O 0 4.797376362830619e-08

Our O 0 8.756627778438997e-08
results O 0 1.151053474757191e-09
indicate O 0 8.510225302238439e-10
that O 0 5.646814396284561e-13
mutations O 0 5.499536590014564e-12
in O 0 3.63305175873907e-12
cardiac O 0 5.1516561683229156e-08
ion O 0 9.819029145319291e-08
- O 0 5.652884169649042e-07
channel O 0 8.323117306474614e-09
genes O 0 5.024682492998922e-12
contribute O 0 5.131140304315274e-12
to O 0 1.5478757598580417e-12
the O 0 4.8468299686244e-12
risk O 0 5.847020090321564e-11
of O 0 6.523195872354393e-11
developing O 0 3.885433841332997e-08
IVF B-Disease 1 1.0
. O 0 4.002794096180651e-09
. O 0 8.906676285391768e-09

Molecular O 0 2.714779157031444e-07
heterogeneity O 0 2.4215063376686885e-07
in O 0 2.23869403015442e-08
mucopolysaccharidosis B-Disease 1 0.9287206530570984
IVA I-Disease 1 1.0
in O 0 5.6473780318810896e-08
Australia O 0 1.2343444044660146e-09
and O 0 2.3836011289746217e-11
Northern O 0 4.764037164761703e-09
Ireland O 0 5.196961971876135e-09
: O 0 2.8124479741625796e-12
nine O 0 6.312617789605568e-11
novel O 0 4.462614739547677e-12
mutations O 0 1.0880000025914605e-11
including O 0 5.468095594374223e-12
T312S O 0 7.398148795800807e-07
, O 0 2.984390165550188e-11
a O 0 2.179427818771451e-11
common O 0 7.194701778789891e-11
allele O 0 2.0729420402432197e-09
that O 0 2.814928845573661e-11
confers O 0 5.747577525028191e-09
a O 0 6.508636740676366e-09
mild O 0 2.2201568583568587e-07
phenotype O 0 7.057033144519664e-07
. O 0 4.6608448656115797e-07

Mucopolysaccharidosis B-Disease 0 0.2160901576280594
IVA I-Disease 1 1.0
( O 0 1.0865095418921555e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.4776830870033564e-09
is O 0 4.1350856766486643e-11
an O 0 1.9203408307966185e-10
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 4.953373604621447e-07
by O 0 1.465562393665465e-10
a O 0 1.673908478494468e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.5208200254690496e-09
N O 0 2.860702075224708e-08
- O 0 1.0871532118983396e-08
acetylgalactosamine O 0 9.2347204372345e-07
- O 0 2.1151750573267236e-08
6 O 0 2.0955866375516052e-08
- O 0 3.310222496111237e-08
sulfate O 0 2.773209661910414e-09
sulfatase O 0 1.7582883060640597e-07
( O 0 6.271095448484587e-11
GALNS O 0 9.767795563675463e-05
) O 0 4.573250389494632e-10
. O 0 1.8750567321035305e-08

Previous O 0 5.1717496063474755e-08
studies O 0 2.4878861193400326e-09
of O 0 1.863919019129412e-10
patients O 0 1.7989285061581484e-10
from O 0 3.2855163034639645e-11
a O 0 1.007499205590845e-11
British O 0 6.163134891323807e-09
- O 0 1.8933201673121403e-08
Irish O 0 5.9532463403400016e-09
population O 0 2.469359786094749e-12
showed O 0 6.1608686902081544e-12
that O 0 1.0164070953432806e-14
the O 0 1.7669407603726484e-12
I113F O 0 3.331206599455072e-08
mutation O 0 6.457363810330463e-11
is O 0 3.9332344889744797e-13
the O 0 2.2559476856032212e-11
most O 0 3.417672178249176e-12
common O 0 1.2530759416207182e-11
single O 0 1.126608459300904e-10
mutation O 0 2.759031891841346e-10
among O 0 4.703810674300257e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 9.129873433266766e-06
and O 0 1.6452510187559e-10
produces O 0 4.957004251515684e-11
a O 0 5.1840674114567165e-11
severe O 0 2.0393885691305513e-08
clinical O 0 6.251065087781171e-08
phenotype O 0 2.9038899285183106e-08
. O 0 3.847190654937549e-08

We O 0 1.0066213462778251e-07
studied O 0 3.7918532314051845e-08
mutations O 0 2.5187291141648416e-10
in O 0 1.5853936219389908e-11
the O 0 2.5756718979863535e-10
GALNS O 0 0.00043269561138004065
gene O 0 3.3504896773672854e-11
from O 0 2.0450335869171e-11
23 O 0 1.611048794369907e-10
additional O 0 6.71721234191125e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.3693688490311615e-05
( O 0 1.8427790543507072e-11
15 O 0 4.519625507182212e-10
from O 0 3.195336217842737e-10
Australia O 0 2.3030423401682043e-10
, O 0 1.156511626916601e-12
8 O 0 5.3883668360565906e-11
from O 0 2.7314364312025496e-11
Northern O 0 9.906476750032311e-10
Ireland O 0 4.03735977982933e-09
) O 0 2.9450151085158582e-12
, O 0 4.592965005718874e-13
with O 0 1.984760690217427e-13
various O 0 3.3486945855143446e-11
clinical O 0 5.5735519310928794e-08
phenotypes O 0 7.069536422932288e-08
( O 0 5.843218964241004e-11
severe O 0 4.722666702150491e-08
, O 0 1.0743608259977666e-11
16 O 0 1.1329027299611383e-10
cases O 0 2.091852515859194e-12
; O 0 6.153663868616391e-14
intermediate O 0 1.3571722912164574e-10
, O 0 1.473262592650848e-12
4 O 0 4.442658740888561e-11
cases O 0 2.006244129160173e-11
; O 0 1.8865622605779286e-11
mild O 0 2.0205510598003684e-09
, O 0 3.109869306516799e-11
3 O 0 1.0271905548364657e-10
cases O 0 5.556761648040087e-11
) O 0 5.446042228296477e-11
. O 0 7.659969547546552e-09

We O 0 3.4428158102173256e-08
found O 0 3.0027486053185726e-10
two O 0 5.854382516962131e-12
common O 0 8.052916840306512e-12
mutations O 0 3.1019234490031744e-12
that O 0 8.218789147515504e-14
together O 0 1.12523350012661e-11
accounted O 0 1.7584308453777453e-09
for O 0 5.09210295457363e-12
32 O 0 2.0202012507297695e-08
% O 0 4.400387165759412e-09
of O 0 1.7388454565114841e-10
the O 0 1.951824812884695e-10
44 O 0 9.73659042280417e-10
unrelated O 0 5.479522946494342e-10
alleles O 0 1.8415598906917907e-11
in O 0 1.1034358322892235e-11
these O 0 1.5621673399301983e-10
patients O 0 5.681580983463164e-09
. O 0 2.4821993349632976e-08

One O 0 1.1588656256833474e-08
is O 0 2.798291286187915e-11
the O 0 5.459815377584221e-10
T312S O 0 5.890724423807114e-06
mutation O 0 4.79466411018592e-10
, O 0 2.3493685295805644e-12
a O 0 5.720085863303304e-12
novel O 0 1.4954622609697488e-11
mutation O 0 6.279221587135453e-11
found O 0 1.8244463231842367e-11
exclusively O 0 5.01291341770127e-10
in O 0 7.566606369246998e-11
milder O 0 4.3971503771444986e-08
patients O 0 3.163013673201931e-08
. O 0 8.218594160780412e-08

The O 0 4.026165356663114e-08
other O 0 1.7350422487627526e-10
is O 0 3.5075265174960846e-12
the O 0 3.293082473376785e-11
previously O 0 8.456150224489534e-10
described O 0 4.434711209366782e-10
I113F O 0 3.7087522741785506e-07
that O 0 3.015866419445179e-12
produces O 0 1.2784122718767499e-11
a O 0 1.3571387069699625e-10
severe O 0 1.887348304308034e-07
phenotype O 0 8.047111350606428e-07
. O 0 2.5636083478275395e-07

The O 0 1.5238398987094115e-07
I113F O 0 6.6662296376307495e-06
and O 0 8.038561483125761e-10
T312S O 0 3.102788355135999e-07
mutations O 0 1.360121321125618e-10
accounted O 0 4.03351130273677e-09
for O 0 1.807270999520938e-11
8 O 0 6.194787460778173e-10
( O 0 2.1703916875531748e-12
18 O 0 2.993912617821337e-10
% O 0 2.8364277940284843e-11
) O 0 9.341056303024259e-14
and O 0 1.9652036074846446e-12
6 O 0 2.1055808485659355e-10
( O 0 6.959385324967204e-13
14 O 0 1.1394104409978567e-10
% O 0 1.8830390371982197e-11
) O 0 2.6303636460785207e-13
of O 0 1.70391183801355e-11
44 O 0 2.153889844258572e-10
unrelated O 0 2.0664125965907942e-09
alleles O 0 7.482019864779588e-11
, O 0 7.764533460630219e-11
respectively O 0 1.628369972195287e-07
. O 0 9.943036047843634e-07

The O 0 1.1070554961634116e-07
relatively O 0 2.817936106680463e-08
high O 0 6.668070096083056e-09
residual O 0 2.255323465760739e-07
GALNS O 0 2.1090585505589843e-05
activity O 0 1.6188766993607828e-09
seen O 0 1.7574475208448348e-10
when O 0 8.538783395628524e-12
the O 0 4.109673365504385e-11
T312S O 0 1.2784971303858583e-08
mutant O 0 2.4931434694508425e-10
cDNA O 0 1.2318778885855863e-08
is O 0 2.501730766990562e-11
overexpressed O 0 1.3940991472338737e-08
in O 0 2.1638701247495007e-11
mutant O 0 5.352487897347658e-10
cells O 0 3.1804392452983166e-10
provides O 0 1.1043111954392448e-12
an O 0 7.431744428838469e-14
explanation O 0 3.11027870125713e-11
for O 0 8.220679345583015e-12
the O 0 3.4659716763307813e-10
mild O 0 8.219338543113963e-10
phenotype O 0 5.647706191602708e-10
in O 0 1.0002843171819098e-11
patients O 0 3.1808014555601005e-11
with O 0 6.048714046996695e-13
this O 0 3.4931470910271045e-11
mutation O 0 2.026297796220433e-09
. O 0 2.036869517496598e-08

The O 0 2.486628902786947e-09
distribution O 0 1.9670505502222824e-10
and O 0 4.0843194169630503e-13
relative O 0 1.3117536223905546e-10
frequencies O 0 6.671934116297962e-10
of O 0 4.953771767790549e-11
the O 0 2.8930235984603314e-10
I113F O 0 3.120656231203611e-07
and O 0 1.7822621156682317e-10
T312S O 0 8.037899306145846e-07
mutations O 0 3.770243284240138e-10
in O 0 4.5213308791369755e-11
Australia O 0 9.88774478960508e-11
corresponded O 0 2.520401110039927e-10
to O 0 8.570050225031878e-11
those O 0 7.987418365607013e-11
observed O 0 1.4864653952173512e-10
in O 0 3.085803487734573e-11
Northern O 0 1.671802429825675e-08
Ireland O 0 3.738909271078228e-08
and O 0 1.767616747416767e-10
are O 0 2.956148173471895e-11
unique O 0 2.5484769849981603e-10
to O 0 8.598916717561522e-11
these O 0 3.7337796049419225e-11
two O 0 3.7215435594317725e-11
populations O 0 5.438430955573281e-12
, O 0 6.51484617121556e-13
suggesting O 0 3.2312371528453454e-11
that O 0 5.199519742711545e-13
both O 0 2.1287303517136813e-11
mutations O 0 1.339341276773709e-10
were O 0 3.9702030552035694e-10
probably O 0 1.2972478646844365e-10
introduced O 0 2.1101670757972535e-11
to O 0 2.648004905625445e-11
Australia O 0 3.1459276156331484e-11
by O 0 1.340927802823133e-11
Irish O 0 9.582078241976433e-09
migrants O 0 2.0838990533178503e-09
during O 0 3.894929268000169e-09
the O 0 2.942418531048929e-10
19th O 0 8.153170583113933e-09
century O 0 1.212393119232047e-08
. O 0 4.052514057661938e-08

Haplotype O 0 2.7385098633203597e-07
analysis O 0 2.6941695541182753e-09
using O 0 4.887999449643132e-10
6 O 0 6.677031905155673e-08
RFLPs O 0 1.3771837075182702e-05
provides O 0 1.4279384966120467e-11
additional O 0 7.804529592037035e-12
data O 0 6.426596754760538e-11
that O 0 1.8097424058470535e-13
the O 0 4.492404365175062e-11
I113F O 0 2.387095037192921e-07
mutation O 0 2.4062088432863504e-10
originated O 0 4.096730732428e-10
from O 0 1.604716082237445e-10
a O 0 1.72827127609132e-10
common O 0 5.669857028323122e-09
ancestor O 0 8.128700983434101e-07
. O 0 1.0049252523458563e-06

The O 0 1.052536404699822e-07
other O 0 7.630597265162464e-10
9 O 0 1.8272131585561624e-09
novel O 0 1.6102615768565087e-11
mutations O 0 1.9665919934186427e-11
identified O 0 2.3368517190758276e-11
in O 0 1.4167578785487245e-12
these O 0 2.4254532843964727e-12
23 O 0 2.0680043788523506e-10
patients O 0 3.782774787852716e-11
were O 0 1.812428332415017e-11
each O 0 1.0947961287532948e-12
limited O 0 1.0192954986998348e-11
to O 0 2.189544205666305e-11
a O 0 2.1319658538576647e-10
single O 0 1.381815639689421e-08
family O 0 9.583247972955178e-09
. O 0 1.6391282997574308e-07

These O 0 6.694525822581454e-09
data O 0 6.987037615147074e-09
provide O 0 6.698248206093993e-11
further O 0 1.918604511375044e-11
evidence O 0 8.743997886861976e-11
for O 0 1.5298198471902502e-11
extensive O 0 5.7572768774605265e-09
allelic O 0 3.930312075794973e-08
heterogeneity O 0 3.5843211065866853e-08
in O 0 1.0167360287027805e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 5.462807983747098e-09
British O 0 5.331061174729257e-07
- O 0 3.860602191707585e-06
Irish O 0 8.272979812318226e-08
patients O 0 1.3934390308278921e-09
and O 0 1.9359726495526974e-12
provide O 0 1.8778993984835957e-11
evidence O 0 3.081868441001667e-11
for O 0 1.1770813273734304e-12
their O 0 5.551263615455326e-11
transmission O 0 2.2581998564419337e-06
to O 0 8.094884484943776e-11
Australia O 0 5.7507519579669264e-11
by O 0 1.062980953259185e-11
British O 0 5.701993543993922e-08
- O 0 2.7532729873769313e-08
Irish O 0 9.677163959054269e-09
migrants O 0 2.504855878271428e-09
. O 0 1.8907454768513077e-10
. O 0 2.8482871616830607e-09

Identification O 0 1.0835045713974978e-06
of O 0 1.0176171372222598e-07
constitutional O 0 1.3104154277243651e-06
WT1 O 1 0.9487193822860718
mutations O 0 2.1970693708794897e-08
, O 0 3.979569711959341e-12
in O 0 6.349384126108637e-12
patients O 0 8.512676119565299e-10
with O 0 8.932543593687114e-11
isolated O 0 4.067308054800378e-06
diffuse B-Disease 1 0.9997432827949524
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 3.843796114733067e-11
and O 0 3.270477855546461e-12
analysis O 0 3.23746279784487e-10
of O 0 1.0510589065759746e-09
genotype O 0 7.275104074722094e-09
/ O 0 9.792972655020549e-09
phenotype O 0 7.538257518202585e-11
correlations O 0 1.7686073092160193e-11
by O 0 5.823385935792291e-13
use O 0 2.625013574564239e-11
of O 0 3.6743597053856547e-10
a O 0 2.4548887922470897e-10
computerized O 0 6.476689407008962e-08
mutation O 0 2.0215495943887163e-09
database O 0 1.5712471324036414e-08
. O 0 5.140015346682958e-08

Constitutional O 0 2.831162930760911e-07
mutations O 0 5.5402367138412956e-09
of O 0 2.7630040477788498e-09
the O 0 3.876992948903535e-09
WT1 O 0 5.31259274794138e-07
gene O 0 2.582739751233465e-11
, O 0 7.514849745086927e-13
encoding O 0 3.8818001590890105e-10
a O 0 1.1049702264287475e-09
zinc O 0 3.824042948963324e-08
- O 0 7.516014477459976e-08
finger O 0 2.196562398637525e-08
transcription O 0 1.0131720351580498e-08
factor O 0 2.4397367459627617e-10
involved O 0 1.2686318662247231e-09
in O 0 2.989497760452764e-09
renal O 1 1.0
and O 0 2.391319355865562e-07
gonadal O 1 1.0
development O 0 0.030677683651447296
, O 0 1.7887351322354306e-11
are O 0 8.746340782704587e-13
found O 0 4.749005876047985e-12
in O 0 8.809779078119973e-13
most O 0 6.194966956953041e-13
patients O 0 1.144067913322333e-11
with O 0 1.2089366834000526e-11
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.530351891522514e-08
DDS B-Disease 1 1.0
) O 0 2.1367543290296e-09
, O 0 6.067566588052742e-11
or O 0 6.477341329969022e-09
diffuse B-Disease 1 0.9999880790710449
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 8.442005317021994e-09
DMS B-Disease 0 7.037971954559907e-06
) O 0 5.57898345576735e-13
associated O 0 9.76330821744753e-11
with O 0 3.0189642452604915e-11
pseudohermaphroditism B-Disease 1 1.0
and O 0 1.5084792082120657e-08
/ O 0 0.012386240996420383
or O 0 3.530528758233231e-08
Wilms B-Disease 1 0.9997790455818176
tumor I-Disease 0 4.065582834300585e-05
( O 0 5.2011368545379355e-09
WT B-Disease 1 1.0
) O 0 7.38304528624667e-10
. O 0 1.8969204873542367e-08

Most O 0 6.983467137899879e-09
mutations O 0 3.3108462638153924e-09
in O 0 1.169284780111468e-09
DDS B-Disease 1 1.0
patients O 0 0.00015500705922022462
lie O 0 2.407995634712279e-05
in O 0 4.5201882237222435e-09
exon O 0 4.165289002600048e-09
8 O 0 1.3488684613705004e-09
or O 0 4.886498428113839e-10
exon O 0 2.284388900264389e-09
9 O 0 3.311065588373907e-10
, O 0 1.5631978350638676e-11
encoding O 0 5.206628728160467e-08
zinc O 0 2.127812734897816e-07
finger O 0 2.0075938664376736e-05
2 O 0 3.06275786954302e-08
or O 0 1.766436241723568e-07
zinc O 0 1.2738877330775722e-06
finger O 0 8.345704372914042e-06
3 O 0 9.667510125765943e-10
, O 0 3.7413848061329524e-12
respectively O 0 4.893633831493105e-10
, O 0 4.862290583183826e-13
with O 0 2.504803005634604e-13
a O 0 7.323616019183632e-11
hot O 0 2.613018779129561e-08
spot O 0 2.7280353975811522e-08
( O 0 4.4204539334513626e-11
R394W O 0 1.9761536407258973e-07
) O 0 1.6226867072255402e-11
in O 0 3.6874603370762316e-10
exon O 0 2.773565555003188e-08
9 O 0 4.124537156258157e-08
. O 0 8.015128827310036e-08

We O 0 2.0734054473336982e-08
analyzed O 0 4.579275625360424e-09
a O 0 1.1040106329129884e-11
series O 0 1.0372150187343276e-11
of O 0 3.0039155191063927e-11
24 O 0 4.260917174647716e-10
patients O 0 3.2255472598441415e-11
, O 0 2.808747700568104e-13
10 O 0 1.4409260243319899e-11
with O 0 1.4691159747060034e-11
isolated B-Disease 0 8.957308637036476e-07
DMS I-Disease 1 0.9823775291442871
( O 0 4.865343239401909e-09
IDMS B-Disease 1 0.9998089671134949
) O 0 5.1067532147452965e-11
, O 0 2.9091895992899852e-12
10 O 0 3.4739121301807785e-11
with O 0 1.5036997688677722e-11
DDS B-Disease 1 1.0
, O 0 4.6358486494035844e-11
and O 0 5.95303277159398e-12
4 O 0 1.3566081591420698e-10
with O 0 2.5025372399345436e-11
urogenital B-Disease 0 0.00014998506230767816
abnormalities I-Disease 1 0.9999288320541382
and O 0 4.5750439880976046e-07
/ O 1 0.9999933242797852
or O 0 0.0074962349608540535
WT B-Disease 1 1.0
. O 0 1.0274109172314638e-06

We O 0 1.2599770116139553e-07
report O 0 1.1222517137809973e-08
WT1 O 0 4.3000718505936675e-06
heterozygous O 0 1.6708230354822717e-09
mutations O 0 1.4576589935089146e-10
in O 0 1.5444910975159765e-11
16 O 0 2.0100305864190204e-09
patients O 0 8.862645617391252e-10
, O 0 5.369701645135949e-12
4 O 0 3.350990041006696e-10
of O 0 3.439268314586741e-10
whom O 0 2.624220396540977e-09
presented O 0 3.832133543824057e-08
with O 0 1.5417677801110585e-08
IDMS B-Disease 1 0.999984622001648
. O 0 3.1159474929154385e-06

One O 0 1.2631298673682068e-08
male O 0 2.1520925042040062e-09
and O 0 1.9587156549483176e-11
two O 0 2.6037771938547394e-10
female O 0 7.12575740635657e-07
IDMS B-Disease 1 1.0
patients O 0 9.101440667791394e-08
with O 0 2.9910034449187606e-09
WT1 O 1 0.9999929666519165
mutations O 0 3.4070319543388905e-07
underwent O 0 4.184005319984863e-06
normal O 0 1.945004078152124e-05
puberty O 0 2.908360693254508e-05
. O 0 5.142290149251494e-08

Two O 0 1.56150150587564e-08
mutations O 0 4.5417327676489094e-09
associated O 0 4.853609070210041e-09
with O 0 2.980074242930897e-10
IDMS B-Disease 1 0.9999997615814209
are O 0 1.6501907479371525e-11
different O 0 9.17154720225799e-12
from O 0 1.1235093584638367e-11
those O 0 4.137482023658379e-12
described O 0 5.602459468567744e-11
in O 0 1.8354180397750497e-09
DDS B-Disease 1 1.0
patients O 0 4.481833286718029e-07
. O 0 7.030352833226061e-08

No O 0 7.681757665523037e-07
WT1 O 0 7.298158743651584e-05
mutations O 0 5.577824424563005e-09
were O 0 4.1877190604111547e-10
detected O 0 6.842097999282259e-10
in O 0 2.1925519125970405e-12
the O 0 4.1775694015200315e-11
six O 0 1.3180341262852835e-09
other O 0 1.0622949186966935e-09
IDMS B-Disease 1 0.9999867677688599
patients O 0 3.396196035510002e-08
, O 0 8.991465211272143e-11
suggesting O 0 4.246445417521727e-09
genetic O 0 8.350657942912676e-09
heterogeneity O 0 3.176095830781378e-08
of O 0 1.6295560456569547e-08
this O 0 2.388651942908382e-08
disease O 0 0.00789425428956747
. O 0 3.08635890178266e-07

We O 0 3.0915401794118225e-08
analyzed O 0 1.3735520099089626e-07
genotype O 0 9.74575797840771e-08
/ O 0 5.621960852408847e-08
phenotype O 0 2.156740119829692e-09
correlations O 0 2.7887245845903408e-09
, O 0 2.4416523490555786e-12
on O 0 2.6916961715084398e-11
the O 0 8.50878829200541e-12
basis O 0 5.588086660068825e-10
of O 0 5.130320820945222e-11
the O 0 1.3840635235129461e-11
constitution O 0 5.847664366620542e-12
of O 0 9.485185553659292e-11
a O 0 2.5344584764219746e-10
WT1 O 0 1.189915224131255e-06
mutation O 0 2.0047304094550356e-10
database O 0 3.2690841700322437e-10
of O 0 5.952187631663719e-10
84 O 0 1.0245777559703129e-07
germ O 1 0.9976291060447693
- O 0 0.0007680949638597667
line O 0 1.7266543750338315e-07
mutations O 0 8.465284029313125e-10
, O 0 1.1495905139283225e-12
to O 0 1.1504948903284795e-11
compare O 0 8.623525227235973e-10
the O 0 1.5553698953785222e-11
distribution O 0 4.36475612597409e-11
and O 0 5.849736385392379e-13
type O 0 1.9875288914672495e-10
of O 0 4.1915548809612346e-10
mutations O 0 2.446576274905965e-11
, O 0 3.298648789014369e-13
according O 0 1.7954927475360982e-11
to O 0 8.376136589882677e-12
the O 0 5.355201004864085e-11
different O 0 3.2057398957618943e-09
symptoms O 0 5.872080350854958e-07
. O 0 1.4077424559388874e-08

This O 0 4.4349675043520165e-09
demonstrated O 0 7.677628133251346e-08
( O 0 1.960334151951404e-11
1 O 0 2.039752255988958e-10
) O 0 1.3642614598782798e-12
the O 0 1.3326489217702076e-11
association O 0 7.657402489869014e-12
between O 0 1.4735282438671504e-10
mutations O 0 1.0572687690613147e-11
in O 0 3.119618452451789e-11
exons O 0 6.263662921668356e-10
8 O 0 1.028872959052407e-10
and O 0 1.4353795062260755e-11
9 O 0 1.7034846866437192e-09
and O 0 7.541798852095383e-10
DMS B-Disease 0 0.001294791465625167
; O 0 7.865234852300063e-11
( O 0 9.08884686262601e-12
2 O 0 5.245055431646328e-11
) O 0 9.2660536361866e-13
among O 0 7.817188736602976e-13
patients O 0 1.9640242557295018e-11
with O 0 9.013027303661492e-12
DMS B-Disease 0 1.754617642291123e-06
, O 0 3.0886123519868747e-11
a O 0 1.860107380624587e-11
higher O 0 1.3070988735819355e-09
frequency O 0 7.166796489599392e-09
of O 0 3.927635106037997e-09
exon O 0 6.299861965430864e-09
8 O 0 6.141481767585333e-10
mutations O 0 7.732610385335903e-11
among O 0 6.7953490057170995e-12
46 O 0 1.6879986297624328e-09
, O 0 7.773261201382553e-11
XY O 0 0.0006705952109768987
patients O 0 2.9484030772408687e-09
with O 0 7.868172259561934e-12
female O 0 3.0549736074192424e-09
phenotype O 0 2.6619878523703733e-10
than O 0 2.6667520188622396e-12
among O 0 5.566720261834801e-12
46 O 0 1.379597547312983e-09
, O 0 5.028846436494483e-11
XY O 1 0.9986189603805542
patients O 0 1.1261929167005746e-08
with O 0 6.457470842768931e-12
sexual O 0 8.226647696396583e-10
ambiguity O 0 4.881647530652344e-09
or O 0 4.307231515898735e-10
male O 0 1.2825907447222562e-08
phenotype O 0 3.2574405395280337e-09
; O 0 3.8995414536335815e-11
and O 0 5.054449747632361e-09
( O 0 8.984607502426911e-11
3 O 0 1.2324271603247894e-09
) O 0 2.9123819241666515e-12
statistically O 0 2.3248824740362828e-12
significant O 0 4.4057360299061543e-13
evidence O 0 4.639420358304447e-12
that O 0 1.9089948805756096e-13
mutations O 0 7.254724165156601e-12
in O 0 3.318644664629389e-11
exons O 0 4.666895758731471e-09
8 O 0 4.936118180864923e-10
and O 0 1.6528525076386913e-11
9 O 0 4.0046399529813925e-10
preferentially O 0 5.766153665653917e-10
affect O 0 3.9341574442630645e-09
amino O 0 5.843611705635965e-10
acids O 0 5.9135938333676474e-12
with O 0 6.627860695170018e-13
different O 0 2.5956093177570416e-11
functions O 0 5.931832247618729e-10
. O 0 3.6635547373542465e-10
. O 0 8.314596122716011e-09

The O 0 1.181402566885481e-07
185delAG O 0 1.570719064147852e-06
BRCA1 O 0 2.482265948344775e-08
mutation O 0 2.6210911913127077e-11
originated O 0 1.9767985859342474e-11
before O 0 2.5545104226365467e-11
the O 0 1.5894964164320236e-11
dispersion O 0 1.096354562690749e-09
of O 0 6.125092100184304e-10
Jews O 0 1.355556111803935e-09
in O 0 4.467837211308279e-11
the O 0 1.0088688218168329e-10
diaspora O 0 1.2927481307656308e-09
and O 0 2.0983832726972906e-11
is O 0 1.8673652034395527e-12
not O 0 1.1054624229900334e-11
limited O 0 6.234793792359028e-10
to O 0 1.9019346098048118e-08
Ashkenazim O 0 0.0008388337446376681
. O 0 2.477187308613793e-06

The O 0 4.0163630643519355e-08
185delAG O 0 4.032498566175491e-07
mutation O 0 3.0233682224434233e-10
in O 0 1.993409742828689e-10
BRCA1 O 0 5.4659454740146884e-09
is O 0 5.724113457533653e-12
detected O 0 5.628628674259062e-10
in O 0 4.1110847365244396e-11
Ashkenazi O 0 6.131666907549516e-08
Jews O 0 1.198167121074789e-09
both O 0 5.560737981191721e-11
in O 0 2.6875165981543603e-10
familial B-Disease 0 0.0002679190074559301
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.00011744588118745014
in O 0 8.315194643948587e-10
the O 0 8.69270155856583e-10
general O 0 5.1991605465318e-10
population O 0 1.4476531084994804e-11
. O 0 5.202999697750954e-10

All O 0 7.603071061623723e-09
tested O 0 2.7796915880173856e-09
Ashkenazi O 0 1.174777874979327e-08
mutation O 0 1.1072772039544265e-11
carriers O 0 1.1611775993861095e-12
share O 0 1.1185167375638017e-11
the O 0 1.1848574205108875e-11
same O 0 1.033268262617959e-10
allelic O 0 1.8627622111466735e-08
pattern O 0 2.004208710104649e-08
at O 0 1.5514197926336237e-08
the O 0 2.214537708766784e-08
BRCA1 O 0 8.836946108203847e-08
locus O 0 6.1939160467261445e-09
. O 0 5.937068081607322e-08

Our O 0 3.6253550206311047e-07
previous O 0 1.9549339924651576e-08
study O 0 1.5973412870184944e-10
showed O 0 6.929034429559167e-11
that O 0 4.915307798367824e-14
this O 0 1.4166524940975589e-12
Ashkenazi O 0 5.4710273644786866e-08
mutation O 0 1.784017100714408e-10
also O 0 8.535115973359875e-13
occurs O 0 2.0359885652410092e-11
in O 0 9.93663051146454e-12
Iraqi O 0 6.037518232915318e-06
Jews O 0 9.490189967209517e-09
with O 0 1.2774300714446518e-11
a O 0 3.252427147049097e-11
similar O 0 1.3807209542360255e-10
allelic O 0 1.2762268397636944e-07
pattern O 0 2.1577969278041564e-07
. O 0 2.9570392712230387e-07

We O 0 2.6855978774165123e-08
extended O 0 5.9195497392749985e-09
our O 0 2.0739818751280836e-09
analysis O 0 1.0387419396851172e-10
to O 0 1.3727453201939355e-11
other O 0 1.492108867018338e-11
non O 0 5.6553865590558416e-08
- O 0 1.3767907702799675e-08
Ashkenazi O 0 5.943390135598747e-08
subsets O 0 2.953164601748881e-09
354 O 0 3.6321563534613688e-09
of O 0 5.526819557566398e-10
Moroccan O 0 1.4869907261072512e-07
origin O 0 1.0787726267835751e-09
, O 0 1.659501876194458e-11
200 O 0 4.379335227788772e-10
Yemenites O 0 5.924188712924661e-07
and O 0 1.5712297782299878e-11
150 O 0 3.3126132392702345e-10
Iranian O 0 2.210392295864949e-07
Jews O 0 3.1229663477461145e-07
. O 0 3.0879459700372536e-07

Heteroduplex O 0 9.097862857743166e-06
analysis O 0 2.2886588180170975e-09
complemented O 0 4.2457468096834816e-10
by O 0 7.040318848738902e-13
direct O 0 1.2841651353401318e-11
DNA O 0 1.2209647737293494e-09
sequencing O 0 7.98773136523323e-09
of O 0 2.2495219020868262e-09
abnormally O 0 6.559293108665543e-10
migrating O 0 5.366090211067487e-11
bands O 0 4.929212593651755e-10
were O 0 1.5043208900777927e-09
employed O 0 2.182341489742612e-07
. O 0 9.033076509012972e-08

Four O 0 1.2700100526785718e-08
of O 0 1.630277424169435e-08
Moroccan O 0 0.00670316768810153
origin O 0 5.682288062303087e-08
( O 0 7.994089765150925e-12
1 O 0 6.343878894421451e-11
. O 0 1.3220959700285806e-12
1 O 0 4.588781611636339e-12
% O 0 3.613886967457347e-12
) O 0 1.711968613475178e-14
and O 0 3.6741017671836074e-13
none O 0 2.852722225110682e-10
of O 0 1.1691883572417794e-10
the O 0 3.749532351271512e-10
Yemenites O 0 2.3335160221904516e-06
or O 0 5.236308955880453e-11
Iranians O 0 1.5912185347133345e-08
was O 0 9.399011430266668e-11
a O 0 3.5386047390895126e-12
carrier O 0 3.441550169847041e-11
of O 0 1.3024245570925075e-10
the O 0 1.877886957046826e-09
185delAG O 0 1.998646439460572e-06
mutation O 0 3.2815442807532236e-08
. O 0 4.5295717399085333e-08

BRCA1 O 0 6.23942696620361e-07
allelic O 0 7.708765537017825e-08
patterns O 0 2.9762243780595554e-09
were O 0 1.371934649219142e-10
determined O 0 9.26118556843214e-11
for O 0 3.0188707436651363e-12
four O 0 1.0664597677179088e-11
of O 0 3.292854704184389e-12
these O 0 1.4428413433638376e-13
individuals O 0 2.333273006228931e-13
and O 0 4.4595064945494867e-13
for O 0 2.078838186661547e-12
12 O 0 8.134274503968086e-11
additional O 0 8.772412657398476e-11
non O 0 1.5080418691582054e-08
- O 0 5.693513660531835e-09
Ashkenazi O 0 3.90791647930655e-08
185delAG O 0 2.281368338685752e-08
mutation O 0 4.352385812866899e-11
carriers O 0 1.2164192396413309e-11
who O 0 1.327600945844054e-10
had O 0 6.366327852447284e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999982118606567

Six O 0 1.7656515183261945e-07
non O 0 2.022661192313535e-06
- O 0 1.556782791567457e-07
Ashkenazi O 0 2.5629753963585244e-07
individuals O 0 5.960977544905433e-11
shared O 0 1.4932008962631471e-09
the O 0 1.901142021587532e-10
common O 0 1.2398983229022775e-10
Ashkenazi O 0 1.7007769770316372e-07
haplotype O 0 7.60983187575448e-09
, O 0 3.046823557339984e-11
four O 0 9.808034384661823e-10
had O 0 7.445210004064506e-10
a O 0 3.137550289022961e-11
closely O 0 9.474373369178224e-11
related O 0 1.684911232757713e-08
pattern O 0 0.0005773139419034123
, O 0 5.7976359824074564e-11
and O 0 2.0331374084303633e-10
the O 0 5.516984401765512e-06
rest O 1 0.9978566765785217
( O 0 2.880135019367458e-10
n O 0 1.707270769202296e-09
= O 0 3.3263902743385643e-10
6 O 0 3.579849472412633e-10
) O 0 6.619522638362518e-13
displayed O 0 1.0791673110688293e-10
a O 0 6.955225978488855e-11
distinct O 0 1.2219083522779783e-09
BRCA1 O 0 1.226352264183106e-08
allelic O 0 8.514129490322375e-08
pattern O 0 2.0882974638425367e-07
. O 0 3.745894332496391e-07

We O 0 2.4612299753812295e-08
conclude O 0 1.2471436150462978e-07
that O 0 2.4492657901831194e-11
the O 0 5.244638057178008e-10
185delAG O 0 8.832360549604346e-07
BRCA1 O 0 7.713030925060593e-08
mutation O 0 2.727486292375403e-10
occurs O 0 6.408248237610437e-11
in O 0 1.932649353053595e-11
some O 0 9.992875277253788e-11
non O 0 6.1059495237714145e-06
- O 0 3.061255483771674e-05
Ashkenazi O 0 0.000199097121367231
populations O 0 6.155284615338985e-10
at O 0 3.369544643305744e-10
rates O 0 5.53578433093449e-11
comparable O 0 1.0495659202858221e-10
with O 0 5.8663170892162e-13
that O 0 5.2788754270616245e-12
of O 0 1.5197885616657913e-08
Ashkenazim O 0 6.502655014628544e-05
. O 0 1.1431455959609593e-06

The O 0 5.810405490080939e-09
majority O 0 1.6944975977928323e-10
of O 0 1.6273740688355076e-10
Jewish O 0 2.4897277572932808e-09
185delAG O 0 2.5296392891505093e-07
mutation O 0 1.0087265051028638e-10
carriers O 0 4.818973345366295e-12
have O 0 1.6695334351113367e-12
a O 0 1.1945377846600547e-11
common O 0 9.491266106387286e-11
allelic O 0 2.7618620279667994e-08
pattern O 0 2.744684479694115e-08
, O 0 3.999386238850988e-11
supporting O 0 8.101485038380929e-10
the O 0 6.1940226281365085e-09
founder O 0 3.6038446893371656e-08
effect O 0 4.598686986767575e-10
notion O 0 4.3966849605503455e-10
, O 0 8.564322211482289e-13
but O 0 3.6365856615101777e-13
dating O 0 2.8664012829970886e-10
the O 0 3.2986443437854618e-12
mutations O 0 1.597632182798181e-12
origin O 0 5.597297798864975e-12
to O 0 4.348923565017371e-12
an O 0 6.024028931933545e-13
earlier O 0 2.6714128131821724e-10
date O 0 1.2671984350731691e-08
than O 0 2.1719414461385256e-11
currently O 0 1.4369636036626332e-10
estimated O 0 3.2425260254598243e-09
. O 0 4.543754528185673e-08

However O 0 2.1196942867618418e-08
, O 0 4.5889059913095664e-11
the O 0 2.3588799316631714e-11
different O 0 2.6852247855813083e-11
allelic O 0 7.3304713410493605e-09
pattern O 0 6.562838272827776e-09
at O 0 2.5412267845581482e-09
the O 0 1.7687575848412962e-09
BRCA1 O 0 1.0738626876616308e-08
locus O 0 1.6234738553499994e-10
even O 0 1.3712642132901465e-11
in O 0 1.0772417680104951e-11
some O 0 3.29315611238834e-12
Jewish O 0 1.2251966108323131e-09
mutation O 0 5.113266476897138e-10
carriers O 0 3.629292699702802e-11
, O 0 5.2466059274891563e-11
might O 0 2.929890774439059e-10
suggest O 0 2.9259830114369834e-09
that O 0 4.486074706155918e-12
the O 0 2.823420941489019e-10
mutation O 0 3.1650682075223813e-10
arose O 0 2.8777971117222023e-09
independently O 0 1.1023310264590691e-08
. O 0 2.4399380293971262e-09
. O 0 7.593305895170488e-08

Crystal O 0 1.4611867982239346e-06
structure O 0 8.156752784316268e-08
of O 0 8.931363737474385e-08
the O 0 1.1817039649031358e-06
hemochromatosis B-Disease 1 1.0
protein O 0 2.129683807083893e-08
HFE O 0 2.464282033542986e-06
and O 0 9.440887308032053e-12
characterization O 0 3.3983243996615897e-10
of O 0 2.5383478652329927e-10
its O 0 6.987213758968824e-12
interaction O 0 6.612062564137489e-10
with O 0 6.972386557002608e-11
transferrin O 0 1.4822208527220937e-07
receptor O 0 2.2186206205532244e-09
. O 0 2.319324465815953e-08

HFE O 0 0.0017946313600987196
is O 0 9.235471831736675e-10
an O 0 1.4696660555202357e-10
MHC O 0 2.8249537535884883e-06
- O 0 1.895652985695051e-06
related O 0 2.3802032956155017e-05
protein O 0 3.3330098681005893e-09
that O 0 3.6267771555062445e-13
is O 0 2.3613159293015863e-14
mutated O 0 7.009127436438667e-13
in O 0 4.880110530090798e-13
the O 0 1.514191882989735e-09
iron B-Disease 1 0.9999651908874512
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.002209837082773447

HFE O 0 1.9499255358823575e-05
binds O 0 1.9297965447861998e-09
to O 0 1.0075040801638124e-09
transferrin O 0 9.903363462626658e-09
receptor O 0 1.3372677964973434e-11
( O 0 4.509099257171689e-12
TfR O 0 4.1099774250596965e-08
) O 0 6.09402773469464e-13
and O 0 7.361913270838294e-13
reduces O 0 3.68918697674081e-12
its O 0 4.801950937577404e-13
affinity O 0 7.60889181522506e-12
for O 0 2.6567062785809448e-11
iron O 0 3.164178252745842e-08
- O 0 5.100411648584213e-09
loaded O 0 1.4593287689379508e-09
transferrin O 0 1.8235200016647468e-08
, O 0 1.53050946916089e-10
implicating O 0 2.4759024199738633e-06
HFE O 0 0.0003218382189515978
in O 0 1.2176519703643862e-07
iron O 0 0.00012244902609381825
metabolism O 0 0.0004936774494126439
. O 0 4.830195621252642e-07

The O 0 1.6739073771532276e-06
2 O 0 2.040497292910004e-06
. O 0 3.775219852286682e-07

6 O 0 9.178930326925183e-07
A O 0 1.034713932313025e-06
crystal O 0 3.7335721003728395e-07
structure O 0 2.7510770905792015e-07
of O 0 5.608224569186859e-07
HFE O 1 0.9987348914146423
reveals O 0 1.7294139453838397e-08
the O 0 7.845158550567888e-11
locations O 0 6.203844660213065e-10
of O 0 7.804406898515026e-09
hemochromatosis B-Disease 1 1.0
mutations O 0 1.5093686300815534e-08
and O 0 1.8507619048424573e-10
a O 0 2.8974926902236575e-09
patch O 1 0.9647213220596313
of O 0 0.0009366361773572862
histidines O 1 0.9863173365592957
that O 0 3.121284827822812e-11
could O 0 1.7585127798369626e-11
be O 0 1.3559969119780746e-11
involved O 0 2.2872403970808364e-09
in O 0 2.329192483330189e-08
pH O 0 0.000487913639517501
- O 0 8.336846235579287e-07
dependent O 0 7.396822638838785e-07
interactions O 0 9.226817354601735e-08
. O 0 1.1710054081959242e-07

We O 0 3.5470790749059233e-08
also O 0 7.471894630795006e-11
demonstrate O 0 6.861600176932825e-09
that O 0 3.0911478932083014e-10
soluble O 0 2.1427302598908682e-08
TfR O 0 9.073153961480784e-08
and O 0 1.4633110001494032e-10
HFE O 0 3.0945720936870202e-06
bind O 0 5.940281599947639e-09
tightly O 0 4.277517007267306e-08
at O 0 2.7896822629713824e-09
the O 0 4.822306443053037e-10
basic O 0 2.6760852733787033e-07
pH O 0 2.4841224188776323e-08
of O 0 4.052541080490357e-10
the O 0 1.5721929313983196e-10
cell O 0 1.7787853412443155e-09
surface O 0 3.5465952397117917e-10
, O 0 1.963053200895737e-12
but O 0 2.2160120960457164e-12
not O 0 1.6793134591241987e-11
at O 0 7.862827722249222e-09
the O 0 9.234863540541483e-08
acidic O 0 6.814701919211075e-06
pH O 0 3.7268382584443316e-06
of O 0 1.0329963515687268e-06
intracellular O 0 8.371363946935162e-06
vesicles O 0 8.973110197985079e-06
. O 0 9.414199553248181e-07

TfR O 0 0.0003776539524551481
HFE O 0 0.0008335543097928166
stoichiometry O 0 5.343574684957275e-06
( O 0 7.74028729999543e-10
2 O 0 1.3082860350621672e-09
1 O 0 1.8506877974555636e-10
) O 0 6.643441222489721e-13
differs O 0 2.7180436720786183e-11
from O 0 2.3682973984695543e-11
TfR O 0 2.1030743369010452e-08
transferrin O 0 4.73629446773316e-09
stoichiometry O 0 2.1160911245488023e-08
( O 0 1.8649600960762847e-11
2 O 0 1.2113400560398446e-10
2 O 0 4.2755857881937587e-11
) O 0 6.103403372981209e-13
, O 0 2.478351725232475e-13
implying O 0 2.765273600380258e-11
a O 0 6.32964655081919e-13
different O 0 8.753166377481469e-13
mode O 0 4.93713514515548e-10
of O 0 2.4019203292979796e-11
binding O 0 2.2196891893977444e-11
for O 0 2.674512833422682e-10
HFE O 0 2.5494735382380895e-05
and O 0 9.461988970116408e-10
transferrin O 0 4.586393131944533e-08
to O 0 1.5663152996836516e-09
TfR O 0 7.281909120138153e-07
, O 0 5.930808361781503e-12
consistent O 0 1.7579000755052476e-10
with O 0 1.1766368044827114e-12
our O 0 3.7288497289900135e-10
demonstration O 0 4.947693366119665e-10
that O 0 5.091461974249256e-12
HFE O 0 6.334009867714485e-07
, O 0 1.502034260858487e-11
transferrin O 0 4.561596878005503e-09
, O 0 2.8047248551432702e-11
and O 0 4.879985651684571e-11
TfR O 0 6.379610795193003e-07
form O 0 2.1396652505334401e-10
a O 0 7.473351937292705e-10
ternary O 0 1.4304821434052428e-06
complex O 0 9.527225302008446e-07
. O 0 5.918943202232185e-07

Identification O 0 6.755377057743317e-07
of O 0 7.41053174380113e-09
three O 0 6.908264238436601e-11
novel O 0 3.699214112112825e-12
mutations O 0 2.2413384082736743e-12
and O 0 3.5606131758292303e-13
a O 0 1.6726762119487204e-12
high O 0 1.5749953424792906e-11
frequency O 0 6.109585615199364e-10
of O 0 2.9322821948341016e-11
the O 0 1.3281428734579492e-10
Arg778Leu O 0 6.493833666354476e-07
mutation O 0 6.785819822718864e-11
in O 0 8.237662288412828e-12
Korean O 0 4.4524803399781376e-08
patients O 0 2.6714042089537315e-09
with O 0 1.9859108801867364e-10
Wilson B-Disease 0 8.520297342329286e-06
disease I-Disease 0 3.977505912189372e-06
. O 0 6.511744032877687e-08

Four O 0 9.259397160121807e-08
mutations O 0 1.4351190458228302e-08
- O 0 1.264556317437382e-07
- O 0 1.4263869729802536e-07
R778L O 0 3.160615278829937e-06
, O 0 7.503628274285745e-11
A874V O 0 2.0448869975098205e-07
, O 0 1.1237965419352847e-11
L1083F O 0 1.4192192310247265e-08
, O 0 7.416426956070865e-13
and O 0 7.291537165721174e-13
2304delC O 0 6.675259900390529e-09
- O 0 1.8567347659370625e-09
- O 0 7.689814340849921e-10
in O 0 1.903747298692693e-10
the O 0 6.9471983721314245e-09
copper O 0 3.686507810130024e-08
- O 0 2.625655803889515e-10
transporting O 0 4.616245163902022e-10
enzyme O 0 2.5820647703289623e-11
, O 0 4.166635786395645e-11
P O 0 1.9303006411064416e-05
- O 0 1.5503496797464322e-07
type O 0 3.7079594505939895e-08
ATPase O 0 5.937293281021994e-06
( O 0 2.6943736131102014e-10
ATP7B O 1 0.9999936819076538
) O 0 5.801902795005143e-12
, O 0 5.175980087243626e-13
were O 0 3.1084147842502796e-12
identified O 0 1.8248952696198195e-11
in O 0 1.947791537434962e-12
Korean O 0 2.060895099020854e-08
Patients O 0 1.4387861568820881e-08
with O 0 2.2794001408588116e-10
Wilson B-Disease 0 3.6473284126259387e-05
disease I-Disease 0 0.0016982397064566612
. O 0 3.981734550961846e-07

Arg778Leu O 1 0.7011905312538147
, O 0 7.720942218902849e-10
the O 0 3.139760673676051e-10
most O 0 3.698345883013099e-12
frequently O 0 5.3984763707937145e-12
reported O 0 1.2802301753433998e-11
mutation O 0 1.8571649426646353e-11
of O 0 8.166361337158534e-11
this O 0 9.59204764228172e-12
enzyme O 0 1.387248302342492e-11
, O 0 9.60262858812344e-12
was O 0 7.444187488658827e-10
found O 0 1.7493298476445318e-11
in O 0 1.713989518890846e-12
six O 0 2.1448615453167896e-11
of O 0 1.885364260545419e-11
eight O 0 8.957520836183619e-11
unrelated O 0 7.839597859771175e-10
patients O 0 3.7344419223650505e-11
studied O 0 1.2292689088866382e-10
, O 0 3.0430687266921885e-13
an O 0 1.02533724512157e-13
allele O 0 5.652649875953486e-11
frequency O 0 6.701270649500657e-09
of O 0 1.2163584806046401e-08
37 O 0 9.095433597394731e-07
. O 0 3.6213884868629975e-07

5 O 0 7.306326210709813e-08
% O 0 2.0202167050342723e-08
, O 0 3.2496351529825995e-12
which O 0 9.32562200747257e-14
is O 0 1.4948761358542922e-13
considerably O 0 3.7027117483212635e-10
higher O 0 7.046805361454744e-10
than O 0 5.303965600056415e-12
those O 0 7.160363447999973e-12
in O 0 3.0232746861535986e-11
other O 0 1.4295252481755227e-10
Asian O 0 1.5484518556263538e-08
populations O 0 2.3278712291130432e-10
. O 0 7.256824474666246e-09

The O 0 3.111569446545559e-09
novel O 0 3.468251380533971e-11
single O 0 9.157900132672481e-11
nucleotide O 0 1.1479073247500082e-09
deletion O 0 3.0496855041306503e-10
, O 0 6.399414418517546e-12
2304delC O 0 3.433962447729755e-08
, O 0 1.3197735439229863e-11
was O 0 5.467057917485363e-10
found O 0 5.737922290083297e-11
in O 0 2.1613705616929657e-11
one O 0 2.922423136819674e-10
patient O 0 4.773471573571442e-07
. O 0 4.7334074793070613e-07

Since O 0 6.401670304967411e-09
a O 0 7.797362061578994e-11
mutation O 0 9.66327885765228e-12
at O 0 7.898383336257808e-11
cDNA O 0 5.652127210709068e-09
nucleotide O 0 1.119207659883159e-08
2302 O 0 3.994506414528587e-07
( O 0 5.813910984586723e-12
2302insC O 0 1.1131169763700655e-08
) O 0 6.321651101898196e-12
had O 0 8.824789510253339e-11
been O 0 6.304952393509922e-11
previously O 0 2.0204614370467056e-10
described O 0 9.141530588063773e-11
, O 0 1.3618384848632092e-12
this O 0 2.0777758853729456e-12
region O 0 9.037894321828333e-10
of O 0 2.5737234565781364e-09
the O 0 2.1367961622331677e-08
ATP7B O 1 1.0
gene O 0 3.248790791943179e-09
may O 0 2.118483721780251e-10
be O 0 4.3445172459577464e-10
susceptible O 0 3.035441764609459e-08
to O 0 3.6183962492941646e-09
gene O 0 1.956609594344627e-07
rearrangements O 1 0.5364097356796265
causing O 0 0.0067748986184597015
Wilson B-Disease 0 0.012920339591801167
disease I-Disease 0 0.002202856121584773
. O 0 1.4786319013637694e-07

Disruption O 0 6.257283985178219e-06
of O 0 4.6247102147845e-08
splicing O 0 3.049938968047172e-08
regulated O 0 4.4657608166964735e-10
by O 0 6.3385780998959085e-12
a O 0 6.156114507049892e-11
CUG O 0 3.157665560138412e-05
- O 0 4.150387589163529e-09
binding O 0 7.881908459239639e-10
protein O 0 3.358343603210301e-09
in O 0 7.943792290632246e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.0268673577229492e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.4345217752852477e-05
DM B-Disease 1 1.0
) O 0 6.367836813403471e-10
is O 0 1.1153743727232435e-11
caused O 0 7.746427804766753e-11
by O 0 1.0511039955085622e-11
a O 0 2.2890198070335543e-10
CTG O 0 9.169270924758166e-07
expansion O 0 2.5182209650864706e-09
in O 0 5.717470941135616e-11
the O 0 1.9844720311468222e-10
3 O 0 3.9589984623944474e-09
untranslated O 0 2.0459789084270597e-05
region O 0 5.157955396128955e-09
of O 0 1.5595927882472438e-09
the O 0 7.999749840337245e-08
DM B-Disease 1 1.0
gene O 0 7.711515337405217e-08
. O 0 1.1184783232920381e-07

One O 0 1.9792416594555107e-09
model O 0 8.691164232743631e-09
of O 0 5.210960694057576e-07
DM B-Disease 1 1.0
pathogenesis O 0 0.0009115764987654984
suggests O 0 1.0969924968406985e-09
that O 0 2.658894805718237e-12
RNAs O 0 1.5044063217395376e-10
from O 0 5.991847296105135e-11
the O 0 3.526565844902407e-11
expanded O 0 4.842821629824634e-11
allele O 0 3.135767340234352e-11
create O 0 5.835753321553616e-12
a O 0 8.8150944876908e-12
gain O 0 3.7990472989690716e-09
- O 0 1.6442950334649709e-09
of O 0 2.6150017706783046e-09
- O 0 1.7908569072133673e-09
function O 0 1.0586818921520802e-10
mutation O 0 1.0486884798044382e-12
by O 0 2.154268788096686e-13
the O 0 5.502463935880275e-12
inappropriate O 0 4.5483863203577e-11
binding O 0 4.1651022908428814e-11
of O 0 8.556187980346408e-10
proteins O 0 4.949559512246182e-11
to O 0 2.5203003573004423e-10
the O 0 1.242423142144844e-08
CUG O 1 0.9981796741485596
repeats O 0 2.407438159934827e-06
. O 0 1.7755854742063093e-07

Data O 0 2.1951682072085532e-07
presented O 0 5.32783106521606e-09
here O 0 3.5635012718415737e-09
indicate O 0 2.877818872093485e-09
that O 0 2.8776555791032443e-12
the O 0 3.383565094772223e-10
conserved O 0 5.097513522400732e-09
heterogeneous O 0 2.511161945051299e-08
nuclear O 0 1.847128316967428e-07
ribonucleoprotein O 0 1.2454783870907704e-07
, O 0 1.6968423888208406e-10
CUG O 0 9.218769992003217e-05
- O 0 1.153929307662338e-08
binding O 0 1.2897237722242494e-09
protein O 0 7.056691342377519e-10
( O 0 1.0075087465699628e-11
CUG O 1 0.9997146725654602
- O 0 1.2416563549777493e-05
BP O 0 1.3226001556176925e-06
) O 0 1.7341645480728474e-11
, O 0 1.1945239936084207e-11
may O 0 1.7113127581680487e-10
mediate O 0 1.6295413729494612e-07
the O 0 4.806480191632545e-08
trans O 0 5.489905774425097e-08
- O 0 1.7541513841479173e-07
dominant O 0 6.941770180901585e-08
effect O 0 1.984407776989272e-10
of O 0 4.99228436368071e-10
the O 0 2.4272244214529337e-09
RNA O 0 1.8105278343227837e-07
. O 0 4.409849907460739e-08

CUG O 1 0.9999560117721558
- O 0 0.09502755105495453
BP O 0 2.261381087009795e-05
was O 0 1.576043473505706e-08
found O 0 4.3384618814146236e-11
to O 0 8.266496862030515e-12
bind O 0 3.607966009289143e-11
to O 0 8.097541387419582e-11
the O 0 6.125337459472746e-10
human O 0 3.714450258485158e-08
cardiac O 1 0.9999998807907104
troponin O 0 0.0018422829452902079
T O 0 7.189073869540152e-08
( O 0 4.166092817947664e-12
cTNT O 0 5.777484712865544e-09
) O 0 3.8199220804731315e-13
pre O 0 1.5015145793384477e-09
- O 0 2.7756161258274403e-10
messenger O 0 1.6355204690565728e-10
RNA O 0 7.377315980328092e-10
and O 0 1.9171412721230574e-11
regulate O 0 2.8534010224068318e-11
its O 0 2.4768221328075324e-12
alternative O 0 2.7330753216148196e-09
splicing O 0 9.633098585482003e-08
. O 0 3.3467966176203845e-08

Splicing O 0 5.10305653733667e-07
of O 0 8.682056318320974e-08
cTNT O 0 6.609096453757957e-05
was O 0 1.2199254229017242e-07
disrupted O 0 2.606563384688343e-06
in O 0 8.306211718434042e-09
DM B-Disease 1 1.0
striated O 0 2.0646210032282397e-05
muscle O 0 1.2306993824040546e-07
and O 0 1.2381401459649055e-10
in O 0 1.808658223190207e-10
normal O 0 9.590565497319403e-08
cells O 0 1.407779226525463e-09
expressing O 0 6.235433003265456e-11
transcripts O 0 3.0918925197909175e-09
that O 0 2.6725518499637335e-12
contain O 0 1.344296063354733e-10
CUG O 0 1.5584908396704122e-05
repeats O 0 1.5999704316982388e-07
. O 0 1.0367323000082251e-07

Altered O 0 1.2070104560280015e-07
expression O 0 6.35064090204196e-09
of O 0 6.610804792472891e-09
genes O 0 2.482050398544544e-10
regulated O 0 2.629745587956478e-10
posttranscriptionally O 0 2.7512347955394034e-09
by O 0 1.1300648611323183e-10
CUG O 1 0.9999938011169434
- O 0 1.5907482520560734e-05
BP O 0 5.215957230575441e-07
therefore O 0 4.654057694786218e-10
may O 0 1.5479777182303422e-10
contribute O 0 7.403411217410394e-09
to O 0 1.379959400082953e-07
DM B-Disease 1 1.0
pathogenesis O 0 0.003489935304969549
. O 0 2.9480954566452056e-08
. O 0 6.544266284436162e-08

Identification O 0 3.052965951155784e-07
of O 0 7.524718625973037e-09
a O 0 2.2319426862260627e-10
novel O 0 5.1060714684192376e-11
nonsense O 0 1.5554139309870152e-08
mutation O 0 1.2199672695667463e-11
and O 0 1.0031383276126737e-12
a O 0 4.81705257279752e-12
missense O 0 1.0019084450973992e-09
substitution O 0 1.429811546937998e-10
in O 0 2.8356596584733218e-11
the O 0 3.023200856322461e-10
vasopressin O 0 6.15796693637094e-08
- O 0 2.0585536830708406e-08
neurophysin O 0 2.9267884116279674e-08
II O 0 1.120338424698275e-06
gene O 0 1.68415073553696e-11
in O 0 3.0964556006068955e-12
two O 0 2.1878692434140756e-12
Spanish O 0 8.535617213034641e-10
kindreds O 0 1.3030735601660126e-07
with O 0 2.148629607567898e-10
familial B-Disease 0 0.00010096305049955845
neurohypophyseal I-Disease 1 0.9999998807907104
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999886751174927
. O 0 1.857355709944386e-05

Familial B-Disease 1 0.9999896287918091
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 3.9557212971885747e-07
FNDI B-Disease 1 1.0
) O 0 1.4489907884662756e-10
is O 0 1.8865037570287013e-12
an O 0 9.08791097931072e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.8077171262120828e-06
by O 0 1.192874687916401e-09
deficiency O 1 0.9150553345680237
in O 0 1.3106937757356718e-09
the O 0 1.7985735567549455e-08
antidiuretic O 0 4.875304071561004e-08
hormone O 0 1.976966590433449e-09
arginine O 0 2.9272850810002637e-08
vasopressin O 0 1.3344408955617837e-07
( O 0 1.0730261817970543e-10
AVP O 0 4.4314099056919076e-08
) O 0 5.776756568758035e-13
encoded O 0 5.524642809201508e-12
by O 0 3.934662057974991e-12
the O 0 1.196182708440574e-09
AVP O 0 9.580832738720346e-06
- O 0 2.7898170174012193e-06
neurophysin O 0 5.778176728199469e-06
II O 1 0.9494096040725708
( O 0 5.542519776469135e-09
AVP O 0 0.00017864053370431066
- O 0 3.836572886939393e-06
NPII O 0 0.0029530352912843227
) O 0 7.526328518747682e-12
gene O 0 1.0229863831034969e-11
on O 0 2.5600330189057274e-10
chromosome O 0 1.1288466161829547e-08
20p13 O 0 4.335707671998534e-06
. O 0 1.9451896093869436e-07

In O 0 7.130255941234509e-09
this O 0 1.072780614341795e-10
study O 0 4.745812076656364e-11
, O 0 4.499105894697347e-13
we O 0 8.254927774328791e-13
analyzed O 0 1.073042089211329e-11
two O 0 1.8114242744671216e-13
families O 0 5.590764938674664e-13
with O 0 5.454884048801401e-13
FNDI B-Disease 1 1.0
using O 0 8.914961130424004e-11
direct O 0 3.502061696192271e-10
automated O 0 1.1902411500841481e-08
fluorescent O 0 4.0458372763119144e-10
, O 0 1.3354471608412188e-12
solid O 0 7.529118301041748e-11
phase O 0 6.911904937290103e-10
, O 0 2.293596627726824e-13
single O 0 1.6938819053999299e-12
- O 0 1.596864459239844e-12
stranded O 0 4.1157346628017955e-12
DNA O 0 1.5222986066154576e-11
sequencing O 0 3.066155315756269e-11
of O 0 1.49866397070042e-10
PCR O 0 2.3804016535677874e-08
- O 0 3.995832003056421e-07
amplified O 0 4.112059741601115e-07
AVP O 0 2.388033681199886e-05
- O 0 2.0472161850193515e-06
NPII O 0 0.0010317059932276607
DNA O 0 2.6797474674822297e-06
. O 0 6.373262095848986e-08

In O 0 4.231762495976454e-09
one O 0 1.1884999928657436e-10
of O 0 1.1428231277976764e-10
the O 0 8.775324911169946e-11
families O 0 2.644522274775074e-11
, O 0 1.218008983602803e-12
affected O 0 7.1800300080471224e-12
individuals O 0 5.617937213521496e-13
presented O 0 2.204126881011348e-10
a O 0 3.6602002678742807e-11
novel O 0 5.894137955486656e-11
nonsense O 0 3.6117235424626415e-08
mutation O 0 1.3692079414706626e-10
in O 0 4.2773168340559664e-10
exon O 0 1.2266977433839088e-09
3 O 0 2.2194321380730742e-10
of O 0 3.514641910840055e-10
the O 0 1.4934563308255377e-10
gene O 0 2.8334361766579885e-12
, O 0 7.209283083703388e-13
consisting O 0 5.942697722804979e-12
in O 0 1.1903028042381525e-11
a O 0 3.4779363417003495e-11
G O 0 2.080229766221464e-09
to O 0 1.952697115115143e-09
T O 0 5.277275505477519e-08
transition O 0 2.050092234640033e-06
at O 0 1.387570502942026e-08
nucleotide O 0 1.575436492373683e-08
2101 O 0 4.4631426021624065e-07
, O 0 4.336556721357132e-12
which O 0 5.1547951833690736e-14
produces O 0 1.2865664751008504e-13
a O 0 1.1845089796166941e-12
stop O 0 5.7628742056170523e-11
signal O 0 5.54970247534925e-09
in O 0 1.3601082760050787e-10
codon O 0 1.532403892667844e-08
82 O 0 5.992620799588622e-08
( O 0 8.955458596915378e-10
Glu O 0 2.818632538037491e-06
) O 0 1.9718889021635988e-10
of O 0 5.498425537098228e-08
NPII O 1 0.9997205138206482
. O 0 3.219159225409385e-06

The O 0 1.3349257699246664e-07
premature O 0 3.5517035712473444e-07
termination O 0 4.638677708612704e-08
eliminates O 0 5.958028737040877e-09
part O 0 3.097982981259406e-10
of O 0 2.936308973744417e-09
the O 0 4.724907576303394e-09
C O 0 4.128825366933597e-06
- O 0 2.084432715321327e-08
terminal O 0 1.485513823062945e-09
domain O 0 6.896655468935364e-10
of O 0 6.22151274942695e-10
NPII O 1 0.9730860590934753
, O 0 1.2698047474613006e-11
including O 0 1.8515263107421465e-12
a O 0 1.0856555238136778e-11
cysteine O 0 3.126710224066187e-09
residue O 0 1.59668857691031e-07
in O 0 1.9242528404017634e-10
position O 0 1.588992581957882e-08
85 O 0 9.11733835096129e-08
, O 0 5.143103824767348e-12
which O 0 2.283992222781861e-13
could O 0 3.353294638491766e-12
be O 0 7.490697298551119e-12
involved O 0 1.3443377522293076e-09
in O 0 9.550575608141543e-11
the O 0 5.999694629998942e-10
correct O 0 6.054858090465132e-07
folding O 0 6.178661493549953e-08
of O 0 4.3644523550767644e-09
the O 0 5.358673149657989e-08
prohormone O 0 0.0001343109761364758
. O 0 5.519876822290826e-07

In O 0 3.0319859956051687e-09
the O 0 7.834112247806502e-10
second O 0 7.746701946587109e-09
family O 0 1.5356207971883862e-10
, O 0 8.709135300953574e-13
a O 0 1.5302248400697605e-12
G279A O 0 1.8851826766308477e-09
substitution O 0 2.018262085234923e-10
at O 0 1.5683443432834565e-10
position O 0 2.8162150389476892e-09
- O 0 9.849652204962922e-10
1 O 0 6.112379352662956e-11
of O 0 9.381065368962993e-11
the O 0 1.879594223319625e-11
signal O 0 1.0969695152240888e-09
peptide O 0 1.294380141264595e-11
was O 0 2.991017156173115e-11
observed O 0 2.2015712169975998e-11
in O 0 9.89215393626397e-12
all O 0 3.661289674217194e-11
affected O 0 4.119226071352955e-10
individuals O 0 1.0066161792998685e-10
. O 0 3.1332010763662765e-08

This O 0 2.3020170658583083e-08
missense O 0 1.3634444258059375e-06
mutation O 0 1.3577271529285895e-09
, O 0 3.050533436965708e-11
which O 0 1.7792857465170897e-11
replaces O 0 1.2749220559271635e-06
Ala O 0 1.2432025869202334e-05
with O 0 2.1804862360141897e-09
Thr O 1 0.9999701976776123
, O 0 5.1662993327816764e-11
is O 0 3.9165498101623175e-12
frequent O 0 1.6850992823336242e-10
among O 0 2.6614410675307454e-09
FNDI B-Disease 1 1.0
patients O 0 0.00013909627159591764
and O 0 2.7291566229159514e-10
is O 0 4.910320761108977e-11
thought O 0 8.750576374616514e-10
to O 0 7.814647540183017e-11
reduce O 0 7.776645993828879e-10
the O 0 2.2427090740073652e-10
efficiency O 0 2.501257334586171e-08
of O 0 2.9764385400810056e-10
cleavage O 0 3.827738959127913e-10
by O 0 6.718939293826054e-11
signal O 0 1.1275614042460802e-07
peptidases O 0 4.254163741279626e-06
. O 0 4.874901371465512e-09
. O 0 3.4345323030038344e-08

Genetic O 0 6.243689085749793e-07
heterogeneity O 0 1.9082631297351327e-07
of O 0 6.456184564740397e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 7.661800013880615e-12
due O 0 3.777251151859673e-07
to O 0 5.327221330730936e-09
TWIST O 0 0.2680027186870575
and O 0 1.1674690547636146e-08
FGFR O 1 0.9999996423721313
mutations O 0 3.904527261511248e-07
. O 0 9.783902044091519e-08

Thirty O 0 0.0001759424339979887
- O 0 3.9426450371138344e-07
two O 0 3.597596179294449e-11
unrelated O 0 3.056360720066209e-09
patients O 0 4.573527320750337e-11
with O 0 1.2771169755412815e-13
features O 0 2.100565728302417e-11
of O 0 1.3359797712553245e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.066696245222154e-10
a O 0 1.8813813007501068e-10
common O 0 3.960480299269875e-08
autosomal B-Disease 1 0.9999991655349731
dominant I-Disease 1 0.9999091625213623
condition I-Disease 1 1.0
of O 1 0.9999998807907104
craniosynostosis B-Disease 1 1.0
and O 0 0.023616835474967957
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999498128890991
, O 0 7.956434400213652e-10
were O 0 5.6586748620190974e-09
screened O 0 1.369242719206909e-09
for O 0 8.522191979887239e-11
mutations O 0 2.543349142403173e-10
in O 0 4.0029141112896127e-10
TWIST O 0 1.0790779924718663e-05
, O 0 1.1658931597935407e-09
FGFR2 O 1 0.9998993873596191
, O 0 8.519563943210073e-10
and O 0 9.123876765215755e-09
FGFR3 O 1 0.99998939037323
. O 0 3.0023390991118504e-06

Nine O 0 1.4205292586666474e-07
novel O 0 8.815334573419875e-11
and O 0 2.2321075543452196e-11
three O 0 6.633470855943457e-11
recurrent O 0 1.0888116719343088e-07
TWIST O 0 4.946787726112234e-07
mutations O 0 2.090809608779054e-10
were O 0 1.2168910323850923e-10
found O 0 4.685547522892408e-12
in O 0 3.308435990445613e-12
12 O 0 9.106277398807094e-10
families O 0 4.344252180210617e-10
. O 0 2.2283972000991525e-08

Seven O 0 5.2358078761471916e-08
families O 0 2.082825162341706e-10
were O 0 1.2921558267819933e-10
found O 0 5.76322279829955e-12
to O 0 5.251158882724205e-12
have O 0 3.3228233532744955e-12
the O 0 4.703397671335097e-10
FGFR3 O 1 0.9809329509735107
P250R O 0 2.214040705439402e-06
mutation O 0 2.1771023872574347e-10
, O 0 3.5519731687166933e-12
and O 0 4.921241365807294e-12
one O 0 5.5104354239332576e-12
individual O 0 2.1455981089046894e-11
was O 0 2.414600297484526e-09
found O 0 2.0134510378411186e-11
to O 0 1.5685499774042988e-11
have O 0 4.710269500829423e-12
an O 0 1.0414751526466315e-11
FGFR2 O 0 0.021551696583628654
VV269 O 0 9.134675929090008e-05
- O 0 4.811562348550069e-07
270 O 0 5.056487566434953e-07
deletion O 0 1.0542416930547915e-06
. O 0 3.2172701480703836e-07

To O 0 7.7367783291038e-09
date O 0 1.0240444936471249e-07
, O 0 7.373866101056947e-11
our O 0 6.271038688332453e-10
detection O 0 1.3165197820796948e-08
rate O 0 2.763450579479354e-10
for O 0 7.553883733801836e-12
TWIST O 0 2.961266716283717e-07
or O 0 1.6144580117227747e-09
FGFR O 0 0.0006113831186667085
mutations O 0 9.914112863995683e-10
is O 0 2.3695025976044892e-12
68 O 0 6.377344874408664e-09
% O 0 5.026135063701531e-10
in O 0 2.392971411302458e-11
our O 0 2.5616085252977427e-08
Saethre B-Disease 1 0.9999995231628418
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
patients O 0 3.915442636781563e-09
, O 0 1.6530754629734412e-12
including O 0 1.2538625519808999e-11
our O 0 4.843623813144404e-08
five O 0 1.3857580638543254e-09
patients O 0 1.3608555948785295e-10
elsewhere O 0 4.087542110342568e-11
reported O 0 4.4672581606119977e-11
with O 0 3.206751530981933e-11
TWIST O 0 7.150078454287723e-05
mutations O 0 2.8256712880647683e-07
. O 0 1.8579176241928508e-07

More O 0 8.458747036144132e-10
than O 0 2.2132379262629343e-11
35 O 0 5.700171445965907e-10
different O 0 2.6966552255092147e-11
TWIST O 0 1.1368244656750903e-07
mutations O 0 2.357189721191588e-10
are O 0 1.2537495997985704e-12
now O 0 1.065715484610541e-11
known O 0 1.2469605209508572e-11
in O 0 2.266756574109685e-11
the O 0 6.036978694723416e-10
literature O 0 2.9342110963170853e-08
. O 0 8.713809052096622e-08

The O 0 1.2373804736398597e-07
most O 0 3.2131819427405617e-10
common O 0 1.0261527044752583e-10
phenotypic O 0 8.009268803732539e-10
features O 0 4.0859128580539306e-11
, O 0 1.3813543408083828e-12
present O 0 5.5179479041544965e-11
in O 0 1.0259858067296346e-11
more O 0 3.9224163196974193e-13
than O 0 2.286603252663749e-13
a O 0 1.6517957791492566e-12
third O 0 1.930367199420857e-09
of O 0 1.2359534506956038e-09
our O 0 2.4654820407477018e-08
patients O 0 1.7059101908856178e-09
with O 0 2.9745417934323726e-11
TWIST O 0 1.888552446871472e-06
mutations O 0 5.032975147756247e-10
, O 0 1.0124402184674697e-11
are O 0 1.1829493981596606e-11
coronal B-Disease 0 7.939326707173677e-08
synostosis I-Disease 0 2.8370870950311655e-06
, O 0 7.831049142481561e-10
brachycephaly B-Disease 0 5.306052571540931e-06
, O 0 9.645997334217782e-10
low B-Disease 0 2.3827558379707625e-06
frontal I-Disease 0 0.3473668396472931
hairline I-Disease 1 1.0
, O 0 2.847202495104284e-06
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 0 9.959474027709803e-07
ptosis B-Disease 1 0.9999991655349731
, O 0 3.301029849467341e-08
hypertelorism B-Disease 0 0.001898442511446774
, O 0 3.653131797065612e-09
broad B-Disease 0 5.216628906623555e-08
great I-Disease 0 1.7833739548223093e-05
toes I-Disease 1 0.9703167676925659
, O 0 2.1682269313316738e-09
and O 0 2.0263064115511042e-08
clinodactyly B-Disease 1 0.9989445805549622
. O 0 1.0188723535975441e-05

Significant O 0 7.800629191478947e-07
intra O 0 0.17588898539543152
- O 0 2.9134547730791382e-05
and O 0 4.003977593924901e-09
interfamilial O 0 0.036594100296497345
phenotypic O 0 1.1719785675268213e-07
variability O 0 2.1591405996446156e-08
is O 0 5.467863033008225e-13
present O 0 8.407765803020162e-12
for O 0 4.679697601650545e-12
either O 0 6.247272033022e-09
TWIST O 0 1.3830273928761017e-05
mutations O 0 1.9483119118035575e-08
or O 0 5.627536214802831e-09
FGFR O 0 0.07364421337842941
mutations O 0 2.4483173888256715e-07
. O 0 1.3571948898061237e-07

The O 0 1.6492278120949777e-07
overlap O 0 5.3783846709620775e-08
in O 0 1.4526048419671866e-10
clinical O 0 1.504387725503875e-08
features O 0 1.0513651754751052e-10
and O 0 2.162917067671799e-11
the O 0 7.000960922098898e-10
presence O 0 5.3046358972075325e-11
, O 0 1.9826427825886395e-12
in O 0 2.6943657808337074e-12
the O 0 2.4454240715732212e-11
same O 0 2.279807592708849e-11
genes O 0 1.7765119236790028e-11
, O 0 7.966535959559595e-13
of O 0 1.9206402093741026e-11
mutations O 0 1.0999602270689302e-11
for O 0 3.6288133956063895e-12
more O 0 1.170177670040129e-12
than O 0 2.85932150352608e-12
one O 0 1.6840542849116957e-11
craniosynostotic B-Disease 0 9.981022230931558e-08
condition I-Disease 0 2.9926974093541503e-05
- O 0 2.2534310417654524e-08
such O 0 3.999508363383697e-11
as O 0 2.3350406053168626e-09
Saethre B-Disease 1 0.9939127564430237
- I-Disease 0 7.764796464471146e-06
Chotzen I-Disease 0 0.0006404408486559987
, I-Disease 0 5.640343192503394e-10
Crouzon I-Disease 0 0.023613229393959045
, I-Disease 0 4.0712280768850917e-10
and I-Disease 0 4.657008112474159e-09
Pfeiffer I-Disease 0 0.007284627761691809
syndromes I-Disease 0 0.04278191551566124
- O 0 8.466211056656903e-07
support O 0 1.5605934322593384e-08
the O 0 1.6626854559831372e-08
hypothesis O 0 3.7169931577096804e-09
that O 0 1.7728891271717728e-12
TWIST O 0 1.6770697186530015e-07
and O 0 7.139407121048436e-11
FGFRs O 0 2.7180067263543606e-06
are O 0 8.860840121534264e-13
components O 0 4.122474361878403e-09
of O 0 1.4705128781322685e-10
the O 0 3.8314334344091705e-11
same O 0 9.723236972514204e-12
molecular O 0 5.388695739627636e-11
pathway O 0 1.4956478763816783e-11
involved O 0 7.202662077876454e-12
in O 0 6.068061417924264e-12
the O 0 1.2205729482683836e-10
modulation O 0 8.728977718419628e-07
of O 0 3.678964048958733e-07
craniofacial O 1 0.9999998807907104
and O 0 3.1923414098855574e-06
limb O 1 0.9852487444877625
development O 0 5.919433533563279e-06
in O 0 6.490384896196133e-10
humans O 0 1.3349704675036378e-09
. O 0 1.6940969460588207e-10
. O 0 7.762201548189296e-09

Mutation O 0 1.0791024074308098e-08
analysis O 0 2.4181951996382622e-09
of O 0 1.552343498190112e-08
UBE3A O 1 0.9999996423721313
in O 0 0.0226152203977108
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 7.981640237630927e-07
. O 0 2.8307626465107205e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.151161179943301e-07
AS B-Disease 1 1.0
) O 0 1.9823799546347942e-10
is O 0 2.723667645587735e-12
caused O 0 5.30067101323084e-11
by O 0 2.5149448495964677e-11
chromosome O 0 6.885408243562097e-09
15q11 O 0 9.86348732112674e-06
- O 0 2.4180195623557665e-07
q13 O 0 1.0591252248559613e-06
deletions O 0 2.3425885675720792e-09
of O 0 2.8446373034896055e-10
maternal O 0 8.889958991176172e-09
origin O 0 2.360888429198127e-10
, O 0 2.686309291330402e-12
by O 0 2.2450961228992483e-11
paternal O 0 8.921469998313114e-07
uniparental B-Disease 1 0.9811586141586304
disomy I-Disease 1 0.9995869994163513
( O 0 1.327282461716095e-07
UPD B-Disease 1 1.0
) O 0 2.3662938275492706e-10
15 O 0 8.304670839898165e-10
, O 0 9.572852493339168e-13
by O 0 1.0024177668488399e-11
imprinting O 0 1.0763770660560112e-05
defects O 0 1.0373617442382965e-05
, O 0 4.6845470211276385e-12
and O 0 1.4693169641047388e-12
by O 0 1.9686448651801136e-11
mutations O 0 1.8718318561816716e-10
in O 0 1.5116516371982414e-10
the O 0 3.587432928497947e-08
UBE3A O 0 0.0015296274796128273
gene O 0 3.412370475075477e-08
. O 0 9.201211526033148e-08

UBE3A O 0 0.0007189205498434603
encodes O 0 2.423506728632674e-08
a O 0 4.858110358441081e-09
ubiquitin O 0 9.085640328976297e-08
- O 0 5.324425842445635e-07
protein O 0 7.982868810429977e-10
ligase O 0 2.547748123582494e-10
and O 0 1.4396960013041138e-10
shows O 0 2.590449987849297e-08
brain O 0 1.192337367683649e-05
- O 0 1.0221296697920934e-08
specific O 0 5.469438679739369e-09
imprinting O 0 1.2005763210254372e-06
. O 0 5.34060227153077e-08

Here O 0 2.1572517994172813e-07
we O 0 1.9260861794379025e-09
describe O 0 5.8845539996355e-08
UBE3A O 0 0.0007330141379497945
coding O 0 0.00017370124987792224
- O 0 1.7237094596112001e-07
region O 0 3.4369223023134055e-09
mutations O 0 1.167383412159495e-10
detected O 0 9.125467742565618e-11
by O 0 4.000864309988694e-12
SSCP O 1 0.957013726234436
analysis O 0 4.915327034282768e-10
in O 0 3.5444342773305326e-12
13 O 0 4.4795042675183083e-10
AS B-Disease 1 0.9999994039535522
individuals O 0 1.5108265333241278e-11
or O 0 5.869748437303812e-11
families O 0 1.5471600389727058e-10
. O 0 1.3360154760277965e-08

Two O 0 5.3033257785273236e-09
identical O 0 5.141983727696697e-09
de O 0 1.02731112505694e-08
novo O 0 4.9726935458238586e-08
5 O 0 4.715933954457796e-08
- O 0 1.2576145991261e-07
bp O 0 2.028661327813097e-08
duplications O 0 1.6046968198679679e-07
in O 0 1.8883279384596108e-09
exon O 0 1.6676018788075453e-08
16 O 0 2.271840271461656e-09
were O 0 2.821451738910241e-09
found O 0 1.590131692985608e-09
. O 0 4.205051595818077e-08

Among O 0 7.439609817083692e-08
the O 0 2.2736088567398838e-09
other O 0 5.081491130654037e-11
11 O 0 7.061592421919727e-10
unique O 0 9.930913730249458e-11
mutations O 0 5.6774369927570234e-11
, O 0 1.7822567423622648e-12
8 O 0 3.994737873824761e-10
were O 0 3.0664857320061856e-09
small O 0 5.298083499694073e-11
deletions O 0 7.355551723264853e-10
or O 0 2.3138650717680065e-10
insertions O 0 9.729451022622015e-08
predicted O 0 4.6768871442282034e-08
to O 0 3.5282650134860205e-09
cause O 0 5.756839414061687e-07
frameshifts O 1 0.9982525706291199
, O 0 2.3613389021903686e-10
1 O 0 1.2757973566479563e-09
was O 0 3.017837368890497e-10
a O 0 7.841624051485585e-12
mutation O 0 3.181382457820292e-12
to O 0 1.3183596575538914e-11
a O 0 4.484725091291608e-11
stop O 0 1.133270810527165e-09
codon O 0 3.104451451463319e-08
, O 0 4.963626731857573e-11
1 O 0 1.7294518595001307e-10
was O 0 1.6411391690063226e-10
a O 0 3.725087252548498e-11
missense O 0 3.029905926155152e-08
mutation O 0 1.6357014354095867e-10
, O 0 9.020111914337381e-12
and O 0 3.0610892293170266e-11
1 O 0 2.2989752324065194e-09
was O 0 4.5070081000631035e-09
predicted O 0 1.1691175805239595e-09
to O 0 1.980927748224115e-11
cause O 0 9.936332312499019e-11
insertion O 0 2.1686572537760185e-09
of O 0 9.022224745081076e-09
an O 0 2.9185684424781755e-10
isoleucine O 0 1.0187100997427478e-05
in O 0 1.0426985941336397e-09
the O 0 2.8703033283505874e-09
hect O 0 1.0232005251964438e-06
domain O 0 1.6014573001044141e-09
of O 0 4.3924353043678366e-10
the O 0 2.1086763446476198e-09
UBE3A O 0 0.0002330845018150285
protein O 0 7.82292841616794e-10
, O 0 7.901555386553849e-13
which O 0 3.100234777014474e-14
functions O 0 7.629716303192424e-12
in O 0 1.629886156595539e-11
E2 O 0 1.169849106474885e-09
binding O 0 1.215721828762284e-10
and O 0 2.2747528860556088e-10
ubiquitin O 0 1.9141918272680414e-08
transfer O 0 7.277972713382042e-07
. O 0 4.917864089293289e-07

Eight O 0 4.2932677501994476e-07
of O 0 4.129951047815439e-09
the O 0 2.1942445083134032e-10
cases O 0 3.793699382415028e-11
were O 0 3.6625066868190004e-10
familial O 0 1.4449678120698195e-09
, O 0 1.0850303294729358e-11
and O 0 1.945052625906829e-11
five O 0 6.566528432117025e-10
were O 0 3.0380871152146938e-09
sporadic O 0 5.40960797934531e-07
. O 0 2.9316163363546366e-07

In O 0 8.343620905293392e-09
two O 0 7.891897690903704e-10
familial O 0 3.07962864098954e-08
cases O 0 5.499311561685261e-10
and O 0 1.0086303320333556e-10
one O 0 7.65540547620347e-11
sporadic O 0 4.848698154091835e-08
case O 0 4.1984202225897604e-10
, O 0 6.616499709233281e-11
mosaicism O 0 5.173230306354526e-07
for O 0 3.2675087080491494e-09
UBE3A O 0 0.00047375314170494676
mutations O 0 9.059212935369487e-09
was O 0 9.483435148283093e-10
detected O 0 3.8369710186891837e-10
in O 0 2.4525602902725208e-12
the O 0 4.942597373047697e-11
mother O 0 7.218085573690303e-10
of O 0 5.940006819749044e-10
three O 0 3.662248282410019e-10
AS B-Disease 1 1.0
sons O 0 1.4817119620147423e-07
, O 0 1.5002497941868365e-12
in O 0 7.057407501280533e-13
the O 0 7.131250884945262e-12
maternal O 0 3.4466185461212717e-09
grandfather O 0 2.2001305666208282e-08
of O 0 6.873192237577541e-09
two O 0 1.7196735146995934e-09
AS B-Disease 1 1.0
first O 0 3.9109213645360796e-08
cousins O 0 4.928869401510383e-08
, O 0 1.1959078692613812e-11
and O 0 5.8763428151253905e-12
in O 0 4.276270657022074e-11
the O 0 7.459936002263134e-10
mother O 0 3.201993781232204e-09
of O 0 1.3804299925368468e-08
an O 0 9.985239302068294e-10
AS B-Disease 1 1.0
daughter O 1 0.6340774893760681
. O 0 5.210950257605873e-05

The O 0 2.7867269380976722e-08
frequencies O 0 1.4215464361200247e-08
with O 0 5.553791801449215e-12
which O 0 1.233716470996904e-12
we O 0 1.2568603276197354e-11
detected O 0 2.1972054731200785e-10
mutations O 0 1.0511802366053313e-11
were O 0 4.7981743578340286e-11
5 O 0 5.466836011658316e-11
( O 0 6.838669170880496e-13
14 O 0 7.361568993280443e-11
% O 0 3.750946428460189e-11
) O 0 2.9202676518277904e-13
of O 0 2.355777378726387e-11
35 O 0 3.853414531906907e-10
in O 0 1.4318494306886365e-11
sporadic O 0 8.882889979133779e-09
cases O 0 1.2359599455002979e-10
and O 0 6.853118073024689e-11
8 O 0 5.547519110749022e-10
( O 0 1.4698159139445166e-12
80 O 0 1.1385348913650617e-10
% O 0 4.531111943983923e-11
) O 0 3.1764632699333994e-13
of O 0 1.0642814754491248e-11
10 O 0 5.196858221534484e-11
in O 0 3.126319342294792e-11
familial O 0 4.527151098443483e-09
cases O 0 4.090710825632726e-10
. O 0 4.947440679359261e-09
. O 0 7.955516423407971e-08

The O 0 3.3223152513528476e-06
hemochromatosis B-Disease 1 1.0
845 O 0 5.735370223192149e-07
G O 0 1.191574980907717e-07
- O 0 1.5031808686671866e-07
- O 0 1.7096503768243565e-08
> O 0 6.880402914077877e-10
A O 0 1.046210673649739e-09
and O 0 9.408579601175027e-13
187 O 0 4.78407157639138e-12
C O 0 1.3603822068830596e-08
- O 0 9.960140090470304e-08
- O 0 1.1993765269835421e-07
> O 0 4.703725409171966e-08
G O 0 1.0343838852122644e-07
mutations O 0 9.903982078895979e-10
: O 0 4.5656985137032535e-12
prevalence O 0 1.2669367777107254e-09
in O 0 6.672834507170933e-11
non O 0 1.750961814650509e-06
- O 0 5.410638095781906e-06
Caucasian O 0 0.00026551162591204047
populations O 0 4.999645852876711e-08
. O 0 7.916478494962575e-08

Hemochromatosis B-Disease 1 0.9984208345413208
, O 0 1.4902730161026057e-09
the O 0 4.6355023641808657e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 3.87647514088485e-09
leads O 0 5.925912915927256e-08
, O 0 1.9302411058408353e-10
if O 0 1.705078389591108e-08
untreated O 1 1.0
, O 0 4.691007027268768e-10
to O 0 1.2590405731316423e-06
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 7.865772033710527e-08
premature B-Disease 0 1.709235948510468e-05
death I-Disease 0 1.2633306596399052e-06
. O 0 2.6395431973469385e-07

The O 0 5.414509359980002e-06
hemochromatosis B-Disease 1 1.0
gene O 0 1.1663829901920053e-08
, O 0 5.693500115810934e-10
HFE O 0 0.01110322866588831
, O 0 2.829777245860754e-10
recently O 0 1.5038295608782448e-10
has O 0 1.654601342005943e-13
been O 0 1.5025779015118146e-12
identified O 0 4.7742563374919555e-11
, O 0 9.10388409623708e-13
and O 0 5.313888652019871e-12
characterization O 0 5.921808821085506e-09
of O 0 3.0061708677919796e-09
this O 0 1.1635532815024163e-10
gene O 0 4.221310453966787e-11
has O 0 1.8505013602183873e-13
shown O 0 1.1510918086765631e-11
that O 0 9.393781732298587e-14
it O 0 1.564806295065342e-14
contains O 0 2.436853311098188e-14
two O 0 1.1776646010371733e-13
mutations O 0 6.595803547435053e-13
that O 0 5.536504143598825e-14
result O 0 8.62851803895559e-12
in O 0 4.954112120536536e-11
amino O 0 1.0873201644612251e-10
acid O 0 2.5243885107273378e-11
substitutions O 0 9.320515886868108e-11
- O 0 5.771321962000364e-11
cDNA O 0 2.2563448331958114e-10
nucleotides O 0 2.393610483431008e-11
845 O 0 7.178503347304854e-10
G O 0 1.958090134479562e-09
- O 0 4.579225176826185e-08
- O 0 2.0013056101220172e-08
> O 0 1.8719970018565846e-09
A O 0 2.0580982251772184e-08
( O 0 4.734571242004382e-12
C282Y O 0 4.157203292720624e-08
) O 0 1.544919520004434e-13
and O 0 4.006207529345246e-13
187 O 0 5.5070730961559455e-12
C O 0 2.0322049820720167e-08
- O 0 2.1362262714319513e-07
- O 0 2.2794378651269653e-07
> O 0 8.267932116723387e-08
G O 0 2.6527817453825264e-07
( O 0 3.6555136695426427e-10
H63D O 1 0.7221006155014038
) O 0 9.374183651544854e-10
. O 0 2.2347178330051065e-08

Although O 0 7.06350983818993e-05
hemochromatosis B-Disease 1 1.0
is O 0 8.917516725048813e-10
common O 0 7.778263033664246e-10
in O 0 2.0062920214058977e-09
Caucasians O 0 6.38875872027711e-06
, O 0 6.210439384979338e-10
affecting O 0 2.4490265815302337e-08
> O 0 8.379632987498553e-09
= O 0 3.386683433692639e-10
1 O 0 2.5653804081038345e-10
/ O 0 5.386715518085339e-10
300 O 0 4.1680502799179564e-11
individuals O 0 6.840120917589454e-12
of O 0 2.7399796320715097e-10
northern O 0 3.0378888293824957e-10
European O 0 7.537182544758991e-10
origin O 0 4.667812802949811e-09
, O 0 5.605206576664301e-11
it O 0 6.854300113601219e-13
has O 0 1.5183706614067816e-13
not O 0 1.028267640305891e-12
been O 0 1.917887376690075e-11
recognized O 0 1.8764860498787783e-10
in O 0 1.0044737958070371e-10
other O 0 2.284684247344515e-10
populations O 0 3.539708526290042e-10
. O 0 1.0799796612559476e-08

The O 0 3.675889592713588e-09
present O 0 2.008569144340555e-10
study O 0 4.4353327434409895e-12
used O 0 2.9384434880978805e-13
PCR O 0 2.813356318742688e-11
and O 0 1.6618830877418445e-12
restriction O 0 1.2199719533201314e-11
- O 0 2.9084807479096142e-11
enzyme O 0 1.0410793321175005e-12
digestion O 0 1.7814057173826114e-10
to O 0 1.3087639479103519e-11
analyze O 0 3.465859266249538e-10
the O 0 1.2892011243270662e-11
frequency O 0 6.466363555723831e-10
of O 0 3.7144662345944823e-11
the O 0 3.3259128090490364e-11
845 O 0 5.004659464624694e-10
G O 0 6.149499243157663e-10
- O 0 3.7207807945804916e-09
- O 0 1.743668764930817e-09
> O 0 1.1539898203682952e-10
A O 0 5.117325452275168e-10
and O 0 1.3841710980525002e-12
187 O 0 1.1818194860235831e-11
C O 0 1.0334545663681638e-08
- O 0 1.1620485018681848e-08
- O 0 7.0356622750011866e-09
> O 0 3.0947895357513744e-09
G O 0 3.744545562511803e-09
mutations O 0 3.879844362453255e-11
in O 0 5.5287989464414267e-11
HLA O 0 4.835295275285034e-09
- O 0 4.649133300560493e-10
typed O 0 3.108222290659768e-10
samples O 0 5.74966636801566e-11
from O 0 5.84248344148719e-11
non O 0 5.791488533191114e-08
- O 0 3.577245522023986e-08
Caucasian O 0 1.869441462076793e-06
populations O 0 5.752869361441704e-11
, O 0 2.9435197226694576e-13
comprising O 0 8.631645745382777e-12
Australian O 0 2.7460355767061628e-08
Aboriginal O 0 1.04083517271647e-06
, O 0 5.259378436234252e-12
Chinese O 0 1.540338523398077e-09
, O 0 4.488695873328119e-11
and O 0 3.668295389669396e-10
Pacific O 0 2.1250095016966952e-08
Islanders O 0 8.281432428702828e-07
. O 0 1.0231249802927778e-07

Results O 0 5.999037000492535e-08
showed O 0 1.0361191016272642e-08
that O 0 1.7120421833688448e-12
the O 0 1.717475467399865e-11
845 O 0 1.0840943698298133e-09
G O 0 3.625885369729076e-09
- O 0 3.2145830886065596e-08
- O 0 1.2095474843931697e-08
> O 0 1.448273279081036e-09
A O 0 1.2399343773950022e-09
mutation O 0 1.5115067183990583e-11
was O 0 2.205277974121067e-11
present O 0 2.1369111341540403e-11
in O 0 5.339257681813425e-12
these O 0 2.890731707824723e-12
populations O 0 1.1392609403602927e-13
( O 0 4.3203521103262876e-15
allele O 0 2.4443363999537837e-12
frequency O 0 6.640090560727785e-11
0 O 0 4.17123529727198e-13
. O 0 1.893179406645129e-12
32 O 0 4.4969761248125906e-10
% O 0 7.642901589388629e-11
) O 0 5.903582744187785e-13
, O 0 1.5150678021186303e-12
and O 0 6.192406830363151e-12
, O 0 4.400262706288904e-12
furthermore O 0 2.4428192801906334e-10
, O 0 3.372923251462878e-12
it O 0 4.4201374873632793e-13
was O 0 2.2053800452503936e-10
always O 0 1.6747146724949147e-10
seen O 0 2.787415021021644e-10
in O 0 2.953566904939642e-11
conjunction O 0 3.2491132007095302e-09
with O 0 2.8092355108810807e-09
HLA O 0 1.6847025108290836e-05
haplotypes O 0 9.917487631128097e-08
common O 0 1.0575401665491313e-09
in O 0 7.138688529195747e-10
Caucasians O 0 3.5706605672203295e-08
, O 0 4.868921932299486e-11
suggesting O 0 1.4461781772112658e-09
that O 0 8.099406562100953e-12
845 O 0 1.814993599857928e-09
G O 0 8.849833221802328e-08
- O 0 2.3331389456870966e-05
- O 0 4.1137009247904643e-05
> O 0 1.0317272653992404e-06
A O 0 3.2747547606959415e-07
may O 0 6.568291049946495e-11
have O 0 1.252681118557586e-12
been O 0 1.610647813038435e-12
introduced O 0 2.1823716878782706e-12
into O 0 2.9390780174193276e-12
these O 0 6.159819833026492e-13
populations O 0 3.6672753592550955e-13
by O 0 7.648891936495872e-12
Caucasian O 0 1.0067209359476692e-06
admixture O 0 9.502824127594067e-07
. O 0 7.67044014082785e-07

187 O 0 7.724112904838876e-09
C O 0 2.1312327191935765e-07
- O 0 1.3031196033352899e-07
- O 0 1.670173865875313e-08
> O 0 2.0068546824347777e-09
G O 0 2.8233198001714754e-09
was O 0 7.528630496800304e-11
present O 0 5.908925692493794e-12
at O 0 3.2838230832471504e-12
an O 0 8.752422784197734e-15
allele O 0 3.808146506467658e-12
frequency O 0 2.796848086461523e-09
of O 0 3.4198683884767433e-09
2 O 0 1.0838223829523486e-07
. O 0 2.500814275663288e-07

68 O 0 7.102687959559262e-06
% O 0 2.996486614392779e-08
in O 0 2.2393953011401457e-11
the O 0 4.198554004464228e-11
two O 0 9.760994963692315e-12
populations O 0 3.0436623273816243e-12
analyzed O 0 8.010639374056439e-11
( O 0 1.3665558485156937e-12
Australian O 0 1.01645287742258e-08
Aboriginal O 0 1.2089827805539244e-07
and O 0 1.4213246031513638e-11
Chinese O 0 2.456435721498451e-09
) O 0 1.262280974190233e-10
. O 0 1.6420237614056532e-08

In O 0 5.3181352654974035e-09
the O 0 1.9528163530679876e-09
Australian O 0 4.303967315877344e-08
Aboriginal O 0 2.7530681734333484e-08
samples O 0 4.552925397804941e-11
, O 0 9.007277887961018e-14
187 O 0 1.1497528189935435e-12
C O 0 5.887953236083376e-09
- O 0 2.982329050382759e-08
- O 0 1.698796836535621e-08
> O 0 5.2802326955259105e-09
G O 0 1.4070284493072904e-08
was O 0 6.52571330306273e-10
found O 0 3.966399257648856e-12
to O 0 1.1831180566496124e-12
be O 0 4.199897374324024e-12
associated O 0 1.1720937553860722e-09
with O 0 3.0429572750456657e-10
HLA O 0 8.521508425474167e-05
haplotypes O 0 3.831037176382779e-08
common O 0 3.9620179359545205e-10
in O 0 2.709592550331763e-10
Caucasians O 0 4.588667934513069e-08
, O 0 7.260413190796067e-12
suggesting O 0 6.230205240598252e-10
that O 0 4.1762743979191497e-13
it O 0 3.469028449915035e-13
was O 0 4.413941087633155e-11
introduced O 0 8.870127722604426e-12
by O 0 6.299263628078977e-12
recent O 0 2.4126839415217205e-10
admixture O 0 3.5771769546499854e-08
. O 0 3.747519983221537e-08

In O 0 1.344597322372465e-08
the O 0 1.121433723660914e-09
Chinese O 0 1.5511824047464984e-09
samples O 0 1.4055061281492698e-10
analyzed O 0 1.0413465922898268e-10
, O 0 8.559141215875796e-14
187 O 0 8.061426959998785e-13
C O 0 1.1449160508547607e-09
- O 0 4.670823283703385e-09
- O 0 2.520373687531219e-09
> O 0 5.227121513406985e-10
G O 0 2.0792894073196067e-09
was O 0 3.0938968054172733e-10
present O 0 2.1396478339097413e-11
in O 0 1.8980060578766e-12
association O 0 1.4516782958010066e-12
with O 0 3.8091180058243135e-13
a O 0 3.057756825519675e-11
wide O 0 1.0390728555353945e-10
variety O 0 6.3386906834495e-11
of O 0 1.4092355060668638e-09
HLA O 0 7.959826575643092e-08
haplotypes O 0 2.3048627451061066e-09
, O 0 4.924442797982209e-12
showing O 0 5.598229171899227e-11
this O 0 3.090950455655883e-12
mutation O 0 1.3915891008964287e-11
to O 0 1.2449309812201381e-11
be O 0 1.1677553368727445e-10
widespread O 0 2.5234665468332196e-09
and O 0 5.594610885673035e-11
likely O 0 4.1866091149422857e-10
to O 0 3.088012900942516e-10
predate O 0 8.814521379463258e-07
the O 0 1.5051101476259987e-09
more O 0 9.879935411460927e-12
genetically O 0 7.297620840951424e-12
restricted O 0 5.2295719837891497e-11
845 O 0 2.0089878649542925e-09
G O 0 6.507857364113079e-08
- O 0 2.251849309686804e-06
- O 0 6.722908665324212e-07
> O 0 1.0428506413973082e-07
A O 0 4.813599829844861e-08
mutation O 0 7.473926366685646e-09
. O 0 5.198439456677306e-09

Genotype O 0 6.321925320662558e-05
- O 0 3.948257926822407e-06
phenotype O 0 1.1543876610176085e-07
correlations O 0 1.237058313563466e-07
in O 0 4.058896152514535e-08
attenuated B-Disease 1 0.999953031539917
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 7.556323544122279e-05

Germ O 0 0.44646960496902466
- O 0 1.747865644574631e-05
line O 0 4.799380803888198e-08
mutations O 0 4.083920701614119e-10
of O 0 2.4438830958928293e-09
the O 0 6.167321320305064e-09
tumor B-Disease 0 1.9373622706098104e-07
suppressor O 0 2.396533282933433e-08
APC O 0 6.106279926143543e-09
are O 0 7.339008741003017e-12
implicated O 0 6.58554952792656e-08
in O 0 4.102583872622745e-08
attenuated B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 3.7545640907410416e-07
AAPC B-Disease 1 1.0
) O 0 1.0515290894963503e-11
, O 0 1.420957264613304e-13
a O 0 3.0184546268713364e-13
variant O 0 1.0818448359373178e-09
of O 0 2.525866875657812e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 7.682960756483226e-08
FAP B-Disease 0 1.2269543958609574e-06
) O 0 6.901366700340361e-10
. O 0 2.33194406007442e-08

AAPC B-Disease 1 1.0
is O 0 5.954640114325116e-10
recognized O 0 4.1534581329827347e-10
by O 0 1.1134486561925616e-11
the O 0 1.321779491414432e-10
occurrence O 0 2.476458504929724e-08
of O 0 6.7338281617423945e-09
< O 0 2.0535505029783963e-07
100 O 0 1.68480198681209e-08
colonic B-Disease 0 1.0008546951212338e-06
adenomas I-Disease 0 2.3211349287066696e-07
and O 0 9.208445637953755e-12
a O 0 5.6321345157095415e-12
later O 0 5.089622057141696e-10
onset O 1 0.9526606798171997
of O 1 0.9903619289398193
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 9.881843954229197e-11
age O 0 3.089304811965121e-09
> O 0 3.7815070519364724e-10
40 O 0 5.4465931764724473e-11
years O 0 5.3285879181297346e-11
) O 0 1.861477291753566e-11
. O 0 6.7086496358115255e-09

The O 0 1.1583971115669556e-08
aim O 0 5.0177018096064785e-08
of O 0 8.661256711839371e-10
this O 0 1.3391719157207493e-11
study O 0 1.5752028154070175e-11
was O 0 4.191768807060292e-11
to O 0 1.8504609303193753e-11
assess O 0 3.067405529577627e-08
genotype O 0 7.803873245393333e-07
- O 0 2.4531084363843547e-07
phenotype O 0 2.8015852748808356e-08
correlations O 0 5.2608637446383e-08
in O 0 2.9075033936010186e-08
AAPC B-Disease 1 1.0
families O 0 3.5223564509578864e-08
. O 0 1.0821162277352414e-07

By O 0 2.056198100675033e-09
protein O 0 7.350643427272985e-10
- O 0 5.357032595298961e-10
truncation O 0 1.3985734348409551e-08
test O 0 2.192145576174198e-09
( O 0 1.0997594501738206e-10
PTT O 0 1.060958993548411e-06
) O 0 2.0824377378741987e-12
assay O 0 8.586968636148384e-11
, O 0 6.496022795197953e-13
the O 0 2.8178390610450466e-12
entire O 0 1.876583777260521e-09
coding O 0 1.22344744113434e-07
region O 0 1.2056451392794543e-09
of O 0 2.1968073193878723e-10
the O 0 2.2308956071359631e-10
APC B-Disease 0 1.335495714016588e-08
gene O 0 5.502855116024108e-11
was O 0 2.9183624961071075e-10
screened O 0 1.7047839528938624e-10
in O 0 6.272551054953279e-12
affected O 0 9.2771325344021e-11
individuals O 0 1.2357706871690688e-11
from O 0 4.695868138782089e-10
11 O 0 1.3093294626287388e-07
AAPC B-Disease 1 1.0
kindreds O 0 4.5546976252808236e-06
, O 0 4.157212768474139e-11
and O 0 1.074051524802e-11
their O 0 3.1725325144726924e-10
phenotypic O 0 7.556359982174854e-09
differences O 0 2.3917566593922857e-08
were O 0 8.283460140035004e-09
examined O 0 2.3620491163001134e-07
. O 0 7.928280609803551e-08

Five O 0 9.11977338091674e-08
novel O 0 2.3707900087543976e-09
germ O 0 3.2705822377465665e-05
- O 0 6.50308606964245e-07
line O 0 3.9593476941490735e-08
APC B-Disease 0 9.586140237161089e-08
mutations O 0 1.0642255965365166e-09
were O 0 2.3453861075495297e-10
identified O 0 3.471383736020073e-10
in O 0 3.5578810730907406e-11
seven O 0 5.302799976902861e-09
kindreds O 0 2.515083906473592e-06
. O 0 1.5326428126627434e-07

Mutations O 0 7.608934993186267e-08
were O 0 1.3353276706595807e-08
located O 0 1.8155189851487563e-10
in O 0 1.1040710446580393e-12
three O 0 5.862134237234751e-13
different O 0 2.2714859507222407e-12
regions O 0 2.4249687327615455e-11
of O 0 1.0721259990909005e-10
the O 0 3.873635023854405e-10
APC B-Disease 0 1.6528044710639733e-08
gene O 0 3.559036398925741e-10
( O 0 3.1765436635244892e-12
1 O 0 3.7733080548996156e-10
) O 0 5.494042720766146e-12
at O 0 1.1765330931723383e-09
the O 0 1.2093155643544407e-10
5 O 0 8.668143980372633e-11
end O 0 2.1362898117160967e-09
spanning O 0 9.03631214299594e-09
exons O 0 6.278351172284147e-10
4 O 0 2.6248532861150586e-11
and O 0 1.1686748790928903e-11
5 O 0 1.7108883754168858e-10
, O 0 4.8867104807115425e-11
( O 0 3.2166554576190665e-12
2 O 0 3.508277349184574e-11
) O 0 2.4411915631322723e-12
within O 0 6.949924524768392e-10
exon O 0 6.420179943233961e-10
9 O 0 2.652120745239017e-10
, O 0 2.558284487030882e-11
and O 0 2.1611984424296793e-10
( O 0 1.494034063131977e-11
3 O 0 2.0584965676473388e-10
) O 0 3.457523113301053e-12
at O 0 1.706592783756733e-10
the O 0 6.985152040117626e-11
3 O 0 2.3360907652758556e-10
distal O 0 6.356530413142991e-09
end O 0 6.695317633642617e-09
of O 0 7.825350145651555e-09
the O 0 2.997098391688269e-08
gene O 0 9.794541178109739e-09
. O 0 9.517020771454554e-08

Variability O 0 3.1748654691909906e-06
in O 0 4.526181929254136e-10
the O 0 4.387545604611631e-10
number O 0 1.1255265608411946e-09
of O 0 7.618692734467913e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.7476791924764257e-07
most O 0 3.866804793029033e-11
apparent O 0 1.4046948049184493e-09
in O 0 2.1163744368113413e-11
individuals O 0 2.7194697882482188e-11
with O 0 2.7332499111243358e-11
mutations O 0 1.2130632054407897e-09
in O 0 5.6469549036819444e-09
region O 0 2.188760163335246e-06
1 O 0 9.694164049278697e-08
, O 0 1.0622822760320005e-10
and O 0 1.7816105257750792e-09
upper O 1 0.9999736547470093
- O 0 0.4791069030761719
gastrointestinal O 0 2.028144990617875e-06
manifestations O 0 4.274395905667916e-05
were O 0 1.791912467297152e-07
more O 0 1.3626134075239715e-11
severe O 0 1.5148620136073987e-09
in O 0 1.130616711364496e-10
them O 0 1.0256328009106142e-09
. O 0 7.163109216890007e-08

In O 0 4.148923427038653e-09
individuals O 0 1.239080366088885e-10
with O 0 1.4558743099968297e-11
mutations O 0 1.035543178984355e-10
in O 0 6.464807161821184e-11
either O 0 7.26670279505015e-08
region O 0 1.7244752825718024e-06
2 O 0 9.42327194053405e-09
or O 0 6.612150826867946e-10
region O 0 1.2888687450640646e-08
3 O 0 2.104589141849189e-10
, O 0 9.95301497469514e-13
the O 0 2.0069243576031903e-12
average O 0 6.114758699382605e-11
number O 0 7.341742491728809e-11
of O 0 1.2275638283654189e-09
adenomas B-Disease 0 2.1256667537272733e-07
tended O 0 7.693163439626005e-09
to O 0 1.512159952810066e-09
be O 0 1.8397641188272473e-09
lower O 0 1.9915042059892585e-08
than O 0 1.2778564664750469e-11
those O 0 6.217959307164289e-12
in O 0 4.860030780595714e-12
individuals O 0 4.2180564596705494e-12
with O 0 5.646289425592643e-12
mutations O 0 2.2014380596235839e-10
in O 0 1.5189986768415764e-10
region O 0 1.520983339275972e-08
1 O 0 8.45737591070872e-10
, O 0 1.7388768376591646e-12
although O 0 6.479444585039129e-12
age O 0 3.209678356430601e-10
at O 0 1.1388368026388207e-10
diagnosis O 0 2.7391305224000462e-08
was O 0 9.415398460888014e-10
similar O 0 1.3944334575910489e-09
. O 0 7.839815197030475e-08

In O 0 2.514136383524601e-07
all O 0 4.299824070130853e-07
AAPC B-Disease 1 1.0
kindreds O 0 8.186338163795881e-06
, O 0 3.037603502065167e-11
a O 0 1.841110423839165e-11
predominance O 0 3.2770035574003487e-08
of O 0 6.740769720181561e-08
right O 0 0.000977572170086205
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.45518991351127625
rectal B-Disease 1 1.0
polyp I-Disease 0 7.153638580348343e-05
sparing O 0 5.484463372340542e-08
was O 0 1.1345776762539117e-08
observed O 0 6.670207053360855e-09
. O 0 2.4181320057437006e-08

No O 0 9.991485057980753e-06
desmoid B-Disease 1 0.9998173117637634
tumors I-Disease 1 1.0
were O 0 3.086674098540243e-07
found O 0 9.39476829664443e-10
in O 0 1.4641653167668522e-10
these O 0 6.790069617679251e-10
kindreds O 0 1.1080552440034808e-06
. O 0 1.195105170381794e-07

Our O 0 4.816313776245806e-06
data O 0 1.7456486034461705e-07
suggest O 0 3.4266001147642555e-09
that O 0 7.173691762146772e-12
, O 0 6.720973170365463e-12
in O 0 2.743069937860554e-10
AAPC B-Disease 1 1.0
families O 0 3.030330708586604e-10
, O 0 8.919680857637224e-13
the O 0 2.5120671601902567e-12
location O 0 3.46757844660317e-10
of O 0 2.680222155326817e-10
the O 0 2.99266389447439e-09
APC B-Disease 0 2.904297161876457e-06
mutation O 0 1.0591797661163582e-08
may O 0 8.658184724730233e-10
partially O 0 1.995477383331945e-08
predict O 0 4.132961084479803e-09
specific O 0 1.5569624478573019e-09
phenotypic O 0 4.775511541765809e-08
expression O 0 1.2276679228762077e-07
. O 0 1.993028462266011e-07

This O 0 1.865680721024887e-09
should O 0 2.2680983480238837e-10
help O 0 2.920071962009274e-10
in O 0 4.806745713265004e-12
the O 0 1.5313000867323012e-11
design O 0 7.514488475912628e-10
of O 0 1.8823398395539925e-10
tailored O 0 2.8598605705809632e-09
clinical O 0 4.778390660931109e-08
- O 0 1.4780503043709814e-08
management O 0 3.0238658244030603e-09
protocols O 0 1.931708837332735e-08
in O 0 6.3097010255530606e-12
this O 0 1.3499988887194503e-12
subset O 0 7.558052794731651e-11
of O 0 1.2629672307973294e-10
FAP B-Disease 0 3.545496340962018e-08
patients O 0 9.128693356785789e-10
. O 0 2.753333394611701e-10
. O 0 1.0698025576516557e-08

Wilms B-Disease 1 0.9974101185798645
' I-Disease 0 1.3972655324323568e-05
tumor I-Disease 0 1.662952399783535e-06
1 O 0 6.625510806657076e-09
and O 0 3.745331156324028e-09
Dax O 1 0.9993723034858704
- O 0 5.487371481649461e-07
1 O 0 1.0003354589116498e-08
modulate O 0 6.137456320942647e-09
the O 0 7.266072743483676e-10
orphan O 0 2.782644947796342e-10
nuclear O 0 7.79838149611578e-09
receptor O 0 3.650063584714758e-11
SF O 0 2.1087093955429737e-06
- O 0 2.5712763473961786e-08
1 O 0 5.779363446145602e-11
in O 0 2.1949371573765086e-12
sex O 0 1.0621196630533625e-11
- O 0 5.341508485523505e-12
specific O 0 2.833965917839465e-12
gene O 0 8.190378930628128e-12
expression O 0 2.3537394255868094e-10
. O 0 3.2676645833618068e-09

Products O 0 4.957820465278928e-07
of O 0 3.6972187444916926e-07
steroidogenic O 0 1.9348697605892085e-05
factor O 0 3.2738343147542537e-09
1 O 0 3.3525945908330357e-10
( O 0 1.5792128021940854e-11
SF O 0 2.0865224996668985e-06
- O 0 2.7790250101134006e-08
1 O 0 1.4199434683614953e-10
) O 0 5.5631116033239e-12
and O 0 4.289367472321004e-10
Wilms B-Disease 0 0.07282063364982605
tumor I-Disease 0 3.932877064016793e-07
1 O 0 2.2311521519213784e-09
( O 0 3.5160614003659774e-11
WT1 O 0 3.369645185102854e-07
) O 0 2.3553585297431123e-12
genes O 0 4.528802680092703e-12
are O 0 6.774972022196429e-14
essential O 0 1.1590411963524616e-10
for O 0 1.1180410763866888e-11
mammalian O 0 1.7588041245630848e-08
gonadogenesis O 0 4.496389038877169e-08
prior O 0 2.314158642491293e-08
to O 0 1.873690314013743e-09
sexual O 0 1.505024904702168e-08
differentiation O 0 2.1611167255741748e-07
. O 0 2.658713356140652e-07

In O 0 1.0978241427039848e-08
males O 0 1.0065153155380813e-08
, O 0 1.9073820300974376e-10
SF O 0 0.0008104448788799345
- O 0 1.8340878114031511e-06
1 O 0 6.176299471860602e-10
participates O 0 2.0555657176402065e-10
in O 0 1.160464628037483e-12
sexual O 0 3.5497791772004517e-12
development O 0 1.9949797022689175e-11
by O 0 2.350227759802259e-13
regulating O 0 1.471443626666069e-11
expression O 0 5.16411002501882e-12
of O 0 5.7060862979074756e-11
the O 0 2.483342975700964e-10
polypeptide O 0 5.226585386708393e-09
hormone O 0 1.1225294027639166e-09
Mullerian O 0 5.506769440444259e-08
inhibiting O 0 3.5879992310583475e-09
substance O 0 1.6303644656545657e-08
( O 0 5.19983500701926e-10
MIS O 0 7.000623008934781e-05
) O 0 6.151246734198423e-10
. O 0 7.561985881920918e-08

Here O 0 5.184381848266639e-07
, O 0 5.732379015910283e-10
we O 0 1.655689890744938e-10
show O 0 3.846394314166446e-10
that O 0 2.4753119692855208e-11
WT1 O 0 1.1167286174895708e-05
- O 0 8.979683912002656e-07
KTS O 0 7.876769814174622e-05
isoforms O 0 2.6186816270978852e-08
associate O 0 6.738800628625086e-09
and O 0 4.1824089330733116e-11
synergize O 0 9.845415860354478e-08
with O 0 3.6559180682793624e-10
SF O 0 0.14524637162685394
- O 0 7.06590924437478e-07
1 O 0 1.3459489078826437e-09
to O 0 9.453997584785157e-10
promote O 0 4.949779963681067e-07
MIS O 0 0.0005579316639341414
expression O 0 4.048357737929109e-08
. O 0 2.61767780784794e-08

In O 0 4.229948658007743e-08
contrast O 0 2.0614180584743735e-08
, O 0 1.6660750556951598e-09
WT1 O 0 2.6803307264344767e-05
missense O 0 2.6258445018356724e-07
mutations O 0 2.934689435907245e-10
, O 0 6.202569382586509e-13
associated O 0 1.691375234313952e-10
with O 0 5.047161993898541e-11
male B-Disease 0 8.283626812044531e-06
pseudohermaphroditism I-Disease 1 1.0
in O 0 5.736492312280461e-06
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.018631733464616e-10
fail O 0 3.47295724623109e-07
to O 0 3.765745937300835e-09
synergize O 0 5.46666387890582e-06
with O 0 2.623806238943871e-08
SF O 1 1.0
- O 0 0.048944734036922455
1 O 0 1.0347879424443818e-06
. O 0 7.59466800559494e-08

Additionally O 0 8.124115424834599e-08
, O 0 3.199871964620904e-11
the O 0 8.892646341518429e-11
X O 0 1.1112416586911422e-06
- O 0 5.055908403051035e-08
linked O 0 1.2466960797041793e-08
, O 0 2.6793760352777918e-12
candidate O 0 5.898963262307433e-11
dosage O 0 4.4797477727342994e-08
- O 0 3.0989064647712894e-09
sensitive O 0 6.557733023271339e-09
sex O 0 2.5936905401202637e-10
- O 0 5.870064434532196e-10
reversal O 0 1.3877180515819987e-09
gene O 0 3.642080040333617e-11
, O 0 2.3373332783127587e-11
Dax O 0 0.00022853759583085775
- O 0 5.347900966512498e-08
1 O 0 2.308717217403e-09
, O 0 6.595005097587148e-11
antagonizes O 0 9.98160842868856e-09
synergy O 0 2.567785539753231e-09
between O 0 3.680197036004529e-09
SF O 0 2.4602861230960116e-05
- O 0 3.3379734531990835e-08
1 O 0 6.174023792215877e-11
and O 0 1.5733350386404332e-11
WT1 O 0 1.2618461369129363e-06
, O 0 2.359832598428091e-12
most O 0 3.426691168231105e-13
likely O 0 1.986117433711021e-12
through O 0 4.989280689982056e-12
a O 0 1.1088284804228188e-11
direct O 0 2.1984002118724533e-10
interaction O 0 6.527733020789128e-09
with O 0 1.7679345765131416e-09
SF O 1 0.9998856782913208
- O 0 4.413873830344528e-05
1 O 0 2.0635016539927165e-07
. O 0 6.02821614847926e-08

We O 0 5.7969920419509435e-08
propose O 0 1.1343850303546787e-08
that O 0 1.8355468534014818e-10
WT1 O 0 6.397525339707499e-06
and O 0 1.331340016008653e-08
Dax O 1 0.6289983987808228
- O 0 4.3737847477132163e-07
1 O 0 2.503079299387423e-09
functionally O 0 5.928058044446516e-09
oppose O 0 2.0419308605079678e-11
each O 0 6.871710232086992e-13
other O 0 1.0815977020267598e-12
in O 0 1.0631816607653555e-11
testis O 0 2.9356315156547907e-09
development O 0 1.2869046106533943e-10
by O 0 1.7990648901178297e-11
modulating O 0 8.775734805510638e-09
SF O 0 8.563355549995322e-06
- O 0 1.3386662089942547e-07
1 O 0 7.999714668471825e-09
- O 0 1.702514218493434e-08
mediated O 0 1.2681492478350265e-07
transactivation O 0 3.494110160318087e-06
. O 0 1.6449317463695934e-09
. O 0 4.137188369668365e-09

A O 0 1.6071335551259835e-07
mouse O 0 6.978110866917575e-10
model O 0 2.780193852913726e-10
for O 0 4.610932524684586e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 0 0.00037928385427221656
centre O 0 1.4477360821274488e-07
mutations O 0 5.0959387820626034e-09
. O 0 2.5230959543875997e-09

Imprinting O 0 6.115559699537698e-06
in O 0 1.6217107656757435e-09
the O 0 5.880792297574544e-09
15q11 O 0 1.757692916726228e-05
- O 0 1.1398260824080353e-07
q13 O 0 4.3626076262626157e-07
region O 0 6.28693097581845e-10
involves O 0 3.007746829375435e-10
an O 0 3.5983698659647345e-12
imprinting O 0 1.5317104953282978e-06
centre O 0 3.654493241356249e-07
( O 0 5.582842868556703e-11
IC O 0 0.00022577146592084318
) O 0 1.650845432576986e-11
, O 0 1.1957773096357704e-12
mapping O 0 2.9266961076857e-10
in O 0 2.4498439301495756e-12
part O 0 8.021307576489e-12
to O 0 5.890271603803399e-11
the O 0 6.248163098021564e-10
promoter O 0 1.0259133631507211e-07
and O 0 3.1332458849675504e-10
first O 0 3.511810930945103e-08
exon O 0 3.157306025514117e-07
of O 0 1.3134916798662744e-07
SNRPN O 1 0.9999759197235107
. O 0 3.922313680959633e-06

Deletion O 0 2.03770170514872e-07
of O 0 2.1986959808373285e-08
this O 0 2.2025101742428888e-09
IC O 0 5.409350342233665e-05
abolishes O 0 2.7780922451370316e-08
local O 0 2.041539604036302e-09
paternally O 0 2.4596342740323962e-08
derived O 0 7.479508679075764e-11
gene O 0 7.15603574660828e-12
expression O 0 5.843917797593301e-12
and O 0 3.3726770291495067e-13
results O 0 7.235463617139004e-11
in O 0 1.2822531481049282e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.862893208861351e-05
PWS B-Disease 1 1.0
) O 0 6.6260796849348935e-09
. O 0 2.7264436042173656e-08

We O 0 2.576224744643696e-08
have O 0 2.280808007737445e-11
created O 0 6.125728396755292e-12
two O 0 3.6210214514331707e-12
deletion O 0 3.495894962401991e-10
mutations O 0 4.743884104985163e-11
in O 0 2.8053722539445047e-11
mice O 0 7.525202683211774e-10
to O 0 6.455778134295542e-10
understand O 0 3.445011316216551e-05
PWS B-Disease 1 1.0
and O 0 1.5781603801556798e-09
the O 0 8.576905852208938e-10
mechanism O 0 1.6825286053290256e-08
of O 0 5.753849063871996e-10
this O 0 4.98159291595357e-10
IC O 0 4.034603261970915e-05
. O 0 9.985782156718415e-08

Mice O 0 5.724883976654382e-06
harbouring O 0 5.1579852879513055e-05
an O 0 1.3774440477121175e-09
intragenic O 0 5.050186155131087e-05
deletion O 0 2.470609103966126e-07
in O 0 5.6708624462942225e-09
Snrpn O 0 0.07008269429206848
are O 0 3.5077241111736157e-10
phenotypically O 0 6.504574798782414e-07
normal O 0 7.72252519709582e-08
, O 0 1.1300340871378545e-11
suggesting O 0 1.400803917306348e-10
that O 0 8.091588922336246e-13
mutations O 0 6.533157348442842e-11
of O 0 2.070420945798901e-09
SNRPN O 1 0.9991445541381836
are O 0 3.6514982010293906e-11
not O 0 3.2264333565956704e-11
sufficient O 0 1.2947302785448755e-08
to O 0 1.75108176847516e-08
induce O 0 9.60939796641469e-05
PWS B-Disease 1 1.0
. O 0 1.542661448183935e-05

Mice O 0 2.537702812333009e-07
with O 0 9.90337256645546e-11
a O 0 8.43636271952164e-11
larger O 0 4.843782666630325e-11
deletion O 0 2.0651190479892279e-10
involving O 0 4.895006067151542e-10
both O 0 8.289937070138365e-10
Snrpn O 0 8.735460141906515e-05
and O 0 1.0560902846679099e-10
the O 0 1.1740605154741957e-09
putative O 0 4.074600212788937e-07
PWS O 1 1.0
- O 0 7.970475053298287e-06
IC O 0 0.00012114685523556545
lack O 0 1.9091497449608141e-07
expression O 0 3.6999162067452573e-10
of O 0 1.7912352157090083e-10
the O 0 2.445052216248911e-10
imprinted O 0 5.845665729253824e-09
genes O 0 4.952112053757673e-10
Zfp127 O 0 2.5773042011678626e-07
( O 0 1.0510679132602618e-11
mouse O 0 3.855634700400401e-10
homologue O 0 8.696984465927926e-09
of O 0 5.059776952975881e-08
ZNF127 O 1 0.9999998807907104
) O 0 2.676749266683487e-09
, O 0 4.793687669035762e-09
Ndn O 0 2.8338090487523004e-05
and O 0 3.1180926729490466e-09
Ipw O 0 5.796356617793208e-06
, O 0 1.0042190690118247e-10
and O 0 3.293585196240123e-11
manifest O 0 4.7218648546731856e-08
several O 0 3.723703845270876e-10
phenotypes O 0 8.726662059643786e-09
common O 0 8.322160738316597e-10
to O 0 3.169657247781288e-07
PWS B-Disease 1 1.0
infants O 0 0.4631298780441284
. O 0 6.330591872938385e-07

These O 0 2.6694992882880797e-09
data O 0 1.0417284812547223e-09
demonstrate O 0 4.19942108864646e-10
that O 0 3.2652781303474376e-13
both O 0 1.8790054148037916e-12
the O 0 7.589150662068445e-12
position O 0 4.1531650341042337e-10
of O 0 1.6774576172551292e-10
the O 0 2.0885855545049736e-10
IC O 0 1.7631757145863958e-05
and O 0 1.8400642121108035e-11
its O 0 2.597083789343535e-12
role O 0 2.942647167603063e-11
in O 0 9.025516445326787e-12
the O 0 3.9659855260998356e-11
coordinate O 0 9.208699913720864e-10
expression O 0 1.0286890228528023e-09
of O 0 4.058398506145977e-09
genes O 0 7.005619001576591e-11
is O 0 5.064552835269687e-13
conserved O 0 8.236551024554117e-11
between O 0 9.510117138233909e-10
mouse O 0 9.520716437450005e-10
and O 0 2.5261367650464273e-11
human O 0 1.7250405270896607e-10
, O 0 2.6788139848715753e-12
and O 0 1.0163615825689587e-12
indicate O 0 4.108764023458278e-11
that O 0 2.0400058053406112e-13
the O 0 2.4848199886573497e-11
mouse O 0 1.187740739094778e-10
is O 0 4.2116554384644123e-13
a O 0 3.1283578158514125e-12
suitable O 0 1.608571831290817e-09
model O 0 2.86077023181619e-10
system O 0 8.117138072805119e-10
in O 0 9.846467391438907e-12
which O 0 7.736615167952543e-13
to O 0 2.3755494099608754e-11
investigate O 0 3.808862114595968e-10
the O 0 1.196234777900429e-10
molecular O 0 4.819079024720452e-10
mechanisms O 0 6.92464219298472e-09
of O 0 2.0297594716112144e-09
imprinting O 0 7.189101580706847e-08
in O 0 3.7870411667695336e-11
this O 0 1.0591983887198175e-11
region O 0 6.185565948335636e-10
of O 0 2.286227318570866e-10
the O 0 1.623130241323878e-10
genome O 0 1.2145958683262847e-09
. O 0 3.3567601476214293e-10
. O 0 1.2146845307370313e-08

Mutations O 0 8.352095193231435e-08
of O 0 1.9488322067218178e-08
the O 0 1.5491696814251554e-08
ATM O 0 0.00013779081928078085
gene O 0 6.210889580415824e-10
detected O 0 1.0141421036280462e-09
in O 0 5.7621924592909934e-11
Japanese O 1 0.9913294315338135
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9981642365455627
: O 0 1.7804740320981338e-11
possible O 0 1.5270044950721484e-10
preponderance O 0 2.135365217981189e-09
of O 0 3.890975389109208e-11
the O 0 1.8693404463254737e-11
two O 0 5.4738165389256466e-11
founder O 0 5.795994351132094e-09
mutations O 0 1.3198981907436291e-09
4612del165 O 0 1.5984910817223863e-07
and O 0 1.5190545488152907e-09
7883del5 O 0 2.3746486476738937e-05
. O 0 4.2308124648116063e-07

The O 0 6.126371232539896e-08
ATM O 0 0.049147896468639374
( O 0 6.8164665023573434e-09
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 4.535746778167038e-11
mutated O 0 8.306912449573822e-12
) O 0 6.093374096309903e-14
gene O 0 5.07699080259244e-13
on O 0 1.083729373602127e-11
human O 0 1.4779587276247952e-10
chromosome O 0 4.2837036140497275e-09
11q22 O 0 2.5578015083738137e-06
. O 0 6.631341875618091e-08

3 O 0 1.1375738040442229e-07
has O 0 6.58715998413939e-11
recently O 0 5.3371317781936156e-11
been O 0 1.352674916521579e-11
identified O 0 5.250891041419514e-11
as O 0 3.8822536765209525e-13
the O 0 4.160018683696531e-12
gene O 0 1.9003860984856402e-12
responsible O 0 1.4099545316004214e-11
for O 0 7.709647156795008e-12
the O 0 2.4662649700246675e-10
human O 0 3.804807136020827e-08
recessive B-Disease 1 0.9999982118606567
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9990164041519165
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.037945698977865e-10
. O 0 7.619766151378826e-09

In O 0 2.9735971462940824e-09
order O 0 1.6392588675362418e-10
to O 0 1.277871836125044e-10
define O 0 7.868660167886787e-10
the O 0 2.2005846797568118e-11
types O 0 2.0352830532033295e-10
of O 0 7.421419589981326e-10
disease O 0 5.153007691660605e-07
- O 0 1.3696370704252558e-09
causing O 0 2.492696327127675e-10
ATM O 0 3.567230351109174e-07
mutations O 0 8.256758991798119e-12
in O 0 1.7010339534509478e-12
Japanese O 0 1.1050260440015336e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.6864329306117725e-07
as O 0 7.823532620354623e-12
well O 0 8.794119078781026e-12
as O 0 1.3118297680775326e-12
to O 0 1.9174046031467107e-11
look O 0 1.0223451252233673e-10
for O 0 2.373076735118218e-11
possible O 0 5.411546322164895e-09
mutational O 0 2.787487858313398e-07
hotspots O 0 5.370078604016726e-09
, O 0 4.687558934762803e-12
reverse O 0 5.88951110103153e-10
- O 0 1.4574511597587048e-09
transcribed O 0 7.547641955873985e-10
RNA O 0 7.407122692981716e-10
derived O 0 7.198421719811776e-11
from O 0 2.4558804642693666e-11
ten O 0 7.366025567279166e-10
patients O 0 2.740192274475195e-11
belonging O 0 1.2607602462022527e-10
to O 0 9.927272545673382e-12
eight O 0 2.1377642711595257e-10
unrelated O 0 8.872557133443593e-10
Japanese O 0 2.7610357733465207e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.8265475798528996e-09
was O 0 2.2124413412427657e-10
analyzed O 0 6.316435569031498e-11
for O 0 2.7999220238335287e-13
mutations O 0 7.412863183529905e-13
by O 0 1.711411231914567e-13
the O 0 6.340464611676033e-12
restriction O 0 8.726332156872019e-12
endonuclease O 0 4.7356393112485407e-11
fingerprinting O 0 1.3384838792873666e-09
method O 0 2.0003934508849852e-08
. O 0 1.1948385747473367e-07

As O 0 1.9539573514748554e-08
has O 0 1.9666969441889393e-11
been O 0 9.726166920465129e-12
reported O 0 5.168169711633475e-12
by O 0 1.288703844158634e-12
others O 0 4.8976184219284846e-11
, O 0 4.2111756790030874e-12
mutations O 0 4.644841108958353e-11
that O 0 1.1214234835882353e-12
lead O 0 6.137804708927774e-10
to O 0 3.4228180290085675e-09
exon O 0 9.813020085402968e-08
skipping O 0 3.16927042831594e-07
or O 0 9.560062963487326e-09
premature O 0 1.1799697858805303e-06
protein O 0 4.864712188634712e-09
truncation O 0 6.776858185730816e-07
were O 0 1.2870999377412318e-08
also O 0 3.410913912427205e-11
predominant O 0 1.2629757684123888e-08
in O 0 2.176579055879202e-10
our O 0 9.872305639646584e-08
mutants O 0 2.8577471766766394e-07
. O 0 1.0956615170698569e-07

Six O 0 7.1940506884971e-09
different O 0 3.6513170958984986e-11
mutations O 0 1.0843909971358645e-11
were O 0 8.175115098763008e-12
identified O 0 1.4530945890989244e-11
on O 0 2.5008242005020165e-11
12 O 0 1.3472632731659218e-10
of O 0 1.3738540860508408e-10
the O 0 1.5712396661538008e-10
16 O 0 6.346753789188142e-09
alleles O 0 4.0172171145158586e-10
examined O 0 1.0102643699383407e-07
. O 0 2.65988006731277e-07

Four O 0 4.1056054556065646e-08
were O 0 3.280948179806842e-09
deletions O 0 2.063139881158804e-09
involving O 0 5.656071722093259e-10
a O 0 1.1933200261271537e-10
loss O 0 6.68812134563268e-08
of O 0 1.0558464964560699e-06
a O 0 8.625026026720661e-09
single O 0 6.017578613182195e-08
exon O 0 6.17110060829873e-08
exon O 0 1.1947036249182474e-08
7 O 0 8.336797030494836e-09
, O 0 4.778759610246652e-10
exon O 0 6.847140632260107e-09
16 O 0 3.919612190372845e-09
, O 0 9.265165856753299e-10
exon O 0 3.580098706379431e-08
33 O 0 4.536826381240644e-08
or O 0 1.7117974593361396e-08
exon O 0 4.4379441987985047e-07
35 O 0 5.705865646632446e-07
. O 0 8.725565407985414e-07

The O 0 5.019080262513853e-08
others O 0 4.912002360413226e-09
were O 0 2.129337373091289e-09
minute O 0 1.552165684870488e-08
deletions O 0 2.9724176453527207e-09
, O 0 2.4798390771407774e-11
4649delA O 0 3.005708393288842e-08
in O 0 8.28216106807389e-10
exon O 0 1.3293963263549813e-08
33 O 0 1.1575313152434319e-08
and O 0 7.490362219364499e-10
7883del5 O 0 2.9111049570929026e-06
in O 0 1.045778308395029e-08
exon O 0 1.5759691507355456e-07
55 O 0 2.2207305505617114e-07
. O 0 1.9641045412299718e-07

The O 0 1.9951507113091793e-07
mutations O 0 6.14458031122922e-08
4612del165 O 0 9.693309266367578e-07
and O 0 2.4345120364088757e-10
7883del5 O 0 1.865647959675698e-06
were O 0 2.317037228749541e-09
found O 0 3.8398759866220544e-11
in O 0 1.5655064050656975e-12
more O 0 9.468668253978518e-14
than O 0 9.064945923889164e-14
two O 0 3.1494061915673943e-13
unrelated O 0 2.6264873609349593e-10
families O 0 6.481447323292144e-12
; O 0 2.3439201426132816e-13
44 O 0 3.689767935632915e-10
% O 0 4.6149425947383804e-10
( O 0 2.7895398664601334e-12
7 O 0 6.078689773758583e-10
of O 0 3.4322300557221297e-10
16 O 0 3.591496267052463e-10
) O 0 9.210794019859359e-13
of O 0 1.0240541921391344e-11
the O 0 6.547861645250785e-12
mutant O 0 2.3077945804361732e-11
alleles O 0 1.6199090679958061e-12
had O 0 1.1304695894664984e-11
one O 0 3.350436898405529e-12
of O 0 6.582839828794818e-11
the O 0 4.790815522071057e-10
two O 0 1.629617552012519e-09
mutations O 0 5.495361055096737e-09
. O 0 6.137564412256324e-08

The O 0 2.612700598092488e-07
4612del165 O 0 1.0225664482277352e-05
mutations O 0 5.566470617779373e-10
in O 0 2.8366371751520347e-12
three O 0 1.031414428691313e-12
different O 0 5.151534580860595e-13
families O 0 1.4032627056875802e-12
were O 0 9.905710800228729e-12
all O 0 9.724530208865545e-13
ascribed O 0 6.446287947881046e-11
to O 0 6.852068825530244e-12
the O 0 3.3467853488566845e-11
same O 0 1.577031144561758e-10
T O 0 1.170957020235619e-08
- O 0 7.396823065164426e-08
- O 0 1.4985454654947716e-08
> O 0 2.195200021759547e-09
A O 0 6.506200578293431e-10
substitution O 0 1.6124691859520368e-10
at O 0 6.154471376973447e-11
the O 0 2.4217006872051527e-11
splice O 0 5.283678383705137e-09
donor O 0 8.211660240675656e-10
site O 0 4.53569681813093e-10
in O 0 5.732881946940438e-10
intron O 0 7.425744570355164e-07
33 O 0 8.082475915216492e-07
. O 0 6.382641117852472e-07

Microsatellite O 0 2.500690470697009e-06
genotyping O 0 1.918192310768063e-06
around O 0 7.522749090327352e-10
the O 0 8.743468171701352e-10
ATM O 0 4.7689945859019645e-06
locus O 0 9.323470884226026e-10
also O 0 2.6091837024289077e-12
indicated O 0 5.881616721437055e-11
that O 0 5.981198609311678e-13
a O 0 4.684126784365583e-12
common O 0 2.4095095710330305e-11
haplotype O 0 1.1751090100986517e-09
was O 0 1.532768356682368e-09
shared O 0 4.910060691365459e-10
by O 0 5.723119894662787e-12
the O 0 7.053982398197434e-11
mutant O 0 1.3402713661125887e-10
alleles O 0 1.0145492952695623e-11
in O 0 1.8661201056646703e-11
both O 0 9.623467578379064e-10
mutations O 0 2.244825481056978e-08
. O 0 1.1946208644530998e-07

This O 0 8.852306110362917e-10
suggests O 0 3.0864524824814055e-10
that O 0 2.0998585086463156e-13
these O 0 1.0043482972371676e-12
two O 0 1.2216554157173931e-11
founder O 0 5.1894937236340866e-09
mutations O 0 4.344276882672915e-10
may O 0 2.7747148328982618e-11
be O 0 8.099657056170884e-11
predominant O 0 1.5122212815299463e-08
among O 0 5.054540813675956e-11
Japanese O 0 1.264086080254856e-07
ATM O 0 1.4304985597846098e-05
mutant O 0 8.578795984703902e-08
alleles O 0 4.8194217505681536e-09
. O 0 1.226953969535316e-07

W474C O 0 1.1437693956395378e-06
amino O 0 1.996496745704235e-09
acid O 0 4.12841878738579e-11
substitution O 0 1.589221254594264e-10
affects O 0 4.501983421473232e-12
early O 0 3.41405757831037e-11
processing O 0 1.6728575191748973e-09
of O 0 7.578204036517988e-11
the O 0 3.292090211548526e-11
alpha O 0 9.345770685120769e-12
- O 0 9.33960461052541e-12
subunit O 0 1.3174792203377028e-12
of O 0 2.520250848292438e-11
beta O 0 4.13536399568315e-10
- O 0 2.638911977825842e-09
hexosaminidase O 0 8.786140170968793e-08
A O 0 7.99555088804027e-09
and O 0 4.8862793151915884e-12
is O 0 6.126566810295275e-13
associated O 0 5.028964467079788e-10
with O 0 5.1707159387515134e-11
subacute O 0 0.0240336861461401
G B-Disease 0 3.29253998643253e-06
( I-Disease 0 2.9061478223901815e-10
M2 I-Disease 0 1.1072968391090399e-06
) I-Disease 0 4.690738908408321e-10
gangliosidosis I-Disease 0 2.968170065287268e-06
. O 0 1.1318223158696128e-07

Mutations O 0 1.0905779390668613e-08
in O 0 2.540692378705245e-10
the O 0 8.697412234859314e-10
HEXA O 0 1.4304221167549258e-06
gene O 0 8.71917815725709e-12
, O 0 1.8716966995388495e-13
encoding O 0 1.1082914100346564e-11
the O 0 1.5694775340469036e-11
alpha O 0 8.277051787020095e-12
- O 0 6.445965722995384e-12
subunit O 0 1.1194232390002168e-12
of O 0 3.423415023684484e-11
beta O 0 2.7569854732512056e-10
- O 0 3.4526057568484703e-09
hexosaminidase O 0 1.152682571614605e-07
A O 0 3.348457155993856e-08
( O 0 3.982318381307026e-12
Hex O 0 1.6690465898250295e-08
A O 0 3.383676450141593e-09
) O 0 8.784392484251224e-13
, O 0 5.024296950706386e-13
that O 0 3.0994084794337684e-13
abolish O 0 1.2575378516288538e-09
Hex O 0 1.1484465822775292e-08
A O 0 8.232612924707894e-10
enzyme O 0 3.7876410341475264e-11
activity O 0 9.473654083436145e-10
cause O 0 3.469037983450107e-05
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 9.26262533340605e-09
TSD B-Disease 1 0.9999998807907104
) O 0 1.4533468178923314e-11
, O 0 9.307608937053624e-13
the O 0 1.7122130102631417e-11
fatal O 0 3.5395981967667467e-07
infantile B-Disease 0 4.1711908238539763e-07
form I-Disease 0 1.6065022645506133e-09
of I-Disease 0 3.4727495403785724e-06
G I-Disease 0 2.788314645840728e-07
( I-Disease 0 6.033602784061287e-11
M2 I-Disease 0 7.502536902848078e-08
) I-Disease 0 3.486038888111942e-11
gangliosidosis I-Disease 0 9.945731704874561e-08
, I-Disease 0 4.6184979451968644e-11
Type I-Disease 0 4.3435415264525545e-09
1 I-Disease 0 1.722408704551981e-08
. O 0 2.900734585864484e-08

Less O 0 6.030332428963447e-07
severe O 0 1.902619442262221e-05
, O 0 3.7802756480687094e-09
subacute O 1 0.9957301020622253
( O 0 1.3355225259026327e-10
juvenile O 0 5.7439447118667886e-05
- O 0 2.2422094048124563e-07
onset O 1 0.95179682970047
) O 0 5.5332401854846225e-11
and O 0 4.961019595128846e-09
chronic O 1 1.0
( O 0 8.044630933623509e-11
adult O 0 0.00034742828574962914
- O 0 3.450815189154355e-09
onset O 0 2.0678841750054744e-08
) O 0 2.896215981883915e-13
variants O 0 2.8573931415420972e-11
are O 0 4.438529350916237e-13
characterized O 0 2.680035230198663e-12
by O 0 1.0795161422758048e-12
a O 0 1.6390047305470112e-11
broad O 0 8.949426616444711e-11
spectrum O 0 1.9997057343346114e-09
of O 0 2.285625577691519e-10
clinical O 0 2.884083416532235e-09
manifestations O 0 1.0090007052099281e-08
and O 0 3.0058296129897855e-11
are O 0 1.3696950474859082e-12
associated O 0 8.737496143274015e-11
with O 0 2.252249168416265e-12
residual O 0 1.9887103519522498e-08
levels O 0 4.647433549109792e-09
of O 0 1.3194426662366254e-09
Hex O 0 2.7232889721062747e-08
A O 0 7.144072888820574e-09
enzyme O 0 5.597303176507751e-10
activity O 0 1.1546558376096527e-08
. O 0 4.030383493613954e-08

We O 0 1.824751905132871e-08
identified O 0 1.6324110951870807e-09
a O 0 6.756876308466886e-11
1422 O 0 2.5215769028363866e-08
G O 0 2.4778902485422805e-08
- O 0 6.010083097862662e-07
- O 0 1.0979061215721231e-07
> O 0 3.4694522810241324e-09
C O 0 1.3589972702732211e-08
( O 0 8.333520505610092e-13
amino O 0 1.2893855254325626e-11
acid O 0 4.563556563891291e-12
W474C O 0 7.471599450248334e-10
) O 0 8.182746540357118e-15
substitution O 0 5.1817118304486876e-12
in O 0 2.3057783980762192e-12
the O 0 2.7093945142997455e-11
first O 0 1.4090090205698402e-10
position O 0 1.2290215956056727e-08
of O 0 8.879587731769334e-09
exon O 0 3.793964253873128e-09
13 O 0 5.780425027523961e-10
of O 0 5.501622268866413e-09
HEXA O 0 5.3665557061322033e-05
of O 0 3.8886366127144356e-08
a O 0 7.671736579339949e-10
non O 0 5.118941999171511e-07
- O 0 3.346407595472556e-08
Jewish O 0 2.384455122239615e-08
proband O 0 0.028218483552336693
who O 0 3.487230781917816e-10
manifested O 0 4.538113884677841e-09
a O 0 7.574649241171016e-11
subacute O 0 1.846082255951842e-07
variant O 0 4.4847467961517395e-09
of O 0 1.0827124015122536e-06
G B-Disease 0 7.0618671088595875e-06
( I-Disease 0 8.301994092185794e-10
M2 I-Disease 0 2.4409134766756324e-06
) I-Disease 0 8.856123057121579e-10
gangliosidosis I-Disease 0 4.5925039557914715e-06
. O 0 1.2528631998520723e-07

On O 0 1.2753751832406124e-07
the O 0 4.968917721726029e-09
second O 0 3.832864337027786e-08
maternally O 0 9.740812174641178e-07
inherited O 0 2.09344577228876e-07
allele O 0 7.441494087601086e-09
, O 0 1.088126550669033e-11
we O 0 2.1497845170692642e-11
identified O 0 7.078286290429503e-10
the O 0 3.7372657746281845e-10
common O 0 3.6171081774227787e-07
infantile O 1 1.0
disease O 1 1.0
- O 0 0.0005107201868668199
causing O 0 1.461775980260427e-07
4 O 0 2.1057935555290896e-06
- O 0 2.5259703306801384e-07
bp O 0 1.088396039961026e-08
insertion O 0 1.1086651596770025e-08
, O 0 2.161206630324486e-10
+ O 0 6.068315627771881e-08
TATC O 0 0.00034474997664801776
1278 O 0 2.6376610549050383e-06
, O 0 2.570783308453173e-10
in O 0 8.454085764775243e-10
exon O 0 1.111577034862421e-07
11 O 0 4.3425913531791593e-08
. O 0 1.1549735035032427e-07

Pulse O 0 3.097076478297822e-05
- O 0 8.705967502464773e-08
chase O 0 1.0564755736908182e-09
analysis O 0 7.094110021643729e-11
using O 0 7.349910263743098e-11
proband O 0 6.475342502199055e-07
fibroblasts O 0 2.9700711934310675e-07
revealed O 0 4.482267002003937e-09
that O 0 2.396906458035364e-13
the O 0 2.4555513872259738e-12
W474C O 0 1.0293916830050875e-09
- O 0 4.851769160041375e-12
containing O 0 5.545300004773657e-13
alpha O 0 3.3774812373960073e-12
- O 0 2.232154391879071e-11
subunit O 0 1.2075724101223706e-11
precursor O 0 3.6241895595701124e-10
was O 0 9.455566329918952e-10
normally O 0 1.780522396188644e-10
synthesized O 0 2.3340878119171293e-09
, O 0 5.711309897238337e-12
but O 0 3.068657524266105e-12
not O 0 4.648809549118171e-12
phosphorylated O 0 6.5183520803202555e-09
or O 0 3.5321551239420046e-10
secreted O 0 5.127721025566245e-10
, O 0 9.429334917043786e-12
and O 0 1.5102157371882363e-11
the O 0 7.952519753828824e-10
mature O 0 1.8897671338891087e-07
lysosomal O 0 2.480451541941875e-07
alpha O 0 3.0486055901945974e-09
- O 0 1.8329937567784782e-09
subunit O 0 4.266544895159541e-10
was O 0 2.6976763045638563e-09
not O 0 3.434050821482515e-10
detected O 0 2.083326506863159e-07
. O 0 4.6495813421643106e-08

When O 0 3.548383364915253e-09
the O 0 1.330057619597369e-09
W474C O 0 1.3665565745668573e-07
- O 0 1.1160431606649368e-10
containing O 0 1.3059455860470193e-12
alpha O 0 1.2456316360320852e-11
- O 0 1.9389927163881993e-11
subunit O 0 1.2964136708593088e-11
was O 0 5.950291925849172e-10
transiently O 0 2.8250020989162294e-08
co O 0 3.2533653548938446e-10
- O 0 1.9528227646059548e-10
expressed O 0 2.2913294525639394e-11
with O 0 2.7251473105026347e-13
the O 0 2.9036846711794073e-12
beta O 0 4.227867188288936e-12
- O 0 6.243292558286151e-13
subunit O 0 5.6018202094143196e-14
to O 0 3.6973920561518547e-13
produce O 0 1.2426416666488915e-11
Hex O 0 7.730362128199886e-09
A O 0 5.2871687472588746e-08
( O 0 3.2210224071294036e-11
alphabeta O 0 4.2308647607569583e-07
) O 0 4.22541645769825e-12
in O 0 1.3016719646596897e-10
COS O 0 1.9563292426028056e-06
- O 0 1.552615813693592e-08
7 O 0 5.558640769898204e-10
cells O 0 1.1035437841311335e-10
, O 0 2.8067663210978866e-13
the O 0 2.451713745216244e-12
mature O 0 1.4981152429704991e-10
alpha O 0 4.427134440293523e-12
- O 0 1.4359134541119811e-11
subunit O 0 2.250093557656929e-12
was O 0 1.1443478109551819e-10
present O 0 8.159074804670041e-11
, O 0 9.409081586780887e-13
but O 0 4.555101413249163e-13
its O 0 2.9047632897107045e-13
level O 0 1.3484343419634115e-08
was O 0 1.6680719028272506e-09
much O 0 9.429627217949488e-11
lower O 0 1.4844395157531665e-10
than O 0 1.7730639818771404e-13
that O 0 7.838086462427091e-14
from O 0 2.227521769468388e-12
normal O 0 1.6673880054440815e-09
alpha O 0 3.16309478609611e-10
- O 0 1.294450546751591e-09
subunit O 0 1.302533775282555e-10
transfections O 0 1.5442996925685293e-07
, O 0 4.616240983218445e-12
although O 0 3.688476607477398e-12
higher O 0 1.626865031578717e-10
than O 0 3.197282120049466e-13
in O 0 4.593963555919733e-13
those O 0 2.4436232117647227e-12
cells O 0 3.7754657039590356e-11
transfected O 0 1.1384203579822838e-09
with O 0 1.367079843425656e-12
an O 0 1.7907927744864605e-12
alpha O 0 2.0125037747398267e-10
- O 0 7.776542743087589e-10
subunit O 0 3.1844332726294056e-10
associated O 0 1.2880454924868445e-08
with O 0 7.666298706965335e-09
infantile O 1 0.9264342188835144
TSD B-Disease 0 0.0915132686495781
. O 0 7.00735938607977e-07

Furthermore O 0 3.3924189324352483e-07
, O 0 6.66791066805672e-11
the O 0 3.783914848121128e-11
precursor O 0 9.667270317592624e-10
level O 0 8.06927644703137e-08
of O 0 1.2012081329615398e-09
the O 0 3.952123073247549e-10
W474C O 0 4.333175951387602e-08
alpha O 0 1.954424955208367e-10
- O 0 1.6161824656357737e-10
subunit O 0 3.5992025332332034e-11
was O 0 4.0843178839011784e-10
found O 0 1.1139987370067939e-11
to O 0 1.709321746645731e-11
accumulate O 0 2.5176614265598474e-11
in O 0 5.489234934652476e-12
comparison O 0 1.7790685591378974e-11
to O 0 6.875188352656325e-12
the O 0 8.227270947847032e-11
normal O 0 5.889596010888454e-08
alpha O 0 4.855535085113161e-09
- O 0 6.447979483681365e-09
subunit O 0 1.9720027832903497e-09
precursor O 0 1.8948808744312373e-08
levels O 0 1.4094128175656806e-07
. O 0 3.875819132304059e-08

We O 0 9.338639195277665e-09
conclude O 0 8.499138459683309e-08
that O 0 1.481395388303053e-11
the O 0 6.068029412276132e-11
1422 O 0 4.501675121559856e-08
G O 0 6.79725431496081e-08
- O 0 4.7162663463495846e-07
- O 0 7.081142427978193e-08
> O 0 1.138208194362278e-08
C O 0 4.538072673199167e-08
mutation O 0 1.6591885851346966e-11
is O 0 5.3420734903806416e-14
the O 0 1.6664157033441374e-12
cause O 0 4.573861012158176e-10
of O 0 1.704919050382614e-08
Hex B-Disease 0 0.0002746478421613574
A I-Disease 1 0.8207723498344421
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.4565924022491572e-09
the O 0 1.3326864944929184e-08
proband O 0 3.357039895490743e-05
. O 0 2.1823831275469274e-07

The O 0 2.550394340161688e-09
resulting O 0 4.129029562705e-09
W474C O 0 4.2858061988226837e-08
substitution O 0 4.595074598601201e-10
clearly O 0 2.35975378126696e-10
interferes O 0 2.2021856560527908e-10
with O 0 6.1399878237278216e-12
alpha O 0 1.672422755838454e-10
- O 0 8.4589529825152e-11
subunit O 0 1.3554486526234921e-11
processing O 0 1.6632111243808367e-09
, O 0 5.491117001203694e-13
but O 0 1.9756204593275595e-13
because O 0 8.567013878900756e-14
the O 0 3.06854503829071e-13
base O 0 7.884577539474247e-12
substitution O 0 1.5389281515787445e-10
falls O 0 2.160268186557346e-09
at O 0 1.5752456283824046e-10
the O 0 4.5202012272094194e-11
first O 0 3.0214314383769647e-10
position O 0 2.4470281800859084e-08
of O 0 4.3883364497787625e-08
exon O 0 3.0745987089630944e-08
13 O 0 1.5974700451337753e-09
, O 0 1.970489223179772e-11
aberrant O 0 8.901237524838734e-10
splicing O 0 1.689490680689687e-08
may O 0 4.20718154758859e-10
also O 0 2.167476441383709e-11
contribute O 0 5.149698001361003e-09
to O 0 3.016729621663217e-08
Hex B-Disease 1 0.8177099823951721
A I-Disease 1 0.9575701951980591
deficiency I-Disease 0 0.009171290323138237
in O 0 1.9086593416872688e-10
this O 0 1.4324402775045542e-10
proband O 0 1.3083998737783986e-06
. O 0 1.0134170169706636e-09
. O 0 1.563307527874258e-08

Two O 0 6.581289735407836e-09
frequent O 0 3.733100051306337e-09
missense O 0 7.899274123701616e-07
mutations O 0 6.319299927781685e-08
in O 0 3.622117219492793e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.1204079783055931e-05

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.679283911926177e-08
an O 0 2.0838303953496506e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 4.934339017381717e-07
by O 0 1.056527001302987e-11
early O 0 2.3969087692421454e-07
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9982604384422302
goiter B-Disease 1 1.0
. O 0 0.026402967050671577

A O 0 4.130220787601502e-08
century O 0 9.781654375373705e-10
after O 0 1.3578610458253593e-10
its O 0 4.93143395043083e-13
recognition O 0 9.269809919665306e-11
as O 0 3.441149795668785e-11
a O 0 1.1329444049579251e-09
syndrome O 0 4.9432742343924474e-08
by O 0 2.2011932207521845e-11
Vaughan O 0 6.986507372630513e-08
Pendred O 0 0.003017609240487218
, O 0 1.7211582853393637e-11
the O 0 1.0408778700066179e-10
disease O 0 5.463089536306143e-09
gene O 0 1.896801812839577e-11
( O 0 4.984344100650295e-12
PDS O 0 0.0001747963106026873
) O 0 1.2258591711167277e-11
was O 0 1.0879055434287466e-09
mapped O 0 4.206766490710834e-09
to O 0 5.260166191511928e-10
chromosome O 0 3.2034677133196965e-08
7q22 O 0 4.4526412239065394e-05
- O 0 7.354979061346967e-06
q31 O 0 5.8487541537033394e-05
. O 0 2.695986154321872e-07

1 O 0 1.0073320311221323e-07
and O 0 9.365266340211065e-10
, O 0 4.6159440852955314e-11
recently O 0 1.543676020343554e-10
, O 0 1.853289223474608e-12
found O 0 1.9407381517816402e-12
to O 0 6.372593858855469e-12
encode O 0 1.0826478602510292e-09
a O 0 3.769741852011066e-09
putative O 0 2.0108846001676284e-06
sulfate O 0 1.0739382787505747e-06
transporter O 0 5.316400347510353e-06
. O 0 1.5445882581843762e-06

We O 0 2.447437585928469e-09
performed O 0 8.716626309634989e-10
mutation O 0 1.6326398566413047e-11
analysis O 0 1.2864819452784726e-11
of O 0 8.215384622589639e-11
the O 0 7.318035066816719e-10
PDS B-Disease 0 0.00531364418566227
gene O 0 1.4194803665823486e-10
in O 0 1.431852206246198e-11
patients O 0 1.6490210585917708e-10
from O 0 4.0356384900519515e-11
14 O 0 6.851605394153637e-10
Pendred B-Disease 0 3.601701052957651e-07
families O 0 1.5771750225268555e-11
originating O 0 2.685164868232448e-10
from O 0 1.3141519990267359e-11
seven O 0 1.601945243123737e-10
countries O 0 6.583756456679524e-11
and O 0 5.35994269801332e-11
identified O 0 6.0196656548328065e-09
all O 0 9.73462199738151e-10
mutations O 0 3.525508773805086e-08
. O 0 8.505024595706345e-08

The O 0 1.0726221688628357e-08
mutations O 0 2.934762433071114e-10
include O 0 4.397745622525262e-12
three O 0 1.374930724828971e-11
single O 0 1.1413636008539285e-10
base O 0 1.5168223344019793e-09
deletions O 0 2.749939165269666e-09
, O 0 2.1925282769896803e-11
one O 0 1.3018185140989402e-10
splice O 0 1.6900587240797904e-07
site O 0 3.730630027121151e-09
mutation O 0 9.33927601920459e-10
and O 0 3.3735059190576067e-10
10 O 0 1.2176542441011406e-07
missense O 0 1.8496031771064736e-05
mutations O 0 1.5628371841103217e-07
. O 0 4.619879234724067e-07

One O 0 2.3226313317081804e-08
missense O 0 9.733328170113964e-07
mutation O 0 9.950561485894127e-10
( O 0 3.214050553479453e-11
L236P O 0 1.2923934491482214e-06
) O 0 8.193020047120303e-12
was O 0 9.499621089759103e-10
found O 0 1.7716189626426626e-11
in O 0 1.9001178668681673e-12
a O 0 2.356167127723352e-12
homozygous O 0 3.319455127437365e-11
state O 0 6.290006709930296e-12
in O 0 6.751655658165934e-12
two O 0 2.000260547474486e-11
consanguineous O 0 3.353276554207696e-07
families O 0 3.442324897351412e-11
and O 0 2.6946227367485864e-12
in O 0 5.018916705845644e-12
a O 0 1.5982912909828784e-11
heterozygous O 0 4.908906267586666e-11
state O 0 9.63346676735588e-12
in O 0 6.4156197715492524e-12
five O 0 2.185801539766885e-11
additional O 0 1.4624657040940292e-10
non O 0 5.495657617871075e-08
- O 0 9.113027488183434e-08
consanguineous O 0 4.5822584979759995e-06
families O 0 7.155227965682798e-09
. O 0 9.483714791258535e-08

Another O 0 1.308075212591575e-07
missense O 0 2.7736323318094946e-06
mutation O 0 3.3560960677192497e-09
( O 0 6.266431817891771e-11
T416P O 0 3.876916252920637e-06
) O 0 1.7959482859208897e-11
was O 0 2.8042246302817375e-09
found O 0 2.513069960463632e-11
in O 0 1.750844478079494e-12
a O 0 3.948886790478001e-12
homozygous O 0 2.6452688997591345e-11
state O 0 1.3646942083334057e-11
in O 0 2.9563511361185846e-11
one O 0 9.135620732125815e-11
family O 0 2.283541584990889e-11
and O 0 3.662908518164976e-12
in O 0 1.0827169889815469e-11
a O 0 1.2465324779331599e-11
heterozygous O 0 2.4781275989593787e-11
state O 0 1.0991318966091512e-11
in O 0 2.3002886054279692e-11
four O 0 3.5025291000856384e-10
families O 0 4.0557113223371744e-10
. O 0 2.4026201472793218e-08

Pendred B-Disease 0 0.0038451766595244408
patients O 0 9.857441796157218e-08
in O 0 2.746069482917335e-10
three O 0 3.0055846700349775e-10
non O 0 7.236246801767265e-08
- O 0 1.4107125245743646e-08
consanguineous O 0 1.2799240494132391e-06
families O 0 2.1882332751355094e-11
were O 0 1.1074926566101428e-11
shown O 0 1.0620750806600299e-11
to O 0 3.1614932026469145e-12
be O 0 8.039595898734486e-12
compound O 0 8.005618390427571e-10
heterozygotes O 0 1.031733276590785e-08
for O 0 6.205039815299074e-10
L236P O 0 7.304636710614432e-06
and O 0 1.1569882829576272e-08
T416P O 0 7.565162377431989e-05
. O 0 3.0887292723491555e-07

In O 0 1.4354147204187484e-08
total O 0 5.4231325208320413e-08
, O 0 1.0013805756825533e-10
one O 0 2.8005445185108613e-11
or O 0 1.718435636843818e-11
both O 0 1.802427478103663e-11
of O 0 6.943826069694126e-11
these O 0 4.564113843807949e-12
mutations O 0 8.54117818138711e-12
were O 0 2.5587823526684872e-11
found O 0 1.84565210337162e-12
in O 0 2.9514426926752213e-12
nine O 0 4.238198125783299e-10
of O 0 1.1035669600367726e-10
the O 0 1.2319917308545314e-10
14 O 0 2.1171921993357046e-09
families O 0 2.0720712645694306e-10
analyzed O 0 3.220855404606482e-08
. O 0 3.295802031288986e-08

The O 0 1.3120694530854848e-09
identification O 0 3.010389804103397e-08
of O 0 2.948200572561177e-09
two O 0 4.026330380213494e-10
frequent O 0 5.251968193675793e-09
PDS B-Disease 0 7.693731458857656e-05
mutations O 0 7.747036900873638e-10
will O 0 1.2874513954930222e-11
facilitate O 0 1.8801125101219895e-09
the O 0 3.2639069225126605e-10
molecular O 0 4.11803604549732e-08
diagnosis O 0 0.2374902218580246
of O 1 0.7381847500801086
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.561965852190042e-06

Insertional O 0 5.183992470847443e-05
mutation O 0 6.564540910858341e-09
by O 0 2.5855603769109337e-10
transposable O 0 1.6356693777197506e-06
element O 0 6.802714835885126e-08
, O 0 8.35473246141305e-10
L1 O 0 0.00012946221977472305
, O 0 2.2566190235884243e-11
in O 0 7.94911532431275e-12
the O 0 4.715029477964094e-10
DMD B-Disease 1 1.0
gene O 0 2.711700308744014e-11
results O 0 5.110748282910471e-11
in O 0 8.620807540049569e-11
X B-Disease 1 0.940050482749939
- I-Disease 1 0.6370349526405334
linked I-Disease 0 0.010830998420715332
dilated I-Disease 1 0.8076731562614441
cardiomyopathy I-Disease 1 1.0
. O 0 2.600911830086261e-05

X B-Disease 1 0.7991904020309448
- I-Disease 1 0.9986342787742615
linked I-Disease 0 0.1979883760213852
dilated I-Disease 1 0.9996620416641235
cardiomyopathy I-Disease 1 1.0
( O 0 9.482123886073168e-08
XLDCM B-Disease 1 1.0
) O 0 4.2084777503170745e-12
is O 0 7.29473244504876e-14
a O 0 1.61645450171867e-13
clinical O 0 5.2034140884948954e-11
phenotype O 0 1.6326905105668033e-10
of O 0 9.560277014486473e-10
dystrophinopathy B-Disease 0 1.219750288328214e-06
which O 0 4.5813305406261495e-12
is O 0 5.367190524484255e-13
characterized O 0 9.055346750219684e-12
by O 0 1.6458810009334357e-11
preferential O 0 1.0255906346401389e-07
myocardial B-Disease 1 0.8501699566841125
involvement I-Disease 0 1.7333081814285833e-07
without O 0 1.4605623377406118e-09
any O 0 5.45065624579788e-11
overt O 0 5.056028928862588e-10
clinical O 0 6.1558860231514245e-09
signs O 0 5.0911106441731135e-09
of O 0 3.6524829738482367e-06
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.0012163629289716482

To O 0 5.032171568331023e-09
date O 0 3.439730988930023e-08
, O 0 1.3935493384242825e-11
several O 0 2.0129815783004323e-12
mutations O 0 2.5270958936562948e-11
in O 0 1.9998523670405888e-11
the O 0 1.321686795563437e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 7.670245395274833e-06
, O 0 2.0694788815944776e-07
DMD O 1 1.0
, O 0 5.475426778644987e-10
have O 0 1.8294458829781757e-12
been O 0 1.3321374168692723e-12
identified O 0 1.0672818531731743e-11
in O 0 9.336269821483278e-13
patients O 0 2.4192632272490577e-11
with O 0 3.690636771885858e-12
XLDCM B-Disease 1 0.999998927116394
, O 0 4.0931907169250437e-11
but O 0 8.212059504630886e-12
a O 0 1.0649982631893984e-11
pathogenic O 0 1.7926409245916375e-09
correlation O 0 5.083180543152821e-10
of O 0 2.6378235706836506e-10
these O 0 9.436247616623206e-11
cardiospecific O 0 1.5593073499076127e-07
mutations O 0 3.869440878823127e-10
in O 0 1.8537966994802701e-10
DMD O 1 1.0
with O 0 1.4172944762247397e-10
the O 0 4.768082373374227e-09
XLDCM B-Disease 1 0.9999852180480957
phenotype O 0 4.517527329994664e-08
has O 0 1.3593790156030128e-11
remained O 0 7.964348291977785e-09
to O 0 3.4228422873816555e-10
be O 0 6.301172028599922e-09
elucidated O 0 3.85509520128835e-05
. O 0 3.8826121340207465e-07

We O 0 1.2614662203702665e-08
report O 0 1.524007586795051e-10
here O 0 1.9562440209397458e-11
the O 0 8.229491849261195e-13
identification O 0 2.7994673246212187e-10
of O 0 1.9704678166920786e-10
a O 0 2.7999731005978745e-11
unique O 0 1.192480558742659e-10
de O 0 2.4799835518507507e-09
novo O 0 9.636127451528864e-09
L1 O 0 1.432238946108555e-06
insertion O 0 6.7032264183808365e-09
in O 0 5.855683715694227e-10
the O 0 2.717429392617987e-09
muscle O 0 3.906910350792714e-08
exon O 0 1.1056749293913981e-08
1 O 0 5.53923018564717e-10
in O 0 5.01232055860612e-10
DMD O 1 1.0
in O 0 9.084349383847723e-10
three O 0 4.979541223804063e-10
XLDCM B-Disease 1 0.9298763275146484
patients O 0 2.655684283592308e-10
from O 0 1.5347709214630356e-11
two O 0 1.82852127536548e-12
unrelated O 0 4.0898837094793805e-10
Japanese O 0 4.814542986508741e-09
families O 0 3.479556920371607e-10
. O 0 1.1544400990715076e-08

The O 0 6.295861609828535e-09
insertion O 0 8.846234855752755e-09
was O 0 4.5049968200316926e-09
a O 0 8.080338481653015e-11
5 O 0 4.031663336512281e-10
- O 0 2.512889063499557e-10
truncated O 0 1.3928007358554595e-10
form O 0 2.8981641739256325e-11
of O 0 7.686001279871846e-10
human O 0 9.016836166608755e-10
L1 O 0 1.5939181707835814e-07
inversely O 0 3.097258005624326e-09
integrated O 0 1.276747507716891e-08
in O 0 4.9263714635428e-11
the O 0 1.3701929868492613e-10
5 O 0 5.178221851309672e-09
- O 0 3.5188847391509626e-08
untranslated O 0 6.188031693454832e-05
region O 0 6.16996898017419e-09
in O 0 1.0827051061257364e-10
the O 0 1.4632726141883268e-09
muscle O 0 1.1154590140449727e-08
exon O 0 4.822879429156046e-09
1 O 0 4.545734622052322e-10
, O 0 5.949071530536587e-12
which O 0 1.7365392435651772e-13
affected O 0 1.873663377227608e-11
the O 0 7.501306867330193e-12
transcription O 0 1.7606045787932345e-10
or O 0 1.2117161440894364e-11
the O 0 2.0317844628969794e-10
stability O 0 2.990092798427213e-05
of O 0 1.0480945888957649e-08
the O 0 1.0894775082093133e-09
muscle O 0 3.3412317357317534e-10
form O 0 1.5030898747880883e-10
of O 0 1.2706157903608073e-08
dystrophin O 0 1.8714914062911703e-07
transcripts O 0 5.685171799996169e-08
but O 0 1.9343782218378403e-12
not O 0 3.063065751561511e-13
that O 0 1.395814345182822e-13
of O 0 1.0812564038564787e-10
the O 0 3.541142046259438e-09
brain O 1 0.8315196633338928
or O 0 2.3155084516446323e-09
Purkinje O 0 8.256302680820227e-05
cell O 0 3.548771587702504e-07
form O 0 1.668501448115478e-09
, O 0 4.589484001171762e-11
probably O 0 1.0517468007620323e-09
due O 0 6.524797413476335e-08
to O 0 1.3892083317035286e-10
its O 0 1.1782925329884009e-11
unique O 0 1.0627727170531287e-10
site O 0 3.874019161020925e-10
of O 0 1.0941025863075993e-09
integration O 0 4.4927114117854217e-07
. O 0 3.9562419829053397e-07

We O 0 1.2799562298937417e-08
speculate O 0 2.3433841533915256e-09
that O 0 9.917043450541688e-14
this O 0 2.2775932615598515e-13
insertion O 0 1.0972284886223704e-10
of O 0 1.8444082372504056e-10
an O 0 7.689249410802734e-12
L1 O 0 1.3780722838419024e-06
sequence O 0 1.2175299657357641e-09
in O 0 3.5966187805769323e-09
DMD O 1 1.0
is O 0 5.7845245954313285e-11
responsible O 0 3.571555828862927e-10
for O 0 2.6067425995535132e-11
some O 0 1.991545600307787e-12
of O 0 1.7768845422816426e-11
the O 0 1.1931441945556287e-11
population O 0 2.345990968762729e-13
of O 0 4.202235076838229e-13
Japanese O 0 4.760982164064842e-10
patients O 0 1.8014074953942583e-10
with O 0 3.103351603472859e-11
XLDCM B-Disease 0 0.030670378357172012
. O 0 1.5294370214746777e-08
. O 0 5.792328039433414e-08

Severe O 0 2.9881884984206408e-05
early O 1 0.9757053256034851
- O 1 0.9999825954437256
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 9.20747478261319e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 3.49652545992285e-05
red O 1 0.6160539984703064
hair O 1 1.0
pigmentation O 1 0.9999423027038574
caused O 0 9.211998076352756e-06
by O 0 8.345180546598385e-09
POMC O 0 0.410603791475296
mutations O 0 1.5076651038725686e-08
in O 0 3.060477427041519e-10
humans O 0 7.276935942712726e-09
. O 0 1.2326699661002749e-08

Sequential O 0 9.017841051672804e-08
cleavage O 0 1.536600890972295e-08
of O 0 9.15605813389675e-09
the O 0 5.534288027853052e-10
precursor O 0 3.5571229295427997e-10
protein O 0 1.1846382381996978e-11
pre O 0 5.233299127382907e-09
- O 0 3.0041189535978674e-09
pro O 0 2.6983215661857685e-07
- O 0 5.3262660912878346e-06
opiomelanocortin O 0 0.00011117754911538213
( O 0 4.537183129205147e-11
POMC O 0 1.3398557712207548e-06
) O 0 1.1825088434488928e-12
generates O 0 3.138554086762335e-12
the O 0 6.8446494132234914e-12
melanocortin O 0 1.1984602643622111e-08
peptides O 0 4.6275822063179817e-10
adrenocorticotrophin O 0 3.294030648248736e-07
( O 0 5.0073112323190117e-11
ACTH O 0 4.695022255418735e-07
) O 0 1.7422240733422356e-11
, O 0 5.052767579338813e-11
melanocyte O 0 1.3089153299006284e-06
- O 0 2.981643319799332e-06
stimulating O 0 8.218092517608966e-08
hormones O 0 2.3585402519898935e-09
( O 0 2.2625566784700846e-12
MSH O 0 2.4255692565589015e-08
) O 0 1.5765446131736638e-13
alpha O 0 8.947300907981293e-13
, O 0 4.743542052752271e-14
beta O 0 1.2474403020962255e-12
and O 0 8.133956832731548e-13
gamma O 0 4.2952330060741506e-12
as O 0 1.510456907119484e-12
well O 0 5.167213445317342e-12
as O 0 2.0851603863697443e-12
the O 0 6.719823308909412e-11
opioid O 0 1.9668640049985697e-09
- O 0 8.046860400234834e-10
receptor O 0 8.720210317725297e-12
ligand O 0 1.2085276113182886e-09
beta O 0 1.348839901993415e-07
- O 0 9.890416095004184e-07
endorphin O 0 6.5033295868488494e-06
. O 0 1.1681076728109474e-07

While O 0 5.40552456129717e-08
a O 0 6.481131742397395e-10
few O 0 1.3378680108200314e-10
cases O 0 3.3464727516863135e-11
of O 0 6.018127329809886e-09
isolated O 0 9.86506711342372e-06
ACTH B-Disease 1 0.9999995231628418
deficiency I-Disease 0 0.00018500564328860492
have O 0 6.5525714194880624e-12
been O 0 1.2414120946491192e-11
reported O 0 9.209995266434845e-11
( O 0 1.6523008655733307e-11
OMIM O 0 3.15563302137889e-05
201400 O 0 1.0266567187500186e-06
) O 0 7.072224056381415e-11
, O 0 4.772835945909826e-11
an O 0 2.136056470591896e-10
inherited O 1 0.9999498128890991
POMC O 1 1.0
defect O 1 0.9999983310699463
has O 0 4.838685355168515e-11
not O 0 1.5447384690836508e-11
been O 0 1.7016651976398123e-10
described O 0 4.420726007481335e-10
so O 0 1.2762543799560433e-10
far O 0 9.914775667141384e-10
. O 0 1.4207197196469679e-08

Recent O 0 1.3415310640141342e-08
studies O 0 1.4908189127638138e-09
in O 0 2.2633350055256685e-11
animal O 0 3.7616434273024524e-11
models O 0 9.444423021420789e-11
elucidated O 0 1.2274145255730673e-08
a O 0 1.8704746085340673e-11
central O 0 6.888242198854755e-10
role O 0 1.8532946011173834e-10
of O 0 6.597402624208826e-09
alpha O 0 8.565875120325472e-09
- O 0 2.2471716931704577e-07
MSH O 0 5.917034286540002e-06
in O 0 2.587063549497337e-11
the O 0 2.5807994630255848e-11
regulation O 0 1.185595094321812e-10
of O 0 6.432213095486361e-11
food O 0 4.728389554897738e-12
intake O 0 1.5949276675839702e-13
by O 0 3.275785785816364e-15
activation O 0 1.3822030542690045e-12
of O 0 7.482490321786273e-11
the O 0 1.0290933660783708e-09
brain O 0 6.343778977679904e-07
melanocortin O 0 1.616457723230269e-07
- O 0 1.7788270412211205e-08
4 O 0 1.8286635539155327e-09
- O 0 1.6157518656356729e-09
receptor O 0 7.579974516981614e-13
( O 0 1.0144945864279387e-12
MC4 O 0 2.330491724933381e-06
- O 0 5.532288227527715e-08
R O 0 3.516682278714711e-09
; O 0 1.0326407697686113e-12
refs O 0 2.648674168881371e-09
3 O 0 3.658274030926556e-11
- O 0 4.6695980415734084e-11
5 O 0 5.569531923328708e-13
) O 0 1.4052003850339827e-14
and O 0 6.811185730010161e-14
the O 0 1.0792861396269338e-11
linkage O 0 6.734858004620037e-08
of O 0 1.7165996402113137e-09
human O 0 3.0020646590855904e-07
obesity B-Disease 1 1.0
to O 0 4.507575201984082e-09
chromosome O 0 1.754658307540069e-09
2 O 0 4.512175078019709e-10
in O 0 1.9244658644446133e-10
close O 0 2.6995101265470112e-08
proximity O 0 5.638043809597093e-09
to O 0 7.531765211510333e-10
the O 0 1.049939424291324e-08
POMC O 0 1.31249553305679e-05
locus O 0 7.347811248337166e-10
, O 0 5.6417787108742345e-12
led O 0 1.840720631474113e-11
to O 0 7.370697802100423e-12
the O 0 1.8150160194241316e-11
proposal O 0 5.2202537431655927e-11
of O 0 1.9844001442059778e-10
an O 0 5.980357702106698e-12
association O 0 2.2428374435445875e-10
of O 0 2.850418923117104e-08
POMC O 1 0.8900578022003174
with O 0 3.422994110380273e-09
human O 0 1.8803964849212207e-05
obesity B-Disease 1 1.0
. O 0 4.4884160388392047e-07

The O 0 3.0108362469860595e-09
dual O 0 2.4981725132988686e-08
role O 0 6.9885306430705896e-09
of O 0 1.4870170161884744e-05
alpha O 0 8.61671105667483e-06
- O 1 0.6148194074630737
MSH O 1 0.9589159488677979
in O 0 3.1485583584789367e-10
regulating O 0 2.0962853675143833e-09
food O 0 1.1039753139430175e-10
intake O 0 3.530511716309803e-10
and O 0 6.057988312380136e-12
influencing O 0 8.077266784312087e-07
hair O 0 0.000655238691251725
pigmentation O 0 5.828934718010714e-06
predicts O 0 7.411319891126311e-10
that O 0 4.0016714985061097e-13
the O 0 3.1779134445492074e-12
phenotype O 0 1.238812611520368e-11
associated O 0 4.055662750079847e-11
with O 0 1.4293765823736315e-12
a O 0 2.7541527392038745e-10
defect O 0 1.3229546311777085e-05
in O 0 4.404400399948827e-09
POMC O 0 0.08527685701847076
function O 0 6.386669415547885e-09
would O 0 9.003375128768809e-11
include O 0 4.922203755697296e-10
obesity B-Disease 1 1.0
, O 0 4.6577491863430964e-11
alteration O 0 1.1638627483989694e-06
in O 0 4.066715320050207e-08
pigmentation O 1 0.9999946355819702
and O 0 7.491920405300334e-05
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999754428863525
. O 0 1.8271239241585135e-06

The O 0 3.8708545702093033e-08
observation O 0 5.453139237943105e-07
of O 0 3.034346107710917e-09
these O 0 5.399532487793124e-10
symptoms O 0 9.585409088685992e-08
in O 0 3.481759325296707e-11
two O 0 1.9446085020025095e-10
probands O 0 1.1805201438619406e-06
prompted O 0 1.5393010477371405e-10
us O 0 5.164309258010036e-11
to O 0 5.7537249270600554e-11
search O 0 4.851961499241497e-09
for O 0 2.0571777614719622e-10
mutations O 0 1.619689049547901e-09
within O 0 4.616300675053253e-09
their O 0 2.4667709652703707e-08
POMC O 0 0.00032982113771140575
genes O 0 1.1602505622931858e-07
. O 0 1.3500175555236638e-07

Patient O 1 0.7254202365875244
1 O 0 4.2951270984303846e-08
was O 0 5.551205717324592e-09
found O 0 1.534443058726076e-11
to O 0 7.162562643686643e-12
be O 0 9.262982741953252e-12
a O 0 9.629773541075526e-12
compound O 0 3.5195055203551817e-10
heterozygote O 0 4.778433648766622e-09
for O 0 2.6247832032866292e-11
two O 0 1.7212871405991592e-10
mutations O 0 3.89054705118852e-10
in O 0 7.809749513754127e-10
exon O 0 4.159770750078451e-09
3 O 0 9.298555259107388e-10
( O 0 5.2509410014556224e-11
G7013T O 0 8.289246693493624e-07
, O 0 4.3099742524921325e-11
C7133delta O 0 7.220019142550882e-07
) O 0 1.1066516626689893e-12
which O 0 8.050666660012681e-14
interfere O 0 3.0816807439215665e-11
with O 0 1.862832262576608e-13
appropriate O 0 1.1080932699192303e-10
synthesis O 0 6.307557143259146e-09
of O 0 6.1781175730857285e-09
ACTH O 0 1.6660574146953877e-06
and O 0 1.6034623628868871e-09
alpha O 0 3.1969585734259454e-07
- O 0 2.53761095336813e-06
MSH O 0 8.9290137111675e-05
. O 0 1.2106141866752296e-07

Patient O 0 0.00018306364654563367
2 O 0 6.3970326813489464e-09
was O 0 1.481029632266484e-09
homozygous O 0 5.6739404841188446e-11
for O 0 1.7612544452386136e-12
a O 0 1.1402925478853909e-11
mutation O 0 3.0429905123474654e-11
in O 0 1.490121637193198e-10
exon O 0 3.883505517165986e-09
2 O 0 1.3194728643028952e-09
( O 0 1.1576537645163754e-10
C3804A O 0 1.145936607827025e-06
) O 0 1.8691050443497836e-11
which O 0 3.098749729035788e-11
abolishes O 0 8.268783346920827e-08
POMC O 0 1.631917621125467e-05
translation O 0 2.038480261035147e-06
. O 0 1.3399579756878666e-06

These O 0 1.3410904609045815e-09
findings O 0 9.334356204648842e-11
represent O 0 1.7917365507935656e-11
the O 0 1.051280416886069e-11
first O 0 1.0024081391335482e-11
examples O 0 3.6811272779990745e-11
of O 0 2.105665225515807e-10
a O 0 9.386064148131368e-10
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 3.9064018686474355e-09
the O 0 5.34159549925306e-10
POMC O 0 5.114236046210863e-06
gene O 0 4.4210610866679545e-11
and O 0 6.538339748091149e-12
define O 0 9.551600621549028e-10
a O 0 2.649021557665776e-10
new O 0 7.249755018534643e-09
monogenic B-Disease 1 1.0
endocrine I-Disease 1 0.9999871253967285
disorder I-Disease 0 0.00012867283658124506
resulting O 0 2.5376036827395865e-09
in O 0 4.661215510792793e-11
early O 0 6.449916327255778e-06
- O 0 0.00041179193067364395
onset O 1 0.9999996423721313
obesity B-Disease 1 1.0
, O 0 1.909880253947449e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 4.803735919267638e-06
red O 0 0.0010840600589290261
hair O 1 0.9999977350234985
pigmentation O 1 0.5146936178207397
. O 0 4.062489722400642e-08
. O 0 9.624650232353815e-08

A O 0 3.184534023148444e-07
European O 0 2.9240874610536594e-08
multicenter O 0 2.0105260318814544e-06
study O 0 2.260952314259157e-08
of O 0 7.3344285738130566e-06
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.451175846156616e-10
classification O 0 1.9491128155912918e-10
of O 0 3.2513247649745836e-10
105 O 0 2.575629043377603e-09
mutations O 0 1.305702074239079e-11
and O 0 8.946225921527273e-13
a O 0 2.8059592410006884e-12
general O 0 1.27890979056966e-11
system O 0 3.5280528498660146e-11
for O 0 6.0678875118957976e-12
genotype O 0 1.2132113091922747e-09
- O 0 1.1810043221149868e-10
based O 0 5.150986841923055e-12
prediction O 0 3.9116677896799956e-08
of O 0 1.078370015505925e-08
metabolic O 0 8.916280421544798e-06
phenotype O 0 1.1060550519914614e-07
. O 0 8.790665617652849e-08

Phenylketonuria B-Disease 0 0.31261879205703735
( O 0 3.5244447360582853e-09
PKU B-Disease 0 0.00017973316425923258
) O 0 1.4593280750485604e-10
and O 0 6.296506649405842e-10
mild B-Disease 0 7.936559268273413e-05
hyperphenylalaninemia I-Disease 1 1.0
( O 0 1.2798604132058244e-07
MHP B-Disease 1 1.0
) O 0 6.028656046597192e-11
are O 0 1.0644641418311451e-11
allelic B-Disease 0 1.0067519440326578e-07
disorders I-Disease 0 8.94914862215046e-08
caused O 0 7.260970991129767e-11
by O 0 1.3857402638567384e-12
mutations O 0 3.733856539928082e-12
in O 0 4.574639278498438e-13
the O 0 7.527922729622105e-12
gene O 0 8.612897721416157e-12
encoding O 0 5.386717738531388e-09
phenylalanine O 0 6.605601470255351e-07
hydroxylase O 0 1.6518581105628982e-05
( O 0 2.3621476330504265e-08
PAH O 0 2.8629008738789707e-05
) O 0 1.9942019147123347e-09
. O 0 1.0739818634419862e-07

Previous O 0 3.5292600841785315e-07
studies O 0 3.1404809863744276e-09
have O 0 1.5588589447057544e-12
suggested O 0 2.865818910305351e-12
that O 0 2.0383868204465472e-14
the O 0 3.73665594993744e-12
highly O 0 7.701850823771395e-10
variable O 0 4.849669466011619e-08
metabolic O 0 1.5447221812792122e-05
phenotypes O 0 1.840434151745285e-06
of O 1 0.9183615446090698
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999493360519409
correlate O 0 0.00030683312797918916
with O 0 5.747700697611435e-07
PAH O 1 0.9988906979560852
genotypes O 0 1.937463639478665e-05
. O 0 4.796232815351686e-07

We O 0 3.1149500756555426e-08
identified O 0 1.1030251378940648e-08
both O 0 5.337552066997375e-10
causative O 0 8.891365865792977e-09
mutations O 0 3.895685440902241e-10
in O 0 5.3043729131285744e-11
686 O 0 2.2129670540493862e-08
patients O 0 2.4676307663895614e-09
from O 0 1.548350558877587e-09
seven O 0 1.821739203933248e-09
European O 0 1.0061353528101336e-08
centers O 0 1.9733393585852355e-08
. O 0 1.7744826052989993e-08

On O 0 2.388447128964799e-08
the O 0 2.4840346446453054e-10
basis O 0 1.6020286208728862e-09
of O 0 1.155994466817134e-10
the O 0 9.396107503167883e-11
phenotypic O 0 1.3530531139949176e-09
characteristics O 0 1.3467861270655135e-09
of O 0 1.8184793670883437e-09
297 O 0 2.3520097869322854e-08
functionally O 0 5.012426527173375e-07
hemizygous O 0 1.084270593310066e-06
patients O 0 5.898414534577512e-10
, O 0 1.346126552240201e-12
105 O 0 1.0363083724485023e-09
of O 0 2.5429078287508844e-10
the O 0 1.9663229378075187e-10
mutations O 0 3.6363051458820905e-11
were O 0 5.276321393687944e-11
assigned O 0 1.7896335802181085e-10
to O 0 3.73347359972076e-11
one O 0 3.113905314156007e-11
of O 0 3.5916333795960043e-10
four O 0 2.6217725213051324e-10
arbitrary O 0 3.889977673310341e-09
phenotype O 0 1.2869624477218622e-08
categories O 0 4.754732163547715e-09
. O 0 2.082668260072751e-08

We O 0 4.694061583876419e-09
proposed O 0 1.1426771334699382e-10
and O 0 5.234718908342373e-12
tested O 0 5.200130256954871e-11
a O 0 8.750245536828793e-13
simple O 0 9.47606251279487e-13
model O 0 2.3840590959722796e-12
for O 0 1.0301659698896959e-12
correlation O 0 3.732519501808973e-11
between O 0 3.780005128350972e-11
genotype O 0 1.5646312023775977e-09
and O 0 1.4254603053487358e-10
phenotypic O 0 1.739978472414805e-08
outcome O 0 6.175116027407057e-07
. O 0 1.2130092272855109e-06

The O 0 2.4422675437563157e-08
observed O 0 2.6377191542081846e-09
phenotype O 0 2.5358473099146295e-09
matched O 0 4.207151960144984e-09
the O 0 3.912723200993895e-10
predicted O 0 1.7330850088370653e-09
phenotype O 0 9.764574565584994e-11
in O 0 4.111827198172158e-12
79 O 0 3.912255408522469e-09
% O 0 3.288441075000037e-09
of O 0 5.378930287291972e-11
the O 0 1.611539894585956e-11
cases O 0 1.066044908598629e-11
, O 0 1.8281968820754724e-12
and O 0 2.8091457111856233e-12
in O 0 1.237275386312131e-11
only O 0 5.82508867530418e-12
5 O 0 2.644118778094562e-11
of O 0 1.969820487279783e-11
184 O 0 1.6791894263956664e-10
patients O 0 1.034090452156633e-10
was O 0 1.548355749170227e-10
the O 0 4.593056837642884e-11
observed O 0 8.047761762552952e-11
phenotype O 0 4.534477238138379e-10
more O 0 6.394018344305086e-13
than O 0 2.0448376065324014e-12
one O 0 1.9183144656098605e-12
category O 0 4.0298774733882325e-11
away O 0 1.6998065455187117e-10
from O 0 3.597898368123964e-11
that O 0 5.044714646018633e-12
expected O 0 7.16108505827151e-09
. O 0 1.0529661409464097e-07

Among O 0 2.9831308978600646e-08
the O 0 1.0958256524418175e-09
seven O 0 7.986935002257667e-10
contributing O 0 1.5962813015857336e-10
centers O 0 4.0179734539513845e-11
, O 0 1.0862302404117744e-13
the O 0 2.300599164298256e-12
proportion O 0 6.498854926428876e-11
of O 0 5.4729498710770486e-11
patients O 0 1.1390105525421745e-10
for O 0 2.5293959635130925e-11
whom O 0 3.547009574944582e-09
the O 0 1.0513576675919012e-09
observed O 0 3.3984801084407934e-10
phenotype O 0 1.5838529099365672e-10
did O 0 2.6899715094286236e-11
not O 0 3.395677185616397e-12
match O 0 3.3105054253468325e-09
the O 0 1.333222310329063e-09
predicted O 0 7.760544207258135e-09
phenotype O 0 4.735136172051568e-10
was O 0 3.92037860508232e-11
4 O 0 7.531991697007356e-11
% O 0 1.5618961679564336e-10
- O 0 1.0106446235447208e-10
23 O 0 4.0006778445622615e-10
% O 0 7.604197826971415e-10
( O 0 1.4421908979544984e-11
P O 0 4.866765834776743e-07
< O 0 1.7436727617337056e-08
. O 0 4.3889825801501914e-11
0001 O 0 3.42861561364316e-08
) O 0 4.563487174952252e-12
, O 0 2.086377728569011e-12
suggesting O 0 1.1392235765850245e-10
that O 0 7.007817720214304e-13
differences O 0 4.395645236687784e-10
in O 0 2.0149407316261136e-12
methods O 0 8.355210967536664e-10
used O 0 3.331595416211641e-11
for O 0 2.5468432918174244e-11
mutation O 0 5.18404985605514e-10
detection O 0 2.237992191567173e-07
or O 0 4.889155191811767e-10
phenotype O 0 4.298599698415728e-09
classification O 0 6.759161008673686e-10
may O 0 4.278914028654768e-11
account O 0 2.0546906190355152e-11
for O 0 3.3310851906692696e-12
a O 0 1.585151628014092e-11
considerable O 0 1.7638650262608024e-10
proportion O 0 2.5343036003100394e-10
of O 0 8.766045112018617e-10
genotype O 0 2.1743360321124783e-06
- O 0 8.550290658604354e-06
phenotype O 0 8.231173751482856e-07
inconsistencies O 0 3.901336640410591e-06
. O 0 7.112022899491421e-07

Our O 0 4.410783844832622e-07
data O 0 1.075041033971047e-08
indicate O 0 3.551733074314001e-10
that O 0 1.0082138032427301e-12
the O 0 4.4593090331446206e-10
PAH O 0 9.831742318056058e-07
- O 0 2.0102643993880065e-09
mutation O 0 1.9476437823628956e-11
genotype O 0 1.5786834339781564e-10
is O 0 5.196357667075491e-13
the O 0 3.801732539887581e-11
main O 0 7.39714423048099e-09
determinant O 0 5.711757466997369e-08
of O 0 1.496723101013231e-08
metabolic O 0 1.011093809211161e-05
phenotype O 0 2.7242175182351502e-09
in O 0 3.473945089926822e-11
most O 0 8.893273617527342e-11
patients O 0 3.3989955738888966e-08
with O 0 4.3023015905419015e-07
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999960660934448
. O 0 1.2121801773901097e-05

In O 0 3.984998997452749e-09
the O 0 6.691994736129914e-10
present O 0 5.485148446560117e-10
study O 0 3.5632937572804835e-11
, O 0 3.3087814714678754e-13
the O 0 1.4522183369031216e-12
classification O 0 7.122867573539082e-11
of O 0 2.4383053354171125e-09
105 O 0 4.809695383301005e-06
PAH O 0 5.898205199628137e-05
mutations O 0 4.174074974550024e-10
may O 0 4.231005303056978e-12
allow O 0 9.451031103557828e-12
the O 0 4.2248544940282073e-11
prediction O 0 2.1161879359965496e-08
of O 0 8.634124526452069e-10
the O 0 1.68531866240329e-09
biochemical O 0 1.3103795382107819e-08
phenotype O 0 4.942092957094246e-09
in O 0 4.831485211909126e-10
> O 0 1.1245250952640617e-08
10 O 0 4.2861039717401184e-10
, O 0 6.702641046352209e-12
000 O 0 6.122724549584291e-09
genotypes O 0 6.696185383958664e-09
, O 0 5.997766519549863e-12
which O 0 2.599158681251129e-13
may O 0 3.678296382758628e-12
be O 0 7.18882722447467e-12
useful O 0 3.053643726769195e-10
for O 0 1.254307508552488e-11
the O 0 7.649264555098512e-10
management O 0 7.7565516676259e-08
of O 0 9.60777697400772e-08
hyperphenylalaninemia B-Disease 1 1.0
in O 0 3.228802114563223e-08
newborns O 0 4.0869409190236183e-07
. O 0 4.060498781655042e-08

Somatic O 0 0.0005419725785031915
instability O 0 0.0010273032821714878
of O 0 7.575159997941228e-06
the O 0 2.121795432685758e-06
CTG O 0 0.0020999328698962927
repeat O 0 4.125433861190686e-08
in O 0 3.293749994970341e-10
mice O 0 1.1378163689013121e-10
transgenic O 0 2.285249593725336e-11
for O 0 1.5627438579302044e-12
the O 0 2.2200217220103013e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 1.8676989554933243e-07
is O 0 9.922312971255565e-12
age O 0 1.228343760040218e-09
dependent O 0 3.037170237529807e-10
but O 0 6.506265253121424e-13
not O 0 5.234047245096518e-13
correlated O 0 4.760510319279376e-10
to O 0 1.9178691620935773e-11
the O 0 2.691728229198276e-10
relative O 0 1.1541620636990046e-07
intertissue O 0 2.1108844521222636e-06
transcription O 0 5.278543468989483e-08
levels O 0 9.43773699191297e-08
and O 0 9.881834017733127e-09
proliferative O 0 0.00012192460417281836
capacities O 0 4.0624549001222476e-05
. O 0 4.181537747172115e-07

A O 0 5.7190369261661544e-05
( O 0 1.3408812726822816e-08
CTG O 0 5.395136759034358e-05
) O 0 1.5652273921418214e-10
nexpansion O 0 5.47336469480797e-07
in O 0 1.061002605218242e-10
the O 0 4.1970507624888853e-10
3 O 0 1.304683472369561e-08
- O 0 4.294537347959704e-07
untranslated O 0 0.11188649386167526
region O 0 2.4174633850293503e-08
( O 0 1.8897314268961907e-11
UTR O 0 3.316275524412049e-06
) O 0 3.3359682204137098e-12
of O 0 1.8663987022549122e-10
the O 0 1.2842161112303074e-08
DM O 1 1.0
protein O 0 3.339591003737041e-08
kinase O 0 1.18650955727162e-09
gene O 0 1.8448374772273013e-10
( O 0 2.6973496353166482e-11
DMPK O 1 0.9999383687973022
) O 0 7.256135362704308e-12
is O 0 3.85920435148554e-13
responsible O 0 2.8459491707710782e-11
for O 0 9.418931606886005e-11
causing O 0 0.008782205171883106
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.32799992672517e-06
DM B-Disease 1 1.0
) O 0 4.079415028002131e-09
. O 0 2.9005409629689893e-08

Major O 0 2.180752926506102e-05
instability O 0 0.014603945426642895
, O 0 3.481455679299472e-10
with O 0 2.504686041904236e-11
very O 0 3.514548096994474e-10
large O 0 6.381180306380685e-12
expansions O 0 6.129965424150896e-10
between O 0 1.5949544462934284e-10
generations O 0 9.438773096448472e-10
and O 0 4.7598700154971585e-12
high O 0 4.798384953264012e-11
levels O 0 3.102660628417908e-10
of O 0 2.263737391983156e-10
somatic O 0 2.833193235574072e-08
mosaicism O 0 8.20878483409615e-07
, O 0 3.058871211880643e-11
is O 0 3.0336356256904784e-12
observed O 0 1.4536163939204982e-10
in O 0 3.940809623070862e-10
patients O 0 8.041298116268081e-08
. O 0 1.30675715581674e-07

There O 0 2.8559590248278255e-08
is O 0 3.2702111851801163e-11
a O 0 7.998425533006781e-11
good O 0 2.343795157955242e-09
correlation O 0 4.726671831711826e-10
between O 0 9.848262205736091e-10
repeat O 0 1.090344969867374e-08
size O 0 1.7855147915746272e-10
( O 0 4.143579142995568e-12
at O 0 5.346505529968404e-11
least O 0 2.6971938137804186e-12
in O 0 4.33463031093706e-12
leucocytes O 0 2.8944892704885206e-08
) O 0 1.3449460729147988e-12
, O 0 7.959245784151803e-13
clinical O 0 3.1589045268454186e-10
severity O 0 8.34564239937663e-09
and O 0 4.556096472319027e-11
age O 0 2.1282787088239274e-08
of O 0 1.7494159010311705e-08
onset O 0 0.0001060107460943982
. O 0 3.7931488350295695e-07

The O 0 5.018294359615538e-06
trinucleotide O 1 0.8242353796958923
repeat O 0 2.1756864953204058e-05
instability O 0 3.0845822038827464e-05
mechanisms O 0 3.7484997505998763e-07
involved O 0 3.2001379324242407e-09
in O 0 7.272648261391623e-09
DM B-Disease 1 1.0
and O 0 2.589381375983635e-09
other O 0 3.2172786657014285e-10
human O 0 1.5691933867856278e-06
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 8.220035763173428e-12
unknown O 0 9.248379839732479e-09
. O 0 3.511588131388521e-09

We O 0 6.901636595557648e-08
studied O 0 1.0353470969448608e-07
somatic O 0 6.310134494924569e-07
instability O 0 1.090940315862099e-07
by O 0 6.330812957200393e-11
measuring O 0 3.4333447196388533e-09
the O 0 5.725451224236622e-10
CTG O 0 1.1329501603540848e-06
repeat O 0 2.809106947054829e-09
length O 0 6.517528183813681e-10
at O 0 7.01233029976045e-11
several O 0 5.363069363606421e-12
ages O 0 2.3122680159470832e-10
in O 0 2.2546560972391827e-12
various O 0 2.0364129826866417e-10
tissues O 0 1.7138449548426138e-09
of O 0 9.71660973902999e-10
transgenic O 0 5.21020004917716e-10
mice O 0 2.7285099526985768e-11
carrying O 0 1.0698095881389591e-10
a O 0 3.4164635009936717e-10
( O 0 2.6188387569625604e-10
CTG O 0 1.2460124025892583e-06
) O 0 2.6072895578654887e-11
55expansion O 0 8.667826278951907e-08
surrounded O 0 8.492259118142442e-10
by O 0 3.4211158211894244e-12
45 O 0 1.0957169616077067e-09
kb O 0 8.913545457289729e-08
of O 0 5.054650031866004e-10
the O 0 8.939416984432569e-10
human O 0 1.2929935166994255e-07
DM B-Disease 1 1.0
region O 0 9.992012195425559e-08
, O 0 5.7132926861713784e-12
using O 0 5.597044355765135e-11
small O 0 1.354994449975777e-10
- O 0 3.5202794013144967e-09
pool O 0 1.2073186894667742e-08
PCR O 0 1.14502846315645e-07
. O 0 6.06207990472285e-08

These O 0 7.229373988337784e-09
mice O 0 3.72330638542806e-10
have O 0 3.16493657453662e-13
been O 0 5.565846720144429e-13
shown O 0 5.194566131405676e-12
to O 0 6.402967565877216e-12
reproduce O 0 2.369628049336825e-09
the O 0 3.611189403063264e-10
intergenerational O 0 2.708567592435429e-07
and O 0 5.223393939601806e-10
somatic O 0 1.6094569446067908e-06
instability O 0 5.01093882121495e-06
of O 0 3.4649175972845114e-08
the O 0 3.060474895733023e-08
55 O 0 8.744758588363766e-07
CTG O 0 1.8695554899750277e-05
repeat O 0 2.052652980921721e-08
suggesting O 0 2.215935213101261e-09
that O 0 2.432996295750889e-12
surrounding O 0 7.44526315599181e-11
sequences O 0 4.1443952436548415e-11
and O 0 1.0476254412583597e-11
the O 0 2.4847074397982283e-10
chromatin O 0 1.984311381875159e-08
environment O 0 2.611275107256006e-08
are O 0 9.095366820810469e-12
involved O 0 1.0709044762080566e-09
in O 0 2.3378927682671247e-09
instability O 0 5.316593160387129e-06
mechanisms O 0 9.85634142125491e-06
. O 0 2.4770875484136923e-07

As O 0 6.229305515859096e-09
observed O 0 9.288965152620676e-10
in O 0 2.8234786036973603e-11
some O 0 8.809262347364566e-12
of O 0 1.4675259618623926e-10
the O 0 2.502977547447216e-10
tissues O 0 9.832613834248605e-09
of O 0 3.164775819186616e-08
DM B-Disease 1 1.0
patients O 0 5.4643813918175965e-09
, O 0 3.0622728745127725e-12
there O 0 2.6026971376713615e-12
is O 0 2.430267900983829e-13
a O 0 3.216950143769548e-12
tendency O 0 5.093212657181212e-11
for O 0 6.3861481207350135e-12
repeat O 0 1.197376642281256e-09
length O 0 4.704671652255854e-10
and O 0 2.928196574103481e-11
somatic O 0 2.613726657330062e-08
mosaicism O 0 2.743664708759752e-07
to O 0 7.635091864299781e-11
increase O 0 4.456832472521377e-11
with O 0 7.656317528755008e-13
the O 0 3.627451811150095e-11
age O 0 3.538549453452333e-09
of O 0 4.5206774434980446e-10
the O 0 1.0310244880074038e-09
mouse O 0 2.110355445950063e-08
. O 0 2.8726985235039137e-08

Furthermore O 0 5.728432483920187e-07
, O 0 1.3204339011085864e-10
we O 0 1.9145541055309856e-11
observed O 0 1.7692246973011194e-11
no O 0 7.09101831072867e-13
correlation O 0 2.429990887328759e-12
between O 0 4.3781861816527545e-12
the O 0 1.0238823677788389e-11
somatic O 0 9.61206225724709e-09
mutation O 0 3.9271608187618767e-10
rate O 0 6.1622182911946766e-09
and O 0 3.3394223497573705e-10
tissue O 0 3.6073421938453976e-07
proliferation O 0 6.7333307924855035e-06
capacity O 0 1.2637270856430405e-06
. O 0 5.204722342000423e-08

The O 0 3.571681972402985e-08
somatic O 0 1.7071859019779367e-06
mutation O 0 1.1815255440694727e-09
rates O 0 2.7963717452728076e-10
in O 0 1.4041622682300914e-12
different O 0 2.168146044645436e-11
tissues O 0 6.465377677677964e-10
were O 0 1.4247535096156838e-10
also O 0 2.8246876409079857e-13
not O 0 4.638869041499738e-13
correlated O 0 1.5379922335689855e-10
to O 0 8.858344613393854e-12
the O 0 6.458570483980353e-11
relative O 0 8.940278206637231e-08
inter O 0 5.697416054317728e-05
- O 0 1.6421448890469037e-05
tissue O 0 9.68174276749778e-07
difference O 0 2.474266569407746e-09
in O 0 3.6885681141407556e-12
transcriptional O 0 4.313625845409064e-11
levels O 0 6.772746252714512e-11
of O 0 4.879889894948697e-12
the O 0 4.166569866903558e-12
three O 0 7.436516680225935e-12
genes O 0 1.4554357719021027e-11
( O 0 3.294500523082222e-12
DMAHP O 0 1.119600437959889e-05
, O 0 1.1416336626046686e-10
DMPK O 0 0.004709299653768539
and O 0 2.0160191571694241e-10
59 O 0 6.839585608986454e-08
) O 0 3.944778184661324e-11
surrounding O 0 5.40199440735023e-10
the O 0 1.7607960922649823e-10
repeat O 0 9.13564779381204e-09
. O 0 1.7011436703739946e-09
. O 0 1.61762141459576e-08

A O 0 1.154437185846291e-07
novel O 0 6.78320899449858e-10
missense O 0 1.7309641009433108e-07
mutation O 0 3.45937389845119e-10
in O 0 1.5660717514465183e-11
patients O 0 5.758724053173125e-10
from O 0 1.3719922420385444e-10
a O 0 1.6993946527765758e-10
retinoblastoma B-Disease 0 3.358356707394705e-06
pedigree O 0 2.897450102068433e-08
showing O 0 6.009043040933193e-09
only O 0 7.88385884353815e-11
mild O 0 2.145419120136438e-10
expression O 0 1.8483665986668285e-10
of O 0 5.42547506920954e-10
the O 0 3.3638121177403946e-09
tumor B-Disease 0 1.16161231744627e-07
phenotype O 0 1.822776063420406e-08
. O 0 2.4549100530180112e-08

We O 0 3.0105546944270145e-09
have O 0 1.1256364763900795e-12
used O 0 4.690624516405506e-13
single O 0 1.8137968340811716e-12
strand O 0 1.9001540792207283e-12
conformation O 0 5.219445101817266e-12
polymorphism O 0 1.231770796472631e-10
analysis O 0 3.6324922236818935e-11
to O 0 2.8971970655877755e-11
study O 0 1.1200736171890213e-10
the O 0 9.690544894302988e-11
27 O 0 9.06536623546117e-09
exons O 0 2.396725129472088e-08
of O 0 2.7259261514700484e-10
the O 0 2.9696167747061963e-10
RB1 O 0 1.2337493444647407e-06
gene O 0 5.343189866252596e-12
in O 0 1.1996860753080152e-12
individuals O 0 3.671231721402712e-12
from O 0 1.1066147997951248e-10
a O 0 2.5914453916087155e-10
family O 0 5.946536041356865e-10
showing O 0 5.076402942449931e-08
mild O 0 2.7731725804613916e-09
expression O 0 1.0154641572057699e-09
of O 0 3.3931253362595726e-09
the O 0 7.141089497508801e-09
retinoblastoma B-Disease 0 2.8898173241032055e-06
phenotype O 0 6.692651766115887e-08
. O 0 2.5859081986823185e-08

In O 0 2.633029350107563e-09
this O 0 1.1158132751099004e-10
family O 0 1.5560473742848302e-10
affected O 0 9.530304323490668e-11
individuals O 0 6.95720878910594e-13
developed O 0 1.3920438413084213e-10
unilateral B-Disease 0 9.993152971787822e-09
tumors I-Disease 1 1.0
and O 0 2.4016615363109395e-09
, O 0 1.5507133771519577e-11
as O 0 2.904277296086888e-12
a O 0 2.5649816472184117e-12
result O 0 4.3946643546455277e-10
of O 0 2.2519086595451654e-09
linkage O 0 7.946795932411987e-08
analysis O 0 2.4926074537745535e-09
, O 0 1.962387891074613e-11
unaffected O 0 1.1786646103573162e-09
mutation O 0 1.8082847719202988e-11
carriers O 0 4.002299359984196e-12
were O 0 1.604483351735908e-10
also O 0 1.57855031129861e-11
identified O 0 1.4856470498259e-09
within O 0 2.5694071315029987e-09
the O 0 4.033780864887149e-09
pedigree O 0 1.9829347763788974e-07
. O 0 2.4373005658162583e-07

A O 0 1.9951881924384907e-08
single O 0 4.817038989912703e-10
band O 0 2.061814052822797e-09
shift O 0 2.6127682239973637e-09
using O 0 2.831407608372416e-10
SSCP O 0 0.0008445707499049604
was O 0 3.3348601657934296e-09
identified O 0 1.69981706488187e-09
in O 0 1.3529491416086614e-10
exon O 0 1.025957541145317e-09
21 O 0 8.852858723873425e-11
which O 0 1.2464051871770992e-13
resulted O 0 6.483390907474629e-11
in O 0 4.20083499236279e-12
a O 0 4.841473402739105e-11
missense O 0 9.006922319088062e-09
mutation O 0 7.133594409625132e-11
converting O 0 2.4558266531471418e-09
a O 0 3.571326123719132e-09
cys O 0 0.0005621888558380306
- O 0 0.01772351935505867
- O 0 2.2008996893418953e-05
> O 0 1.0724936316819367e-07
arg O 0 8.33186852844392e-09
at O 0 4.558915189800672e-10
nucleotide O 0 1.944207989046376e-10
position O 0 4.959730959264164e-10
28 O 0 1.317777664766595e-09
in O 0 1.8232816645369354e-10
the O 0 7.164309145935022e-09
exon O 0 3.800455772307032e-07
. O 0 1.1452775083853339e-07

The O 0 3.287163607978982e-08
mutation O 0 6.484473846768424e-09
destroyed O 0 2.6657403395802248e-08
an O 0 4.352219973302596e-11
NdeI O 0 8.177250379048928e-07
restriction O 0 1.1106541242256185e-09
enzyme O 0 6.543748320986253e-10
site O 0 3.7251619566802674e-09
. O 0 3.375646073777716e-08

Analysis O 0 8.693091757550064e-08
of O 0 2.0962502844668052e-08
all O 0 8.256074157664273e-10
family O 0 4.1675177198108315e-11
members O 0 3.925277203969957e-12
demonstrated O 0 1.4727527530844498e-10
that O 0 7.403255525978425e-13
the O 0 1.0424037327760871e-10
missense O 0 1.2585360309458338e-07
mutation O 0 2.54821097556146e-09
co O 0 2.8736355517366974e-08
- O 0 5.718068223359296e-07
segregated O 0 6.971556221202491e-09
with O 0 6.0962393987062935e-12
patients O 0 3.281824145773271e-09
with O 0 3.1818103707337286e-10
tumors B-Disease 1 1.0
or O 0 0.0035570492036640644
who O 0 1.1579115266613371e-07
, O 0 1.5706283496008666e-10
as O 0 5.6203330184301237e-11
a O 0 1.7486293663049324e-11
result O 0 1.396434967659843e-09
of O 0 1.3250422092880854e-08
linkage O 0 2.8915428273990074e-08
analysis O 0 3.649703594899023e-10
had O 0 2.4504011666981462e-11
been O 0 7.846815211487446e-12
predicted O 0 9.509005388652625e-11
to O 0 6.469565334843441e-12
carry O 0 7.660111989160612e-10
the O 0 3.0372877546369637e-09
predisposing O 0 2.0324200704635587e-06
mutation O 0 9.904369591140494e-08
. O 0 1.6227889432229858e-07

These O 0 6.757038040205998e-09
observations O 0 2.938871013213884e-08
point O 0 9.116009613840959e-10
to O 0 1.689497847179311e-11
another O 0 3.531843220661024e-11
region O 0 6.583897871337285e-10
of O 0 7.92319321263335e-10
the O 0 2.055131842482183e-09
RB1 O 0 8.235577297455166e-06
gene O 0 1.5264331465481007e-11
where O 0 2.4823886436015075e-12
mutations O 0 2.4346163106370167e-12
only O 0 6.933866458433413e-13
modify O 0 1.23374366278739e-10
the O 0 8.864095568661412e-11
function O 0 1.0199753264217293e-09
of O 0 1.0875820244393708e-09
the O 0 4.802644948398438e-10
gene O 0 5.35953399716238e-11
and O 0 1.3576220876665435e-11
raise O 0 1.4020709593332015e-10
important O 0 1.117551329254951e-10
questions O 0 2.492030748424412e-10
for O 0 8.76389585902082e-12
genetic O 0 8.094765968635897e-10
counseling O 0 5.010103443225944e-10
in O 0 1.9162447236625857e-12
families O 0 1.3814103506926134e-11
with O 0 2.228405611079398e-12
these O 0 1.1269222360832387e-10
distinctive O 0 1.5657536378554937e-09
phenotypes O 0 5.581932693843328e-09
. O 0 1.4595764596947447e-09
. O 0 6.530113694225292e-08

Maternal B-Disease 0 0.00010152086179004982
disomy I-Disease 0 0.00013897630560677499
and O 0 4.856144073528412e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.059085913002491
with O 0 8.447726893012764e-12
gamete O 0 1.8955628888761566e-07
complementation O 0 7.161960979829018e-07
in O 0 9.456174732136446e-11
a O 0 1.3772614125551197e-11
case O 0 3.305050677582244e-11
of O 0 1.4423133798402432e-09
familial O 0 1.8658310452224214e-08
translocation O 0 3.50080682665066e-07
( O 0 3.0278970303276864e-11
3 O 0 3.4264086012925077e-10
; O 0 8.217884380802565e-13
15 O 0 3.9835509890728815e-11
) O 0 2.8396509861410013e-13
( O 0 5.106348829019003e-13
p25 O 0 7.1891537167800834e-09
; O 0 6.013425001005768e-12
q11 O 0 4.205661596756727e-08
. O 0 5.551136633696885e-11
2 O 0 3.468735854106342e-10
) O 0 1.0319015086857064e-10
. O 0 8.419766217571123e-09

Maternal B-Disease 0 0.0051918006502091885
uniparental I-Disease 1 0.9975242018699646
disomy I-Disease 1 0.9997413754463196
( I-Disease 0 3.9636244508756135e-08
UPD I-Disease 1 1.0
) I-Disease 0 6.785664391495416e-11
for I-Disease 0 5.636038510892227e-11
chromosome I-Disease 0 9.176823190237826e-10
15 I-Disease 0 2.0448316651044962e-10
is O 0 4.599995514706356e-13
responsible O 0 2.8688719802549834e-11
for O 0 1.1089320434143346e-11
an O 0 2.336681195758139e-12
estimated O 0 5.6967344036484846e-11
30 O 0 2.2833554491619168e-10
% O 0 4.299054515155554e-11
of O 0 9.829518926238179e-13
cases O 0 1.6928902940929746e-12
of O 0 7.145396807572979e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.051904212683439255
PWS B-Disease 1 1.0
) O 0 1.980265729173425e-08
. O 0 4.069818970720007e-08

We O 0 1.3743349569494967e-08
report O 0 2.5906893297289457e-10
on O 0 1.01026485788136e-10
an O 0 4.794181002708287e-13
unusual O 0 2.9980753123159953e-12
case O 0 1.582888854712028e-11
of O 0 2.8658122541713738e-09
maternal B-Disease 0 7.544562777184183e-06
disomy I-Disease 0 7.480162457795814e-05
15 I-Disease 0 7.791497225184685e-09
in O 0 1.1956375889354831e-09
PWS B-Disease 1 1.0
that O 0 4.482005738770667e-11
is O 0 1.7569898444133591e-12
most O 0 1.6858016718690472e-12
consistent O 0 9.835797731838625e-10
with O 0 1.0900231238453184e-11
adjacent O 0 4.669789444022854e-09
- O 0 1.0033867070546876e-09
1 O 0 1.8040860472190445e-10
segregation O 0 2.0209944828764037e-09
of O 0 3.464687564624924e-11
a O 0 3.908916940131846e-11
paternal O 0 4.897298921946458e-08
t O 0 4.596968083969699e-10
( O 0 2.9083961801401603e-12
3 O 0 4.171899978255844e-11
; O 0 2.5511577984686784e-13
15 O 0 1.9345523447067414e-11
) O 0 1.4659347141125073e-13
( O 0 2.3224393870709126e-13
p25 O 0 2.1145125650434693e-09
; O 0 9.556141685254649e-13
q11 O 0 5.106524536557799e-09
. O 0 2.5416734689143183e-12
2 O 0 1.4632872821426779e-12
) O 0 2.1332304548033268e-14
with O 0 6.409057854740718e-14
simultaneous O 0 4.5275980187220455e-10
maternal O 0 1.0319993748453271e-07
meiotic O 0 1.2567717021738645e-05
nondisjunction O 0 4.355093551566824e-06
for O 0 2.826973544145517e-09
chromosome O 0 1.5537297670675798e-08
15 O 0 4.109146445330225e-08
. O 0 6.96495305874123e-08

The O 0 3.6784729218197754e-07
patient O 0 0.019136348739266396
( O 0 9.26832499636987e-11
J O 0 3.108426938069897e-08
. O 0 2.628681126937149e-11
B O 0 2.0700051395206032e-10
. O 0 6.365543942649099e-13
) O 0 4.2714218121721326e-14
, O 0 9.194816403493983e-14
a O 0 5.392186263469823e-13
17 O 0 2.1464371946500194e-11
- O 0 1.1914635944521024e-11
year O 0 8.587541788784847e-11
- O 0 1.9073294055260703e-08
old O 0 1.3248699133328046e-06
white O 0 3.8771386101643657e-10
male O 0 1.4148859861506935e-09
with O 0 4.691792093725056e-11
PWS B-Disease 1 1.0
, O 0 4.74153738494465e-09
was O 0 1.7855344935924222e-07
found O 0 5.677353587252298e-10
to O 0 3.695374284351516e-10
have O 0 5.4096935264702495e-11
47 O 0 2.965169443314153e-09
chromosomes O 0 6.570776145409241e-10
with O 0 2.0289176588805802e-11
a O 0 7.70686181539304e-10
supernumerary O 0 2.6648260700312676e-06
, O 0 9.800006639526515e-11
paternal O 0 2.724370347095828e-07
der O 0 4.947508205077611e-05
( O 0 9.479867585371338e-11
15 O 0 4.0786582444773956e-10
) O 0 2.8918002974859247e-13
consisting O 0 6.698666361187877e-12
of O 0 2.536662373209264e-11
the O 0 2.1258656293654532e-11
short O 0 1.7565929266716296e-10
arm O 0 1.3830285361393635e-08
and O 0 3.56790465227963e-11
the O 0 2.7233704180673612e-09
proximal O 0 5.1243521738797426e-05
long O 0 5.204176645179359e-08
arm O 0 3.805957931035664e-06
of O 0 7.454011097252078e-07
chromosome O 0 2.666218961167033e-07
15 O 0 6.225887005939512e-08
, O 0 3.059722961107347e-11
and O 0 1.82939177695296e-10
distal O 0 7.537443707406055e-06
chromosome O 0 1.004985642794054e-05
arm O 1 0.9979220032691956
3p O 1 0.9999842643737793
. O 0 0.006878651212900877

The O 0 2.3174301531980745e-05
t O 0 6.079796577296293e-08
( O 0 8.708048171435223e-11
3 O 0 3.0586508326102546e-10
; O 0 7.024089968520053e-13
15 O 0 3.143600310617778e-11
) O 0 2.1173171451793066e-13
was O 0 2.26512281154001e-11
present O 0 1.7088523304731318e-11
in O 0 3.105220941490572e-12
the O 0 3.7265159708033124e-11
balanced O 0 4.248403850937166e-10
state O 0 1.16267637878531e-11
in O 0 2.7194683137332643e-12
the O 0 2.5963372077275615e-11
patients O 0 1.2084901135356318e-10
father O 0 8.983790378280787e-10
and O 0 7.207750368776189e-11
a O 0 3.6201703856875156e-09
sister O 0 1.2199421917102882e-06
. O 0 8.626755629848049e-07

Fluorescent O 0 4.4154469946988684e-07
in O 0 1.5156307320296492e-09
situ O 0 1.7825706777330197e-07
hybridization O 0 1.5802960051658488e-09
analysis O 0 5.375504555371613e-11
demonstrated O 0 6.885769038289524e-11
that O 0 1.3948357443019366e-12
the O 0 2.347409211456153e-10
PWS B-Disease 1 1.0
critical O 0 2.095271440794022e-07
region O 0 1.9692599551035528e-08
resided O 0 6.869459667768751e-08
on O 0 5.626031307492951e-10
the O 0 1.769461938083694e-10
derivative O 0 3.2376006320333772e-09
chromosome O 0 4.266447195533374e-10
3 O 0 7.164301790707484e-11
and O 0 5.760607702659515e-12
that O 0 7.620535604456469e-13
there O 0 5.414067631714925e-12
was O 0 5.222434637519591e-11
no O 0 2.1390591121300817e-12
deletion O 0 8.628489589490584e-11
of O 0 1.7703566390636638e-10
the O 0 1.3629378514679047e-08
PWS B-Disease 1 1.0
region O 0 4.7633128019697324e-07
on O 0 2.2996504700500964e-09
the O 0 1.0447803733271144e-10
normal O 0 6.089322379665418e-09
pair O 0 1.0846382680895772e-09
of O 0 9.061368877461007e-10
15s O 0 1.97254038880601e-07
present O 0 3.834617512410432e-09
in O 0 3.45164452575375e-09
J O 0 8.364477253053337e-06
. O 0 2.1788788728827058e-07

B O 0 0.0002700439654290676
. O 0 1.8656959355212166e-06

Methylation O 0 9.36384552119307e-08
analysis O 0 1.7127446128029078e-08
at O 0 2.114311747902775e-08
exon O 0 5.396610713859218e-09
alpha O 0 1.9838400366900544e-10
of O 0 1.254670145556247e-09
the O 0 1.7310235467249413e-09
small O 0 1.1431632723768459e-10
nuclear O 0 4.088117222522669e-08
ribonucleoprotein O 0 2.546279347370728e-07
- O 0 6.2527796274025604e-09
associated O 0 2.588670389158665e-09
polypeptide O 0 7.65097496469025e-09
N O 0 1.1293957768998553e-08
( O 0 2.819667025907857e-12
SNRPN O 0 4.741195880342275e-06
) O 0 9.161070339824828e-13
gene O 0 1.731311383319778e-12
showed O 0 2.1214668910474188e-11
a O 0 2.0039866033966236e-12
pattern O 0 1.0818654860855759e-09
characteristic O 0 5.125052049415046e-10
of O 0 5.659287483084086e-10
only O 0 1.0854070246757441e-11
the O 0 5.641050127014324e-11
maternal O 0 9.589867566717203e-09
chromosome O 0 3.33909094818452e-10
15 O 0 4.39345754221776e-10
in O 0 1.0887712953433493e-09
J O 0 3.51039921042684e-06
. O 0 4.4828163936472265e-07

B O 0 0.000361581624019891
. O 0 2.497349441910046e-06

Maternal B-Disease 0 5.125652751303278e-05
disomy I-Disease 0 1.885399251477793e-05
was O 0 1.763751478200959e-09
confirmed O 0 9.361403319196882e-11
by O 0 6.524508038875665e-13
polymerase O 0 1.0683776779929488e-11
chain O 0 1.060705993524702e-12
reaction O 0 2.0186402462790687e-13
analysis O 0 8.059309296315487e-12
of O 0 5.1714955234816173e-11
microsatellite O 0 2.0922865662242884e-09
repeats O 0 6.264905261232911e-10
at O 0 2.5608131934418132e-11
the O 0 4.0165867160046886e-11
gamma O 0 1.1395696608573758e-09
- O 0 5.5285198641286115e-09
aminobutyric O 0 1.2711920760466455e-07
acid O 0 1.0731209254544183e-09
receptor O 0 2.911494656476776e-11
beta3 O 0 2.7503757493718695e-08
subunit O 0 2.3244192681737275e-10
( O 0 1.4960564731492099e-10
GABRB3 O 0 0.0003055399574805051
) O 0 9.027608660616693e-10
locus O 0 1.6742212949338864e-08
. O 0 3.5434950973467494e-08

A O 0 4.7217436076607555e-05
niece O 0 7.683363219257444e-05
( O 0 1.8103632482002752e-10
B O 0 1.2552236583474041e-08
. O 0 7.780495865639114e-12
B O 0 1.3751517979887495e-10
. O 0 2.728538423847626e-13
) O 0 1.0203579958224535e-14
with O 0 4.307041919296428e-14
45 O 0 1.4951942461927104e-11
chromosomes O 0 6.372499750106897e-11
and O 0 6.302051328704872e-12
the O 0 1.250171216549134e-10
derivative O 0 3.7570632716033003e-10
3 O 0 2.864366729915524e-11
but O 0 5.496733710558255e-13
without O 0 5.521777479700063e-12
the O 0 3.5491984351487815e-11
der O 0 1.633337518569533e-07
( O 0 5.256088966842931e-12
15 O 0 1.052552975333576e-10
) O 0 4.4207191618288177e-13
demonstrated O 0 9.526941735504835e-11
a O 0 1.503805933944502e-11
phenotype O 0 1.788831582860695e-10
consistent O 0 7.598775497719146e-10
with O 0 1.5092762109536473e-12
that O 0 8.444082022149302e-13
reported O 0 5.541256342667111e-11
for O 0 1.4764420588897487e-11
haploinsufficiency O 0 2.5358183393109357e-06
of O 0 3.2299787733336416e-08
distal O 0 2.2777435333409812e-06
3 O 0 1.360202873001981e-06
p O 0 4.5533683987741824e-06
. O 0 1.708282297840924e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999998807907104
associated O 0 1.0481344361323863e-06
with O 0 3.364062362010145e-09
unbalanced O 0 2.2990254365140572e-05
segregation O 0 9.64944433690107e-07
of O 0 3.9024421027988865e-08
non O 0 2.131724431819748e-05
- O 0 1.38339203203941e-06
Robertsonian O 0 0.00010967934940708801
translocations O 0 7.949236646709323e-08
has O 0 1.0014063146421281e-12
been O 0 1.7939857498844303e-12
reported O 0 1.849698692824031e-11
previously O 0 2.1141323414131108e-10
but O 0 4.538063501369205e-12
has O 0 4.166297569527938e-13
not O 0 4.1594869909511445e-12
, O 0 3.5516617858527555e-12
to O 0 1.5113085782836322e-10
our O 0 1.4479673460243703e-08
knowledge O 0 1.9544290807971265e-06
, O 0 2.9677187790566606e-11
been O 0 4.871151051966116e-11
observed O 0 4.6012468141176655e-11
in O 0 8.841515193591665e-12
a O 0 2.848045237147101e-11
case O 0 2.9775287790911875e-10
of O 0 1.242350151642313e-07
PWS B-Disease 1 1.0
. O 0 5.630396117339842e-06

Furthermore O 0 1.333047180196445e-06
, O 0 9.013878532471153e-10
our O 0 3.1559128643721124e-09
findings O 0 2.0431084601924e-10
are O 0 5.329761154984625e-13
best O 0 2.5974452623478417e-12
interpreted O 0 5.653477685996222e-12
as O 0 1.4982223361242886e-12
true O 0 1.6195027263687933e-10
gamete O 0 2.7869774044120277e-07
complementation O 0 2.443053972456255e-06
resulting O 0 5.640732769762735e-09
in O 0 3.1155840130026036e-09
maternal B-Disease 0 0.0001314463879680261
UPD I-Disease 1 1.0
15 I-Disease 0 3.911260591848986e-06
and O 0 9.325379437541415e-07
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999923706054688
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 6.660064855168457e-08
2 I-Disease 0 6.403135799359916e-09
and O 0 9.722987970306463e-10
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 3.342664339767154e-11
a O 0 1.991079523477879e-11
case O 0 8.460384302855228e-12
for O 0 5.648185478351886e-12
" O 0 2.980926894213809e-10
lumping O 0 7.90328957833708e-09
" O 0 2.844682267522103e-09
. O 0 1.2805569937768269e-08

Recent O 0 1.3580022439896311e-08
studies O 0 6.488974357843347e-10
demonstrated O 0 1.230488766434945e-10
the O 0 3.1294456609431975e-11
existence O 0 1.7560578546849115e-09
of O 0 3.5643218931902254e-10
a O 0 4.2177691894629277e-11
genetically O 0 6.944263220010072e-11
distinct O 0 2.7211921951875162e-11
, O 0 4.82443349592715e-13
usually O 0 5.527106008117177e-13
lethal O 0 8.054299414916866e-12
form O 0 4.0499873420196675e-12
of O 0 2.2380514108633065e-10
the O 0 1.6762238264078633e-09
Schwartz B-Disease 1 0.9999642372131348
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.495526587244285e-10
SJS B-Disease 1 1.0
) O 0 1.7566900711862843e-10
of O 0 8.803381774669106e-07
myotonia B-Disease 1 1.0
and O 0 6.046055204933509e-05
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 3.33342287106575e-09
which O 0 7.158578591015541e-11
we O 0 2.2782928876807773e-09
called O 0 8.824667929729912e-08
SJS B-Disease 1 0.9999990463256836
type I-Disease 0 9.502035709374468e-07
2 I-Disease 0 1.4557732583853067e-06
. O 0 1.3255608166673483e-07

This O 0 3.764498757163892e-08
disorder O 1 0.9885602593421936
is O 0 3.270088089202261e-10
reminiscent O 0 1.1654238818437079e-07
of O 0 1.0024326257962457e-08
another O 0 8.026151965268014e-10
rare O 0 2.8082700054277154e-10
condition O 0 3.2832638680702075e-05
, O 0 1.5152044549604504e-11
the O 0 1.0777073677914473e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.2264509052783978e-07
SWS B-Disease 1 1.0
) O 0 3.3296514850844616e-11
, O 0 1.0387348533397178e-12
which O 0 2.2256052252880854e-13
comprises O 0 9.142885233626163e-12
campomelia B-Disease 0 4.546823362261421e-08
at O 0 3.240341883703479e-10
birth O 0 3.3176874580931326e-08
with O 0 1.9940991080602544e-09
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 4.97064540638803e-08
contractures B-Disease 1 0.9999998807907104
, O 0 2.864380510558817e-09
and O 0 8.494980829887311e-10
early B-Disease 0 0.0007096399203874171
death I-Disease 0 9.712595783639699e-05
. O 0 1.646482360229129e-06

To O 0 4.910372108923866e-09
test O 0 4.667917163914126e-10
for O 0 2.93472156298602e-11
possible O 0 1.8538790502731217e-09
nosologic O 0 2.344440326851327e-05
identity O 0 5.122105761756757e-08
between O 0 1.5951986398476947e-09
these O 0 1.3058397418941325e-10
disorders O 0 4.319428015264748e-08
, O 0 4.721996990468547e-13
we O 0 1.4961433784585476e-12
reviewed O 0 6.253083467688825e-11
the O 0 4.700764950904546e-12
literature O 0 2.5805337033890652e-11
and O 0 5.798558790244546e-13
obtained O 0 8.134119072744639e-11
a O 0 2.8588633196879876e-12
follow O 0 2.931981324394428e-10
- O 0 1.2108372082764163e-09
up O 0 8.551191005290448e-11
of O 0 1.6404913538714538e-10
the O 0 3.047619795415457e-11
only O 0 3.829327046428466e-12
two O 0 1.281482840849446e-12
surviving O 0 2.6890716320338015e-09
patients O 0 1.352809808619071e-10
, O 0 1.2376193819774173e-12
one O 0 1.0138411811466685e-11
with O 0 1.7517548522860693e-10
SJS B-Disease 1 0.9999963045120239
type I-Disease 0 2.4595626655354863e-06
2 I-Disease 0 2.3246823275258066e-06
at O 0 8.457464417688243e-08
age O 0 1.7802761931307032e-08
10 O 0 4.42357435403995e-11
years O 0 8.81243862604908e-12
and O 0 9.591416202936465e-14
another O 0 2.4781734823953183e-12
with O 0 1.851318751078246e-11
SWS B-Disease 1 0.985639214515686
at O 0 4.316683455130033e-09
age O 0 5.864103425068379e-09
7 O 0 3.653542801629328e-09
years O 0 1.595277687727048e-09
. O 0 1.2218762890370272e-08

Patients O 0 3.6239103451407573e-07
reported O 0 2.393375275744347e-09
as O 0 1.852148642789153e-11
having O 0 5.704696159902767e-10
either O 0 2.7464631102702697e-07
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 7.234155532387376e-07
SWS B-Disease 1 0.999996542930603
presented O 0 6.763571924750522e-10
a O 0 1.1806276442594132e-11
combination O 0 3.8274234476221025e-11
of O 0 5.86715190320497e-11
a O 0 3.198066117482412e-11
severe O 0 4.521956142866657e-09
, O 0 3.3286606110349837e-11
prenatal O 0 0.05615301430225372
- O 0 5.8299910961068235e-06
onset O 1 0.9999977350234985
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
( O 0 2.03290079214824e-10
with O 0 4.854368018669675e-09
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9997956156730652
respiratory O 1 1.0
and O 0 6.6482375586929265e-06
feeding O 0 0.03906043991446495
difficulties O 1 0.9999995231628418
, O 0 1.0123544225137948e-09
tendency O 0 2.4033077750118537e-08
to O 0 2.448951974542979e-08
hyperthermia B-Disease 1 0.9999407529830933
, O 0 3.106254697904376e-10
and O 0 4.441718173819886e-11
frequent O 0 1.6345412523488534e-10
death O 0 1.4251673174925372e-09
in O 0 1.114970824001027e-10
infancy O 0 9.215751788360649e-07
) O 0 6.130260687096933e-13
with O 0 4.090634352516692e-13
a O 0 1.3460631047290672e-11
distinct O 0 1.2741098176505261e-09
campomelic B-Disease 0 0.0005566664040088654
- I-Disease 0 0.01211317628622055
metaphyseal I-Disease 0 0.38708606362342834
skeletal I-Disease 1 0.9999982118606567
dysplasia I-Disease 1 0.9999972581863403
. O 0 4.730356522486545e-05

The O 0 1.845194574912057e-08
similarity O 0 1.599599031010257e-08
of O 0 6.831929688644323e-09
the O 0 2.2580635139490823e-09
clinical O 0 4.532371988830164e-08
and O 0 2.7097371568807205e-10
radiographic O 0 6.20493892711238e-07
findings O 0 2.2944368627264566e-09
is O 0 3.912003099931782e-12
so O 0 5.564692370091384e-12
extensive O 0 1.1193908022733012e-09
that O 0 6.641581815763908e-12
these O 0 1.0020798774101891e-10
disorders O 0 1.091271286668416e-07
appear O 0 9.890315233462843e-10
to O 0 7.319496397872882e-11
be O 0 9.210662788028401e-11
a O 0 1.867018067924775e-10
single O 0 4.4874335358713324e-09
entity O 0 1.2060934295732295e-07
. O 0 8.252741849901213e-07

The O 0 1.1686721812509404e-08
follow O 0 2.145568522848862e-08
- O 0 1.9690084229750937e-08
up O 0 4.9374997146411914e-11
observation O 0 6.351416281802358e-09
of O 0 9.043976678668741e-11
an O 0 1.9438935866793877e-13
identical O 0 1.8965450737651324e-11
and O 0 4.885615566621593e-13
unique O 0 4.593115818241067e-12
pattern O 0 2.198321524815583e-09
of O 0 2.5800849456913966e-08
progressive O 1 0.9999560117721558
bone B-Disease 1 0.9999995231628418
dysplasia I-Disease 1 0.98972088098526
in O 0 9.558854818791929e-10
the O 0 1.1363594509816721e-09
two O 0 8.261803741138607e-11
patients O 0 5.462607033379641e-10
( O 0 8.917231102828493e-13
one O 0 6.357806208584504e-12
with O 0 2.1013390680280075e-11
SJS B-Disease 1 0.9999159574508667
type I-Disease 0 4.4354855788242276e-08
2 I-Disease 0 1.2480426470062866e-08
, O 0 8.867134457246628e-12
one O 0 5.925493602731979e-12
with O 0 3.051196795222921e-11
SWS B-Disease 1 0.9999979734420776
) O 0 4.584514712302479e-11
surviving O 0 3.1408873724103614e-07
beyond O 0 1.000942461359955e-06
infancy O 0 1.4910300706105772e-05
adds O 0 3.0015459562271474e-10
to O 0 4.214898222110186e-11
the O 0 1.3614243066228937e-10
evidence O 0 4.145875864836057e-10
in O 0 1.3054132427803289e-11
favor O 0 2.618933958586922e-10
of O 0 6.807991392854262e-10
identity O 0 2.1450800602451636e-07
. O 0 2.7368596988708305e-07

The O 0 2.7889388576340934e-08
hypothesis O 0 1.4998693842471766e-08
that O 0 2.951935362816016e-10
SWS B-Disease 1 0.9987667798995972
and O 0 7.986527883474537e-09
SJS B-Disease 1 0.9999997615814209
type I-Disease 0 1.627509931267923e-07
2 I-Disease 0 1.2307035390790588e-08
are O 0 7.674084458175745e-12
the O 0 4.0958382518940795e-11
same O 0 4.768306860469806e-10
disorder O 0 5.797475832736154e-09
should O 0 6.597103072158994e-12
be O 0 1.0428885185986836e-11
testable O 0 5.418483994823475e-10
by O 0 1.7896864545896563e-12
molecular O 0 3.955856198167851e-10
methods O 0 1.3291427514161569e-08
. O 0 1.4071243059632366e-09
. O 0 1.93254177105473e-08

A O 0 2.1461318056026357e-07
mouse O 0 2.4683557420246416e-09
model O 0 7.011932701139756e-10
of O 0 1.4844346862830093e-09
severe O 1 0.9999713897705078
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 8.823133725854859e-07
defects O 1 0.9999946355819702
in O 0 2.6103338157668077e-08
hemostasis O 1 0.9999825954437256
and O 0 2.353549461986404e-07
thrombosis B-Disease 1 0.9516196250915527
. O 0 1.6818676158436574e-05

von B-Disease 1 0.9999852180480957
Willebrand I-Disease 1 0.9999480247497559
factor I-Disease 0 6.296781793935224e-05
( I-Disease 0 2.0688041502125998e-07
vWf I-Disease 1 0.9997966885566711
) I-Disease 0 1.0328916687285528e-05
deficiency I-Disease 1 1.0
causes O 1 0.9999926090240479
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.13780303299427032
humans O 0 1.1500114851514809e-06
. O 0 3.8809453428712004e-08

We O 0 9.729633099198054e-09
generated O 0 3.258793512816993e-10
a O 0 1.7961127377064123e-11
mouse O 0 2.5743688431001388e-11
model O 0 1.3419128655489665e-11
for O 0 2.4333768507134312e-12
this O 0 5.545228772690924e-12
disease O 0 2.7595935953028672e-11
by O 0 8.243972453476911e-14
using O 0 3.6144245148944654e-12
gene O 0 3.364996128962794e-11
targeting O 0 5.964325144880434e-10
. O 0 9.838072578816082e-09

vWf B-Disease 0 0.0006678399513475597
- I-Disease 1 0.9907241463661194
deficient I-Disease 0 0.0004994819755665958
mice O 0 3.1627479302187567e-08
appeared O 0 8.405112161824491e-10
normal O 0 2.627452033721056e-08
at O 0 1.3148596100798216e-10
birth O 0 1.3482427674293973e-10
; O 0 3.4224974742279313e-13
they O 0 2.2619785818717153e-12
were O 0 2.2827154055882204e-10
viable O 0 2.923430599821586e-07
and O 0 1.90424964685576e-09
fertile O 0 5.309327207214665e-06
. O 0 1.000440832399363e-07

Neither O 0 4.761557647725567e-05
vWf O 0 3.0917948606656864e-05
nor O 0 4.399283170641866e-06
vWf O 0 2.3463571778847836e-05
propolypeptide O 0 0.00018814473878592253
( O 0 4.73747796547741e-09
von B-Disease 0 0.0006564610521309078
Willebrand I-Disease 0 2.2535834432346746e-05
antigen O 0 4.2474685102433796e-08
II O 1 0.9999891519546509
) O 0 3.3727483028656025e-09
were O 0 5.250558956504392e-07
detectable O 0 1.9786334348737e-07
in O 0 2.869523195447865e-11
plasma O 0 1.3589629421772997e-09
, O 0 1.2208145085124134e-11
platelets O 0 2.7239888122920775e-09
, O 0 8.830783326807534e-11
or O 0 2.9785512944968673e-10
endothelial O 0 3.5266284337254206e-10
cells O 0 1.1950744838173932e-09
of O 0 1.5123647889581093e-09
the O 0 1.8038635030137584e-09
homozygous O 0 1.276866168353763e-09
mutant O 0 4.0591494609998335e-09
mice O 0 7.63272645087909e-09
. O 0 1.4005542503525703e-08

The O 0 1.1833804336447429e-07
mutant O 0 2.934357610229199e-07
mice O 0 2.0374756104502012e-08
exhibited O 0 3.6138234627003385e-09
defects O 0 1.3262326774565736e-06
in O 0 4.060456137988666e-10
hemostasis O 0 2.1210316845099442e-05
with O 0 3.4152822930844096e-11
a O 0 4.723733626477156e-10
highly O 0 5.8668021551966376e-08
prolonged O 0 0.20741598308086395
bleeding O 1 0.9998863935470581
time O 0 7.615381747427818e-08
and O 0 3.6602582076383783e-10
spontaneous O 0 1.2042418973123858e-07
bleeding O 0 0.00016982493980322033
events O 0 2.672498611300256e-10
in O 0 1.1176445186000805e-11
approximately O 0 8.736424778055252e-12
10 O 0 2.6651821374845674e-11
% O 0 7.416406377913631e-11
of O 0 1.1596515414602493e-10
neonates O 0 8.413798013862106e-08
. O 0 1.2552385442177183e-07

As O 0 1.3256968856012463e-08
in O 0 4.209911030894631e-10
the O 0 1.055118326043214e-09
human O 0 5.264012781225347e-09
disease O 0 5.947903218839201e-07
, O 0 9.153665238986752e-13
the O 0 1.0351694328114558e-11
factor O 0 6.756293441378958e-12
VIII O 0 4.2708645509037524e-08
level O 0 2.2367653684796096e-07
in O 0 3.4577032209659464e-11
these O 0 2.4869915155045774e-11
mice O 0 3.6522226215529585e-11
was O 0 4.665351438504217e-11
reduced O 0 8.590900213434338e-11
strongly O 0 6.885804860329303e-12
as O 0 1.2880279525243066e-12
a O 0 2.856862966679752e-12
result O 0 1.1432417512668991e-10
of O 0 3.770962431204339e-10
the O 0 2.832434009558682e-10
lack O 0 2.1072944278444083e-08
of O 0 1.531519772113299e-10
protection O 0 4.549967902445218e-10
provided O 0 1.2429196560859168e-10
by O 0 2.4237584161923564e-10
vWf O 0 1.4814818314334843e-06
. O 0 1.41401045539169e-07

Defective O 0 0.0007811975083313882
thrombosis B-Disease 0 1.0510149877518415e-05
in O 0 7.677859237276152e-09
mutant O 0 4.03280573380016e-08
mice O 0 3.2605858013567968e-09
was O 0 4.131075481694779e-10
also O 0 1.1993473705493307e-12
evident O 0 3.2861087184699045e-09
in O 0 3.3786346116670973e-12
an O 0 2.7969648624080745e-13
in O 0 5.53957357415924e-12
vivo O 0 1.3547419852599774e-09
model O 0 3.8134508884013485e-09
of O 0 1.3784060115540342e-07
vascular B-Disease 1 0.9218680262565613
injury I-Disease 1 0.9999674558639526
. O 0 1.5935282135615125e-05

In O 0 1.5596166580422732e-09
this O 0 1.1343725438150987e-11
model O 0 1.0434501179767963e-10
, O 0 2.325685217324791e-12
the O 0 5.2414753093366073e-11
exteriorized O 0 3.393237761883938e-07
mesentery O 0 5.28883333572594e-07
was O 0 5.7444431433850696e-09
superfused O 0 5.729039571633621e-07
with O 0 3.124896175155101e-10
ferric O 0 3.892127551807789e-06
chloride O 0 1.0295045882457998e-07
and O 0 3.843499296607433e-09
the O 0 7.326993767264867e-08
accumulation O 0 3.527394437696785e-05
of O 0 9.635649576011929e-07
fluorescently O 0 3.5546312915357703e-07
labeled O 0 1.295371809817425e-09
platelets O 0 1.769030921749959e-09
was O 0 9.553277058316212e-10
observed O 0 1.0173790282452799e-10
by O 0 1.2325229725718145e-10
intravital O 0 1.730970325297676e-06
microscopy O 0 4.333308243076317e-05
. O 0 9.843422503763577e-07

We O 0 6.391156404106368e-08
conclude O 0 1.452237370358489e-06
that O 0 9.478910018012598e-11
these O 0 9.176259058163438e-11
mice O 0 7.217659248048847e-10
very O 0 4.254726779229223e-11
closely O 0 2.6608182324139307e-08
mimic O 0 8.70317035150947e-06
severe O 0 6.139633478596807e-05
human O 1 0.9998968839645386
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 1.59752786998979e-07
will O 0 4.358693406203429e-10
be O 0 8.35724683900807e-11
very O 0 1.4172450539529091e-11
useful O 0 4.96006846706365e-11
for O 0 8.923100431289244e-13
investigating O 0 2.1107236791717554e-10
the O 0 1.2680627381467247e-10
role O 0 7.187929695895434e-10
of O 0 7.79491582392211e-09
vWf O 0 1.0511440251548265e-07
in O 0 5.39688627121393e-10
normal O 0 1.6320107079081936e-06
physiology O 0 8.654987482259457e-07
and O 0 1.1036890151805423e-10
in O 0 1.7045920230884803e-10
disease O 0 4.297435740596711e-09
models O 0 3.8634231924739026e-10
. O 0 2.0005821999014017e-10
. O 0 6.249035955363524e-09

Oral O 0 0.0013585295528173447
contraceptives O 0 2.5269457182730548e-05
and O 0 7.031134008350648e-11
the O 0 6.254875506428448e-10
risk O 0 2.07620601599956e-07
of O 1 0.9959940910339355
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9595264196395874

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.8184372186660767
Study O 0 3.349236266103617e-08
Group O 0 5.315556883545014e-10
. O 0 8.310061971883442e-09

BACKGROUND O 0 0.16230034828186035
Women O 0 1.0595556432235753e-08
with O 0 4.552916724187561e-11
mutations O 0 6.91799534324744e-11
in O 0 1.7683037326077233e-11
either O 0 1.4519296875903365e-09
the O 0 6.6129737241737985e-09
BRCA1 O 0 1.5636683059483403e-08
or O 0 4.41607167500635e-11
the O 0 2.1583561327087608e-10
BRCA2 O 0 1.2862010345671138e-09
gene O 0 4.119858100504192e-12
have O 0 4.950687754710914e-13
a O 0 2.0091534772698205e-12
high O 0 6.459137391612302e-11
lifetime O 0 3.3131204446590345e-09
risk O 0 9.235233022764078e-08
of O 0 3.4485055948607624e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.185097613022663e-06

Oral O 1 0.9990748167037964
contraceptives O 1 0.9999490976333618
protect O 0 2.0705699625978014e-06
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 7.829988135199528e-06
general O 0 1.0764957814046738e-08
, O 0 2.9876346622353944e-12
but O 0 6.22018604158614e-13
it O 0 2.5067802854653563e-14
is O 0 1.9836354577689765e-14
not O 0 2.2412005248623884e-13
known O 0 7.63275814080755e-12
whether O 0 3.443211341047636e-11
they O 0 1.1217497764004492e-10
also O 0 1.996243274848819e-11
protect O 0 1.2591476472589846e-10
against O 0 1.0394697325111224e-09
hereditary B-Disease 1 1.0
forms I-Disease 1 0.999998927116394
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.004841814748942852

METHODS O 0 4.887435352429748e-06
We O 0 4.408073461803497e-09
enrolled O 0 1.2834129314853726e-08
207 O 0 1.1631965390890286e-09
women O 0 4.5391305297792783e-11
with O 0 6.485459946858896e-10
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 5.092916754989574e-09
161 O 0 3.979135243525889e-09
of O 0 2.6765464511413484e-08
their O 0 4.4899270079667986e-08
sisters O 0 1.3327068337787296e-08
as O 0 1.6798108737337003e-10
controls O 0 3.5204137383004763e-09
in O 0 7.302874277526072e-11
a O 0 1.109010869249083e-10
case O 0 5.311148187914227e-10
- O 0 2.3624224354534817e-08
control O 0 1.844388819449705e-08
study O 0 1.6644996492232167e-09
. O 0 5.120227353216933e-09

All O 0 6.239900596227699e-09
the O 0 4.414844323452627e-10
patients O 0 1.5590240209917283e-10
carried O 0 1.9293160818945054e-11
a O 0 3.58724096434504e-12
pathogenic O 0 2.1149632045691646e-10
mutation O 0 2.1925449303350497e-11
in O 0 3.5290152744504866e-11
either O 0 1.276048777754113e-08
BRCA1 O 0 2.396222242850854e-08
( O 0 3.475819024961746e-12
179 O 0 2.4463175929412273e-09
women O 0 1.4537690495863842e-10
) O 0 9.40833435464361e-12
or O 0 3.9458036837913824e-10
BRCA2 O 0 2.6741123093643182e-08
( O 0 2.4919299262959882e-11
28 O 0 6.5938547955113336e-09
women O 0 2.0356791252673645e-10
) O 0 1.906116375849365e-10
. O 0 4.2163758706692533e-08

The O 0 1.9060674816273604e-08
control O 0 4.161780964295758e-08
women O 0 6.247134753945005e-11
were O 0 8.821995217678236e-11
enrolled O 0 1.2978522700990425e-09
regardless O 0 1.3419961808480707e-09
of O 0 1.3662365683231315e-10
whether O 0 2.4886761054720985e-11
or O 0 2.8352863459812916e-11
not O 0 1.2380732723749066e-11
they O 0 2.3294333476031603e-11
had O 0 1.7549520170412336e-10
either O 0 6.875172431364263e-09
mutation O 0 1.6764357013698827e-08
. O 0 5.789920010101923e-08

Lifetime O 0 2.7202034402762365e-07
histories O 0 1.3081799465908261e-07
of O 0 9.142794965555368e-09
oral O 0 2.9478139822458616e-06
- O 0 3.081779098579318e-08
contraceptive O 0 1.741010113853747e-09
use O 0 2.044194024122814e-12
were O 0 1.0053952462230065e-11
obtained O 0 3.142568844038962e-11
by O 0 3.602469668059771e-12
interview O 0 9.149663249274909e-10
or O 0 7.550452233925919e-13
by O 0 1.2168751791809262e-13
written O 0 3.1791724201118976e-13
questionnaire O 0 1.908470668825213e-13
and O 0 2.2509841280976724e-14
were O 0 6.112586565382161e-12
compared O 0 1.1445595166081901e-10
between O 0 4.6287626509489144e-11
patients O 0 5.945093028980608e-11
and O 0 2.541319585325219e-12
control O 0 2.4270081055988157e-08
women O 0 1.6662640017761632e-11
, O 0 3.720375786955832e-13
after O 0 3.218848104724614e-11
adjustment O 0 7.875600616102929e-09
for O 0 2.4846860680050042e-12
year O 0 2.2855111900255132e-11
of O 0 2.831125264779466e-11
birth O 0 1.2964568307793911e-09
and O 0 2.444366931086961e-10
parity O 0 4.825246264772431e-07
. O 0 4.991632707174176e-08

RESULTS O 0 3.010617035670293e-07
The O 0 5.740171893364732e-09
adjusted O 0 1.2784435732271504e-08
odds O 0 1.1026759061394387e-08
ratio O 0 3.668465309303315e-09
for O 0 4.035034972815765e-09
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 2.0745249074138883e-08
with O 0 1.2295350284782791e-12
any O 0 2.9962061477706303e-12
past O 0 1.5722881330226812e-11
use O 0 9.616040602677955e-13
of O 0 3.0770757469822385e-11
oral O 0 3.921079638757874e-08
contraceptives O 0 1.0827272944879951e-07
was O 0 1.8863623996168144e-09
0 O 0 1.3698043810350669e-09
. O 0 9.830325886639457e-09

5 O 0 6.548333875144863e-09
( O 0 1.3584769593955048e-11
95 O 0 5.95245186474358e-09
percent O 0 1.5358968541434592e-09
confidence O 0 1.0812327033704605e-08
interval O 0 1.8926415989994894e-08
, O 0 6.500984212759464e-12
0 O 0 3.924341320654667e-12
. O 0 2.2052600631011776e-12
3 O 0 8.942476967255253e-12
to O 0 2.6442802808501753e-11
0 O 0 2.5047518312920625e-12
. O 0 4.847994835438518e-12
8 O 0 1.0229479069367997e-10
) O 0 2.8368769139364147e-11
. O 0 2.835164991665806e-09

The O 0 5.441378192472257e-08
risk O 0 1.1214642547940912e-08
decreased O 0 3.4227134459996478e-09
with O 0 5.218108388958809e-13
increasing O 0 1.1798419879971433e-11
duration O 0 1.1430073776352856e-08
of O 0 6.99663244008164e-11
use O 0 1.3851727924396595e-11
( O 0 3.624406981136974e-12
P O 0 8.370783177724661e-09
for O 0 1.3504192555857664e-11
trend O 0 4.387177288123212e-10
, O 0 1.8869641092711387e-12
< O 0 8.547864499552915e-11
0 O 0 6.522007326564827e-13
. O 0 1.8524127544383706e-12
001 O 0 1.8549294322767196e-09
) O 0 1.4538388125751728e-13
; O 0 1.2375992463101951e-14
use O 0 4.849379903713869e-13
for O 0 1.1663762403829603e-12
six O 0 1.179068787049431e-10
or O 0 3.161035018808822e-12
more O 0 1.4378496765617144e-13
years O 0 8.470218450240541e-12
was O 0 9.937162204209926e-12
associated O 0 1.2256582034020358e-11
with O 0 3.942540467271466e-13
a O 0 9.321541802331801e-12
60 O 0 1.1540080002703235e-09
percent O 0 1.6645114453428533e-10
reduction O 0 8.439843823815352e-10
in O 0 1.2029155449511109e-10
risk O 0 1.905547541980468e-08
. O 0 6.757504422694183e-08

Oral O 0 0.24975988268852234
- O 0 2.6905898266704753e-05
contraceptive O 0 1.1829737331936485e-06
use O 0 1.8441909110933352e-09
protected O 0 6.52850758342538e-07
against O 1 0.9998973608016968
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 4.431720324049593e-09
for O 0 3.03327697161182e-12
carriers O 0 1.0696861148587478e-12
of O 0 6.92396209811541e-11
the O 0 1.1724538007129581e-09
BRCA1 O 0 4.00009980694449e-09
mutation O 0 4.7516539314340633e-11
( O 0 2.3048769923900148e-12
odds O 0 4.44104735208839e-08
ratio O 0 2.185224001749475e-09
, O 0 4.944424210340248e-12
0 O 0 1.4401229774668733e-12
. O 0 1.627536972380328e-12
5 O 0 1.6902318303660402e-12
; O 0 2.6978804051349357e-14
95 O 0 1.2592846210246478e-10
percent O 0 3.4197947251790595e-10
confidence O 0 2.669937160248992e-09
interval O 0 7.394266532401161e-09
, O 0 9.665343178588692e-12
0 O 0 3.372486101146932e-12
. O 0 2.7241715827575064e-12
3 O 0 1.271108478889671e-11
to O 0 3.919204891178474e-11
0 O 0 1.2928448459362252e-12
. O 0 7.492522769748933e-13
9 O 0 2.894363568262115e-11
) O 0 1.4696300816921526e-13
and O 0 7.761471315908403e-14
for O 0 6.465392457521979e-13
carriers O 0 4.715609413369348e-12
of O 0 2.576020785571842e-10
the O 0 4.2083074802690135e-09
BRCA2 O 0 3.505326162667188e-08
mutation O 0 1.8840855264823375e-10
( O 0 4.191862568864169e-12
odds O 0 7.647958710776948e-08
ratio O 0 3.2815363759652882e-09
, O 0 7.416628942935599e-12
0 O 0 3.401459669483131e-12
. O 0 1.3482157014063634e-12
4 O 0 2.8705672821399686e-12
; O 0 1.553523477394736e-14
95 O 0 6.408162889215419e-11
percent O 0 4.744318479743548e-11
confidence O 0 1.348508305021312e-09
interval O 0 4.039655276955045e-09
, O 0 1.0938261581217024e-11
0 O 0 1.420754681437375e-12
. O 0 3.1861917618170033e-12
2 O 0 8.886639688010511e-12
to O 0 2.293940037922937e-11
1 O 0 4.195295846831648e-11
. O 0 1.7490463938285572e-11
1 O 0 1.2967778240113859e-10
) O 0 2.2081064407486473e-11
. O 0 2.7466104945972347e-09

CONCLUSIONS O 0 1.722618253552355e-05
Oral O 1 0.9842043519020081
- O 0 4.087367778993212e-05
contraceptive O 0 3.6573942452378105e-07
use O 0 5.026928526219443e-11
may O 0 2.1640354438967613e-11
reduce O 0 2.7724891826785836e-10
the O 0 1.1168544561401816e-10
risk O 0 2.1066901467747812e-07
of O 1 0.9997208714485168
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.4615433308051706e-09
women O 0 4.631082843598033e-12
with O 0 2.3224570053562155e-13
pathogenic O 0 5.003129854852517e-11
mutations O 0 1.8550336614020502e-11
in O 0 2.5347375240403203e-11
the O 0 3.712246066100988e-09
BRCA1 O 0 1.8703458692925778e-07
or O 0 4.2916713738350154e-08
BRCA2 O 0 1.3825440419168444e-06
gene O 0 2.6220632776130515e-07

A O 0 1.1555452772427088e-07
Japanese O 0 2.8879938440695696e-07
family O 0 7.82000464383259e-10
with O 0 2.0490835417330544e-10
adrenoleukodystrophy B-Disease 1 1.0
with O 0 6.05307193257687e-11
a O 0 8.403040069326906e-11
codon O 0 4.750353888027803e-09
291 O 0 2.453593328510806e-09
deletion O 0 3.770374679135102e-09
: O 0 6.7442679045626175e-12
a O 0 4.047008214658199e-11
clinical O 0 6.520814110899664e-09
, O 0 5.109861492269552e-11
biochemical O 0 1.259240178796972e-08
, O 0 1.959120227157385e-10
pathological O 0 2.0885950107185636e-06
, O 0 2.0246471166274205e-10
and O 0 5.357165822061916e-10
genetic O 0 8.858800981670356e-08
report O 0 9.240093135076677e-09
. O 0 6.601596425070966e-08

We O 0 4.8461346047190546e-09
report O 0 1.1027610075098337e-10
a O 0 2.7182962911848074e-12
Japanese O 0 9.488664298729077e-10
family O 0 4.950333545861163e-11
with O 0 2.522334563437312e-10
adrenoleukodystrophy B-Disease 1 1.0
( O 0 3.775875256906147e-07
ALD B-Disease 1 1.0
) O 0 2.3272174118349476e-11
with O 0 1.4024171364132587e-12
a O 0 4.927721859032674e-12
three O 0 3.949338685943493e-12
base O 0 4.9370382781965816e-11
pair O 0 3.975279827539424e-10
deletion O 0 1.7993653234071871e-09
( O 0 1.9078103680181258e-11
delGAG O 0 3.5527742170415877e-07
291 O 0 1.57154012025984e-09
) O 0 4.665954254912119e-12
in O 0 7.659888695554784e-11
the O 0 4.2034560721049274e-08
ALD B-Disease 1 1.0
gene O 0 2.0294748992455425e-07
. O 0 1.7381384509462805e-07

A O 0 4.349057007857482e-07
variety O 0 4.907357631367404e-09
of O 0 3.0889573121584135e-09
phenotypes O 0 4.0436947124078415e-09
were O 0 1.8413535973760276e-10
observed O 0 1.1317424428169964e-11
within O 0 3.8023636322881416e-11
this O 0 1.366652971346305e-11
family O 0 6.822017395435864e-10
. O 0 4.342177106764211e-08

While O 0 7.225996689896874e-09
the O 0 2.88785950708359e-09
proband O 1 0.9986648559570312
( O 0 2.2663210197393369e-10
patient O 0 1.2012956176477019e-06
1 O 0 7.293175507960825e-10
) O 0 2.090125598638859e-12
was O 0 9.718717497442242e-11
classified O 0 1.1207574451832514e-10
as O 0 3.4300407566328905e-12
having O 0 1.069479158011255e-10
a O 0 4.5671964474247595e-12
rare O 0 7.130421253442876e-12
intermediate O 0 2.986492719792011e-10
type O 0 4.409491938250909e-10
of O 0 3.5177689650112143e-09
adult O 0 4.693589232829254e-07
cerebral O 0 1.669400262471754e-05
and O 0 5.0640220905506794e-09
cerebello O 1 0.9999995231628418
- O 1 0.9998990297317505
brain O 1 0.9474818110466003
stem O 0 1.755894452060147e-08
forms O 0 2.4538154494435638e-11
, O 0 1.9656937752868253e-13
his O 0 4.504373610214607e-11
younger O 0 4.690251387273747e-08
brother O 0 1.150373191194376e-05
( O 0 1.309885949707379e-10
patient O 0 0.00015241549408528954
2 O 0 3.665777403849546e-10
) O 0 1.0895922835860161e-12
and O 0 2.4957542976711267e-11
nephew O 0 0.0002049529430223629
( O 0 1.02601177554007e-10
patient O 0 4.797143446921837e-07
3 O 0 6.555553322407093e-10
) O 0 1.9770840780503063e-12
had O 0 3.456305033844309e-11
a O 0 1.3451141589460036e-10
childhood O 0 1.3312861483427696e-05
ALD B-Disease 1 1.0
type O 0 4.711443125415826e-06
. O 0 5.848467594660178e-07

Another O 0 1.1467879090787392e-07
nephew O 0 0.0017678061267361045
( O 0 7.270786195334722e-10
patient O 0 0.00033404125133529305
4 O 0 8.813930918449842e-09
) O 0 8.718380184458141e-12
of O 0 1.479787181679626e-09
patient O 0 1.3507454923455953e-06
1 O 0 6.805749297456032e-09
was O 0 1.5793318874912643e-09
classified O 0 2.590526126944326e-10
as O 0 3.684152375532657e-12
having O 0 2.7352853315676384e-10
an O 0 3.869586248650414e-11
adolescent O 0 7.757631692584255e-08
form O 0 8.029004128218276e-09
. O 0 2.6595350277602847e-07

The O 0 1.7009278963087127e-07
tau O 0 1.9052203370506504e-08
level O 0 1.3498758733021532e-07
in O 0 1.5478890391662503e-10
the O 0 2.95310820241923e-09
cerebrospinal O 0 2.2304111553239636e-05
fluid O 0 3.0694741326442454e-06
( O 0 7.506809618362809e-10
CSF O 1 0.9917047023773193
) O 0 5.078080664300266e-11
in O 0 2.2729671478316504e-09
patient O 1 0.8406980037689209
1 O 0 2.3497946699535532e-08
was O 0 1.3444101831794342e-08
as O 0 5.466270231596626e-12
high O 0 1.4224393364570265e-11
as O 0 9.832701330664967e-14
that O 0 2.0052998500543102e-14
of O 0 3.98000989804137e-12
patients O 0 3.401890991128198e-10
with O 0 1.5400477559879278e-09
Alzheimers B-Disease 1 1.0
disease I-Disease 0 8.578081747145916e-07
( O 0 8.947185874130792e-12
AD B-Disease 0 5.5538670551413816e-08
) O 0 9.763383157501693e-11
. O 0 1.1971716951109102e-08

His O 0 2.2588665160583332e-07
brain O 0 2.0086401946173282e-06
magnetic O 0 2.7241927824661616e-08
resonance O 0 1.9607968582135982e-08
image O 0 9.186806315675256e-10
( O 0 4.892574193005039e-12
MRI O 0 1.8092994650942273e-05
) O 0 9.148746864251489e-12
showed O 0 4.6868326997184795e-09
abnormalities B-Disease 0 5.5469751458758765e-08
in I-Disease 0 1.16636127839298e-11
the I-Disease 0 5.497696187184431e-10
bilateral I-Disease 0 0.3777066767215729
cerebellar I-Disease 1 0.9999972581863403
hemispheres I-Disease 0 9.874568058876321e-05
and O 0 3.176629093104566e-08
brain O 0 0.0012157990131527185
stem O 0 3.967360839851608e-08
, O 0 1.90211952091901e-12
but O 0 8.804940825925256e-13
not O 0 1.9141806195666078e-12
in O 0 8.783680727209031e-11
the O 0 3.48936346483697e-08
cerebral O 1 0.9998828172683716
white O 0 2.006246058172678e-09
matter O 0 9.38162969532641e-09
, O 0 1.615508941898991e-12
where O 0 5.315244772097216e-13
marked O 0 1.5410540898930236e-11
reductions O 0 3.3287850254026807e-09
of O 0 2.0657782151545234e-09
the O 0 9.667957989734077e-09
cerebral O 0 9.757224688655697e-06
blood O 0 5.490031540489326e-08
flow O 0 8.994908284876146e-08
and O 0 3.9457134781706316e-10
oxygen O 0 1.6120310419864836e-08
metabolism O 0 1.9732114608927986e-08
were O 0 8.301372783625638e-11
clearly O 0 3.3234951249405675e-12
demonstrated O 0 2.8867758877781924e-12
by O 0 1.1706727167520858e-13
positron O 0 2.0445195536566985e-10
emission O 0 4.925143071154992e-10
tomography O 0 6.988639711380529e-08
( O 0 2.1052004584021233e-09
PET O 0 6.271370239119278e-06
) O 0 1.483257183743092e-09
. O 0 4.809139397821127e-08

In O 0 2.73366424607957e-07
patients O 0 9.026184102367552e-07
2 O 0 6.222418136303531e-09
and O 0 1.0624241764123354e-10
3 O 0 2.812778066019206e-10
, O 0 8.54678036243256e-13
the O 0 1.5608999552954583e-12
autopsy O 0 8.472795798297739e-10
findings O 0 1.8992500627756925e-10
showed O 0 8.159857234346646e-10
massive O 0 6.033965771479188e-09
demyelination B-Disease 1 1.0
of I-Disease 0 0.003191176801919937
the I-Disease 0 0.11909253150224686
cerebral I-Disease 1 1.0
white I-Disease 0 1.4544748516698291e-08
matter I-Disease 0 5.966831029269315e-09
with O 0 2.1503699428743195e-12
sparing O 0 1.0652512205666653e-09
of O 0 1.4645355150832984e-08
the O 0 3.0875102652316855e-07
U O 1 0.9999924898147583
- O 0 1.4655669474450406e-05
fibers O 0 3.3667856058627876e-08
, O 0 5.765971901328104e-12
compatible O 0 1.0594464860957942e-08
with O 0 1.8515085298265177e-12
the O 0 2.2311541503228227e-11
findings O 0 2.410457666801591e-10
of O 0 9.018745195099598e-10
childhood O 0 0.00031670278985984623
ALD B-Disease 1 1.0
. O 0 2.501773451513145e-06

Oleic O 0 0.0002072505740216002
and O 0 1.7955406406144903e-07
erucic O 1 0.6752143502235413
acids O 0 5.990860785232144e-08
( O 0 2.2989081471802564e-10
Lorenzos O 0 1.938420973601751e-05
Oil O 0 1.7234670579568956e-08
) O 0 4.5301135347293464e-13
were O 0 6.833261820965442e-12
administered O 0 8.837978265896496e-11
to O 0 7.11227812755233e-11
patients O 0 9.798459821297456e-10
1 O 0 1.7873071078700065e-10
and O 0 1.6975698624577262e-11
4 O 0 2.45000519871752e-10
, O 0 1.1424820508046385e-12
but O 0 4.655488776601768e-13
sufficient O 0 8.998910644431035e-11
effectiveness O 0 3.5879699211704974e-10
was O 0 1.0799929700544553e-10
not O 0 2.3486886047141553e-11
obtained O 0 2.1147556594769412e-08
. O 0 6.350268222377053e-08

The O 0 2.040891189381e-07
findings O 0 7.695349246716887e-09
in O 0 4.749696469463771e-11
this O 0 6.314757744485533e-12
family O 0 2.319656966509598e-11
suggest O 0 1.5137174846913126e-10
that O 0 8.321703244031087e-13
delGAG291 O 0 9.217807850347981e-09
is O 0 2.1418598231820463e-12
part O 0 7.074395236283948e-11
of O 0 1.4414744953228364e-09
the O 0 1.8741763696539238e-09
cause O 0 6.832816534796393e-09
of O 0 5.942570879824416e-09
Japanese O 0 7.598812226206064e-05
ALD B-Disease 1 1.0
with O 0 1.0175560394287686e-09
phenotypic O 0 4.4178982250286936e-08
variations O 0 1.215769351858853e-08
. O 0 6.448560441185691e-08

Moreover O 0 7.321614816646616e-07
, O 0 4.001415865317881e-11
although O 0 8.573724195881649e-12
the O 0 8.713858627718007e-12
scale O 0 3.2696517715535833e-10
of O 0 1.4261455905106857e-10
the O 0 1.268778831997608e-10
study O 0 4.053357996469664e-11
is O 0 1.9036246916900174e-13
limited O 0 8.713593215026183e-12
, O 0 2.5834232756510866e-12
there O 0 2.7332499111243358e-11
is O 0 1.5673648360095549e-12
a O 0 2.630205775400185e-11
possibility O 0 2.1275796679987025e-09
that O 0 3.1521876775464364e-10
PET O 0 5.959013378742384e-06
can O 0 2.771803231382819e-09
detect O 0 1.1664862995530711e-06
an O 0 3.4215383859503845e-09
insidious B-Disease 0 3.3046510452550137e-06
lesion I-Disease 0 5.01130816701334e-05
which O 0 3.107059054485717e-11
is O 0 4.058020846436916e-12
undetectable O 0 1.3817404165283875e-10
by O 0 7.267988294534788e-13
computed O 0 3.1560334345925867e-09
tomogram O 0 1.0241006975775235e-06
( O 0 3.924261263166251e-11
CT O 0 2.5204766984643356e-07
) O 0 5.44990528400513e-12
or O 0 2.2550570785706547e-11
MRI O 0 1.843489059183412e-07
analysis O 0 2.2575845359806834e-10
, O 0 2.670960512225068e-13
and O 0 1.6846050108262206e-13
that O 0 3.485096055060727e-14
the O 0 1.9379638952626843e-12
higher O 0 1.5854760559985692e-10
level O 0 4.079578452831356e-09
of O 0 4.1202868894529843e-10
tau O 0 1.6123677393231617e-10
reflects O 0 1.2860746322063132e-11
the O 0 2.3775382704260828e-12
process O 0 2.012831012976335e-09
of O 0 8.797773176638657e-09
neuronal B-Disease 0 0.00016422098269686103
degeneration I-Disease 1 0.9999575614929199
in O 0 1.2166588021500502e-06
ALD B-Disease 1 1.0
. O 0 1.098916709452169e-05

Lorenzos O 0 0.004530356731265783
Oil O 0 1.6096629451567424e-07
should O 0 5.0924358480086696e-11
be O 0 9.611350777760652e-12
given O 0 2.5906770218658837e-12
in O 0 1.222827394897763e-12
the O 0 3.2968139936778718e-12
early O 0 2.5653218438392855e-10
stage O 0 2.3821082884012412e-09
. O 0 7.00649205320758e-10
. O 0 1.7854757672353117e-08

Nonsense O 0 4.2590327211655676e-05
mutation O 0 5.967787153338122e-09
in O 0 2.6187052526438492e-09
exon O 0 2.165599433112675e-08
4 O 0 2.708813395813081e-09
of O 0 2.322825043421517e-09
human O 0 1.538952520974135e-09
complement O 0 3.941775972293726e-08
C9 O 0 0.0048287408426404
gene O 0 3.3849528735530043e-10
is O 0 1.36954878861284e-12
the O 0 7.222251442728922e-12
major O 0 1.3684951782888533e-10
cause O 0 4.425821653608608e-10
of O 0 1.7388861461853367e-09
Japanese O 0 3.712078751050285e-06
complement B-Disease 0 2.363907333347015e-05
C9 I-Disease 1 0.9999949932098389
deficiency I-Disease 0 0.0076203844510018826
. O 0 5.558810585171159e-07

Deficiency B-Disease 1 0.9334458112716675
of I-Disease 0 3.209240048818174e-06
the I-Disease 0 3.576085561007858e-08
ninth I-Disease 0 3.012141633007559e-06
component I-Disease 0 5.137565040058689e-08
of I-Disease 0 1.930396731353312e-09
human I-Disease 0 1.0118794691038602e-09
complement I-Disease 0 2.9430278658537645e-08
( O 0 1.193436044433227e-10
C9 O 1 0.6213384866714478
) O 0 1.0767159733249265e-11
is O 0 4.930615377790604e-13
the O 0 1.1023945645227684e-11
most O 0 6.5029808794803134e-12
common O 0 4.779983520108999e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.191307023670987e-10
Japan O 0 9.673177814306655e-09
but O 0 2.8968875909196612e-11
is O 0 3.148134964520155e-12
rare O 0 2.519155196945011e-11
in O 0 1.9286575808630246e-11
other O 0 6.536896718367657e-11
countries O 0 9.269213729901082e-10
. O 0 8.60956319570505e-08

We O 0 1.1123167276139156e-08
studied O 0 4.435271705460764e-09
the O 0 6.76807221378084e-11
molecular O 0 3.389080960314317e-10
basis O 0 4.539386200264062e-09
of O 0 2.910588570159689e-08
C9 B-Disease 1 0.9999943971633911
deficiency I-Disease 0 6.305614078883082e-06
in O 0 1.9024223862906808e-10
four O 0 1.6289733451024802e-10
Japanese O 0 9.041694681855006e-08
C9 B-Disease 1 0.9998581409454346
- I-Disease 0 1.4062354239285924e-05
deficient I-Disease 0 1.038855771184899e-06
patients O 0 4.171919698592319e-09
who O 0 6.287743242738841e-11
had O 0 1.2551990558051784e-09
suffered O 0 0.0793832391500473
from O 0 1.9646417058538646e-05
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.3975339641092432e-07

Direct O 0 8.106759707970923e-09
sequencing O 0 1.5967337674283044e-08
of O 0 9.14746944857825e-09
amplified O 0 7.838047544339588e-09
C9 O 0 2.6488910975785984e-07
cDNA O 0 7.707085636354805e-09
and O 0 3.4488113753727845e-11
DNA O 0 8.382926353078801e-09
revealed O 0 8.811892882043537e-10
a O 0 1.8859577094465507e-11
nonsense O 0 2.220517325568494e-09
substitution O 0 4.1799225192207246e-10
( O 0 1.1101235382338093e-11
CGA O 0 1.3974209878142574e-06
- O 0 2.0008110368507914e-06
- O 0 1.8949972968584916e-07
> O 0 1.0585092802273266e-08
TGA O 0 2.528666698253801e-08
) O 0 4.554997329840604e-13
at O 0 5.761863208775253e-11
codon O 0 5.285146764677506e-10
95 O 0 5.388320900578947e-09
in O 0 1.0964507080046815e-09
exon O 0 4.603445624695723e-09
4 O 0 3.9811981489279447e-10
in O 0 4.821586879755202e-11
the O 0 2.158113271422124e-10
four O 0 3.716567720246644e-09
C9 B-Disease 1 0.998934805393219
- I-Disease 0 7.2856702900026e-05
deficient I-Disease 0 1.7624983001951477e-06
individuals O 0 4.527945574039904e-09
. O 0 2.3663149306685227e-07

An O 0 1.918466357997417e-10
allele O 0 8.076675439561143e-10
- O 0 1.6267687197313307e-10
specific O 0 3.00523356200344e-11
polymerase O 0 1.0547395595805753e-10
chain O 0 2.154266695586493e-11
reaction O 0 6.439157367033044e-12
system O 0 5.660763524595325e-11
designed O 0 2.4402986575911e-11
to O 0 2.5275151763204384e-11
detect O 0 3.6971367634031083e-10
exclusively O 0 4.992856128538392e-10
only O 0 5.457123902069538e-12
one O 0 2.2674470807892977e-12
of O 0 2.111733357623713e-11
the O 0 3.137131179831165e-11
normal O 0 1.9129571260378953e-09
and O 0 4.512093389891225e-12
mutant O 0 1.3985926999859899e-11
alleles O 0 1.1761476124624859e-12
indicated O 0 1.800719642841564e-11
that O 0 2.1862119590782686e-13
all O 0 1.916094886922348e-12
the O 0 6.89309763782231e-12
four O 0 1.2885520775385295e-11
patients O 0 6.9576640455981664e-12
were O 0 1.7688637013457686e-11
homozygous O 0 1.8921262126547767e-11
for O 0 2.719821113120191e-12
the O 0 2.546280963855452e-10
mutation O 0 2.7000585101077945e-10
in O 0 6.175804867503132e-10
exon O 0 4.880232218340552e-09
4 O 0 3.3794048115431963e-10
and O 0 4.008380433129233e-12
that O 0 3.058617270047803e-13
the O 0 1.421235264892351e-11
parents O 0 3.093936912224038e-11
of O 0 2.0190976668388316e-10
patient O 0 4.458222679915025e-09
2 O 0 1.911429237111406e-09
were O 0 2.3751440814123725e-09
heterozygous O 0 3.5945888487987077e-09
. O 0 9.677108003813828e-09

The O 0 1.7813734487504007e-08
common O 0 8.240624849165101e-10
mutation O 0 4.169354445027196e-11
at O 0 2.919626207464887e-10
codon O 0 6.948069342094243e-10
95 O 0 3.589007135929023e-08
in O 0 4.373460704698573e-09
exon O 0 1.2099698132317371e-08
4 O 0 4.232664496672811e-10
might O 0 1.4794809474749648e-11
be O 0 1.2486312331305705e-11
responsible O 0 2.80283296572037e-10
for O 0 1.3206102877916237e-10
most O 0 8.24971480017922e-10
Japanese O 0 2.979410237458069e-05
C9 B-Disease 1 1.0
deficiency I-Disease 0 0.00025945890229195356
. O 0 5.371266986742285e-09
. O 0 5.3799954713440457e-08

BRCA1 O 0 1.5679122000733514e-08
required O 0 2.9794562372842393e-09
for O 0 1.6750789644248698e-10
transcription O 0 5.981875261795722e-08
- O 0 1.2148437633641151e-07
coupled O 0 7.342522678754904e-08
repair O 0 4.938627535011619e-05
of O 0 1.8432002590884622e-08
oxidative O 0 1.2025220712530427e-06
DNA O 0 6.767746526747942e-06
damage O 0 2.0019333533127792e-06
. O 0 8.539566209719851e-08

The O 0 8.461335028187023e-07
breast B-Disease 1 0.9999558925628662
and I-Disease 1 0.8959806561470032
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 6.193860144776409e-07
gene O 0 2.648733732346642e-10
BRCA1 O 0 4.161745115194293e-10
encodes O 0 8.328503685317568e-12
a O 0 8.039507948254254e-11
zinc O 0 2.9684912306038314e-09
finger O 0 2.3158365891617905e-08
protein O 0 4.6161571787273203e-10
of O 0 4.492587135640491e-10
unknown O 0 2.305623212350838e-07
function O 0 5.9068081981195064e-08
. O 0 7.037074567506352e-08

Association O 0 5.334857888783517e-09
of O 0 5.192998919767433e-09
the O 0 1.7464413248902133e-09
BRCA1 O 0 7.622044106980752e-10
protein O 0 2.0249114884851593e-12
with O 0 3.571044488218621e-14
the O 0 5.4890571254961884e-12
DNA O 0 7.569720850142403e-08
repair O 0 2.684771789063234e-05
protein O 0 3.363414435852974e-09
Rad51 O 0 4.4198706916631636e-08
and O 0 2.1165833842540227e-12
changes O 0 3.5497926213073905e-12
in O 0 7.506884653826762e-13
the O 0 1.3064987459954214e-12
phosphorylation O 0 8.827175101977502e-12
and O 0 3.1663814365617826e-12
cellular O 0 3.7689940057816784e-09
localization O 0 3.709700422405149e-07
of O 0 3.90555987550556e-09
the O 0 2.0786710130948904e-09
protein O 0 3.7866967894650827e-10
after O 0 4.471002457151485e-10
exposure O 0 1.1959341295053605e-09
to O 0 3.650383814668423e-11
DNA O 0 8.478835297864862e-06
- O 0 2.2166342716900544e-07
damaging O 0 3.18710835500724e-09
agents O 0 1.4044235219223822e-10
are O 0 1.7681342501241204e-12
consistent O 0 3.025565908920669e-10
with O 0 2.617716156685934e-13
a O 0 3.523377336417388e-12
role O 0 4.3917463415921176e-11
for O 0 1.9292326070008414e-10
BRCA1 O 0 7.2084587188214755e-09
in O 0 3.679703763914688e-10
DNA O 0 2.153809646188165e-06
repair O 0 0.0003067477373406291
. O 0 3.624573992055957e-07

Here O 0 1.087692453438649e-06
, O 0 1.0163801050788734e-10
it O 0 4.3676165657237365e-13
is O 0 1.0711759577215416e-13
shown O 0 3.568796300146282e-11
that O 0 8.407990449710301e-12
mouse O 0 9.476148754572478e-10
embryonic O 0 3.009264659681321e-08
stem O 0 5.961464211168277e-08
cells O 0 4.0097727804777605e-08
deficient B-Disease 0 9.640488229933908e-08
in I-Disease 0 4.2572861902456793e-10
BRCA1 I-Disease 0 2.254349817931711e-09
are O 0 2.863502187103184e-12
defective O 0 3.73785752350031e-10
in O 0 3.741726980338589e-12
the O 0 1.3782259188077628e-11
ability O 0 5.5877961979700075e-11
to O 0 7.755116861185574e-12
carry O 0 1.9636693660007865e-10
out O 0 4.031707259710693e-11
transcription O 0 2.522221720369089e-08
- O 0 4.0319594774018697e-08
coupled O 0 6.53438760878089e-08
repair O 0 7.275201369338902e-06
of O 0 5.653000290095633e-09
oxidative O 0 3.6213052112543664e-08
DNA O 0 1.1148995326948352e-06
damage O 0 6.057838675133098e-08
, O 0 1.2350025516139063e-11
and O 0 1.3544872688731058e-11
are O 0 3.03162425718817e-11
hypersensitive O 0 9.916769272422243e-08
to O 0 2.3673074167618324e-08
ionizing O 0 0.00011535279918462038
radiation O 0 0.00018437606922816485
and O 0 3.1834874736347274e-09
hydrogen O 0 1.409672165664233e-07
peroxide O 0 2.04242655854614e-06
. O 0 4.022182338303537e-07

These O 0 4.2235694941439306e-09
results O 0 4.4334451665406505e-09
suggest O 0 2.373685692447225e-09
that O 0 2.343247644531754e-11
BRCA1 O 0 2.183132785660291e-09
participates O 0 1.733394955349965e-10
, O 0 3.7336161939904855e-11
directly O 0 2.687707612025747e-09
or O 0 5.222059451526206e-10
indirectly O 0 4.84206008621868e-09
, O 0 4.38309935221759e-12
in O 0 6.10247824495147e-11
transcription O 0 1.3012667920975218e-07
- O 0 7.306994831424163e-08
coupled O 0 7.820668201929948e-08
repair O 0 7.0947467065707315e-06
of O 0 7.88839482623871e-09
oxidative O 0 1.2391660675348248e-07
DNA O 0 7.138735327316681e-07
damage O 0 5.9303452815129276e-08
. O 0 1.680981576157592e-09
. O 0 1.1137412769812727e-08

Truncation O 0 2.994418900925666e-05
mutations O 0 9.085601604397198e-09
in O 0 3.1316566007077995e-10
the O 0 1.0249561199771051e-09
transactivation O 0 7.2643715611775406e-06
region O 0 2.72020539426876e-08
of O 0 3.070326570764337e-08
PAX6 O 0 0.0002133087400579825
result O 0 1.05884847556581e-08
in O 0 7.485577713239877e-10
dominant O 0 3.3193464332725853e-07
- O 0 3.9605030366374194e-08
negative O 0 4.907176887058995e-10
mutants O 0 1.7428117615736483e-08
. O 0 1.4892054700510471e-08

PAX6 O 0 0.0004594390047714114
is O 0 3.415036586851272e-10
a O 0 6.190284396190293e-11
transcription O 0 2.2275324640386174e-10
factor O 0 8.303126415587503e-12
with O 0 1.2942258213483743e-13
two O 0 1.7203172480301232e-12
DNA O 0 5.7964917310471264e-09
- O 0 4.3806216987185564e-10
binding O 0 5.3564572916053876e-11
domains O 0 1.5692097621311518e-09
( O 0 1.838032330503392e-12
paired O 0 5.328509300461803e-10
box O 0 5.533696834092439e-10
and O 0 3.748243382339922e-11
homeobox O 0 3.170169016186719e-09
) O 0 7.721799545265529e-13
and O 0 3.75621408976734e-12
a O 0 2.3016021033495093e-10
proline O 0 1.7279556630001025e-07
- O 0 2.981600744078605e-08
serine O 0 1.533670683784294e-07
- O 0 5.339482527233486e-07
threonine O 0 1.0664633691703784e-06
( O 0 1.4798542946614646e-10
PST O 1 0.932928740978241
) O 0 4.893092042657088e-10
- O 0 3.131563985903085e-08
rich O 0 2.0620305463125987e-09
transactivation O 0 4.182441898592515e-06
domain O 0 5.894236920767071e-08
. O 0 1.5431858457759517e-08

PAX6 O 1 0.9999784231185913
regulates O 0 9.70805103861494e-06
eye O 0 0.0003956517903134227
development O 0 8.118482583086006e-06
in O 0 1.6214880549370037e-09
animals O 0 9.385700550090803e-11
ranging O 0 1.3086903782877357e-09
from O 0 3.036301488013038e-10
jellyfish O 0 1.1355112163047298e-11
to O 0 1.3610867988234077e-10
Drosophila O 0 7.887146047380611e-09
to O 0 2.17034124005977e-09
humans O 0 3.8559473836130564e-08
. O 0 5.384974244293517e-08

Heterozygous O 0 2.0936894884471258e-07
mutations O 0 3.0390203686891937e-09
in O 0 7.834810578088991e-11
the O 0 7.305664406764834e-10
human O 0 6.930231943869103e-09
PAX6 O 0 0.0010037272004410625
gene O 0 2.663623210885646e-10
result O 0 1.6268680846920347e-10
in O 0 9.839915340870142e-12
various O 0 7.543017599420665e-11
phenotypes O 0 1.7743015390259131e-10
, O 0 7.031354665176792e-13
including O 0 6.583992032127561e-12
aniridia B-Disease 1 1.0
, O 0 6.053932022354047e-09
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 5.030367233871402e-09
autosomal B-Disease 0 0.048261430114507675
dominant I-Disease 0 0.04397963732481003
keratitis I-Disease 1 1.0
, O 0 1.885845435367628e-08
and O 0 2.11165655628065e-07
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9999997615814209

It O 0 2.13688372552312e-10
is O 0 6.9412006524494085e-12
believed O 0 2.1436069586044937e-10
that O 0 1.49335716861064e-13
the O 0 1.4576046532960296e-12
mutated O 0 6.530712168967279e-12
allele O 0 1.2930088943985396e-10
of O 0 1.1209589922955843e-09
PAX6 O 0 4.400177567731589e-05
produces O 0 6.958490034181253e-11
an O 0 2.2398938172990546e-12
inactive O 0 4.188783542247165e-09
protein O 0 2.8352353798055674e-09
and O 0 8.876839818761084e-10
aniridia B-Disease 1 1.0
is O 0 1.5209962456186332e-10
caused O 0 2.300119872344908e-09
due O 0 4.627331051665351e-08
to O 0 3.956031946472649e-09
genetic O 0 3.226958824598114e-07
haploinsufficiency O 0 1.3080719327263068e-05
. O 0 3.064353677473264e-07

However O 0 3.730589170913845e-08
, O 0 7.340551777534898e-11
several O 0 2.181790338673384e-11
truncation O 0 8.037281418182829e-08
mutations O 0 2.438471369270445e-10
have O 0 3.268625821395421e-12
been O 0 2.1779317932457687e-11
found O 0 4.9250911508813555e-12
to O 0 5.546254861626965e-12
occur O 0 4.950402865411263e-10
in O 0 2.8724748274422396e-11
the O 0 3.271036497221047e-10
C O 0 3.925697455997579e-07
- O 0 7.2927761607388675e-09
terminal O 0 1.4548708904271734e-09
half O 0 1.1395669130553898e-10
of O 0 1.3044507141124484e-10
PAX6 O 0 2.2585961687582312e-06
in O 0 3.837818257634851e-11
patients O 0 2.089358547285869e-10
with O 0 1.8944625382322222e-11
Aniridia B-Disease 1 1.0
resulting O 0 3.142722082571936e-09
in O 0 4.198778477682019e-11
mutant O 0 8.89559745309576e-11
proteins O 0 2.7591869761200982e-12
that O 0 3.357965218820508e-13
retain O 0 1.9946649887359058e-10
the O 0 8.362444764431487e-11
DNA O 0 3.1451701687501554e-08
- O 0 1.3463494763499284e-09
binding O 0 8.636326376265657e-11
domains O 0 7.969951920649976e-10
but O 0 1.0269471037438471e-11
have O 0 4.3307709848838805e-12
lost O 0 6.827015619492727e-10
most O 0 3.6284879181142093e-12
of O 0 1.0533684341451632e-10
the O 0 2.640054619362786e-09
transactivation O 0 1.2294937732804101e-05
domain O 0 2.781189323286526e-07
. O 0 8.80182327023249e-08

It O 0 1.3189369596489087e-09
is O 0 1.9007023385753108e-11
not O 0 1.1894586010585684e-11
clear O 0 3.301668938249236e-10
whether O 0 4.511492915360016e-11
such O 0 1.981517207261252e-11
mutants O 0 2.6079002068968293e-08
really O 0 1.8269901147505152e-09
behave O 0 3.722823438412348e-10
as O 0 2.750124954153943e-11
loss O 0 1.4098490375147321e-08
- O 0 2.4788828767441373e-08
of O 0 3.3711879154907365e-07
- O 0 2.1729130139647168e-07
function O 0 3.0133411321742187e-09
mutants O 0 8.233491666231885e-10
as O 0 1.7946564373483298e-12
predicted O 0 2.0974720571498295e-10
by O 0 6.802484270318487e-11
haploinsufficiency O 0 2.100822939610225e-06
. O 0 1.696003693041348e-07

Contrary O 0 3.2182430231841863e-07
to O 0 3.9969327847444447e-10
this O 0 3.793808323049319e-11
theory O 0 1.5450996038168796e-09
, O 0 2.1901196134432865e-12
our O 0 1.1771003616267706e-10
data O 0 3.935926862208561e-10
showed O 0 8.057730177535305e-11
that O 0 1.0327426170101892e-13
these O 0 9.677329467286389e-13
mutants O 0 1.001724397875492e-10
are O 0 9.43888413609817e-13
dominant O 0 6.357609549922927e-09
- O 0 9.656913046995896e-10
negative O 0 3.1536776662344224e-11
in O 0 7.000045942201494e-12
transient O 0 6.563535825954148e-10
transfection O 0 6.574389477265186e-09
assays O 0 1.0636569403033036e-10
when O 0 2.4079660140841064e-11
they O 0 4.796415001284693e-12
are O 0 2.593945240894624e-12
coexpressed O 0 5.6023075956090906e-08
with O 0 2.6866130847791325e-11
wild O 0 1.1597058424683837e-08
- O 0 1.1413936107373956e-07
type O 0 5.766043500443629e-07
PAX6 O 0 0.006150863133370876
. O 0 1.182894720841432e-06

We O 0 8.309490873159575e-09
found O 0 5.292780796972707e-11
that O 0 2.3438621377970537e-13
the O 0 1.0648864602613717e-11
dominant O 0 2.738179993855283e-08
- O 0 1.911892200112675e-09
negative O 0 3.576735088661742e-11
effects O 0 1.7294154996960742e-10
result O 0 5.256342236470424e-11
from O 0 1.3684058226826057e-11
the O 0 8.267316518872914e-12
enhanced O 0 2.037846696945067e-10
DNA O 0 4.4503195573142307e-10
binding O 0 3.929054304130375e-11
ability O 0 6.333920055112685e-10
of O 0 1.5834671351910856e-09
these O 0 1.8604427998170081e-09
mutants O 0 2.761394171102438e-07
. O 0 4.259702635067697e-08

Kinetic O 0 3.0477065138256876e-07
studies O 0 4.921577367866803e-09
of O 0 3.809029203161174e-10
binding O 0 1.6075987763208843e-10
and O 0 4.52809664763798e-11
dissociation O 0 3.632274259146584e-09
revealed O 0 2.6189350688099466e-09
that O 0 7.831022614222805e-13
various O 0 3.057587863453115e-11
truncation O 0 1.1612331540789e-08
mutants O 0 1.6952840242723255e-09
have O 0 5.039732953876497e-12
3 O 0 1.136226737696866e-10
- O 0 1.9299538356332135e-10
5 O 0 1.0494499019797487e-10
- O 0 1.7404215568728176e-10
fold O 0 6.431698229558691e-11
higher O 0 1.180569669800846e-10
affinity O 0 2.312905075796401e-12
to O 0 1.46260076532706e-12
various O 0 7.23233140043078e-11
DNA O 0 4.897034777684439e-09
- O 0 1.2419386352657824e-10
binding O 0 3.6522204531486135e-12
sites O 0 9.004023221459434e-12
when O 0 1.820555642004229e-12
compared O 0 3.084244318274365e-11
with O 0 2.7666158751958603e-13
the O 0 3.7742919900551897e-11
wild O 0 1.3161951528672944e-09
- O 0 1.8043081695395813e-08
type O 0 6.061490864794905e-08
PAX6 O 0 0.0005285342922434211
. O 0 6.383456820913125e-07

These O 0 7.640631460859026e-10
results O 0 1.01304986621642e-09
provide O 0 2.016665306969756e-10
a O 0 2.021192761769708e-11
new O 0 1.6101387584344096e-11
insight O 0 1.2695129392170657e-09
into O 0 1.4595638933578847e-11
the O 0 3.288362637743347e-11
role O 0 8.010399010771607e-10
of O 0 3.0377744764109593e-09
mutant O 0 4.269708142601303e-08
PAX6 O 0 0.00010165512503590435
in O 0 2.4910198348493395e-09
causing O 0 1.1797678212133178e-07
aniridia B-Disease 1 1.0
. O 0 2.3279444150148265e-08
. O 0 5.6402519987841515e-08

Reversal O 0 6.158743417472579e-07
of O 0 5.98049467726014e-08
severe O 1 0.8646663427352905
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 1.891079136839835e-06
excellent O 0 1.4010610982495564e-07
neuropsychologic O 0 1.9439748655258882e-07
outcome O 0 9.381164289834487e-09
in O 0 2.596124357157059e-11
very B-Disease 0 3.523258074178415e-11
- I-Disease 0 1.3899185968835326e-10
long I-Disease 0 6.387016610043261e-11
- I-Disease 0 2.785969233087826e-10
chain I-Disease 0 6.779972416826041e-11
acyl I-Disease 0 3.088114874927328e-09
- I-Disease 0 7.97466981339312e-09
coenzyme I-Disease 0 4.136093778583927e-08
A I-Disease 0 4.573205660562962e-05
dehydrogenase I-Disease 0 0.00032596400706097484
deficiency I-Disease 0 0.0012836219975724816
. O 0 3.240216130961926e-07

Very B-Disease 0 4.411793241843043e-08
- I-Disease 0 2.388692976751372e-08
long I-Disease 0 8.979301746592228e-10
- I-Disease 0 3.9747641289444857e-10
chain I-Disease 0 1.599794949291855e-11
acyl I-Disease 0 7.260610168646764e-11
- I-Disease 0 4.206024070696479e-11
coenzyme I-Disease 0 5.4882012129331414e-11
A I-Disease 0 2.0087427277104553e-09
dehydrogenase I-Disease 0 8.268413731471469e-10
( I-Disease 0 1.6374830311138844e-11
VLCAD I-Disease 1 1.0
) I-Disease 0 5.8820120996117e-10
deficiency I-Disease 0 2.2152046312839957e-06
is O 0 1.3284253254711165e-12
a O 0 9.376146387074513e-11
disorder O 1 0.5334498882293701
of O 0 1.1527474271133542e-05
fatty O 0 5.732688102000338e-09
acid O 0 6.864542267948082e-10
beta O 0 3.250066049620415e-10
oxidation O 0 2.6788418705514516e-10
that O 0 2.1778019925616787e-12
reportedly O 0 1.0858444698946812e-10
has O 0 2.612224943732838e-13
high O 0 3.104204046588954e-11
rates O 0 3.490471522926697e-10
of O 0 1.4958424776612134e-10
morbidity O 0 1.0305236628482817e-06
and O 0 1.7756667247681435e-09
mortality O 0 3.841879151877947e-05
. O 0 1.9149337049384485e-07

We O 0 1.2832586548938707e-08
describe O 0 2.9257931632997725e-09
the O 0 1.0774437592120378e-10
outcome O 0 5.306728567688879e-08
of O 0 6.730874968496892e-09
a O 0 7.887153430363725e-11
5 O 0 6.168644761661568e-11
- O 0 6.37738386405351e-12
year O 0 1.0890672044738814e-11
- O 0 1.6555447290844683e-10
old O 0 1.900758661577129e-09
girl O 0 5.360623056560598e-09
with O 0 2.2516714881515298e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 6.6125829256691304e-09
was O 0 4.922056096035021e-09
first O 0 1.15087128715885e-09
seen O 0 1.6420166337738351e-09
at O 0 1.2969757212655253e-10
5 O 0 2.6638302674797387e-11
months O 0 4.304929676623992e-11
of O 0 1.1975010393017183e-11
age O 0 1.886350797786207e-10
with O 0 1.143640217249331e-11
severe O 0 3.7873578548897058e-06
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9982301592826843
hepatomegaly B-Disease 1 1.0
, O 1 0.997173547744751
encephalopathy B-Disease 1 0.9999440908432007
, O 0 9.382287169401593e-10
and O 0 8.467839762715812e-09
hypotonia B-Disease 0 0.001464319066144526
. O 0 8.496124792145565e-06

Biochemical O 0 7.266446004905447e-07
studies O 0 4.857936630742188e-08
indicated O 0 0.0072716111317276955
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 1.221230263581674e-07
by O 0 9.231112402252606e-12
a O 0 4.507089493288596e-11
stable O 0 2.0183918536531564e-07
yet O 0 1.306829644498464e-09
inactive O 0 1.216571909878894e-08
enzyme O 0 5.413022918787647e-09
. O 0 3.155372851892935e-08

Molecular O 0 6.824248544035072e-08
genetic O 0 6.879484204524999e-10
analysis O 0 3.622759037202883e-10
of O 0 1.3297658529864975e-09
her O 0 7.326012685382466e-09
VLCAD O 1 0.9999998807907104
gene O 0 1.1880019190613211e-09
revealed O 0 8.101056714338029e-09
a O 0 9.674514661606182e-11
T1372C O 0 2.9216354846539616e-07
( O 0 4.142996362643814e-11
F458L O 0 1.0541214834347556e-07
) O 0 2.939954529823652e-11
missense O 0 8.34387918757784e-08
mutation O 0 9.336070805332497e-10
and O 0 4.022354116450799e-10
a O 0 6.263835672370988e-08
1668 O 0 0.0001547347492305562
ACAG O 1 0.9995001554489136
1669 O 0 0.00013699050759896636
splice O 0 2.846093957487028e-05
site O 0 1.474029431847157e-07
mutation O 0 7.409545332848211e-08
. O 0 1.2069311594586907e-07

After O 0 2.77690959116228e-09
initial O 0 2.107884311541852e-09
treatment O 0 2.988501535128307e-08
with O 0 4.0422096225789517e-11
intravenous O 0 1.9596228639784385e-08
glucose O 0 6.233586447024209e-08
and O 0 5.510693013022205e-10
carnitine O 0 8.449544175448409e-09
, O 0 2.664636957264155e-12
the O 0 4.540013850973246e-11
patient O 0 7.900275100780618e-09
has O 0 1.2168177706758931e-12
thrived O 0 1.6392369406315055e-10
on O 0 1.6390642315622372e-11
a O 0 4.407043133203281e-11
low O 0 4.66877665417087e-08
- O 0 3.699157957726129e-08
fat O 0 1.927725534756064e-09
diet O 0 1.6472857800042817e-10
supplemented O 0 2.1732107780003673e-10
with O 0 2.082052629262532e-12
medium O 0 1.3225298189922796e-08
- O 0 6.869509405760255e-09
chain O 0 5.172997585844996e-10
triglyceride O 0 2.7931925217217213e-08
oil O 0 1.4057033759229398e-08
and O 0 2.2262751364632294e-10
carnitine O 0 1.4814937721041588e-08
and O 0 4.4496552276118706e-11
avoidance O 0 7.11922325535852e-08
of O 0 1.494101908861012e-08
fasting O 0 1.6155034927578527e-06
. O 0 1.516337704288162e-07

Her O 0 4.194124267087318e-05
ventricular O 1 0.998206377029419
hypertrophy O 1 0.9999823570251465
resolved O 1 0.9982308745384216
significantly O 0 2.9828555625499575e-07
over O 0 3.272565274325956e-10
1 O 0 8.841367915568554e-11
year O 0 5.329197846903888e-11
, O 0 1.2619280620462803e-12
and O 0 6.827477385534797e-12
cognitively O 0 5.324451421984122e-07
, O 0 3.9819102876093027e-11
she O 0 2.9883314572876074e-11
is O 0 1.945764079372414e-12
in O 0 3.920279031954799e-12
the O 0 1.767197846391788e-11
superior O 0 3.431333550629745e-10
range O 0 6.204637359452647e-10
for O 0 8.639325366210926e-11
age O 0 1.02213014940844e-07
. O 0 5.9104483085548054e-08

Clinical O 0 1.8324655570722825e-07
recognition O 0 5.063078560851864e-07
of O 1 0.9999990463256836
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 8.715496657707433e-10
important O 0 3.640220347378431e-10
because O 0 1.8044973067871117e-12
it O 0 2.890491800989006e-14
is O 0 7.339953162410415e-14
one O 0 2.5117653183054367e-12
of O 0 1.26905957964496e-10
the O 0 4.690202115575914e-10
few O 0 1.962779272446369e-09
directly O 0 2.008651733831357e-08
treatable O 0 0.01208493672311306
causes O 0 2.216921224373891e-08
of O 0 2.8687844633168424e-07
cardiomyopathy B-Disease 1 1.0
in O 0 7.080453201524506e-08
children O 0 1.080813660792046e-09
. O 0 3.9701728016261484e-10
. O 0 8.621440450440332e-09

Cloning O 0 3.5731272873817943e-07
of O 0 5.608666420187092e-09
a O 0 8.150301961107331e-11
novel O 0 1.8243523011718388e-11
member O 0 1.8918094868425328e-10
of O 0 4.846751333609234e-10
the O 0 9.387961519280452e-10
low O 0 9.67535882523407e-08
- O 0 5.011787873598905e-09
density O 0 1.0168654807074518e-09
lipoprotein O 0 1.291186535468114e-08
receptor O 0 8.025661801802642e-10
family O 0 5.139836556367072e-09
. O 0 1.511359926098521e-07

A O 0 2.938097765081693e-08
gene O 0 1.8765754228322606e-10
encoding O 0 2.623314454552883e-09
a O 0 1.289969103757116e-10
novel O 0 1.2456916054226497e-10
transmembrane O 0 9.77703340510061e-09
protein O 0 2.3521811234883394e-11
was O 0 2.5406799060434526e-12
identified O 0 8.202850833478881e-13
by O 0 1.6313549632256813e-14
DNA O 0 3.243827775833985e-11
sequence O 0 2.122020007627734e-12
analysis O 0 1.6001298593429358e-12
within O 0 2.248622078468432e-12
the O 0 1.0268922864820063e-11
insulin B-Disease 0 0.0036094614770263433
- I-Disease 1 0.9844902157783508
dependent I-Disease 1 0.9998583793640137
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.3715166780059462e-09
IDDM B-Disease 0 0.0006470429361797869
) O 0 2.0810490483635924e-11
locus O 0 1.639362118277532e-10
IDDM4 O 0 6.921217732269724e-07
on O 0 3.5560121514066623e-09
chromosome O 0 8.720954625118793e-09
11q13 O 0 3.453474846537574e-06
. O 0 1.9156095731887035e-07

Based O 0 3.7807137975853777e-10
on O 0 9.011523194324411e-10
its O 0 1.767457534496142e-11
chromosomal O 0 1.2261346604702794e-08
position O 0 2.256906483921739e-08
, O 0 6.692791720136482e-12
this O 0 2.2091204733565295e-12
gene O 0 3.2190678074528467e-12
is O 0 2.3588504196800364e-13
a O 0 3.743368896108601e-12
candidate O 0 4.202602155167767e-10
for O 0 9.07004471528694e-11
conferring O 0 8.91063734798081e-07
susceptibility O 0 4.148667358094826e-06
to O 0 1.5559960786504234e-07
diabetes B-Disease 1 0.9999756813049316
. O 0 6.939260856597684e-06

The O 0 2.021612210967305e-08
gene O 0 1.6898500654338733e-10
, O 0 9.58553722507638e-12
termed O 0 1.4935653824821316e-09
low O 0 7.15233809955862e-08
- O 0 2.1334800592853753e-09
density O 0 8.945911372792992e-11
lipoprotein O 0 1.9227487657591524e-10
receptor O 0 5.582754744604124e-12
related O 0 2.860995440556735e-09
protein O 0 1.0531534672120202e-10
5 O 0 8.394437922554232e-11
( O 0 1.0343458945252793e-12
LRP5 O 0 1.016132955555804e-06
) O 0 6.706192675828837e-13
, O 0 3.5847223084882474e-13
encodes O 0 1.2775732078154634e-12
a O 0 1.3783388493060489e-11
protein O 0 1.3956114042201762e-10
of O 0 7.353195274895086e-10
1615 O 0 6.951302680135996e-07
amino O 0 2.4754386984682242e-08
acids O 0 3.725423303180264e-10
that O 0 6.495530675831862e-12
contains O 0 4.6753438794067126e-12
conserved O 0 1.4134933501441793e-10
modules O 0 1.0842473585626067e-09
which O 0 4.061495605979515e-13
are O 0 9.027801292985083e-13
characteristic O 0 3.0663263594910006e-10
of O 0 8.275686802505788e-10
the O 0 3.1843132575204436e-09
low O 0 1.6981596218101913e-07
- O 0 1.506460911571139e-08
density O 0 9.436071923829559e-10
lipoprotein O 0 8.041079802012518e-09
( O 0 3.2320521259343593e-10
LDL O 0 1.1693472146134809e-07
) O 0 2.526552578263619e-10
receptor O 0 1.2398557180937075e-10
family O 0 9.520989552314063e-10
. O 0 5.1324132499530606e-08

These O 0 4.3664821758326866e-10
modules O 0 4.0605740991850325e-09
include O 0 2.7434857770985976e-12
a O 0 3.850273398720017e-12
putative O 0 7.645282185109181e-10
signal O 0 1.937331184365121e-09
peptide O 0 5.4892063117151224e-11
for O 0 2.7903925697847498e-11
protein O 0 5.330011085269426e-11
export O 0 2.1392909665962634e-09
, O 0 9.751578884664713e-12
four O 0 7.453905825904883e-10
epidermal O 0 9.11500563915979e-09
growth O 0 2.9727281747327083e-10
factor O 0 5.587060675216193e-11
( O 0 2.42439505970804e-11
EGF O 0 3.594617936641953e-08
) O 0 7.111040489088394e-12
repeats O 0 4.2850087367263257e-10
with O 0 4.00873952088876e-12
associated O 0 8.931530182110237e-09
spacer O 0 5.69797657590243e-06
domains O 0 6.9684054082586044e-09
, O 0 2.6384044688604336e-12
three O 0 5.627273300112812e-11
LDL O 0 2.6606914005355975e-08
- O 0 8.564082065731782e-08
receptor O 0 2.035561302848876e-11
( O 0 1.9197721537467238e-11
LDLR O 1 0.9986006617546082
) O 0 1.1020624517132926e-11
repeats O 0 7.067588181364215e-10
, O 0 7.177616248750518e-13
a O 0 1.3186556881150668e-12
single O 0 8.070250023806125e-11
transmembrane O 0 1.8932724277220814e-09
spanning O 0 3.067491816111101e-09
domain O 0 7.658504941332467e-10
, O 0 8.097197391754296e-12
and O 0 2.8699612131255492e-11
a O 0 3.3662703735615196e-09
cytoplasmic O 0 1.3550251196647878e-06
domain O 0 7.746334063085669e-07
. O 0 3.8946720337662555e-07

The O 0 2.653489694637301e-08
encoded O 0 4.200290248945748e-08
protein O 0 1.041482122765558e-09
has O 0 1.0456804692970945e-12
a O 0 1.6117264857798408e-12
unique O 0 1.4889900076808793e-11
organization O 0 1.5913566298042525e-10
of O 0 4.178803081344995e-08
EGF O 0 4.857352905673906e-06
and O 0 2.7511666278456914e-09
LDLR O 1 0.9997003078460693
repeats O 0 1.6459180685046704e-08
; O 0 1.8835768448438595e-12
therefore O 0 4.677272805175825e-11
, O 0 1.6333125824052885e-11
LRP5 O 0 0.018727151677012444
likely O 0 2.281019151340047e-09
represents O 0 1.622234985232396e-11
a O 0 3.806788651666837e-12
new O 0 1.270574465951635e-12
category O 0 1.0324605753675442e-10
of O 0 7.15394132821956e-10
the O 0 1.811328509404575e-08
LDLR O 1 0.9999817609786987
family O 0 7.735158646937634e-08
. O 0 4.090395862021978e-07

Both O 0 6.570468258360052e-08
human O 0 1.1988832149256723e-08
and O 0 5.56987211908222e-09
mouse O 0 9.159904124089735e-08
LRP5 O 1 0.9999139308929443
cDNAs O 0 1.0243047654512338e-05
have O 0 9.128911168665432e-12
been O 0 3.1863633259687774e-11
isolated O 0 1.2031176055415926e-10
and O 0 6.900039350651865e-13
the O 0 3.772442427885103e-11
encoded O 0 3.475802423658081e-10
mature O 0 3.4623459654881117e-09
proteins O 0 1.5276002034506075e-12
are O 0 1.9794827940417675e-13
95 O 0 3.191571729121989e-10
% O 0 1.084415803681571e-11
identical O 0 8.05108930912457e-12
, O 0 4.711219478772954e-13
indicating O 0 1.585479109111887e-10
a O 0 1.2048185366042574e-11
high O 0 1.3603133897088782e-10
degree O 0 1.3083366390276296e-08
of O 0 3.3703304591625738e-09
evolutionary O 0 1.1291158230619658e-08
conservation O 0 5.716045414771997e-10
. O 0 2.482689331895216e-10
. O 0 7.63894547617383e-09

The O 0 1.7142046715434844e-07
APC B-Disease 0 6.016661018293235e-07
variants O 0 2.8498371662522004e-08
I1307K O 0 8.733109098102432e-06
and O 0 5.497612365346072e-10
E1317Q O 0 1.8219038793176878e-06
are O 0 6.113542398017424e-12
associated O 0 7.442874050411774e-08
with O 0 2.1527150693145813e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.4795536351641658e-08
but O 0 1.7656043294067558e-11
not O 0 7.58794936606133e-12
always O 0 3.064214160186651e-11
with O 0 2.5636075293850036e-12
a O 0 2.0432019964822246e-10
family O 0 6.330103108354024e-10
history O 0 1.7595932888525567e-07
. O 0 2.4602988446531526e-07

Classical O 0 0.029268139973282814
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.9874642254744685e-08
FAP B-Disease 0 1.4439181086345343e-06
) O 0 2.524937377235137e-11
is O 0 1.1571095644147267e-12
a O 0 3.993120764600455e-11
high O 0 5.826494202665344e-07
- O 0 0.30957409739494324
penetrance O 1 0.9999974966049194
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999622106552124
disease I-Disease 1 0.822327733039856
that O 0 1.3618078886779017e-11
predisposes O 0 2.793320419414158e-08
to O 0 1.647555182560101e-11
hundreds O 0 3.8251606743200384e-11
or O 0 3.5301057216274856e-11
thousands O 0 8.809792895192459e-10
of O 0 0.0009781254921108484
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
carcinoma I-Disease 1 1.0
and O 0 4.710656753559306e-08
that O 0 8.633065790020211e-11
results O 0 2.87232415630001e-09
from O 0 1.365614732407039e-09
truncating O 0 6.665644036729645e-08
mutations O 0 7.535037177541781e-11
in O 0 1.6730792098962333e-11
the O 0 1.6833591187648267e-09
APC B-Disease 0 3.5289608035782294e-07
gene O 0 1.6557798687699687e-08
. O 0 1.5295471200715838e-07

A O 0 9.646466025969858e-08
variant O 0 3.174709206632542e-08
of O 0 5.170802808152075e-08
FAP B-Disease 0 3.406860287213931e-06
is O 0 7.812375635296576e-09
attenuated B-Disease 0 0.11170349270105362
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 1.931478588179658e-10
which O 0 2.511797464899851e-13
results O 0 4.838787009964207e-11
from O 0 1.758335976820291e-10
germ O 0 1.4024554957359214e-06
- O 0 2.070690463540359e-08
line O 0 1.7868854174096782e-09
mutations O 0 4.247007953650517e-11
in O 0 1.3849745135463554e-11
the O 0 2.2349118389275446e-10
5 O 0 2.386891517769385e-10
and O 0 1.7660445588568718e-12
3 O 0 5.057964810872839e-11
regions O 0 3.4646348290312545e-11
of O 0 6.233827343216092e-11
the O 0 1.731733534349189e-09
APC B-Disease 0 2.730993173827301e-07
gene O 0 9.61943591448744e-09
. O 0 1.0986916976207795e-07

Attenuated B-Disease 1 0.9999979734420776
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 9.188528906634019e-07
have O 0 9.573861668721317e-12
" O 0 2.291858196279417e-11
multiple O 0 1.2276527572296914e-09
" O 0 3.521847020238056e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 1.7284122050265083e-11
typically O 0 8.028501474743877e-12
fewer O 0 7.779230818544258e-13
than O 0 3.7289270250154966e-14
100 O 0 4.3365320015475994e-12
) O 0 1.613288089273926e-13
without O 0 9.388973105928233e-12
the O 0 1.0283196516525095e-10
florid O 0 9.368615394578228e-08
phenotype O 0 2.6782662754243347e-09
of O 0 2.1480570655540987e-09
classical O 0 4.401489093197597e-07
FAP B-Disease 0 2.095126546919346e-06
. O 0 1.6628176524591254e-07

Another O 0 9.024926583833803e-09
group O 0 8.759488273613059e-11
of O 0 2.0531256694766853e-09
patients O 0 1.971702801029096e-08
with O 0 9.533394906835468e-11
multiple O 0 0.001977517968043685
adenomas B-Disease 1 0.9999781847000122
has O 0 1.6363287114185e-10
no O 0 2.485834454946101e-11
mutations O 0 1.9278703633496264e-11
in O 0 1.0696376943897246e-11
the O 0 4.6544038068141447e-10
APC B-Disease 0 2.2198110016802275e-08
gene O 0 5.1428417080501276e-11
, O 0 2.9936298665683703e-12
and O 0 3.61102055375373e-12
their O 0 1.3999758297078557e-10
phenotype O 0 4.3830958307289336e-10
probably O 0 8.803404533130887e-11
results O 0 6.033755717282929e-10
from O 0 8.140891294416974e-10
variation O 0 5.310655026846689e-09
at O 0 5.481710196875156e-09
a O 0 4.121882557495127e-10
locus O 0 6.61077637076346e-10
, O 0 1.2355680714670747e-11
or O 0 3.657374056387219e-11
loci O 0 9.270981760067798e-10
, O 0 1.209633261611831e-11
elsewhere O 0 1.205111010982307e-10
in O 0 1.5444969955757948e-11
the O 0 6.894919080124851e-10
genome O 0 1.878378519393209e-08
. O 0 3.110669055672588e-08

Recently O 0 1.3589719571882597e-07
, O 0 8.23568643837369e-11
however O 0 4.097807163039313e-11
, O 0 9.488614321345734e-13
a O 0 3.3097047238278554e-12
missense O 0 1.109747849170617e-09
variant O 0 3.2738078914462676e-10
of O 0 2.4611876980884517e-08
APC B-Disease 0 1.7918064258992672e-06
( O 0 7.986067362963922e-10
I1307K O 0 4.607537994161248e-05
) O 0 2.4457507200037476e-11
was O 0 8.532963780005787e-10
described O 0 2.1281063022904334e-10
that O 0 1.4097117570499584e-12
confers O 0 9.873780265623466e-11
an O 0 5.514407290171941e-13
increased O 0 7.729591411376191e-10
risk O 0 2.109264762850671e-08
of O 0 0.03132062032818794
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.2104746094365737e-09
including O 0 2.8437949911586102e-11
multiple O 0 1.1660453225204037e-07
adenomas B-Disease 0 3.5240049328422174e-05
, O 0 1.943189609221463e-09
in O 0 6.214118286607118e-08
Ashkenazim O 0 0.007162978406995535
. O 0 7.872840797062963e-06

We O 0 1.8321522077258123e-08
have O 0 3.190182493173488e-11
studied O 0 2.717511216054902e-10
a O 0 3.6099599871886046e-12
set O 0 1.3437748309919062e-11
of O 0 1.1703568669751974e-11
164 O 0 5.791294666046554e-10
patients O 0 2.2592762730089255e-11
with O 0 7.995489036474734e-13
multiple O 0 1.3241309716249816e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.16414949297904968
/ I-Disease 1 1.0
or I-Disease 1 0.9999023675918579
carcinoma I-Disease 1 1.0
and O 0 8.626000891354124e-08
analyzed O 0 1.2062119481015543e-07
codons O 0 5.034014538551901e-09
1263 O 0 1.3032666856815922e-06
- O 0 9.301738401745752e-08
1377 O 0 6.658781614987674e-08
( O 0 9.938947581611401e-11
exon O 0 1.915652703132764e-08
15G O 0 5.692181304084443e-08
) O 0 1.3168611166791688e-12
of O 0 9.044132109892189e-11
the O 0 4.58563603755735e-10
APC B-Disease 0 2.0085520802126666e-08
gene O 0 9.213158014276246e-11
for O 0 3.406598614308365e-10
germ O 1 0.9872477054595947
- O 0 7.479870419047074e-06
line O 0 6.693787923950367e-08
variants O 0 3.081073884914076e-08
. O 0 4.944010001395327e-08

Three O 0 1.3664334552743185e-08
patients O 0 1.8651433730809686e-09
with O 0 4.499597309332026e-12
the O 0 4.6191428459962935e-10
I1307K O 0 1.2224410284034093e-07
allele O 0 1.9375813453681445e-10
were O 0 4.9048352185332433e-11
detected O 0 1.6164414251562675e-10
, O 0 3.552472985918209e-13
each O 0 2.308621176172476e-12
of O 0 9.691401015032852e-10
Ashkenazi O 0 2.5874826405924978e-06
descent O 0 4.0191349398810416e-05
. O 0 1.0084707355417777e-05

Four O 0 9.102464559873624e-08
patients O 0 1.788410308734001e-08
had O 0 4.5221781874715816e-10
a O 0 4.5072551246860826e-10
germ O 0 2.012518234550953e-05
- O 0 2.694659713142755e-07
line O 0 3.0160908437437683e-08
E1317Q O 0 4.348667062004097e-07
missense O 0 1.0258993654588267e-08
variant O 0 2.4719729041500216e-10
of O 0 4.838838219001218e-09
APC O 0 5.855466156390321e-08
that O 0 1.612757496993744e-11
was O 0 4.579744916632933e-10
not O 0 5.6037067347469716e-12
present O 0 1.1625660850667074e-10
in O 0 2.1604225353133444e-11
controls O 0 7.945424318478445e-10
; O 0 6.802503439012897e-13
one O 0 2.9788550098830413e-12
of O 0 1.600695270775887e-11
these O 0 2.2840195446766076e-12
individuals O 0 6.98610743907202e-12
had O 0 1.7606918700785457e-10
an O 0 4.976137123885449e-12
unusually O 0 8.971216824971151e-11
large O 0 2.611852574496698e-12
number O 0 6.192150264761054e-11
of O 0 9.375654919097087e-09
metaplastic B-Disease 0 8.063639688771218e-05
polyps I-Disease 0 2.4829571287909857e-08
of I-Disease 0 1.4668474435097778e-08
the I-Disease 0 9.784592691630678e-08
colorectum I-Disease 0 0.00016557966591790318
. O 0 6.616458563257765e-07

There O 0 6.925160533910457e-08
is O 0 3.82855518121783e-11
increasing O 0 1.0054763271982736e-10
evidence O 0 1.0628538327228654e-10
that O 0 6.541804316133326e-13
there O 0 3.2395538075019603e-12
exist O 0 3.770545264902836e-10
germ O 0 4.195550502572587e-07
- O 0 1.2884746602992436e-09
line O 0 1.1463947846568345e-10
variants O 0 9.965447217430423e-11
of O 0 3.19132831272384e-10
the O 0 6.633764648711349e-10
APC B-Disease 0 3.458394459698866e-08
gene O 0 3.6038734496646185e-11
that O 0 2.134991185578916e-12
predispose O 0 2.286699496423239e-09
to O 0 2.174416202649354e-11
the O 0 7.274430363635176e-11
development O 0 3.3276183586394836e-08
of O 0 8.816789964782856e-09
multiple O 1 0.9961546063423157
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9993866682052612
carcinoma I-Disease 1 1.0
, O 0 6.06236394418147e-10
but O 0 3.968202155757439e-11
without O 0 4.1398703909401036e-10
the O 0 4.347918025615627e-09
florid O 0 3.0900051228854863e-07
phenotype O 0 3.4721998609654747e-09
of O 0 3.3502121077333413e-09
classical O 0 2.3237262780639867e-07
FAP B-Disease 0 7.709942195788244e-08
, O 0 1.192880169642585e-11
and O 0 1.3196068586809884e-12
possibly O 0 1.0179632831119889e-10
with O 0 2.5148186484635904e-12
importance O 0 8.989385946733819e-08
for O 0 6.997182026680093e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 1.0470620281921583e-07
in O 0 6.139976114344359e-12
the O 0 2.8289015227556114e-11
general O 0 4.5156423739145524e-11
population O 0 2.4482464666686354e-12
. O 0 2.4047713473307475e-11
. O 0 3.605685527929836e-09

Genomic O 0 2.2397260579509748e-07
structure O 0 7.511096633550096e-09
of O 0 5.168167227509457e-09
the O 0 1.8142294777589996e-08
human O 1 0.9999783039093018
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 8.046197876865335e-07
CLD B-Disease 1 1.0
) O 0 4.743904713500058e-10
gene O 0 9.718666982294621e-10
. O 0 5.808112213401273e-09

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 0.003449701936915517
CLD B-Disease 1 1.0
) O 0 1.1686822343204284e-10
is O 0 7.580452108038593e-13
caused O 0 6.867219466688557e-12
by O 0 4.0374442070861827e-13
mutations O 0 2.4169052176281625e-12
in O 0 2.99519306926066e-13
a O 0 8.868077171035604e-13
gene O 0 5.106845393614001e-13
which O 0 4.688289687027059e-13
encodes O 0 1.0835789904239945e-10
an O 0 1.1079664269386669e-10
intestinal O 0 2.179503326260601e-06
anion O 0 8.158663717949821e-07
transporter O 0 8.344474053956219e-07
. O 0 2.1624690305088734e-07

We O 0 3.8199754470724656e-08
report O 0 1.0009036932601134e-09
here O 0 8.037545629058229e-11
the O 0 3.301269197245049e-12
complete O 0 5.600079844292338e-10
genomic O 0 1.162943630284019e-09
organization O 0 1.789502920845898e-11
of O 0 1.4513917845349056e-10
the O 0 2.537970111848864e-10
human O 0 4.310192203149654e-09
CLD B-Disease 1 0.9999946355819702
gene O 0 1.1470422528470081e-10
which O 0 1.3487685360941137e-12
spans O 0 1.6322358742382193e-10
approximately O 0 9.676060300223277e-12
39kb O 0 3.2363058011242174e-08
, O 0 2.9930377620779325e-11
and O 0 1.1483732020867166e-10
comprises O 0 2.84738543854246e-09
21 O 0 8.648405724898112e-08
exons O 0 1.0718335943238344e-06
. O 0 1.5636973671462329e-07

All O 0 9.957099109669798e-07
exon O 0 1.1760713505282183e-06
/ O 0 3.535172368174244e-07
intron O 0 8.180153088233055e-08
boundaries O 0 1.532230675671542e-09
conform O 0 9.739251183304987e-09
to O 0 8.146980312595531e-10
the O 0 9.67183044764397e-09
GT O 0 9.471949852013495e-06
/ O 0 1.1014116353180725e-05
AG O 0 2.1203875348874135e-06
rule O 0 1.0833883834493463e-07
. O 0 2.6463888502803457e-07

An O 0 3.1066993422257383e-10
analysis O 0 7.46899153636349e-10
of O 0 2.4214108496067865e-10
the O 0 3.6766589772696534e-10
putative O 0 1.3194081383005596e-08
promoter O 0 3.235991030692276e-08
region O 0 1.043685471380229e-09
sequence O 0 8.15357170669273e-10
shows O 0 2.7704907812342583e-10
a O 0 1.7550957909229226e-10
putative O 0 2.8768994297934114e-07
TATA O 0 1.3565491826739162e-05
box O 0 1.3868402426453486e-08
and O 0 4.854514012997413e-10
predicts O 0 5.18504128521613e-09
multiple O 0 2.4033708356796524e-09
transcription O 0 7.347451091987978e-09
factor O 0 5.365632937959219e-10
binding O 0 1.246448055880478e-09
sites O 0 1.3489771966135322e-08
. O 0 7.753622810469096e-08

The O 0 9.730004357777489e-09
genomic O 0 4.5509967350199076e-08
structure O 0 1.5287364707461393e-09
was O 0 6.923433354399933e-11
determined O 0 2.0259708841119384e-11
using O 0 3.4403471824845377e-12
DNA O 0 3.835802342422312e-09
from O 0 9.197965306073641e-12
several O 0 8.943325680715875e-13
sources O 0 3.3468172677686425e-11
including O 0 1.6052553709032524e-13
multiple O 0 1.2788470282742992e-10
large O 0 3.0588551136467856e-10
- O 0 3.1604326267142824e-08
insert O 0 2.6787732920752205e-08
libaries O 0 2.269360379614227e-07
and O 0 1.0725427490587691e-11
genomic O 0 2.1492456703242624e-09
DNA O 0 1.9966462261322704e-08
from O 0 5.748923559423247e-10
Finnish O 0 0.001130490330979228
CLD B-Disease 1 1.0
patients O 0 2.679954320683464e-07
and O 0 1.0283869311678018e-09
controls O 0 6.407817636500113e-07
. O 0 2.5691591076792974e-07

Exon O 0 6.037512775947107e-06
- O 0 1.4102309542352032e-08
specific O 0 5.486320286962609e-10
primers O 0 3.351650068594836e-09
developed O 0 1.1758483076107495e-10
in O 0 2.3055101664587463e-12
this O 0 1.2214661790702075e-12
study O 0 1.712960068928071e-12
will O 0 4.2308740061738903e-13
facilitate O 0 9.87661064044687e-10
mutation O 0 3.261975758950264e-11
screening O 0 4.5494275013879815e-11
studies O 0 2.1428833707481942e-10
of O 0 8.703796711140299e-11
patients O 0 2.1780326153741925e-10
with O 0 6.936740678392672e-12
the O 0 4.491937932726842e-09
disease O 0 5.325880010786932e-06
. O 0 2.6806183939243056e-08

Genomic O 0 2.7922283152292948e-08
sequencing O 0 1.2410920291472394e-08
of O 0 9.965989811178133e-09
a O 0 1.327723886390686e-08
BAC O 0 0.000228716351557523
clone O 0 2.80060544355365e-06
H O 1 1.0
_ O 0 8.119088734659385e-10
RG364P16 O 0 5.434956733552099e-07
revealed O 0 1.7500192406316728e-09
the O 0 1.0282916879100767e-11
presence O 0 7.58819569679492e-12
of O 0 1.0132541333751632e-10
another O 0 1.8752623065498852e-10
, O 0 1.6105564798474248e-11
highly O 0 6.923067674691197e-10
homologous O 0 5.256555746235847e-10
gene O 0 3.189257885560792e-11
3 O 0 1.3912872243171392e-10
of O 0 2.995152181828331e-10
the O 0 1.0906460179427313e-09
CLD B-Disease 1 0.9428621530532837
gene O 0 1.1245389341940637e-10
, O 0 1.289591480477248e-12
with O 0 3.063708412399252e-13
a O 0 3.441102004037022e-12
similar O 0 1.0653293351647886e-11
genomic O 0 2.884006367054326e-09
structure O 0 4.0710415594169547e-10
, O 0 3.7237283569135915e-12
recently O 0 8.71630198573392e-12
identified O 0 1.8706244886423917e-11
as O 0 3.3759807015892873e-12
the O 0 6.199885049795739e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 1.5163941213813814e-09
( O 0 5.5848659030743875e-11
PDS B-Disease 0 0.00020086660515516996
) O 0 8.788037658691294e-11
. O 0 2.203098370401335e-09
. O 0 2.9090623243632763e-08

The O 0 1.9860441113905836e-07
APCI1307K O 0 0.45793500542640686
allele O 0 2.1521719872907852e-07
and O 0 1.5015260146356013e-09
cancer B-Disease 0 5.1366228035476524e-06
risk O 0 1.238134217373954e-08
in O 0 8.518876576379952e-11
a O 0 1.2572182184200642e-10
community O 0 8.778655580243822e-11
- O 0 4.1738817263548e-11
based O 0 5.424277021472135e-13
study O 0 1.1864540599981765e-11
of O 0 8.595145428724749e-11
Ashkenazi O 0 9.309796666912007e-08
Jews O 0 6.231411475710047e-08
. O 0 2.0062094563400024e-07

Mutations O 0 6.362269999726777e-08
in O 0 1.4591088337567726e-09
APC O 0 8.641777071716206e-08
are O 0 2.8648474217907172e-11
classically O 0 1.805716287606174e-08
associated O 0 3.104587520397217e-08
with O 0 7.375311383839289e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 9.265509959277551e-08
FAP B-Disease 0 8.997762392937148e-07
) O 0 7.871324252117784e-12
, O 0 8.907745418021418e-13
a O 0 2.8668754870064816e-11
highly O 0 4.170681791038078e-07
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 9.443531894248736e-07
by O 0 2.712338131871661e-10
multiple O 0 2.1745204321632627e-06
intestinal O 1 0.9999995231628418
polyps B-Disease 0 4.061875724659103e-09
and O 0 2.5945784149633555e-12
, O 0 9.653377001841296e-14
without O 0 1.0606863477813366e-11
surgical O 0 1.0267116294926382e-06
intervention O 0 5.543996621781844e-07
, O 0 9.749347162912869e-12
the O 0 2.518752983959871e-10
development O 0 0.00015849740884732455
of O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 5.446227291372452e-08
CRC B-Disease 0 1.4684489542560186e-05
) O 0 4.475968207184877e-10
. O 0 1.4672782988611743e-08

APC B-Disease 0 2.7906341983907623e-06
is O 0 4.741805836872004e-10
a O 0 5.86010040493079e-09
tumour O 1 1.0
- O 0 3.7509421417780686e-06
suppressor O 0 1.2103414270825397e-08
gene O 0 1.8032322163241687e-11
, O 0 4.2115911994856925e-13
and O 0 2.3517804457334757e-12
somatic O 0 2.8245233352208743e-07
loss O 0 8.854138400238298e-08
occurs O 0 5.770472455424169e-08
in O 0 5.902629851561869e-08
tumours B-Disease 1 1.0
. O 0 2.099276798617211e-06

The O 0 5.607683988273493e-07
germline O 0 9.350945219921414e-06
T O 0 6.464113511128744e-08
- O 0 6.472031355286845e-09
to O 0 7.301596549602607e-10
- O 0 2.0705559933276163e-08
A O 0 2.2359714080266713e-08
transversion O 0 2.190287489156617e-07
responsible O 0 9.902541286965771e-11
for O 0 2.626249261464264e-12
the O 0 5.988270296297671e-11
APC O 0 1.7815866559800497e-09
I1307K O 0 1.4142283788487475e-08
allele O 0 8.831170517087372e-11
converts O 0 5.59000276623145e-11
the O 0 2.2893593271122725e-11
wild O 0 6.782817363326643e-11
- O 0 2.7483317704968258e-11
type O 0 8.406738846722384e-12
sequence O 0 4.019544766475924e-11
to O 0 9.291335062444617e-11
a O 0 1.3166194801073061e-09
homopolymer O 1 0.9995927214622498
tract O 0 5.922600848862203e-06
( O 0 2.2200968841090685e-10
A8 O 0 9.086936188396066e-06
) O 0 3.032746276332432e-11
that O 0 9.45487178133364e-12
is O 0 8.642386285784287e-12
genetically O 0 1.1514575959381546e-09
unstable O 0 6.6980801420868374e-06
and O 0 9.253266597397669e-09
prone O 0 4.801555860467488e-06
to O 0 8.756394009878932e-08
somatic O 0 0.055161263793706894
mutation O 0 9.264039704248717e-07
. O 0 2.909285115038074e-07

The O 0 6.680929942604052e-08
I1307K O 0 1.970484390767524e-06
allele O 0 4.169644629570257e-09
was O 0 2.6103672556843094e-09
found O 0 1.4448511831410826e-10
in O 0 1.363446022750736e-10
6 O 0 8.56733350929062e-08
. O 0 1.0070207423495958e-07

1 O 0 1.0231776315094976e-07
% O 0 2.0180369375566443e-08
of O 0 3.1109521625438674e-09
unselected O 0 0.00035592500353232026
Ashkenazi O 0 5.280424375087023e-06
Jews O 0 1.3627558637097081e-08
and O 0 1.4298606743068376e-10
higher O 0 6.149713183134509e-09
proportions O 0 2.050533770558971e-10
of O 0 1.0857166277133956e-09
Ashkenazim O 0 6.693252998957178e-06
with O 0 6.758049675426037e-11
family O 0 3.1359542740361235e-10
or O 0 1.3120388109300052e-10
personal O 0 1.206210811233177e-07
histories O 0 0.027096755802631378
of O 1 0.999966025352478
CRC B-Disease 1 0.9999991655349731
( O 0 6.213191294790477e-09
ref O 0 3.7408213415801583e-08
. O 0 5.517337281490953e-11
2 O 0 2.3538831994684983e-10
) O 0 1.7832506304937823e-11
. O 0 2.5875053211166232e-09

To O 0 2.3252820113839334e-08
evaluate O 0 5.696004024002832e-08
the O 0 9.686965674049475e-10
role O 0 2.991733527579754e-09
of O 0 1.0342142076069649e-07
I1307K O 0 0.09322644770145416
in O 0 6.578249611699505e-10
cancer B-Disease 0 2.4823650690564136e-08
, O 0 2.334401595638358e-11
we O 0 3.825396388545954e-10
genotyped O 0 4.6124040409267764e-07
5 O 0 3.4109046698205248e-09
, O 0 1.1158920315557097e-10
081 O 0 4.771833573613549e-06
Ashkenazi O 0 1.180730691885401e-06
volunteers O 0 1.641434899113392e-08
in O 0 5.545139347695738e-10
a O 0 5.630840238524115e-10
community O 0 8.680060559207448e-10
survey O 0 8.801063877683646e-09
. O 0 1.2911594460263132e-08

Risk O 0 6.4026398831629194e-06
of O 0 9.673030945123173e-07
developing O 1 0.9998890161514282
colorectal B-Disease 1 1.0
, I-Disease 0 3.6721289689012337e-06
breast I-Disease 0 0.13731735944747925
and I-Disease 0 1.6505731226246212e-09
other I-Disease 0 1.4322278918399434e-09
cancers I-Disease 1 0.9999760389328003
were O 0 5.725943083234597e-06
compared O 0 4.052529334330757e-08
between O 0 1.2300816365495848e-08
genotyped O 0 6.193658919073641e-07
I1307K O 0 1.3274724608436372e-07
carriers O 0 1.994842832586663e-11
and O 0 2.170152772762446e-11
non O 0 8.223623559899806e-09
- O 0 4.873672021510345e-10
carriers O 0 7.069751901955801e-12
and O 0 1.6670705614563186e-12
their O 0 2.5292415731237305e-11
first O 0 1.4833393402469142e-09
- O 0 6.202168112423578e-09
degree O 0 1.853215820801779e-07
relatives O 0 4.495334238185933e-08
. O 0 2.7056547224901806e-08

Sperm O 0 2.463615800252228e-08
DNA O 0 3.4441491436609795e-08
analysis O 0 1.2486824907398386e-09
in O 0 2.0361023977955028e-10
a O 0 4.740180692408558e-09
Friedreich B-Disease 0 0.2074708789587021
ataxia I-Disease 1 0.9291662573814392
premutation O 0 0.32820966839790344
carrier O 0 2.168087398501939e-08
suggests O 0 2.426423728607574e-09
both O 0 2.945085564309835e-10
meiotic O 0 3.0760763820580905e-06
and O 0 4.0062597683743206e-10
mitotic O 0 1.0412050244212878e-07
expansion O 0 9.161717606787079e-09
in O 0 4.5755867844610165e-11
the O 0 2.440706081685562e-09
FRDA B-Disease 0 0.00031217560172080994
gene O 0 7.454961981068209e-09
. O 0 3.832381878510205e-08

Friedreich B-Disease 1 0.9999969005584717
ataxia I-Disease 1 1.0
is O 0 2.8486471848054862e-08
usually O 0 1.0061909527792068e-08
caused O 0 4.06700761956813e-09
by O 0 6.632164435693699e-12
an O 0 7.539170026119035e-13
expansion O 0 9.16956288676829e-10
of O 0 2.8026634346645096e-09
a O 0 7.738653273747786e-09
GAA O 0 8.774307389103342e-06
trinucleotide O 0 3.7847544263058808e-06
repeat O 0 1.7361330151288712e-08
in O 0 1.3986634073148707e-09
intron O 0 2.3836502549556826e-08
1 O 0 5.195760488518886e-10
of O 0 7.105434574050662e-10
the O 0 4.243660089997547e-09
FRDA B-Disease 0 0.020293893292546272
gene O 0 7.169148386054758e-09
. O 0 3.617825683477349e-08

Occasionally O 0 2.432526287066139e-07
, O 0 1.7960144482742635e-10
a O 0 1.180333331074479e-10
fully O 0 1.180947073464722e-08
expanded O 0 1.6691659165957162e-10
allele O 0 3.8702674398649606e-10
has O 0 2.794000382617956e-13
been O 0 5.1937642554789054e-12
found O 0 1.849136945994423e-12
to O 0 7.960038878040976e-12
arise O 0 5.6691535910147195e-09
from O 0 1.0292301733105802e-10
a O 0 1.7031329124783667e-10
premutation O 0 1.4091132243265747e-06
of O 0 7.052362249737598e-09
100 O 0 2.9179702210058167e-08
or O 0 4.2869460759042965e-10
less O 0 1.8086357300717282e-08
triplet O 0 1.0792292414407711e-05
repeats O 0 4.906761432721396e-07
. O 0 4.826042641070671e-07

We O 0 1.5876141290505075e-08
have O 0 6.851546240083106e-12
examined O 0 2.5154595073573205e-10
the O 0 6.933619043497652e-12
sperm O 0 5.5882010824293005e-11
DNA O 0 3.223508793226415e-09
of O 0 7.299507664981775e-10
a O 0 1.0407751327434767e-09
premutation O 0 6.545422820636304e-06
carrier O 0 5.986509421518349e-08
. O 0 4.03807121074351e-07

This O 0 2.2396111631906024e-09
mans O 0 1.273347649544121e-08
leucocyte O 0 4.1530658023702927e-08
DNA O 0 1.7102571803206956e-08
showed O 0 5.424533600084658e-10
one O 0 9.44214324782866e-13
normal O 0 1.4852977181512017e-10
allele O 0 4.1238856079983677e-11
and O 0 9.516344960311396e-13
one O 0 1.8103820309187113e-12
allele O 0 8.256762634717418e-11
of O 0 1.7900704529782985e-10
approximately O 0 1.4889568744624881e-10
100 O 0 3.6624945298768807e-09
repeats O 0 2.6946487707846245e-08
. O 0 4.091026539754239e-08

His O 0 1.0181821608057362e-07
sperm O 0 2.7159956061950652e-08
showed O 0 8.718759048065294e-09
an O 0 1.4954987118467877e-12
expanded O 0 1.2337735000311767e-11
allele O 0 3.8426890142106984e-11
in O 0 6.6577277545165625e-12
a O 0 9.751899288090726e-11
tight O 0 2.338803817281132e-08
range O 0 1.8600382345468347e-09
centering O 0 6.305283406504714e-09
on O 0 1.0548385498410084e-09
a O 0 1.4436447870469493e-10
size O 0 1.0155914303977553e-10
of O 0 3.436160245229303e-10
approximately O 0 2.545989807867244e-10
320 O 0 5.9529847717954e-09
trinucleotide O 0 4.130215529585257e-06
repeats O 0 5.828512144034903e-07
. O 0 5.597404424406704e-07

His O 0 6.308185334091831e-07
affected O 0 6.911027412570547e-07
son O 0 5.7109496992779896e-05
has O 0 1.2025502121870701e-11
repeat O 0 2.888078387552895e-10
sizes O 0 9.881787749188575e-11
of O 0 1.9826675023981721e-10
1040 O 0 2.241205976361016e-08
and O 0 3.761738420759997e-10
540 O 0 2.3997310449885845e-07
. O 0 1.6209375530706893e-07

These O 0 8.339404722335075e-09
data O 0 1.0817897688752964e-08
suggest O 0 5.718411855148986e-10
that O 0 2.82070916103605e-13
expansion O 0 3.2111341363716406e-11
occurs O 0 1.8762695390417417e-12
in O 0 1.5444893627925005e-13
two O 0 2.2683631774149393e-13
stages O 0 3.3474065186389623e-10
, O 0 1.5147556603131718e-12
the O 0 3.4280132985703426e-12
first O 0 6.124256483885926e-12
during O 0 2.862849679541313e-10
meiosis O 0 3.0851003973708657e-09
followed O 0 2.4442208673702837e-11
by O 0 2.392746374299537e-12
a O 0 1.9285840285876432e-11
second O 0 1.4449732521626402e-09
mitotic O 0 5.953623940513353e-07
expansion O 0 8.199286867238698e-07
. O 0 7.670498689549277e-07

We O 0 7.153197145726153e-08
also O 0 6.734643398509377e-11
show O 0 2.1838647557004265e-10
that O 0 2.843911358577783e-13
in O 0 1.956825109936111e-12
all O 0 5.46223699951498e-12
informative O 0 5.023218993538414e-11
carrier O 0 1.569307010729215e-11
father O 0 9.36403399265373e-10
to O 0 3.409159621270419e-10
affected O 0 6.422694376340132e-09
child O 0 7.018693626292816e-09
transmissions O 0 2.8688766633422347e-06
, O 0 6.182914423502606e-13
with O 0 1.7087756719585262e-13
the O 0 2.1481818060498092e-11
notable O 0 3.279311891479786e-11
exception O 0 3.1325390198455594e-11
of O 0 1.1900470886505587e-10
the O 0 4.3231410118416136e-10
premutation O 0 2.494395232588431e-07
carrier O 0 1.1079438477779036e-09
, O 0 5.7771259998062874e-11
the O 0 7.497737986028596e-10
expansion O 0 2.6266903319083212e-08
size O 0 9.041549176025399e-10
decreases O 0 2.983550739799057e-09
. O 0 1.1127957444401204e-09
. O 0 4.354418692287254e-08

The O 0 4.6403322073729214e-08
R496H O 0 4.299473403079901e-06
mutation O 0 2.196129722520368e-09
of O 0 1.0755332624512448e-08
arylsulfatase O 0 0.06866949051618576
A O 0 2.4975568067020504e-06
does O 0 1.8292138637132638e-10
not O 0 1.1528025201101855e-09
cause O 0 0.018515456467866898
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 1.2142095329181757e-06

Deficiency B-Disease 0 0.0818503275513649
of I-Disease 0 1.4711991752847098e-05
arylsulfatase I-Disease 1 0.9999990463256836
A I-Disease 1 0.9991400241851807
( O 0 3.205299581310328e-09
ARSA O 1 0.9895939826965332
) O 0 1.703489259374802e-11
enzyme O 0 2.0252921562047277e-10
activity O 0 7.906002963409264e-09
causes O 0 2.537167915761529e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 4.414680532249804e-08
MLD B-Disease 1 1.0
) O 0 2.2098824992156096e-09
. O 0 1.4299002870643562e-08

A O 0 8.626264502709091e-08
number O 0 1.032051666349787e-09
of O 0 1.1195855798007415e-08
ARSA O 0 0.006869467906653881
gene O 0 3.686561944604705e-09
mutations O 0 8.026794229287759e-10
responsible O 0 2.4954092125994976e-09
for O 0 1.5418590848526037e-08
MLD B-Disease 1 1.0
have O 0 5.722852192135974e-10
been O 0 1.9063089995441374e-10
identified O 0 2.2921184950064344e-09
. O 0 6.32173335901598e-09

Recently O 0 5.1279414492455544e-08
, O 0 2.5663580635604255e-11
the O 0 4.9005802887913674e-11
R496H O 0 8.710485843721472e-08
mutation O 0 6.435502131196813e-11
of O 0 4.166639477887202e-09
ARSA O 1 0.998753547668457
was O 0 1.719434905567141e-08
proposed O 0 1.2667718263248418e-10
to O 0 2.7620895154401026e-11
be O 0 6.619857439993382e-11
a O 0 2.357270767472386e-10
cause O 0 1.495330614886825e-08
of O 0 1.7976702793021104e-06
MLD B-Disease 1 1.0
( O 0 1.2881879563053644e-08
Draghia O 0 8.220824383897707e-06
et O 0 5.430004890172313e-08
al O 0 5.3872138749966325e-08
. O 0 3.516665084135617e-11
, O 0 2.093105853570587e-12
1997 O 0 1.4034300110932207e-10
) O 0 8.080492525097682e-11
. O 0 1.1553608736392107e-08

We O 0 4.366777872633065e-08
have O 0 4.317848162349591e-11
investigated O 0 1.3856683578339357e-09
the O 0 6.607974584182941e-11
R496H O 0 4.7083211995868623e-08
mutation O 0 7.377153575516271e-12
and O 0 5.424773586067133e-13
found O 0 3.7479555049790836e-12
this O 0 9.714593495954715e-13
mutation O 0 1.0784424568643924e-11
at O 0 1.709505176306081e-10
a O 0 1.7272423075143095e-11
relatively O 0 1.730210696937462e-10
high O 0 1.1183844648987584e-11
frequency O 0 1.309094083135065e-10
in O 0 3.8080229074199945e-12
an O 0 1.772503584879237e-12
African O 0 1.142732242165323e-09
American O 0 4.486258864400128e-10
population O 0 9.185009523793308e-12
( O 0 1.0544784311136354e-13
f O 0 2.0270183101467332e-11
= O 0 1.7359582521470074e-11
0 O 0 2.1826590014539793e-12
. O 0 7.300725995973423e-12
09 O 0 8.332897705187747e-10
, O 0 1.4236146116120008e-11
n O 0 1.1469240834838246e-10
= O 0 1.9446604049289107e-10
61 O 0 2.387662290104231e-09
subjects O 0 6.341988267877241e-08
) O 0 5.463617891443562e-10
. O 0 4.296724753771741e-08

The O 0 4.0502044384993496e-07
ARSA O 0 0.00014386944530997425
enzyme O 0 3.6531158653652085e-10
activity O 0 2.6617341664092464e-10
in O 0 4.4388533647354844e-12
subjects O 0 2.221355988041296e-09
with O 0 1.4926546327079238e-12
and O 0 1.1517655319065456e-12
without O 0 3.726245700885755e-11
the O 0 8.646315607929722e-11
R496H O 0 5.3864944504766754e-08
mutation O 0 1.4853054550179046e-11
was O 0 1.785571863976987e-11
determined O 0 4.9747278518808e-10
and O 0 5.6705539569490426e-11
found O 0 1.2534877302794456e-10
to O 0 1.1836497060269124e-10
be O 0 8.557232145101068e-10
normal O 0 2.7752646474255016e-06
. O 0 1.8254102940318262e-07

It O 0 8.858488387275543e-10
is O 0 1.0706603138788129e-11
therefore O 0 4.3635161456334615e-11
concluded O 0 2.0020098079331916e-10
that O 0 5.21621808247108e-13
the O 0 1.6159105303836796e-11
R496H O 0 3.975313944692971e-08
mutation O 0 2.188234454747473e-10
of O 0 7.84373010986883e-09
ARSA O 0 0.2874329388141632
does O 0 1.3346590499452304e-10
not O 0 4.9869715995631836e-11
negatively O 0 8.61346438618682e-10
influence O 0 3.5734093462025385e-10
the O 0 7.143547559040897e-11
activity O 0 2.4758999295215744e-09
of O 0 3.0806668327443276e-09
ARSA O 1 0.9495292901992798
and O 0 1.702918361878858e-10
is O 0 4.297740548858675e-12
not O 0 1.4727828331895232e-11
a O 0 4.4629336337642656e-10
cause O 0 1.4402871784113813e-07
of O 0 7.381604518741369e-06
MLD B-Disease 1 1.0

Down O 0 4.946999524690909e-06
- O 0 4.545929925825476e-07
regulation O 0 3.710641038878748e-08
of O 0 2.709265061184851e-07
transmembrane O 0 1.3748085621045902e-05
carbonic O 0 4.072563388035633e-05
anhydrases O 0 0.0007672360516153276
in O 0 2.15825181726359e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9998688697814941
lines O 0 1.6898219490357747e-09
by O 0 2.4037717996638897e-11
wild O 0 1.8117596312094975e-09
- O 0 2.980327096224755e-08
type O 0 3.327717195134028e-07
von B-Disease 1 0.9999942779541016
Hippel I-Disease 1 0.9999996423721313
- I-Disease 1 0.995415210723877
Lindau I-Disease 0 0.0032433662563562393
transgenes O 0 0.00018715657643042505
. O 0 9.481993856752524e-07

To O 0 2.2928374221464765e-07
discover O 0 5.857119589336435e-08
genes O 0 4.839371126053038e-10
involved O 0 5.106629563655929e-10
in O 0 7.488462627769366e-10
von B-Disease 1 0.9999078512191772
Hippel I-Disease 1 0.9999998807907104
- I-Disease 1 0.9999994039535522
Lindau I-Disease 1 0.9999959468841553
( O 0 2.9736156648141332e-08
VHL B-Disease 1 0.9758954644203186
) O 0 2.95787727644381e-09
- O 0 2.3145830141402257e-07
mediated O 0 3.53928817276028e-06
carcinogenesis O 1 0.9999901056289673
, O 0 2.2238604013846697e-10
we O 0 5.17756532092406e-11
used O 0 2.3829671569330912e-09
renal B-Disease 1 0.9999997615814209
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9995858073234558
lines O 0 1.7232918025911204e-07
stably O 0 8.739006034375052e-07
transfected O 0 6.292911081118291e-08
with O 0 4.596202932138915e-11
wild O 0 1.3766378037516347e-09
- O 0 1.3294774170446999e-08
type O 0 1.3003160326263696e-08
VHL O 0 0.0011173072271049023
- O 0 6.685971811748459e-07
expressing O 0 7.858435679963804e-09
transgenes O 0 1.2193524980830261e-06
. O 0 4.733542624535403e-08

Large O 0 3.438036966230129e-09
- O 0 1.3217096306306075e-09
scale O 0 1.8963841608155008e-09
RNA O 0 1.085191314587064e-08
differential O 0 1.9930467942685937e-08
display O 0 1.3637614371120321e-09
technology O 0 4.77992223579804e-08
applied O 0 3.466123776885155e-10
to O 0 2.8864632906078214e-11
these O 0 1.6785897324900212e-11
cell O 0 1.2642911162430437e-09
lines O 0 6.984698930345701e-11
identified O 0 3.7512756789759294e-11
several O 0 7.619812766868073e-12
differentially O 0 4.47026282657248e-09
expressed O 0 5.423020713046789e-11
genes O 0 3.238171536468215e-11
, O 0 8.048920145838079e-13
including O 0 3.7198456120934864e-12
an O 0 2.9431131143287104e-11
alpha O 0 1.2670678728454732e-08
carbonic O 0 8.048615995903674e-07
anhydrase O 0 2.020311058004154e-06
gene O 0 5.150719850632868e-09
, O 0 3.435853823674506e-09
termed O 0 3.84823670174228e-06
CA12 O 1 0.9999613761901855
. O 0 5.497986876434879e-06

The O 0 9.09021302675228e-09
deduced O 0 1.218387879475813e-08
protein O 0 4.878570811217564e-11
sequence O 0 3.424890926417845e-11
was O 0 2.336558724280735e-10
classified O 0 1.9489752867141164e-10
as O 0 3.4764090477840126e-12
a O 0 1.6326275401046253e-11
one O 0 2.2902688079362576e-10
- O 0 1.1743299666022722e-08
pass O 0 5.9157493126349436e-08
transmembrane O 0 1.347410716334707e-06
CA O 0 5.672389988831128e-07
possessing O 0 1.6417660564371772e-09
an O 0 1.8822634423321105e-11
apparently O 0 1.6554704274085452e-08
intact O 0 5.594320100499317e-07
catalytic O 0 1.815122452342166e-08
domain O 0 3.612915477901879e-08
in O 0 2.2476349670341733e-09
the O 0 9.613569318389636e-08
extracellular O 0 9.42330552788917e-06
CA O 0 7.005697989370674e-05
module O 0 9.140475413005333e-06
. O 0 1.4852672336473915e-07

Reintroduced O 0 9.629605983718648e-07
wild O 0 1.3526666897689665e-08
- O 0 4.6111370721746425e-08
type O 0 5.7955853449698225e-09
VHL B-Disease 0 2.0379715351737104e-05
strongly O 0 3.447471197404184e-10
inhibited O 0 7.459765583028855e-10
the O 0 1.9470569254109726e-11
overexpression O 0 3.064256626217343e-10
of O 0 7.881002794807301e-11
the O 0 1.8372736665384082e-10
CA12 O 0 2.4041501092142425e-05
gene O 0 7.522067170528945e-12
in O 0 2.971579796465229e-12
the O 0 1.0525128685268115e-10
parental O 0 1.058408756193785e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 0 5.543713541555917e-06
. O 0 4.970806912751868e-07

Similar O 0 6.225667203985097e-10
results O 0 5.650723222672127e-10
were O 0 1.8667332957189586e-10
obtained O 0 3.2038066644091145e-10
with O 0 1.720856269982196e-11
CA9 O 0 3.4164237149525434e-05
, O 0 5.334852004601487e-11
encoding O 0 1.074208810791788e-08
another O 0 3.836021722491978e-09
transmembrane O 0 2.9517732968997734e-07
CA O 0 1.3222419283920317e-06
with O 0 1.3926831042565535e-11
an O 0 1.7183667683218218e-11
intact O 0 2.4263934506052465e-07
catalytic O 0 3.818081495410297e-08
domain O 0 2.623108912302996e-07
. O 0 9.171039749844567e-08

Although O 0 3.286992678042111e-09
both O 0 4.2423956014836506e-10
domains O 0 3.2343541178647683e-09
of O 0 2.0186752269779618e-09
the O 0 4.684830745560475e-09
VHL B-Disease 0 1.1328139407851268e-05
protein O 0 7.528806467149707e-10
contribute O 0 1.1139207611865487e-10
to O 0 1.0364956115616053e-10
regulation O 0 3.021674910286265e-09
of O 0 1.2196783139017953e-08
CA12 O 1 0.9999792575836182
expression O 0 4.033811507042628e-09
, O 0 8.112655512648725e-12
the O 0 2.826533625210903e-11
elongin O 0 1.722408704551981e-08
binding O 0 4.0990050242939446e-10
domain O 0 5.3676418865222786e-09
alone O 0 1.262960624970333e-09
could O 0 6.46590725406071e-10
effectively O 0 1.1124806320594871e-07
regulate O 0 9.175761874757882e-07
CA9 O 0 0.415128618478775
expression O 0 2.743429149631993e-06
. O 0 7.77018726694223e-07

We O 0 1.5216281212815375e-07
mapped O 0 1.942988546943525e-06
CA12 O 0 0.038939762860536575
and O 0 1.0075006606768966e-08
CA9 O 0 0.0003234228934161365
loci O 0 1.3777101237621991e-08
to O 0 6.229230464782631e-10
chromosome O 0 1.3510055296706014e-09
bands O 0 2.5030947981008467e-08
15q22 O 0 8.95182711246889e-06
and O 0 1.100826718669623e-08
17q21 O 0 8.69390059961006e-05
. O 0 3.2831164276103664e-07

2 O 0 2.907048823885816e-08
respectively O 0 1.0682207118861697e-07
, O 0 1.228938339981056e-10
regions O 0 2.6261379737491097e-09
prone O 0 1.6637384803175337e-08
to O 0 7.92319321263335e-10
amplification O 0 3.8464463614218403e-07
in O 0 1.1686158707391314e-09
some O 0 9.76074332470489e-10
human O 0 8.085437741556234e-08
cancers B-Disease 1 0.9993895292282104
. O 0 1.7679003576631658e-06

Additional O 0 6.479083491939264e-09
experiments O 0 1.0815070616843059e-08
are O 0 5.200742614341891e-12
needed O 0 6.658407714077441e-10
to O 0 3.5427057121228955e-11
define O 0 1.2874847854504878e-09
the O 0 3.3412572708613197e-10
role O 0 2.1835575569895127e-09
of O 0 4.680653020727732e-08
CA O 0 9.496024722466245e-05
IX O 0 2.094221599691082e-06
and O 0 4.283965182594329e-09
CA O 0 2.6151635665883077e-06
XII O 0 3.3961701007001466e-08
enzymes O 0 1.4234815583213933e-11
in O 0 6.894255132061655e-12
the O 0 3.284801944336557e-11
regulation O 0 1.2560708029241141e-09
of O 0 2.589549463749563e-09
pH O 0 1.553676298726714e-08
in O 0 9.575819998053348e-11
the O 0 9.511859078159546e-10
extracellular O 0 3.0086503954862565e-08
microenvironment O 0 6.105327088334889e-08
and O 0 1.0636259234475531e-11
its O 0 2.288711971679125e-12
potential O 0 1.269984672980229e-10
impact O 0 5.181084450356366e-10
on O 0 4.335223735552063e-09
cancer B-Disease 0 5.437528329821362e-07
cell O 0 5.737251740356442e-07
growth O 0 9.347265184089792e-09
. O 0 2.1828673979484847e-08

A O 0 2.1464487076627847e-08
gene O 0 2.584411573636203e-10
encoding O 0 1.1801319921289632e-08
a O 0 5.551523685198845e-09
transmembrane O 0 1.6148166537277575e-07
protein O 0 1.330181242931161e-10
is O 0 1.2541267395242695e-13
mutated O 0 3.762488150899079e-12
in O 0 9.624425822279958e-13
patients O 0 4.666181330215124e-10
with O 0 1.3122991582292798e-10
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9948794841766357
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 0.0029854094609618187
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 4.54368903612945e-10
. O 0 1.3585852443043223e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.697864490779466e-06
WFS B-Disease 1 0.9999480247497559
; O 0 8.175481958083708e-10
OMIM O 0 0.0016876348527148366
222300 O 0 2.885197147861618e-07
) O 0 3.6139557058750826e-12
is O 0 2.3598865916962808e-12
an O 0 1.5352401294688178e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
defined O 0 1.2899198376103982e-10
by O 0 5.2756540455667356e-12
young O 0 1.0513937498402015e-09
- O 0 5.741033759498748e-10
onset O 1 0.975750744342804
non O 1 0.9985161423683167
- O 0 7.645822734048124e-06
immune O 0 7.865396867146046e-08
insulin B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
dependent I-Disease 1 0.9986597299575806
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 2.8446203941712156e-05
progressive O 1 1.0
optic B-Disease 1 0.9999982118606567
atrophy I-Disease 0 0.00028997805202379823
. O 0 2.4608930289105047e-06

Linkage O 0 7.008582088019466e-06
to O 0 7.091641496259626e-09
markers O 0 6.649336636854741e-09
on O 0 7.030739102020789e-09
chromosome O 0 2.909711582788077e-08
4p O 0 1.0522275260882452e-05
was O 0 1.3545403687587054e-09
confirmed O 0 7.702468107773086e-10
in O 0 2.0777730230792102e-11
five O 0 1.246775599428318e-10
families O 0 1.6698059601694126e-10
. O 0 6.4145044831320774e-09

On O 0 4.325372415792117e-08
the O 0 7.522935052683977e-10
basis O 0 1.416866179937415e-08
of O 0 2.865473414104258e-09
meiotic O 0 0.00023268106451723725
recombinants O 1 0.6781976222991943
and O 0 8.108631099901231e-09
disease O 0 6.478980503743514e-05
- O 0 1.3915752994364539e-08
associated O 0 1.3739470894336137e-08
haplotypes O 0 1.620178124994709e-08
, O 0 8.062753589777039e-12
the O 0 5.528527635689784e-10
WFS B-Disease 0 3.5896333429263905e-05
gene O 0 1.1287206586052534e-10
was O 0 6.698149812578436e-10
localized O 0 1.5607980463627769e-09
to O 0 3.2170086039506884e-10
a O 0 4.775372097753916e-09
BAC O 0 6.0245358326938e-05
/ O 0 2.5187014216498937e-06
P1 O 0 0.0005805643741041422
contig O 0 1.9830606106552295e-05
of O 0 9.806655043576029e-09
less O 0 6.952072806321041e-10
than O 0 1.0322789498196094e-11
250 O 0 2.2566384316746735e-09
kb O 0 1.1386584901629249e-06
. O 0 4.935699493557877e-08

Mutations O 0 2.96843616354181e-08
in O 0 1.0590050364411852e-10
a O 0 2.7094047491682538e-11
novel O 0 5.424135099407756e-12
gene O 0 1.3594929869353845e-11
( O 0 2.6737858888764565e-12
WFS1 O 0 0.00023386898101307452
) O 0 5.254324753067863e-12
encoding O 0 4.7216461851462554e-09
a O 0 7.838910076607419e-10
putative O 0 1.1226288876287072e-07
transmembrane O 0 3.543603099842585e-08
protein O 0 1.717463393724472e-10
were O 0 9.76479869185809e-11
found O 0 1.2148332687034191e-11
in O 0 1.5026066328693855e-12
all O 0 4.625635811883466e-12
affected O 0 3.030618464516799e-11
individuals O 0 3.888184045564014e-12
in O 0 2.1296197444398146e-11
six O 0 9.046245530441865e-09
WFS B-Disease 0 0.00024962585303001106
families O 0 3.235296197612314e-10
, O 0 7.531584730879892e-12
and O 0 2.5351858199545996e-12
these O 0 5.097758153105314e-12
mutations O 0 3.434029102744596e-11
were O 0 1.4622723171209273e-11
associated O 0 2.7138594149711537e-10
with O 0 1.692116412266298e-11
the O 0 3.8613496400330405e-08
disease O 1 0.9353052973747253
phenotype O 0 2.7030787919102295e-07
. O 0 8.985391275473376e-08

WFS1 O 1 0.999871015548706
appears O 0 7.286824921237667e-09
to O 0 1.3835600720657482e-10
function O 0 4.719878932135657e-10
in O 0 7.565033321998982e-11
survival O 0 1.6590034874752746e-06
of O 0 5.649766876558715e-09
islet O 0 8.303359777528385e-09
beta O 0 3.5748580984318323e-08
- O 0 1.523805615022411e-08
cells O 0 1.0138887507338268e-09
and O 0 5.171722425312275e-11
neurons O 0 1.4548245275136651e-08
. O 0 5.75247682821356e-10
. O 0 1.160670670685704e-08

Stable O 0 0.2969721555709839
interaction O 0 3.807704445080162e-07
between O 0 6.225599591402897e-09
the O 0 1.24800086931387e-10
products O 0 7.303375265665935e-11
of O 0 7.408573754474901e-11
the O 0 3.2500907520827127e-10
BRCA1 O 0 9.855195548524875e-10
and O 0 9.600838873913276e-11
BRCA2 O 0 4.6960497712689175e-09
tumor B-Disease 0 3.7708418609838645e-09
suppressor O 0 1.7224506265733908e-09
genes O 0 2.096475076873716e-11
in O 0 2.6341720471556584e-11
mitotic O 0 1.1523923859613205e-07
and O 0 2.138492405379111e-08
meiotic O 0 0.001563228783197701
cells O 0 4.2421368561917916e-05
. O 0 1.3308446114024264e-06

BRCA1 O 0 7.0125934144016355e-06
and O 0 7.962602133204655e-09
BRCA2 O 0 8.218218283673195e-08
account O 0 4.2062187066704837e-10
for O 0 1.3462658939034089e-11
most O 0 2.0177943517440955e-12
cases O 0 3.258417190579732e-12
of O 0 7.782726546556873e-11
familial O 0 8.773237136772138e-10
, O 0 2.112437395146438e-12
early O 0 9.943205370177566e-09
onset O 1 0.9883409142494202
breast B-Disease 0 4.141914814681513e-06
and I-Disease 0 3.9213116309610996e-08
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.137204332570036e-08
encode O 0 5.051614127005166e-10
products O 0 8.134243972834909e-11
that O 0 6.678620872481444e-13
each O 0 3.887694419862919e-12
interact O 0 9.802007122639012e-11
with O 0 3.374308818471228e-11
hRAD51 O 0 8.410971759076347e-07
. O 0 1.4039768814200215e-07

Results O 0 6.488039616669994e-08
presented O 0 2.2454464954080322e-08
here O 0 6.767110871663817e-09
show O 0 1.2206666788472376e-09
that O 0 1.555497571026354e-11
BRCA1 O 0 1.0355871715717058e-09
and O 0 7.765230125578171e-11
BRCA2 O 0 9.298825709436187e-09
coexist O 0 2.3859790587721363e-08
in O 0 6.565222671062187e-11
a O 0 1.3012822763780463e-10
biochemical O 0 8.001485696240707e-09
complex O 0 6.764581783613721e-09
and O 0 6.125150386893097e-10
colocalize O 0 5.8861419347522315e-06
in O 0 2.0118522403578254e-09
subnuclear O 0 2.135323029506253e-06
foci O 0 9.656940846980433e-08
in O 0 2.498289075614224e-10
somatic O 0 3.301111917153321e-08
cells O 0 1.1842622438251738e-09
and O 0 9.675617078375165e-12
on O 0 7.655361761171875e-11
the O 0 9.21380333140931e-12
axial O 0 2.9651101018934867e-11
elements O 0 8.170692594733353e-11
of O 0 1.1163799884528203e-09
developing O 0 2.7137120994780162e-08
synaptonemal O 0 1.7206099300892674e-06
complexes O 0 2.2017594858425582e-08
. O 0 2.700669021749036e-08

Like O 0 1.9974906706465845e-07
BRCA1 O 0 7.579095608889475e-07
and O 0 3.378641366680313e-08
RAD51 O 0 0.011853277683258057
, O 0 1.8388800482327383e-09
BRCA2 O 0 6.2829781377615745e-09
relocates O 0 7.554987191404905e-10
to O 0 3.208833476708861e-10
PCNA O 0 5.506970865098992e-06
+ O 0 2.268847998365686e-09
replication O 0 2.2526294718439033e-10
sites O 0 4.3935202698186515e-12
following O 0 5.387532000383777e-12
exposure O 0 7.582126038130355e-10
of O 0 1.8621387765094255e-10
S O 0 1.248266467968051e-08
phase O 0 2.7143701686327404e-07
cells O 0 1.657897286122534e-08
to O 0 4.040333401178486e-09
hydroxyurea O 0 6.518031341329333e-07
or O 0 1.0023561536343095e-08
UV O 0 1.0732660484791268e-05
irradiation O 0 7.671305013445817e-08
. O 0 2.1612995837472226e-08

Thus O 0 3.1724212590233947e-07
, O 0 2.673167687206046e-09
BRCA1 O 0 7.980451854905368e-09
and O 0 1.9909437987131184e-10
BRCA2 O 0 8.428953091055291e-10
participate O 0 4.651530272070659e-09
, O 0 2.511972574392729e-11
together O 0 1.8076752594797796e-10
, O 0 2.7599871173233925e-12
in O 0 8.824297195730857e-12
a O 0 9.006879270190282e-11
pathway O 0 3.8351857800655864e-10
( O 0 1.152594079206759e-12
s O 0 1.459238285761444e-11
) O 0 1.1244728293034051e-13
associated O 0 3.688808980495395e-11
with O 0 5.645716099483833e-13
the O 0 1.783220099360605e-11
activation O 0 4.0993083927354235e-11
of O 0 9.574194909101053e-11
double O 0 1.4430996675418584e-10
- O 0 1.2535195104135255e-09
strand O 0 2.744514338015591e-10
break O 0 1.6511251033080043e-08
repair O 0 0.0003926786012016237
and O 0 3.0553697349944287e-09
/ O 0 1.740775985581422e-07
or O 0 3.7913722161775354e-10
homologous O 0 3.3931253362595726e-09
recombination O 0 6.538411589929183e-09
. O 0 3.2525129256555374e-08

Dysfunction O 1 0.9998407363891602
of O 0 1.6861764379427768e-05
this O 0 9.56606349689082e-09
pathway O 0 4.218449145554359e-09
may O 0 1.5664032571027775e-11
be O 0 5.410103788572318e-12
a O 0 1.251193940121631e-11
general O 0 1.5842849254710245e-10
phenomenon O 0 6.087458315207073e-11
in O 0 4.248121765384333e-13
the O 0 1.6604445682993907e-12
majority O 0 8.933317952562747e-13
of O 0 1.4003109652729884e-12
cases O 0 1.7046716685800711e-12
of O 0 6.524281670472476e-10
hereditary B-Disease 1 0.9999998807907104
breast I-Disease 1 0.9999997615814209
and I-Disease 1 0.9780201315879822
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0002195577835664153
. O 0 2.3344546207226813e-07

A O 0 1.7851974121185776e-07
novel O 0 1.0105390968462302e-09
Arg362Ser O 0 1.9440358300926164e-06
mutation O 0 8.880492868845735e-11
in O 0 5.128449748204034e-12
the O 0 5.930901603168337e-11
sterol O 0 3.1863427452094584e-09
27 O 0 6.845965128121634e-09
- O 0 1.0466083999460807e-08
hydroxylase O 0 4.651692719903622e-08
gene O 0 3.6464051222928617e-10
( O 0 3.465665948665375e-11
CYP27 O 1 0.9999978542327881
) O 0 1.4697605979496764e-11
: O 0 1.608761816254342e-13
its O 0 1.4057292385249304e-13
effects O 0 7.890369781160533e-12
on O 0 2.0391558233634477e-11
pre O 0 1.2999482601472323e-09
- O 0 1.9420656749424836e-10
mRNA O 0 6.45698494672331e-10
splicing O 0 1.708639008057844e-09
and O 0 2.6697866140068527e-11
enzyme O 0 8.099904774683253e-11
activity O 0 3.45325767980853e-09
. O 0 2.971427193187992e-08

A O 0 1.341482942507355e-07
novel O 0 3.522534208766359e-10
C O 0 2.1325902821445197e-08
to O 0 6.509784378216921e-11
A O 0 1.59292434798175e-09
mutation O 0 1.0559548027644361e-11
in O 0 2.048338929028226e-12
the O 0 1.3638303160423693e-11
sterol O 0 2.54070342542434e-09
27 O 0 4.313893242624545e-09
- O 0 5.760352639327948e-09
hydroxylase O 0 2.1661033855480127e-08
gene O 0 1.1222570095448248e-10
( O 0 1.2958796362372293e-11
CYP27 O 0 0.0047208690084517
) O 0 5.454168800628212e-12
was O 0 5.4201147042798326e-11
identified O 0 9.823545622789087e-12
by O 0 5.510705823955075e-13
sequencing O 0 1.9805896922520105e-09
amplified O 0 4.205402692747384e-09
CYP27 O 0 4.783388249052223e-06
gene O 0 3.552632493741825e-11
products O 0 4.293638014574164e-11
from O 0 1.7406430463662304e-11
a O 0 2.7606096228427468e-11
patient O 0 1.5064005154385995e-08
with O 0 7.022104564491372e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.3959217781689404e-08
CTX B-Disease 0 0.00010850271792151034
) O 0 1.7013285225075947e-09
. O 0 3.8753533715407684e-08

The O 0 2.16091624594128e-08
mutation O 0 9.433571701578103e-10
changed O 0 1.225617385358646e-09
the O 0 1.7646926975256605e-10
adrenodoxin O 0 3.023267680646313e-08
cofactor O 0 1.815814054673126e-09
binding O 0 5.037643080463283e-10
residue O 0 1.3059511161372939e-07
362Arg O 0 3.339342669050893e-08
to O 0 1.2440658503365398e-09
362Ser O 0 6.679260877717752e-07
( O 0 8.601807599539768e-10
CGT O 0 3.61616753252747e-06
362Arg O 0 3.6478144238571986e-07
to O 0 7.831277848424634e-09
AGT O 1 0.991597592830658
362Ser O 0 4.455870339370449e-07
) O 0 6.210954060087426e-12
, O 0 6.166167836746395e-13
and O 0 6.442090242329834e-13
was O 0 2.558412648401287e-10
responsible O 0 1.4282640625751242e-09
for O 0 4.958011334821322e-09
deficiency O 0 0.04162001237273216
in O 0 7.095629639408685e-10
the O 0 2.64022070872727e-09
sterol O 0 1.542361971473838e-08
27 O 0 2.97461415499356e-08
- O 0 6.291540177727484e-09
hydroxylase O 0 1.2241437197246796e-08
activity O 0 1.041243757882171e-09
, O 0 2.7850102866239235e-12
as O 0 6.888388514106336e-13
confirmed O 0 1.546719696765564e-11
by O 0 2.1129491385718513e-12
expression O 0 4.133161868313806e-11
of O 0 8.744598101184664e-11
mutant O 0 8.119641764503527e-11
cDNA O 0 7.75804309682826e-09
into O 0 9.62488577727072e-09
COS O 0 3.5764474887400866e-05
- O 0 7.614138439748785e-07
1 O 0 1.1251064080397555e-08
cells O 0 1.986227360362136e-08
. O 0 2.167450574575014e-08

Quantitative O 0 1.131876246063257e-07
analysis O 0 2.074682203812017e-09
showed O 0 3.851019225731278e-10
that O 0 1.8554564351971892e-13
the O 0 1.5847337548127727e-12
expression O 0 2.6294032923201982e-11
of O 0 2.94573726522529e-10
CYP27 O 0 1.5225976994770463e-06
gene O 0 3.3446522461344497e-12
mRNA O 0 1.4899198541584724e-10
in O 0 7.834149128027601e-12
the O 0 4.502758929603168e-11
patient O 0 8.238994375631137e-09
represented O 0 4.55740251092962e-10
52 O 0 2.365771081258572e-07
. O 0 2.2328586624098534e-07

5 O 0 4.030552247513697e-08
% O 0 6.876168523461956e-09
of O 0 5.510462086633083e-10
the O 0 7.144082547760888e-10
normal O 0 5.117106525176496e-07
level O 0 4.769349288835656e-06
. O 0 1.286972803882236e-07

As O 0 2.3764719081498242e-09
the O 0 4.0629896669308607e-10
mutation O 0 6.328772228503254e-11
occurred O 0 1.1296387159021037e-09
at O 0 2.3015920766478182e-11
the O 0 3.878791818984206e-12
penultimate O 0 1.344769273714519e-08
nucleotide O 0 4.331429881432314e-09
of O 0 4.727218083644402e-08
exon O 0 1.0994459564983572e-08
6 O 0 4.203333681118693e-09
( O 0 6.288798648501626e-11
- O 0 5.644607448118677e-09
2 O 0 3.567974526941242e-10
position O 0 1.9737008472020534e-08
of O 0 2.7667391933050567e-08
exon O 0 1.4352832700126328e-08
6 O 0 1.495008383756158e-08
- O 0 5.986965589954707e-08
intron O 0 1.9357290881316658e-08
6 O 0 2.3461925735546174e-09
splice O 0 1.4337208753545383e-08
site O 0 1.2209736000023952e-10
) O 0 1.95607527571362e-12
of O 0 6.773457489339663e-11
the O 0 5.035682981713308e-10
gene O 0 9.988054133769353e-11
, O 0 1.9760934208412628e-11
we O 0 2.068687027234617e-10
hypothesized O 0 6.54266252286817e-10
that O 0 8.891551232272088e-13
the O 0 1.1337782795939333e-10
mutation O 0 4.143330400996348e-10
may O 0 9.267653311439972e-11
partially O 0 5.24490051390103e-09
affect O 0 1.8708903315456382e-09
the O 0 3.89079907181511e-10
normal O 0 3.2276570749445455e-08
splicing O 0 1.1586644532712853e-08
efficiency O 0 2.5809168135992877e-08
in O 0 4.3534842397718876e-10
exon O 0 5.3657376319904415e-09
6 O 0 6.443710565129379e-10
and O 0 2.3556425907123035e-11
cause O 0 8.997984302094864e-11
alternative O 0 7.30775440160869e-10
splicing O 0 4.363212458002863e-09
elsewhere O 0 3.0792141059166056e-10
, O 0 5.960164545064373e-13
which O 0 4.753060670200336e-14
resulted O 0 5.717372755786876e-11
in O 0 1.4576888307527014e-11
decreased O 0 3.292244477037798e-09
transcript O 0 1.7129112350744435e-08
in O 0 7.370589555355522e-11
the O 0 1.6555455895073123e-09
patient O 0 2.0799905087187653e-06
. O 0 3.4206013310722483e-07

Transfection O 0 0.00013875702279619873
of O 0 8.66020570811088e-07
constructed O 0 4.25732707753923e-07
minigenes O 0 1.1909769455087371e-05
, O 0 1.696394934247447e-11
with O 0 8.768405923217926e-13
or O 0 5.5509854525459534e-12
without O 0 6.341289993105903e-11
the O 0 6.886977099718194e-11
mutation O 0 3.009650167973277e-11
, O 0 2.231561506763069e-12
into O 0 2.981212832153801e-09
COS O 0 0.00037899796734564006
- O 0 1.5813785125828872e-07
1 O 0 4.794517560746669e-10
cells O 0 6.84092019143101e-11
confirmed O 0 1.4628749600564817e-11
that O 0 1.595687591662929e-14
the O 0 4.323546728968175e-13
mutant O 0 7.348116559668938e-11
minigene O 0 5.9485132375414196e-09
was O 0 2.0368440267759524e-10
responsible O 0 2.2670430810389774e-10
for O 0 4.8651898482132694e-11
a O 0 9.09178149433032e-11
mRNA O 0 3.839110807035695e-09
species O 0 1.6051175417020752e-13
alternatively O 0 6.736788904504465e-11
spliced O 0 1.4621128308078823e-08
at O 0 7.442672256274818e-09
an O 0 1.983885417056186e-10
activated O 0 1.2092411338926468e-07
cryptic O 0 3.617397581479054e-08
5 O 0 2.886405559010541e-09
splice O 0 9.147647972440609e-08
site O 0 3.55553053665858e-09
88 O 0 2.4041145962883093e-08
bp O 0 6.102614946712492e-08
upstream O 0 2.1286036044898538e-08
from O 0 1.9143333584992206e-09
the O 0 3.119234870396781e-09
3 O 0 6.128600738009027e-09
end O 0 1.5160948407810793e-07
of O 0 1.4607698517465906e-07
exon O 0 2.405372185876331e-07
6 O 0 1.8346513286360278e-07
. O 0 1.0385551263425441e-07

Our O 0 6.872807603031106e-07
data O 0 1.5491902871644925e-08
suggest O 0 1.5708410960879604e-10
that O 0 1.8886915685925598e-13
the O 0 6.019862993505987e-12
C O 0 1.1192626825362595e-09
to O 0 2.5415926308003378e-11
A O 0 2.844302349203076e-09
mutation O 0 7.088158532342348e-11
at O 0 5.877658082464876e-11
the O 0 3.335251172464915e-11
penultimate O 0 2.1421215024020057e-08
nucleotide O 0 1.0064711730706222e-08
of O 0 1.5691208332668793e-08
exon O 0 1.112529002256224e-08
6 O 0 9.235048836764292e-10
of O 0 5.01603147906593e-10
the O 0 7.767484988541185e-10
CYP27 O 0 0.3242761790752411
gene O 0 9.718513493961467e-11
not O 0 1.3276104174342329e-11
only O 0 3.551460514561455e-11
causes O 0 6.064885260670394e-10
the O 0 1.8590168293641796e-09
deficiency B-Disease 0 2.1929083970917418e-07
in I-Disease 0 6.875545965900898e-11
the I-Disease 0 1.05470787659101e-09
sterol I-Disease 0 2.4602911707916064e-08
27 I-Disease 0 3.007692583878452e-08
- I-Disease 0 1.1653689568902337e-08
hydroxylase I-Disease 0 2.4780792529099926e-08
activity I-Disease 0 1.1806041699813363e-09
, O 0 9.135948074445732e-12
but O 0 1.03665522346863e-11
also O 0 4.525710969177643e-12
partially O 0 1.251851844408236e-09
leads O 0 7.0216020497948506e-12
to O 0 5.77084604061473e-12
alternative O 0 4.728033520251529e-10
pre O 0 1.3028556899996602e-08
- O 0 1.033065855082782e-09
mRNA O 0 4.415192211837393e-09
splicing O 0 6.3119980353576466e-09
of O 0 7.857576811431954e-10
the O 0 1.4388978897272864e-09
gene O 0 1.5009991027881142e-09
. O 0 2.7686448689223653e-08

To O 0 4.9365656451527684e-08
our O 0 9.312567073038736e-08
knowledge O 0 1.1829374670924153e-06
, O 0 3.633973547426117e-12
this O 0 2.384517279810372e-13
is O 0 5.138901795959973e-14
the O 0 5.368859653728797e-13
first O 0 5.013300538592169e-12
report O 0 3.821673012771587e-12
regarding O 0 4.5558706113224545e-11
effects O 0 9.905506970220301e-11
on O 0 8.778806848130927e-11
pre O 0 2.7154916093508064e-09
- O 0 1.731683130223871e-10
mRNA O 0 7.742945173916382e-10
splicing O 0 1.061968846194361e-09
of O 0 1.4274136039826857e-10
a O 0 1.1035074763687813e-11
mutation O 0 7.66859752782123e-12
at O 0 1.865188697935949e-10
the O 0 1.1750685979805553e-09
- O 0 1.079996092556712e-08
2 O 0 4.011673493398149e-10
position O 0 8.344942514781906e-09
of O 0 1.8593111494880077e-09
a O 0 7.263689649761318e-10
5 O 0 1.174603170284172e-08
splice O 0 1.4869169717712793e-07
site O 0 7.177576311079292e-09
. O 0 3.0483860768981685e-08

ATM O 0 0.00046031249803490937
germline O 0 2.337504156457726e-05
mutations O 0 3.789508706830702e-09
in O 0 5.173619310738786e-10
classical O 0 0.04070345312356949
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9995260238647461
in O 0 2.795156328616599e-10
the O 0 2.586773850676849e-10
Dutch O 0 9.8579828744505e-09
population O 0 7.1063489294476145e-12
. O 0 3.0372454551397254e-10

Germline O 0 0.0001414206635672599
mutations O 0 7.031422999403958e-09
in O 0 1.2038291197224993e-10
the O 0 7.854715211585983e-10
ATM O 0 4.6939389903855044e-06
gene O 0 1.3904085348348527e-11
are O 0 2.1623578849803288e-13
responsible O 0 2.2718628193973966e-12
for O 0 2.656502188363996e-12
the O 0 5.143457570966348e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.01157340221107006
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.534730534468736e-10
. O 0 1.0962840413242247e-08

In O 0 5.9375661720650896e-08
our O 0 5.486943521759713e-08
study O 0 2.393132081390803e-10
, O 0 1.273966934549342e-12
we O 0 7.181807232248261e-13
have O 0 4.933641995917733e-14
determined O 0 8.925880000398845e-12
the O 0 3.200976983475101e-11
ATM O 0 5.063981802777562e-07
mutation O 0 1.5592439839284822e-10
spectrum O 0 8.518523664236e-10
in O 0 1.0425145989534368e-11
19 O 0 9.715047516456465e-11
classical O 0 6.594486023914214e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.6662052360061352e-07
, O 0 1.4942042828730573e-12
including O 0 6.862240810312503e-13
some O 0 1.7579476286125328e-13
immigrant O 0 2.2544034347649067e-11
populations O 0 1.4913569511276759e-12
, O 0 1.95447052097307e-13
as O 0 1.6248725455414448e-12
well O 0 3.819503394120183e-11
as O 0 1.414191073273452e-11
12 O 0 6.430916354993599e-10
of O 0 2.1803561733868548e-10
Dutch O 0 1.2547520356065434e-08
ethnic O 0 6.557504539372871e-10
origin O 0 1.52042058942925e-08
. O 0 7.279535196857978e-08

Both O 0 4.781643081486209e-09
the O 0 6.77797151737991e-10
protein O 0 2.668300129460288e-11
truncation O 0 2.1653008275279717e-09
test O 0 9.851662818860518e-10
( O 0 9.551650442807258e-11
PTT O 0 1.0717866416598554e-06
) O 0 1.5303064804933486e-12
and O 0 8.146797039060294e-13
the O 0 3.0560877179591772e-12
restriction O 0 1.3516142415362364e-12
endonuclease O 0 9.020954989946706e-12
fingerprinting O 0 8.551309660376205e-10
( O 0 2.5627286751039868e-11
REF O 0 2.0790089649835863e-08
) O 0 1.678427904473756e-13
method O 0 6.027103816030888e-11
were O 0 4.336757689071824e-11
used O 0 1.2097533044763686e-11
and O 0 5.474523612214455e-12
compared O 0 3.008142623883714e-10
for O 0 2.861460200731525e-12
their O 0 2.495230758126077e-11
detection O 0 2.7799726964872207e-09
efficiency O 0 8.756185776448433e-10
, O 0 4.0033433382560824e-13
identifying O 0 7.71836136670423e-11
76 O 0 2.0239954157119655e-09
% O 0 1.640948210646087e-10
and O 0 1.1862226695705247e-12
60 O 0 3.9501635296090853e-10
% O 0 1.2165730922664153e-10
of O 0 1.8190291287134563e-11
the O 0 8.770371234811947e-11
mutations O 0 8.260732375919844e-11
, O 0 1.3677534799194646e-11
respectively O 0 1.6193746787962482e-08
. O 0 9.936573519553349e-08

Most O 0 8.979922583307598e-09
patients O 0 3.753255040095382e-09
were O 0 6.781721295645582e-10
found O 0 4.7191747037933496e-11
to O 0 3.058287650903324e-11
be O 0 1.5106198236747304e-10
compound O 0 4.7805329472794256e-08
heterozygote O 0 2.273741529279505e-06
. O 0 2.4536606701985875e-07

Seventeen O 0 1.2285245247767307e-06
mutations O 0 2.006272925569874e-09
were O 0 2.9458496753065333e-10
distinct O 0 2.6232618507981975e-11
, O 0 1.7074115558901592e-12
of O 0 1.9147659152674024e-11
which O 0 2.60130621470428e-13
10 O 0 1.459012771709567e-11
were O 0 2.70146838926566e-11
not O 0 1.4055832019133074e-11
reported O 0 1.5914181084042411e-09
previously O 0 4.604079961723073e-08
. O 0 1.765164938660746e-07

Mutations O 0 7.02127294971433e-07
are O 0 7.446814831446602e-10
small O 0 7.157175963001805e-10
deletions O 0 2.769389517709442e-08
or O 0 1.1436136482245729e-08
point O 0 1.0330091981813894e-06
mutations O 0 3.23146380765138e-08
frequently O 0 4.393979402550485e-09
affecting O 0 4.725414726181043e-08
splice O 0 6.011516120452143e-07
sites O 0 5.425822280358261e-08
. O 0 9.146967272499751e-08

Moreover O 0 2.518823748687282e-06
, O 0 7.369173604665491e-10
a O 0 1.2965409856846577e-09
16 O 0 6.683963960085748e-08
. O 0 8.564474285321921e-08

7 O 0 2.987048617342225e-07
- O 0 5.5016354139070245e-08
kb O 0 7.633821752506265e-08
genomic O 0 2.0841615100408717e-09
deletion O 0 1.6426149329618056e-09
of O 0 7.574209703875567e-09
the O 0 2.0975610137696776e-09
3 O 0 5.712906814281382e-10
end O 0 6.289332610265319e-09
of O 0 2.7700469695801644e-10
the O 0 5.584919679502143e-11
gene O 0 1.692645849871166e-11
, O 0 2.254531413989347e-12
most O 0 1.5466304452427249e-12
likely O 0 5.5848981689310406e-11
a O 0 1.475893018909602e-11
result O 0 1.4189613928294875e-09
of O 0 2.5128186198486446e-09
recombination O 0 4.2895551000121657e-10
between O 0 3.5847413926148874e-10
two O 0 5.1265353073759456e-11
LINE O 0 8.430873776887893e-08
elements O 0 1.8366402843028595e-09
, O 0 1.7899808371635295e-11
was O 0 5.834657756942363e-10
identified O 0 8.870463474863755e-09
. O 0 3.018703864654526e-08

The O 0 8.308163756964859e-08
most O 0 4.2948519740626523e-10
frequently O 0 3.093306444323929e-10
found O 0 4.430726965876097e-11
mutation O 0 1.9022073846630683e-11
, O 0 6.165626819862324e-13
identified O 0 1.2459150378063555e-10
in O 0 7.895774312149939e-12
three O 0 3.542095870084916e-12
unrelated O 0 1.07582970310105e-10
Turkish O 0 6.971690709178802e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 2.8032407506373147e-09
, O 0 1.358702386711208e-11
was O 0 5.083840015629448e-10
previously O 0 1.1437237268374645e-10
described O 0 3.3619274898699647e-12
to O 0 8.62630821808763e-13
be O 0 9.006319995341627e-13
a O 0 2.1524175670972756e-12
Turkish O 0 1.9947589180446812e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 1.6057292668847367e-05
mutation O 0 1.2245996572346485e-07
. O 0 2.3939289661711882e-08

The O 0 1.512082903332157e-08
presence O 0 5.234454536484634e-10
of O 0 3.68586605681287e-09
a O 0 2.0882997553428595e-09
founder O 0 6.040393429884716e-08
mutation O 0 1.6708356920247525e-09
among O 0 1.4118248237160458e-11
relatively O 0 5.6181146540490445e-11
small O 0 3.445382271583669e-13
ethnic O 0 1.0708584192997694e-11
population O 0 6.018712004479676e-13
groups O 0 1.307998983646544e-13
in O 0 5.3213536008178686e-12
Western O 0 1.4381598134605156e-09
Europe O 0 8.551586661020849e-10
could O 0 7.542658164716443e-11
indicate O 0 1.7001769991864535e-09
a O 0 2.7003146246817877e-11
high O 0 1.0957895701935172e-10
carrier O 0 5.982756651201626e-11
frequency O 0 3.5075651272364894e-09
in O 0 4.751127963276147e-11
such O 0 7.911907934365914e-11
communities O 0 3.3472355998043213e-09
. O 0 4.199745617938788e-08

In O 0 1.006175676110388e-08
patients O 0 3.5406961806927484e-09
of O 0 1.507095115371726e-09
Dutch O 0 3.0685292529142316e-08
ethnic O 0 3.1417796142463317e-10
origin O 0 2.853326186436078e-10
, O 0 1.2641010200403757e-12
however O 0 1.3006314775187988e-11
, O 0 5.097717495523846e-13
no O 0 7.527086050805598e-13
significant O 0 2.2645050765102148e-11
founder O 0 1.3707478485613933e-09
effect O 0 1.0548079770744678e-10
could O 0 4.887642374162837e-11
be O 0 4.872166003977441e-10
identified O 0 1.3826281985984679e-07
. O 0 3.2681529660294473e-07

The O 0 2.6132779495924296e-08
observed O 0 4.224947502962095e-09
genetic O 0 5.77707381932413e-10
heterogeneity O 0 5.495850996517504e-10
including O 0 6.468788178726204e-12
the O 0 1.4947987292401876e-10
relative O 0 1.6269410707536736e-08
high O 0 1.9045327537270396e-09
percentage O 0 8.978342513898951e-10
of O 0 3.105466717112648e-10
splice O 0 1.1096641827634812e-07
- O 0 4.420846355657204e-09
site O 0 1.112642977751932e-09
mutations O 0 1.0278378148598222e-09
had O 0 9.389461430586721e-11
no O 0 4.968798983373546e-11
reflection O 0 2.094091344773119e-09
on O 0 1.5993846247397414e-09
the O 0 1.0564398245094253e-08
phenotype O 0 4.588340232203336e-07
. O 0 2.116783974770442e-07

All O 0 2.0292911795394275e-09
patients O 0 2.7147240011515805e-10
manifested O 0 4.304404055410771e-11
classical O 0 1.0119996396440456e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 0.9999997615814209
and O 0 1.7577593547368764e-10
increased O 0 7.124976719730114e-10
cellular O 0 1.0173969444693398e-09
radioresistant O 0 6.076119607456576e-09
DNA O 0 5.010375758729424e-08
synthesis O 0 1.440248666995103e-07
. O 0 5.25938901319023e-08

Determination O 0 2.009737954722368e-06
of O 0 4.9156692938367996e-08
the O 0 9.88850445970968e-10
genomic O 0 5.393606006265372e-09
structure O 0 3.1107311171396645e-10
of O 0 1.6651496848041347e-10
the O 0 2.987643465957035e-10
COL4A4 O 0 0.004314085468649864
gene O 0 2.374498341006781e-11
and O 0 4.420831322543561e-12
of O 0 1.0611685835604234e-10
novel O 0 4.968754296896805e-10
mutations O 0 5.3651778131325045e-08
causing O 0 9.603487569620484e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.352160415990511e-05

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.888176726083657e-09
a O 0 1.5414796550317078e-08
progressive O 1 0.9999997615814209
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 5.116089596413076e-06
by O 0 8.298325582245525e-09
glomerular B-Disease 1 0.7785115838050842
basement I-Disease 1 0.999859094619751
membrane I-Disease 0 3.5605789889814332e-06
abnormalities I-Disease 0 0.00025559033383615315
and O 0 6.098917204599985e-11
associated O 0 8.204072088346948e-09
with O 0 7.453816730507157e-11
mutations O 0 4.467175240829846e-10
in O 0 2.7993697637729298e-11
either O 0 8.433825304798859e-10
the O 0 5.865523622361479e-09
COL4A3 O 1 0.9999680519104004
or O 0 1.905123975243228e-10
the O 0 1.0857000853903287e-09
COL4A4 O 0 0.0007103286916390061
gene O 0 2.8641262972417536e-11
, O 0 5.062099827854438e-13
which O 0 2.116871876899594e-14
encode O 0 3.0717161453308606e-11
the O 0 2.340202753803311e-10
alpha3 O 0 1.6981884982669726e-06
and O 0 9.719242077821377e-10
alpha4 O 0 1.2250882718944922e-05
type O 0 1.271180281037232e-06
IV O 1 0.9999830722808838
collagen O 0 0.00039794135955162346
chains O 0 1.3726301517635875e-07
, O 0 5.633010724537257e-10
respectively O 0 1.3284765998378134e-07
. O 0 1.088027019591209e-07

To O 0 4.075067838726909e-09
date O 0 3.6978036632717703e-08
, O 0 2.0733114877713454e-11
mutation O 0 2.1861130527350836e-12
screening O 0 1.6783689021915293e-11
in O 0 5.136212202078161e-12
the O 0 6.402237767710872e-11
two O 0 5.6935622883003134e-11
genes O 0 7.501396032116858e-11
has O 0 3.043585349027378e-13
been O 0 5.5105928500887025e-12
hampered O 0 2.4540391052596533e-08
by O 0 4.748761280037872e-12
the O 0 1.0001780653690062e-10
lack O 0 2.4771846796056707e-09
of O 0 2.463181048018015e-10
genomic O 0 7.891901354639685e-09
structure O 0 1.9910360027353136e-09
information O 0 5.796049418194116e-09
. O 0 1.1671707156324373e-08

We O 0 2.5637886480467387e-08
report O 0 6.566165389187972e-10
here O 0 1.276514866033196e-10
the O 0 5.346972430791963e-12
complete O 0 5.856934937042979e-10
characterization O 0 7.423104353421195e-10
of O 0 1.4482780252844663e-10
the O 0 1.2081904920968611e-10
48 O 0 1.5798839569924894e-08
exons O 0 7.79924302918289e-09
of O 0 1.3959336464530736e-10
the O 0 5.543701053767336e-10
COL4A4 O 0 0.003483632579445839
gene O 0 1.0164460245709606e-10
, O 0 1.5920653467435542e-12
a O 0 2.299133973482359e-12
comprehensive O 0 3.3010960631685293e-10
gene O 0 1.0004293400645015e-11
screen O 0 2.3074613053619686e-10
, O 0 6.017888878190325e-12
and O 0 4.2818019095614e-12
the O 0 3.854015023785351e-11
subsequent O 0 1.0143491602221388e-09
detection O 0 4.436974521127013e-08
of O 0 8.477430563091914e-11
10 O 0 1.8836642315389618e-11
novel O 0 1.6239213749755232e-12
mutations O 0 2.3738090486336016e-12
in O 0 4.3632035918311773e-13
eight O 0 1.0350535012415563e-10
patients O 0 1.8619621400262076e-09
diagnosed O 0 7.875166261328559e-07
with O 0 5.336730612981455e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 3.474239565548487e-05

Furthermore O 0 2.444682252189523e-07
, O 0 1.467212462635814e-10
we O 0 4.352668225848788e-11
identified O 0 1.2356912715283386e-10
a O 0 1.3493610742654205e-11
glycine O 0 1.9010477914083168e-10
to O 0 2.2362464657810222e-10
alanine O 0 1.485581768712052e-09
substitution O 0 4.2622363416455755e-09
in O 0 1.566487772830527e-10
the O 0 9.891240049242356e-10
collagenous O 0 7.975097560120048e-07
domain O 0 7.838372173551988e-10
that O 0 3.321858304920766e-13
is O 0 3.7290220282308606e-13
apparently O 0 6.462886892322217e-10
silent O 0 8.062854273127584e-10
in O 0 4.9761774562062655e-11
the O 0 3.906578671664107e-10
heterozygous O 0 5.218823151409424e-10
carriers O 0 2.1002572944683884e-11
, O 0 1.0560716363905431e-11
in O 0 1.7063063462163797e-10
11 O 0 4.441911372055074e-08
. O 0 1.6821361725760653e-07

5 O 0 9.812417545163044e-09
% O 0 2.4428576939072855e-09
of O 0 7.537279828051524e-11
all O 0 1.0995324442597543e-11
control O 0 4.56234244827769e-10
individuals O 0 4.024621347992197e-12
, O 0 4.1297217381885964e-13
and O 0 5.785048004872118e-13
in O 0 1.768090448356352e-12
one O 0 2.0450169335717305e-12
control O 0 3.5527410874314214e-11
individual O 0 3.340323460540584e-12
homozygous O 0 2.1864643776070558e-11
for O 0 3.960019378385082e-12
this O 0 4.961875701980922e-11
glycine O 0 1.527646986687614e-08
substitution O 0 1.0036727360329678e-07
. O 0 2.8005442231915367e-07

There O 0 1.0348117029934656e-08
has O 0 1.7407351601828047e-12
been O 0 1.6460278235916337e-12
no O 0 5.858981919418249e-13
previous O 0 4.606190082134809e-11
finding O 0 1.73785069668142e-10
of O 0 7.489044107078513e-11
a O 0 1.4158698519173285e-11
glycine O 0 1.905818280967253e-10
substitution O 0 6.550929243509529e-10
that O 0 1.0917329323553715e-12
is O 0 1.8545364896538352e-13
not O 0 3.7127199643653686e-13
associated O 0 4.739181616586485e-11
with O 0 2.2029563503250804e-12
any O 0 1.321814879773342e-10
obvious O 0 9.699208547431226e-09
phenotype O 0 1.8881622931843367e-09
in O 0 7.925259754015812e-11
homozygous O 0 4.120014107655834e-09
individuals O 0 1.0668718131157107e-09
. O 0 1.6249602197149215e-07

Founder O 0 0.00014204802573658526
BRCA1 O 0 1.8808058257491211e-06
and O 0 6.151238185481134e-09
BRCA2 O 0 5.413727421910153e-08
mutations O 0 7.349770098086239e-11
in O 0 2.508290797287316e-11
French O 0 1.6172203132214236e-08
Canadian O 0 0.05520862340927124
breast B-Disease 1 1.0
and I-Disease 1 0.999993085861206
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.2778894144012156e-08
. O 0 3.484900190642293e-08

We O 0 1.6848503037181217e-08
have O 0 1.757144950376155e-11
identified O 0 6.543707936623733e-11
four O 0 3.476767268181802e-12
mutations O 0 1.0030541935240889e-12
in O 0 1.1795011039920922e-13
each O 0 7.493722981553874e-13
of O 0 7.347223385245627e-10
the O 0 1.152060491449447e-07
breast B-Disease 1 0.8210005164146423
cancer I-Disease 1 0.8052573800086975
- O 0 1.7328602552879602e-05
susceptibility O 0 1.9081552338207075e-08
genes O 0 6.970993782218216e-10
, O 0 5.380736134430464e-11
BRCA1 O 0 6.558867893247111e-10
and O 0 6.842329480782894e-11
BRCA2 O 0 5.036854822115799e-10
, O 0 9.696563213826281e-13
in O 0 4.716778616992157e-12
French O 0 4.002366438271565e-09
Canadian O 0 5.416675890046463e-07
breast B-Disease 0 2.888976723625092e-06
cancer I-Disease 0 4.224001258990029e-06
and O 0 1.0693026979424758e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 9.224019237308312e-08
from O 0 2.3728722098326216e-08
Quebec O 0 5.694520837096206e-07
. O 0 4.3788048742499086e-08

To O 0 1.5233966621508443e-07
identify O 0 1.1472423011582578e-06
founder O 0 7.919021527413861e-07
effects O 0 8.658157639729325e-07
, O 0 4.167724498849168e-11
we O 0 1.7346242497939812e-11
examined O 0 2.8300253807067577e-10
independently O 0 2.0566952307898845e-10
ascertained O 0 1.2526494286291268e-09
French O 0 4.80020911908241e-10
Canadian O 0 5.857161422540003e-09
cancer B-Disease 0 2.330528880989391e-09
families O 0 4.562843158861796e-12
for O 0 5.449455448523766e-13
the O 0 8.563885711687647e-12
distribution O 0 1.5457354840542337e-10
of O 0 2.924808312210203e-11
these O 0 1.0170369754702868e-11
eight O 0 1.106001290551717e-09
mutations O 0 1.5870470493339894e-09
. O 0 1.430685969694423e-08

Mutations O 0 8.226122361065791e-08
were O 0 4.399320907566562e-09
found O 0 6.813924424697859e-11
in O 0 1.722964826367246e-11
41 O 0 3.231684031490545e-09
of O 0 1.0774195979834644e-09
97 O 0 3.622569693106925e-07
families O 0 5.094130894889304e-09
. O 0 6.815637476620395e-08

Six O 0 1.1093446516952099e-07
of O 0 2.3588193620582842e-09
eight O 0 1.6465452334912811e-09
mutations O 0 6.197348884073861e-11
were O 0 3.81794457160467e-11
observed O 0 3.487601527019102e-11
at O 0 2.453035274907478e-10
least O 0 1.8303585036516523e-10
twice O 0 1.6340193198516317e-08
. O 0 7.855546613200204e-08

The O 0 3.3658744769127225e-07
BRCA1 O 0 4.0771462295197125e-07
C4446T O 0 1.6744868389650946e-06
mutation O 0 7.26537996431631e-10
was O 0 8.172598153777244e-10
the O 0 7.871118340441186e-11
most O 0 5.867260236686045e-12
common O 0 5.580968673313258e-11
mutation O 0 6.541311936558714e-11
found O 0 2.2218324402523137e-11
, O 0 1.1955217631837156e-12
followed O 0 4.938827818934399e-11
by O 0 2.420135446212779e-11
the O 0 5.5216275995917385e-09
BRCA2 O 0 1.423951232482068e-07
8765delAG O 0 6.490366217803967e-07
mutation O 0 2.9791054956262997e-08
. O 0 6.018336762281251e-08

Together O 0 7.224386422421958e-08
, O 0 4.8612475156417645e-11
these O 0 8.852365021572162e-12
mutations O 0 3.040890456107448e-11
were O 0 5.605238495576259e-11
found O 0 2.43761803277176e-12
in O 0 1.56053382022181e-12
28 O 0 3.1558089474970075e-10
of O 0 1.0042458531422938e-10
41 O 0 3.15168424691592e-09
families O 0 4.385501684023296e-11
identified O 0 6.29312157940376e-10
to O 0 1.0121453675182579e-10
have O 0 3.929549394210419e-11
a O 0 1.0084498791584906e-09
mutation O 0 3.4081033106758696e-08
. O 0 1.2840219199006242e-07

The O 0 4.4005570742911004e-08
odds O 0 1.3551579058912466e-07
of O 0 5.545753301028356e-10
detection O 0 2.1110504633270466e-07
of O 0 1.871697019595331e-09
any O 0 1.063263366241074e-10
of O 0 5.47732859068617e-10
the O 0 1.9699417097562844e-10
four O 0 1.452255676825942e-10
BRCA1 O 0 5.058903296273343e-10
mutations O 0 1.4823621496962147e-11
was O 0 2.3073953858698815e-10
18 O 0 8.775066007160603e-09
. O 0 5.206867115248315e-08

7x O 0 0.0006671653827652335
greater O 0 1.2310350427924277e-07
if O 0 1.5702457112354296e-09
one O 0 1.775462693531793e-10
or O 0 1.4309457264938263e-11
more O 0 3.6673664322375843e-13
cases O 0 2.3246132449528112e-11
of O 0 7.191590611910215e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 4.041383405706256e-08
also O 0 1.313179166101408e-12
present O 0 1.827960699474218e-11
in O 0 2.1819815052004365e-11
the O 0 8.473668433595094e-10
family O 0 3.619825106326857e-09
. O 0 1.355280687675986e-07

The O 0 1.0257549831749202e-07
odds O 0 8.885476177056262e-07
of O 0 3.7595455637529085e-09
detection O 0 2.8516160455183126e-07
of O 0 1.8801626922027026e-09
any O 0 1.6479834163973806e-10
of O 0 1.123495407817643e-09
the O 0 2.768515139361938e-10
four O 0 3.1305874559350855e-10
BRCA2 O 0 1.7129855311992515e-09
mutations O 0 4.4594685583154714e-11
was O 0 9.124585531594676e-10
5 O 0 9.067908202098351e-09
. O 0 3.7358155680067284e-08

3x O 0 0.0001602649863343686
greater O 0 1.3228653727992423e-08
if O 0 1.557252660155939e-10
there O 0 3.6559161947780083e-11
were O 0 3.9062340168039e-11
at O 0 1.351584035663711e-11
least O 0 3.785687041624186e-13
five O 0 8.60126965311625e-13
cases O 0 1.1632147068479926e-12
of O 0 7.629433196321145e-10
breast B-Disease 0 1.0684203743949183e-07
cancer I-Disease 0 4.288218136139221e-08
in O 0 8.055075495505548e-10
the O 0 5.025507476830171e-08
family O 0 4.956274324285914e-08
. O 0 5.479590186041605e-07

Interestingly O 0 1.348712714843714e-07
, O 0 2.4014805768968195e-11
the O 0 1.8523396358438582e-11
presence O 0 1.4764757125251826e-11
of O 0 4.683490928414358e-09
a O 0 1.3212356009262294e-07
breast B-Disease 0 0.007818270474672318
cancer I-Disease 0 1.0298319921275834e-06
case O 0 4.1459630173434903e-10
< O 0 3.5713123569536265e-09
36 O 0 4.810630227503054e-10
years O 0 2.0552785168215237e-11
of O 0 1.115355204028834e-11
age O 0 2.0331646088944666e-10
was O 0 1.0981407623511519e-11
strongly O 0 4.78955633834155e-13
predictive O 0 1.7123705231547603e-10
of O 0 5.166200800488241e-11
the O 0 3.3622372247466004e-11
presence O 0 1.7051537265500016e-11
of O 0 9.590552657590123e-11
any O 0 6.887187348203483e-11
of O 0 6.580784805976236e-10
the O 0 3.3809718913424547e-10
eight O 0 2.331458137661002e-09
mutations O 0 2.3877658184012773e-10
screened O 0 1.3637874163308084e-09
. O 0 8.007837060119982e-09

Carriers O 0 4.24252721842322e-09
of O 0 3.1034670389118446e-09
the O 0 1.895461010370525e-10
same O 0 1.6361133281517226e-10
mutation O 0 2.023761713765282e-11
, O 0 1.7504427811745882e-13
from O 0 1.3003480670709111e-12
different O 0 6.463645157300801e-12
families O 0 1.7438397947877604e-11
, O 0 7.986938476041427e-13
shared O 0 4.140468176649925e-11
similar O 0 1.1620510977083942e-11
haplotypes O 0 7.182228700663984e-10
, O 0 4.509434492483422e-12
indicating O 0 3.949335025676959e-10
that O 0 4.970177372963513e-13
the O 0 1.1112336745222606e-11
mutant O 0 2.7876582986419152e-11
alleles O 0 4.11900982072444e-12
were O 0 5.958000065531266e-11
likely O 0 2.966213039079513e-11
to O 0 4.382338675973374e-12
be O 0 2.4156837554606403e-12
identical O 0 3.5925016433902e-11
by O 0 2.016028403245551e-12
descent O 0 8.452638589062644e-09
for O 0 3.477538049190265e-11
a O 0 4.720146842829287e-11
mutation O 0 6.395464019481878e-11
in O 0 1.1646561319522686e-11
the O 0 7.303198046315629e-10
founder O 0 5.2907200398522036e-08
population O 0 1.2170209284789735e-10
. O 0 6.160678633904126e-09

The O 0 1.2699440388175276e-09
identification O 0 5.8591311358213716e-08
of O 0 7.001859536615029e-09
common O 0 8.608345147820273e-09
BRCA1 O 0 4.324687452594844e-08
and O 0 1.7049344158692747e-09
BRCA2 O 0 7.474881158486824e-09
mutations O 0 1.0848336985669338e-11
will O 0 3.4410232909592997e-12
facilitate O 0 9.699278047392568e-10
carrier O 0 7.084401121293382e-11
detection O 0 6.135738317425421e-08
in O 0 1.5369158723466114e-10
French O 0 3.8332299112653345e-08
Canadian O 0 6.986297375988215e-05
breast B-Disease 0 0.30458641052246094
cancer I-Disease 0 0.05401971936225891
and O 0 0.0002549327618908137
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.965873306948197e-07
. O 0 1.0641414149858974e-07

Are O 0 1.2549363326286311e-08
Dp71 O 0 0.00010368470248067752
and O 0 1.4244071699920369e-08
Dp140 O 0 0.0009998292662203312
brain O 0 0.00024795005447231233
dystrophin O 0 3.2756605605754885e-07
isoforms O 0 8.102663429099266e-09
related O 0 2.152765743446139e-09
to O 0 3.0098126768685063e-10
cognitive B-Disease 0 0.000818006054032594
impairment I-Disease 0 0.4559989869594574
in O 0 1.6262349163298495e-05
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9998916387557983

Molecular O 0 6.162231613870972e-08
study O 0 2.2789828357794306e-10
and O 0 3.36747231662049e-12
neuropsychological O 0 7.463238360649882e-10
analysis O 0 3.295105507894469e-11
were O 0 5.036369758737447e-12
performed O 0 1.737591320827292e-11
concurrently O 0 9.842247850055941e-11
on O 0 7.003785138653962e-12
49 O 0 1.3491997796766242e-10
patients O 0 4.2943339856327256e-11
with O 0 1.3198497850197555e-10
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.43695640563964844
DMD B-Disease 1 1.0
) O 0 1.5789394791632105e-10
in O 0 3.448921053264553e-12
order O 0 1.3841948420800776e-12
to O 0 5.5188922008786445e-12
find O 0 3.0169842318850115e-11
a O 0 2.4655004600415698e-12
molecular O 0 4.615996473944506e-11
explanation O 0 3.661080119621296e-11
for O 0 4.716319782632761e-12
the O 0 3.118602598384257e-10
cognitive B-Disease 0 3.1635859158996027e-06
impairment I-Disease 0 9.117495380905893e-08
observed O 0 1.4542349269230925e-10
in O 0 9.561220565279527e-11
most O 0 1.2494377754634911e-09
DMD B-Disease 1 1.0
patients O 0 3.6521416291179776e-07
. O 0 4.135667808213839e-08

Complete O 0 2.1068162325832418e-08
analysis O 0 6.607662750290899e-10
of O 0 1.7474433011699375e-10
the O 0 7.667533968858109e-11
dystrophin O 0 5.017124937722883e-09
gene O 0 1.7225311454982517e-11
was O 0 8.481457897113742e-11
performed O 0 3.750333377183779e-10
to O 0 4.845907702888397e-11
define O 0 1.9743136014938045e-09
the O 0 1.5575148948343553e-09
localization O 0 4.176260335952975e-05
of O 0 1.8997303286028e-08
deletions O 0 6.5829346418411205e-09
and O 0 3.6837205508177817e-10
duplications O 0 8.951180063831998e-08
in O 0 5.880797238067004e-11
relation O 0 1.3388055108976005e-09
to O 0 1.338192195943222e-10
the O 0 1.1393566090589502e-09
different O 0 2.8128614104616645e-08
DMD B-Disease 1 1.0
promoters O 0 4.901873126073042e-06
. O 0 2.1809184147514316e-07

Qualitative O 0 4.0473008766639396e-07
analysis O 0 3.741347232022463e-09
of O 0 3.43788597589878e-09
the O 0 2.9397106970918685e-09
Dp71 O 0 1.1912450645468198e-05
transcript O 0 9.38420718910038e-09
and O 0 6.276688695704136e-13
testing O 0 3.5771700272052565e-12
for O 0 1.9603021734083265e-13
the O 0 1.8848169552887484e-12
specific O 0 7.342102620322422e-12
first O 0 1.690027284784179e-10
exon O 0 4.01114785830714e-09
of O 0 1.5993053548157832e-09
Dp140 O 0 1.8065520634991117e-06
were O 0 2.3580453145655156e-09
also O 0 1.2317984306176033e-11
carried O 0 7.895781806155355e-10
out O 0 6.910336192156308e-10
. O 0 3.760042233125205e-08

Neuropsychological O 0 4.404576884553535e-06
analysis O 0 3.198179054919592e-09
assessed O 0 6.1153713204475935e-09
verbal O 0 2.1430041741155037e-08
and O 0 1.3940930632116988e-09
visuospatial O 1 0.9787771701812744
intelligence O 0 1.2287190429560724e-06
, O 0 3.885931854075153e-11
verbal O 0 3.241019186361882e-08
memory O 0 0.23918630182743073
, O 0 6.73736691436666e-11
and O 0 3.95061379443451e-11
reading O 0 1.806849780905395e-08
skills O 0 7.2807538344932254e-06
. O 0 8.173992682714015e-08

Comparison O 0 3.0215991841942014e-07
of O 0 2.7981409189692386e-08
molecular O 0 1.377429015292364e-08
and O 0 6.695786702870521e-10
psychometric O 0 6.459774937184193e-08
findings O 0 1.189169429594017e-09
demonstrated O 0 8.939212148284525e-10
that O 0 9.231130616849104e-12
deletions O 0 2.0329939121044305e-10
and O 0 2.4194108522168634e-11
duplications O 0 2.168753177045346e-08
that O 0 6.22882041084738e-12
were O 0 2.880019556172897e-10
localized O 0 3.4494331835333014e-09
in O 0 2.1297373586914858e-11
the O 0 2.947175836709448e-10
distal O 0 1.289261319925572e-07
part O 0 2.498500073500054e-09
of O 0 5.937928548860327e-08
the O 0 6.359018556167939e-08
gene O 0 1.326690313163681e-09
seemed O 0 1.745858457802285e-09
to O 0 1.3006613147625856e-11
be O 0 1.0158001176319154e-11
preferentially O 0 2.7602739538501453e-10
associated O 0 2.7794846424455955e-09
with O 0 4.6196982350643623e-10
cognitive B-Disease 1 0.999987006187439
impairment I-Disease 1 0.9969022870063782
. O 0 3.019835503437207e-06

Two O 0 2.356616946030954e-08
altered O 0 6.79286031868287e-08
Dp71 O 0 7.875122719269712e-06
transcripts O 0 1.725145182263077e-07
and O 0 3.184869035166571e-11
two O 0 3.3216526751367326e-11
deleted O 0 5.970402505717232e-10
Dp140 O 0 2.5814914650368337e-09
DNA O 0 3.2987859666100405e-10
sequences O 0 7.522454013864088e-12
were O 0 8.035808997386429e-12
found O 0 1.0426373306393621e-12
in O 0 1.91389859147649e-13
four O 0 2.682607608273102e-12
patients O 0 8.129187600847132e-11
with O 0 5.243375178487497e-11
severe O 1 0.9999971389770508
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 0.9999998807907104
. O 0 0.01124418992549181

These O 0 1.364847257434576e-08
findings O 0 1.7972009436206804e-09
suggest O 0 3.1961527868773487e-10
that O 0 4.1858679608423877e-13
some O 0 1.5494640889356787e-13
sequences O 0 1.2343031111083924e-11
located O 0 4.6817150850531064e-12
in O 0 1.4361674826809945e-12
the O 0 1.1799326793404674e-10
distal O 0 6.937362684311665e-08
part O 0 2.833618895081713e-09
of O 0 7.064926421662676e-08
the O 0 2.1494679813827133e-08
gene O 0 3.360712819144851e-10
and O 0 1.5847746726027623e-10
, O 0 5.897114827707606e-12
in O 0 7.302648069584805e-12
particular O 0 6.570722438370424e-11
, O 0 4.734616344814757e-12
some O 0 1.5141846110289237e-11
DMD B-Disease 1 0.9999997615814209
isoforms O 0 1.3533687059918975e-08
expressed O 0 7.308364330382844e-11
in O 0 3.076119220457585e-11
the O 0 1.60320234865452e-09
brain O 0 1.3362227036850527e-05
may O 0 1.864095856840553e-11
be O 0 3.018093370707464e-12
related O 0 2.875842342042745e-10
to O 0 4.803778555495519e-11
the O 0 6.61400489931907e-10
cognitive B-Disease 0 1.6311196304741316e-05
impairment I-Disease 0 2.874921847251244e-07
associated O 0 1.9167748277482133e-08
with O 0 3.8773699806426976e-09
DMD B-Disease 1 1.0
. O 0 6.524001605612284e-08
. O 0 3.711299001452062e-08

I1307K O 0 0.00010521021613385528
APC O 0 1.1358072242728667e-06
and O 0 1.2262509896387996e-09
hMLH1 O 0 3.812500608546543e-07
mutations O 0 6.366914218070008e-10
in O 0 2.202285229180312e-11
a O 0 4.600983136149317e-11
non O 0 5.500313804418511e-08
- O 0 2.653721020706712e-09
Jewish O 0 5.048222950776449e-10
family O 0 3.438499138197493e-11
with O 0 4.965168033665979e-12
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.986615777015686

We O 0 1.6182447382107057e-08
describe O 0 1.1037807112757037e-08
a O 0 1.7112114503170517e-10
French O 0 4.845395196184654e-09
Canadian O 0 1.390043991023049e-07
hereditary B-Disease 1 0.9999995231628418
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.5383997126482427e-07
HNPCC B-Disease 1 1.0
) O 0 1.6323480067637064e-10
kindred O 0 3.158407579917366e-08
which O 0 1.3198685850854264e-12
carries O 0 4.387816932710509e-12
a O 0 1.6406273041502661e-12
novel O 0 1.2389473995344513e-11
truncating O 0 1.91128783910699e-08
mutation O 0 9.285741620068677e-10
in O 0 8.467544998502774e-10
hMLH1 O 0 4.0362292565987445e-06
. O 0 6.647310328844469e-07

Interestingly O 0 4.739622738725302e-07
, O 0 7.753286207501375e-11
the O 0 1.38814890138228e-10
I1307K O 0 2.0908082376536186e-07
APC O 0 1.1491324336532216e-08
polymorphism O 0 6.883149605840799e-09
, O 0 1.964551568298112e-12
associated O 0 3.955743232975095e-10
with O 0 3.789951425609006e-12
an O 0 1.0680734725473928e-12
increased O 0 2.275344135327373e-09
risk O 0 1.8686231229025907e-08
of O 1 0.9338430166244507
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.7212657965615108e-08
is O 0 1.7828654134618982e-12
also O 0 3.9018067206006424e-13
present O 0 2.7570314087288494e-11
in O 0 1.6929428345302533e-11
this O 0 7.290779785451562e-11
family O 0 1.1049281489761142e-09
. O 0 5.9220258918912805e-08

The O 0 8.42653378185787e-08
I1307K O 0 6.230006874829996e-06
polymorphism O 0 2.0380514342832612e-07
has O 0 2.2506784630449417e-11
previously O 0 1.455405934658316e-10
only O 0 4.38941591407449e-12
been O 0 5.647032754602099e-12
identified O 0 3.327657940865869e-11
in O 0 7.969074076845384e-13
individuals O 0 4.015122002237748e-12
of O 0 5.092176125209846e-10
self O 0 1.2568099805321253e-07
- O 0 3.214374544313614e-08
reported O 0 7.785926570136326e-09
Ashkenazi O 0 2.895934301250236e-07
Jewish O 0 1.5889318305539746e-08
origins O 0 2.1926072690803267e-07
. O 0 9.197052719400745e-08

In O 0 8.56055049069937e-09
addition O 0 1.4700901607156425e-09
, O 0 2.6361321112111646e-11
in O 0 6.927128575612285e-12
this O 0 1.5901056513167866e-11
family O 0 9.896990171842646e-11
, O 0 2.154376720422957e-12
there O 0 3.235934957490638e-12
appears O 0 3.5081150224353097e-12
to O 0 6.232017072532736e-12
be O 0 3.987435381880289e-11
no O 0 9.5468237482077e-11
relationship O 0 1.200770594067535e-09
between O 0 1.0156985252862683e-09
the O 0 2.4511503937674206e-10
I1307K O 0 3.453970975897391e-08
polymorphism O 0 1.4091386946191164e-09
and O 0 3.893542172700437e-12
the O 0 7.229367104955031e-11
presence O 0 2.1456472015790595e-11
or O 0 8.261126505093586e-11
absence O 0 1.7072463265321858e-07
of O 0 4.92334457646848e-08
cancer B-Disease 0 2.549199962231796e-07
. O 0 4.233279948806512e-09
. O 0 2.7310445460670962e-08

Identification O 0 8.985646218206966e-07
of O 0 1.1519809106630419e-08
a O 0 4.931749106318328e-11
novel O 0 8.113538486897998e-12
mutation O 0 1.2706089652647634e-11
of O 0 1.608837923994244e-10
the O 0 9.607382667198294e-10
CPO O 0 4.4706143853545655e-07
gene O 0 1.4226998051869444e-11
in O 0 5.272555829438641e-12
a O 0 4.2077171608090325e-11
Japanese O 0 3.976493871959974e-07
hereditary B-Disease 1 0.9999991655349731
coproporphyria I-Disease 1 0.9999927282333374
family O 0 5.6919748914197044e-08
. O 0 1.660614969978269e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 1.3408156291916384e-06
HCP B-Disease 1 1.0
) O 0 3.8049194350797677e-10
is O 0 4.118634600036586e-11
an O 0 2.210104738109564e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 2.5410146875515238e-08
by O 0 9.496481379045463e-11
a O 0 1.164506269191179e-09
deficiency B-Disease 0 0.024045102298259735
of I-Disease 0 0.0003203083178959787
coproporphyrinogen I-Disease 0 2.2452797566074878e-05
oxidase I-Disease 0 5.169158157070086e-11
( O 0 9.94121798769676e-12
CPO O 0 1.0934151362107514e-07
) O 0 1.7893245479044806e-12
caused O 0 1.524675524722241e-11
by O 0 3.6028181848481167e-13
a O 0 2.0059140980188683e-12
mutation O 0 3.2547898837914646e-12
in O 0 8.654478175773583e-12
the O 0 1.3329629622305106e-09
CPO O 0 2.9829830054950435e-06
gene O 0 1.0900414793013624e-08
. O 0 4.8599662960668866e-08

Only O 0 1.6344682052249482e-08
11 O 0 5.48519318854801e-09
mutations O 0 1.9968308950790714e-10
of O 0 1.3570274071117439e-10
the O 0 2.7625388088203806e-10
gene O 0 4.2216809909012554e-11
have O 0 5.747196121785869e-12
been O 0 2.8797325635210314e-11
reported O 0 2.0018875446226048e-10
in O 0 8.383769234399097e-10
HCP B-Disease 1 0.9999271631240845
patients O 0 1.2239730722285458e-06
. O 0 4.565655444821459e-07

We O 0 2.284285649523099e-08
report O 0 2.998055415037726e-10
another O 0 5.0008591018224635e-11
mutation O 0 2.1736822411466683e-11
in O 0 4.979934867255231e-12
a O 0 5.935948954594039e-11
Japanese O 0 2.5499682010377e-07
family O 0 9.848492688036004e-09
. O 0 8.504521531449427e-08

Polymerase O 0 5.5136188947813025e-09
chain O 0 3.6256000979228986e-10
reaction O 0 3.78424687419443e-11
- O 0 1.9406215523432024e-10
single O 0 3.5752619614859427e-11
strand O 0 2.7002013472388064e-11
conformational O 0 7.647855439218976e-12
polymorphism O 0 5.327764618368036e-11
and O 0 3.0830822920699386e-13
direct O 0 1.8843028266185557e-12
sequence O 0 1.4196178087233502e-11
analyses O 0 9.68145563717826e-11
demonstrated O 0 1.4907954037912674e-10
a O 0 2.8091577675137813e-11
C O 0 2.3029556039944055e-09
to O 0 1.299880758587335e-10
T O 0 7.371141474976639e-10
substitution O 0 6.0246246880169e-10
in O 0 3.237629886410076e-10
exon O 0 5.916171441633367e-10
1 O 0 3.436473328122247e-11
of O 0 6.602053626014737e-11
the O 0 9.228265374083833e-11
CPO O 0 3.615314270177805e-08
gene O 0 8.440736824766315e-12
at O 0 7.936453577661595e-11
nucleotide O 0 1.2416424832739636e-10
position O 0 3.4739620069501598e-09
85 O 0 2.107197971668029e-08
, O 0 2.2218282769159714e-11
which O 0 1.8034098520081088e-12
lies O 0 3.5383315721837505e-10
in O 0 1.5356787022580143e-11
the O 0 7.349801878220319e-10
putative O 0 1.55705009774465e-07
presequence O 0 6.563078045473958e-07
for O 0 4.3434980612211405e-10
targeting O 0 2.2541918553997675e-08
to O 0 4.465279701548752e-08
mitochondria O 0 9.73996975517366e-06
. O 0 8.673083016219607e-07

This O 0 3.899997269574129e-10
mutation O 0 5.6814560001061665e-11
changes O 0 4.080692814906195e-12
the O 0 6.296044414988433e-12
codon O 0 2.6004121078671005e-10
for O 0 1.226261366754633e-11
glutamine O 0 2.505362362015262e-09
to O 0 7.377171790112769e-11
a O 0 5.827558574589276e-11
termination O 0 1.0556362006752806e-08
codon O 0 2.0411707879475216e-08
at O 0 3.941157178388721e-09
amino O 0 8.002034590504081e-09
acid O 0 2.195513992830911e-09
position O 0 3.7458978141557964e-08
29 O 0 8.348454230144853e-07
. O 0 5.771946689492324e-07

MaeI O 0 1.432808676327113e-05
restriction O 0 1.5936051367404502e-09
analysis O 0 9.467441275390343e-10
showed O 0 6.192802937121655e-10
two O 0 3.0715152643523425e-12
other O 0 2.6477799987267847e-13
carriers O 0 1.2438100679620923e-12
in O 0 3.880597232441829e-12
the O 0 9.13055631102111e-10
family O 0 3.752653743305245e-09
. O 0 9.430287661871262e-08

The O 0 8.996264000415977e-08
C O 0 3.999215550720692e-05
- O 0 1.3337108612176962e-05
T O 0 8.467294776437484e-08
mutation O 0 8.08297387355772e-11
is O 0 9.883907928220914e-13
located O 0 4.9560563986084105e-12
within O 0 1.958712012029018e-11
a O 0 3.466258963885638e-12
recently O 0 2.2119244370150115e-12
proposed O 0 1.2256810150157449e-12
putative O 0 3.072138030080218e-11
alternative O 0 8.639057351433888e-12
translation O 0 4.6540462456112763e-11
initiation O 0 1.26179955373118e-10
codon O 0 7.986984407182263e-09
( O 0 2.857775960318776e-10
TIC O 0 4.693537266575731e-05
- O 0 4.8359709126089e-07
1 O 0 4.837082401287773e-10
) O 0 1.8013369658745337e-12
, O 0 8.443566484016285e-13
supporting O 0 2.317790750994142e-11
that O 0 2.775646552877209e-11
TIC O 0 1.0015125553763937e-05
- O 0 4.0667462286592126e-08
1 O 0 8.081005864468693e-10
is O 0 4.0612808255291455e-12
the O 0 1.0679625933596171e-10
real O 0 8.108105298276769e-09
TIC O 0 2.1167981856251572e-07
rather O 0 5.916803713645891e-10
than O 0 4.3431502838586766e-10
TIC O 0 6.674423275399022e-06
- O 0 6.498876103933071e-08
2 O 0 1.313221198451231e-09
. O 0 2.940191423661531e-10
. O 0 3.1965812219425516e-09

Human B-Disease 0 1.867475774020022e-08
complement I-Disease 0 2.048773524165881e-07
factor I-Disease 0 3.943539013562258e-06
H I-Disease 1 1.0
deficiency I-Disease 0 0.004805958829820156
associated O 0 1.2675772268266883e-05
with O 0 0.00034124962985515594
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9996967315673828

This O 0 3.8325023710150674e-10
study O 0 8.315587801677182e-11
reports O 0 1.611521333044763e-11
on O 0 8.840047617530988e-12
six O 0 1.1973389293928882e-11
cases O 0 1.1893587677225259e-11
of O 0 2.5496647015899043e-09
deficiency B-Disease 0 1.5948791087794234e-06
in I-Disease 0 7.661116185886385e-11
the I-Disease 0 2.4909807549988727e-10
human I-Disease 0 1.1751757900135829e-10
complement I-Disease 0 5.443324124776439e-10
regulatory I-Disease 0 2.311122626608153e-09
protein I-Disease 0 9.611356155403428e-11
Factor I-Disease 0 3.039065110677086e-10
H I-Disease 0 0.00021616343292407691
( O 0 1.3786412983440854e-11
FH O 0 5.129751343702083e-07
) O 0 5.759154546487733e-13
in O 0 3.401165796484279e-13
the O 0 1.472585616814348e-12
context O 0 6.748208936091515e-11
of O 0 9.356816016437008e-11
an O 0 7.135040891448341e-10
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 6.681594641122501e-06

Five O 0 3.2054725096486436e-08
of O 0 1.2397641802053272e-09
the O 0 4.4347428507229836e-11
cases O 0 2.41406265637234e-12
were O 0 6.99968555339936e-12
observed O 0 1.193730878035204e-12
in O 0 1.062406252924121e-13
children O 0 2.2945940937255105e-13
presenting O 0 7.85123632773832e-11
with O 0 6.472558045089727e-10
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.10848218202590942
HUS B-Disease 1 1.0
) O 0 1.3436749668471748e-07
. O 0 9.368058044856298e-07

Two O 0 1.1298090241140812e-09
of O 0 1.1489258433527993e-09
the O 0 5.37767108621523e-10
children O 0 6.261605123292213e-11
exhibited O 0 5.324791163552334e-10
a O 0 3.5689412536399345e-10
homozygous O 0 5.860919216615912e-08
deficiency O 0 9.029906777868746e-08
characterized O 0 1.4394378744508884e-10
by O 0 1.2227604345715903e-11
the O 0 7.61740837074143e-10
absence O 0 1.2080515432444372e-07
of O 0 3.0454090360620967e-09
the O 0 1.2232742596651747e-10
150 O 0 7.403972435149342e-10
- O 0 4.047365775861067e-10
kD O 0 3.0588449551061103e-09
form O 0 9.104170889395746e-11
of O 0 7.687427583391582e-09
Factor O 0 1.8135340340563744e-08
H O 1 0.9999839067459106
and O 0 9.199285777583555e-11
the O 0 7.749648839316947e-11
presence O 0 4.04803317602398e-12
, O 0 7.939908631829709e-14
upon O 0 6.925811313340802e-11
immunoblotting O 0 3.3747706851272596e-08
, O 0 3.2403448414070057e-12
of O 0 9.794269562046765e-11
the O 0 3.063572728834174e-10
42 O 0 7.168245552691133e-09
- O 0 1.0148831774969835e-09
kD O 0 5.379612755262997e-09
Factor O 0 2.7734690100089665e-09
H O 1 0.9999077320098877
- O 0 5.810596803712542e-07
like O 0 1.977387698026689e-10
protein O 0 7.779476368652283e-11
1 O 0 4.7012876230878575e-11
( O 0 3.5436365213720178e-12
FHL O 0 5.463473826239351e-06
- O 0 4.474203674220689e-09
1 O 0 1.2381417072160339e-11
) O 0 6.413411604089606e-14
and O 0 2.1785114131481903e-13
other O 0 2.4468786372078277e-12
FH O 0 1.0276618240823154e-06
- O 0 1.3305625490289685e-09
related O 0 4.059768965447574e-09
protein O 0 5.380431100654448e-10
( O 0 3.489962225461385e-12
FHR O 0 1.896366484288592e-05
) O 0 4.973957010157015e-11
bands O 0 6.901044002916024e-08
. O 0 6.818485331905322e-08

Southern O 0 4.066657481871516e-07
blot O 0 1.5514663687099528e-07
and O 0 8.065337460394506e-12
PCR O 0 4.791756436084427e-10
analysis O 0 1.0461677531214963e-11
of O 0 3.451211105093277e-12
DNA O 0 6.461038370986216e-10
of O 0 4.7394890095864284e-11
one O 0 4.549963270733537e-12
patient O 0 1.25067034506543e-09
with O 0 2.2926060355699107e-11
homozygous O 0 3.6390439106526173e-08
deficiency O 0 3.263521648477763e-07
ruled O 0 1.323402276653951e-09
out O 0 1.1800265625749873e-11
the O 0 8.926016176191709e-12
presence O 0 7.42563129041418e-12
of O 0 1.1294615243073736e-10
a O 0 1.3799961173788233e-11
large O 0 3.857786052413603e-12
deletion O 0 1.2327344700580056e-10
of O 0 3.336620979510485e-10
the O 0 2.211877125901651e-09
FH O 0 0.0001371490361634642
gene O 0 7.416944142191184e-11
as O 0 3.895554885613439e-12
the O 0 1.0052615684319477e-10
underlying O 0 1.1296564252916141e-06
defect O 0 3.80558390133956e-07
for O 0 2.870947923838685e-10
the O 0 2.2811340727457718e-07
deficiency O 1 0.9995135068893433
. O 0 5.427224323284463e-07

The O 0 8.078405500100416e-09
other O 0 1.835398673322164e-11
four O 0 1.0773917348549933e-11
children O 0 4.705723657960625e-13
presented O 0 6.652396515594017e-12
with O 0 1.938784636307256e-12
heterozygous O 0 1.1704249791577581e-09
deficiency O 0 1.1018690315722779e-07
and O 0 8.863081102372661e-11
exhibited O 0 1.292226237126215e-08
a O 0 4.301812794871296e-10
normal O 0 5.369218342821114e-06
immunoblotting O 0 1.5180280570348259e-05
pattern O 0 1.8070325680241694e-08
of O 0 4.698450517537367e-09
proteins O 0 4.140563239496409e-11
of O 0 7.843082849845473e-10
the O 0 4.104303563678968e-09
FH O 0 8.5161387687549e-05
family O 0 3.629469391697171e-09
. O 0 3.9786822725318416e-08

Factor B-Disease 0 0.003124462440609932
H I-Disease 1 1.0
deficiency I-Disease 1 0.9946454763412476
is O 0 2.1531987998146818e-11
the O 0 1.1374279296205714e-10
only O 0 2.246066443944983e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 4.1316675947200565e-07
with O 0 8.968351394855745e-09
HUS B-Disease 1 1.0
. O 0 2.4343940822291188e-05

These O 0 3.5486875660240003e-09
observations O 0 1.533766358363664e-08
suggest O 0 6.968002841389875e-10
a O 0 1.9991810290553857e-11
role O 0 1.438570651490778e-10
for O 0 8.759810654623834e-10
FH O 1 0.9999880790710449
and O 0 2.9937673673430254e-08
/ O 0 0.030363351106643677
or O 0 2.6956255894106107e-08
FH O 0 0.011498249135911465
receptors O 0 9.484353580280214e-11
in O 0 1.2647673706955853e-11
the O 0 1.896954815450158e-10
pathogenesis O 0 3.9765660631019273e-07
of O 0 2.8675197327743263e-08
idiopathic O 0 4.179295865469612e-05
HUS B-Disease 1 0.9999974966049194
. O 0 7.827024717244058e-08
. O 0 1.5430659061621554e-07

Further O 0 7.124056899954212e-09
evidence O 0 9.741735196300283e-10
for O 0 1.6139145575522207e-11
a O 0 2.0173911152721047e-11
major O 0 1.3055732883682225e-10
ancient O 0 3.6786900636798237e-08
mutation O 0 5.47328681932413e-07
underlying O 0 0.0007717019179835916
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 6.331050599328591e-07
linkage O 0 3.2808045489218784e-06
disequilibrium O 0 3.4222107387904543e-06
studies O 0 1.3566728296332542e-10
in O 0 3.1162093305087124e-12
the O 0 1.857285332473868e-11
Japanese O 0 5.936860780764164e-09
population O 0 2.395560659562701e-11
. O 0 1.1963995349972834e-09

The O 0 2.962813596241176e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.135095797939357e-07
DM B-Disease 1 1.0
) O 0 1.4254983304873292e-10
mutation O 0 2.1206993106037686e-10
is O 0 1.950059037858498e-12
an O 0 1.0404664976815248e-11
unstable O 1 0.6950137615203857
( O 0 8.638608939293135e-09
CTG O 0 0.0002770162536762655
) O 0 5.0988893662839985e-11
n O 0 2.6927451934888325e-10
repeat O 0 1.5975950562463481e-09
, O 0 3.247918860943555e-12
present O 0 2.1803508651330183e-11
at O 0 2.9014493932444374e-11
a O 0 7.304259736114205e-13
copy O 0 6.307249861281505e-11
number O 0 7.69527930960523e-12
of O 0 3.039058241172121e-11
5 O 0 8.141414625795207e-11
- O 0 3.1176450310255177e-10
37 O 0 2.34028296741684e-10
repeats O 0 2.642869534330572e-10
on O 0 2.47815712395294e-10
normal O 0 2.5519415469688056e-09
chromosomes O 0 2.3757409928215623e-10
but O 0 1.682737803265777e-11
amplified O 0 3.686904948008163e-10
to O 0 5.212225095974077e-11
50 O 0 4.4407313382066604e-09
- O 0 6.558342757756463e-10
3000 O 0 3.7328418134308095e-10
copies O 0 8.07978794981068e-10
on O 0 1.5440280165535114e-08
DM B-Disease 1 0.999997615814209
chromosomes O 0 4.3030894403273123e-07
. O 0 1.426011522198678e-07

Previous O 0 8.074509310063149e-07
findings O 0 4.043378520890428e-09
in O 0 1.6661791391037184e-10
Caucasian O 0 1.41751428373027e-07
populations O 0 7.049594848845819e-12
of O 0 3.597399045318639e-10
a O 0 2.1307076991661233e-08
DM B-Disease 1 1.0
founder O 0 9.917155693983659e-06
chromosome O 0 7.121722944702924e-08
raise O 0 4.413017451465606e-10
a O 0 2.9713662086372494e-11
question O 0 7.983158023527892e-10
about O 0 3.990058283775966e-12
the O 0 1.2842802342427628e-11
molecular O 0 8.030588000140781e-11
events O 0 5.579585057868819e-11
involved O 0 5.552621695770199e-10
in O 0 5.4539633226324824e-11
the O 0 5.60264390436771e-10
expansion O 0 5.28192742876854e-08
mutation O 0 8.079068081201513e-09
. O 0 1.6944703418175777e-08

To O 0 3.9725399858525634e-08
investigate O 0 2.5481153187456584e-08
whether O 0 6.038222144510996e-10
a O 0 2.392073483736823e-10
founder O 0 5.653431500718398e-09
chromosome O 0 1.010190264771893e-09
for O 0 8.38717151285806e-11
the O 0 8.000756679393817e-08
DM B-Disease 1 1.0
mutation O 0 1.673712723970766e-09
exists O 0 2.490000913790702e-11
in O 0 9.121856915650373e-13
the O 0 2.853845848874159e-12
Japanese O 0 1.403580696113238e-09
population O 0 1.1600618469304047e-12
, O 0 3.4894545477941186e-13
we O 0 6.112492890314458e-12
genotyped O 0 2.2251269271578167e-08
families O 0 6.749595240357342e-12
using O 0 2.251653204166093e-11
polymorphic O 0 1.289187645525658e-09
markers O 0 1.28727117854055e-09
near O 0 5.433423666545423e-08
the O 0 1.4493461542031127e-08
( O 0 2.1529793503560768e-09
CTG O 0 3.064801785512827e-05
) O 0 2.1258263205314876e-10
n O 0 3.8286538384113555e-09
repeat O 0 1.279780459384483e-08
region O 0 6.763845927793e-09
and O 0 4.3796025139819506e-10
constructed O 0 1.521642616353347e-07
haplotypes O 0 2.0409670753451792e-07
. O 0 7.093091625165471e-08

Six O 0 1.9421861452428857e-08
different O 0 1.4270407078242897e-10
haplotypes O 0 1.6660433033166555e-09
were O 0 1.225588658337884e-10
found O 0 2.9734069373343885e-11
and O 0 5.116873591504145e-11
DM B-Disease 1 1.0
alleles O 0 3.2748131983950657e-10
were O 0 1.1805770805395355e-09
always O 0 5.19077836269588e-10
haplotype O 0 1.3450154767724598e-08
A O 0 4.773057185047946e-07
. O 0 7.781555950714392e-07

To O 0 9.956186097781483e-09
find O 0 1.0828956620301255e-09
an O 0 8.739687033972043e-13
origin O 0 9.69106322967761e-11
of O 0 3.4690224026689975e-09
the O 0 3.635753920150364e-09
( O 0 1.1735942773150043e-10
CTG O 0 1.3457810155159677e-06
) O 0 3.691988555154513e-12
n O 0 5.0716434524256115e-11
repeat O 0 5.226343802178235e-10
mutation O 0 1.1366877925023111e-11
and O 0 2.2282312713700625e-12
to O 0 3.744663260030201e-11
investigate O 0 3.6520431123676644e-10
the O 0 6.997072365955148e-11
mechanism O 0 1.7444271582789384e-09
of O 0 2.3446081187650236e-10
the O 0 2.971864768164245e-11
expansion O 0 1.2139977911829192e-10
mutation O 0 1.2851838733854426e-12
in O 0 1.45360584463336e-13
the O 0 5.582868694252452e-13
Japanese O 0 3.236617085455862e-10
population O 0 2.400690323617338e-13
we O 0 1.1132117634388844e-13
have O 0 1.93725227239051e-14
studied O 0 8.642682923498679e-12
90 O 0 1.12868624169149e-10
Japanese O 0 2.3980604169082653e-08
DM B-Disease 1 0.9999995231628418
families O 0 4.4948236799235985e-10
comprising O 0 1.9913121152015378e-10
190 O 0 5.231689526041805e-10
affected O 0 3.331190323585531e-10
and O 0 5.349688053657431e-11
130 O 0 6.936556218306578e-08
unaffected O 0 9.163449021798442e-07
members O 0 2.3073095434256174e-08
. O 0 4.7382667389683775e-07

The O 0 3.8577425698349543e-08
results O 0 2.4109844787290058e-08
suggest O 0 8.420167674216827e-09
that O 0 5.074302089624894e-12
a O 0 2.714360160249729e-11
few O 0 1.289720691355356e-10
common O 0 7.589848888267525e-11
ancestral O 0 1.3127009701463521e-08
mutations O 0 1.8481197128217275e-10
in O 0 2.5287400645668257e-11
both O 0 5.640988232080701e-10
Caucasian O 0 0.000458839611383155
and O 0 1.1670967525745368e-09
Japanese O 0 9.360268450109288e-06
populations O 0 1.296322164195951e-11
have O 0 5.3942920551393325e-14
originated O 0 3.423293820723622e-13
by O 0 3.3484340652848235e-14
expansion O 0 1.6159173998886445e-10
of O 0 1.2991618891788903e-10
an O 0 1.397243518802549e-11
ancestral O 0 1.4150647764665791e-08
n O 0 6.199799007511331e-10
= O 0 3.193879882790185e-10
5 O 0 3.061656761449427e-10
repeat O 0 1.1532730326280216e-09
to O 0 3.9386455208401117e-10
n O 0 2.8134863883089167e-10
= O 0 2.4798971209882836e-10
19 O 0 1.7474809377304723e-09
- O 0 1.2587977327171984e-09
37 O 0 1.139289329543658e-09
copies O 0 1.945117844570632e-09
. O 0 1.0348117029934656e-08

These O 0 5.320943130548983e-10
data O 0 1.6146882442225063e-10
support O 0 9.909451731404673e-12
multistep O 0 1.9704988751811925e-09
models O 0 7.367571552840957e-10
of O 0 3.252374369822064e-09
triplet O 0 9.814832537813345e-07
repeat O 0 6.692329357349536e-09
expansion O 0 2.178008662312436e-09
that O 0 7.9086265531228e-13
have O 0 1.209366808085921e-13
been O 0 5.571986014946129e-13
proposed O 0 8.817477997746792e-13
for O 0 2.721782651690652e-12
both O 0 2.907196927637301e-09
DM B-Disease 1 1.0
and O 0 5.703897087983023e-08
Friedreichs B-Disease 1 0.9991278052330017
ataxia I-Disease 0 0.027856802567839622
. O 0 6.42388542360095e-08
. O 0 3.7398550034595246e-07

The O 0 6.0481615271612554e-09
molecular O 0 4.19777324012216e-09
basis O 0 3.050637360502151e-07
of O 0 0.12131454050540924
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 8.416024321888926e-09
the O 0 1.677458505433549e-09
western O 0 6.1188365485520535e-09
Cape O 0 6.479577763229827e-09
, O 0 3.943304016651439e-11
South O 0 1.6408299163828133e-09
Africa O 0 1.1535794541828182e-08
. O 0 4.699743882952134e-08

Deficiency B-Disease 1 0.9867643117904663
of I-Disease 0 8.277600500150584e-06
the I-Disease 0 8.101862647436064e-08
sixth I-Disease 0 9.087318176170811e-06
component I-Disease 0 1.4371794065937138e-07
of I-Disease 0 1.780653313687708e-08
human I-Disease 0 1.0959830376577884e-08
complement I-Disease 0 8.319389621647133e-07
( O 0 8.957354857841437e-10
C6 O 1 0.9099863171577454
) O 0 1.8611152549641297e-11
has O 0 3.4792199503363985e-13
been O 0 2.0771023789833976e-12
reported O 0 3.5587004263565314e-12
in O 0 5.199569616011479e-13
a O 0 8.131164470036312e-13
number O 0 4.637385527667126e-12
of O 0 1.4333222976559146e-11
families O 0 1.5180131457404045e-11
from O 0 6.07622979709177e-11
the O 0 3.0079533308580153e-10
western O 0 1.5549749932119994e-08
Cape O 0 2.994995185190419e-08
, O 0 3.9432307419318136e-10
South O 0 7.785748046273966e-09
Africa O 0 2.343756122513696e-08
. O 0 1.1446387304658856e-07

Meningococcal B-Disease 1 0.9999431371688843
disease I-Disease 1 0.9989125728607178
is O 0 2.0516617293964146e-09
endemic O 0 4.544844056653119e-09
in O 0 8.285316877021387e-11
the O 0 2.6410367226503695e-09
Cape O 0 2.225789152987545e-08
and O 0 5.288196963659786e-12
almost O 0 1.3040197394120767e-11
all O 0 1.56054563802549e-12
pedigrees O 0 1.0111772530407848e-09
of O 0 5.332497554633164e-09
total O 0 0.031020618975162506
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.2299315343966555e-08
C6Q0 O 1 0.9993550181388855
) O 0 6.579840144960158e-11
have O 0 8.548414580367147e-12
been O 0 1.192862041782261e-11
ascertained O 0 1.1441024128089339e-08
because O 0 2.025951628681355e-11
of O 0 2.7225812715414577e-09
recurrent O 1 0.7865458726882935
disease O 0 0.003168676979839802
. O 0 5.402534384302271e-07

We O 0 1.228407686681976e-08
have O 0 1.3587568570283537e-11
sequenced O 0 3.995088426744786e-10
the O 0 2.3719498587482235e-11
expressed O 0 7.216279657162872e-11
exons O 0 6.70300970284643e-09
of O 0 3.7780178985258317e-10
the O 0 5.542760139753966e-10
C6 O 0 4.60207047581207e-06
gene O 0 1.7390967138597446e-11
from O 0 1.3177487746818262e-11
selected O 0 2.4351052424487207e-11
cases O 0 3.794306015214577e-12
and O 0 1.8167918341624456e-12
have O 0 9.831881402772025e-13
found O 0 3.5576823605165675e-12
three O 0 4.233580500057066e-12
molecular O 0 5.728884033828763e-09
defects O 0 4.3504718405529275e-07
leading O 0 2.7228772569998227e-09
to O 0 1.7301488020038391e-09
total O 0 7.972955063451082e-05
deficiency O 1 0.5967631340026855
879delG O 0 0.002910727635025978
, O 0 2.935236775858385e-11
which O 0 8.796027599865253e-13
is O 0 8.468420192517256e-13
the O 0 1.7765060256191845e-10
common O 0 4.722132906920251e-09
defect O 0 7.051254215184599e-06
in O 0 2.2383812581239226e-09
the O 0 1.1518802978116582e-07
Cape O 0 1.1675948599076946e-06
and O 0 3.202885512365583e-09
hitherto O 0 1.90058744919952e-06
unreported O 0 6.949864683747364e-08
, O 0 5.809654406857545e-12
and O 0 1.640212098086291e-11
1195delC O 0 6.527697848923708e-08
and O 0 4.424336452757416e-10
1936delG O 0 7.934858103908482e-07
, O 0 1.6808356789743684e-11
which O 0 4.0098618327676083e-13
have O 0 8.847127674557753e-13
been O 0 2.5324518523883732e-11
previously O 0 1.408232558341993e-10
reported O 0 1.0262192484677968e-10
in O 0 1.0482575224513013e-10
African O 0 1.1873573413367922e-07
- O 0 6.554784448553619e-08
Americans O 0 1.887770828545854e-08
. O 0 6.371730165710687e-08

We O 0 6.55013536743354e-08
also O 0 8.165115111813392e-11
show O 0 1.3971163115300556e-10
that O 0 6.249357043137949e-13
the O 0 1.1436185332058812e-11
879delG O 0 1.7480916270073976e-08
and O 0 7.273404101226788e-11
1195delC O 0 7.717414405306045e-07
defects O 0 4.85583882436913e-07
are O 0 2.2179742851374806e-12
associated O 0 2.2717145942152683e-09
with O 0 1.6005351488601605e-09
characteristic O 1 0.9999943971633911
C6 O 1 1.0
/ O 1 1.0
C7 O 1 1.0
region O 0 7.585792332065466e-07
DNA O 0 2.023284423557925e-06
marker O 0 9.376048382137014e-09
haplotypes O 0 1.8505827981130096e-09
, O 0 1.9514507197671005e-12
although O 0 6.865831254226906e-12
small O 0 1.2267310648197971e-12
variations O 0 1.8613425037394826e-11
were O 0 8.505762760790958e-10
observed O 0 6.876641034381237e-09
. O 0 1.1417822065595828e-07

The O 0 5.730198537889919e-08
1936delG O 0 7.070924311847193e-06
defect O 0 7.294118404388428e-06
was O 0 6.690287879251855e-09
observed O 0 2.8409502528248254e-10
only O 0 2.3794084758055334e-11
once O 0 7.650661354441368e-11
in O 0 1.4910961354530627e-11
the O 0 7.871917562241038e-10
Cape O 0 1.049358822058366e-08
, O 0 3.4473691262748574e-12
but O 0 1.7200514016574298e-12
its O 0 2.2238029560167627e-12
associated O 0 9.583426274772933e-10
haplotype O 0 7.44941885955086e-09
could O 0 7.759370368454199e-10
be O 0 7.179055128148093e-09
deduced O 0 1.2705718290817458e-06
. O 0 3.078331189954042e-07

The O 0 5.105397704596726e-08
data O 0 6.251863737816166e-08
from O 0 4.81008899377855e-10
the O 0 2.803902665604596e-10
haplotypes O 0 2.6685369469703346e-09
indicate O 0 2.8458094214478535e-10
that O 0 4.566444878478793e-13
these O 0 1.2960842251871774e-12
three O 0 1.1320144474580296e-11
molecular O 0 1.0209528333859907e-08
defects O 0 1.135436420440783e-07
account O 0 5.985632822724796e-11
for O 0 7.554147585242532e-11
the O 0 1.2058070808507182e-07
defects O 1 0.9999884366989136
in O 0 1.1835734614606963e-09
all O 0 1.6476439657076014e-10
the O 0 3.5996161606988153e-10
38 O 0 9.586355709245709e-09
unrelated O 0 2.7819259784678252e-08
C6Q0 O 0 0.02149607613682747
individuals O 0 2.9689653513464975e-10
we O 0 2.4451454749829793e-10
have O 0 8.216587132903186e-12
studied O 0 3.2294227292339883e-09
from O 0 2.791373521215945e-10
the O 0 3.4782714486425448e-09
Cape O 0 3.645870663149253e-07
. O 0 4.695093736017952e-08

We O 0 3.4825813344241396e-08
have O 0 3.629569561569568e-11
also O 0 4.0184446482155467e-13
observed O 0 3.0656623073443967e-12
the O 0 1.7404373081619795e-11
879delG O 0 9.160358871440621e-08
defect O 0 1.4548805893355166e-07
in O 0 2.6429805566330344e-10
two O 0 2.5115343138537582e-09
Dutch O 1 0.9999786615371704
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 0.019421420991420746
, O 0 5.010893783241599e-11
but O 0 2.8965488861609767e-12
the O 0 5.049164558679209e-11
879delG O 0 1.1811086153556971e-07
defect O 0 8.612911983618687e-07
in O 0 3.9708691890183445e-10
the O 0 2.1913942660489738e-08
Cape O 0 1.9386430949452915e-07
probably O 0 1.1501778418576691e-09
did O 0 4.08822073416637e-11
not O 0 1.2296152811230865e-11
come O 0 5.819297821396674e-10
from O 0 5.87859150247283e-10
The O 0 4.105023876377345e-09
Netherlands O 0 6.32972287917255e-08
. O 0 5.364509725325206e-09
. O 0 6.542169472822934e-08

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.193090737316993e-09
seven O 0 1.3038667923126468e-09
further O 0 2.852444946910282e-10
molecular O 0 1.3107244178911515e-08
defects O 0 9.950001356173743e-08
and O 0 1.1832992051485913e-11
their O 0 6.779225514286225e-10
associated O 0 1.387069914926542e-06
marker O 0 5.942075063103402e-07
haplotypes O 0 6.246619363992068e-07
. O 0 5.021871629651287e-07

Seven O 0 1.7613821512441064e-08
further O 0 3.0198754608079525e-10
molecular O 0 1.2489945744320607e-09
bases O 0 1.0731827870813504e-08
of O 0 8.821739902487025e-05
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 9.136797984865552e-09
described O 0 1.7921426120892647e-08
. O 0 4.3065455201940495e-08

All O 0 6.038087363435807e-09
these O 0 3.15736707612313e-11
new O 0 1.0455213951543474e-11
molecular O 0 6.284137654688493e-10
defects O 0 1.45354794867103e-09
involve O 0 5.317280504790745e-10
single O 0 1.891146572674529e-09
- O 0 5.2811892636839275e-09
nucleotide O 0 6.311600575514831e-09
events O 0 9.245024190640549e-10
, O 0 2.401347523606212e-11
deletions O 0 2.863002612762955e-10
and O 0 1.2263221688124659e-11
substitutions O 0 1.461891718790298e-09
, O 0 1.0671352690394542e-11
some O 0 3.8671791463551486e-12
of O 0 2.114850239376409e-10
which O 0 4.6569234579685315e-11
alter O 0 9.640231013463563e-08
splice O 0 1.9551957564090117e-07
sites O 0 1.4911772927561628e-09
, O 0 2.3171497706697686e-11
and O 0 3.631204018028633e-11
others O 0 2.2254864617821113e-09
codons O 0 2.9951669944239256e-07
. O 0 4.781289817401557e-07

They O 0 8.53809190015653e-10
are O 0 1.0467559978522e-12
distributed O 0 3.980222401667177e-12
along O 0 8.153531669274905e-12
the O 0 7.89360937725192e-11
C7 O 0 9.518446859146934e-06
gene O 0 1.0347889906059393e-10
, O 0 3.4996411150955975e-12
but O 0 3.430237214066545e-12
predominantly O 0 1.8892411940418796e-11
towards O 0 8.426043751619261e-10
the O 0 5.683453152549589e-10
3 O 0 6.472068214691262e-09
end O 0 7.894614384440501e-08
. O 0 8.361643466514579e-08

All O 0 7.325760886800481e-09
were O 0 1.200628707564988e-09
found O 0 1.3153104473639932e-11
in O 0 4.72198148637748e-12
compound O 0 7.807887114630319e-10
heterozygous O 0 5.057725904755728e-10
individuals O 0 2.1545144834878016e-10
. O 0 6.489623416428003e-08

The O 0 0.00014084573194850236
C6 O 1 0.9999920129776001
/ O 1 0.9577405452728271
C7 O 0 0.49776485562324524
marker O 0 1.496015897828329e-07
haplotypes O 0 1.6982914630148116e-08
associated O 0 1.0458022003945189e-08
with O 0 6.704182764494249e-10
most O 0 1.3398131670783187e-07
C7 B-Disease 1 1.0
defects I-Disease 1 0.7082675695419312
are O 0 7.519216499440873e-11
tabulated O 0 4.941473719100031e-08
. O 0 3.555435723612277e-09
. O 0 3.554908545311264e-08

A O 0 1.9271719509106333e-07
genome O 0 2.118716224686068e-08
- O 0 1.2675948291018813e-08
wide O 0 7.392679524098611e-11
search O 0 3.7522293605540824e-10
for O 0 1.7538734353728103e-11
chromosomal O 0 4.2433146063558524e-07
loci O 0 1.9861630562445498e-08
linked O 0 1.488645153813195e-07
to O 0 1.3493959283294998e-09
mental O 1 0.8541528582572937
health O 0 6.469552715770988e-08
wellness O 0 3.727103958794942e-08
in O 0 8.286498223708527e-12
relatives O 0 9.377505022500898e-11
at O 0 8.116962657567228e-11
high O 0 3.965238415393202e-10
risk O 0 8.459538070049177e-10
for O 0 2.794949605089414e-09
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999608993530273
disorder I-Disease 1 0.9993149042129517
among O 0 6.343107705752971e-10
the O 0 6.036172672807538e-10
Old O 0 2.541490573548799e-07
Order O 0 4.827112487504337e-09
Amish O 0 5.896507673242013e-07
. O 0 3.7597263968791594e-08

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 1.0724420462793205e-06
BPAD B-Disease 1 1.0
; O 0 3.756766318474547e-06
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 1.1287334955589756e-10
is O 0 3.695694791860937e-12
characterized O 0 1.2668340335086903e-11
by O 0 4.070058959998457e-12
episodes O 0 1.1920314513247376e-08
of O 0 2.6032074273985017e-09
mania B-Disease 0 1.7694469889306674e-08
and O 0 9.383981786070805e-11
/ O 0 1.0868426159049704e-07
or O 0 5.021325022447343e-10
hypomania B-Disease 0 2.686799689399777e-06
interspersed O 0 9.973063264112625e-09
with O 0 1.063629436262592e-12
periods O 0 3.642308143980699e-08
of O 0 1.741236665964152e-08
depression B-Disease 0 7.546107667621982e-07
. O 0 2.749861671702547e-08

Compelling O 0 4.216167326376308e-07
evidence O 0 1.6824964532702325e-08
supports O 0 4.669021280712116e-10
a O 0 3.5758618288639354e-11
significant O 0 1.8451928873730594e-10
genetic O 0 1.0177522158372199e-09
component O 0 1.2892515943718763e-09
in O 0 3.37933882266217e-11
the O 0 4.726320446124532e-10
susceptibility O 0 6.971595745142167e-09
to O 0 3.592902642068907e-09
develop O 0 0.000330565293552354
BPAD B-Disease 1 1.0
. O 0 2.5410630769329146e-05

To O 0 6.122736095903747e-09
date O 0 5.418975490556477e-08
, O 0 3.600911929746431e-11
however O 0 6.774530242337207e-11
, O 0 4.381168604988828e-12
linkage O 0 2.1395929472589614e-09
studies O 0 6.833877908007935e-11
have O 0 4.85498793945105e-13
attempted O 0 6.876492708585147e-10
only O 0 2.4616064395188708e-11
to O 0 1.4033899042864562e-10
identify O 0 1.1616754846954791e-07
chromosomal O 0 1.2667396731558256e-05
loci O 0 4.203367964805693e-08
that O 0 1.0363138125413229e-10
cause O 0 4.860519986493728e-09
or O 0 6.207049457751523e-11
increase O 0 1.4984581631072302e-10
the O 0 5.5790320280246775e-11
risk O 0 6.524791817952291e-10
of O 0 2.6296567146033567e-09
developing O 0 3.126458250335418e-05
BPAD B-Disease 1 1.0
. O 0 4.01309625885915e-06

To O 0 1.924111714401988e-08
determine O 0 2.992003445001501e-08
whether O 0 7.415929537124555e-10
there O 0 1.0926339694128373e-10
could O 0 2.5360625058312714e-11
be O 0 1.3682179521301574e-11
protective O 0 1.9822590791029882e-10
alleles O 0 3.0788604304943235e-11
that O 0 8.041584976040128e-13
prevent O 0 7.689198722182766e-10
or O 0 2.522478892430513e-10
reduce O 0 7.3257471200349755e-09
the O 0 3.03678804325358e-10
risk O 0 1.5592983571011132e-09
of O 0 1.8430937887004006e-09
developing O 0 0.0009270540322177112
BPAD B-Disease 1 1.0
, O 0 2.235464938160625e-11
similar O 0 1.6654052269193809e-12
to O 0 4.483286138168285e-12
what O 0 2.876212506011666e-12
is O 0 3.7062036382581875e-13
observed O 0 4.16309278716831e-11
in O 0 2.836443926956811e-11
other O 0 1.5854616508548247e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 1.1871671180829768e-11
we O 0 1.5358044697100226e-11
used O 0 1.0256288041077255e-09
mental O 0 4.376265860628337e-05
health O 0 5.4843769525803054e-09
wellness O 0 1.363561885625586e-08
( O 0 1.2973505733246404e-12
absence O 0 3.9648148653093074e-10
of O 0 1.0185925714001343e-10
any O 0 2.312312008534434e-10
psychiatric B-Disease 0 0.19203145802021027
disorder I-Disease 0 3.12881420541089e-05
) O 0 1.8320683511929836e-12
as O 0 4.668499961613115e-12
the O 0 4.593442640143941e-11
phenotype O 0 8.299678305734304e-11
in O 0 1.2334535302860328e-11
our O 0 2.213109473458985e-09
genome O 0 4.398423403273455e-09
- O 0 2.301568047258229e-09
wide O 0 3.211564347793683e-10
linkage O 0 3.97770882898385e-09
scan O 0 1.0508730774461128e-08
of O 0 2.673227472715922e-10
several O 0 3.554164254571113e-11
large O 0 8.970989749668146e-12
multigeneration O 0 3.003679438506879e-08
Old O 0 9.961010682957294e-09
Order O 0 2.683772093448056e-10
Amish O 0 8.06049342827464e-08
pedigrees O 0 1.6556473525497495e-08
exhibiting O 0 5.039778816495755e-09
an O 0 7.010738517498893e-11
extremely O 0 2.6960830012967563e-08
high O 0 6.654705941855354e-08
incidence O 0 2.5403278414160013e-06
of O 0 3.5244006539869588e-06
BPAD B-Disease 1 1.0
. O 0 1.78575464815367e-05

We O 0 1.7225501025563972e-08
have O 0 4.817753140873293e-11
found O 0 1.264224662456126e-11
strong O 0 1.129731833256209e-12
evidence O 0 1.4111302404362647e-11
for O 0 3.42390308813445e-12
a O 0 2.3619908112726407e-11
locus O 0 1.241786951045043e-10
on O 0 6.25444640522943e-10
chromosome O 0 2.6184856505295784e-09
4p O 0 2.200730250478955e-06
at O 0 1.3256133968297945e-08
D4S2949 O 0 1.2563714335556142e-07
( O 0 1.2660828115074185e-11
maximum O 0 2.8256150752525855e-09
GENEHUNTER O 0 1.953944592969492e-05
- O 0 6.469846436374382e-09
PLUS O 0 7.612561248038219e-09
nonparametric O 0 1.2337476107404655e-07
linkage O 0 1.1699702540113321e-08
score O 0 2.337316451495042e-10
= O 0 2.6897151172988742e-11
4 O 0 3.316227500937963e-11
. O 0 7.364346112093134e-12
05 O 0 3.8137857316655754e-09
, O 0 1.66637832005323e-11
P O 0 7.714763050614692e-09
= O 0 2.163614253036794e-11
5 O 0 1.9363982639575283e-11
. O 0 7.336233400281889e-13
22 O 0 3.0211861658246963e-12
x O 0 2.311279119482368e-11
10 O 0 1.4173485995971902e-10
( O 0 9.333959820334581e-12
- O 0 6.060629775817006e-10
4 O 0 3.645812124419834e-11
) O 0 9.826932019854628e-13
; O 0 2.2386383111833164e-12
SIBPAL O 0 1.1285761502222158e-05
Pempirical O 0 2.468666480126558e-06
value O 0 4.515475104938105e-09
< O 0 5.429067195805715e-10
3 O 0 7.172583707526492e-12
x O 0 4.039019119161935e-11
10 O 0 8.580403748625898e-11
( O 0 5.4091648694909455e-12
- O 0 5.366328492684147e-10
5 O 0 1.6087757861993346e-11
) O 0 3.5440877663162063e-13
) O 0 7.074995428922592e-13
and O 0 9.955905891367856e-12
suggestive O 0 1.6646773959294592e-09
evidence O 0 4.1523334770587894e-10
for O 0 7.861351153382046e-11
a O 0 4.616262927470416e-10
locus O 0 9.44190503560094e-10
on O 0 6.154336595898258e-09
chromosome O 0 1.8527520850852852e-08
4q O 0 9.432967829070549e-08
at O 0 1.250950099063175e-08
D4S397 O 0 3.919147388842248e-07
( O 0 1.3613508757781556e-11
maximum O 0 8.437304188646522e-09
GENEHUNTER O 0 1.1125162018288393e-05
- O 0 3.827412609069825e-09
PLUS O 0 2.721682879069931e-09
nonparametric O 0 3.4326657072369926e-08
linkage O 0 4.8461346047190546e-09
score O 0 1.7091564274984705e-10
= O 0 1.311162550060585e-11
3 O 0 7.154657075125748e-12
. O 0 1.7361792342338034e-12
29 O 0 7.524036949035917e-11
, O 0 2.2230143073564967e-12
P O 0 3.0798501526874134e-09
= O 0 8.945650643854552e-12
2 O 0 4.172367312760272e-12
. O 0 5.535165967067435e-13
57 O 0 1.603567799379757e-11
x O 0 3.286932878654447e-11
10 O 0 1.711182029406899e-10
( O 0 4.810854839498724e-12
- O 0 7.43927697222091e-10
3 O 0 1.986781399121451e-11
) O 0 5.120500919976456e-13
; O 0 2.639094238282569e-12
SIBPAL O 0 1.2124230124754831e-05
Pempirical O 0 3.101580432485207e-06
value O 0 6.080269621122625e-09
< O 0 1.37043931758285e-09
1 O 0 2.7039375946613653e-11
x O 0 2.3102311730305303e-10
10 O 0 1.1319767345696619e-09
( O 0 3.7983626660631487e-11
- O 0 1.8265858825472492e-09
3 O 0 1.702933800917794e-11
) O 0 2.356471680113603e-13
) O 0 1.2860929498020174e-13
that O 0 1.2414772172526095e-13
are O 0 4.717748002154576e-13
linked O 0 1.642625235831474e-08
to O 0 2.1386922455235435e-08
mental O 1 0.9999971389770508
health O 0 5.3733252570964396e-05
wellness O 0 1.96555247384822e-05
. O 0 7.300085513861632e-08

These O 0 3.6361560429298834e-09
findings O 0 3.406650517234766e-10
are O 0 7.437817722832918e-13
consistent O 0 2.2785612285858292e-10
with O 0 8.870783339658128e-13
the O 0 3.50439850749229e-11
hypothesis O 0 7.723383044222487e-11
that O 0 5.138980061804299e-14
certain O 0 1.3331801808347254e-11
alleles O 0 2.8310064362213616e-11
could O 0 9.304493980843986e-11
prevent O 0 8.28744273206894e-09
or O 0 1.0318567111866628e-09
modify O 0 9.713390092258578e-09
the O 0 5.062513186437911e-10
clinical O 0 1.7940919860848226e-08
manifestations O 0 1.2374005109450081e-07
of O 0 6.865405453027051e-07
BPAD B-Disease 1 1.0
and O 0 2.5771915712624605e-09
perhaps O 0 3.5275229959275123e-10
other O 0 6.040131589335473e-11
related O 0 8.704340871190652e-06
affective B-Disease 0 0.0032437301706522703
disorders I-Disease 1 0.9976863861083984
. O 0 3.6305350477050524e-06

Segregation O 0 0.00015555696154478937
distortion O 0 0.000650356407277286
in O 0 9.566100516167353e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0002544138696976006

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.836151467519812e-05
DM B-Disease 1 1.0
) O 0 9.465636052752302e-10
is O 0 2.322392798903561e-11
an O 0 2.8643884139589737e-11
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
which O 0 1.3519785985183219e-11
, O 0 1.912655363950355e-12
in O 0 7.335201890334986e-12
the O 0 3.4165675844022303e-10
typical O 0 1.132186788765921e-08
pedigree O 0 1.5738887970684345e-09
, O 0 2.0856337490382515e-12
shows O 0 3.3306423591339396e-11
a O 0 1.0483770102043266e-11
three O 0 7.106054633609915e-11
generation O 0 1.626688970191026e-07
anticipation O 0 1.243623302116248e-07
cascade O 0 2.4128735276462976e-07
. O 0 2.3134575144467817e-07

This O 0 2.1273026395984829e-10
results O 0 1.0915803816402558e-09
in O 0 5.729164920253993e-10
infertility B-Disease 1 0.9873251914978027
and O 0 9.182487303860398e-08
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.3475099197867166e-08
CDM B-Disease 0 0.021693352609872818
) O 0 8.579347085188593e-13
with O 0 2.0203272648594561e-13
the O 0 2.838386817249905e-11
disappearance O 0 5.551081727617202e-08
of O 0 1.1938954003198887e-07
DM B-Disease 1 1.0
in O 0 9.860968708252926e-10
that O 0 5.247136752872805e-11
pedigree O 0 1.0526664873111713e-08
. O 0 1.888386691462074e-08

The O 0 1.5682283249773832e-09
concept O 0 1.1224994267422517e-09
of O 0 1.3253802499946232e-09
segregation O 0 1.5597274583001308e-08
distortion O 0 1.513309122458395e-08
, O 0 1.2381831400020554e-13
where O 0 1.227217248178994e-13
there O 0 4.1612285855583894e-14
is O 0 4.302392470745655e-15
preferential O 0 5.906469324051811e-12
transmission O 0 1.4272456549946355e-09
of O 0 2.990509576084044e-11
the O 0 3.232395948127298e-11
larger O 0 1.3982219028429999e-11
allele O 0 9.767909397995211e-11
at O 0 7.588593642360308e-10
the O 0 1.0008756490265114e-08
DM B-Disease 1 1.0
locus O 0 6.389252682481583e-09
, O 0 2.4838249512715294e-11
has O 0 3.532850281848937e-13
been O 0 5.536858298238467e-12
put O 0 1.8564849310620524e-11
forward O 0 1.0493417246237868e-10
to O 0 1.6813399283943653e-10
explain O 0 1.6452778694997505e-08
partially O 0 1.0116831816731064e-08
the O 0 8.377771393286437e-11
maintenance O 0 3.849925633403473e-06
of O 0 2.2564617552234267e-07
DM B-Disease 1 1.0
in O 0 2.107345631330304e-09
the O 0 1.44122713763295e-09
population O 0 5.4372718133466336e-11
. O 0 2.2021320322807014e-09

In O 0 8.829713848967913e-09
a O 0 8.732985445902841e-10
survey O 0 2.6158197830028485e-09
of O 0 6.974335331477732e-09
DM B-Disease 1 1.0
in O 0 7.017381786766919e-09
Northern O 0 1.6320171880579437e-07
Ireland O 0 6.730773804974888e-08
, O 0 2.4017565714018474e-10
59 O 0 4.86991353909616e-08
pedigrees O 0 1.0673002037719925e-07
were O 0 1.4476000842478243e-08
ascertained O 0 4.2235460568917915e-06
. O 0 1.815666621496348e-07

Sibships O 0 0.0003017079725395888
where O 0 5.326863394827797e-10
the O 0 6.409459074596668e-11
status O 0 2.615993255350446e-10
of O 0 3.7733366431424997e-10
all O 0 1.6683978851239623e-11
the O 0 1.5708132711234057e-11
members O 0 2.4046281459078056e-12
had O 0 1.0969496144763724e-11
been O 0 2.7154771486959106e-12
identified O 0 3.163075357193179e-11
were O 0 2.420213855713893e-11
examined O 0 3.4904848456029924e-10
to O 0 2.4003253811660796e-12
determine O 0 8.848875104883192e-11
the O 0 6.19915785371461e-11
transmission O 0 0.0004124987463001162
of O 0 2.3517841007958395e-09
the O 0 3.456303687698892e-08
DM B-Disease 1 1.0
expansion O 0 1.2821570294363482e-07
from O 0 2.6105900774453517e-10
affected O 0 2.063870879753793e-10
parents O 0 5.773455064722599e-12
to O 0 1.467444048219857e-11
their O 0 3.680714621978609e-10
offspring O 0 6.862964596621168e-08
. O 0 7.233514764948268e-08

Where O 0 1.1471653627026512e-09
the O 0 4.275293730149343e-10
transmitting O 0 3.4528486025919847e-07
parent O 0 1.3805846466041771e-09
was O 0 7.85178322360025e-09
male O 0 9.66084279241386e-09
, O 0 1.6233375754737267e-10
58 O 0 5.566943173107575e-07
. O 0 3.7748023373751494e-07

3 O 0 6.580414435575221e-08
% O 0 1.0462032129510135e-08
of O 0 2.4918930807693584e-10
the O 0 8.412244512090439e-11
offspring O 0 1.0244791681657262e-09
were O 0 4.6314144186432316e-10
affected O 0 2.2713711467226005e-10
, O 0 6.012791176415733e-13
and O 0 5.120236916747456e-13
in O 0 3.2430406016886737e-12
the O 0 1.0618543370977118e-11
case O 0 4.247500354909173e-12
of O 0 9.117743365871789e-11
a O 0 4.430101771535355e-11
female O 0 1.5356801386090524e-09
transmitting O 0 7.876565888409459e-08
parent O 0 1.0039015174712063e-09
, O 0 7.40292771528317e-10
68 O 0 7.98947803559713e-06
. O 0 2.1602913875540253e-06

7 O 0 4.1386039129065466e-07
% O 0 2.0078779527921142e-08
were O 0 1.3800186549062232e-09
affected O 0 8.751181113098028e-09
. O 0 3.114765689815613e-08

Studies O 0 3.3029319723709705e-08
on O 0 1.7915026129244893e-09
meiotic O 0 4.1461692035227316e-07
drive O 0 1.325103369254066e-07
in O 0 1.032045671145454e-09
DM B-Disease 1 1.0
have O 0 2.256558828683808e-11
shown O 0 2.0398911726449143e-11
increased O 0 8.879878603262892e-12
transmission O 0 3.709809404117692e-10
of O 0 3.5679027007157194e-12
the O 0 2.711833578875056e-12
larger O 0 3.4503227098331424e-12
allele O 0 4.9934625878655936e-11
at O 0 5.417977733124246e-10
the O 0 5.871725328177035e-09
DM B-Disease 1 0.9999992847442627
locus O 0 1.970228202807789e-09
in O 0 7.506022470238349e-10
non O 0 1.7573542208992876e-05
- O 0 0.0034170595463365316
DM O 1 1.0
heterozygotes O 0 1.3936625009591808e-06
for O 0 7.733503615270365e-09
CTGn O 0 0.00028172743623144925
. O 0 2.564899546086963e-07

This O 0 3.1294609126319983e-09
study O 0 1.0123120119942541e-09
provides O 0 1.5895963365042398e-11
further O 0 6.5296032469852605e-12
evidence O 0 9.075201007346934e-11
that O 0 1.9211411975139647e-12
the O 0 2.558199208024803e-09
DM B-Disease 1 1.0
expansion O 0 4.2864070337600424e-07
tends O 0 5.472913677806446e-09
to O 0 2.3091871470537484e-10
be O 0 6.438624078342059e-10
transmitted O 0 2.2271274247032125e-07
preferentially O 0 2.377992025515141e-08
. O 0 6.084414394535997e-08

Diagnosis O 1 0.9999997615814209
of O 1 0.9917657971382141
hemochromatosis B-Disease 1 1.0
. O 0 0.0014666873030364513

If O 0 1.8729031580733135e-05
untreated O 1 1.0
, O 0 1.1728439375247035e-07
hemochromatosis B-Disease 1 1.0
can O 0 7.313617516047088e-07
cause O 0 0.00016823515761643648
serious O 0 0.3198206126689911
illness O 1 0.9999991655349731
and O 0 2.8902590390456062e-11
early B-Disease 0 1.193466925286657e-08
death I-Disease 0 9.846796711343586e-10
, O 0 1.2974370926580048e-12
but O 0 7.934796483061168e-13
the O 0 3.8387553552565734e-11
disease O 0 1.0758224533446992e-08
is O 0 9.820898434764747e-13
still O 0 8.663313122436733e-12
substantially O 0 1.490756296185225e-09
under O 0 5.4417000683315564e-08
- O 0 2.2948437617742456e-05
diagnosed O 0 0.0032576723024249077
. O 0 6.285246172410552e-07

The O 0 2.39732393936265e-08
cornerstone O 0 1.0254013886878965e-06
of O 0 4.381024432120739e-09
screening O 0 2.3929509485043354e-09
and O 0 7.364247232855003e-12
case O 0 9.116904280126459e-12
detection O 0 3.631824174732401e-09
is O 0 3.0956097060719223e-13
the O 0 9.797404207367855e-12
measurement O 0 6.014753139993445e-09
of O 0 6.154216025677783e-10
serum O 0 9.217627217061874e-10
transferrin O 0 2.998285841826487e-09
saturation O 0 4.544844056653119e-09
and O 0 3.5596053882258616e-11
the O 0 6.793359763612727e-10
serum O 0 1.3275617050112487e-08
ferritin O 0 2.281255859770681e-07
level O 0 4.011291707683995e-07
. O 0 5.6756373822963724e-08

Once O 0 5.9060642598751656e-08
the O 0 4.457200164509345e-10
diagnosis O 0 2.2385331703844713e-06
is O 0 4.81037779054283e-12
suspected O 0 2.835209578222475e-08
, O 0 5.2309583747911503e-11
physicians O 0 4.854701529666272e-09
must O 0 1.4430672212739637e-09
use O 0 4.559039368245976e-09
serum O 0 8.574613730161218e-07
ferritin O 0 6.041625510988524e-06
levels O 0 2.518189603506471e-06
and O 0 4.009166332252789e-09
hepatic O 0 1.698488813417498e-05
iron O 0 7.850915721974161e-07
stores O 0 1.1829663915108313e-09
on O 0 1.1826752910337746e-09
liver O 0 1.0511898018705779e-08
biopsy O 0 3.378042023882699e-08
specimens O 0 3.2790697934714785e-10
to O 0 5.00612711007431e-11
assess O 0 9.830776193098245e-09
patients O 0 1.5937905439855626e-09
for O 0 1.5878328166185618e-11
the O 0 8.911837379166343e-10
presence O 0 3.449656782450461e-09
of O 0 3.6839284689449414e-07
iron B-Disease 0 0.0500040128827095
overload I-Disease 0 0.0038126283325254917
. O 0 5.306405341798381e-07

Liver O 0 0.0195104219019413
biopsy O 1 0.998028576374054
is O 0 3.7218150783502324e-10
also O 0 2.866343664156834e-12
used O 0 1.5276621981308303e-11
to O 0 1.671580929230032e-10
establish O 0 1.805840277313564e-08
the O 0 7.15908776705021e-10
presence O 0 3.3083494277441616e-11
or O 0 2.7122795329126426e-11
absence O 0 4.2609954675754125e-07
of O 0 7.051045827211055e-07
cirrhosis B-Disease 1 1.0
, O 0 2.2712789982115567e-11
which O 0 6.160266524321556e-13
can O 0 1.6669188598883444e-11
affect O 0 1.1852119286004381e-08
prognosis O 0 7.164548878790811e-05
and O 0 5.146732817706834e-09
management O 0 4.555548912321683e-06
. O 0 6.529304528157809e-07

A O 0 5.904251310084874e-08
DNA O 0 5.0436181453505924e-08
- O 0 2.6920363160876093e-10
based O 0 2.3666333649752236e-13
test O 0 2.1221902273688142e-12
for O 0 1.2147422824571041e-12
the O 0 9.353211954943319e-11
HFE O 0 5.206969035498332e-06
gene O 0 2.424936119960197e-11
is O 0 1.4602028082771196e-13
commercially O 0 1.0440353442886519e-10
available O 0 2.1270105121651284e-10
, O 0 1.3572744273979143e-12
but O 0 6.75263068117965e-13
its O 0 1.5193759878712187e-13
place O 0 1.3460964981559798e-11
in O 0 2.540282654367454e-12
the O 0 2.458594092202837e-11
diagnosis O 0 1.0822263902809937e-05
of O 0 2.5151268800982507e-07
hemochromatosis B-Disease 1 1.0
is O 0 4.266984265921536e-10
still O 0 3.880675225609309e-10
being O 0 1.5696648425489457e-09
evaluated O 0 1.495910311177795e-07
. O 0 1.8815883606748685e-07

Currently O 0 7.309838423452675e-08
, O 0 7.495703363558093e-11
the O 0 1.2048927133800902e-10
most O 0 9.52791838482181e-12
useful O 0 1.818901695926911e-10
role O 0 4.0169773757314786e-11
for O 0 7.400266163748448e-12
this O 0 2.5039872519200257e-12
test O 0 4.4204286064886134e-11
is O 0 3.874885438556741e-13
in O 0 7.032468140807935e-13
the O 0 1.0456091721622318e-11
detection O 0 2.7707798722076404e-07
of O 0 3.046712038212718e-08
hemochromatosis B-Disease 1 1.0
in O 0 5.539336211946022e-10
the O 0 1.848500519319174e-10
family O 0 1.2727216849861556e-11
members O 0 4.642119588033067e-12
of O 0 1.8227949705185154e-10
patients O 0 2.9364699560829877e-10
with O 0 5.2873296019217975e-12
a O 0 2.279113148206946e-10
proven O 0 7.230079290820868e-07
case O 0 2.3007767913085786e-10
of O 0 5.0072497259634474e-09
the O 0 5.220022814000913e-08
disease O 0 1.75874556589406e-05
. O 0 4.1089585067766166e-08

It O 0 4.506249262625772e-10
is O 0 4.9727427037238314e-11
crucial O 0 1.9735244904950378e-07
to O 0 3.863991366870323e-07
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999997615814209
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 5.489077921083663e-07
because O 0 2.2411237310393517e-09
phlebotomy O 1 0.9631981253623962
therapy O 1 0.9618077278137207
can O 0 1.7423057441234846e-09
avert O 0 1.1932572760997573e-06
serious O 1 0.9999779462814331
chronic O 1 1.0
disease O 1 0.999984622001648
and O 0 1.0936701544395078e-10
can O 0 6.30857310834898e-11
even O 0 1.964597581838312e-11
lead O 0 1.3705196699742572e-10
to O 0 6.477199332444172e-11
normal O 0 3.705959272792825e-07
life O 0 4.787629404034988e-09
expectancy O 0 7.54140287995142e-08
. O 0 2.1392775051420898e-10
. O 0 6.592923984527488e-09

Prevalence O 0 1.263200283574406e-05
of O 0 7.623371267584389e-09
the O 0 5.7282067977837414e-09
I1307K O 0 6.154507445899071e-06
APC B-Disease 0 2.1762740942676828e-08
gene O 0 7.406818214317212e-12
variant O 0 1.3528581033206422e-11
in O 0 1.3678858393206816e-12
Israeli O 0 1.076462829985303e-08
Jews O 0 1.7155678266878027e-10
of O 0 1.024636452073846e-11
differing O 0 1.8038124162747526e-12
ethnic O 0 1.0873065685659822e-12
origin O 0 1.3676230287140712e-11
and O 0 1.1096324380177602e-11
risk O 0 5.26278798318458e-09
for O 0 1.195407293153039e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00010144065163331106

BACKGROUND O 0 0.008343073539435863
& O 0 2.109642764480668e-06
AIMS O 0 2.6871228442360007e-07
Israeli O 0 6.172513735691609e-07
Jews O 0 2.193543835460332e-08
of O 0 3.642528501046627e-09
European O 0 2.9825208969214145e-09
birth O 0 1.9851364996270604e-08
, O 0 5.619550658142458e-11
i O 0 8.190574329880462e-10
. O 0 2.2686942602323512e-11
e O 0 2.692558849493043e-11
. O 0 1.1136142355483436e-11
, O 0 1.5649101806070043e-11
Ashkenazim O 0 5.401710723162978e-07
, O 0 1.3719286991176194e-11
have O 0 4.938504900159346e-12
the O 0 8.823732855489652e-10
highest O 1 0.997420072555542
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.0006223719101399183
of O 0 1.3563190570664574e-09
any O 0 6.368975485893102e-11
Israeli O 0 2.2722623782556184e-07
ethnic O 0 9.277265178297966e-09
group O 0 6.01467042837811e-10
. O 0 4.2726977511620134e-08

The O 0 8.156658992675148e-08
I1307K O 0 1.9453580080153188e-06
APC B-Disease 0 3.007514592923144e-08
gene O 0 7.742778640462689e-11
variant O 0 5.023978455476197e-10
was O 0 1.8363925491371447e-08
found O 0 4.779734941173786e-10
in O 0 3.3001140709032484e-10
6 O 0 1.4214059262940282e-07
. O 0 7.51316306946137e-08

1 O 0 1.9401571904609227e-08
% O 0 9.093090724832109e-09
of O 0 3.036452200788631e-10
American O 0 6.997766949234929e-11
Jews O 0 4.4309741986658935e-10
, O 0 2.4060458486685476e-12
28 O 0 1.2515265213064453e-10
% O 0 6.866738427868668e-11
of O 0 3.322134234373664e-11
their O 0 7.897216214303171e-09
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 6.485045673798595e-07
, O 0 1.8725234904315435e-11
but O 0 1.7399750260396751e-12
not O 0 1.2959532535647411e-12
in O 0 4.0584716143321486e-11
non O 0 2.691367342322337e-07
- O 0 4.095945627113906e-08
Jews O 0 2.5136394299352105e-08
. O 0 1.3311601776422322e-07

We O 0 1.2682042971334795e-08
assessed O 0 3.705993734115509e-08
the O 0 2.7487696563355257e-09
I1307K O 0 5.946076726104366e-06
prevalence O 0 1.2615137823246414e-09
in O 0 2.0839107078406832e-13
Israeli O 0 2.1594523946788513e-09
Jews O 0 3.739362153254433e-10
of O 0 4.877156664639948e-11
differing O 0 5.6138058611432395e-12
ethnic O 0 3.3402469158672066e-12
origin O 0 2.4271435555833776e-11
and O 0 1.2788854177048226e-11
risk O 0 4.859592728223561e-09
for O 0 1.147236403653551e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.000536220904905349

METHODS O 0 7.61549642902537e-07
DNA O 0 4.4879751470716656e-08
samples O 0 6.881623604293452e-10
from O 0 2.190676459679075e-11
500 O 0 3.447555088631482e-11
unrelated O 0 2.3855761810409604e-10
Jews O 0 4.0231518116939924e-10
of O 0 3.481244847947096e-09
European O 0 6.043272104960806e-09
or O 0 1.067276822475094e-09
non O 0 7.561537813671748e-07
- O 0 4.8315063061465935e-09
European O 0 6.992820766882346e-10
origin O 0 1.0153284879521607e-09
, O 0 1.3494169974134773e-12
with O 0 1.607553201882564e-13
or O 0 7.944927268160873e-13
without O 0 2.197887531696363e-11
a O 0 1.2239994608143068e-11
personal O 0 2.130317611204191e-08
and O 0 2.0241730513959055e-09
/ O 1 0.9999836683273315
or O 0 8.388604477715944e-09
family O 0 3.6877978448757176e-10
history O 0 1.1646311470769888e-08
of O 0 9.669373080001264e-10
neoplasia B-Disease 0 4.1238838122126253e-08
, O 0 3.997889259227394e-12
were O 0 2.2090794471463227e-11
examined O 0 1.994992226972414e-10
for O 0 1.6814087015065704e-12
the O 0 3.0310403492661564e-11
I1307K O 0 8.116832539428742e-09
variant O 0 5.020180451897893e-12
by O 0 4.457439734158186e-13
the O 0 1.3837520539128345e-11
allele O 0 1.7445160593876352e-10
- O 0 3.248700961022699e-11
specific O 0 2.5608621126438358e-11
oligonucleotide O 0 3.67513450783008e-08
( O 0 3.7712213907248326e-10
ASO O 1 0.9991708993911743
) O 0 1.129203050509453e-10
method O 0 6.27811687081703e-08
. O 0 6.982643441233449e-08

RESULTS O 0 1.037595438901917e-06
In O 0 1.3005484467143447e-09
persons O 0 1.2021043049870173e-09
at O 0 5.2028586300378876e-11
average O 0 1.7623036710490148e-11
risk O 0 4.181699084226942e-11
for O 0 8.956586583508397e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 4.968140565608792e-09
I1307K O 0 4.259452907717787e-06
was O 0 1.2681455885399373e-09
found O 0 2.5824243785055323e-11
in O 0 2.5671707815089206e-11
5 O 0 4.941018261206409e-09
. O 0 1.697614671059e-08

0 O 0 4.946421494622655e-09
% O 0 2.2241115615884155e-09
of O 0 1.0517743620486186e-10
120 O 0 1.1540916000640777e-09
European O 0 7.47654915755902e-09
and O 0 2.686303401944201e-09
1 O 0 1.9726438438283367e-07
. O 0 1.4554883875916858e-07

6 O 0 5.014238624312384e-08
% O 0 1.3474439342076039e-09
of O 0 8.787819777422712e-11
188 O 0 5.52742018822272e-10
non O 0 8.78325820963255e-08
- O 0 3.2843370689761286e-08
European O 0 1.3987815350446908e-08
Jews O 0 4.2355603113719553e-07
( O 0 1.7045367894930052e-10
P O 0 3.2788764769975387e-07
= O 0 1.318717496312516e-10
0 O 0 4.242650501751211e-12
. O 0 5.385179281669483e-12
08 O 0 2.586971192819476e-10
) O 0 1.537035256016228e-11
. O 0 3.4901470602477502e-09

It O 0 9.13104369892892e-10
occurred O 0 7.723202344322999e-08
in O 0 3.040311613577984e-10
15 O 0 1.1880501027405899e-08
. O 0 2.6242467754400423e-08

4 O 0 3.026885053714068e-08
% O 0 1.2381643488268423e-09
of O 0 6.960720194681969e-11
52 O 0 5.403406055926041e-10
Ashkenazi O 0 1.7605996660563505e-08
Israelis O 0 5.993181275698589e-07
with O 0 8.631456660523895e-10
familial O 0 0.0006223811651580036
cancer B-Disease 1 0.9999992847442627
( O 0 5.416658233059479e-09
P O 0 0.012446042150259018
= O 0 7.989068295799484e-10
0 O 0 1.1725330775758103e-11
. O 0 4.734833185249254e-12
02 O 0 1.7183447720281464e-10
) O 0 1.0390534190430484e-13
and O 0 4.2094230661912646e-13
was O 0 1.0692949997670453e-11
not O 0 1.4172390474728735e-12
detected O 0 7.324454237567224e-11
in O 0 3.911353879670898e-12
51 O 0 3.4665486037255278e-09
non O 0 1.7600766000214207e-07
- O 0 1.9989744970416723e-08
European O 0 3.1482836337914932e-09
Jews O 0 2.6667015262660243e-08
at O 0 6.090902449074065e-09
increased O 0 4.622538796184017e-09
cancer B-Disease 0 3.455130581642152e-08
risk O 0 5.081709275600588e-09
. O 0 4.829085753499385e-08

Colorectal B-Disease 1 0.7267215847969055
neoplasia I-Disease 0 0.24284088611602783
occurred O 1 0.9776744246482849
personally O 0 4.403535058372654e-06
or O 0 5.186977514171076e-10
in O 0 4.4089013689907475e-11
the O 0 1.2923159764532954e-10
families O 0 3.8042496236512235e-11
of O 0 1.3691950351280013e-10
13 O 0 9.589954386157729e-10
of O 0 7.071552787785151e-10
20 O 0 2.6102278116724165e-09
Ashkenazi O 0 1.6999516105897783e-07
I1307K O 0 2.3077679145444563e-07
carriers O 0 3.814771068477718e-11
, O 0 3.947395795650399e-12
8 O 0 3.515178148560949e-10
of O 0 2.1095334368226304e-09
whom O 0 3.212780796957304e-08
also O 0 1.3645230778625006e-10
had O 0 1.394108939400951e-09
a O 0 2.874356030968528e-10
personal O 0 3.7711464528911165e-07
or O 0 6.9389081147619436e-09
family O 0 1.4137286896698242e-09
history O 0 1.2183511444163742e-07
of O 0 3.340101386584138e-07
noncolonic O 0 0.0032697590067982674
neoplasia B-Disease 0 0.024553699418902397
. O 0 2.7705470984074054e-06

CONCLUSIONS O 0 4.058597369294148e-06
The O 0 4.93511578270045e-08
I1307K O 0 8.604573849879671e-06
APC O 0 9.398020495154924e-08
variant O 0 2.3233035495451304e-09
may O 0 1.915544944885994e-10
represent O 0 3.6142769332947466e-10
a O 0 3.5608768711448135e-10
susceptibility O 0 1.909297386859521e-09
gene O 0 1.8854480476893087e-10
for O 0 4.546734100330241e-09
colorectal B-Disease 1 1.0
, I-Disease 0 1.0820047435800006e-07
or I-Disease 0 1.1032438962388369e-08
other I-Disease 0 2.739934057416349e-09
, I-Disease 0 2.9080440833162413e-10
cancers I-Disease 0 0.0010149654699489474
in O 0 1.621368284077107e-08
Ashkenazi O 0 0.00012233723828103393
Jews O 0 1.0179238785212874e-07
, O 0 1.0377656373128374e-10
and O 0 1.695457801931255e-10
partially O 0 2.1436096631077817e-07
explains O 0 9.445363380322647e-10
the O 0 2.52495302444089e-10
higher O 0 3.05531884237098e-08
incidence O 0 2.240797357444535e-06
of O 0 1.2298760339035653e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 5.570658601072864e-09
European O 0 1.264778948240064e-08
Israelis O 0 1.9535887076926883e-06
. O 0 9.367222020273402e-08

Systematic O 0 4.832384448150151e-08
analysis O 0 7.529844303633126e-09
of O 0 6.53246612358771e-09
coproporphyrinogen O 0 3.295876467745984e-06
oxidase O 0 1.801732452122451e-08
gene O 0 1.1491894547077663e-08
defects O 0 8.345668334186485e-07
in O 0 1.6746452002891488e-09
hereditary B-Disease 1 0.9999996423721313
coproporphyria I-Disease 1 0.9999994039535522
and O 0 7.951738467681935e-08
mutation O 0 2.0735756223189128e-08
update O 0 9.244764669347205e-07
. O 0 1.7793672668631189e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 1.793311987796642e-08
HC B-Disease 1 1.0
) O 0 1.5093887029138386e-08
is O 0 5.78025904918178e-10
an O 0 1.2424224982154897e-09
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 4.1890843931469135e-06
autosomal O 1 0.9999998807907104
dominant O 1 0.9976307153701782
inheritance O 0 4.679297035181662e-06
caused O 0 1.7123428008858355e-08
by O 0 3.629472763999608e-11
deficient B-Disease 0 4.74435024599984e-09
activity I-Disease 0 4.2099670971573744e-10
of I-Disease 0 8.684548635784495e-10
coproporphyrinogen I-Disease 0 1.78775806602971e-07
III I-Disease 0 8.579008863307536e-06
oxidase I-Disease 0 1.3009603394564806e-09
( O 0 2.9770688692032365e-10
CPO O 0 6.508142860184307e-07
) O 0 3.800828263234024e-10
. O 0 2.3718767394598217e-08

Clinical O 0 6.171929999254644e-05
manifestations O 0 0.03211118280887604
of O 0 2.3634111130377278e-05
the O 0 6.646980068580888e-07
disease O 0 0.0006565417861565948
are O 0 1.3683686345480894e-12
characterized O 0 6.284982083382129e-12
by O 0 1.2480067977313491e-12
acute O 0 1.8356979580858024e-07
attacks O 0 2.2599637716780308e-09
of O 0 0.020224347710609436
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 3.5891304150936776e-08
precipitated O 0 4.397693764701671e-09
by O 0 4.6446882798201194e-12
drugs O 0 1.2377528169071894e-10
, O 0 1.5284366654266801e-12
fasting O 0 1.7923067474612253e-08
, O 0 2.377173458079085e-10
cyclical O 0 5.95092160438071e-07
hormonal O 0 5.42201462394587e-07
changes O 0 2.2074391203830146e-09
, O 0 1.5502832351188545e-09
or O 0 1.6535162217223842e-07
infectious B-Disease 1 0.9693165421485901
diseases I-Disease 1 0.9245573878288269
. O 0 1.5304110547731398e-06

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 3.0839055398246273e-07
also O 0 1.1584710274403776e-10
be O 0 1.0389063914706398e-10
present O 0 2.617047467623479e-09
. O 0 4.012289878119191e-08

The O 0 5.92333648796739e-08
seven O 0 1.4554101035457734e-08
exons O 0 1.818952100052229e-08
, O 0 8.617103558483663e-12
the O 0 1.557433904064709e-10
exon O 0 2.0393795541195914e-09
/ O 0 3.1279032697284492e-09
intron O 0 5.181936657550068e-09
boundaries O 0 1.9967623388073008e-10
and O 0 2.32840725866712e-11
part O 0 4.806622322384158e-10
of O 0 9.069291984076244e-09
3 O 0 1.048226061506341e-09
noncoding O 0 1.143678485249211e-09
sequence O 0 3.394746636575796e-11
of O 0 1.949473499296417e-10
the O 0 1.645345110157237e-10
CPO O 0 2.5955488425211115e-08
gene O 0 3.0170631618031685e-12
were O 0 3.25011406676623e-11
systematically O 0 6.754067444214584e-11
analyzed O 0 2.8138123775445223e-11
by O 0 7.497726940176863e-13
an O 0 1.5251052374112839e-12
exon O 0 7.540673641059925e-11
- O 0 3.302718862285836e-11
by O 0 3.019638011858561e-11
- O 0 5.595469865227187e-09
exon O 0 1.0079942436291844e-09
denaturing O 0 4.8021369991602114e-08
gradient O 0 1.863113219258139e-09
gel O 0 7.616075770044972e-09
electrophoresis O 0 8.410617091669792e-09
( O 0 4.165030473290976e-11
DGGE O 0 0.07812269032001495
) O 0 7.88111492299598e-13
strategy O 0 3.812152676863079e-11
followed O 0 9.598193550716672e-13
by O 0 3.5846247980553594e-14
direct O 0 1.1598162751383367e-12
sequencing O 0 1.6190394858117685e-10
in O 0 6.21829107302907e-12
seven O 0 2.168838025840003e-10
unrelated O 0 1.6800103530556498e-09
heterozygous O 0 8.272278417820189e-10
HC B-Disease 1 0.9943045973777771
patients O 0 2.415949711576104e-05
from O 0 2.3780879132573318e-07
France O 0 2.449982616781199e-07
, O 0 3.1141564327263893e-10
Holland O 0 1.081100808875135e-08
, O 0 1.551340653160871e-11
and O 0 1.4287939754942247e-11
Czech O 0 1.0399719485576497e-06
Republic O 0 1.18027746793814e-05
. O 0 2.294947080372367e-06

Seven O 0 3.858625419184136e-08
novel O 0 1.6991774653973835e-10
mutations O 0 1.8469992202341246e-10
and O 0 2.4252403470897965e-12
two O 0 4.794558413484529e-12
new O 0 1.3257024818191798e-11
polymorphisms O 0 2.341141280837178e-09
were O 0 5.650445444871366e-09
detected O 0 7.366748633330644e-08
. O 0 3.092005940175113e-08

Among O 0 1.350212741613177e-08
these O 0 1.5041624890077543e-10
mutations O 0 8.320029387665073e-11
two O 0 1.2346092030657285e-11
are O 0 1.6325775800685172e-11
missense O 0 2.9386413302745495e-08
( O 0 1.815051442477511e-10
G197W O 0 8.022399924811907e-06
, O 0 2.7358487697526357e-10
W427R O 0 1.5159891972871264e-06
) O 0 1.5917656082109488e-11
, O 0 3.4256341253230405e-12
two O 0 1.164014371002331e-11
are O 0 2.9890614289262984e-11
nonsense O 0 3.146608094084513e-07
( O 0 3.672061821280437e-10
Q306X O 0 5.16775480718934e-06
, O 0 3.0010649521017285e-10
Q385X O 0 1.2026000604237197e-06
) O 0 8.131680225009763e-12
, O 0 4.574834001208616e-12
two O 0 8.287794062145082e-12
are O 0 2.9213445898457202e-12
small O 0 1.3409201700398388e-11
deletions O 0 4.31405577927535e-10
( O 0 3.3105018726331537e-11
662de14bp O 0 2.4677032683939615e-07
; O 0 4.467837211308279e-11
1168del3bp O 0 2.242117460582449e-07
removing O 0 1.70937326515741e-08
a O 0 1.5859880075907995e-09
glycine O 0 6.206298142075184e-09
at O 0 1.2789167058713247e-08
position O 0 8.36261282444184e-09
390 O 0 1.9181125576750446e-09
) O 0 2.3542309594837274e-12
, O 0 8.841712626807274e-13
and O 0 1.0271052671567693e-12
one O 0 2.497609974741466e-12
is O 0 9.493279643293939e-14
a O 0 4.790189512410281e-12
splicing O 0 2.1753268075741516e-09
mutation O 0 5.979892969687484e-11
( O 0 6.0972160480232684e-12
IVS1 O 0 1.8178885511588305e-05
- O 0 4.505170991819796e-08
15c O 0 1.0371056760050124e-06
- O 0 6.593743933080987e-07
- O 0 7.129972345865099e-08
> O 0 1.5162495703435752e-09
g O 0 6.913405264930006e-11
) O 0 3.7868709903965403e-13
which O 0 2.1336711152238064e-13
creates O 0 4.676788470381332e-12
a O 0 2.3484053243705283e-12
new O 0 1.4506687517901184e-11
acceptor O 0 2.0034633507748367e-08
splice O 0 3.947282948502107e-06
site O 0 1.0397998551070486e-07
. O 0 2.3647062619147619e-07

The O 0 3.6215817544871243e-07
pathological O 0 3.4290321764274267e-06
significance O 0 3.2160794916080704e-08
of O 0 2.837389878607155e-08
the O 0 7.352721986819688e-09
point O 0 1.100559998690187e-08
mutations O 0 3.0511168591651483e-10
G197W O 0 4.525547936395924e-08
, O 0 2.3883795982615474e-11
W427R O 0 2.2975478941589245e-07
, O 0 5.997697564291693e-12
and O 0 3.6104695622096727e-12
the O 0 1.2861685327880679e-10
in O 0 2.0176732506982376e-10
- O 0 6.782329697863076e-10
frame O 0 1.618898348709763e-09
deletion O 0 1.7529046270059467e-10
390delGly O 0 6.791857076748897e-10
were O 0 5.924939792262274e-12
assessed O 0 1.1036736628777799e-11
by O 0 3.4180026430713495e-13
their O 0 4.995460642365224e-12
respective O 0 3.6910086098629336e-09
expression O 0 3.174982846076979e-11
in O 0 2.2090658295670362e-12
a O 0 5.897100299398494e-13
prokaryotic O 0 5.38894241730592e-11
system O 0 4.4706762597490624e-11
using O 0 1.6753527384838485e-11
site O 0 2.5972349271263795e-10
- O 0 9.04347638441827e-11
directed O 0 2.7456962051197742e-11
mutagenesis O 0 1.2002702476365812e-07
. O 0 3.523922131876134e-08

These O 0 2.2903823282405256e-10
mutations O 0 3.005210663653557e-11
resulted O 0 7.507164334619176e-11
in O 0 3.503561156470436e-12
the O 0 4.9569476995303674e-11
absence O 0 1.711748609523056e-08
or O 0 8.697358111486864e-11
a O 0 5.931308916240496e-11
dramatic O 0 1.0892344803892229e-09
decrease O 0 2.4018872224473853e-08
of O 0 2.1207378964049894e-08
CPO O 0 6.31533930572914e-06
activity O 0 1.1318093129375484e-07
. O 0 1.0719516296830989e-07

The O 0 6.639540472974659e-09
two O 0 1.096977370051988e-10
polymorphisms O 0 5.422547411093603e-10
were O 0 1.2966194784524987e-10
localized O 0 2.7889468512398707e-10
in O 0 2.0359032168459912e-11
noncoding O 0 8.25776336199624e-09
part O 0 2.507789809147454e-10
of O 0 3.9790140071716e-09
the O 0 2.229029405498295e-09
gene O 0 5.1062444203497925e-12
1 O 0 2.8643065350109076e-11
) O 0 2.9085056845595814e-13
a O 0 3.4257797987269356e-11
C O 0 7.354461484254671e-09
/ O 0 2.1097907865197385e-09
G O 0 1.4224760258585434e-09
polymorphism O 0 5.84334414188703e-10
in O 0 5.274781653130667e-11
the O 0 5.674787306730877e-10
promotor O 0 1.5299765436793678e-05
region O 0 4.0387480026993217e-08
, O 0 7.673781055039797e-11
142 O 0 7.652449340866951e-09
bp O 0 1.0281010709434213e-08
upstream O 0 2.8844575616915336e-09
from O 0 1.171375774156047e-10
the O 0 1.5879243753236238e-10
transcriptional O 0 1.0699978680861477e-09
initiation O 0 2.517222208453518e-09
site O 0 7.367557119941637e-10
( O 0 2.4761430753028613e-11
- O 0 3.7331943758545094e-08
142C O 0 1.2524634485089337e-06
/ O 0 1.0685708318192155e-08
G O 0 6.122899520732972e-09
) O 0 3.1384461002259556e-12
, O 0 2.2761785945651924e-12
and O 0 2.3655105652053976e-12
2 O 0 1.5841300493590893e-11
) O 0 3.920202107810661e-13
a O 0 4.239916143872202e-12
6 O 0 3.306822871085302e-11
bp O 0 4.4457781206430624e-11
deletion O 0 1.608573343969688e-11
polymorphism O 0 4.1998535205145515e-10
in O 0 4.92082138925376e-11
the O 0 3.079578536624439e-10
3 O 0 1.1256253706903863e-09
noncoding O 0 2.2705505031694884e-08
part O 0 1.4974610440532388e-10
of O 0 3.097216483283205e-09
the O 0 5.772131661530011e-09
CPO O 0 9.483223948336672e-07
gene O 0 1.0099797387308485e-10
, O 0 2.460794415459766e-11
574 O 0 2.8734312707001664e-09
bp O 0 2.965984124969623e-09
downstream O 0 1.912614289167891e-09
of O 0 3.187277108906983e-10
the O 0 1.062720050848398e-10
last O 0 3.2492042389975495e-10
base O 0 2.879838312264127e-10
of O 0 9.677578877154147e-11
the O 0 9.362582237271155e-11
normal O 0 1.392424842094897e-08
termination O 0 3.1625475571672723e-09
codon O 0 2.218248251750765e-09
( O 0 2.232086217246465e-11
+ O 0 7.40226768769503e-09
574 O 0 8.536895279576129e-08
delATTCTT O 0 1.2133366453781491e-06
) O 0 1.4794344638247026e-09
. O 0 5.1781260168581866e-08

Five O 0 3.4412082072776684e-07
intragenic O 0 4.056686884723604e-05
dimorphisms O 0 1.0537307389313355e-05
are O 0 4.592145760873301e-11
now O 0 2.65714204111811e-11
well O 0 1.561344456502134e-11
characterized O 0 5.7957784405093804e-11
and O 0 4.007019976243198e-12
the O 0 1.1532989147022832e-10
high O 0 1.5118131746483243e-10
degree O 0 2.2784014674925857e-09
of O 0 5.944449932293594e-10
allelic O 0 5.9104006133736675e-09
heterogeneity O 0 1.8796895151496074e-09
in O 0 2.6403806918651185e-10
HC B-Disease 0 0.11214270442724228
is O 0 3.234827405940166e-10
demonstrated O 0 1.3450326408204205e-09
with O 0 2.733238115004699e-12
seven O 0 1.2746262378904305e-11
new O 0 5.990626966928883e-14
different O 0 1.3822444707919934e-13
mutations O 0 4.4588090815020354e-13
making O 0 8.689208207124377e-13
a O 0 2.6648605197521213e-12
total O 0 1.998023413385397e-10
of O 0 5.825927518188223e-10
nineteen O 0 2.3095800827377388e-07
CPO O 0 4.1545345084159635e-06
gene B-Disease 0 2.308806301698496e-08
defects I-Disease 0 1.286046398263352e-07
reported O 0 6.530157525830305e-10
so O 0 1.2563960982703293e-10
far O 0 3.724940078608796e-10
. O 0 7.237179189267806e-10
. O 0 1.9726055455748792e-08

Coincidence O 0 8.665030577503785e-07
of O 0 4.910531536950202e-09
two O 0 2.7048918660455e-11
novel O 0 1.3473808006814192e-11
arylsulfatase O 0 8.336495049832138e-09
A O 0 9.26702159453896e-10
alleles O 0 1.4547002491482885e-11
and O 0 3.763660216815623e-11
mutation O 0 1.4845444318289935e-10
459 O 0 1.4864632857936044e-09
+ O 0 2.8669948193282835e-08
1G O 0 7.308764793378941e-07
> O 0 1.6248881351543787e-08
A O 0 3.342482512991296e-09
within O 0 5.326659668902778e-10
a O 0 7.953061820220597e-11
family O 0 2.7927152257412047e-10
with O 0 2.765017770300915e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 2.0887758536702883e-11
molecular O 0 1.501299085049368e-10
basis O 0 4.678898934962206e-10
of O 0 9.262921540909019e-10
phenotypic O 0 3.191550490555528e-08
heterogeneity O 0 5.248636512078519e-07
. O 0 5.335257355909562e-07

In O 0 7.807816615468255e-09
a O 0 9.940166467714562e-10
family O 0 4.149512677908973e-11
with O 0 2.346506886366506e-12
three O 0 5.8155553289696016e-11
siblings O 0 1.2792942261086182e-09
, O 0 1.509361890030328e-13
one O 0 2.9348627748979755e-14
developed O 0 2.8948091753550065e-12
classical O 0 4.7318882145930274e-09
late O 0 0.01215208601206541
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.4730632713622072e-08
MLD B-Disease 1 1.0
) O 0 3.310124674360537e-10
, O 0 1.6950560746686882e-11
fatal O 0 1.4245701507320518e-08
at O 0 1.5911632011977872e-09
age O 0 4.3516186210013075e-09
5 O 0 8.553539820876921e-11
years O 0 3.015649535642595e-11
, O 0 4.5461700268027705e-13
with O 0 1.8350759280194584e-12
deficient O 0 5.273099645819457e-08
arylsulfatase O 0 5.008034349884838e-06
A O 0 3.701823061419418e-06
( O 0 4.050624835549854e-10
ARSA O 0 0.0009886514162644744
) O 0 4.5255387978726525e-12
activity O 0 1.1162773483341937e-10
and O 0 4.644785858015643e-12
increased O 0 3.2392605264774943e-10
galactosylsulfatide O 0 4.6515154394910496e-07
( O 0 4.767870542821129e-10
GS O 1 0.9915158748626709
) O 0 1.8619621400262076e-09
excretion O 0 1.712172092993569e-07
. O 0 3.221912336925925e-08

The O 0 2.896466533286457e-08
two O 0 2.3980029073555897e-10
other O 0 4.651667592781017e-11
siblings O 0 2.81360601483982e-09
, O 0 4.3940398194997066e-12
apparently O 0 1.5572306111266698e-08
healthy O 0 1.1332418807796785e-06
at O 0 7.828682413446586e-08
12 O 0 1.050132070190557e-07
( O 0 4.942107140193386e-11
1 O 0 4.549293386446607e-09
/ O 0 1.8919486421964393e-08
2 O 0 2.9200161733022867e-10
) O 0 1.1614301100720814e-12
and O 0 4.39114066289048e-12
15 O 0 7.511589961151088e-11
years O 0 1.0932843519384505e-10
, O 0 7.356494970481298e-13
respectively O 0 1.4293152772459905e-10
, O 0 5.349560312957469e-13
and O 0 4.92713725722127e-13
their O 0 2.8006780922185115e-11
father O 0 7.408736735214916e-09
, O 0 4.4437942908759354e-11
apparently O 0 1.878701105795244e-08
healthy O 0 1.0434908936929332e-08
as O 0 1.0135608498329507e-11
well O 0 7.199960072590272e-11
, O 0 1.5883629481128203e-11
presented O 0 3.326698205796674e-08
ARSA O 0 0.4984610378742218
and O 0 1.425437279323205e-08
GS O 1 0.9999828338623047
values O 0 1.5042779244467397e-09
within O 0 1.9437258746979325e-10
the O 0 1.3709164012332131e-11
range O 0 2.1227752888819396e-10
of O 0 3.4485319044819107e-09
MLD B-Disease 1 1.0
patients O 0 3.168895545968553e-07
. O 0 5.3512273723299586e-08

Mutation O 0 3.7174467948375423e-09
screening O 0 4.924626262337028e-10
and O 0 3.910824355329856e-12
sequence O 0 7.278400104837601e-11
analysis O 0 2.1368633251750424e-10
disclosed O 0 1.723091336280902e-09
the O 0 1.6102801383977017e-11
involvement O 0 1.3820441457923494e-09
of O 0 2.8487151526590537e-10
three O 0 1.8816856059422626e-11
different O 0 1.48736162275398e-10
ARSA O 0 4.280621215002611e-05
mutations O 0 8.97506791108782e-11
being O 0 8.572072739132519e-12
the O 0 7.036805166338311e-12
molecular O 0 9.219837393548147e-11
basis O 0 1.5769929806452865e-09
of O 0 4.6742094639284915e-09
intrafamilial O 0 7.774807272653561e-06
phenotypic O 0 6.112051096351934e-07
heterogeneity O 0 4.026114311272977e-06
. O 0 1.2545291383503354e-06

The O 0 2.0063314565277324e-08
late O 0 6.023675268806983e-06
infantile O 0 0.23351827263832092
patient O 0 1.3558473028751905e-06
inherited O 0 1.0870930964301806e-06
from O 0 1.3977966561995459e-09
his O 0 1.6758059828703153e-08
mother O 0 1.7085714176801048e-08
the O 0 3.4741605148269628e-09
frequent O 0 1.5436031342019874e-09
0 O 0 2.2093631091291144e-10
- O 0 1.7234529359200224e-09
type O 0 8.302326603981669e-10
mutation O 0 3.5462502379068894e-10
459 O 0 1.991901976694521e-09
+ O 0 2.45167064427676e-09
1G O 0 5.5376300878151596e-08
> O 0 1.298335106092452e-09
A O 0 1.5006956788354842e-09
, O 0 1.5418794713228934e-12
and O 0 5.283103056592797e-13
from O 0 3.012200211482963e-11
his O 0 4.265088560106989e-10
father O 0 5.099419553289408e-09
a O 0 2.1684520498665982e-11
novel O 0 1.9922637758268413e-12
, O 0 1.953065666008072e-13
single O 0 3.391141881192716e-11
basepair O 0 3.3376299057863434e-08
microdeletion O 0 8.902672021804392e-08
of O 0 1.0145972950681426e-08
guanine O 0 7.059885565041668e-09
at O 0 2.982537772311389e-09
nucleotide O 0 1.5360404059805433e-09
7 O 0 1.6139500846890087e-09
in O 0 4.5904319234679747e-10
exon O 0 2.9078679464333845e-09
1 O 0 2.2646313990737355e-10
( O 0 2.7873925390053955e-11
7delG O 0 1.785623027217298e-07
) O 0 6.095792204341421e-10
. O 0 5.544521286537929e-08

The O 0 2.0193692051861944e-08
two O 0 1.0179171949786792e-09
clinically O 0 5.924058314121794e-06
unaffected O 0 2.580685354303114e-08
siblings O 0 2.528292852854719e-10
carried O 0 1.2222614413637256e-11
the O 0 4.8935567403818325e-11
maternal O 0 1.104701041754197e-08
mutation O 0 1.6935121360805994e-10
459 O 0 1.697872953343449e-09
+ O 0 1.2677786820347592e-08
1G O 0 2.7590539275479387e-07
> O 0 9.142480550394794e-09
A O 0 7.1410624080670004e-09
and O 0 1.6245635045541995e-11
, O 0 8.147745173860133e-13
on O 0 1.7793605130989043e-11
their O 0 1.1546674207052465e-11
paternal O 0 7.355187015001263e-10
allele O 0 1.3075394933448337e-10
, O 0 1.2657078076599992e-12
a O 0 3.364005688594185e-12
novel O 0 4.129314511852611e-12
cytosine O 0 7.725390882562522e-10
to O 0 1.2504287882908471e-10
thymidine O 0 4.010996690340107e-08
transition O 0 7.331816505029565e-07
at O 0 2.152741984673412e-08
nucleotide O 0 2.8831388831918048e-08
2435 O 0 6.433651833503973e-07
in O 0 1.5218355464696742e-09
exon O 0 1.0292842134163038e-08
8 O 0 6.553015907684312e-10
, O 0 2.6597268224654025e-12
resulting O 0 1.7442524855026953e-11
in O 0 2.602776718110822e-12
substitution O 0 7.122585854446584e-10
of O 0 2.424268119582962e-09
alanine O 0 5.906636513230978e-09
464 O 0 5.3217781292858035e-09
by O 0 1.7539222296747425e-09
valine O 0 4.288191848900169e-05
( O 0 2.618046002211827e-09
A464V O 0 6.494703029602533e-06
) O 0 8.359307135386018e-10
. O 0 4.509348983106065e-08

The O 0 3.5496437789106494e-08
fathers O 0 2.9319622285584046e-08
genotype O 0 5.385814016989343e-09
thus O 0 6.975077182502787e-10
was O 0 2.347778504940834e-08
7delG O 0 7.172499408625299e-06
/ O 0 7.847896631574258e-05
A464V O 0 0.0001183289714390412
. O 0 2.2225675877507456e-07

Mutation O 0 4.208269501759787e-07
A464V O 0 1.2836554560635705e-05
was O 0 4.811027576323568e-09
not O 0 4.64020107060481e-11
found O 0 1.1586648307471137e-11
in O 0 6.53240612644157e-12
18 O 0 1.4759030664279749e-09
unrelated O 0 4.898410566056555e-07
MLD B-Disease 1 1.0
patients O 0 1.595792831210474e-08
and O 0 7.353346404004313e-11
50 O 0 9.818763579971801e-09
controls O 0 1.274289616048918e-07
. O 0 1.725775291561149e-07

A464V O 0 7.940988143673167e-05
, O 0 4.699496902738076e-10
although O 0 3.5595323910619925e-10
clearly O 0 1.1018238543769598e-09
modifying O 0 8.094742298681012e-08
ARSA O 1 0.8880950808525085
and O 0 3.607103948866097e-08
GS O 1 1.0
levels O 0 1.6556954562929604e-07
, O 0 9.324671243482463e-12
apparently O 0 7.452228278914674e-10
bears O 0 8.294128162056325e-10
little O 0 8.377994825670143e-11
significance O 0 1.0112712750531827e-10
for O 0 1.62982110446519e-11
clinical O 0 2.3001122784194195e-08
manifestation O 0 9.003591117107135e-07
of O 0 4.721181085187709e-06
MLD B-Disease 1 1.0
, O 0 7.961037162829143e-09
mimicking O 0 1.4921687352398294e-07
the O 0 7.867373419401247e-09
frequent O 0 1.6185896356546436e-07
ARSA O 0 0.0016651912592351437
pseudodeficiency O 0 5.909043102292344e-05
allele O 0 7.561508823528129e-07
. O 0 2.617771031054872e-07

Our O 0 1.4954281368773081e-07
results O 0 1.644069214101762e-09
demonstrate O 0 1.917655145788899e-09
that O 0 1.1472817054020146e-12
in O 0 8.493379610730045e-13
certain O 0 5.858850730955378e-12
genetic O 0 1.0931384269996514e-10
conditions O 0 3.062536180209463e-08
MLD B-Disease 1 1.0
- O 0 9.023929123941343e-06
like O 0 3.878181664696001e-10
ARSA O 0 0.012672267854213715
and O 0 8.856595457018557e-10
GS O 1 0.9999992847442627
values O 0 2.296524082012752e-10
need O 0 2.0645115825224103e-11
not O 0 2.8616879373978554e-13
be O 0 1.4285124732421606e-12
paralleled O 0 6.61963373005392e-10
by O 0 6.006284011816909e-12
clinical O 0 1.8699566339819285e-08
disease O 0 5.9638498584035915e-09
, O 0 1.5085078368740068e-12
a O 0 5.4346670393112806e-12
finding O 0 3.5085065408502203e-10
with O 0 1.8968741508085252e-11
serious O 0 2.3776026125688077e-07
diagnostic O 0 1.0692211844798294e-06
and O 0 1.0743564260451421e-08
prognostic O 0 4.335666289989604e-06
implications O 0 3.730888522568421e-07
. O 0 2.2506181096559885e-07

Moreover O 0 3.4577656151668634e-06
, O 0 2.7685589376602593e-09
further O 0 1.52657513297072e-08
ARSA O 0 9.655462781665847e-05
alleles O 0 3.4327751752272206e-09
functionally O 0 3.8523307210880375e-08
similar O 0 9.458953065255571e-11
to O 0 1.3338811166718756e-09
A464V O 0 1.8492801245884039e-06
might O 0 3.697228634358396e-10
exist O 0 7.598398577002285e-10
which O 0 1.515454970714425e-12
, O 0 1.2833932050773655e-12
together O 0 3.32423220894551e-11
with O 0 1.0695601522503484e-11
0 O 0 8.007068896809244e-10
- O 0 9.823203583891882e-09
type O 0 1.1300767432942393e-08
mutations O 0 8.12777045666735e-09
, O 0 2.4609680612797113e-11
may O 0 1.0008006645634282e-09
cause O 0 3.6409679182725085e-07
pathological O 0 0.0013684676960110664
ARSA O 1 0.9998090863227844
and O 0 5.475495612472514e-08
GS O 1 1.0
levels O 0 6.400733099098943e-08
, O 0 2.111559191386725e-12
but O 0 2.910220079244824e-13
not O 0 1.6893542229175218e-13
clinical O 0 7.071063873320682e-11
outbreak O 0 2.6541942255153828e-11
of O 0 4.898730379676586e-11
the O 0 1.2095261459066364e-09
disease O 0 6.680318875851299e-08
. O 0 7.856392758576192e-10
. O 0 3.6082052901065254e-08

Human O 1 0.8912031054496765
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 0.007292145863175392
to O 0 7.992947104185077e-08
hematological B-Disease 1 0.9999998807907104
malignancy I-Disease 1 1.0
and O 0 2.2979598668371182e-07
neurofibromatosis B-Disease 1 0.9999983310699463
type I-Disease 0 0.0655701756477356
1 I-Disease 0 0.006137280724942684
. O 0 7.907316330602043e-07

Heterozygous O 0 7.937916279843193e-07
germ O 0 3.9138416468631476e-05
- O 0 4.521130563261977e-07
line O 0 1.070467980923695e-08
mutations O 0 6.533282248533112e-11
in O 0 4.588387395726423e-12
the O 0 9.340073159336271e-11
DNA O 0 4.819139007850026e-07
mismatch O 0 0.00041209982009604573
repair O 0 2.3669748770771548e-05
genes O 0 7.235840260300108e-10
lead O 0 4.2082090589978804e-10
to O 0 3.4326770315118438e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0011915102368220687

The O 0 1.9027804398774606e-07
disease O 0 3.738585519386106e-06
susceptibility O 0 1.4201100739796857e-08
of O 0 2.4018962818672662e-08
individuals O 0 1.0510695425125505e-08
who O 0 2.429240630874574e-08
constitutionally O 0 2.2514181182486936e-05
lack O 0 0.004602061118930578
both O 0 2.3774193724790393e-09
wild O 0 4.882222404134495e-10
- O 0 3.768431677819706e-10
type O 0 1.3946988008939343e-10
alleles O 0 4.333400652201114e-11
is O 0 8.591223218945565e-12
unknown O 0 6.368182425831037e-08
. O 0 4.2395367216840896e-08

We O 0 1.1355432150139677e-08
have O 0 1.0976297995513029e-11
identified O 0 5.600814256823128e-11
three O 0 1.451426327216121e-12
offspring O 0 3.946561827339323e-11
in O 0 1.552529806103653e-12
a O 0 2.4858071157041195e-10
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 3.735504287760705e-05
who O 0 1.4001475534541896e-09
developed O 0 2.7825052484331536e-07
hematological B-Disease 1 0.9999995231628418
malignancy I-Disease 1 1.0
at O 0 2.4408547005805303e-07
a O 0 1.3732802395249877e-10
very O 0 4.2302491370938e-11
early O 0 6.339506697372599e-09
age O 0 2.1477346123788266e-08
, O 0 3.2351573676925316e-12
and O 0 2.0737771309203845e-12
at O 0 1.0722835119825191e-10
least O 0 3.153988788889839e-12
two O 0 9.39900175918329e-13
of O 0 4.237910803533973e-12
them O 0 6.60852232312048e-13
displayed O 0 2.517028807602628e-10
signs O 0 7.992710937543279e-10
of O 0 8.21833978648101e-09
neurofibromatosis B-Disease 0 1.7088985259761102e-05
type I-Disease 0 1.749305056364392e-07
1 I-Disease 0 1.8765994980185496e-07
( O 0 2.3672745985692245e-09
NF1 B-Disease 0 2.849013253580779e-05
) O 0 1.5382275453390548e-09
. O 0 4.129732289470667e-08

DNA O 0 2.6673578901181827e-08
sequence O 0 2.897977691151965e-10
analysis O 0 6.51569770360183e-11
and O 0 3.917931951091802e-12
allele O 0 1.4870382702980578e-10
- O 0 2.651082652016523e-11
specific O 0 1.3251665390012768e-11
amplification O 0 2.0809272360811093e-10
in O 0 2.768966696556352e-12
two O 0 1.2075286083546022e-11
siblings O 0 1.244564229452294e-09
revealed O 0 7.354836184525482e-10
a O 0 3.611105511835966e-11
homozygous O 0 2.819423805533461e-09
MLH1 O 0 7.738733984297141e-05
mutation O 0 4.639347128687632e-09
( O 0 6.195141621923028e-10
C676T O 0 0.00034222227986902
- O 0 0.02256140112876892
- O 0 5.0736558478092775e-05
> O 0 1.734880584081111e-06
Arg226Stop O 0 7.692410872550681e-05
) O 0 1.5471718350923425e-10
. O 0 4.021742050497323e-09

Thus O 0 6.35787884561978e-08
, O 0 1.6372622702043316e-10
a O 0 2.5379798263003295e-10
homozygous O 0 1.4759685029730463e-08
germ O 0 3.97457079088781e-05
- O 0 5.647501097882923e-07
line O 0 3.650110969033449e-08
MLH1 O 1 0.9989911913871765
mutation O 0 2.526341580377789e-09
and O 0 8.958803143777061e-11
consequent O 0 6.38543424429372e-05
mismatch O 1 1.0
repair O 1 1.0
deficiency O 0 4.211676059640013e-05
results O 0 1.2630714252281905e-09
in O 0 6.911664296449516e-11
a O 0 1.4034674811203018e-10
mutator O 0 7.855588819438708e-07
phenotype O 0 3.822014260634887e-09
characterized O 0 2.4404337925498787e-11
by O 0 1.6041858813542476e-11
leukemia B-Disease 1 1.0
and O 0 6.604354751971186e-08
/ O 1 1.0
or O 0 0.1399650275707245
lymphoma B-Disease 1 1.0
associated O 1 1.0
with O 0 3.5530829336494207e-06
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 0.1234576627612114
1 I-Disease 0 2.0029983716085553e-05
. O 0 1.0469198841178695e-08
. O 0 1.7937020757585742e-08

Missense O 0 6.478579598478973e-05
mutations O 0 2.3100310997392626e-08
in O 0 2.785289221485243e-10
the O 0 4.02461786119801e-10
most O 0 9.027065553390834e-12
ancient O 0 8.938223494681097e-10
residues O 0 9.552479696139926e-09
of O 0 7.181269467970708e-10
the O 0 3.811865489922184e-09
PAX6 O 0 4.499719580053352e-05
paired O 0 2.0073420259336672e-08
domain O 0 2.1933052707368006e-08
underlie O 0 1.2900201795673638e-07
a O 0 8.22796136779047e-11
spectrum O 0 1.0469482703001631e-07
of O 0 3.497225620208155e-08
human O 1 0.9999772310256958
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9999737739562988

Mutations O 0 2.026233545393552e-07
of O 0 1.6982170336632407e-08
the O 0 4.032603584391836e-09
human O 0 1.6432611715799794e-08
PAX6 O 1 0.9106467962265015
gene O 0 1.8481064500974753e-07
underlie O 1 0.5911973714828491
aniridia B-Disease 1 1.0
( O 0 2.987623659578276e-08
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999428987503052
of I-Disease 0 0.077364481985569
the I-Disease 0 2.959866378660081e-07
iris I-Disease 0 9.310293336284303e-08
) O 0 7.776049248953143e-11
, O 0 1.7284319808741344e-11
a O 0 8.338092716275725e-11
rare O 0 2.1590912169244802e-08
dominant O 1 0.9998273253440857
malformation B-Disease 1 0.9999998807907104
of I-Disease 1 0.9999657869338989
the I-Disease 1 0.9999861717224121
eye I-Disease 1 0.9999996423721313
. O 0 7.453829766745912e-06

The O 0 4.580675394549871e-08
spectrum O 0 2.1284600393300934e-07
of O 0 1.942478888850019e-08
PAX6 O 0 0.00025665698922239244
mutations O 0 3.070219634082605e-09
in O 0 1.420922157713278e-09
aniridia B-Disease 1 1.0
patients O 0 1.3968117684726167e-07
is O 0 5.44896940068984e-12
highly O 0 8.247291738427975e-10
biased O 0 2.109549424034185e-09
, O 0 2.3879409734306467e-12
with O 0 8.436853104164255e-13
92 O 0 1.888768430546861e-08
% O 0 9.624182562006922e-10
of O 0 1.4100513291703809e-11
all O 0 1.981266713191321e-12
reported O 0 3.192532349594046e-11
mutations O 0 3.839048176579318e-11
leading O 0 6.671294766613656e-11
to O 0 1.7103336802382074e-10
premature O 0 1.1985750347776047e-07
truncation O 0 5.511652034329018e-06
of O 0 2.2335752873914316e-06
the O 0 5.547482260226388e-07
protein O 0 1.1818483969250337e-08
( O 0 2.627879164274205e-11
nonsense O 0 2.244200558720877e-08
, O 0 6.687432291957451e-12
splicing O 0 7.529394885352758e-10
, O 0 5.15251990379495e-12
insertions O 0 6.911984318236364e-10
and O 0 1.2652692261971854e-11
deletions O 0 1.8394509526675762e-10
) O 0 1.8867986600196174e-12
and O 0 5.921429319100113e-11
just O 0 1.0376592918248662e-09
2 O 0 1.5197115788012638e-10
% O 0 5.22143890624438e-11
leading O 0 5.246120920489317e-13
to O 0 1.3517529109940973e-13
substitution O 0 4.040221282530787e-11
of O 0 1.5237634765075114e-10
one O 0 3.355209513000723e-11
amino O 0 1.7804545338062638e-10
acid O 0 5.886405512328663e-12
by O 0 2.2555163032428327e-12
another O 0 1.6916139322642465e-10
( O 0 5.92414103883776e-11
missense O 0 1.710022985434989e-07
) O 0 3.0018093566397397e-10
. O 0 3.3182889325189535e-08

The O 0 1.3180700086934394e-08
extraordinary O 0 1.4123791025610899e-08
conservation O 0 1.2742118471464892e-09
of O 0 1.8733675721804843e-10
the O 0 3.8064146279381816e-10
PAX6 O 0 6.960689461266156e-06
protein O 0 9.794574040711268e-10
at O 0 2.724730441272527e-10
the O 0 5.639524958134245e-10
amino O 0 2.3844913599191386e-08
acid O 0 5.603651320740255e-09
level O 0 5.469847792483051e-07
amongst O 0 1.4101024703450094e-07
vertebrates O 0 7.471734164710142e-08
predicts O 0 2.315168501354492e-09
that O 0 4.447016366260215e-11
pathological O 0 2.0020620183913707e-07
missense O 0 1.0867603350561694e-06
mutations O 0 2.8690390063701443e-09
should O 0 1.7093618187580262e-10
in O 0 2.3224074052752286e-10
fact O 0 1.0984686493742402e-09
be O 0 1.9791272787283987e-10
common O 0 3.709356433123645e-10
even O 0 4.6531053315979065e-11
though O 0 3.9117438455082976e-11
they O 0 8.483476074405694e-12
are O 0 4.139471317804455e-12
hardly O 0 2.9838691517625193e-09
ever O 0 1.702854302010337e-09
seen O 0 3.4054765674085274e-09
in O 0 1.2667271676036762e-08
aniridia B-Disease 1 1.0
patients O 0 6.643262167926878e-06
. O 0 6.227406856851303e-07

This O 0 7.897197895623265e-10
indicates O 0 1.2530964044188408e-09
that O 0 6.328837735998516e-13
there O 0 2.9163173612123394e-12
is O 0 8.865536072193841e-14
a O 0 4.207522785043549e-12
heavy O 0 8.753885616386015e-09
ascertainment O 0 4.553800681605935e-05
bias O 0 5.508320910507791e-09
in O 0 2.429260091696417e-11
the O 0 4.790328897441576e-11
selection O 0 2.0758132712739297e-10
of O 0 1.6477666453518225e-10
patients O 0 1.3106131457885084e-10
for O 0 6.50669379487212e-11
PAX6 O 0 3.7108893593540415e-06
mutation O 0 1.2996599629833128e-10
analysis O 0 9.279291224295605e-11
and O 0 3.704678924743021e-12
that O 0 2.609089159999467e-12
the O 0 7.650431399497393e-10
missing O 0 9.291750757256523e-06
PAX6 O 1 0.9589765667915344
missense O 0 9.824581502471119e-05
mutations O 0 2.9822780334143317e-07
frequently O 0 6.864571577835932e-09
may O 0 1.290354401106697e-08
underlie O 0 1.168587914435193e-05
phenotypes O 0 6.363993065860996e-08
distinct O 0 2.0029580216629483e-09
from O 0 8.594678746476347e-09
textbook O 0 3.1515289720118744e-06
aniridia B-Disease 1 1.0
. O 0 1.8922427216239157e-06

Here O 0 3.7061994362375117e-07
we O 0 1.450556785798085e-09
present O 0 5.088894305949054e-10
four O 0 6.642789096567014e-11
novel O 0 1.2972652119191963e-10
PAX6 O 0 1.857290044426918e-06
missense O 0 1.1234471486432085e-07
mutations O 0 3.30247523772087e-10
, O 0 1.5672123971841034e-12
two O 0 2.666818155194761e-12
in O 0 7.811454608153134e-12
association O 0 1.4706185921808945e-11
with O 0 6.171324302278736e-12
atypical O 0 5.619727794226037e-09
phenotypes O 0 2.6503434114033553e-08
ectopia B-Disease 0 4.136305506108329e-06
pupillae I-Disease 0 9.725054042064585e-06
( O 0 1.3034675769296733e-11
displaced B-Disease 0 1.1969656377175397e-09
pupils I-Disease 0 8.06015165721874e-09
) O 0 1.2420758865872017e-10
and O 0 2.4606761073187045e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 0 2.1699219360016286e-05
( O 0 2.185132519372246e-09
searching B-Disease 0 0.0005254410207271576
gaze I-Disease 0 1.2153970601502806e-05
) O 0 1.482978670419577e-11
, O 0 4.9791659510745045e-12
and O 0 3.752912910992556e-12
two O 0 7.585126970965916e-12
in O 0 9.24744829322588e-12
association O 0 1.5736622074880025e-11
with O 0 7.0456960578335615e-12
more O 0 4.4221997591575857e-11
recognizable O 0 1.0880249590172753e-07
aniridia B-Disease 1 0.9999972581863403
phenotypes O 0 1.082494577531179e-06
. O 0 2.657174889009184e-07

Strikingly O 0 2.3434802187694004e-06
, O 0 5.890769538829943e-10
all O 0 1.0349567730605358e-10
four O 0 7.356081715981233e-11
mutations O 0 2.6164060501487896e-11
are O 0 7.603577056175537e-13
located O 0 3.721364362496704e-12
within O 0 1.1682832479209537e-10
the O 0 1.0506441272539746e-09
PAX6 O 0 3.7221474485704675e-05
paired O 0 2.5233957146042485e-08
domain O 0 1.426397311377059e-08
and O 0 1.2339436417097005e-10
affect O 0 3.8008248992582594e-08
amino O 0 7.158053261235864e-09
acids O 0 1.209742445107409e-10
which O 0 6.043973915098588e-13
are O 0 6.122291259028079e-13
highly O 0 1.3824785760618852e-10
conserved O 0 2.0595256056132882e-10
in O 0 2.316950797887074e-11
all O 0 9.034890197101575e-11
known O 0 3.747187005131991e-10
paired O 0 2.6210553727423758e-08
domain O 0 7.576871041692357e-08
proteins O 0 5.8348827991494545e-09
. O 0 6.04763243927664e-08

Our O 0 1.614919966641537e-07
results O 0 2.5064903486082812e-09
support O 0 2.794473819012211e-10
the O 0 2.4425666350635922e-11
hypothesis O 0 1.3267623978630017e-11
that O 0 9.689860404945433e-15
the O 0 3.0669770108987526e-13
under O 0 1.141637964718889e-10
- O 0 5.733581387445952e-10
representation O 0 1.2033568586033994e-09
of O 0 2.7980913142044983e-09
missense O 0 1.137416916208167e-06
mutations O 0 1.1621963391661438e-09
is O 0 2.9338133485101725e-12
caused O 0 1.0508278969201257e-10
by O 0 1.1873059480027592e-10
ascertainment O 0 0.00012201112986076623
bias O 0 1.7905675164797685e-08
and O 0 8.251850591722842e-11
suggest O 0 5.76951986186458e-10
that O 0 4.4117482020031296e-13
a O 0 2.1672808946798794e-12
substantial O 0 2.9805743984034905e-10
burden O 0 3.8235327792790486e-08
of O 0 1.0544111006538515e-07
PAX6 B-Disease 1 0.9999996423721313
- I-Disease 0 0.002538236090913415
related I-Disease 0 0.2387259155511856
disease I-Disease 1 0.9998800754547119
remains O 0 7.099680399136332e-09
to O 0 2.4011322444228433e-11
be O 0 6.550163883511928e-11
uncovered O 0 1.0569320352260547e-07
. O 0 8.673523566038455e-10
. O 0 1.467465882143415e-08

The O 0 2.7105151900741475e-08
chromosomal O 0 9.765444985987415e-08
order O 0 4.252124763404197e-10
of O 0 1.6859560858506484e-08
genes O 0 2.7959574655511688e-09
controlling O 0 1.0866743949122792e-08
the O 0 7.709481941731156e-09
major O 0 7.227363596484793e-08
histocompatibility O 0 2.654021727721556e-06
complex O 0 1.540341543204704e-07
, O 0 5.662048260801633e-11
properdin O 0 1.4065902576021472e-07
factor O 0 2.798773157675072e-10
B O 0 2.6677495768012705e-08
, O 0 1.3390441533367436e-11
and O 0 9.985026000469688e-11
deficiency B-Disease 0 6.925716297701001e-05
of I-Disease 0 1.4884806205373025e-06
the I-Disease 0 3.512313284659285e-08
second I-Disease 0 1.5475474413051415e-07
component I-Disease 0 6.011796926941315e-08
of I-Disease 0 1.7599013801827823e-08
complement I-Disease 0 1.5468938840967894e-07
. O 0 4.780706035489857e-07

The O 0 9.821479629579244e-09
relationship O 0 1.1535068011880867e-08
of O 0 3.1809987977027276e-09
the O 0 2.47931536412338e-10
genes O 0 1.274322487809787e-11
coding O 0 6.185624790155941e-10
for O 0 7.195919641406201e-12
HLA O 0 4.6441170353794803e-10
to O 0 4.8248683694185335e-12
those O 0 1.9374391414112013e-12
coding O 0 3.038510332231681e-09
for O 0 1.943584009012067e-11
properdin O 0 5.1931106526126314e-08
Factor O 0 2.721510239389602e-10
B O 0 3.835136652696747e-09
allotypes O 0 4.1728931421403104e-08
and O 0 1.6198231991837453e-11
for O 0 9.36981811583415e-11
deficiency B-Disease 0 9.894180948322173e-06
of I-Disease 0 5.9074274361137213e-08
the I-Disease 0 1.6028172122872775e-09
second I-Disease 0 7.3760393348720754e-09
component I-Disease 0 9.088097385756555e-09
of I-Disease 0 7.763859777298876e-09
complement I-Disease 0 2.175402613602273e-08
( O 0 1.9889852265198016e-10
C2 O 0 2.2781011921324534e-07
) O 0 5.729465079457041e-12
was O 0 1.9126425443438677e-10
studied O 0 3.634531564600252e-10
in O 0 1.875163869666241e-12
families O 0 5.604187686830686e-12
of O 0 3.473010767862661e-11
patients O 0 1.131173821278253e-09
with O 0 2.4146371568889435e-09
connective O 1 0.9999998807907104
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9999490976333618

Patients O 0 2.885541050545726e-07
were O 0 1.1966437840627009e-09
selected O 0 8.525427586114631e-11
because O 0 1.4540281955896517e-12
they O 0 2.778069386945997e-13
were O 0 1.4873409795446157e-11
heterozygous O 0 7.691702830214808e-11
or O 0 5.988282092417307e-11
homozygous O 0 5.607823894138164e-08
for O 0 4.406026619108161e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 5.0533948524389416e-05

12 O 0 2.88659443015149e-08
families O 0 4.699057809531837e-10
with O 0 2.0067454642447302e-11
15 O 0 4.382496143762182e-09
matings O 0 1.263977446797071e-05
informative O 0 6.431511110349675e-07
for O 0 4.649803315714962e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 1.792091808283658e-07
found O 0 3.6331613273432595e-09
. O 0 2.166289370109098e-08

Of O 0 1.0553568245086353e-05
57 O 0 1.6468089597765356e-05
informative O 0 1.0208009371126536e-06
meioses O 0 2.320932026123046e-06
, O 0 3.0653597715701864e-11
two O 0 1.2632436763304611e-11
crossovers O 0 2.2777658925665634e-10
were O 0 5.382840700951519e-11
noted O 0 2.4351005586953356e-11
between O 0 7.62325091940852e-10
the O 0 1.0226079183439651e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999984502792358
gene O 0 9.108074537633737e-12
and O 0 3.2507696621358884e-12
the O 0 1.453990816635553e-10
HLA O 0 1.3708400636858187e-08
- O 0 4.834317834934154e-09
B O 0 5.695262483840224e-09
gene O 0 3.901354933555368e-12
, O 0 1.8005872671773143e-13
with O 0 7.702554414602825e-14
a O 0 2.545467525996714e-12
recombinant O 0 1.586201135717058e-11
fraction O 0 4.908440875972531e-10
of O 0 4.231582584335314e-10
0 O 0 7.981970084891543e-10
. O 0 1.0833053565306727e-08

035 O 0 0.0019285695161670446
. O 0 8.827915735309944e-06

A O 0 5.960145017525065e-07
lod O 0 1.5874028349571745e-06
score O 0 2.9687308611414664e-08
of O 0 1.865260834676974e-09
13 O 0 4.0283426594456273e-10
was O 0 2.926655445767423e-11
calculated O 0 3.220131800096837e-11
for O 0 1.8292723238944042e-11
linkage O 0 2.316018168357914e-07
between O 0 2.0966115243936656e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
and O 0 6.608040781230784e-10
HLA O 0 2.0927785726598813e-08
- O 0 2.3683224270598657e-09
B O 0 1.9567647502327645e-09
at O 0 2.5113017568245688e-11
a O 0 1.037000211178904e-13
maximum O 0 8.99845627698459e-13
likelihood O 0 9.954001598672102e-13
value O 0 3.0635405236928426e-12
of O 0 6.041465071271457e-12
the O 0 7.63140418913455e-12
recombinant O 0 1.9296252096179245e-11
fraction O 0 3.1890221019459375e-10
of O 0 9.16699216535477e-10
0 O 0 1.7649293138077837e-09
. O 0 2.2470530325335858e-08

04 O 0 0.0006133620045147836
. O 0 1.37491615532781e-05

18 O 0 1.526948523178362e-07
families O 0 5.105528777527013e-10
with O 0 1.375896185179526e-11
21 O 0 2.7931001955749934e-09
informative O 0 9.713700954705473e-10
matings O 0 2.464254933443044e-08
for O 0 1.5030152122896823e-10
both O 0 3.086660038675859e-09
properdin O 0 1.8403499097985332e-06
Factor O 0 4.288657873274815e-09
B O 0 2.3514131086699308e-08
allotype O 0 4.766593519889284e-08
and O 0 2.2712585978634792e-10
HLA O 0 1.4383819291197142e-07
- O 0 3.551235394638752e-08
B O 0 6.568651400584713e-08
were O 0 4.105282336297478e-09
found O 0 5.415456971746835e-10
. O 0 6.311203115672015e-09

Of O 0 5.746534498030087e-06
72 O 0 2.9613605875056237e-05
informative O 0 3.0084615332270914e-07
meioses O 0 1.548840828036191e-06
, O 0 1.2338395062594376e-11
three O 0 2.420264683111739e-11
recombinants O 0 2.417864486403687e-08
were O 0 1.5782589124491153e-10
found O 0 1.4021611996484218e-11
, O 0 3.2856757679194937e-13
giving O 0 3.2188466302096597e-12
a O 0 4.802062827241604e-12
recombinant O 0 1.2305662044909127e-10
fraction O 0 1.7213307446084514e-09
of O 0 7.143786451280221e-09
0 O 0 1.0409583417470003e-08
. O 0 6.490365933586872e-08

042 O 0 0.003714001039043069
. O 0 7.64290689403424e-06

A O 0 9.869328323475202e-07
lod O 0 1.365320713375695e-06
score O 0 2.2060890003672284e-08
of O 0 3.742589349542413e-09
16 O 0 1.1224929874487088e-09
between O 0 4.880229553805293e-10
HLA O 0 3.488157318543017e-09
- O 0 5.095002753030542e-10
B O 0 2.90543811232169e-10
and O 0 3.9425802032810875e-12
Factor O 0 7.718831823710914e-11
B O 0 8.243957738685026e-10
allotypes O 0 8.360570902254949e-09
was O 0 9.721387583816465e-11
calculated O 0 1.411015193575338e-10
at O 0 2.5816709880999156e-11
a O 0 6.690274419532405e-13
maximum O 0 2.6533338026712983e-11
likelihood O 0 1.1331729304897564e-10
value O 0 6.510293693029467e-11
of O 0 4.0578214399733525e-11
the O 0 7.955702069351034e-11
recombinant O 0 9.578743354055064e-11
fraction O 0 1.4777959966849608e-09
of O 0 1.964633122852888e-09
0 O 0 3.2485432122086877e-09
. O 0 2.5577612916549697e-08

04 O 0 0.000473967898869887
. O 0 1.2584290743689053e-05

A O 0 1.538666225542329e-07
crossover O 0 6.340099112378539e-09
was O 0 1.756071177361207e-09
shown O 0 3.607361909185869e-10
to O 0 1.239373464967386e-10
have O 0 1.1154424606196756e-11
occurred O 0 3.2234594993241217e-09
between O 0 8.434528769862837e-11
genes O 0 4.585010756480434e-12
for O 0 2.7329826769728616e-12
Factor O 0 7.372529670091055e-11
B O 0 5.921319545798553e-10
and O 0 1.276108246850427e-10
HLA O 0 5.7738962055964294e-08
- O 0 8.90588154334182e-08
D O 0 1.1251042764115482e-08
, O 0 7.0000728304153714e-12
in O 0 3.4865224856489574e-12
which O 0 8.021119575832292e-13
HLA O 0 1.7512379324458038e-09
- O 0 9.91729032229216e-10
D O 0 1.6829673210594365e-09
segregared O 0 3.3819294031900426e-08
with O 0 2.537678747693839e-11
HLA O 0 2.1780645909075247e-07
- O 0 3.002195825274612e-08
A O 0 3.381910218536177e-08
and O 0 4.2190104188044586e-10
B O 0 1.120350248129398e-06
. O 0 1.4821324612057651e-08

These O 0 1.203092958590446e-09
studies O 0 5.69440161690693e-10
suggest O 0 5.359983290542658e-11
that O 0 1.2778162859425346e-13
the O 0 1.669195922975042e-12
genes O 0 2.4836389455468177e-12
for O 0 4.216383752558839e-12
Factor O 0 2.1708337349934936e-09
B O 0 4.426807663548971e-06
and O 0 1.225987148245622e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.5555665089372894e-10
located O 0 1.2749885348883883e-11
outside O 0 5.238456890488408e-11
those O 0 1.0289194843360328e-11
for O 0 1.2179404706991193e-10
HLA O 0 3.1050731763571093e-08
, O 0 4.396110211968285e-12
that O 0 2.690436035849425e-13
the O 0 4.797055547928197e-12
order O 0 6.175716622119909e-12
of O 0 1.3796264131116232e-09
genese O 0 1.6880758835213783e-07
is O 0 2.4862232064770673e-11
HLA O 0 3.460286057688222e-09
- O 0 2.3498829548884714e-09
A O 0 9.8596375508464e-09
, O 0 1.6662768387298854e-11
- O 0 4.161848088379827e-10
B O 0 7.19890946854207e-09
, O 0 2.013673776335434e-11
- O 0 5.479650955209081e-09
D O 0 5.391076474126066e-09
, O 0 1.163142065302436e-11
Factor O 0 2.034787227600532e-09
B O 0 4.998911435905029e-07
allotype O 0 0.0005836404743604362
, O 0 1.9801360906512855e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 2.0758717661495396e-11
that O 0 1.663563086113165e-13
the O 0 1.9162638489889083e-11
genes O 0 7.890693098921986e-10
coding O 0 7.215595542220399e-05
for O 0 4.689599336415995e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 8.739716728101143e-10
Factor O 0 1.6458859830592587e-09
B O 0 7.052658457240568e-09
allotypes O 0 3.308865359485935e-08
are O 0 1.1165976997185023e-12
approximately O 0 9.641108441107993e-13
3 O 0 1.38790194614824e-11
- O 0 2.830209122617333e-10
- O 0 1.0113079124129953e-10
5 O 0 3.980315729790185e-11
centimorgans O 0 1.1649067488406217e-08
from O 0 2.7585727105372548e-11
the O 0 2.0887847007600158e-10
HLA O 0 1.0115963178236598e-08
- O 0 2.172449331538928e-09
A O 0 3.824187189138684e-09
and O 0 1.8895592035494957e-10
HLA O 0 2.2096081409017643e-07
- O 0 9.462643113522518e-09
B O 0 5.374126033075299e-09
loci O 0 1.526620080349872e-10
, O 0 2.1231566580803135e-13
and O 0 5.784670566990821e-14
that O 0 2.0929679295017198e-14
the O 0 1.2784506526336559e-12
apparent O 0 8.877533708151475e-10
lack O 0 5.28077954697892e-08
of O 0 2.182001601624961e-08
recombinants O 0 5.3676212701248005e-06
between O 0 1.2693700535137964e-09
the O 0 1.3906611973091287e-10
Factor O 0 1.1864824678298191e-09
B O 0 7.749305552806618e-08
gene O 0 6.9785137668532116e-09
and O 0 3.6931589875166537e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 3.9876981716702176e-09
suggests O 0 6.268834756850694e-11
that O 0 1.1088442582749339e-13
these O 0 7.626569731647437e-13
two O 0 2.2045410202203852e-12
genes O 0 1.1799866639350398e-10
lie O 0 5.91446287501185e-08
in O 0 2.135669419089936e-10
close O 0 1.1966095314619452e-07
proximity O 0 4.5947111004807084e-08
to O 0 1.9419372776496857e-09
one O 0 2.975168555963137e-09
another O 0 2.635668749917386e-08
. O 0 3.2102852287607675e-07

Distribution O 0 3.203340099844354e-07
of O 0 1.3752467964422976e-07
emerin O 0 6.875500548630953e-05
and O 0 3.2524178905646295e-09
lamins O 0 6.0548598412424326e-05
in O 0 4.730090208404647e-10
the O 0 2.6405533315454477e-09
heart O 0 5.036956167714379e-07
and O 0 1.9387977334694995e-10
implications O 0 1.3158788503275787e-09
for O 0 3.0480340473815204e-10
Emery B-Disease 1 0.6848427653312683
- I-Disease 1 0.9999997615814209
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
. O 0 0.0010594679042696953

Emerin O 0 0.0484168715775013
is O 0 7.363412657390711e-10
a O 0 6.425864840231554e-10
nuclear O 0 5.493471917361603e-07
membrane O 0 4.095875283383066e-08
protein O 0 5.270248681910061e-10
which O 0 6.677461860359057e-13
is O 0 1.242994205827297e-12
missing O 0 3.3253023445922736e-08
or O 0 1.434310170633779e-10
defective O 0 9.595575889420616e-09
in O 0 6.24402862747786e-10
Emery B-Disease 0 0.046597179025411606
- I-Disease 1 0.9999984502792358
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.81159030541312e-06
EDMD B-Disease 1 1.0
) O 0 1.141388850101066e-08
. O 0 3.201726883617084e-08

It O 0 2.375641350305102e-10
is O 0 8.123231254320018e-12
one O 0 1.5294727290227073e-11
member O 0 2.6604651814921e-10
of O 0 3.009859916858204e-09
a O 0 9.063822470345428e-10
family O 0 8.695006936676464e-10
of O 0 2.4628079131616687e-08
lamina O 1 0.9999914169311523
- O 0 2.0933468931616517e-06
associated O 0 6.71724436074328e-08
proteins O 0 2.2258493659332856e-11
which O 0 3.549939747542197e-13
includes O 0 1.995640848753699e-12
LAP1 O 0 0.00023570099438074976
, O 0 5.613808723436975e-11
LAP2 O 1 0.9990594983100891
and O 0 1.0142431783322081e-08
lamin O 0 1.74588494701311e-05
B O 0 1.8015087334788404e-05
receptor O 0 2.454750713809517e-08
( O 0 1.022675810702367e-08
LBR O 0 1.848344072641339e-05
) O 0 1.9760766356569093e-09
. O 0 5.787181933669672e-08

A O 0 1.2680814506893512e-05
panel O 0 3.2370344626997394e-08
of O 0 4.156677668731845e-09
16 O 0 8.064853229683422e-10
monoclonal O 0 1.1894154931801904e-11
antibodies O 0 3.5220199152974363e-12
( O 0 2.5582539558977047e-12
mAbs O 0 6.556720055783671e-09
) O 0 3.5976287053596234e-12
has O 0 5.212965475953624e-13
been O 0 8.900871359407425e-12
mapped O 0 1.8501723764163813e-10
to O 0 6.9089716586701044e-12
six O 0 1.7953079994859067e-11
specific O 0 6.593090223078191e-12
sites O 0 1.1104158391395114e-11
throughout O 0 2.0218557730822262e-11
the O 0 4.8727216706012655e-11
emerin O 0 9.360788588708147e-09
molecule O 0 3.752061161765852e-12
using O 0 3.379235780087697e-11
phage O 0 6.11639461300939e-10
- O 0 5.897031196688829e-10
displayed O 0 3.7699268706781197e-10
peptide O 0 1.6515738776590183e-10
libraries O 0 1.5467559177917423e-10
and O 0 6.848410727400278e-12
has O 0 1.3314914763199598e-13
been O 0 1.7939687279103222e-12
used O 0 3.816413764873294e-12
to O 0 7.000587332051111e-10
localize O 0 2.922944440797437e-05
emerin O 0 3.143789945170283e-05
in O 0 1.403666405330739e-09
human O 0 1.6443177486280547e-08
and O 0 1.2870803089981564e-08
rabbit O 0 7.256037974912033e-07
heart O 0 1.6447984307887964e-05
. O 0 4.3357468371141294e-07

Several O 0 2.8837492394018227e-08
mAbs O 0 2.3315222108521994e-07
against O 0 1.825021384016523e-10
different O 0 1.8709189752996735e-09
emerin O 0 4.89262163227977e-07
epitopes O 0 1.158931883793457e-08
did O 0 1.8919936450867425e-10
not O 0 1.801695424796801e-11
recognize O 0 4.829357469482431e-10
intercalated O 0 2.658139841571483e-08
discs O 0 4.797257702193747e-07
in O 0 1.3704777590550776e-10
the O 0 7.936942214570308e-10
heart O 0 8.619751667993114e-08
, O 0 4.358132344589594e-12
though O 0 5.999254044930513e-12
they O 0 3.8411556921302825e-12
recognized O 0 2.8716490296787356e-10
cardiomyocyte O 0 4.943245812683017e-07
nuclei O 0 5.196687524744448e-08
strongly O 0 8.857947153551038e-10
, O 0 8.065294959669345e-11
both O 0 9.800702471807199e-10
at O 0 6.151850584501517e-08
the O 0 5.4004029692578115e-08
rim O 0 6.841060695705892e-08
and O 0 7.333834234346526e-11
in O 0 9.572465042850808e-10
intranuclear O 0 6.93223046255298e-06
spots O 0 2.2093701090852846e-07
or O 0 3.981823315513111e-09
channels O 0 5.418365276455006e-07
. O 0 1.3312211422089604e-07

A O 0 2.585403535704245e-06
polyclonal O 0 8.901421324480907e-07
rabbit O 0 5.195052210638096e-08
antiserum O 0 4.201251897484326e-07
against O 0 2.7910658229046703e-09
emerin O 0 1.8665892639546655e-05
did O 0 2.0132651101789634e-09
recognize O 0 2.6144133524752533e-09
both O 0 3.5106553775143823e-10
nuclear O 0 1.0623729451708641e-07
membrane O 0 7.348147645913627e-10
and O 0 5.309056146096669e-12
intercalated O 0 3.995164477021973e-10
discs O 0 3.990216601579277e-09
but O 0 8.305149645261578e-13
, O 0 2.2871038152542586e-14
after O 0 2.2054411248639827e-12
affinity O 0 5.006879025964972e-12
purification O 0 2.0315442383900262e-10
against O 0 2.4483970406663502e-11
a O 0 1.0171267300629339e-10
pure O 0 8.512505900171163e-08
- O 0 5.72531497766704e-08
emerin O 0 5.237255891188397e-07
band O 0 2.199064930152872e-08
on O 0 1.5500171146598518e-09
a O 0 1.3012449451288433e-10
western O 0 3.67050878580244e-09
blot O 0 1.2176860764157027e-06
, O 0 8.284922053958255e-11
it O 0 1.1138479028005577e-11
stained O 0 9.969834025014279e-08
only O 0 1.3974095491864347e-10
the O 0 6.329668456039883e-10
nuclear O 0 5.963124749541748e-07
membrane O 0 2.2451644099419354e-07
. O 0 6.603901425705772e-08

These O 0 1.234141899786323e-09
results O 0 6.264558871649228e-10
would O 0 2.2077147401877717e-11
not O 0 4.1199916742118425e-12
be O 0 8.058879084893444e-12
expected O 0 8.761631975495732e-10
if O 0 4.788010543599341e-10
immunostaining O 0 3.221984798074118e-06
at O 0 1.914625347154697e-09
intercalated O 0 1.9363938008609693e-08
discs O 0 7.700771220697789e-08
were O 0 2.126718523509652e-10
due O 0 5.325869967265362e-09
to O 0 3.545585700037712e-11
a O 0 1.8097613685430503e-11
product O 0 3.152836880460086e-10
of O 0 3.798038272773141e-10
the O 0 1.158902529496686e-09
emerin O 0 1.7700497210171307e-06
gene O 0 7.890418179945513e-11
and O 0 1.4413026327986245e-11
, O 0 1.6279250083378605e-12
therefore O 0 3.19521249736443e-11
, O 0 1.6132951094829928e-12
cast O 0 4.922107166294154e-11
some O 0 4.464257522679427e-12
doubt O 0 4.6117304419723837e-10
upon O 0 3.9145145458441277e-10
the O 0 2.7963611981540737e-10
hypothesis O 0 3.888857236233889e-09
that O 0 6.866895940760287e-11
cardiac B-Disease 0 0.0016252463683485985
defects I-Disease 0 1.998865081986878e-05
in O 0 1.1387683684915828e-08
EDMD B-Disease 1 1.0
are O 0 8.880374907649369e-11
caused O 0 1.1591032300639625e-10
by O 0 4.3855162557004945e-12
absence O 0 1.902315638346863e-08
of O 0 5.5041439850356255e-08
emerin O 0 1.7872251191874966e-05
from O 0 6.800415786045733e-09
intercalated O 0 3.691081360557291e-07
discs O 0 6.045008376531769e-06
. O 0 1.0291805807582932e-07

Although O 0 2.0696369062989106e-07
emerin O 0 7.390344399027526e-05
was O 0 9.632326936070967e-08
abundant O 0 2.25239848994363e-09
in O 0 2.7739527688752652e-11
the O 0 1.088814927108217e-09
membranes O 0 2.310740399025235e-08
of O 0 1.1041701775127422e-08
cardiomyocyte O 0 7.09421385636233e-07
nuclei O 0 8.553777242070737e-09
, O 0 1.969880508712052e-11
it O 0 1.129871912176894e-12
was O 0 3.090230071833844e-09
absent O 0 2.4748067062319024e-07
from O 0 4.984073709302095e-10
many O 0 6.878601854776178e-11
non O 0 5.265913500807073e-07
- O 0 1.337303530135614e-07
myocyte O 0 1.305245950788958e-05
cells O 0 1.1210407713235782e-08
in O 0 1.9623513924926783e-10
the O 0 5.153471427377099e-09
heart O 0 3.5133634810335934e-06
. O 0 1.6052908335950633e-07

This O 0 1.4379424040367184e-10
distribution O 0 1.0643718129088597e-09
of O 0 3.4158460504585264e-09
emerin O 0 2.8796987407986308e-06
was O 0 6.487687054246294e-10
similar O 0 5.627549207881666e-12
to O 0 1.0897944872911847e-11
that O 0 3.0770446954320185e-12
of O 0 1.3964029932367339e-09
lamin O 0 1.2104133872981038e-07
A O 0 6.449554224019494e-09
, O 0 2.1761618115151427e-12
a O 0 3.32637433222982e-12
candidate O 0 1.4228389300097177e-10
gene O 0 7.56658884853989e-12
for O 0 6.190895018853837e-12
an O 0 2.4196091311101675e-11
autosomal O 0 4.939014388583018e-07
form O 0 1.6099576782835356e-07
of O 1 0.999650239944458
EDMD B-Disease 1 1.0
. O 0 0.000154581677634269

In O 0 4.48770123284703e-08
contrast O 0 3.864274589204797e-08
, O 0 4.848612622510018e-09
lamin O 0 1.2198631338833366e-05
B1 O 0 1.8343960618949495e-05
was O 0 9.718119287072113e-08
absent O 0 1.4877709872962441e-06
from O 0 6.9859718010434335e-09
cardiomyocyte O 0 1.2526975297078025e-06
nuclei O 0 4.045995538604075e-08
, O 0 7.295231779780309e-11
showing O 0 1.3278656396664701e-08
that O 0 1.2534095983340876e-09
lamin O 0 6.819382633693749e-06
B1 O 0 2.537381078582257e-06
is O 0 9.121983550464119e-12
not O 0 8.578631728595187e-12
essential O 0 4.025664246398719e-09
for O 0 1.2705490826103727e-10
localization O 0 0.003221311140805483
of O 0 2.5061527253456006e-07
emerin O 0 1.870491905719973e-05
to O 0 2.9642026611043093e-09
the O 0 1.5076622617016255e-08
nuclear O 0 7.614293281221762e-06
lamina O 1 0.9828351140022278
. O 0 2.252564399896073e-06

Lamin O 1 0.980682373046875
B1 O 0 0.0019812576938420534
is O 0 1.9678472185091778e-09
also O 0 6.32029220626329e-11
almost O 0 1.1562774071549597e-09
completely O 0 2.5784424906305503e-07
absent O 0 5.820302249048837e-07
from O 0 7.1244641297596445e-09
skeletal O 0 0.002203956013545394
muscle O 0 7.238268722176144e-07
nuclei O 0 8.372641786991153e-06
. O 0 1.1142659559482126e-06

In O 0 5.388117187976604e-07
EDMD B-Disease 1 1.0
, O 0 2.7686156145456664e-10
the O 0 1.3976540411131388e-11
additional O 0 4.5068143661453064e-11
absence O 0 2.8877933377913223e-09
of O 0 1.3560636169529516e-08
lamin O 0 1.407233503414318e-05
B1 O 0 7.883495709393173e-05
from O 0 4.066606607011636e-08
heart O 0 0.28984832763671875
and O 0 2.401116034889128e-07
skeletal O 1 1.0
muscle O 0 0.00034082989441230893
nuclei O 0 5.623061042570043e-06
which O 0 4.240874595939914e-10
already O 0 1.105984526184045e-09
lack O 0 4.053384327562526e-05
emerin O 0 5.890892862225883e-05
may O 0 2.823146161290424e-10
offer O 0 1.0200365725687721e-11
an O 0 1.8972449750565695e-13
alternative O 0 2.3646062885518404e-10
explanation O 0 3.0301575137947623e-10
of O 0 4.733555769576014e-10
why O 0 4.426209954111471e-10
these O 0 1.4404212544949502e-10
tissues O 0 5.7850826351568685e-09
are O 0 8.302175787122668e-12
particularly O 0 6.366085436582125e-11
affected O 0 3.957705274615364e-10
. O 0 5.848383999307316e-10
. O 0 2.5635097600229528e-08

Genetic O 0 1.2268311877505766e-07
mapping O 0 1.751025990870403e-07
of O 0 1.4261122771586088e-07
the O 0 3.467536373591429e-07
copper B-Disease 0 9.459339707973413e-06
toxicosis I-Disease 0 4.8546844482189044e-05
locus O 0 1.4882959309403532e-09
in O 0 5.148301229773722e-10
Bedlington O 0 7.997825377970003e-06
terriers O 0 5.365002948565234e-07
to O 0 6.5104499569201835e-09
dog O 0 2.138639700888234e-07
chromosome O 0 1.7671904828375773e-08
10 O 0 2.4478064020172496e-09
, O 0 1.1221044059206431e-11
in O 0 1.835703464236893e-11
a O 0 1.6023730953218518e-10
region O 0 4.142606968571272e-08
syntenic O 0 2.5243225536542013e-05
to O 0 9.654759214328124e-10
human O 0 4.61402960283408e-09
chromosome O 0 1.1612264927407523e-08
region O 0 9.2359030645639e-08
2p13 O 0 0.00010004702198784798
- O 0 1.5169321159191895e-06
p16 O 0 2.3124150629882934e-06
. O 0 7.470622165328678e-08

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9993382096290588
accumulation I-Disease 0 2.6587702450342476e-05
is O 0 1.5113741855254936e-11
recognized O 0 1.247441594465215e-10
as O 0 5.191568008822145e-11
an O 0 4.28142243880103e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 3.741670084878024e-08
man O 0 2.025536218752677e-07
, O 0 4.6158202260393466e-11
mouse O 0 7.687530612088267e-09
, O 0 7.264839285703317e-10
rat O 0 2.1526493583223782e-06
and O 0 4.185016422297849e-08
dog O 1 0.8995110392570496
. O 0 0.00012141388288000599

The O 0 5.613859954678446e-08
major O 0 9.998246497389118e-08
cause O 0 4.122415339224972e-05
of O 1 0.9996026158332825
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999974966049194
accumulation I-Disease 1 0.8043338060379028
in O 0 2.433256440781406e-08
man O 0 1.4674958492832957e-07
is O 0 2.7115865108839898e-11
a O 0 6.408202857244305e-10
dysfunctional O 0 1.8397058738628402e-06
ATP7B O 1 0.999996542930603
gene O 0 3.1933029553954384e-09
, O 0 2.910828522662001e-11
causing O 0 5.691453708323024e-08
Wilson B-Disease 0 5.030450120102614e-05
disease I-Disease 0 3.3712909498717636e-05
( O 0 1.850006675629956e-10
WD B-Disease 0 1.214188705489505e-05
) O 0 5.008689574204084e-10
. O 0 2.7054895213041164e-08

Mutations O 0 6.3443479803027e-08
in O 0 1.3248999675141704e-09
the O 0 6.3838077046796116e-09
ATP7B O 1 0.9999810457229614
genes O 0 1.2870795540464997e-09
have O 0 1.865763186309488e-12
also O 0 7.143577721545336e-14
been O 0 2.4952102016528865e-12
demonstrated O 0 8.875666868135568e-11
in O 0 1.2561372775277135e-10
mouse O 0 1.0199408428945844e-08
and O 0 9.976241166498312e-09
rat O 0 2.489519147275132e-06
. O 0 5.51350012756302e-07

The O 0 2.115629484933379e-07
ATP7B O 1 0.9997294545173645
gene O 0 1.6344549047531132e-09
has O 0 5.7942830221369146e-12
been O 0 1.4021532199204323e-11
excluded O 0 3.226816591705983e-10
in O 0 4.7076648135302435e-12
the O 0 2.2846056990655228e-10
much O 0 3.8280258962686275e-09
rarer O 0 9.699227803139365e-07
human O 0 2.670048615982523e-06
copper B-Disease 1 0.9999417066574097
overload I-Disease 1 0.9665982127189636
disease O 0 1.8153044720747857e-06
non B-Disease 0 5.424620894700638e-07
- I-Disease 0 1.4066795728240322e-08
Indian I-Disease 0 6.763420934419173e-09
childhood I-Disease 0 4.461486605578102e-05
cirrhosis I-Disease 0 0.17500169575214386
, O 0 8.189664918445416e-11
indicating O 0 7.43970618444223e-09
genetic O 0 7.92681031924758e-09
heterogeneity O 0 1.1045897707617769e-07
. O 0 2.8991701128688874e-07

By O 0 9.226034380915848e-10
investigating O 0 6.899132820592513e-09
the O 0 1.1062037952314085e-09
common O 0 2.4180028646014762e-08
autosomal O 1 0.9980393052101135
recessive O 1 0.9999649524688721
copper B-Disease 1 0.9999973773956299
toxicosis I-Disease 1 1.0
( O 0 2.862938552894434e-09
CT B-Disease 0 0.00015932154201436788
) O 0 2.3321908293461036e-10
in O 0 3.6329532715484447e-09
Bedlington O 0 0.0005730046541430056
terriers O 0 1.4713764358020853e-06
, O 0 6.419405285118529e-11
we O 0 3.768206580101463e-11
have O 0 1.1812150649964659e-12
identified O 0 3.269095064095673e-11
a O 0 5.868230706050637e-13
new O 0 2.8321811042231193e-13
locus O 0 1.2193019163775354e-11
involved O 0 6.099243332613469e-11
in O 0 2.900716555842564e-09
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 8.003112270671409e-07

We O 0 1.0032780828339583e-08
examined O 0 6.677284503098235e-09
whether O 0 3.799471154364298e-11
the O 0 1.5973503075805695e-10
WD B-Disease 0 4.122036898479564e-07
gene O 0 8.778510696139108e-10
ATP7B O 1 0.7081466317176819
was O 0 9.196558181656656e-09
also O 0 6.2438791116614656e-12
causative O 0 2.6327368063405743e-10
for O 0 4.422427354877634e-11
CT B-Disease 0 1.9962774899795477e-07
by O 0 7.138303836917714e-11
investigating O 0 2.123298648015748e-09
the O 0 2.5885025234373416e-09
chromosomal O 0 4.5431130502038286e-07
co O 0 4.761414018616961e-08
- O 0 9.255547439579459e-08
localization O 0 0.015107736922800541
of O 0 1.3181777376303216e-06
ATP7B O 1 0.9999998807907104
and O 0 2.1802271099602422e-10
C04107 O 0 3.3781773822738614e-08
, O 0 7.095317172342575e-14
using O 0 2.9686778209303544e-13
fluorescence O 0 1.0144109996446105e-09
in O 0 1.0715781040282479e-10
situ O 0 1.5746260828564118e-07
hybridization O 0 9.082864238507682e-09
( O 0 8.698419068364771e-11
FISH O 0 4.371995032670384e-08
) O 0 8.435558501718177e-11
. O 0 6.3056924126669855e-09

C04107 O 0 0.0009052916429936886
is O 0 2.5625834787490476e-10
an O 0 1.6412666364873374e-11
anonymous O 0 5.67909663740096e-10
microsatellite O 0 2.038983915042536e-08
marker O 0 3.6259613089839604e-09
closely O 0 7.595446938069017e-09
linked O 0 1.3085146974844974e-06
to O 0 5.477693889588409e-07
CT B-Disease 1 0.9999985694885254
. O 0 2.9587832614197396e-05

However O 0 4.518294360877917e-07
, O 0 1.2892867218283754e-08
BAC O 0 4.0357845136895776e-05
clones O 0 2.7702876437274426e-08
containing O 0 1.8470810436710394e-09
ATP7B O 0 0.0005096765817143023
and O 0 1.8457005923622205e-09
C04107 O 0 5.071030955150491e-06
mapped O 0 3.839486240053702e-08
to O 0 3.000790171903134e-10
the O 0 1.1025491630789475e-09
canine O 0 2.753661654253392e-08
chromosome O 0 7.96557930726749e-09
regions O 0 1.3069898052719964e-08
CFA22q11 O 0 0.0004892593715339899
and O 0 3.4472296128740254e-09
CFA10q26 O 0 0.0925074964761734
, O 0 2.7994979598378045e-11
respectively O 0 2.1255028848088386e-09
, O 0 4.421851773628305e-12
demonstrating O 0 9.212072771269675e-10
that O 0 4.248166748932469e-11
WD B-Disease 0 1.5266937225533184e-07
cannot O 0 1.7965499088390402e-09
be O 0 7.436907756286359e-10
homologous O 0 1.87597599676792e-08
to O 0 5.4033289842436716e-08
CT B-Disease 0 0.003368313889950514
. O 0 1.836955107137328e-06

The O 0 1.449635988137743e-06
copper O 0 3.8194187368389976e-07
transport O 0 7.421737535651118e-08
genes O 0 2.29381980076937e-09
CTR1 O 0 0.00046483296318911016
and O 0 4.752154780796047e-10
CTR2 O 1 0.9999783039093018
were O 0 7.744692887001747e-09
also O 0 9.836857023381995e-12
excluded O 0 4.517712315355027e-10
as O 0 9.235373750471343e-12
candidate O 0 1.0875073064298135e-09
genes O 0 1.2515574687732567e-10
for O 0 7.394682088879279e-11
CT B-Disease 0 4.870828433922725e-06
since O 0 1.6667869306985494e-09
they O 0 2.907388219064444e-11
both O 0 1.018936532370951e-10
mapped O 0 8.58599502606694e-09
to O 0 1.0925073068435154e-09
canine O 0 1.5361561622739828e-07
chromosome O 0 8.649659832826728e-08
region O 0 8.043045340855315e-07
CFA11q22 O 1 0.9991426467895508
. O 0 2.381704007348162e-06

2 O 0 2.0076020064152544e-06
- O 0 3.239269062760286e-06
22 O 0 1.6105013855849393e-07
. O 0 5.712705331006873e-08

5 O 0 3.713296564455959e-06
. O 0 9.74609974946361e-07

A O 0 9.571269288244366e-08
transcribed O 0 5.394356961119229e-09
sequence O 0 1.4180137619668187e-10
identified O 0 1.1057476462239535e-10
from O 0 2.8828266163127836e-11
the O 0 1.1560827295475917e-10
C04107 O 0 2.3398305870614422e-07
- O 0 6.041597777617369e-10
containing O 0 2.827035133767808e-11
BAC O 0 2.874902520488831e-07
was O 0 1.7845480648759349e-10
found O 0 5.993238023915826e-12
to O 0 4.514262661597934e-12
be O 0 1.3896661599233084e-11
homologous O 0 3.430358497258368e-10
to O 0 5.4132649751625905e-11
a O 0 4.6571187878319265e-11
gene O 0 6.543320746343895e-11
expressed O 0 5.24658615164153e-11
from O 0 7.072790270123974e-11
human O 0 1.795839726925763e-10
chromosome O 0 3.7830291677032335e-10
2p13 O 0 7.90350327406486e-08
- O 0 3.5796050568137616e-09
p16 O 0 5.214357834404382e-09
, O 0 2.863250869039602e-12
a O 0 1.3423685774061056e-11
region O 0 4.0314502847138556e-09
devoid O 0 7.955516423407971e-08
of O 0 3.666336956253957e-10
any O 0 2.2142650213385906e-10
positional O 0 8.270423990097697e-08
candidate O 0 1.419755903953046e-07
genes O 0 7.84280587140529e-08
. O 0 1.514482050879451e-07

Molecular O 0 6.873598579204554e-09
analysis O 0 1.0000412720145846e-09
of O 0 1.452334030815905e-09
the O 0 2.477737570671934e-09
APC B-Disease 0 4.508893169941075e-08
gene O 0 1.5748333193066344e-11
in O 0 1.055016577572454e-11
205 O 0 4.3656578352369024e-10
families O 0 1.2861310974554563e-11
: O 0 8.520590374754e-13
extended O 0 3.250648916708343e-10
genotype O 0 1.1689798462555245e-08
- O 0 2.420059486141213e-09
phenotype O 0 2.8527438744596623e-10
correlations O 0 4.0100975318146936e-10
in O 0 3.654759134219532e-11
FAP B-Disease 0 3.606669185529654e-09
and O 0 5.551007136589403e-12
evidence O 0 4.254296914751876e-11
for O 0 1.2626069894466907e-12
the O 0 1.751610315126051e-11
role O 0 1.102615845849364e-10
of O 0 3.1828439883696547e-09
APC B-Disease 0 1.0251133630845288e-07
amino O 0 8.191641143184825e-09
acid O 0 9.833546199544685e-10
changes O 0 2.3091224488069884e-09
in O 0 8.460640970042732e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 6.25309330644086e-05
. O 0 6.541638981616416e-07

BACKGROUND O 0 0.0037002747412770987
/ O 0 6.636415150751418e-07
AIMS O 0 2.4301542111970775e-07
The O 0 2.7203891916904865e-10
development O 0 3.8410757241535975e-08
of O 0 9.620206355975824e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.8340315377507466e-10
a O 0 4.783633558713696e-12
variable O 0 3.279193236394029e-11
range O 0 9.864725702968258e-11
of O 0 4.612460691166831e-10
extracolonic O 0 1.4210307881512563e-06
manifestations O 0 7.285354399755306e-07
in O 0 1.4395497771602095e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 1.0
( O 0 3.8127163648482565e-09
FAP B-Disease 0 1.3244842023141246e-07
) O 0 5.724702829834616e-12
is O 0 1.7038384863155703e-13
the O 0 5.053658771840552e-13
result O 0 1.647303821128432e-11
of O 0 7.28484494949555e-11
the O 0 9.306161397049095e-11
dominant O 0 1.4568071193821197e-08
inheritance O 0 1.4208502818746638e-07
of O 0 1.9850247099384433e-06
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.4933972947162033e-09
APC B-Disease 0 1.532001192572352e-07
) O 0 5.091272403667801e-10
gene O 0 3.136350512633612e-09
mutations O 0 5.091877586238525e-09
. O 0 4.212597914943217e-08

In O 0 2.20721618759967e-09
this O 0 2.0595284158653193e-11
study O 0 8.480919959363842e-12
, O 0 5.853919237373828e-14
direct O 0 1.1193613310561679e-12
mutation O 0 4.474331061904424e-13
analysis O 0 1.4533135112015927e-11
of O 0 2.688873949885373e-11
the O 0 6.505465610651129e-11
APC B-Disease 0 4.676233622546988e-09
gene O 0 9.593823131759383e-12
was O 0 1.370862173777354e-10
performed O 0 2.1336905853264199e-10
to O 0 4.9379705185925715e-11
determine O 0 1.121586201691116e-08
genotype O 0 2.3320735920151492e-07
- O 0 2.103688245824742e-08
phenotype O 0 2.3317561215208116e-09
correlations O 0 1.2191985199194733e-09
for O 0 1.6955345114033626e-11
nine O 0 1.7718955191980967e-08
extracolonic O 0 9.161385605693795e-06
manifestations O 0 3.412374098843429e-07
and O 0 1.509191382975672e-10
to O 0 2.139020488511889e-10
investigate O 0 2.611567628818534e-09
the O 0 6.280099773547931e-10
incidence O 0 4.2902637886754746e-08
of O 0 3.6220004773213077e-09
APC B-Disease 0 1.614363398516616e-08
mutations O 0 3.454764807564459e-10
in O 0 8.647011995321918e-10
non O 1 0.9975789189338684
- O 1 0.9999998807907104
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.650798008602578e-06

METHODS O 0 2.8367730919853784e-06
The O 0 3.051067665182927e-08
APC B-Disease 0 7.141105129448988e-08
gene O 0 1.444487585100518e-10
was O 0 8.8529139574689e-10
analysed O 0 2.393462095184873e-09
in O 0 9.727039486373545e-12
190 O 0 2.45656550657003e-10
unrelated O 0 1.2713328167990312e-09
FAP B-Disease 0 3.4187985775702145e-09
and O 0 1.2032064580780322e-11
15 O 0 1.3211399751966724e-09
non O 0 3.748368180822581e-05
- O 1 0.8906158208847046
FAP O 1 0.9998490810394287
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.260796911317641e-09
using O 0 1.2612935869349418e-11
denaturing O 0 2.1299602082081037e-08
gradient O 0 9.523658528465262e-10
gel O 0 8.950711283262081e-10
electrophoresis O 0 1.2741778743219356e-09
, O 0 1.0256591582991081e-11
the O 0 6.699577698165982e-11
protein O 0 3.457775732407242e-11
truncation O 0 1.8619124020347044e-09
test O 0 1.4248024982066454e-10
, O 0 2.3720077551442342e-12
and O 0 1.3816969486948882e-12
direct O 0 1.5678926212903121e-10
sequencing O 0 3.6501944578049006e-08
. O 0 4.919918339396645e-08

RESULTS O 0 1.2355661738183699e-06
Chain O 0 4.695180688685241e-09
terminating O 0 4.788999863336585e-09
signals O 0 3.0317199861684685e-09
were O 0 3.364276912609654e-11
only O 0 1.3470897574502372e-12
identified O 0 2.7847673819691998e-11
in O 0 1.9087047480742525e-12
patients O 0 2.228827365724495e-11
belonging O 0 7.396124823699779e-10
to O 0 1.1674390620886044e-10
the O 0 1.91243931801921e-09
FAP B-Disease 0 1.2703631568911078e-07
group O 0 6.291461795981945e-11
( O 0 2.774513778447396e-11
105 O 0 2.502515599189792e-07
patients O 0 2.3546309790845044e-08
) O 0 5.548016490664054e-10
. O 0 5.779482492584975e-08

Amino O 0 1.1080816193498322e-06
acid O 0 1.357861711959174e-09
changes O 0 4.8471095193125535e-11
were O 0 4.77350069194582e-11
identified O 0 6.051432271947377e-11
in O 0 1.0342866970866615e-12
four O 0 2.977395240078007e-12
patients O 0 4.005346401769749e-12
, O 0 2.449673154754882e-14
three O 0 1.733545273475967e-12
of O 0 1.8263097978366005e-10
whom O 0 2.9379392252337766e-09
belonged O 0 0.00016429397510364652
to O 0 6.2601781536386625e-09
the O 0 8.893710656820986e-08
non O 1 0.9237843155860901
- O 0 6.239597496460192e-06
FAP O 0 6.689539077342488e-06
group O 0 1.329868037913684e-08
of O 1 0.9999988079071045
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999910593032837
. O 0 4.767661891946773e-07

Genotype O 0 0.0001269203785341233
- O 0 7.13705230737105e-06
phenotype O 0 8.690870600958078e-08
correlations O 0 2.7292896831454527e-08
identified O 0 3.2762019763765693e-09
significant O 0 5.205372244354578e-10
differences O 0 1.8243412114316016e-08
in O 0 4.441175899261296e-11
the O 0 1.553425860167934e-10
nature O 0 3.644256840740212e-10
of O 0 1.924829184929422e-10
certain O 0 7.03879898811266e-10
extracolonic O 0 1.1743946970455e-06
manifestations O 0 1.806432869955188e-08
in O 0 2.0837311043298001e-10
FAP B-Disease 0 3.779145885118851e-08
patients O 0 1.7875935454103598e-10
belonging O 0 1.9821617680548798e-09
to O 0 2.7009855463333565e-10
three O 0 1.1390611787120974e-09
mutation O 0 9.814102419625215e-09
subgroups O 0 1.0387329218985997e-08
. O 0 6.178154876579356e-08

CONCLUSIONS O 0 1.3746202967013232e-06
Extended O 0 7.312195293707191e-08
genotype O 0 2.061894406324427e-07
- O 0 2.4684510435690754e-08
phenotype O 0 7.31877447535112e-10
correlations O 0 2.0060586525261215e-09
made O 0 2.6526657606606996e-11
in O 0 1.350210741823954e-11
this O 0 8.995028680236494e-12
study O 0 1.4542536445893983e-11
may O 0 1.2394573215002147e-12
have O 0 2.9061543210980034e-13
the O 0 2.7691724781286897e-12
potential O 0 5.881983268507529e-12
to O 0 5.424600872661056e-12
determine O 0 2.081797401132235e-09
the O 0 5.639352873565429e-10
most O 0 2.337622977133247e-11
appropriate O 0 9.411107448897837e-10
surveillance O 0 1.0847236886490919e-08
and O 0 2.728166650922681e-11
prophylactic O 0 9.017445279368985e-08
treatment O 0 1.4066795728240322e-08
regimens O 0 6.793000828508866e-09
for O 0 7.569605532664614e-12
those O 0 6.189029757436293e-12
patients O 0 3.643426272487149e-12
with O 0 9.344674150148571e-14
mutations O 0 1.4353384800158686e-11
associated O 0 6.446205236265712e-10
with O 0 3.773291401554246e-11
life O 0 9.99058258344121e-08
threatening O 0 2.2770043983655341e-07
conditions O 0 0.0031434560660272837
. O 0 3.675040261441609e-06

This O 0 3.3499181206764206e-09
study O 0 6.436364774486947e-10
also O 0 1.4967085730510643e-12
provided O 0 6.3728362864612365e-12
evidence O 0 2.4891649505476288e-11
for O 0 2.047569362326196e-12
the O 0 2.3099051837949247e-10
pathological O 0 1.6502552568908868e-07
nature O 0 8.664330364283046e-10
of O 0 3.8115168798924515e-09
amino O 0 1.3271256316116364e-09
acid O 0 4.611315149172235e-11
changes O 0 2.1103754594548052e-12
in O 0 3.97590510861634e-12
APC O 0 6.903578264605414e-10
associated O 0 2.2088487983129568e-10
with O 0 3.9592565337365215e-12
both O 0 7.495046250305393e-11
FAP B-Disease 0 3.8111021005704515e-09
and O 0 8.312986410352607e-11
non O 1 0.8014765381813049
- O 1 0.9999967813491821
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.3251254194510693e-07
. O 0 5.795062762992131e-10
. O 0 3.699409889534877e-09

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 1.7822925656219013e-05
cancer B-Disease 1 0.9999772310256958
risk O 0 9.670125109551009e-07
of O 0 5.903985993427341e-07
the O 0 1.6786776768640266e-06
APC O 0 6.403610768757062e-06
I1307K O 0 1.2120241080992855e-05
polymorphism O 0 2.773899723251816e-07
. O 0 3.505460099972879e-08

Germ O 0 0.212980717420578
- O 0 3.282002217019908e-05
line O 0 3.9890846181833695e-08
and O 0 9.822500451894811e-11
somatic O 0 4.661924890569935e-08
truncating O 0 1.3219717232004768e-07
mutations O 0 2.767897300248734e-10
of O 0 2.4731094949714816e-10
the O 0 3.411683713316904e-10
APC B-Disease 0 5.119964008315492e-09
gene O 0 1.1139074905519575e-11
are O 0 8.426930485881667e-13
thought O 0 3.973807394253015e-11
to O 0 4.774702508369977e-11
initiate O 0 1.5344825499141734e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 8.856839485815726e-06
formation O 0 8.607632366874896e-07
in O 0 1.4374525107996305e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 3.0902810976840556e-06
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 5.8695865945423975e-09
respectively O 0 6.83862026562565e-07
. O 0 1.2985790931452357e-07

Recently O 0 3.375684798356815e-08
, O 0 2.916563865418276e-11
an O 0 2.2058837395588782e-11
isoleucine O 0 0.0001331950188614428
- O 0 0.03433016315102577
- O 0 3.681501038954593e-05
> O 0 5.54989526335703e-07
lysine O 0 2.9552564839718798e-08
polymorphism O 0 8.965063691412922e-10
at O 0 2.226967221741205e-10
codon O 0 3.392271130664426e-09
1307 O 0 3.6911654177629316e-08
( O 0 5.785230627886051e-11
I1307K O 0 3.663775771656219e-07
) O 0 8.267379836279787e-12
of O 0 4.530820163495264e-10
the O 0 1.4036127815586497e-09
APC B-Disease 0 7.964929693571321e-08
gene O 0 1.7023923937209418e-10
has O 0 4.021919949859232e-12
been O 0 3.8835459154062946e-11
identified O 0 3.6242309153777796e-10
in O 0 2.3595504022866365e-11
6 O 0 1.2366820900666653e-09
% O 0 9.939312706208625e-10
- O 0 9.312784571280375e-11
7 O 0 3.0770241910005325e-10
% O 0 1.291581841478262e-10
of O 0 1.8343347674143473e-11
the O 0 9.445648430084219e-11
Ashkenazi O 0 2.6215301929255475e-08
Jewish O 0 1.182191056159354e-08
population O 0 6.631791227285078e-10
. O 0 1.6291334503648613e-08

To O 0 6.779425376635118e-08
assess O 0 4.564340656543209e-07
the O 0 4.250594098920146e-09
risk O 0 4.283556620521267e-09
of O 0 3.2807839778215e-10
this O 0 1.6973434810441113e-11
common O 0 1.1757540774315345e-10
APC B-Disease 0 4.66112215491421e-09
allelic O 0 6.38351549397953e-09
variant O 0 1.2656476755523727e-08
in O 0 4.0670638412620974e-08
colorectal O 1 1.0
carcinogenesis O 1 0.9999998807907104
, O 0 5.1176014537190895e-09
we O 0 2.1791794757586302e-10
have O 0 5.75867391966467e-12
analyzed O 0 9.146936680304307e-11
a O 0 2.1092728258453874e-12
large O 0 1.6049929397674023e-12
cohort O 0 1.0327605437510101e-09
of O 0 1.0250577053838583e-09
unselected O 0 7.599883974762633e-05
Ashkenazi O 0 1.9716856058948906e-06
Jewish O 0 5.420071147455019e-08
subjects O 0 4.438220912561519e-06
with O 0 4.2662704480278535e-09
adenomatous B-Disease 0 9.753648191690445e-05
polyps I-Disease 0 7.906277232905268e-08
and O 0 3.534500470081525e-10
. O 0 1.9699774256309865e-08
or O 1 0.9924731254577637
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 5.480630949072918e-10
for O 0 1.051593881418178e-10
the O 0 9.96226479088591e-09
APC O 0 4.7305368866545905e-07
I1307K O 0 5.9164422054891475e-06
polymorphism O 0 6.436879971261078e-07
. O 0 1.567041323369267e-07

The O 0 9.275004941855514e-08
APC O 0 2.6812250553120975e-07
I1307K O 0 3.935642212127277e-07
allele O 0 1.5767522842935477e-09
was O 0 6.265861718368626e-10
identified O 0 5.660398816331735e-10
in O 0 3.0114646887291485e-11
48 O 0 5.054683782645952e-08
( O 0 1.0152500368176831e-11
10 O 0 2.237061369481097e-10
. O 0 8.781632539200945e-12
1 O 0 5.244074965937706e-11
% O 0 3.874209286713892e-11
) O 0 6.640944846987573e-13
of O 0 5.884522730204012e-11
476 O 0 1.9623833225068665e-08
patients O 0 2.1712365239068276e-08
. O 0 1.1124339494017477e-07

Compared O 0 4.4162131729308385e-08
with O 0 6.022436022101729e-12
the O 0 3.1922277321516646e-11
frequency O 0 3.579084528748666e-10
in O 0 4.57415138752082e-13
two O 0 1.7607361966001656e-13
separate O 0 2.303106056561477e-12
population O 0 5.003293853983633e-14
control O 0 7.475410915280811e-12
groups O 0 5.484606367157918e-13
, O 0 9.332957583846335e-13
the O 0 1.4684051197200176e-10
APC O 0 2.6871349589896454e-08
I1307K O 0 1.3177123037166893e-07
allele O 0 8.119708239107126e-10
is O 0 9.923481307516635e-13
associated O 0 8.648739363570357e-11
with O 0 4.542973636167957e-12
an O 0 1.9303642885548644e-12
estimated O 0 5.029441099702048e-11
relative O 0 9.292904223912046e-09
risk O 0 2.740780713494928e-09
of O 0 1.0011218520844523e-08
1 O 0 5.235907565293019e-07
. O 0 3.6693913330054784e-07

5 O 0 3.90834884456126e-06
- O 0 3.367831141076749e-06
1 O 0 9.668348610603061e-08
. O 0 6.201307201081363e-08

7 O 0 3.0423080943364766e-07
for O 0 3.2770284263961e-08
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9988517761230469
( O 0 2.2513719777350616e-09
both O 0 1.5392497942912087e-08
P O 0 7.877602001826745e-06
= O 0 2.711832314261642e-09
. O 0 1.4868652142840943e-10
01 O 0 2.7287745396620267e-08
) O 0 3.7021167381690034e-11
. O 0 3.744310195230582e-09

Furthermore O 0 2.341290468166335e-07
, O 0 6.46083811450815e-11
compared O 0 7.815232905272751e-10
with O 0 1.1169135928634777e-11
noncarriers O 0 8.307805501317489e-07
, O 0 2.474454252610059e-10
APC O 0 5.954873216751366e-08
I1307K O 0 3.149150415993063e-07
carriers O 0 5.5594435305339474e-11
had O 0 2.4542225890433755e-11
increased O 0 4.34768991641743e-11
numbers O 0 2.34417728284253e-11
of O 0 3.0801305950234337e-10
adenomas B-Disease 0 1.364711465612345e-06
and O 0 3.9083861480548876e-08
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 1 0.9475293159484863
patient O 1 0.9998761415481567
( O 0 7.845012972573784e-10
P O 0 2.4218488761107437e-06
= O 0 4.186473112621769e-10
. O 0 3.4280737970515673e-11
03 O 0 1.78056414057437e-09
) O 0 9.16379710828863e-13
, O 0 2.854775335396631e-13
as O 0 1.7028313980226029e-13
well O 0 3.6124258966097056e-12
as O 0 2.2470571410526663e-12
a O 0 2.508735753858904e-11
younger O 0 1.3825432354508393e-08
age O 0 1.8849824812150473e-08
at O 0 1.7239798921764304e-08
diagnosis O 0 3.4427288483129814e-05
. O 0 2.7327101292939915e-07

We O 0 1.1197969662646301e-08
conclude O 0 1.197795711505023e-07
that O 0 5.0821668921841034e-12
the O 0 1.141820943351135e-10
APC O 0 1.8993462802541217e-08
I1307K O 0 2.8223209369571123e-07
variant O 0 2.2689690126753703e-09
leads O 0 6.98563484835546e-10
to O 0 3.513851154490766e-10
increased O 0 2.2400891452889482e-07
adenoma B-Disease 1 1.0
formation O 0 3.20243852911517e-05
and O 0 1.8223865083655255e-08
directly O 0 4.805022868481501e-08
contributes O 0 3.6388531077236053e-10
to O 0 7.176582939028009e-11
3 O 0 7.323354700439211e-10
% O 0 6.346569381143752e-10
- O 0 8.11694739200064e-11
4 O 0 1.365871218211856e-11
% O 0 7.572739310623966e-12
of O 0 1.384208069346582e-12
all O 0 6.314733458356869e-12
Ashkenazi O 0 2.756763137767848e-07
Jewish O 0 8.869889279594645e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.4984187803056557e-06

The O 0 1.536586147210528e-08
estimated O 0 2.290383660508155e-09
relative O 0 1.6470425023840107e-08
risk O 0 3.8809636060399555e-10
for O 0 1.818210512705143e-11
carriers O 0 5.108740860904071e-11
may O 0 5.0814231294937784e-11
justify O 0 2.8371432980733857e-10
specific O 0 8.696988441914133e-12
clinical O 0 9.483267643384252e-11
screening O 0 2.326862313939415e-11
for O 0 5.440796684713645e-12
the O 0 1.1773654273738998e-10
360 O 0 8.785549177048324e-09
, O 0 9.83811383054034e-12
000 O 0 4.493823091422655e-09
Americans O 0 1.4613001086960509e-10
expected O 0 1.7927800910477742e-10
to O 0 1.217568962319504e-10
harbor O 0 5.758350463125339e-10
this O 0 2.820382382501263e-12
allele O 0 1.8395035494833678e-10
, O 0 2.899732971101132e-12
and O 0 1.9987874202986866e-12
genetic O 0 5.118455312369541e-11
testing O 0 2.2238591176892974e-11
in O 0 1.5206146888532834e-12
the O 0 5.2074425500869825e-12
setting O 0 1.0842964026647195e-10
of O 0 2.768309470546626e-10
long O 0 3.9005254581780946e-10
- O 0 8.343728485904478e-10
term O 0 4.244300022548941e-09
- O 0 1.0006212525226488e-09
outcome O 0 2.663980369632668e-09
studies O 0 4.566233779979001e-10
may O 0 8.774734411298724e-12
impact O 0 5.678909772988128e-11
significantly O 0 3.4684797256545608e-09
on O 0 3.434673772062524e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 1.3250443771539722e-05
in O 0 9.096164793609418e-12
this O 0 3.5422175175686688e-12
population O 0 2.835858284311321e-12
. O 0 8.860921441034009e-10

Localization O 0 0.0005316411261446774
of O 0 5.602109354185814e-07
human O 0 9.42316731311621e-08
BRCA1 O 0 3.2090266444129156e-08
and O 0 1.93037003048957e-10
its O 0 2.0540716696992867e-11
loss O 0 6.952828868200811e-10
in O 0 6.778174549415539e-11
high O 0 2.2965647161754532e-09
- O 0 2.673084809057258e-10
grade O 0 2.2699604418363606e-09
, O 0 1.3579380675476926e-11
non B-Disease 0 3.368640591361327e-06
- I-Disease 0 0.027859481051564217
inherited I-Disease 1 0.9999904632568359
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.020304853096604347

Although O 0 1.0987751153379577e-08
the O 0 1.4049172936125842e-09
link O 0 3.756413402555836e-09
between O 0 4.3184436582244246e-10
the O 0 2.0026409419671154e-09
BRCA1 O 0 1.0123379468041094e-07
tumour B-Disease 1 1.0
- O 0 5.905816991003121e-08
suppressor O 0 1.5731955738118586e-09
gene O 0 1.7764610962811567e-11
and O 0 1.4472949227961607e-10
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 2.498568107967003e-08
established O 0 1.2703897933619146e-09
, O 0 8.830639127918594e-13
the O 0 2.0011650322948604e-11
role O 0 1.200637228526702e-10
, O 0 2.288952014040113e-12
if O 0 1.5368527847905988e-12
any O 0 1.3726615330500458e-11
, O 0 6.763525937231174e-12
of O 0 8.457182731902435e-10
BRCA1 O 0 3.445921548106412e-09
in O 0 1.0304249675741062e-09
non B-Disease 0 0.08208944648504257
- I-Disease 1 0.7999556064605713
familial I-Disease 0 0.0009647501865401864
cancers I-Disease 1 0.9999872446060181
is O 0 7.376457777930057e-10
unclear O 0 1.2915974139104947e-06
. O 0 2.2539860822234914e-07

BRCA1 O 0 6.376404780894518e-05
mutations O 0 5.5410957600088295e-08
are O 0 6.642598970874047e-11
rare O 0 7.574721405667617e-11
in O 0 8.258432132590698e-11
sporadic B-Disease 0 1.7797486862036749e-06
cancers I-Disease 1 0.754144012928009
, O 0 3.725598995973911e-11
but O 0 1.391971433950534e-11
loss O 0 3.7781635597866625e-09
of O 0 2.996229397922434e-08
BRCA1 O 0 6.252970585762796e-09
resulting O 0 6.34062802262747e-10
from O 0 3.505895920796753e-11
reduced O 0 5.984331780117813e-11
expression O 0 6.671303700439557e-12
or O 0 1.3204805087915772e-12
incorrect O 0 3.093761080652513e-10
subcellular O 0 7.331257734222163e-08
localization O 0 4.3595338183877175e-07
is O 0 3.130735254375239e-11
postulated O 0 1.2824505901676275e-09
to O 0 6.855079004441933e-11
be O 0 5.721976364947423e-11
important O 0 1.4990556018723566e-10
in O 0 1.7726980994225983e-10
non B-Disease 0 0.0001729426730889827
- I-Disease 0 0.29791173338890076
familial I-Disease 1 0.9999774694442749
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9999967813491821

Epigenetic O 0 7.095698674675077e-05
loss O 0 4.02297109758365e-06
, O 0 1.5172178791100777e-10
however O 0 4.920073237713041e-10
, O 0 1.1300292299121217e-12
has O 0 9.916054624279063e-15
not O 0 1.895666851031881e-14
received O 0 1.4868458569385068e-13
general O 0 7.009278574221511e-12
acceptance O 0 2.556929390440388e-10
due O 0 9.89062165501764e-09
to O 0 1.5988439738823246e-10
controversy O 0 2.4285340405327815e-10
regarding O 0 6.060109636329969e-10
the O 0 6.392710805158686e-10
subcellular O 0 1.231403075507842e-06
localization O 0 1.2804704965674318e-05
of O 0 3.691415884077287e-07
BRCA1 O 0 4.051748803135524e-08
proteins O 0 7.857258593757521e-11
, O 0 3.207790153295087e-12
reports O 0 6.162541310583691e-11
of O 0 7.316761085895962e-11
which O 0 4.628228681378965e-13
have O 0 1.5828848648480331e-12
ranged O 0 1.6394566815236544e-09
from O 0 3.8188917306225534e-11
exclusively O 0 4.005541454077388e-10
nuclear O 0 2.022152045810799e-08
, O 0 2.4096108788840276e-11
to O 0 1.3995860026483342e-10
conditionally O 0 1.1395637322664243e-08
nuclear O 0 1.0539767458794813e-07
, O 0 2.09725899841251e-11
to O 0 2.596313719571697e-10
the O 0 4.584180501865376e-08
ER O 1 0.643137514591217
/ O 0 2.9630086828547064e-06
golgi O 0 3.395276144146919e-05
, O 0 1.068667515591315e-10
to O 0 7.007266433767256e-10
cytoplasmic O 0 6.180123790500147e-08
invaginations O 0 1.2224519423398306e-06
into O 0 3.0907194581430986e-09
the O 0 9.414200086155233e-09
nucleus O 0 4.853732207266148e-07
. O 0 1.3632750039960229e-07

In O 0 3.665319781021026e-08
an O 0 2.471393090175411e-10
attempt O 0 5.75541321268247e-08
to O 0 6.213475511884781e-09
resolve O 0 1.747174064803403e-05
this O 0 3.925154090644867e-10
issue O 0 3.9056846645735277e-10
, O 0 1.7992870648270154e-12
we O 0 5.1940608931932974e-12
have O 0 3.227656423382408e-12
comprehensively O 0 1.0175780218446562e-08
characterized O 0 3.0332800160515205e-10
19 O 0 2.1380142101179445e-09
anti O 0 1.4929481650938214e-08
- O 0 7.52371704493271e-07
BRCA1 O 0 6.055932288973054e-08
antibodies O 0 4.6324569180633546e-10
. O 0 2.2749894412754657e-08

These O 0 7.195409157390031e-09
reagents O 0 7.695569514964973e-09
detect O 0 7.997301154638592e-10
a O 0 8.95569382541872e-11
220 O 0 3.884930066533343e-08
- O 0 2.3995207243387995e-07
kD O 0 1.5858639699217747e-06
protein O 0 1.2240434443810955e-08
localized O 0 9.867859418477565e-09
in O 0 4.93020659020349e-11
discrete O 0 8.491680247857403e-09
nuclear O 0 1.0450887089064054e-07
foci O 0 1.2088605672033736e-07
in O 0 2.812231003623822e-10
all O 0 6.294021415165219e-10
epithelial O 0 1.334157104793121e-07
cell O 0 1.5024870947399904e-07
lines O 0 5.113676149193225e-10
, O 0 7.52052825396532e-13
including O 0 4.961691322559469e-13
those O 0 2.679130571905941e-12
derived O 0 7.054322681554481e-10
from O 0 7.351656616805258e-09
breast B-Disease 0 1.0855742402782198e-06
malignancies I-Disease 0 7.728470336587634e-06
. O 0 6.746261647094798e-07

Immunohistochemical O 0 9.109379607252777e-05
staining O 0 1.1094393812527414e-05
of O 0 7.822090992704034e-07
human O 0 1.4511573454001336e-06
breast O 0 0.0029786720406264067
specimens O 0 2.45619311556311e-08
also O 0 7.721173700403483e-11
revealed O 0 4.5252800617845423e-08
BRCA1 O 0 1.254486381441211e-08
nuclear O 0 9.728560002031372e-08
foci O 0 7.373263883891923e-07
in O 0 1.397608073716583e-08
benign O 1 0.9979419112205505
breast O 1 0.9998955726623535
, O 0 3.254502018990024e-07
invasive B-Disease 1 0.9999940395355225
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 3.974074570578523e-05
low B-Disease 1 1.0
- I-Disease 1 0.9999914169311523
grade I-Disease 1 0.9999977350234985
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 7.061886572046205e-05

Conversely O 0 8.595646932008094e-07
, O 0 1.6411961789586371e-09
BRCA1 O 0 1.0838756558939622e-08
expression O 0 1.13275211433006e-09
was O 0 4.95544005829629e-09
reduced O 0 1.158999785033643e-09
or O 0 3.655386410228445e-11
undetectable O 0 8.276255236694396e-10
in O 0 1.5490423613956361e-12
the O 0 1.146422626968624e-11
majority O 0 5.710318936452685e-12
of O 0 3.458153208235615e-10
high O 0 1.4604684572816495e-08
- O 0 2.3493644363270505e-08
grade O 0 7.967327633195964e-07
, O 0 4.721313118238868e-09
ductal B-Disease 1 0.9998612403869629
carcinomas I-Disease 1 1.0
, O 0 5.412802983606468e-10
suggesting O 0 1.8751991071042085e-09
that O 0 6.465716417131118e-12
absence O 0 1.4065754783132434e-07
of O 0 2.1828065655427054e-05
BRCA1 O 0 1.919919895954081e-06
may O 0 4.68203253944921e-10
contribute O 0 2.140915444925895e-09
to O 0 2.2323683179781284e-10
the O 0 1.4823295924060176e-09
pathogenesis O 0 1.5039026948215906e-05
of O 0 9.93584947650561e-09
a O 0 5.173340575370666e-11
significant O 0 2.7199378860309764e-10
percentage O 0 3.4537979143323128e-09
of O 0 1.1377214725882823e-09
sporadic B-Disease 0 1.4558215298166033e-05
breast I-Disease 0 9.630808926885948e-05
cancers I-Disease 0 0.0009987900266423821
. O 0 1.3112800445469475e-07
. O 0 8.462190521640878e-07

